data_1ry4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ry4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.784 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.21 -45.37 7.64 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 122.85 2.367 . . . . 0.0 112.405 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -119.9 103.17 9.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.254 0.55 . . . . 0.0 110.678 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.0 mt -110.45 142.92 21.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.5 t -134.52 93.36 3.04 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.91 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.1 tt -115.06 92.26 30.36 Favored Pre-proline 0 N--CA 1.415 -2.193 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.06 122.63 3.83 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.152 1.901 . . . . 0.0 111.446 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -94.59 114.57 26.55 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -83.23 119.93 25.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.297 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -179.17 92.24 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.595 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 . . . . . 0 C--N 1.301 -1.525 0 CA-C-O 122.535 1.16 . . . . 0.0 108.107 178.536 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.82 150.37 78.67 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 122.548 2.166 . . . . 0.0 111.69 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 77.3 4.33 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.2 p -74.39 101.76 4.2 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.452 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -76.4 95.65 3.86 Favored 'General case' 0 CA--C 1.466 -2.277 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.456 ' CB ' HD13 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -96.08 117.3 30.42 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.324 -167.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -87.25 99.49 12.0 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.724 0.773 . . . . 0.0 109.716 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 247' ' ' ILE . 62.5 t -88.94 105.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -105.69 139.42 40.3 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.322 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.19 121.34 44.96 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.82 100.21 10.83 Favored 'General case' 0 N--CA 1.403 -2.783 0 CA-C-O 121.752 0.787 . . . . 0.0 109.729 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER -90.64 120.58 31.83 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.282 176.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -152.31 89.32 1.42 Allowed 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.113 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.07 -10.37 41.58 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.36 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 32.9 t -141.61 135.04 29.6 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.498 ' OD2' ' HG3' ' A' ' 165' ' ' LYS . 13.4 t70 -130.42 87.04 2.45 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -119.01 147.51 42.71 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.563 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 112.4 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 107.886 -1.621 . . . . 0.0 107.886 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 172' ' ' LEU . 4.9 tt -62.73 -29.2 70.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.357 0.599 . . . . 0.0 109.607 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.76 -4.91 1.71 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.337 -1.411 . . . . 0.0 113.468 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -103.06 147.56 26.81 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -137.93 158.51 44.19 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.404 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.1 pt -117.57 149.17 19.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.476 0.655 . . . . 0.0 112.377 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 60.1 ttt180 -125.45 152.33 45.03 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.124 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.415 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 8.7 t70 -115.59 123.23 47.92 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.39 179.68 29.55 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.288 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.9 p -93.41 120.61 33.9 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.163 0.506 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.8 t -101.7 124.45 47.37 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.46 123.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 121.381 0.61 . . . . 0.0 110.445 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -124.76 161.57 26.13 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.272 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.16 107.41 22.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 36.2 p -108.88 178.87 4.34 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.78 -16.88 64.33 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.948 0.404 . . . . 0.0 110.818 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.3 m -87.88 -4.7 58.83 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.9 -151.7 18.17 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.592 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.577 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.5 pt? -84.28 108.53 17.19 Favored 'General case' 0 N--CA 1.394 -3.253 0 CA-C-O 122.016 0.912 . . . . 0.0 109.796 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.4 158.85 23.73 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.496 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.46 131.87 54.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -116.49 151.1 46.61 Favored Pre-proline 0 C--N 1.273 -2.731 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.11 125.16 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.893 1.728 . . . . 0.0 109.902 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.74 151.52 20.21 Favored Glycine 0 C--N 1.278 -2.64 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 122.47 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.08 -168.44 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.5 136.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 69.4 p -95.42 -46.94 6.49 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.453 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -146.58 146.88 30.6 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 56.4 tp -127.78 125.44 39.88 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.3 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.17 130.59 26.94 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.416 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 50.6 Cg_exo -57.52 126.28 21.41 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.148 1.899 . . . . 0.0 110.24 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.66 -14.9 41.91 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.64 146.02 28.16 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.44 ' H ' HD21 ' A' ' 172' ' ' LEU . 34.6 tp -53.96 -34.42 59.66 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 123.927 0.891 . . . . 0.0 113.271 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.457 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -69.37 -35.26 75.65 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.8 tp10 -77.04 -35.52 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 36.4 m -61.73 -33.11 73.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.486 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.3 m -67.12 -39.89 86.73 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.46 -32.27 2.61 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.941 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.89 -19.25 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 123.74 0.816 . . . . 0.0 110.189 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.456 HD13 ' CB ' ' A' ' 159' ' ' ARG . 71.1 mt -109.42 141.84 41.24 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.476 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.3 163.06 27.63 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 124.622 1.169 . . . . 0.0 110.128 -177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.86 -26.74 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.816 0.846 . . . . 0.0 112.579 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.12 -23.55 64.0 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.504 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.1 m-20 -63.66 159.13 19.71 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.52 148.46 24.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.919 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -101.56 139.02 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.829 0.852 . . . . 0.0 109.477 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.7 mp -116.12 -50.64 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.401 ' HB2' ' HG1' ' A' ' 248' ' ' THR . 47.6 mt-10 -136.22 152.44 50.76 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' A' ' 245' ' ' LEU . 50.4 t -119.84 106.82 19.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.811 -1.54 . . . . 0.0 107.975 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 70.25 -69.01 0.18 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.475 1.11 . . . . 0.0 110.49 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -166.0 21.19 0.11 Allowed Glycine 0 C--N 1.291 -1.926 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.582 HG23 ' SD ' ' A' ' 237' ' ' MET . 13.2 mt -113.19 124.91 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.8 143.48 41.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 118.621 0.646 . . . . 0.0 109.664 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.9 m -96.15 -5.19 10.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.682 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.04 123.05 19.98 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.172 0.511 . . . . 0.0 111.684 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.7 7.4 75.13 Favored Glycine 0 CA--C 1.499 -0.907 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.201 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' OE1' ' A' ' 233' ' ' GLN . 23.3 ttmm -107.47 156.29 19.13 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.439 ' O ' HG22 ' A' ' 234' ' ' VAL . 87.1 m -77.14 157.47 30.97 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 50.0 tp -62.45 -44.3 96.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.42 -35.4 70.02 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.035 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 237' ' ' MET . 79.2 mt-30 -73.34 -42.47 62.23 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.946 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 230' ' ' THR . 61.1 t -64.75 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.596 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.0 p -65.87 -41.63 91.36 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.615 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.39 -44.88 95.41 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.1 0.476 . . . . 0.0 110.463 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 33.8 mtm -60.14 -42.9 95.83 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.8 -17.92 62.13 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.395 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 235' ' ' THR . 85.0 t -85.39 -36.73 11.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.24 -25.22 67.7 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.534 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -129.92 28.76 5.04 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.687 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.9 t -59.16 -35.57 73.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.459 1.103 . . . . 0.0 111.953 -175.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.454 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 22.8 t -70.36 -20.5 62.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.216 0.532 . . . . 0.0 110.759 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -130.15 37.12 3.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.401 ' CD2' HG13 ' A' ' 221' ' ' VAL . 3.2 tm? -85.02 123.01 30.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.829 0.823 . . . . 0.0 112.219 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 61.6 mt -129.02 119.61 49.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.317 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 161' ' ' VAL . 10.8 tt -109.66 131.99 59.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.584 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.401 ' HG1' ' HB2' ' A' ' 220' ' ' GLU . 33.4 m -95.46 120.15 35.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.093 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.53 149.97 26.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.582 0.551 . . . . 0.0 110.208 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.405 ' CB ' HD13 ' A' ' 219' ' ' ILE . 0.5 OUTLIER -134.77 126.06 17.73 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.504 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 77.7 Cg_exo -52.56 132.06 43.76 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.659 2.906 . . . . 0.0 114.494 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -101.78 8.15 41.53 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 114.152 -1.386 . . . . 0.0 108.122 179.546 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.92 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.0 108.39 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.635 1.557 . . . . 0.0 108.736 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 t -92.85 85.82 5.3 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.315 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.59 119.6 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.1 m -145.24 91.31 2.12 Favored 'General case' 1 C--N 1.235 -4.401 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -116.63 108.15 45.47 Favored Pre-proline 0 N--CA 1.424 -1.734 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.178 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.16 123.92 12.63 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 N-CA-C 106.504 -2.152 . . . . 0.0 106.504 172.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.38 112.14 20.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.388 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 142' ' ' PHE . 11.6 m-20 -107.22 118.85 37.81 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 141' ' ' ASP . 48.6 t80 166.66 93.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 O-C-N 125.029 1.455 . . . . 0.0 107.217 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 122.178 0.989 . . . . 0.0 109.357 -179.111 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.417 -2.097 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.49 146.66 13.77 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.338 2.025 . . . . 0.0 113.381 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.452 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 2.4 mp0 -83.0 72.32 10.08 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.717 177.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -106.07 138.53 42.09 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -126.08 135.91 52.3 Favored 'General case' 0 CA--C 1.469 -2.136 0 CA-C-O 121.147 0.498 . . . . 0.0 112.082 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -113.65 115.76 28.4 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.416 ' O ' ' HD2' ' A' ' 160' ' ' ARG 0.334 4.0 ppt_? -97.97 103.81 15.78 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 122.162 0.982 . . . . 0.0 110.659 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.31 125.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.916 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -95.55 126.68 41.0 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.305 0.574 . . . . 0.0 109.862 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.01 121.43 38.89 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.512 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.28 105.16 15.75 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.322 1.058 . . . . 0.0 110.639 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -74.98 136.28 41.31 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.441 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.449 ' HB2' ' H ' ' A' ' 170' ' ' LYS . 88.3 m-70 -139.53 -75.63 0.35 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.556 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.2 -10.96 58.46 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.251 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.7 m -134.01 25.5 3.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 122.123 0.963 . . . . 0.0 108.476 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -165.14 -70.48 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.161 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 166' ' ' HIS . 12.7 mptt -123.79 114.27 28.37 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -84.31 -40.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.037 1.825 . . . . 0.0 110.234 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.95 159.16 36.21 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 125.618 1.567 . . . . 0.0 107.153 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -122.73 17.81 8.18 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.584 -1.293 . . . . 0.0 112.449 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -165.68 143.67 5.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.414 ' CE2' HG23 ' A' ' 201' ' ' VAL . 76.1 m-85 -108.99 136.03 49.2 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.973 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.409 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -134.44 140.31 46.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -137.82 159.9 40.74 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.29 145.08 44.26 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.947 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.1 109.72 0.43 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 m -93.3 143.76 25.96 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 51.0 m -126.24 133.79 51.38 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.4 p -108.65 125.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.484 ' HB2' ' OE1' ' A' ' 190' ' ' GLU . 72.7 mtp180 -124.72 162.21 24.71 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.428 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.98 113.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.893 0.854 . . . . 0.0 108.856 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 57.0 p -113.8 178.24 4.35 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.498 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.48 -10.88 59.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 109.916 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.2 m -94.55 -4.19 48.39 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.219 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.08 -159.6 14.27 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.527 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -83.98 129.13 34.93 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 117.593 0.697 . . . . 0.0 110.272 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.484 ' OE1' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -137.78 161.82 35.57 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.761 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 181' ' ' SER . 98.3 mttt -121.64 150.15 42.15 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -131.13 139.0 34.17 Favored Pre-proline 0 N--CA 1.414 -2.23 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.7 133.74 8.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.546 2.164 . . . . 0.0 110.854 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.23 153.7 25.5 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.869 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.57 123.1 63.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -127.56 163.97 23.01 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.6 114.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -84.52 -49.59 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.064 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.11 155.41 50.22 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.743 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -113.57 140.62 48.01 Favored 'General case' 0 N--CA 1.395 -3.2 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 178.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.414 HG23 ' CE2' ' A' ' 175' ' ' TYR . 40.1 t -96.54 129.69 32.5 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.15 126.05 17.8 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 121.939 1.76 . . . . 0.0 109.236 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.07 -6.56 83.1 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.39 156.3 53.29 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.89 -25.88 65.72 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.46 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.496 ' N ' HD22 ' A' ' 200' ' ' LEU . 42.8 tt0 -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.0 m -54.81 -31.27 58.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.288 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.4 p -60.75 -43.12 98.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.96 29.28 74.39 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.9 tp -145.43 -46.47 0.22 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.011 -1.095 . . . . 0.0 110.458 -172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 71.9 mt -115.4 110.43 19.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.445 0.641 . . . . 0.0 111.3 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.69 134.01 44.27 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.613 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 71.2 t 43.22 -72.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -23.6 65.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.613 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -67.41 153.2 44.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.363 -173.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -101.29 156.44 17.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.63 143.3 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.491 0.717 . . . . 0.0 109.964 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.8 mp -121.69 -45.52 2.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 111.968 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.452 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 35.9 mt-10 -135.58 150.85 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.768 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.4 t -121.87 101.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 123.804 0.69 . . . . 0.0 109.338 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.502 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 39.2 t-20 69.59 -72.09 0.11 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 0.0 111.269 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.54 12.18 0.4 Allowed Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.592 HG23 ' SD ' ' A' ' 237' ' ' MET . 19.9 mt -105.21 133.06 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.92 146.3 28.12 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.432 ' HA ' ' CG ' ' A' ' 229' ' ' LYS . 12.7 m -91.63 -4.94 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.945 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.76 112.34 7.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.575 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 4.29 50.76 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.5 mmpt? -96.79 163.04 13.16 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -104.57 168.7 8.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -57.59 -47.59 81.71 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -68.31 -40.99 81.53 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.237 0.541 . . . . 0.0 110.529 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.672 ' O ' ' HG3' ' A' ' 237' ' ' MET . 35.5 tt0 -59.09 -43.59 91.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.309 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.49 -46.86 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.483 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.0 p -65.97 -31.01 71.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.888 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.65 -42.79 77.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.18 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.672 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 24.6 mtm -59.3 -46.35 88.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.68 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.3 ptp -67.15 -23.15 65.76 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.967 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 235' ' ' THR . 58.8 t -90.14 -27.05 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.557 0.694 . . . . 0.0 109.161 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.02 71.95 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.449 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.58 -70.17 0.72 Allowed 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.28 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.2 t 60.16 -41.28 0.09 Allowed 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 42.5 m -68.6 -73.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.885 0.766 . . . . 0.0 111.588 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.52 81.17 2.92 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -95.87 129.1 43.21 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.207 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 3.3 mp -127.46 134.5 65.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 220' ' ' GLU . 7.2 tp -124.18 131.17 73.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.59 . . . . 0.0 110.001 178.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 28.5 m -98.03 120.22 38.04 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.052 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.06 149.37 24.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.278 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 80.7 tttt -127.72 141.07 39.88 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 124.001 0.92 . . . . 0.0 109.258 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.613 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.5 Cg_endo -64.39 130.09 25.84 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 121.626 1.551 . . . . 0.0 111.039 175.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -95.48 -35.15 11.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.928 0.871 . . . . 0.0 109.07 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 45.1 m-80 . . . . . 0 N--CA 1.495 1.796 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.932 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.579 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.28 133.2 31.93 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.736 1.624 . . . . 0.0 110.093 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.9 t -96.32 96.31 8.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.404 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.57 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.3 t -161.95 93.21 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.23 114.18 61.44 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.32 123.0 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.313 2.008 . . . . 0.0 112.286 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -98.44 132.26 44.03 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.83 157.17 17.66 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -96.27 138.91 33.18 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 122.106 0.955 . . . . 0.0 109.005 -177.108 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 253' ' ' ASN . 41.3 t . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 154' ' ' VAL . 35.1 Cg_endo -65.04 151.79 84.55 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.391 2.061 . . . . 0.0 109.266 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 78.64 0.22 Allowed 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.8 p -81.84 96.96 7.79 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -66.04 116.39 7.1 Favored 'General case' 0 CA--C 1.457 -2.622 0 CA-C-O 121.861 0.838 . . . . 0.0 112.42 -175.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -110.12 116.7 32.01 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.67 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 30.7 ptt180 -99.14 113.62 25.95 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.92 132.32 41.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 19.6 ptt180 -112.13 148.79 33.24 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.001 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 2.5 tm? -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 171.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.46 HD11 ' H ' ' A' ' 164' ' ' LEU 0.273 0.0 OUTLIER -108.04 101.33 10.58 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-O 121.956 0.884 . . . . 0.0 112.72 179.39 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -71.91 131.83 43.52 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.817 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.26 79.07 0.52 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.801 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.95 17.62 69.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -102.94 113.89 27.72 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 114.616 -0.792 . . . . 0.0 111.049 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.14 4.24 7.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.769 1.271 . . . . 0.0 107.687 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -74.2 169.19 20.32 Favored Pre-proline 0 C--O 1.246 0.869 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -56.07 146.17 71.32 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.257 1.972 . . . . 0.0 110.523 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.72 -47.23 80.44 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.442 0.639 . . . . 0.0 111.853 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 115.83 -18.78 14.47 Favored Glycine 0 CA--C 1.487 -1.692 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -132.67 133.36 43.47 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 114.275 -0.962 . . . . 0.0 108.857 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -138.04 148.08 44.74 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 123.524 0.515 . . . . 0.0 111.926 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.6 pt -124.71 143.14 39.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.992 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -140.24 159.39 42.28 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.841 0.353 . . . . 0.0 111.43 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.65 135.78 35.53 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.932 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -142.17 175.01 22.98 Favored Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.5 m -95.04 133.42 38.84 Favored 'General case' 0 C--N 1.27 -2.881 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.725 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.3 t -103.88 119.12 38.25 Favored 'General case' 0 C--N 1.252 -3.668 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.41 123.16 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.544 0.688 . . . . 0.0 109.168 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.89 51.65 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.529 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.82 107.41 21.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.28 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.3 p -111.87 179.11 4.1 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.753 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.12 -15.21 62.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.2 m -87.62 -5.32 58.78 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.95 -157.36 15.04 Favored Glycine 0 C--O 1.214 -1.119 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 189' ' ' LEU . 4.0 pp -88.19 129.97 35.19 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 118.346 1.073 . . . . 0.0 109.203 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.69 147.78 44.82 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.507 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -121.34 130.12 53.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -142.21 154.83 64.83 Favored Pre-proline 0 C--N 1.279 -2.486 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.69 121.56 6.39 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 109.23 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.41 139.35 10.71 Favored Glycine 0 C--N 1.276 -2.791 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.8 pt -100.6 126.58 54.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-O 121.532 0.682 . . . . 0.0 112.164 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -120.19 174.47 6.48 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.952 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.9 mt -68.33 135.7 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.3 t -121.23 -59.29 1.73 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.593 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -122.86 147.01 47.05 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.442 -173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 206' ' ' ALA . 12.9 mt -127.36 134.11 49.98 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.464 174.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.7 129.38 27.71 Favored Pre-proline 0 C--N 1.275 -2.632 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.66 126.45 19.73 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.334 2.023 . . . . 0.0 110.682 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.04 72.5 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.214 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 158.35 47.48 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -55.95 -39.32 71.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.474 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -74.01 -26.98 60.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.171 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.0 -45.46 57.79 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 m -55.36 -32.22 62.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.263 1.025 . . . . 0.0 111.846 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.527 HG21 ' HG ' ' A' ' 211' ' ' LEU . 27.6 m -62.58 -43.49 98.69 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.033 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 77.59 -27.64 1.85 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.387 0.915 . . . . 0.0 115.387 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 209' ' ' THR . 4.2 pp -97.56 7.98 45.47 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 94.9 mt -116.0 145.05 43.28 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.938 0.399 . . . . 0.0 110.045 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.47 161.89 26.1 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 120.889 0.376 . . . . 0.0 111.75 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.61 -19.41 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-O 121.547 0.689 . . . . 0.0 111.114 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.77 -25.07 58.82 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.528 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.598 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 51.8 m-20 -70.98 156.67 39.35 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.245 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.47 165.74 18.54 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.628 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.6 m -82.77 142.88 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.234 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.511 HG13 ' HG3' ' A' ' 250' ' ' LYS . 42.8 mm -116.06 -47.43 4.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.069 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.479 ' H ' ' HB ' ' A' ' 248' ' ' THR . 39.1 mt-10 -145.99 159.49 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.42 HG23 ' CG1' ' A' ' 226' ' ' VAL . 77.2 t -123.38 97.26 4.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 169.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.3 t30 68.3 -70.17 0.13 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.36 17.56 0.68 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.419 HG23 ' SD ' ' A' ' 237' ' ' MET . 9.0 mt -120.3 142.33 36.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -86.12 153.83 21.8 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.991 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' A' ' 221' ' ' VAL . 16.3 m -118.03 -3.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.94 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -86.27 121.77 29.32 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.81 -10.22 72.52 Favored Glycine 0 C--N 1.318 -0.441 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -91.95 153.79 19.25 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 124.48 1.112 . . . . 0.0 109.153 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.4 m -74.92 156.28 36.53 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.65 -36.82 85.49 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.686 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.37 -36.85 76.53 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.75 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.645 ' O ' ' HG3' ' A' ' 237' ' ' MET . 5.8 tp-100 -72.42 -48.52 40.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.422 ' HA ' ' HE1' ' A' ' 237' ' ' MET . 95.6 t -56.74 -48.97 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.932 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.615 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.5 p -65.0 -34.0 77.39 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.32 -38.58 81.69 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.99 0.424 . . . . 0.0 110.276 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.645 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 20.2 mtm -57.8 -45.6 85.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.84 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.28 -15.01 60.54 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.465 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 235' ' ' THR . 65.9 t -78.82 -38.72 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.251 0.548 . . . . 0.0 110.028 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.27 -29.06 68.57 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.281 0.563 . . . . 0.0 110.806 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -110.79 32.13 5.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.8 p -60.02 -27.52 66.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.2 p -46.9 -63.55 1.0 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.137 0.575 . . . . 0.0 111.564 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 40.1 m-80 -129.96 87.68 2.56 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.9 pp -90.33 131.99 35.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.453 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.3 mp -106.7 125.29 62.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.094 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.1 tt -111.37 128.27 67.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 110.649 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.1 m -106.44 129.44 54.42 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.315 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.66 165.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.511 ' HG3' HG13 ' A' ' 219' ' ' ILE . 43.9 mtpt -126.42 129.02 24.25 Favored Pre-proline 0 CA--C 1.482 -1.637 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.55 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.598 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 50.0 Cg_exo -58.62 127.23 23.79 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.811 1.674 . . . . 0.0 110.164 172.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.12 9.69 21.83 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.125 0.964 . . . . 0.0 109.712 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.439 ' HB2' ' HB ' ' A' ' 154' ' ' VAL . 24.8 m-80 . . . . . 0 C--N 1.306 -1.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.29 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 147.82 91.87 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.26 1.973 . . . . 0.0 111.263 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.3 m -79.7 85.85 5.36 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.47 0.652 . . . . 0.0 110.614 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.9 mm -99.81 144.18 12.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m 58.26 73.93 0.45 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.141 0.977 . . . . 0.0 111.148 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.79 119.43 70.56 Favored Pre-proline 0 N--CA 1.421 -1.896 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.815 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.17 121.82 10.22 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.464 2.11 . . . . 0.0 112.114 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -101.94 161.19 13.86 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.759 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -83.52 149.44 26.6 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.704 -0.398 . . . . 0.0 109.944 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -103.45 -37.72 7.48 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? . . . . . 0 N--CA 1.429 -1.516 0 CA-C-O 121.118 0.485 . . . . 0.0 110.647 -176.192 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.75 131.2 1.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.049 1.833 . . . . 0.0 112.283 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.505 ' HA ' ' HG2' ' A' ' 251' ' ' PRO . 42.2 mt-10 -84.27 85.57 7.35 Favored 'General case' 0 N--CA 1.403 -2.811 0 CA-C-O 121.387 0.613 . . . . 0.0 112.109 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -91.0 100.45 13.31 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -88.61 105.01 17.38 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -126.36 116.11 20.7 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.25 129.58 34.6 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.997 0.427 . . . . 0.0 110.074 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.3 t -89.71 115.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -106.28 137.61 43.93 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 111.836 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.72 141.49 48.56 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.356 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.43 115.3 23.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 121.822 0.82 . . . . 0.0 110.801 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.56 130.08 38.92 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.345 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 169' ' ' ASP . 0.5 OUTLIER -164.99 76.33 0.28 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.99 -178.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.37 17.35 76.32 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.009 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.0 m 67.58 97.0 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.587 1.155 . . . . 0.0 111.154 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.455 ' HB2' ' CD2' ' A' ' 166' ' ' HIS . 19.2 t70 -86.56 -49.56 7.46 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.926 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -145.17 150.35 44.86 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.76 -61.93 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 121.312 1.341 . . . . 0.0 109.756 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.04 -65.56 0.39 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.511 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.445 ' HA3' ' H ' ' A' ' 205' ' ' LEU . . . 92.65 11.48 59.22 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.46 156.92 26.74 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -137.27 136.1 37.75 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 123.339 0.399 . . . . 0.0 110.326 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 176' ' ' ILE . 2.3 pp -128.81 141.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.307 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -141.31 158.08 44.36 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.498 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -96.95 130.41 44.26 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -122.2 158.89 16.89 Favored Glycine 0 CA--C 1.47 -2.751 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 m -92.91 131.45 37.91 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.72 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -111.43 140.2 46.22 Favored 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.463 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.4 123.15 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.86 152.52 21.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.0 104.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.1 p -117.74 179.03 4.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.97 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.39 -15.89 63.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 109.656 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.6 m -87.25 -4.13 59.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.208 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.54 -142.3 15.52 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.06 123.28 33.79 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -117.2 146.18 43.4 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.58 133.52 55.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.065 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -146.93 147.61 30.05 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.514 ' O ' ' HA2' ' A' ' 228' ' ' GLY . 13.9 Cg_exo -69.12 133.29 26.37 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.414 2.076 . . . . 0.0 111.512 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -129.82 127.19 5.32 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.446 HG21 ' HB ' ' A' ' 218' ' ' VAL . 10.5 tt -91.19 124.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-O 121.25 0.548 . . . . 0.0 110.881 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.58 173.11 10.56 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.47 131.99 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 37.3 t -90.69 -54.31 4.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.223 0.535 . . . . 0.0 110.83 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -155.65 155.66 33.61 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 53.5 tp -127.33 139.63 52.75 Favored 'General case' 0 N--CA 1.403 -2.819 0 O-C-N 123.317 0.386 . . . . 0.0 110.228 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.37 128.62 32.62 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.481 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 29.6 Cg_exo -63.36 126.27 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 108.934 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.6 73.45 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.51 158.42 41.43 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.445 ' H ' ' HA3' ' A' ' 173' ' ' GLY . 27.4 tp -57.95 -38.8 76.66 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.71 -29.27 63.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.512 0.672 . . . . 0.0 109.963 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -76.72 -34.07 58.14 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -58.84 -33.54 70.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.9 m -77.16 -45.59 26.24 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.27 -6.0 0.87 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.02 -14.95 58.88 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.218 0.607 . . . . 0.0 111.287 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.418 ' CD1' HG23 ' A' ' 249' ' ' VAL . 94.1 mt -119.22 146.89 44.83 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.146 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.2 161.28 13.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.961 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 51.7 t -67.36 -18.65 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.669 0.747 . . . . 0.0 110.239 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.99 -24.58 59.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.144 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.596 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 73.7 m-20 -66.06 157.2 31.64 Favored 'General case' 0 C--O 1.248 1.026 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -172.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.81 150.4 22.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.576 0.703 . . . . 0.0 112.425 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.446 ' HB ' HG21 ' A' ' 195' ' ' ILE . 57.1 t -94.32 136.94 24.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.465 HG21 ' HG3' ' A' ' 220' ' ' GLU . 31.4 mm -115.6 -53.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.543 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.484 ' H ' ' HB ' ' A' ' 248' ' ' THR . 41.5 mt-10 -143.55 159.79 41.8 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.42 0.629 . . . . 0.0 111.594 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.498 ' HB ' ' HE3' ' A' ' 237' ' ' MET . 93.6 t -117.4 104.8 16.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 169.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.0 t30 65.97 -74.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.801 1.24 . . . . 0.0 110.612 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -147.23 3.4 0.89 Allowed Glycine 0 C--N 1.306 -1.113 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.3 mt -100.38 117.94 46.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.51 131.75 42.11 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.386 0.612 . . . . 0.0 109.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.3 m -117.17 7.19 7.09 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.204 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.38 3.39 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.706 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 193' ' ' PRO . . . 102.56 -3.09 49.7 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.292 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -87.54 170.04 11.67 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.15 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.486 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 20.9 m -101.39 159.38 15.32 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.476 ' HA ' HG12 ' A' ' 234' ' ' VAL . 2.4 pt? -52.9 -45.26 67.48 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.09 -46.48 88.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.584 0.707 . . . . 0.0 110.074 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.486 ' OE1' ' HB ' ' A' ' 230' ' ' THR . 2.0 mp0 -66.1 -37.94 86.99 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.34 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 231' ' ' LEU . 9.8 p -74.8 -45.08 44.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.672 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.472 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 14.6 t -68.92 -38.62 79.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.88 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.55 -37.46 87.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.856 0.836 . . . . 0.0 108.8 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.498 ' HE3' ' HB ' ' A' ' 221' ' ' VAL . 10.9 tmm? -69.16 -49.26 58.38 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.418 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.472 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 18.4 ptp -67.29 -22.58 65.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.62 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 235' ' ' THR . 89.7 t -83.12 -33.0 9.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.731 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.11 -35.05 70.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.31 -79.21 0.18 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.731 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.5 t 59.59 -37.31 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.77 1.628 . . . . 0.0 114.871 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.4 p -55.75 -68.52 0.19 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.482 0.713 . . . . 0.0 110.271 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -100.55 80.5 2.22 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.54 103.89 16.05 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.05 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.4 135.77 62.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.441 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.0 tp -118.49 134.18 62.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.316 0.579 . . . . 0.0 110.245 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 25.2 m -103.39 119.62 39.24 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.553 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 212' ' ' LEU . 4.3 m -127.73 137.07 58.7 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 96.6 mttt -134.8 143.57 46.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.168 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.596 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 93.2 Cg_exo -45.79 132.3 13.57 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.362 2.708 . . . . 0.0 112.05 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.04 -16.88 64.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 . . . . . 0 N--CA 1.497 1.891 0 C-N-CA 125.627 1.571 . . . . 0.0 114.33 -178.586 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.02 118.6 2.45 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.692 2.928 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.2 m -83.52 89.73 7.12 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.853 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -63.66 131.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.678 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m -151.73 102.45 2.85 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.214 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.4 tt -87.89 133.66 37.03 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.58 127.59 22.18 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.008 1.806 . . . . 0.0 110.268 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -98.48 157.35 16.27 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.68 157.18 22.29 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.279 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -134.61 139.58 45.43 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 . . . . . 0 N--CA 1.466 0.358 0 C-N-CA 123.98 0.912 . . . . 0.0 110.885 -178.383 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 N--CA 1.426 -1.649 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.57 136.42 30.8 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.967 1.778 . . . . 0.0 110.726 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.05 76.15 2.24 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-O 121.608 0.718 . . . . 0.0 111.694 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 41.1 m -83.72 103.85 13.35 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 173.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.408 ' CE1' ' HG3' ' A' ' 250' ' ' LYS . 13.0 m170 -69.06 122.53 18.91 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 121.901 0.858 . . . . 0.0 110.984 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.56 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 4.1 mmp_? -105.27 116.62 32.25 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.786 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -107.88 107.11 17.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 247' ' ' ILE . 38.5 t -89.09 125.65 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.568 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.82 138.41 32.65 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.229 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -123.33 129.25 51.07 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.661 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.04 120.02 39.19 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.48 123.89 20.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 122.672 1.225 . . . . 0.0 113.259 -173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -123.84 29.95 6.34 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 113.013 -1.903 . . . . 0.0 108.677 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.26 -10.34 56.58 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.198 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.2 m 60.95 21.15 11.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.42 0.688 . . . . 0.0 111.705 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.96 -55.34 7.62 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.999 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 171' ' ' PRO . 83.8 tttt -99.4 128.22 32.27 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 21.4 Cg_exo -67.96 156.83 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.062 1.841 . . . . 0.0 110.342 172.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.97 -8.03 54.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.509 0.671 . . . . 0.0 111.137 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.23 0.52 7.47 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.024 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -103.95 144.62 31.29 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.24 136.86 38.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.02 135.93 58.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 79.9 ttt180 -142.07 150.43 41.2 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.151 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.471 ' CB ' ' HB3' ' A' ' 231' ' ' LEU . 20.4 t70 -92.59 134.23 35.2 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.411 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -135.28 166.79 24.36 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 191' ' ' LYS . 1.6 m -92.71 131.36 37.85 Favored 'General case' 0 C--N 1.27 -2.86 0 C-N-CA 117.394 -1.723 . . . . 0.0 107.972 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 25.3 m -100.8 134.8 43.23 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.43 128.62 75.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.979 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.2 mtt180 -117.47 154.37 31.54 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.9 109.94 30.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.574 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 74.7 p -107.03 177.89 4.72 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.12 -20.95 62.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.225 0.536 . . . . 0.0 109.874 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.6 p -86.51 -3.8 59.07 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.434 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.95 -171.55 14.54 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.737 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.479 ' CD2' ' H ' ' A' ' 189' ' ' LEU . 1.6 pt? -84.95 133.75 34.27 Favored 'General case' 0 N--CA 1.4 -2.951 0 O-C-N 122.306 -0.526 . . . . 0.0 110.298 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.47 156.72 46.24 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.373 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.462 ' HB3' HG21 ' A' ' 180' ' ' THR . 96.9 mttt -121.36 150.33 41.63 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.84 161.48 62.51 Favored Pre-proline 0 N--CA 1.426 -1.654 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.627 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.55 142.68 85.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.94 89.96 0.15 Allowed Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.586 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 218' ' ' VAL . 12.1 tt -95.97 117.66 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-O 121.77 0.795 . . . . 0.0 109.998 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -132.46 179.16 6.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.283 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.416 HD13 ' HB2' ' A' ' 216' ' ' ASP . 44.9 mt -68.7 122.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 26.1 p -96.33 -32.89 12.16 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 120.905 0.383 . . . . 0.0 111.887 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -153.34 148.79 27.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.47 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.9 tt -124.54 136.73 54.22 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 71.3 t -99.57 124.42 44.44 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.12 127.23 24.14 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.477 2.118 . . . . 0.0 111.353 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.42 63.15 Favored Glycine 0 C--N 1.309 -0.953 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.39 161.4 44.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.736 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.35 -39.68 64.34 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.8 0.84 . . . . 0.0 110.862 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 212' ' ' LEU . . . -55.47 -42.14 73.91 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.3 -36.12 54.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.1 m -54.45 -34.74 62.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.435 0.694 . . . . 0.0 112.816 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 73.1 p -60.17 -41.26 92.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 111.557 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.83 3.16 90.68 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.452 HD13 ' HG ' ' A' ' 212' ' ' LEU . 2.7 pp -127.96 -2.32 5.86 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.517 ' HA ' ' OD2' ' A' ' 216' ' ' ASP . 97.2 mt -108.55 130.58 55.29 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.237 0.541 . . . . 0.0 110.305 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.95 164.36 25.51 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 125.318 1.447 . . . . 0.0 109.663 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.0 p -52.49 -20.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.733 0.777 . . . . 0.0 112.435 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -68.79 -25.29 64.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.929 -0.482 . . . . 0.0 111.898 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.8 m-20 -61.3 159.34 12.53 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -114.96 144.87 42.9 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.15 -1.841 . . . . 0.0 110.448 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 195' ' ' ILE . 7.7 p -96.61 140.4 17.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.053 0.454 . . . . 0.0 109.819 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.409 HG21 ' HG3' ' A' ' 220' ' ' GLU . 40.2 mm -110.44 -52.92 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.189 0.519 . . . . 0.0 111.803 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.531 ' H ' ' HB ' ' A' ' 248' ' ' THR . 45.1 mt-10 -134.73 142.74 46.85 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.57 0.7 . . . . 0.0 112.646 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.6 t -115.62 113.5 43.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.213 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 70.6 -66.19 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.221 1.008 . . . . 0.0 110.327 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -169.34 12.91 0.05 OUTLIER Glycine 0 C--N 1.292 -1.891 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.529 HG23 ' SD ' ' A' ' 237' ' ' MET . 28.9 mt -105.37 125.49 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -176.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -77.48 141.64 39.57 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.453 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 33.6 m -100.91 14.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.08 104.01 2.46 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.276 0.56 . . . . 0.0 111.02 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.78 12.32 55.71 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.231 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 6.0 mmpt? -91.8 152.36 20.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 234' ' ' VAL . 38.7 p -86.94 159.46 19.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.471 ' HB3' ' CB ' ' A' ' 178' ' ' ASP . 1.9 pt? -60.26 -38.07 82.38 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.596 0.236 . . . . 0.0 111.288 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.87 -46.5 87.66 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.854 0.861 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.572 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.6 tp-100 -63.48 -51.05 67.23 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.144 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 230' ' ' THR . 75.0 t -56.93 -49.03 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 239' ' ' VAL . 9.9 t -66.86 -38.47 86.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.801 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.92 -46.88 88.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.159 0.504 . . . . 0.0 109.969 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.572 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 40.7 mtm -62.3 -42.94 99.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.066 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 13.0 ptp -71.1 -18.44 62.53 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.121 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 235' ' ' THR . 84.8 t -89.12 -33.57 6.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.772 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.22 79.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.44 0.638 . . . . 0.0 109.392 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -105.52 23.27 14.08 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.233 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 239' ' ' VAL . 55.4 p -60.63 -26.44 67.03 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.813 0.445 . . . . 0.0 111.66 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m -51.15 -51.26 55.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -130.15 89.42 2.79 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 246' ' ' ILE . 2.8 tm? -96.71 130.04 44.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.721 0.772 . . . . 0.0 110.801 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 245' ' ' LEU . 73.0 mt -127.6 128.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.419 ' CG2' ' HB ' ' A' ' 161' ' ' VAL . 8.1 tp -119.86 126.38 75.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.632 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.531 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 28.4 m -103.99 119.84 39.78 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.745 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.92 149.31 23.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.367 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 158' ' ' HIS . 10.0 tmtt? -135.8 128.06 17.65 Favored Pre-proline 0 C--N 1.286 -2.168 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.326 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 50.3 Cg_exo -57.69 127.3 24.72 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.627 2.218 . . . . 0.0 113.041 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -106.58 4.1 27.68 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.972 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 . . . . . 0 C--N 1.312 -1.028 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.485 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.872 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.67 149.19 73.32 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.475 2.117 . . . . 0.0 113.052 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -86.15 91.43 8.43 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.1 pt -64.71 113.21 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.118 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.2 m -90.85 77.73 6.17 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-O 121.955 0.883 . . . . 0.0 109.887 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -109.65 125.38 31.41 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.911 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.88 134.12 33.62 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.135 1.89 . . . . 0.0 110.852 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -101.27 139.49 36.88 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.06 135.72 34.74 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -101.83 -64.64 1.04 Allowed 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.484 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 . . . . . 0 C--N 1.308 -1.23 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.484 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.434 -1.254 0 CA-C-O 121.234 0.54 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.26 142.31 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.057 1.838 . . . . 0.0 110.666 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.5 82.15 5.66 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 121.339 0.59 . . . . 0.0 110.285 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.3 p -85.05 108.87 17.84 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -82.3 99.22 9.21 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -96.5 131.94 42.59 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.029 -163.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.495 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 22.1 ptt180 -105.14 112.74 25.97 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.16 133.41 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.865 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.551 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -98.44 134.8 40.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.627 0.727 . . . . 0.0 112.659 -176.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 45.0 tp -98.53 122.4 41.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.024 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.75 100.68 9.39 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-O 122.106 0.955 . . . . 0.0 112.21 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.466 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 64.2 pttt -74.61 147.31 41.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.376 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -100.62 20.5 14.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.49 -11.35 59.01 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.9 t -162.16 131.36 4.39 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 71.23 108.06 0.06 Allowed 'General case' 0 C--O 1.248 1.006 0 O-C-N 124.442 1.089 . . . . 0.0 112.014 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.466 ' HG3' ' HB3' ' A' ' 165' ' ' LYS . 3.5 mppt? -90.62 121.96 67.65 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -81.21 70.0 7.64 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.964 1.776 . . . . 0.0 112.55 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -69.92 112.99 6.72 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.393 0.616 . . . . 0.0 110.992 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -104.93 33.78 6.3 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -158.85 145.25 16.96 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -137.11 135.81 37.75 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -135.37 139.6 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -141.88 158.65 43.53 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.142 0.577 . . . . 0.0 112.185 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.487 ' H ' HD21 ' A' ' 231' ' ' LEU . 13.0 t70 -74.5 139.41 43.83 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.173 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.05 179.23 36.64 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 m -99.44 141.59 32.03 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.739 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 43.4 t -112.46 146.82 37.74 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.002 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.04 123.86 71.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.9 mtt180 -123.5 160.64 26.53 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.35 106.45 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 43.7 p -111.1 179.61 3.99 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.0 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.27 -18.16 65.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.0 m -92.06 4.97 51.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.589 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.26 -152.54 19.26 Favored Glycine 0 C--O 1.212 -1.274 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.5 pt? -85.88 121.26 28.27 Favored 'General case' 0 N--CA 1.395 -3.199 0 CA-C-N 117.34 0.57 . . . . 0.0 110.034 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.03 159.98 35.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.846 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 181' ' ' SER . 68.1 mttm -106.93 143.76 34.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.648 0.592 . . . . 0.0 109.722 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -136.31 154.09 76.88 Favored Pre-proline 0 N--CA 1.426 -1.626 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.09 129.44 6.87 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.047 1.832 . . . . 0.0 109.397 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.63 -177.82 24.9 Favored Glycine 0 C--N 1.287 -2.157 0 C-N-CA 120.611 -0.805 . . . . 0.0 111.718 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.447 HG21 ' HB ' ' A' ' 218' ' ' VAL . 12.0 tt -129.48 122.24 55.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.526 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -114.48 173.15 6.61 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.087 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.4 126.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.3 t -89.53 -45.58 9.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.753 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -146.62 153.65 40.57 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 49.1 tp -127.73 137.78 52.57 Favored 'General case' 0 N--CA 1.407 -2.601 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.47 137.3 19.21 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.84 126.45 18.14 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.765 1.643 . . . . 0.0 108.913 172.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.64 1.33 66.05 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.16 162.75 40.72 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.435 ' H ' HD21 ' A' ' 205' ' ' LEU . 2.1 mm? -63.99 -36.32 83.59 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 112.144 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -76.6 -27.9 55.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.611 0.719 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.41 -37.65 56.79 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.29 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.3 m -57.9 -33.63 68.96 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 120.773 0.321 . . . . 0.0 111.568 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 211' ' ' LEU . 4.3 m -68.06 -39.98 82.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.79 -33.6 2.36 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.25 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 209' ' ' THR . 27.1 mt -77.84 -8.1 57.58 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.62 ' HA ' ' OD2' ' A' ' 216' ' ' ASP . 82.7 mt -108.63 127.85 54.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.964 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.53 163.85 25.06 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.65 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -54.41 -26.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 C-N-CA 123.502 0.721 . . . . 0.0 112.123 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.08 -23.64 64.04 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.62 ' OD2' ' HA ' ' A' ' 212' ' ' LEU . 34.7 m-20 -66.73 166.01 13.92 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.135 0.574 . . . . 0.0 112.077 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.526 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -134.0 169.56 16.94 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.447 ' HB ' HG21 ' A' ' 195' ' ' ILE . 87.7 t -89.47 136.45 23.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.279 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.427 HD13 ' HB2' ' A' ' 250' ' ' LYS . 31.2 mt -96.68 -58.76 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.483 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.8 mt-10 -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.895 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.7 110.26 31.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.36 -77.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.752 0.821 . . . . 0.0 110.366 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -151.88 10.39 0.67 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.514 HG23 ' SD ' ' A' ' 237' ' ' MET . 3.0 mp -107.58 133.14 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.18 158.57 27.65 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.0 m -116.37 6.91 7.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.321 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -57.59 109.07 0.64 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.769 0.668 . . . . 0.0 111.554 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.99 5.37 47.23 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.53 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.411 ' HD2' ' HB3' ' A' ' 233' ' ' GLN . 35.9 mtmm -110.53 174.99 5.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 234' ' ' VAL . 31.8 m -118.69 163.42 16.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.691 -1.595 . . . . 0.0 108.866 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.632 HD11 ' N ' ' A' ' 232' ' ' ASP . 2.7 pp -50.53 -41.5 53.92 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.632 ' N ' HD11 ' A' ' 231' ' ' LEU . 29.6 t70 -61.3 -51.03 70.58 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.267 0.556 . . . . 0.0 110.482 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 237' ' ' MET . 48.1 mt-30 -58.53 -45.12 89.52 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.774 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 230' ' ' THR . 71.5 t -66.59 -49.07 78.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.48 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 45.5 p -59.63 -37.11 77.76 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.3 -44.13 97.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.066 0.46 . . . . 0.0 109.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.514 ' SD ' HG23 ' A' ' 224' ' ' ILE . 30.7 mtm -64.11 -49.62 71.5 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.546 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.48 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 24.0 ptm -67.88 -23.44 65.13 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.325 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 60.7 t -79.41 -30.93 14.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.499 0.666 . . . . 0.0 109.933 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.77 -15.04 57.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -132.56 27.44 4.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 37.0 t -65.95 -18.68 65.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -172.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.2 t -52.08 -64.46 0.81 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 90.76 3.3 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.4 tm? -91.18 126.88 36.4 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.495 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.1 mp -110.82 119.04 58.67 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.77 139.01 34.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.483 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.2 m -108.51 120.11 41.46 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.111 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.7 m -122.67 157.5 27.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 120.733 0.302 . . . . 0.0 110.915 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.51 ' HB3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -130.09 124.92 21.71 Favored Pre-proline 0 N--CA 1.432 -1.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.112 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.587 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.1 Cg_endo -65.36 134.12 37.58 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.821 2.347 . . . . 0.0 113.329 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.71 4.68 43.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 CA--C 1.504 -0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 113.386 175.443 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.63 123.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.457 2.105 . . . . 0.0 112.032 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.0 t -89.93 89.85 7.91 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.2 mt -91.1 161.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.7 t -162.05 170.79 18.62 Favored 'General case' 0 N--CA 1.38 -3.934 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.6 120.84 69.56 Favored Pre-proline 0 C--N 1.257 -3.454 0 CA-C-O 120.988 0.423 . . . . 0.0 110.367 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -72.7 131.08 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.646 2.231 . . . . 0.0 111.654 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -101.15 113.9 27.37 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.531 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 143' ' ' ARG . 13.8 t70 -84.41 157.69 21.32 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -48.93 -46.88 43.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 141' ' ' ASP . 37.9 ptt180 . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 127.204 2.202 . . . . 0.0 116.103 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.52 131.22 9.32 Favored 'Trans proline' 0 C--O 1.253 1.255 0 C-N-CA 121.629 1.552 . . . . 0.0 110.949 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -72.82 91.84 1.54 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -83.16 97.69 8.95 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.852 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -81.57 99.28 8.74 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.433 ' HB3' HD13 ' A' ' 212' ' ' LEU . 26.7 tpt180 -109.87 136.07 49.75 Favored 'General case' 0 C--N 1.257 -3.423 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.932 -165.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.461 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 4.6 ptp180 -114.44 116.79 29.44 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.904 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.97 129.88 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -109.59 133.25 53.32 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.754 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.45 120.46 42.5 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.718 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -115.12 110.23 19.22 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -72.59 121.22 19.36 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.935 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -126.9 124.75 40.26 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.84 16.29 77.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.239 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m 63.36 26.6 15.05 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 109.796 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -111.82 95.14 5.31 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -81.91 111.73 29.15 Favored Pre-proline 0 C--N 1.268 -2.967 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.551 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -73.79 -36.54 3.57 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.316 2.011 . . . . 0.0 111.123 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 35.9 tp 63.62 -91.31 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.455 1.102 . . . . 0.0 110.35 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 79.19 19.61 71.73 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.296 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -161.33 149.17 15.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -136.96 135.79 38.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -141.08 142.13 30.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.935 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.424 HH11 HD11 ' A' ' 231' ' ' LEU . 36.7 mmt180 -138.21 158.35 44.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.05 138.31 31.7 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.327 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -129.77 152.61 19.68 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -93.08 129.92 38.88 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 117.691 0.746 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -129.67 137.26 50.53 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.7 123.96 67.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.316 0.579 . . . . 0.0 110.203 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.15 160.38 18.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.045 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -103.3 113.23 39.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.234 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.3 p -110.23 178.62 4.34 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.794 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.95 -14.35 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.321 0.581 . . . . 0.0 109.752 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.0 m -89.27 -4.99 57.95 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 109.53 -161.07 13.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.558 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -84.14 124.5 31.21 Favored 'General case' 0 N--CA 1.396 -3.139 0 CA-C-N 117.877 0.839 . . . . 0.0 110.921 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -126.63 150.57 48.85 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.721 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.89 134.77 54.6 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.427 0.632 . . . . 0.0 110.125 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -130.03 149.56 73.52 Favored Pre-proline 0 C--N 1.265 -3.07 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.631 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.64 121.8 2.6 Favored 'Trans proline' 0 N--CA 1.429 -2.31 0 C-N-CA 122.084 1.856 . . . . 0.0 110.369 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -114.03 131.23 9.78 Favored Glycine 0 C--N 1.275 -2.845 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 66.2 mt -96.51 118.58 43.17 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -119.67 160.03 23.31 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 123.109 0.256 . . . . 0.0 110.984 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 67.8 mt -68.47 119.36 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.7 m -91.1 -35.21 14.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.053 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -150.82 140.05 21.24 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 47.4 tp -128.2 134.7 49.07 Favored 'General case' 0 N--CA 1.383 -3.824 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.896 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.36 128.26 25.74 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.66 128.5 28.42 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.538 2.159 . . . . 0.0 109.783 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.49 -10.87 61.35 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 155.11 34.61 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -27.99 69.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -73.94 -33.9 64.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.732 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.53 -37.59 56.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.2 t -54.08 -31.79 52.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.951 1.3 . . . . 0.0 112.137 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 79.4 p -59.55 -41.6 90.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.845 0.355 . . . . 0.0 111.434 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.24 -25.56 4.84 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.394 -0.367 . . . . 0.0 113.293 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.3 -18.56 26.72 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.338 0.59 . . . . 0.0 110.184 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.47 HD11 ' CG2' ' A' ' 249' ' ' VAL . 35.7 mt -113.28 145.6 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.758 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.71 163.23 26.6 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.376 1.07 . . . . 0.0 110.627 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.585 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 47.0 t -48.28 -35.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.316 1.046 . . . . 0.0 113.627 -176.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.67 -25.12 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.533 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.2 m-20 -62.42 159.63 15.09 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -114.74 165.3 12.96 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 195' ' ' ILE . 93.4 t -95.19 142.52 13.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 124.694 1.197 . . . . 0.0 110.805 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.423 HD13 ' HB2' ' A' ' 250' ' ' LYS . 35.8 mt -109.71 -59.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.049 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.524 ' H ' ' HB ' ' A' ' 248' ' ' THR . 50.1 mt-10 -135.98 159.11 42.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.564 -173.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.1 t -122.42 118.83 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.974 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.43 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.5 t-20 70.28 -62.85 0.42 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.467 1.107 . . . . 0.0 110.739 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 178.77 24.64 0.04 OUTLIER Glycine 0 C--N 1.281 -2.487 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.33 133.27 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.71 141.87 48.2 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.914 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -117.66 20.17 6.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.718 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.67 129.88 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.692 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.06 1.91 59.48 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' A' ' 233' ' ' GLN . 28.7 mmmt -99.08 153.67 18.7 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.331 0.652 . . . . 0.0 109.933 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.499 ' O ' HG22 ' A' ' 234' ' ' VAL . 17.2 m -101.91 161.35 13.73 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.424 HD11 HH11 ' A' ' 177' ' ' ARG . 1.7 pt? -49.43 -46.28 47.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.19 -38.86 78.88 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.823 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.462 ' HB3' ' HE3' ' A' ' 229' ' ' LYS . 47.5 mt-30 -58.12 -44.88 87.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.086 175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 230' ' ' THR . 61.7 t -66.66 -43.89 90.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 O-C-N 123.494 0.496 . . . . 0.0 111.122 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.4 p -70.35 -34.67 72.91 Favored 'General case' 0 C--O 1.206 -1.218 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.42 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.1 -41.2 99.33 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.019 0.914 . . . . 0.0 109.485 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 234' ' ' VAL . 8.5 tpt -56.78 -48.66 77.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.96 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 235' ' ' THR . 22.2 ptm -76.11 -17.97 59.37 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.913 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 235' ' ' THR . 70.0 t -88.7 -25.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.42 0.629 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.83 -20.78 16.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.628 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -121.13 -69.43 0.84 Allowed 'General case' 0 N--CA 1.389 -3.516 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.767 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 32.2 t 61.04 -39.76 0.11 Allowed 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.7 m -58.36 -39.77 80.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.811 0.844 . . . . 0.0 110.276 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -129.24 90.37 3.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 238' ' ' MET . 3.2 tm? -99.88 124.35 45.1 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.315 0.579 . . . . 0.0 110.088 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 60.7 mt -127.24 123.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.8 tp -109.42 122.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.727 0.775 . . . . 0.0 108.97 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.524 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.6 m -106.29 127.23 53.09 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.641 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.47 ' CG2' HD11 ' A' ' 212' ' ' LEU . 18.5 m -129.29 162.91 35.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.267 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 26.4 ttmt -130.45 136.58 29.19 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 124.759 1.224 . . . . 0.0 108.307 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.533 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 27.6 Cg_exo -65.03 127.4 18.39 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.494 1.463 . . . . 0.0 110.569 173.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -85.34 -27.55 25.8 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.223 0.535 . . . . 0.0 109.83 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 C--N 1.301 -1.514 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.836 178.093 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.425 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.1 -39.74 88.67 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.74 2.293 . . . . 0.0 109.862 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.4 p -147.0 112.97 5.77 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.96 119.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.537 1.16 . . . . 0.0 113.044 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 96.28 3.97 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.576 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.6 tp -95.31 133.69 25.61 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.197 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.06 126.88 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.933 1.755 . . . . 0.0 110.293 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -82.88 164.15 20.68 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.857 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.89 121.73 25.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.437 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -152.8 -55.53 0.12 Allowed 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.651 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 . . . . . 0 N--CA 1.426 -1.653 0 CA-C-O 122.509 1.147 . . . . 0.0 109.595 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.433 -1.281 0 CA-C-O 121.311 0.577 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.2 150.83 23.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.586 2.191 . . . . 0.0 111.453 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 158' ' ' HIS . 41.4 mt-10 -75.34 84.37 2.48 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 120.967 0.413 . . . . 0.0 112.092 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -91.88 100.5 13.17 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 78.5 m80 -75.26 112.48 11.59 Favored 'General case' 0 CA--C 1.47 -2.108 0 CA-C-O 121.782 0.801 . . . . 0.0 109.292 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -110.53 135.16 51.62 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.106 -1.407 . . . . 0.0 107.578 -170.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 85.2 mtm180 -114.3 140.95 48.2 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.037 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.87 132.11 57.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.457 ' C ' HD12 ' A' ' 163' ' ' LEU . 6.6 mpt_? -105.9 138.72 41.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.072 0.463 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 162' ' ' ARG . 8.2 mp -126.77 124.69 40.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.89 0.876 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.48 107.74 18.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 122.064 0.935 . . . . 0.0 113.022 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.455 ' HD2' ' OG ' ' A' ' 242' ' ' SER . 88.5 tttt -78.23 142.87 37.59 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.288 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -106.24 26.44 9.8 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.323 0.582 . . . . 0.0 110.414 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.95 -11.54 65.98 Favored Glycine 0 CA--C 1.498 -0.974 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -164.08 146.68 9.28 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 125.624 1.57 . . . . 0.0 106.868 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.256 6.8 m-20 49.69 96.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 175.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.495 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -84.25 127.06 67.91 Favored Pre-proline 0 C--N 1.299 -1.616 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.065 174.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.422 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 26.1 Cg_endo -62.06 102.83 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.835 2.357 . . . . 0.0 112.614 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.61 144.25 28.91 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.824 0.821 . . . . 0.0 112.459 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.6 38.19 1.53 Allowed Glycine 0 C--N 1.286 -2.238 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.406 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -158.58 151.89 22.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -137.0 135.14 37.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.9 pt -137.49 148.64 25.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.517 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 13.2 ptm180 -142.56 158.5 43.61 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.22 145.47 30.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 0.0 109.727 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.85 -172.5 13.48 Favored Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.462 ' CG2' ' HB3' ' A' ' 191' ' ' LYS . 6.5 m -126.54 142.93 51.37 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 117.836 0.818 . . . . 0.0 109.003 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.0 m -114.9 131.32 56.91 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.7 122.46 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -121.85 155.16 35.97 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.279 0.561 . . . . 0.0 110.504 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 120.47 54.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.639 -174.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.3 p -115.73 177.66 4.59 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.05 -2.9 49.99 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.707 0.765 . . . . 0.0 109.317 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.4 m -97.34 -4.37 38.67 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.82 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.73 -156.25 15.74 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.49 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.434 ' N ' HD21 ' A' ' 189' ' ' LEU . 2.0 mm? -88.96 135.32 33.61 Favored 'General case' 0 N--CA 1.403 -2.819 0 C-N-CA 122.747 0.419 . . . . 0.0 109.979 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.28 150.13 46.37 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.832 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.462 ' HB3' ' CG2' ' A' ' 180' ' ' THR . 50.9 mtmt -108.14 142.76 37.86 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.998 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -134.76 141.98 40.7 Favored Pre-proline 0 N--CA 1.413 -2.319 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.666 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.46 129.05 12.45 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 110.895 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.32 137.41 8.55 Favored Glycine 0 C--N 1.287 -2.172 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 57.3 mt -97.41 125.32 50.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 89.8 m-85 -118.63 167.01 12.04 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.945 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.53 136.51 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.404 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 30.5 p -117.05 -44.07 2.82 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.978 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -137.63 145.17 42.41 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 206' ' ' ALA . 4.8 mt -127.74 137.69 52.52 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.829 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.67 130.1 27.39 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -59.94 126.77 21.24 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.763 1.642 . . . . 0.0 110.079 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 90.74 -7.66 80.95 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.779 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.2 160.94 52.46 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -56.66 -45.09 81.85 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.472 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -70.71 -28.94 65.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.325 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' A' ' 200' ' ' LEU . 8.7 tp10 -76.37 -42.46 44.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.516 0.675 . . . . 0.0 109.209 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 39.7 t -60.56 -33.3 72.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.812 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.417 HG21 ' HG ' ' A' ' 211' ' ' LEU . 29.1 m -62.61 -41.5 99.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.112 0.482 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.86 -45.85 3.58 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 121.171 -0.538 . . . . 0.0 114.372 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.417 ' HG ' HG21 ' A' ' 209' ' ' THR . 4.3 pp -74.39 -4.25 35.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.68 143.97 38.7 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -128.87 163.06 26.07 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 124.311 1.044 . . . . 0.0 109.204 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.71 -21.3 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 123.82 0.848 . . . . 0.0 112.99 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -71.87 -29.24 64.16 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.059 0.544 . . . . 0.0 111.559 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.689 ' HB3' ' O ' ' A' ' 250' ' ' LYS . 74.5 m-20 -68.03 163.09 23.1 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -169.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 0.5 OUTLIER -116.37 167.06 11.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.243 -0.983 . . . . 0.0 113.231 -173.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 61.0 t -98.88 142.12 15.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.465 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.17 -46.98 6.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.949 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.15 154.3 51.01 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 121.57 0.7 . . . . 0.0 112.085 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.52 101.79 12.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 113.534 -1.666 . . . . 0.0 106.509 166.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.564 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 61.0 t30 71.23 -68.36 0.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.56 1.544 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.05 8.25 0.32 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.414 HG23 ' SD ' ' A' ' 237' ' ' MET . 29.2 mt -107.27 118.2 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.04 142.16 45.72 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.72 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 29.0 m -95.08 18.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.49 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.08 109.46 2.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.08 0.466 . . . . 0.0 110.325 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.59 61.95 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.637 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -84.42 169.16 14.85 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 85.3 m -121.29 158.73 27.51 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.37 -1.741 . . . . 0.0 106.696 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.477 ' HA ' HG12 ' A' ' 234' ' ' VAL . 57.8 tp -67.1 -46.82 73.07 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.984 0.811 . . . . 0.0 111.894 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.06 -37.96 75.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.13 0.49 . . . . 0.0 111.251 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.5 mp0 -74.42 -44.52 51.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 231' ' ' LEU . 8.9 p -66.25 -38.47 81.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.689 0.28 . . . . 0.0 110.833 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 239' ' ' VAL . 10.8 t -66.12 -32.13 73.4 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.91 -43.5 83.19 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 22.7 mtm -62.4 -43.78 98.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.193 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.521 ' SD ' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptm -75.58 -13.89 60.37 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.828 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.531 ' HA ' ' HB2' ' A' ' 242' ' ' SER . 66.0 t -87.78 -37.25 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 109.829 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.88 69.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.492 0.663 . . . . 0.0 110.281 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -108.66 21.25 17.51 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.423 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 36.9 t -67.05 -24.5 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -174.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 31.7 m -52.12 -51.63 56.63 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.559 0.537 . . . . 0.0 110.59 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -128.75 87.98 2.66 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.3 tm? -93.43 131.36 38.7 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.969 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 71.1 mt -127.43 139.48 51.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 9.3 tt -129.62 134.53 63.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.144 174.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 39.4 m -102.31 120.63 40.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.213 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.35 155.25 15.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 36.2 tttm -138.34 140.29 27.88 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.422 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.515 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 36.6 Cg_endo -68.75 127.46 15.44 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 121.626 1.55 . . . . 0.0 110.157 172.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -4.67 58.65 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 122.596 0.358 . . . . 0.0 111.454 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.453 ' N ' HD21 ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 120.471 0.177 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.79 111.92 2.94 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.161 1.907 . . . . 0.0 108.962 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.8 p -101.9 103.27 13.94 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.54 0.686 . . . . 0.0 112.566 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 62.2 mt 68.15 147.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.822 1.649 . . . . 0.0 112.23 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -156.33 91.37 1.25 Allowed 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.5 tt -120.68 103.98 42.9 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-O 121.539 0.685 . . . . 0.0 112.599 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -84.47 137.84 7.11 Favored 'Trans proline' 0 N--CA 1.429 -2.283 0 C-N-CA 121.667 1.578 . . . . 0.0 109.711 174.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -82.48 114.39 20.87 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.88 124.4 34.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -170.87 96.46 0.21 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 . . . . . 0 C--N 1.275 -2.665 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.517 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.15 150.25 29.15 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.114 1.876 . . . . 0.0 110.04 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.51 69.07 6.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.327 0.584 . . . . 0.0 112.506 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.2 t -91.33 128.39 37.14 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -99.74 128.27 45.85 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.23 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -96.76 120.81 37.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.914 -169.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -106.33 107.84 19.05 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.23 132.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -108.88 149.08 29.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.92 130.37 43.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.401 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.85 111.61 18.18 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 121.591 0.71 . . . . 0.0 111.203 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -68.25 146.72 53.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.619 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -121.41 76.85 1.28 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.46 -2.67 84.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.522 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.4 t 58.63 72.77 0.51 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.56 1.144 . . . . 0.0 110.3 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -103.92 -49.77 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.97 150.24 47.25 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.562 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 -162.93 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 110.992 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.435 HD22 ' CZ ' ' A' ' 174' ' ' PHE . 4.9 mp -92.94 144.32 25.38 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -89.9 25.47 11.73 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.61 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.435 ' CZ ' HD22 ' A' ' 172' ' ' LEU . 41.9 p90 -158.7 147.32 18.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -132.31 142.83 49.5 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.2 pt -133.16 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.327 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.539 ' HG2' ' N ' ' A' ' 178' ' ' ASP . 78.1 ttt180 -141.23 159.87 41.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.539 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 7.7 p-10 -72.99 157.71 36.88 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.878 0.847 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.32 149.91 18.01 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -93.86 140.76 29.29 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -131.23 134.22 46.23 Favored 'General case' 0 C--N 1.261 -3.279 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.84 123.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.95 107.69 21.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.3 p -115.18 177.72 4.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.14 59.92 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.448 0.642 . . . . 0.0 109.416 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.1 m -89.51 -4.42 57.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.528 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.64 -154.48 16.86 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.494 ' H ' HD21 ' A' ' 189' ' ' LEU . 2.1 pt? -84.35 118.35 24.17 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-O 122.001 0.905 . . . . 0.0 109.962 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -120.89 144.88 48.18 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.059 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -101.42 143.87 30.91 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 41.6 tt0 -133.08 144.2 51.68 Favored Pre-proline 0 C--N 1.281 -2.412 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.266 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 1.6 Cg_endo -83.12 128.62 5.03 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 C-N-CA 122.519 2.146 . . . . 0.0 109.298 171.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 178' ' ' ASP . . . -140.31 163.06 26.45 Favored Glycine 0 C--N 1.277 -2.725 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.797 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.414 ' O ' HG21 ' A' ' 218' ' ' VAL . 63.0 mt -116.89 119.64 62.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 56.6 m-85 -118.95 167.04 12.11 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.998 -175.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.0 122.73 18.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.513 ' C ' ' HD2' ' A' ' 199' ' ' ARG . 76.6 p -96.04 -67.36 0.85 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.867 0.365 . . . . 0.0 111.494 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.513 ' HD2' ' C ' ' A' ' 198' ' ' SER . 7.2 mpt_? -124.88 154.19 41.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.938 0.495 . . . . 0.0 110.351 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.74 139.44 52.68 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.966 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -99.25 126.86 36.37 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.87 126.44 20.43 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.108 1.872 . . . . 0.0 109.946 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.9 -6.86 54.66 Favored Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.26 151.46 34.86 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.65 -29.9 70.37 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.19 70.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.224 0.535 . . . . 0.0 110.568 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -77.34 -43.47 32.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 m -55.24 -33.61 63.27 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.615 ' OG1' ' HG ' ' A' ' 211' ' ' LEU . 5.2 t -69.61 -44.92 69.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.744 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 -12.75 4.52 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.469 -0.872 . . . . 0.0 114.39 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.615 ' HG ' ' OG1' ' A' ' 209' ' ' THR . 3.8 pp -89.67 -3.93 58.0 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 118.836 1.318 . . . . 0.0 111.494 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 88.5 mt -109.54 146.11 35.19 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.617 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.69 162.68 16.92 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 123.671 0.788 . . . . 0.0 110.533 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.16 -16.82 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-O 122.454 1.121 . . . . 0.0 110.425 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -75.52 -23.67 56.71 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.301 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.548 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.8 m-20 -63.75 156.43 27.17 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -171.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.485 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 31.1 mt-10 -109.51 150.84 27.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.929 -170.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 195' ' ' ILE . 23.2 m -98.58 143.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 43.1 mt -109.33 -56.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.489 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.4 mt-10 -130.27 149.86 51.77 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.633 -172.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.405 HG12 ' HB3' ' A' ' 238' ' ' MET . 67.5 t -116.02 112.48 39.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 67.73 -70.14 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.26 1.024 . . . . 0.0 110.014 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.84 11.09 0.1 OUTLIER Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.53 135.78 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.25 159.18 29.83 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.287 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.414 HG22 HG23 ' A' ' 218' ' ' VAL . 20.6 m -102.95 3.63 10.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.867 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -55.21 108.9 0.46 Allowed 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.993 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.49 90.53 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.465 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -87.17 160.12 18.62 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.8 m -81.55 158.28 24.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.537 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 178' ' ' ASP . 4.1 mp -70.55 -41.39 72.53 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 118.425 0.557 . . . . 0.0 109.98 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.73 -39.26 73.62 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.378 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 237' ' ' MET . 21.1 tp60 -67.74 -47.16 70.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.294 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.29 -45.42 86.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.048 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.459 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 8.8 t -64.59 -29.11 70.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.14 -48.91 77.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.292 0.567 . . . . 0.0 109.478 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 29.4 mtm -62.67 -40.18 96.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.129 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.459 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 15.4 ptm -76.24 -20.27 57.57 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.695 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 79.8 t -91.7 -36.8 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.352 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.42 69.94 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -109.23 23.24 14.79 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.323 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 63.7 m -64.97 -18.82 65.6 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -67.52 -39.66 85.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -129.45 79.66 1.92 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -99.41 129.59 45.61 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.535 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.06 132.28 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 6.9 tp -118.24 120.8 65.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.029 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.489 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.3 m -92.35 119.32 31.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.359 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -120.45 139.43 47.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.802 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.65 123.46 23.91 Favored Pre-proline 0 N--CA 1.413 -2.305 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.092 -173.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.548 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 31.6 Cg_exo -58.25 133.72 57.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.866 2.377 . . . . 0.0 113.515 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -94.92 3.1 55.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 . . . . . 0 CA--C 1.487 -1.478 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.196 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.42 -34.86 75.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.343 2.028 . . . . 0.0 110.61 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.7 t -121.06 108.02 13.32 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.72 154.36 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.1 t -91.83 83.45 5.25 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.58 112.61 32.43 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.449 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.74 133.05 45.86 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.306 2.004 . . . . 0.0 110.733 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -100.17 114.54 28.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.31 153.4 18.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.786 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -92.68 79.74 4.79 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 . . . . . 0 C--N 1.297 -1.687 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.275 177.652 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 N--CA 1.439 -1.024 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.79 151.44 83.99 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 122.769 2.313 . . . . 0.0 109.232 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.54 80.35 0.1 Allowed 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 121.936 0.874 . . . . 0.0 113.322 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.1 m -92.96 85.11 5.03 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -98.81 113.54 25.7 Favored 'General case' 0 CA--C 1.467 -2.228 0 CA-C-O 121.391 0.615 . . . . 0.0 109.845 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 4.1 tpm_? -100.25 123.69 44.79 Favored 'General case' 0 C--N 1.271 -2.847 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.283 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.536 ' HB3' ' CG2' ' A' ' 246' ' ' ILE . 67.9 mtm180 -99.92 112.33 24.6 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.92 125.75 42.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 39.6 ptt180 -102.87 142.24 34.32 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.07 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -116.77 123.1 46.32 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.497 HD11 ' O ' ' A' ' 164' ' ' LEU . 2.9 pp -111.05 100.87 9.47 Favored 'General case' 0 N--CA 1.398 -3.038 0 CA-C-O 122.499 1.142 . . . . 0.0 112.049 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 243' ' ' SER . 12.8 tmtt? -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.811 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 14.2 p80 179.8 117.9 0.05 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.326 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.75 0.41 66.63 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.115 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 t -171.88 148.56 2.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.98 -39.87 83.23 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt 62.89 121.38 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.027 1.331 . . . . 0.0 113.629 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.42 22.94 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.365 2.71 . . . . 0.0 113.108 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp 66.5 -73.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.798 1.239 . . . . 0.0 112.854 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 108.89 -12.71 34.8 Favored Glycine 0 CA--C 1.497 -1.06 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -128.12 143.9 51.08 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.17 161.07 35.42 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 123.185 0.303 . . . . 0.0 110.813 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 176' ' ' ILE . 2.3 pp -130.62 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -141.66 147.95 38.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 12.2 p-10 -102.46 127.12 49.63 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.532 0.682 . . . . 0.0 111.521 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -112.23 117.32 4.35 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 23.5 p -92.72 143.19 26.54 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 117.722 0.761 . . . . 0.0 112.363 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.0 t -127.42 132.4 50.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.16 124.0 49.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -120.97 157.09 30.7 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 63.2 t -102.64 116.6 46.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.8 p -115.62 177.81 4.53 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.701 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.37 -14.57 62.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.204 0.526 . . . . 0.0 109.918 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.3 p -91.94 -0.24 57.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.056 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.83 -165.35 12.04 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.536 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.7 pt? -84.83 106.47 16.38 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.314 1.054 . . . . 0.0 110.712 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -104.31 152.44 22.23 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.266 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -121.3 133.39 55.13 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -116.7 143.91 32.3 Favored Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.358 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.18 126.51 2.0 Allowed 'Trans proline' 0 N--CA 1.427 -2.428 0 C-N-CA 122.227 1.951 . . . . 0.0 112.734 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.67 86.32 0.45 Allowed Glycine 0 C--N 1.279 -2.617 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 12.1 tt -82.11 133.66 28.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 120.597 0.237 . . . . 0.0 110.438 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -142.87 177.56 8.26 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.542 0.737 . . . . 0.0 110.74 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.2 mt -71.99 134.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 68.3 p -109.84 -59.95 1.85 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.8 147.87 47.19 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.059 0.457 . . . . 0.0 111.043 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 206' ' ' ALA . 11.2 mt -127.06 138.3 53.19 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.646 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.89 132.63 20.71 Favored Pre-proline 0 C--N 1.286 -2.16 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.96 126.79 23.74 Favored 'Trans proline' 0 C--O 1.251 1.125 0 C-N-CA 121.808 1.672 . . . . 0.0 110.057 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.89 60.78 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.83 149.14 51.13 Favored Glycine 0 C--O 1.214 -1.144 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -56.73 -35.61 68.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.505 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -73.42 -28.08 61.79 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.738 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.19 -43.33 43.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.1 m -54.7 -32.9 60.15 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.223 1.009 . . . . 0.0 112.222 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.488 HG21 ' HG ' ' A' ' 211' ' ' LEU . 25.5 m -63.94 -43.28 96.36 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.845 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.8 -56.72 3.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.433 -0.349 . . . . 0.0 113.857 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.488 ' HG ' HG21 ' A' ' 209' ' ' THR . 4.1 pp -70.93 2.23 4.6 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.625 1.17 . . . . 0.0 113.292 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CG2' ' A' ' 249' ' ' VAL . 25.7 tp -119.99 145.74 46.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.82 161.64 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.245 0.545 . . . . 0.0 112.062 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.63 -24.66 13.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.844 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -68.93 -24.6 64.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.348 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.667 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 70.5 m-20 -60.13 139.96 57.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.249 0.62 . . . . 0.0 111.878 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.66 145.08 26.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -170.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.406 ' HB ' HG21 ' A' ' 195' ' ' ILE . 84.1 t -78.0 135.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.886 1.274 . . . . 0.0 110.993 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.8 mm -122.23 -43.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.134 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.49 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.5 mt-10 -136.58 151.33 49.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.484 0.659 . . . . 0.0 112.045 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.49 109.12 26.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.533 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 69.82 -66.62 0.26 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.452 1.101 . . . . 0.0 111.229 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.93 15.78 0.09 OUTLIER Glycine 0 C--N 1.294 -1.765 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.92 133.55 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 44.6 mt-10 -82.33 149.42 27.76 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.57 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.56 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 19.1 m -89.62 14.1 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.021 -177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -88.73 109.36 20.08 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.4 15.09 26.27 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.737 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 1.1 pptp? -104.85 174.36 5.91 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 26.3 m -106.06 158.64 16.66 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.646 ' O ' HG12 ' A' ' 234' ' ' VAL . 4.7 tt -60.44 -47.49 85.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.859 0.464 . . . . 0.0 110.798 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.15 -36.42 74.74 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.281 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.71 -37.86 80.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 231' ' ' LEU . 7.5 p -58.18 -44.67 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.409 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.7 p -70.54 -35.47 73.15 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.341 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.35 -43.36 81.69 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.815 0.817 . . . . 0.0 110.327 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 76.1 mtp -61.92 -44.59 96.46 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.701 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 25.7 ptm -70.54 -24.4 62.8 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 235' ' ' THR . 96.8 t -83.24 -32.26 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 0.0 109.798 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.64 68.75 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.618 0.723 . . . . 0.0 109.844 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -107.98 22.24 16.24 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 68.4 m -54.45 -31.46 55.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 34.2 t -50.83 -58.16 6.65 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.736 0.303 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -130.58 89.61 2.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.4 tm? -101.14 130.88 47.29 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 160' ' ' ARG . 68.1 mt -118.32 123.81 72.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.85 118.79 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 122.098 0.951 . . . . 0.0 109.565 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.49 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 19.8 m -95.82 120.15 35.58 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.942 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.576 ' CG2' HD22 ' A' ' 212' ' ' LEU . 29.8 m -129.34 149.53 33.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -127.03 128.49 24.16 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.667 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.9 Cg_exo -39.23 126.9 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.07 3.18 . . . . 0.0 115.009 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.25 8.49 32.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.535 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.415 176.708 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.801 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.86 110.56 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.237 1.958 . . . . 0.0 110.189 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 m -80.15 99.06 7.58 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.7 tt -54.02 135.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.728 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.7 p -129.25 88.93 2.77 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.039 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.95 138.77 19.65 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.766 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.12 123.13 11.26 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.373 2.049 . . . . 0.0 111.021 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -90.29 152.64 20.95 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.828 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.33 121.96 33.53 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -113.12 -52.35 2.78 Favored 'General case' 0 C--N 1.261 -3.274 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 . . . . . 0 C--O 1.238 0.464 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.839 177.169 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.232 0.134 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -81.32 148.71 16.68 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.202 1.935 . . . . 0.0 109.259 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -74.81 85.71 2.2 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.547 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.7 p -81.73 114.94 20.73 Favored 'General case' 0 N--CA 1.408 -2.566 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.399 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -87.74 99.7 12.28 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.415 ' HG3' HG12 ' A' ' 161' ' ' VAL . 32.9 tpt180 -103.24 125.72 50.05 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.054 -170.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.484 ' HG2' ' OG1' ' A' ' 248' ' ' THR . 88.2 mtt180 -103.3 105.0 15.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.698 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.415 HG12 ' HG3' ' A' ' 159' ' ' ARG . 23.0 m -104.69 132.53 51.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 120.96 0.409 . . . . 0.0 110.94 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -103.06 142.76 33.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.1 mt -133.39 145.42 50.31 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.828 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -120.4 120.43 35.94 Favored 'General case' 0 N--CA 1.404 -2.744 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.578 172.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -65.98 143.48 57.35 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.538 -178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 169' ' ' ASP . 37.5 m80 -110.86 -37.34 5.43 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.494 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.53 -11.69 37.71 Favored Glycine 0 N--CA 1.459 0.183 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.959 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 3.13 15.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 25.2 t70 171.68 117.19 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.413 2.285 . . . . 0.0 105.916 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 169' ' ' ASP . 56.7 mttp 66.77 86.59 0.13 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 124.949 1.3 . . . . 0.0 112.478 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -75.84 -32.27 4.59 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.168 1.912 . . . . 0.0 107.915 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 174' ' ' PHE . 1.8 pt? -152.95 127.12 9.12 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.118 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -95.65 48.11 1.87 Allowed Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.443 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.449 ' CE1' ' HB2' ' A' ' 172' ' ' LEU . 54.1 p90 -169.75 156.82 6.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 67.6 m-85 -137.73 135.41 36.37 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 169.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.593 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.0 pt -132.78 144.71 35.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -136.4 136.63 39.75 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.729 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -87.21 123.16 31.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.847 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -131.1 174.72 19.82 Favored Glycine 0 C--N 1.276 -2.789 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 141.84 32.63 Favored 'General case' 0 C--N 1.271 -2.81 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.322 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t -123.09 136.87 54.98 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.44 124.03 63.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -116.19 154.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-O 121.019 0.438 . . . . 0.0 110.254 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.37 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.7 p -115.6 177.29 4.72 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.098 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.36 -16.86 61.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.6 p -91.85 5.75 48.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.17 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 -156.26 15.66 Favored Glycine 0 C--O 1.214 -1.154 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.882 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.509 HD21 ' H ' ' A' ' 189' ' ' LEU . 0.5 OUTLIER -98.95 106.77 19.06 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.77 0.795 . . . . 0.0 109.373 175.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.21 152.14 23.21 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.697 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -121.09 130.92 53.97 Favored 'General case' 0 N--CA 1.402 -2.852 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -147.76 150.88 37.52 Favored Pre-proline 0 C--N 1.265 -3.09 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.977 -172.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.68 134.96 19.07 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.206 1.937 . . . . 0.0 110.273 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.04 134.65 6.87 Favored Glycine 0 C--N 1.301 -1.391 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.593 ' CG2' ' HB ' ' A' ' 176' ' ' ILE . 58.2 mt -104.61 119.82 54.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.753 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -120.65 156.97 30.58 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 68.5 mt -63.51 123.38 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.602 0.715 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -91.09 -42.46 10.47 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.865 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 68.5 ttt180 -151.65 152.98 33.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.197 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.513 HD22 ' HB2' ' A' ' 206' ' ' ALA . 13.8 mt -128.08 138.76 52.68 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.14 130.21 26.6 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.72 137.25 59.5 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.55 2.22 58.8 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.79 153.09 34.18 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.64 -26.39 61.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.513 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -67.19 -26.87 66.84 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 122.077 0.941 . . . . 0.0 109.224 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.62 -41.36 46.22 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.031 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.1 t -64.78 -36.12 83.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.0 p -62.62 -44.29 96.67 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.95 -51.84 2.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.631 -0.259 . . . . 0.0 113.032 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.3 mt -57.58 -39.77 77.49 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.48 1.112 . . . . 0.0 108.922 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.9 mp -115.37 108.67 16.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.27 116.62 16.38 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.614 -0.434 . . . . 0.0 112.054 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.488 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 70.8 t 57.23 -43.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.067 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 174.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -74.63 -23.82 58.75 Favored 'General case' 0 CA--C 1.484 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 112.465 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.26 173.44 2.54 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.656 0.741 . . . . 0.0 112.566 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -128.65 140.43 51.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.641 -170.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.12 141.4 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.371 0.605 . . . . 0.0 110.086 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.73 -52.62 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.942 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.445 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 36.5 mt-10 -125.49 146.51 49.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.899 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.526 HG13 ' SD ' ' A' ' 238' ' ' MET . 92.2 t -109.18 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 171.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.519 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 25.1 t-20 70.33 -73.83 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.806 0.812 . . . . 0.0 109.788 -174.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.95 12.53 0.1 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 175.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.449 ' CG2' ' HE2' ' A' ' 237' ' ' MET . 9.0 mt -95.45 118.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.24 150.1 33.5 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.981 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 22.5 m -95.84 13.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 120.922 0.391 . . . . 0.0 112.05 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.75 114.52 18.73 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.22 15.07 28.98 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.295 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 0.5 OUTLIER -109.93 175.98 5.24 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.536 -0.391 . . . . 0.0 110.443 -177.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 32.9 m -113.77 160.77 18.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.565 ' O ' HG12 ' A' ' 234' ' ' VAL . 3.0 tm? -55.11 -46.36 75.57 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.177 0.444 . . . . 0.0 111.876 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.47 -35.5 77.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.232 0.539 . . . . 0.0 110.478 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 237' ' ' MET . 97.7 mt-30 -69.96 -39.79 75.81 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.664 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 231' ' ' LEU . 10.4 p -61.17 -42.23 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 118.498 0.59 . . . . 0.0 111.855 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 239' ' ' VAL . 6.7 t -75.27 -28.95 60.01 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.918 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.68 -39.58 88.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 73.1 mtp -56.41 -43.93 79.83 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.455 174.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.598 ' SD ' HD22 ' A' ' 245' ' ' LEU . 24.6 mmt -64.12 -29.38 70.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.062 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.566 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 87.7 t -82.7 -34.85 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.306 0.574 . . . . 0.0 110.755 -175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.55 -23.3 67.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.243 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.7 26.37 5.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.455 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 49.3 m -54.32 -28.66 43.9 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -95.28 -5.51 43.45 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.986 -0.446 . . . . 0.0 111.696 -176.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.27 35.52 4.26 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.598 HD22 ' SD ' ' A' ' 238' ' ' MET . 2.6 tm? -83.22 124.11 30.23 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.506 -167.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 56.6 mt -130.22 129.63 65.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.479 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.68 122.06 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 42.0 m -90.78 119.84 31.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-O 121.118 0.485 . . . . 0.0 111.81 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.482 ' HB3' ' HZ3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -138.04 126.8 14.51 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 123.743 0.817 . . . . 0.0 108.858 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.48 127.71 21.59 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.14 2.56 . . . . 0.0 112.974 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -105.2 19.02 21.31 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.892 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 N--CA 1.432 -1.326 0 CA-C-O 122.905 1.335 . . . . 0.0 108.838 176.779 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.52 109.42 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.228 1.952 . . . . 0.0 110.594 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -84.12 73.55 10.39 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 122.001 0.905 . . . . 0.0 109.397 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.5 tt -121.08 156.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.475 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -150.97 130.36 12.88 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 115.47 63.01 Favored Pre-proline 0 C--N 1.284 -2.242 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -85.9 128.71 3.33 Favored 'Trans proline' 0 N--CA 1.429 -2.307 0 C-N-CA 122.359 2.039 . . . . 0.0 109.273 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -79.36 114.01 17.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.91 156.22 22.49 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.607 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -63.59 141.67 58.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.746 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.529 0.68 . . . . 0.0 110.584 -176.134 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.437 -1.117 0 CA-C-O 121.026 0.441 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.24 150.3 65.08 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.438 1.425 . . . . 0.0 109.392 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.77 83.36 1.18 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.3 m -83.88 109.78 17.85 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.416 ' NE2' ' HG3' ' A' ' 250' ' ' LYS . 14.0 m-70 -72.0 123.66 23.26 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-O 121.876 0.846 . . . . 0.0 112.116 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.409 ' HD2' HD13 ' A' ' 212' ' ' LEU . 22.1 ttm-85 -113.41 140.26 48.21 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.957 -171.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.454 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 19.8 ptt180 -123.92 119.51 29.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.98 133.82 55.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 122.257 -0.277 . . . . 0.0 111.685 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.4 ' HB3' HG13 ' A' ' 246' ' ' ILE . 26.5 ptt180 -99.6 135.62 40.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.764 0.792 . . . . 0.0 112.832 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.436 ' HB2' HD13 ' A' ' 245' ' ' LEU . 3.5 mm? -124.67 121.42 34.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.574 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.418 HD11 ' O ' ' A' ' 164' ' ' LEU 0.264 1.6 pp -107.01 105.04 14.87 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-O 122.2 1.0 . . . . 0.0 113.295 175.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -100.58 134.52 43.41 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.527 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.401 ' C ' ' H ' ' A' ' 168' ' ' SER . 70.3 m80 -95.06 29.71 2.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 87.11 -11.44 65.12 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 166' ' ' HIS . 30.2 p -175.69 133.53 0.28 Allowed 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 t70 178.46 -57.37 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.534 ' HB3' ' HZ2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -149.04 148.27 26.52 Favored Pre-proline 0 N--CA 1.412 -2.354 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.676 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -86.7 23.73 0.8 Allowed 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 122.466 2.111 . . . . 0.0 110.886 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 87.5 mt 75.01 123.6 0.04 OUTLIER 'General case' 0 C--N 1.347 0.469 0 C-N-CA 125.952 1.701 . . . . 0.0 111.421 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.93 44.08 3.08 Favored Glycine 0 C--O 1.241 0.589 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.991 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -172.2 144.23 1.59 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -135.77 135.42 39.91 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 121.3 0.572 . . . . 0.0 111.111 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -130.94 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.451 -175.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -122.87 158.72 29.71 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -74.27 137.48 42.98 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 123.2 0.313 . . . . 0.0 111.046 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.71 163.92 37.4 Favored Glycine 0 N--CA 1.406 -3.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 m -107.07 143.7 34.81 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.4 t -92.84 125.54 37.5 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.439 HG23 ' HG2' ' A' ' 191' ' ' LYS . 24.0 t -117.3 124.62 73.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.276 -174.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -110.34 151.61 27.22 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.29 106.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-O 122.167 0.984 . . . . 0.0 109.127 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.2 p -116.41 178.28 4.38 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.562 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.7 -15.83 62.74 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 m -88.02 -3.81 58.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.72 -160.04 14.17 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.078 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.497 HD22 ' O ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.77 109.97 18.45 Favored 'General case' 0 N--CA 1.385 -3.716 0 CA-C-O 121.931 0.872 . . . . 0.0 110.783 177.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -101.92 144.02 31.08 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.51 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 181' ' ' SER . 52.7 mtmt -123.29 142.35 51.03 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.439 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.62 154.87 79.83 Favored Pre-proline 0 N--CA 1.42 -1.945 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.83 131.01 17.65 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.752 1.635 . . . . 0.0 109.282 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 178.63 103.63 0.17 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.2 pt -77.47 144.84 10.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.62 158.87 17.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.9 mt -68.89 136.54 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.6 t -136.03 -39.67 0.68 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.744 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -127.11 147.53 50.17 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.874 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 206' ' ' ALA . 30.2 mt -128.31 139.71 52.26 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.441 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.48 132.47 23.15 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 126.86 23.26 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.5 1.467 . . . . 0.0 110.12 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.92 -5.1 57.85 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.79 155.99 53.44 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 74.0 mt -65.94 -35.62 81.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -173.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -75.66 -26.27 57.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.674 0.75 . . . . 0.0 109.294 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.21 -56.17 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.876 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.4 m -62.85 -34.94 78.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.2 p -66.98 -43.76 82.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.689 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.76 10.64 51.14 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 29.3 tp -119.95 15.4 12.51 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 122.711 1.244 . . . . 0.0 109.252 -173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 159' ' ' ARG . 78.7 mt -135.17 129.33 33.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.383 -1.735 . . . . 0.0 106.648 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.31 162.26 13.03 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 -174.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.8 -22.72 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-O 122.629 1.204 . . . . 0.0 108.858 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -74.59 -23.09 58.68 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.432 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.531 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 59.5 m-20 -67.65 154.96 40.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.679 0.792 . . . . 0.0 112.094 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -116.02 163.8 15.38 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.593 0.711 . . . . 0.0 112.866 -172.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.82 137.94 25.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.833 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.563 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.7 mp -107.66 -50.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.67 0.747 . . . . 0.0 110.235 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.469 ' H ' ' HB ' ' A' ' 248' ' ' THR . 43.1 mt-10 -141.35 159.39 42.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.401 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.2 t -106.33 97.61 5.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 44.3 t30 72.99 -73.4 0.1 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 111.261 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.05 18.4 0.73 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.84 111.95 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.85 147.53 53.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 219' ' ' ILE . 15.4 m -98.76 3.67 10.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.147 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.8 103.48 0.11 Allowed 'General case' 0 C--O 1.244 0.773 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.74 7.56 84.01 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.336 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.25 160.03 17.86 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 96.8 m -74.83 156.29 36.64 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.005 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.536 HD11 ' N ' ' A' ' 232' ' ' ASP . 4.1 pp -71.32 -34.93 71.01 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.132 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.536 ' N ' HD11 ' A' ' 231' ' ' LEU . 21.9 t70 -70.1 -37.05 75.3 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.509 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.62 ' O ' ' HG3' ' A' ' 237' ' ' MET . 23.6 tp60 -66.12 -51.01 62.0 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.433 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.28 -48.68 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.532 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.0 p -65.43 -32.42 74.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.973 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.03 -42.95 93.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.62 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 23.6 mtm -58.32 -46.05 86.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.905 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.6 ptp -68.43 -23.19 64.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 235' ' ' THR . 89.4 t -83.56 -33.15 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.5 67.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.067 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -95.82 -63.07 1.19 Allowed 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.457 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.8 t 66.04 -41.31 0.35 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.94 1.829 . . . . 0.0 115.94 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -97.57 -39.29 9.19 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.72 -0.613 . . . . 0.0 112.398 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.18 42.03 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.446 ' C ' HD11 ' A' ' 246' ' ' ILE . 3.2 tm? -85.34 129.67 34.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.99 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -128.42 140.73 48.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.9 tp -122.26 138.18 53.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 118.547 0.612 . . . . 0.0 109.751 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.469 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.8 m -102.82 120.68 41.03 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.958 -174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.74 149.25 29.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 CA-C-O 121.366 0.603 . . . . 0.0 112.411 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.467 ' HB2' HD13 ' A' ' 219' ' ' ILE . 32.1 ttmt -124.35 124.74 25.76 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.822 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.531 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.6 Cg_exo -63.81 126.48 17.47 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.162 1.241 . . . . 0.0 109.07 171.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.6 -0.01 17.41 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.656 -176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.035 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.243 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.38 144.77 91.77 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.245 1.963 . . . . 0.0 111.424 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 64.9 m -82.99 100.8 10.68 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 tt -50.71 139.1 6.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.635 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.3 t -160.48 102.93 1.38 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.5 mt -87.68 116.14 65.2 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.284 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.8 123.74 3.76 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.873 2.382 . . . . 0.0 112.243 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.57 132.22 47.35 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.1 156.8 18.11 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.493 ' C ' ' HD2' ' A' ' 143' ' ' ARG . 96.9 m-85 -96.09 122.67 39.17 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.493 ' HD2' ' C ' ' A' ' 142' ' ' PHE . 3.4 mpt_? . . . . . 0 CA--C 1.485 -1.523 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.431 -1.389 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.87 151.63 31.54 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.0 2.467 . . . . 0.0 110.843 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.37 81.35 1.04 Allowed 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 t -79.85 105.26 11.01 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -79.1 99.05 6.77 Favored 'General case' 0 CA--C 1.458 -2.565 0 CA-C-O 122.482 1.134 . . . . 0.0 109.531 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.49 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -96.26 138.2 34.22 Favored 'General case' 0 N--CA 1.39 -3.451 0 CA-C-N 112.5 -2.137 . . . . 0.0 107.007 -174.018 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 77.8 mtm180 -116.57 121.53 42.01 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 121.107 0.48 . . . . 0.0 111.01 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 205' ' ' LEU . 97.0 t -89.01 116.02 29.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -112.5 122.57 48.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.6 0.714 . . . . 0.0 111.494 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.7 121.02 37.35 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.378 -1.283 . . . . 0.0 107.655 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 166' ' ' HIS . 85.5 mt -113.01 111.74 22.7 Favored 'General case' 0 N--CA 1.396 -3.142 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.612 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 168' ' ' SER . 77.5 tttt -80.65 125.02 29.5 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.832 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' A' ' 164' ' ' LEU . 8.8 p80 -150.74 93.93 2.02 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.462 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.89 6.02 89.71 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.098 -0.956 . . . . 0.0 113.283 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.507 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 22.9 t -165.31 143.25 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.58 76.51 8.91 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.451 0.644 . . . . 0.0 110.708 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.21 121.47 85.19 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.18 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -57.48 135.52 70.33 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.688 2.259 . . . . 0.0 111.724 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -53.39 121.2 7.16 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.207 1.003 . . . . 0.0 111.421 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -80.15 46.65 3.23 Favored Glycine 0 C--O 1.246 0.871 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.717 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -174.78 152.26 1.55 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -137.98 140.99 40.47 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.125 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.4 pt -135.46 136.26 50.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 123.663 0.602 . . . . 0.0 109.832 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.52 158.84 43.34 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.931 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.432 ' CB ' ' HB3' ' A' ' 231' ' ' LEU . 8.3 t70 -84.84 125.42 32.59 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.71 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -130.89 117.98 2.33 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 105.247 -3.141 . . . . 0.0 105.247 171.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.8 t -91.32 144.42 25.61 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.295 1.045 . . . . 0.0 112.711 -170.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t -105.04 129.44 53.47 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.919 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.47 125.17 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 CA-C-O 121.382 0.611 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 98.4 mtt180 -120.38 153.22 36.81 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.5 p -109.07 178.28 4.51 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.534 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.38 -16.56 63.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.9 m -89.84 -4.54 57.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.78 -168.31 12.59 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.527 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.6 pt? -83.93 106.29 15.49 Favored 'General case' 0 N--CA 1.402 -2.828 0 CA-C-O 122.127 0.965 . . . . 0.0 109.878 177.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -112.58 149.93 32.06 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.936 -173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -108.46 150.8 26.92 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.321 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -131.82 147.21 65.02 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.66 135.47 69.62 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.979 1.786 . . . . 0.0 109.986 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.66 76.72 0.39 Allowed Glycine 0 C--N 1.284 -2.33 0 C-N-CA 120.025 -1.084 . . . . 0.0 111.69 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.86 117.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.27 175.91 8.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 54.7 mt -66.05 122.43 17.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.3 p -102.02 -55.28 2.52 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -137.07 155.98 48.96 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.856 0.36 . . . . 0.0 110.268 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.504 HD22 ' HB2' ' A' ' 206' ' ' ALA . 18.4 mt -129.13 140.51 51.51 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.8 t -98.58 124.04 47.83 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.4 127.02 24.21 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.166 1.911 . . . . 0.0 109.986 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.89 21.28 12.31 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.406 -0.902 . . . . 0.0 110.943 -173.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.26 159.57 16.23 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.471 ' HB2' HG12 ' A' ' 161' ' ' VAL . 87.7 mt -70.21 -25.97 63.66 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.807 -0.82 . . . . 0.0 113.117 -176.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.504 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -67.24 -38.22 84.85 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.288 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.412 ' HB3' HD13 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -77.56 -33.95 53.89 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.945 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.2 t -68.0 -33.68 75.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.018 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.1 p -71.57 -43.95 65.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.72 -42.93 1.58 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.9 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.459 ' CD1' ' HG ' ' A' ' 212' ' ' LEU . 1.0 OUTLIER -65.87 -13.56 59.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.351 1.061 . . . . 0.0 113.633 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.459 ' HG ' ' CD1' ' A' ' 211' ' ' LEU . 96.8 mt -108.79 145.77 34.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.44 163.39 25.96 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.027 0.441 . . . . 0.0 111.804 -171.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 58.4 t -54.7 -22.03 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.619 0.768 . . . . 0.0 111.535 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -74.55 -24.08 58.89 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.55 ' HB3' ' N ' ' A' ' 252' ' ' ALA 0.655 0.4 OUTLIER -65.41 158.5 26.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 119.249 3.055 . . . . 0.0 119.249 -176.819 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.02 146.31 34.13 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.07 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.75 142.58 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.922 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.428 HG21 ' HG3' ' A' ' 220' ' ' GLU . 40.0 mm -110.78 -56.59 4.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.048 0.451 . . . . 0.0 110.297 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG3' HG21 ' A' ' 219' ' ' ILE . 44.3 mt-10 -138.4 155.59 48.36 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.383 0.611 . . . . 0.0 112.418 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.7 t -127.54 110.68 22.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 124.657 1.183 . . . . 0.0 107.887 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 69.52 -70.6 0.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.965 1.306 . . . . 0.0 110.471 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -161.95 16.14 0.15 Allowed Glycine 0 C--N 1.299 -1.492 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 19.6 mt -112.49 131.38 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -85.35 167.99 15.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.214 0.531 . . . . 0.0 110.329 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.03 9.71 9.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.378 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.0 102.58 0.08 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.047 -176.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.61 13.16 80.6 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.838 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -97.56 164.03 12.6 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 98.9 m -91.13 157.89 16.96 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 113.046 -1.888 . . . . 0.0 108.955 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 178' ' ' ASP . 1.9 pt? -63.33 -42.1 98.94 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.681 0.277 . . . . 0.0 111.313 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.37 -49.99 72.84 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.312 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.25 -46.4 89.92 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.443 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.487 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 91.2 t -67.57 -45.95 84.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.901 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 10.6 t -68.02 -29.91 69.03 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.68 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.98 -48.53 52.8 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.394 0.616 . . . . 0.0 109.988 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.487 ' HG2' ' HA ' ' A' ' 234' ' ' VAL . 21.5 ptt? -65.0 -33.54 76.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -175.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.405 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 14.7 ptp -73.15 -25.21 60.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.481 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.612 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 93.6 t -85.33 -37.44 12.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.608 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.51 67.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.939 175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.03 21.98 15.32 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 73.0 m -59.25 -20.81 57.32 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 15.1 m -53.62 -50.65 65.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.685 0.794 . . . . 0.0 109.647 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -125.69 75.44 1.49 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.9 tp -103.2 104.3 14.42 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.139 0.971 . . . . 0.0 112.728 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.58 118.11 55.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.575 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 10.8 tt -111.23 133.32 57.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.512 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 21.8 m -100.15 125.02 46.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.034 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.49 163.36 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 123.3 0.375 . . . . 0.0 110.475 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -133.79 123.48 17.2 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.78 135.82 71.43 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.484 2.79 . . . . 0.0 113.544 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.55 ' N ' ' HB3' ' A' ' 216' ' ' ASP . . . -116.78 20.86 13.74 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 N--CA 1.472 0.658 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.335 179.401 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.9 101.84 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.21 1.94 . . . . 0.0 111.749 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -88.93 85.05 6.65 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.42 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 136' ' ' ILE . 2.5 pp -86.11 136.77 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.3 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.4 m -102.98 90.9 3.91 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.3 tt -87.83 123.0 69.91 Favored Pre-proline 0 C--N 1.29 -1.978 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.131 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -66.8 122.12 9.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.695 1.597 . . . . 0.0 110.362 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -94.19 120.34 34.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.455 -177.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.62 130.32 53.68 Favored 'General case' 0 CA--C 1.484 -1.583 0 CA-C-O 120.82 0.343 . . . . 0.0 110.718 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -153.24 86.44 1.23 Allowed 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 . . . . . 0 C--N 1.3 -1.578 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.327 -178.869 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 N--CA 1.426 -1.663 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.05 130.41 16.23 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.033 2.489 . . . . 0.0 113.955 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.78 -7.35 49.83 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.668 0.747 . . . . 0.0 109.722 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.3 t -75.3 102.22 4.98 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -91.19 143.91 26.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.858 -173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -97.87 121.34 39.67 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.97 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -99.86 104.35 16.01 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.74 117.32 32.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 120.956 0.408 . . . . 0.0 110.376 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.418 ' HG2' HG12 ' A' ' 246' ' ' ILE . 58.3 mtp180 -88.75 136.66 32.89 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 171' ' ' PRO . 3.4 tm? -120.38 121.3 38.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.62 99.78 9.45 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.8 145.76 46.79 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -101.78 -12.2 18.5 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.377 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.94 44.63 Favored Glycine 0 N--CA 1.46 0.233 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.085 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.7 t -149.33 128.63 12.9 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.3 t70 72.2 -42.5 0.53 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.832 1.253 . . . . 0.0 113.172 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -122.05 94.77 47.92 Favored Pre-proline 0 C--O 1.254 1.319 0 CA-C-O 120.671 0.272 . . . . 0.0 110.399 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.403 ' O ' HD12 ' A' ' 163' ' ' LEU . 4.3 Cg_exo -83.46 -69.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.063 2.509 . . . . 0.0 112.123 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 pp -157.19 157.39 34.3 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.342 0.657 . . . . 0.0 110.597 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -128.57 48.2 0.98 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.515 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -160.47 147.58 15.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -138.54 146.21 41.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.52 152.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 123.441 0.463 . . . . 0.0 111.868 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 79.2 ttt180 -141.82 149.9 40.95 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.86 133.98 44.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.974 0.416 . . . . 0.0 110.595 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.36 165.99 15.92 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.8 p -93.11 120.4 33.36 Favored 'General case' 0 N--CA 1.391 -3.413 0 CA-C-N 117.986 0.893 . . . . 0.0 111.181 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.6 t -118.7 132.42 56.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.6 p -98.34 127.2 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.623 0.725 . . . . 0.0 109.177 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -112.85 153.43 27.9 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.68 107.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.1 p -110.18 178.15 4.48 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.19 -13.6 61.19 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.4 m -87.99 -4.6 58.79 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.588 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.55 -159.19 13.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.477 HD11 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.89 128.31 34.56 Favored 'General case' 0 N--CA 1.379 -3.977 0 CA-C-N 117.154 0.477 . . . . 0.0 110.003 175.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.38 153.49 48.67 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -119.89 140.27 51.11 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-O 121.311 0.577 . . . . 0.0 109.618 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -139.62 144.74 40.55 Favored Pre-proline 0 C--N 1.277 -2.554 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.81 119.52 5.93 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.246 1.964 . . . . 0.0 110.288 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.61 118.01 5.67 Favored Glycine 0 C--N 1.276 -2.758 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 177' ' ' ARG . 2.6 pt -96.5 117.53 41.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.598 0.713 . . . . 0.0 112.2 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -119.77 169.9 9.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.684 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.61 131.06 34.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.0 p -114.26 -56.02 2.43 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -123.55 142.01 51.45 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.486 HD22 ' HB2' ' A' ' 206' ' ' ALA . 18.2 mt -128.15 139.12 52.66 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.33 123.25 49.18 Favored Pre-proline 0 N--CA 1.416 -2.142 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -50.51 130.59 30.11 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.616 2.211 . . . . 0.0 112.215 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.62 5.14 65.12 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.34 146.06 41.84 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 114.785 -0.708 . . . . 0.0 112.779 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.425 HD13 ' H ' ' A' ' 205' ' ' LEU . 5.0 mp -55.4 -33.65 63.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.414 1.086 . . . . 0.0 113.14 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.486 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -66.13 -41.14 90.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.194 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.9 -34.97 57.68 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.9 m -54.87 -30.58 58.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.064 0.946 . . . . 0.0 112.558 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 205' ' ' LEU . 80.8 p -58.26 -43.24 87.79 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.636 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.73 21.18 72.83 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 tp -138.2 -35.42 0.62 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.154 -1.023 . . . . 0.0 110.804 -173.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.0 mm? -108.23 139.15 43.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.83 0.824 . . . . 0.0 111.179 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.38 162.28 13.15 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.393 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.83 -24.89 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-O 121.514 0.673 . . . . 0.0 110.983 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.436 HD21 ' HB2' ' A' ' 252' ' ' ALA . 8.2 t30 -73.28 -23.88 60.36 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.292 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.559 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 64.1 m-20 -62.45 158.73 17.04 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.448 0.699 . . . . 0.0 112.079 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.36 157.32 25.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.57 130.59 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.921 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.81 -42.96 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.179 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.447 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 34.2 mt-10 -137.68 152.7 49.56 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.341 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.58 96.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.467 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.494 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 67.13 1.15 2.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.164 1.386 . . . . 0.0 112.583 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 123.8 -4.29 9.21 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.68 134.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.14 147.36 31.39 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.842 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 195' ' ' ILE . 25.8 m -117.19 10.64 7.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.083 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -61.48 105.82 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.067 0.46 . . . . 0.0 110.806 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.33 2.64 53.95 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.942 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.526 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.0 mmpt? -88.95 141.67 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.582 -0.364 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.476 ' O ' HG22 ' A' ' 234' ' ' VAL . 11.7 t -85.57 164.75 17.57 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.454 ' O ' HG22 ' A' ' 235' ' ' THR . 1.7 pt? -55.78 -41.66 74.42 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.278 0.49 . . . . 0.0 112.203 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.418 ' H ' HD23 ' A' ' 231' ' ' LEU . 25.0 t70 -59.89 -40.57 89.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.543 0.687 . . . . 0.0 110.677 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 11.9 mm-40 -69.22 -47.04 65.88 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.462 177.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 230' ' ' THR . 58.9 t -61.09 -43.74 96.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.54 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 239' ' ' VAL . 8.4 t -65.36 -40.09 93.13 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.095 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.62 -45.0 85.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.238 0.542 . . . . 0.0 110.517 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 77.3 mtp -56.43 -49.24 75.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.461 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.426 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.1 ptp -76.79 -9.76 58.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.183 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.654 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 70.4 t -83.07 -31.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.626 0.727 . . . . 0.0 109.171 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.5 -13.12 61.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.496 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -130.86 29.16 4.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.128 0.571 . . . . 0.0 110.848 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.654 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 68.1 m -61.99 -28.26 69.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -173.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.3 m -51.85 -61.92 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.169 0.509 . . . . 0.0 110.836 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -129.69 88.42 2.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 245' ' ' LEU . 3.6 pp -92.02 133.47 35.69 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 62.6 mt -114.37 119.52 61.61 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.296 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.1 tt -109.89 118.69 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 111.134 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 38.5 m -90.51 119.71 31.0 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.456 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 15.7 m -114.93 144.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.407 ' HD3' ' C ' ' A' ' 250' ' ' LYS . 13.1 tmtt? -125.62 125.42 25.0 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.978 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 18.7 Cg_endo -68.02 127.24 15.68 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.34 2.027 . . . . 0.0 114.097 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.436 ' HB2' HD21 ' A' ' 215' ' ' ASN . . . -106.42 -35.32 7.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.308 -1.222 0 CA-C-N 112.75 -2.023 . . . . 0.0 113.197 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.98 102.82 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.848 2.365 . . . . 0.0 112.773 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 m -86.37 91.77 8.61 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.1 mm -71.59 140.51 18.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 23.0 t -94.61 96.07 9.19 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.7 tt -94.19 107.96 32.48 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.8 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 137' ' ' SER . 12.2 Cg_exo -71.24 136.35 28.94 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.139 1.893 . . . . 0.0 109.507 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -101.37 113.87 27.35 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -95.55 128.63 42.57 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.279 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -134.39 99.16 4.29 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 . . . . . 0 N--CA 1.41 -2.442 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.343 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -82.73 142.34 11.35 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.074 1.849 . . . . 0.0 109.257 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.2 96.84 0.11 Allowed 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.195 0.521 . . . . 0.0 112.025 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.8 m -88.07 93.51 9.51 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -82.22 113.26 19.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -132.86 138.12 46.93 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.106 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.582 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 0.0 OUTLIER -110.94 114.49 27.85 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 205' ' ' LEU . 21.8 t -100.64 132.39 46.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.415 ' HG2' HG13 ' A' ' 246' ' ' ILE . 97.4 mtt180 -94.63 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.106 0.479 . . . . 0.0 112.089 -176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.6 tm? -127.31 125.43 40.8 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.405 HD11 ' O ' ' A' ' 164' ' ' LEU 0.276 2.1 pp -112.36 101.68 9.86 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-O 122.442 1.115 . . . . 0.0 112.232 176.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -100.8 120.72 40.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.93 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -151.45 92.12 1.74 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.942 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.01 88.03 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.734 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 p -110.73 137.43 48.4 Favored 'General case' 0 N--CA 1.392 -3.34 0 C-N-CA 123.711 0.804 . . . . 0.0 109.699 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -125.18 82.75 2.09 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.938 0.875 . . . . 0.0 108.783 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -129.0 143.79 50.12 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.383 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.84 141.77 95.72 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.058 1.838 . . . . 0.0 111.226 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.75 123.56 21.25 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.42 46.43 2.52 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.152 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.577 ' HE1' ' SD ' ' A' ' 238' ' ' MET . 50.7 p90 -174.7 134.04 0.37 Allowed 'General case' 0 N--CA 1.416 -2.139 0 C-N-CA 125.803 1.641 . . . . 0.0 107.711 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.4 141.33 51.08 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 176' ' ' ILE . 2.3 pp -126.11 140.92 47.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.873 -177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 231' ' ' LEU . 55.9 ttt180 -142.19 148.05 37.58 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.754 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.85 145.37 29.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -132.26 163.94 23.9 Favored Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.7 m -104.65 131.78 51.68 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.041 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.9 m -106.13 136.02 46.57 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.518 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.2 128.93 60.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.514 0.674 . . . . 0.0 111.408 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -114.01 152.75 30.49 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.45 115.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 120.724 0.297 . . . . 0.0 110.464 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.9 p -113.08 169.86 8.63 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.42 61.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.017 0.437 . . . . 0.0 111.034 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.0 m -93.65 -3.81 51.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.546 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.78 -168.86 22.19 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.339 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.505 HD21 ' H ' ' A' ' 189' ' ' LEU . 2.1 pt? -85.24 130.37 34.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.427 0.632 . . . . 0.0 111.127 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -108.55 155.63 20.42 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.323 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -119.8 148.8 43.0 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -139.63 153.47 70.31 Favored Pre-proline 0 N--CA 1.411 -2.408 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.52 138.57 21.96 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.34 2.027 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.1 107.03 0.57 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.4 tt -105.51 118.52 53.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.649 0.738 . . . . 0.0 111.369 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.408 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 70.4 m-85 -125.81 165.56 18.44 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.458 -175.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.4 mt -70.68 127.8 33.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 172.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.5 p -102.45 -39.93 6.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -150.24 147.75 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.427 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 206' ' ' ALA . 15.4 mt -114.56 139.34 49.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.246 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.0 t -103.99 128.76 26.53 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.85 126.41 21.87 Favored 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.032 1.821 . . . . 0.0 110.67 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.57 13.45 58.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.43 160.24 24.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.7 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.415 ' HB3' HG11 ' A' ' 161' ' ' VAL . 85.6 mt -54.35 -46.2 72.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.573 1.149 . . . . 0.0 113.906 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.501 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -68.45 -27.18 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.858 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.76 -42.22 50.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.9 m -56.38 -31.56 63.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.2 p -61.08 -44.36 97.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.37 -47.65 1.73 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 121.474 0.486 . . . . 0.0 112.767 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.53 -23.96 65.5 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.039 1.336 . . . . 0.0 111.167 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.2 mm? -108.02 146.0 33.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.174 0.511 . . . . 0.0 109.728 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -92.39 158.32 16.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.05 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 23.6 t -67.0 -27.33 39.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.603 -178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.87 58.89 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 89.4 m-20 -48.75 161.03 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -169.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.408 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 41.5 mt-10 -93.41 154.28 18.03 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.302 -172.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.22 134.81 45.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.416 HG21 ' HG3' ' A' ' 220' ' ' GLU . 46.7 mm -111.0 -44.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.867 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.541 ' H ' ' HB ' ' A' ' 248' ' ' THR . 40.4 mt-10 -141.07 154.32 45.89 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.371 0.605 . . . . 0.0 111.591 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 65.9 t -128.75 108.34 17.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.588 172.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 70.56 -9.96 0.74 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.524 0.678 . . . . 0.0 111.937 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 127.98 -9.37 6.72 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.455 HG23 ' SD ' ' A' ' 237' ' ' MET . 48.5 mt -84.01 121.01 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -75.65 137.76 40.93 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.045 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.5 m -91.75 17.41 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.837 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.7 109.32 2.38 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.115 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.55 9.69 64.39 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.877 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 10.4 mmpt? -93.93 168.43 10.97 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 234' ' ' VAL . 9.9 t -120.02 163.46 17.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 232' ' ' ASP . 0.0 OUTLIER -50.5 -46.77 57.34 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -171.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.512 ' N ' HD23 ' A' ' 231' ' ' LEU . 23.5 t70 -74.29 -40.55 62.21 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.304 0.574 . . . . 0.0 109.828 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.555 ' O ' ' HG3' ' A' ' 237' ' ' MET . 36.1 tt0 -59.24 -43.28 92.39 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.93 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 230' ' ' THR . 97.7 t -70.25 -46.61 71.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.984 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.462 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 21.4 p -60.97 -37.8 83.71 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.155 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.45 -44.61 84.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 37.6 mtm -64.28 -47.06 80.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.402 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.577 ' SD ' ' HE1' ' A' ' 174' ' ' PHE . 20.9 ptp -67.27 -25.71 66.2 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.01 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.78 -28.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.901 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.58 75.12 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 121.664 0.745 . . . . 0.0 109.268 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.91 -62.06 1.67 Allowed 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.575 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 38.1 t 64.6 -40.97 0.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.309 1.444 . . . . 0.0 114.176 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 -46.47 51.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.27 75.39 0.98 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 238' ' ' MET . 4.3 tt -92.89 116.34 28.95 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 3.3 mp -127.16 127.92 69.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.4 pt -109.43 118.67 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.541 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 64.7 m -92.2 120.16 32.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.417 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 20.8 m -113.89 141.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.963 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.15 129.0 14.43 Favored Pre-proline 0 N--CA 1.42 -1.936 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.614 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 12.3 Cg_endo -56.03 130.9 42.77 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.24 2.626 . . . . 0.0 114.811 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.43 -7.39 44.66 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 112.953 -1.93 . . . . 0.0 112.45 179.068 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.3 -159.91 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.05 2.5 . . . . 0.0 110.633 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.1 p -82.61 87.08 6.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.56 153.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.9 p -103.05 103.64 13.75 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.0 tt -92.83 114.73 63.41 Favored Pre-proline 0 C--N 1.275 -2.648 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.577 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.58 145.25 37.12 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.477 2.118 . . . . 0.0 111.727 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -97.73 114.45 26.45 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -90.24 154.08 20.0 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.4 t80 53.65 -145.37 0.6 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? . . . . . 0 C--N 1.278 -2.514 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 166.804 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -65.47 151.97 83.34 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 123.26 2.64 . . . . 0.0 109.509 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.529 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 13.1 pt-20 -58.7 88.07 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -93.08 116.0 28.63 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 171.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -91.56 109.51 20.81 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.495 ' HD3' ' N ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -120.74 134.87 55.26 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.495 ' N ' ' HD3' ' A' ' 159' ' ' ARG . 37.8 ptt180 -113.92 123.03 48.77 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.647 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.422 HG22 ' NH1' ' A' ' 159' ' ' ARG . 47.4 t -90.03 115.69 30.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.439 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -96.11 145.15 25.73 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.975 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.8 mt -126.44 121.56 32.77 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.936 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 164' ' ' LEU . 1.7 pp -106.91 101.07 10.53 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-O 122.727 1.251 . . . . 0.0 108.689 169.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 165' ' ' LYS 0.259 0.0 OUTLIER -75.47 127.84 34.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -172.242 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -105.7 112.26 25.26 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.759 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.79 -4.2 80.41 Favored Glycine 0 C--O 1.222 -0.645 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.714 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.4 m 61.8 20.98 11.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.748 0.819 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.59 102.46 3.81 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.331 0.586 . . . . 0.0 109.605 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -160.41 131.26 3.74 Favored Pre-proline 0 C--N 1.275 -2.64 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.098 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.88 141.42 93.15 Favored 'Trans proline' 0 C--O 1.254 1.319 0 C-N-CA 122.861 2.374 . . . . 0.0 112.698 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.6 130.85 38.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.107 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -87.03 -23.57 40.77 Favored Glycine 0 C--N 1.289 -2.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -108.27 144.85 35.2 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -134.95 147.41 49.76 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.528 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.5 149.41 30.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.517 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 75.4 ttt180 -134.06 153.14 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.508 ' HA ' HG23 ' A' ' 195' ' ' ILE . 19.6 m-20 -74.73 151.73 39.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.073 0.463 . . . . 0.0 111.302 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.36 161.32 26.6 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 p -101.98 136.44 41.81 Favored 'General case' 0 N--CA 1.394 -3.242 0 CA-C-O 121.125 0.488 . . . . 0.0 111.62 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.4 t -111.6 120.3 41.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.0 p -91.16 123.59 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.668 0.746 . . . . 0.0 111.144 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.02 158.55 24.76 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.2 t -100.23 116.57 43.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.9 p -115.17 177.54 4.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.53 -21.4 61.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.044 0.45 . . . . 0.0 109.857 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.6 p -87.17 -1.27 57.77 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.61 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.75 -168.9 13.69 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.953 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.515 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.07 106.17 15.51 Favored 'General case' 0 N--CA 1.384 -3.737 0 CA-C-O 122.899 1.333 . . . . 0.0 110.593 175.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -111.46 155.42 23.23 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.387 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 7.7 mptt -116.93 127.2 53.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.48 153.58 47.69 Favored Pre-proline 0 C--N 1.263 -3.176 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.466 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 14.2 Cg_exo -68.11 113.4 3.04 Favored 'Trans proline' 0 N--CA 1.423 -2.629 0 C-N-CA 121.343 1.362 . . . . 0.0 109.013 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -132.31 92.06 0.27 Allowed Glycine 0 CA--C 1.457 -3.567 0 N-CA-C 106.889 -2.484 . . . . 0.0 106.889 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 178' ' ' ASP . 23.4 pt -77.22 135.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.34 -172.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.05 166.9 10.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.258 -173.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.3 mt -67.44 130.77 33.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.517 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 67.6 p -98.73 -36.46 9.83 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.507 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -151.01 146.02 25.93 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.557 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.451 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 52.4 tp -127.43 124.93 39.62 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.91 128.9 29.74 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.42 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 50.7 Cg_exo -57.63 126.86 23.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.16 1.907 . . . . 0.0 109.451 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.75 -9.87 60.46 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.87 149.87 24.66 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.82 -26.09 65.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -173.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -74.73 -32.36 62.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.009 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.449 ' N ' HD11 ' A' ' 200' ' ' LEU . 3.6 tm-20 -76.45 -38.85 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.0 m -57.88 -32.03 67.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.355 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.0 m -61.56 -43.55 98.66 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 78.52 -14.44 12.58 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.854 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 53.4 mt -85.93 -36.83 19.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.097 0.475 . . . . 0.0 111.099 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 81.0 mt -115.33 146.92 41.06 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.34 163.84 17.24 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.666 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 13.7 p -45.84 -33.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.24 -24.26 66.24 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -69.29 165.91 19.62 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.28 142.18 45.08 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -171.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 195' ' ' ILE . 14.1 m -95.82 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.469 HD13 ' CD ' ' A' ' 250' ' ' LYS . 25.1 pt -120.06 -41.9 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.418 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 39.6 mt-10 -133.55 151.25 51.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.581 0.705 . . . . 0.0 112.75 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.76 108.73 23.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.516 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.1 t-20 70.22 -71.1 0.13 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.165 0.986 . . . . 0.0 110.72 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.14 21.75 0.13 Allowed Glycine 0 C--N 1.298 -1.574 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.452 ' CG2' ' HE2' ' A' ' 237' ' ' MET . 15.8 mt -116.73 121.77 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.11 151.08 37.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 118.806 0.73 . . . . 0.0 111.5 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.55 -6.39 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.995 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.45 121.33 15.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.314 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.466 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 93.12 10.3 59.82 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.101 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -111.13 173.35 6.38 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 234' ' ' VAL . 90.4 m -100.9 158.52 15.92 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.007 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.37 -46.19 86.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.441 0.296 . . . . 0.0 111.62 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.25 -41.79 89.59 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.327 0.584 . . . . 0.0 110.286 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.58 -49.34 75.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.946 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 230' ' ' THR . 85.1 t -59.88 -45.92 94.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.946 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.474 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 12.1 t -69.17 -37.13 78.02 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -42.56 90.56 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.452 ' HE2' ' CG2' ' A' ' 224' ' ' ILE . 52.4 mtp -56.5 -51.08 69.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.761 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.474 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptp -73.19 -15.03 61.46 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.356 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.581 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 98.1 t -91.4 -27.01 4.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.89 66.17 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.461 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -142.94 32.72 1.38 Allowed 'General case' 0 N--CA 1.419 -1.997 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.933 -173.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 61.7 m -54.19 -27.98 37.67 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 t -72.29 -29.62 64.04 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -126.22 56.48 1.44 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.8 122.65 29.44 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.733 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.516 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 67.0 mt -130.22 125.11 59.24 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.658 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.16 121.42 64.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.768 0.794 . . . . 0.0 110.513 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 15.3 m -94.15 128.57 40.65 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.21 -175.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.431 HG12 HG13 ' A' ' 218' ' ' VAL . 4.9 m -124.88 148.46 29.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.469 ' CD ' HD13 ' A' ' 219' ' ' ILE . 58.1 mtpt -130.28 138.24 32.62 Favored Pre-proline 0 CA--C 1.508 -0.658 0 C-N-CA 124.394 1.078 . . . . 0.0 109.366 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.579 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 26.5 Cg_endo -64.76 126.86 17.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.628 1.552 . . . . 0.0 111.423 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.4 -28.18 19.93 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 121.833 0.825 . . . . 0.0 109.721 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 44.1 m-80 . . . . . 0 C--N 1.289 -2.032 0 CA-C-N 113.113 -1.858 . . . . 0.0 112.024 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -93.48 12.51 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.887 2.392 . . . . 0.0 112.487 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m 68.36 94.89 0.07 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.927 0.891 . . . . 0.0 111.75 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.5 mt -81.48 157.12 4.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.4 m 71.58 96.02 0.07 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.582 -176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.1 tt -102.55 136.74 19.3 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.259 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 129.8 37.05 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.297 1.998 . . . . 0.0 109.953 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -98.13 161.02 13.92 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.267 0.556 . . . . 0.0 112.335 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.89 156.04 22.59 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -80.49 -29.12 37.35 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.038 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' A' ' 143' ' ' ARG . 1.7 mmp_? . . . . . 0 N--CA 1.443 -0.816 0 C-N-CA 124.008 0.923 . . . . 0.0 108.898 -177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.421 -1.894 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 130.74 41.77 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.547 2.164 . . . . 0.0 113.727 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.94 8.99 43.23 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.637 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -74.15 99.91 3.51 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.575 ' CE1' ' HE3' ' A' ' 250' ' ' LYS . 30.3 m170 -70.13 130.06 41.09 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.463 0.649 . . . . 0.0 112.423 -169.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -102.54 116.78 33.3 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.395 -167.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -100.73 135.81 41.58 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.72 128.53 56.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.538 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.42 ' CB ' HG12 ' A' ' 246' ' ' ILE . 36.8 ptt180 -108.62 126.88 53.45 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.81 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.2 mt -107.91 121.23 44.34 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.428 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.76 107.34 19.76 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.819 0.818 . . . . 0.0 111.662 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -88.27 120.47 29.66 Favored 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.919 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -152.5 102.33 2.73 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.432 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.75 63.66 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.113 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -130.26 178.23 6.73 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.67 -49.21 3.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.743 0.306 . . . . 0.0 110.689 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -166.58 100.13 0.68 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.5 44.44 1.24 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 123.481 2.787 . . . . 0.0 113.768 -175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . 0.342 0.6 OUTLIER -69.59 90.78 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -178.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -97.84 38.93 2.91 Favored Glycine 0 C--N 1.308 -0.986 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.98 150.49 24.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 77.9 m-85 -136.71 134.88 37.66 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.794 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.2 pt -133.71 142.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.626 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.09 159.7 41.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.44 1.096 . . . . 0.0 108.094 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -91.44 122.24 33.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.461 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -119.38 114.89 2.89 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 104.584 -3.407 . . . . 0.0 104.584 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -89.0 128.23 35.7 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.614 -165.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -92.85 127.52 38.39 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.855 -172.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.02 138.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.928 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -121.23 152.77 38.46 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.44 107.99 24.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.2 p -115.42 177.31 4.71 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.422 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.71 -6.09 54.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.276 0.56 . . . . 0.0 109.577 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.1 m -88.04 -4.49 58.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.77 -142.4 17.44 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.488 HD21 ' H ' ' A' ' 189' ' ' LEU . 0.4 OUTLIER -101.86 115.59 30.88 Favored 'General case' 0 N--CA 1.392 -3.372 0 CA-C-O 121.169 0.509 . . . . 0.0 109.971 176.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.66 152.04 30.96 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.924 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -122.22 146.44 47.26 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.734 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -127.07 147.91 63.67 Favored Pre-proline 0 N--CA 1.417 -2.125 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.36 137.04 64.39 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.949 2.433 . . . . 0.0 111.542 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -138.85 73.7 0.41 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.337 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 11.9 tt -84.21 116.39 27.91 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.746 0.784 . . . . 0.0 109.091 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.617 ' CE2' ' HG2' ' A' ' 217' ' ' GLU . 87.2 m-85 -130.18 172.1 12.15 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.908 -175.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.2 136.18 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 47.1 m -126.17 -16.89 5.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.345 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 50.9 ttt180 -158.98 142.96 15.29 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.436 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 206' ' ' ALA . 18.5 mt -128.4 139.31 52.44 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.94 124.59 45.06 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.88 129.47 32.22 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.689 1.593 . . . . 0.0 109.857 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.19 -9.83 57.98 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.02 153.25 46.62 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.15 -38.94 80.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -68.64 -33.45 74.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.035 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.21 -43.5 42.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.204 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.4 m -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 m -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.92 -12.21 9.41 Favored Glycine 0 N--CA 1.465 0.58 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.935 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 36.7 mt -93.84 -15.78 24.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 71.9 mt -108.92 143.56 38.01 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.791 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.65 163.45 27.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.812 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.33 -14.44 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 121.582 0.706 . . . . 0.0 111.768 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.18 -22.35 58.09 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.659 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 58.9 m-20 -63.41 157.37 23.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -174.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.617 ' HG2' ' CE2' ' A' ' 196' ' ' PHE . 37.6 mt-10 -106.69 145.37 32.09 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.681 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.36 134.36 29.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.466 HG13 ' CD ' ' A' ' 250' ' ' LYS . 50.3 mm -116.2 -49.87 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.42 ' H ' ' HB ' ' A' ' 248' ' ' THR . 44.0 mt-10 -125.38 147.79 49.03 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.413 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.558 ' HB ' ' HE3' ' A' ' 237' ' ' MET . 67.3 t -111.0 96.72 4.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 105.655 -1.979 . . . . 0.0 105.655 165.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 45.3 t30 68.41 -77.62 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 124.392 1.077 . . . . 0.0 111.333 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -146.0 10.27 1.59 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.502 ' CG2' ' HE2' ' A' ' 237' ' ' MET . 10.8 mt -107.14 133.05 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -81.32 149.77 28.78 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.11 2.24 8.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.519 0.676 . . . . 0.0 109.881 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.33 109.26 2.2 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.966 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 6.51 48.24 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 9.4 mmpt? -103.4 166.89 10.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 234' ' ' VAL . 16.9 m -118.59 159.77 22.99 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.37 -46.92 56.28 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.23 -37.15 84.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.3 0.571 . . . . 0.0 110.894 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.411 ' NE2' ' HB ' ' A' ' 230' ' ' THR . 1.9 mp0 -70.3 -37.82 74.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.215 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 230' ' ' THR . 96.8 t -63.09 -44.19 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 0.0 110.974 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.546 ' O ' HG23 ' A' ' 239' ' ' VAL . 11.7 t -67.89 -35.28 78.23 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.841 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.35 -43.15 86.86 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.948 0.88 . . . . 0.0 109.167 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.558 ' HE3' ' HB ' ' A' ' 221' ' ' VAL . 16.9 ttt -56.59 -45.82 81.18 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.372 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 19.1 ptp -76.28 -16.46 59.78 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.765 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 75.3 t -81.02 -33.78 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.277 0.56 . . . . 0.0 109.547 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.47 -22.48 43.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.188 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -132.91 30.24 4.03 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.243 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.765 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 67.8 m -74.1 -18.83 60.76 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 38.5 m -58.77 -48.04 82.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.37 0.605 . . . . 0.0 109.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -124.23 79.32 1.73 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.934 -2.246 . . . . 0.0 104.934 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.8 tp -86.4 118.65 25.97 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.349 -1.751 . . . . 0.0 111.06 -170.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.42 HG12 ' CB ' ' A' ' 162' ' ' ARG . 59.8 mt -127.03 133.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.843 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.3 tt -131.8 132.09 61.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 121.317 0.58 . . . . 0.0 111.981 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.42 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 61.8 m -102.35 125.68 49.13 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.872 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.23 139.98 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 158' ' ' HIS . 57.4 mtpt -110.91 122.57 37.68 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.659 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 14.5 Cg_endo -60.27 133.12 47.63 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 122.645 2.23 . . . . 0.0 113.766 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -97.27 8.75 43.94 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 . . . . . 0 N--CA 1.425 -1.685 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.731 178.149 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.29 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.37 115.61 3.44 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 122.41 2.073 . . . . 0.0 111.079 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -75.69 94.52 3.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.271 0.558 . . . . 0.0 109.592 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.8 mt 72.51 138.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 125.662 1.585 . . . . 0.0 110.721 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t -120.98 100.7 7.22 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.902 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.2 tt -94.71 123.19 58.74 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.82 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -68.03 131.19 23.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.848 1.699 . . . . 0.0 109.048 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -76.32 150.24 36.94 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.26 155.85 23.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.95 117.54 25.75 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 . . . . . 0 N--CA 1.432 -1.352 0 CA-C-O 122.382 1.087 . . . . 0.0 110.106 -175.768 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.427 -1.621 0 CA-C-O 121.43 0.633 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.55 152.7 43.51 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.941 2.428 . . . . 0.0 109.601 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -63.93 83.29 0.03 OUTLIER 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 121.426 0.632 . . . . 0.0 109.898 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.1 m -82.82 111.09 18.41 Favored 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -82.32 110.86 17.86 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HB3' HG11 ' A' ' 249' ' ' VAL . 77.8 ttt180 -94.3 116.78 29.22 Favored 'General case' 0 C--N 1.267 -2.992 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.89 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -125.66 109.62 12.83 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.588 -173.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.7 m -105.29 132.32 52.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.434 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -114.89 147.96 39.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -170.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 90.5 mt -126.34 120.02 28.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.313 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.33 108.19 13.85 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.586 175.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.624 ' HD2' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.73 121.36 21.6 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -173.99 105.66 0.12 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.133 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.434 ' C ' ' HG ' ' A' ' 168' ' ' SER . . . 96.42 -10.42 67.11 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.685 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.434 ' HG ' ' C ' ' A' ' 167' ' ' GLY . 51.0 m -157.93 164.14 37.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -106.53 85.51 2.18 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.445 ' HD3' ' HB3' ' A' ' 242' ' ' SER . 24.5 pttm 38.5 97.45 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.663 1.985 . . . . 0.0 116.272 170.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 100.73 1.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.861 1.708 . . . . 0.0 110.461 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.81 99.69 2.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.546 0.689 . . . . 0.0 111.35 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -93.59 43.99 2.44 Favored Glycine 0 C--N 1.282 -2.425 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.007 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -170.29 145.69 2.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.889 0.876 . . . . 0.0 108.729 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.1 143.94 42.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.702 0.287 . . . . 0.0 111.051 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.444 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 2.3 pp -124.71 154.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.258 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -141.26 158.78 43.43 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.006 0.522 . . . . 0.0 110.321 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.8 131.96 36.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.26 -172.38 18.14 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 191' ' ' LYS . 3.1 m -126.43 143.19 51.27 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.332 -0.947 . . . . 0.0 108.734 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t -120.3 119.77 34.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.68 123.38 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.791 0.805 . . . . 0.0 110.652 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 16.2 ptp180 -117.37 160.06 21.76 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.351 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -99.22 108.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.135 0.969 . . . . 0.0 110.811 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.8 p -108.13 178.21 4.57 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.82 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.91 -17.32 63.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.057 0.456 . . . . 0.0 109.944 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.7 m -87.9 -4.74 58.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.367 0.603 . . . . 0.0 109.424 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.04 -158.47 14.3 Favored Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 183' ' ' ARG 0.266 1.1 pp -84.6 106.9 16.51 Favored 'General case' 0 N--CA 1.4 -2.942 0 CA-C-O 122.224 1.012 . . . . 0.0 112.642 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -109.95 155.39 21.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.052 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 180' ' ' THR . 7.3 ptpp? -106.21 139.69 40.32 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 121.516 0.674 . . . . 0.0 111.362 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.436 ' NE2' ' HD2' ' A' ' 193' ' ' PRO . 56.3 tp60 -127.95 141.63 41.78 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -177.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.436 ' HD2' ' NE2' ' A' ' 192' ' ' GLN . 16.9 Cg_exo -66.16 125.58 14.31 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.654 2.236 . . . . 0.0 109.699 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -140.6 135.32 6.94 Favored Glycine 0 C--N 1.28 -2.559 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.629 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.444 ' CG2' ' HB ' ' A' ' 176' ' ' ILE . 49.7 mm -93.04 122.21 44.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -107.84 162.23 14.19 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.01 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.6 mt -73.16 136.67 24.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.7 t -118.38 -61.02 1.72 Allowed 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.129 -1.029 . . . . 0.0 112.172 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -123.12 155.65 36.56 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 206' ' ' ALA . 17.0 mt -126.65 138.74 53.46 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.874 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.3 t -99.6 128.45 31.36 Favored Pre-proline 0 C--N 1.283 -2.313 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.29 126.81 22.59 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 121.952 1.768 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.37 40.16 6.55 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 -172.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.31 162.39 12.61 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.902 -0.649 . . . . 0.0 112.794 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.92 -43.43 68.28 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.086 0.555 . . . . 0.0 111.494 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.478 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -72.41 -26.64 61.94 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.932 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -67.64 -45.28 75.8 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.8 t -64.49 -38.23 90.3 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.281 0.563 . . . . 0.0 110.314 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 206' ' ' ALA . 17.1 p -79.19 -6.18 55.97 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 52.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 125.412 1.482 . . . . 0.0 116.518 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.55 -19.96 15.27 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.459 ' HB3' ' OD2' ' A' ' 216' ' ' ASP . 6.7 mp -109.69 149.91 29.05 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.479 -2.146 . . . . 0.0 107.261 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.13 162.36 16.77 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.467 0.651 . . . . 0.0 111.461 -170.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.49 -15.82 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.486 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -69.78 -23.63 63.38 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.55 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.571 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.2 m-20 -61.79 159.75 13.14 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -106.23 145.32 31.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.515 -170.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 195' ' ' ILE . 35.2 m -89.55 143.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.6 mp -115.27 -51.87 4.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -174.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.438 ' H ' ' HB ' ' A' ' 248' ' ' THR . 41.9 mt-10 -135.44 153.31 51.82 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.561 0.696 . . . . 0.0 112.597 -172.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 92.6 t -117.02 98.28 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.424 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 49.1 t-20 65.82 -78.53 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.522 1.129 . . . . 0.0 110.522 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -137.0 -0.52 2.77 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.9 mt -101.79 129.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -82.08 150.85 27.31 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.254 0.479 . . . . 0.0 110.409 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.582 HG11 ' SD ' ' A' ' 237' ' ' MET . 12.5 m -117.02 6.49 7.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.207 0.527 . . . . 0.0 109.627 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.7 101.89 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.896 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.68 0.52 59.12 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.535 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 226' ' ' VAL . 47.3 mtmt -89.26 166.51 13.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.724 0.762 . . . . 0.0 112.729 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 34.2 m -87.58 158.59 18.86 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -59.33 -45.12 92.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.8 -45.98 88.64 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.506 0.67 . . . . 0.0 110.515 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.467 ' OE1' ' HD2' ' A' ' 229' ' ' LYS . 33.8 tt0 -64.6 -39.0 92.93 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.97 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 94.4 t -73.95 -36.41 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 9.1 t -74.46 -35.16 63.3 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.761 -1.175 . . . . 0.0 110.483 177.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.62 -48.38 77.57 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.429 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.582 ' SD ' HG11 ' A' ' 226' ' ' VAL . 26.2 ptm -62.06 -39.16 91.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.229 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.42 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.7 ptp -72.29 -21.09 61.41 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.15 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.697 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 91.8 t -85.91 -32.5 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.01 66.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.899 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.88 21.69 13.62 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.722 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.6 m -60.91 -18.71 58.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.403 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 21.9 p -56.74 -48.79 76.99 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.0 0.428 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -129.93 90.37 2.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.1 tm? -99.7 122.76 43.17 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.29 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 58.2 mt -129.92 119.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.5 tp -109.78 129.63 64.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.131 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.438 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 15.2 m -103.56 131.52 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.35 -174.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' ' 159' ' ' ARG 0.28 0.4 OUTLIER -134.44 139.3 48.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 123.308 0.643 . . . . 0.0 112.457 176.92 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.509 ' CB ' HD13 ' A' ' 219' ' ' ILE . 87.3 tttt -124.01 138.87 31.39 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.589 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.571 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 16.8 Cg_endo -56.0 126.8 23.6 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.708 2.272 . . . . 0.0 112.896 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.66 -30.73 16.96 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 C--N 1.301 -1.528 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.766 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.7 105.23 1.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.258 1.972 . . . . 0.0 108.956 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.6 t -86.77 95.5 9.85 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 121.714 0.769 . . . . 0.0 111.52 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.4 148.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.6 t -160.65 123.95 3.4 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.0 tt -91.98 125.69 56.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-O 120.653 0.264 . . . . 0.0 110.776 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.12 122.83 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.878 1.719 . . . . 0.0 110.135 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -89.13 120.76 30.81 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -83.76 156.76 22.39 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -59.63 -57.22 13.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 . . . . . 0 C--O 1.242 0.705 0 O-C-N 123.782 0.676 . . . . 0.0 110.346 -176.759 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 152.4 74.55 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.151 2.567 . . . . 0.0 110.779 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 3.4 mp0 -56.33 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.568 0.747 . . . . 0.0 111.359 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.476 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.5 m -98.0 147.82 24.11 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -126.61 113.54 16.87 Favored 'General case' 0 CA--C 1.474 -1.966 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.45 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 0.5 OUTLIER -98.76 114.97 27.74 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -177.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -97.44 100.99 12.43 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.45 ' HA ' ' NH1' ' A' ' 159' ' ' ARG . 7.3 p -89.38 110.44 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 121.731 0.777 . . . . 0.0 108.911 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.44 ' HB3' HG12 ' A' ' 246' ' ' ILE . 30.9 ptt180 -118.68 142.14 47.94 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.771 -173.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.581 ' O ' HD21 ' A' ' 245' ' ' LEU . 4.8 tt -129.94 141.85 50.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.487 ' N ' HD21 ' A' ' 163' ' ' LEU 0.26 0.7 OUTLIER -112.34 101.19 9.41 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 179.096 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.59 120.87 25.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 164' ' ' LEU . 39.6 m80 -153.21 25.74 0.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 123.364 0.666 . . . . 0.0 109.625 -177.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.58 -11.46 57.99 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.4 t -100.66 101.05 11.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.8 80.91 1.36 Allowed 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.889 0.852 . . . . 0.0 111.894 -170.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.28 151.76 41.84 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.273 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.48 167.3 27.4 Favored 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 122.877 2.384 . . . . 0.0 113.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -102.33 143.06 32.57 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.163 177.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -114.45 56.37 0.5 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.573 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.32 145.39 23.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.35 145.62 43.56 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.166 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.97 152.32 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 40.2 ttm180 -141.13 153.25 45.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -96.83 144.12 27.09 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.792 0.683 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.09 27.75 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 p -94.74 121.95 36.85 Favored 'General case' 0 N--CA 1.385 -3.72 0 CA-C-N 117.158 0.479 . . . . 0.0 110.375 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 t -110.67 119.38 38.95 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.03 123.36 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -107.33 155.16 20.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.79 110.26 31.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.182 0.515 . . . . 0.0 109.955 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 39.7 p -111.22 178.72 4.25 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.49 -3.25 32.92 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.288 0.566 . . . . 0.0 109.794 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.8 m -98.62 -4.43 33.95 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.89 -152.83 17.97 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -92.32 134.41 34.93 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-N 117.164 0.482 . . . . 0.0 109.746 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -132.59 148.99 52.38 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -107.4 127.73 53.85 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.982 0.896 . . . . 0.0 111.03 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.34 160.06 54.51 Favored Pre-proline 0 C--N 1.259 -3.36 0 CA-C-N 113.595 -1.639 . . . . 0.0 108.618 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.02 122.66 6.84 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.158 1.906 . . . . 0.0 108.569 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.61 111.43 3.03 Favored Glycine 0 C--N 1.271 -3.033 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.331 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -98.97 116.68 42.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 14.1 p90 -131.59 172.3 12.4 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.386 -175.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mt -67.6 123.48 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 79.2 p -87.08 -41.98 13.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -162.22 156.02 21.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.996 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 48.7 tp -122.91 138.53 54.64 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.536 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.07 133.69 20.51 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.53 130.21 25.96 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.256 1.971 . . . . 0.0 110.511 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.79 2.64 81.28 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -175.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.23 30.21 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.6 mt -55.37 -38.58 69.02 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -76.45 -30.38 57.32 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.402 ' N ' HD11 ' A' ' 200' ' ' LEU . 4.8 tm-20 -75.93 -34.03 59.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.0 m -55.53 -32.21 62.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.911 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 m -77.21 -44.89 28.39 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.501 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.97 21.65 63.81 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 114.006 0.362 . . . . 0.0 114.006 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt -107.48 -39.19 5.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.359 0.599 . . . . 0.0 111.001 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . 6.8 mp -109.13 146.55 33.89 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.665 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.08 162.69 17.04 Favored 'General case' 0 C--O 1.198 -1.643 0 O-C-N 123.612 0.57 . . . . 0.0 112.086 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -50.16 -25.94 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -72.06 -25.26 61.71 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.617 -0.677 . . . . 0.0 111.722 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 212' ' ' LEU 0.457 0.8 OUTLIER -73.76 170.79 14.57 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.232 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.1 pt-20 -135.26 165.56 25.15 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -164.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 248' ' ' THR . 58.0 t -80.02 132.85 30.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.22 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.413 HG21 ' HG3' ' A' ' 220' ' ' GLU . 43.5 mm -112.72 -60.6 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.733 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.609 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.7 mt-10 -125.92 153.48 44.17 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.852 0.834 . . . . 0.0 111.947 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.418 HG22 HG11 ' A' ' 234' ' ' VAL . 92.1 t -119.45 103.36 14.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.977 174.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.491 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.4 t-20 68.2 -69.34 0.15 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.847 0.859 . . . . 0.0 111.04 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.31 7.62 0.45 Allowed Glycine 0 C--N 1.308 -1.012 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.2 mt -104.43 120.81 55.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.3 158.4 31.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.01 7.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.744 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.33 108.07 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.43 . . . . 0.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.75 2.66 46.38 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.105 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.469 ' HE3' ' SD ' ' A' ' 237' ' ' MET . 34.8 mtmm -107.46 158.98 16.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 234' ' ' VAL . 55.1 m -85.26 158.47 20.31 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.224 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.52 HD11 ' N ' ' A' ' 232' ' ' ASP 0.254 1.2 pp -68.74 -31.99 71.45 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.52 ' N ' HD11 ' A' ' 231' ' ' LEU . 10.8 m-20 -64.21 -34.84 79.02 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.286 0.565 . . . . 0.0 110.052 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.567 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.0 tp-100 -69.51 -47.77 62.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 230' ' ' THR . 82.2 t -57.47 -49.47 80.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.931 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 239' ' ' VAL . 40.1 p -67.05 -36.59 82.4 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.199 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.08 -42.53 98.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.022 0.439 . . . . 0.0 109.99 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.3 mtm -59.63 -48.63 80.92 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.868 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 235' ' ' THR . 4.6 ppp? -71.26 -16.92 62.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.651 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 235' ' ' THR . 98.3 t -84.73 -33.04 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.337 0.589 . . . . 0.0 109.574 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.9 -12.02 61.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.891 0.853 . . . . 0.0 109.806 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.43 27.61 8.2 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.757 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 245' ' ' LEU . 69.4 m -57.59 -20.44 32.6 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.8 m -50.55 -56.96 9.36 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -131.6 84.9 2.21 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 163' ' ' LEU . 1.4 pt? -86.7 121.56 29.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.382 0.61 . . . . 0.0 110.403 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 32.0 mt -122.35 124.52 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.478 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 19.1 mm -110.24 139.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.609 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 30.1 m -117.63 125.3 50.5 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.457 HG23 HD23 ' A' ' 212' ' ' LEU . 17.0 m -114.59 148.73 17.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 216' ' ' ASP . 1.0 OUTLIER -139.46 131.18 14.97 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.438 -176.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 157' ' ' THR . 6.6 Cg_endo -47.44 136.09 20.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.309 3.339 . . . . 0.0 113.066 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -80.83 4.2 19.98 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.861 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.3 m120 . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.837 -176.908 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -96.14 162.37 1.31 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 122.36 2.04 . . . . 0.0 111.429 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.5 p -90.35 97.67 11.32 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.26 133.7 30.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.627 0.727 . . . . 0.0 109.237 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.4 t 177.85 108.98 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -86.68 120.92 72.13 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.894 -172.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.53 124.33 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.277 1.985 . . . . 0.0 109.154 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -78.18 124.95 28.66 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.06 -174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.6 157.6 22.22 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.142 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -51.18 122.08 7.15 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 124.002 0.814 . . . . 0.0 110.521 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.419 ' HD3' ' C ' ' A' ' 143' ' ' ARG . 1.7 tmt_? . . . . . 0 N--CA 1.417 -2.103 0 CA-C-O 122.48 1.133 . . . . 0.0 108.243 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -87.5 152.36 7.72 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.139 2.559 . . . . 0.0 109.535 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.579 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 1.6 mp0 -70.05 84.47 0.52 Allowed 'General case' 0 N--CA 1.418 -2.05 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.51 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 101.71 12.73 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -80.72 94.22 6.33 Favored 'General case' 0 CA--C 1.463 -2.404 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -115.22 126.78 54.96 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.592 -169.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.547 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.7 ptt180 -95.74 94.32 7.62 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.16 133.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.759 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 18.9 ptp180 -99.52 155.74 17.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.77 126.72 37.1 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . 0.258 1.1 pp -105.32 101.54 11.07 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-O 122.152 0.977 . . . . 0.0 113.039 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.613 ' HE2' ' O ' ' A' ' 168' ' ' SER . 12.6 tmtt? -65.2 121.01 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.597 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -162.23 132.89 4.9 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.62 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.37 90.12 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 114.548 0.579 . . . . 0.0 114.548 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.613 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 47.9 m -158.52 153.6 25.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.53 -47.63 69.35 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.702 0.626 . . . . 0.0 109.832 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.498 ' HB3' ' HZ1' ' A' ' 170' ' ' LYS . 6.8 ttpm? -137.56 83.72 24.62 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.416 ' HB3' ' HB2' ' A' ' 168' ' ' SER . 88.8 Cg_endo -91.91 25.08 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.236 2.624 . . . . 0.0 112.576 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.08 109.31 6.52 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.78 53.66 4.84 Favored Glycine 0 C--N 1.305 -1.176 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.529 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -170.41 142.26 2.11 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.25 158.89 42.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 176' ' ' ILE . 2.5 pp -131.08 143.31 41.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.181 0.515 . . . . 0.0 112.257 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -142.22 157.41 44.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -74.12 131.75 41.6 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.967 0.792 . . . . 0.0 110.62 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -144.8 125.91 2.51 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 24.5 p -92.59 139.07 30.95 Favored 'General case' 0 N--CA 1.383 -3.777 0 CA-C-N 117.367 0.583 . . . . 0.0 111.959 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.2 m -110.86 130.54 55.55 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.31 128.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -109.66 155.4 21.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.07 118.86 56.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.255 0.55 . . . . 0.0 110.466 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 41.5 p -115.24 177.83 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.332 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.03 58.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.57 0.7 . . . . 0.0 109.99 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.0 m -101.1 7.47 43.28 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.558 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.18 -141.58 12.94 Favored Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.764 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 189' ' ' LEU . 2.9 pp -125.08 137.86 54.19 Favored 'General case' 0 N--CA 1.388 -3.549 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 153.11 46.56 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.76 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.402 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 38.3 ttpt -121.27 144.09 48.81 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 121.394 0.616 . . . . 0.0 112.027 -172.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 19.8 pt20 -122.2 140.51 32.57 Favored Pre-proline 0 N--CA 1.41 -2.43 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.346 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 6.3 Cg_exo -75.08 134.79 18.1 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.214 1.942 . . . . 0.0 109.203 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.86 154.35 22.65 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.764 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.91 117.09 49.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -119.37 166.53 12.93 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 62.6 mt -67.09 129.79 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 39.7 p -96.68 -51.68 4.21 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -137.5 143.54 41.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.362 0.601 . . . . 0.0 111.122 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 138.85 49.73 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.62 138.33 20.74 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -59.8 126.38 20.31 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 121.669 1.579 . . . . 0.0 109.339 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.7 16.36 68.4 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 156.5 29.81 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.862 -0.669 . . . . 0.0 113.218 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.28 -46.08 76.16 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 124.799 1.239 . . . . 0.0 111.446 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.31 -30.14 70.96 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.158 0.504 . . . . 0.0 111.077 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.44 -33.72 54.72 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.364 0.666 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.3 t -55.02 -32.85 62.14 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.375 1.07 . . . . 0.0 113.843 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.404 ' OG1' ' HG ' ' A' ' 211' ' ' LEU . 2.9 t -79.86 -44.02 21.26 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.38 -23.18 5.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.631 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.404 ' HG ' ' OG1' ' A' ' 209' ' ' THR . 46.7 mt -75.85 -40.34 54.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.938 0.875 . . . . 0.0 109.383 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 86.3 mt -109.64 147.37 33.2 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.568 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.05 162.89 17.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.016 0.436 . . . . 0.0 111.289 -174.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 14.3 p -62.2 -15.45 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-O 121.987 0.899 . . . . 0.0 111.323 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -71.88 -24.02 61.6 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.822 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.4 m-20 -64.56 173.39 2.17 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -116.46 147.75 41.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.242 -172.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.67 142.69 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.065 0.546 . . . . 0.0 110.43 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.5 mp -112.04 -51.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 110.456 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.479 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.3 mt-10 -140.48 149.74 42.9 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.56 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.0 t -113.62 108.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.494 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 6.9 t30 69.87 -68.82 0.18 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.332 1.453 . . . . 0.0 110.939 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.73 26.36 0.19 Allowed Glycine 0 C--N 1.301 -1.388 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.414 ' CG2' ' HE2' ' A' ' 237' ' ' MET . 13.1 mt -123.52 119.1 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 225' ' ' GLU . 1.2 pm0 -75.53 145.91 40.93 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-O 121.007 0.432 . . . . 0.0 111.985 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 219' ' ' ILE . 20.3 m -94.11 9.31 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.892 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -64.54 106.11 1.09 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.834 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.25 12.2 58.95 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.497 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 70.6 mmtt -87.03 170.58 11.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.27 1.033 . . . . 0.0 113.327 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 234' ' ' VAL . 86.0 m -110.26 157.09 19.83 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 113.363 -1.744 . . . . 0.0 106.65 174.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.67 -34.35 78.08 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.34 -49.48 55.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.551 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -60.48 -40.57 91.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.681 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.546 ' HA ' ' SD ' ' A' ' 237' ' ' MET . 92.0 t -57.53 -43.31 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 O-C-N 123.266 0.354 . . . . 0.0 111.439 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 239' ' ' VAL . 60.2 p -65.19 -28.89 69.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.5 -40.75 63.83 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.546 ' SD ' ' HA ' ' A' ' 234' ' ' VAL . 54.3 mtp -55.84 -50.16 71.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.02 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 20.7 ptm -76.49 -10.67 59.57 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.046 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.683 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 59.0 t -91.81 -34.96 6.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.045 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.43 -22.07 66.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.643 0.735 . . . . 0.0 109.902 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -114.32 21.83 14.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.1 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.683 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 75.2 m -63.92 -32.0 73.38 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.8 m -51.94 -53.08 45.42 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 0.0 110.815 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -129.81 86.17 2.38 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.1 tm? -97.09 131.45 43.86 Favored 'General case' 0 C--O 1.191 -1.993 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.722 -174.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -117.07 118.86 60.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.42 130.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.922 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 18.7 m -97.35 120.18 37.23 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.93 150.4 29.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 123.781 0.675 . . . . 0.0 112.251 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.526 ' HB3' ' HZ3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -139.04 130.36 15.11 Favored Pre-proline 0 C--O 1.247 0.921 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.682 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.8 Cg_endo -62.41 132.2 37.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.024 2.483 . . . . 0.0 115.119 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.58 -4.48 15.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.655 -1.157 . . . . 0.0 107.919 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.2 p30 . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.766 -177.496 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.078 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 m 69.0 149.68 0.07 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.314 1.045 . . . . 0.0 112.317 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -116.95 73.41 0.86 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.4 p -109.73 112.37 24.38 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.545 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -159.34 -174.65 4.79 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.32 90.89 35.67 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 166.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.21 -45.37 7.64 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 122.85 2.367 . . . . 0.0 112.405 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -119.9 103.17 9.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.254 0.55 . . . . 0.0 110.678 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.0 mt -110.45 142.92 21.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.5 t -134.52 93.36 3.04 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.91 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.1 tt -115.06 92.26 30.36 Favored Pre-proline 0 N--CA 1.415 -2.193 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.06 122.63 3.83 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.152 1.901 . . . . 0.0 111.446 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -94.59 114.57 26.55 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -83.23 119.93 25.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.297 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -179.17 92.24 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.595 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -112.3 7.51 19.36 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.535 1.16 . . . . 0.0 108.107 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.02 154.1 42.36 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.618 -1.628 . . . . 0.0 107.927 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.29 125.53 32.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 p -68.6 114.86 7.36 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 121.68 0.753 . . . . 0.0 113.021 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.41 153.97 27.72 Favored 'General case' 0 N--CA 1.403 -2.806 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.2 tt -67.04 88.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 CA-C-O 122.324 1.059 . . . . 0.0 113.503 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.1 mm -105.89 115.57 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -120.04 113.54 20.66 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 121.525 0.679 . . . . 0.0 112.754 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 51.9 t -136.32 -68.3 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.219 -1.355 . . . . 0.0 107.948 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -107.51 107.39 18.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.056 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.9 mp 59.06 125.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.69 115.75 65.81 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.82 150.37 78.67 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 122.548 2.166 . . . . 0.0 111.69 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 77.3 4.33 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.2 p -74.39 101.76 4.2 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.452 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -76.4 95.65 3.86 Favored 'General case' 0 CA--C 1.466 -2.277 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.456 ' CB ' HD13 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -96.08 117.3 30.42 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.324 -167.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -87.25 99.49 12.0 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.724 0.773 . . . . 0.0 109.716 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 247' ' ' ILE . 62.5 t -88.94 105.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -105.69 139.42 40.3 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.322 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.19 121.34 44.96 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.82 100.21 10.83 Favored 'General case' 0 N--CA 1.403 -2.783 0 CA-C-O 121.752 0.787 . . . . 0.0 109.729 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER -90.64 120.58 31.83 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.282 176.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -152.31 89.32 1.42 Allowed 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.113 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.07 -10.37 41.58 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.36 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 32.9 t -141.61 135.04 29.6 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.498 ' OD2' ' HG3' ' A' ' 165' ' ' LYS . 13.4 t70 -130.42 87.04 2.45 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -119.01 147.51 42.71 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.563 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 112.4 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 107.886 -1.621 . . . . 0.0 107.886 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 172' ' ' LEU . 4.9 tt -62.73 -29.2 70.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.357 0.599 . . . . 0.0 109.607 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.76 -4.91 1.71 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.337 -1.411 . . . . 0.0 113.468 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -103.06 147.56 26.81 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -137.93 158.51 44.19 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.404 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.1 pt -117.57 149.17 19.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.476 0.655 . . . . 0.0 112.377 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 60.1 ttt180 -125.45 152.33 45.03 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.124 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.415 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 8.7 t70 -115.59 123.23 47.92 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.39 179.68 29.55 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.288 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.9 p -93.41 120.61 33.9 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.163 0.506 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.8 t -101.7 124.45 47.37 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.46 123.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 121.381 0.61 . . . . 0.0 110.445 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -124.76 161.57 26.13 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.272 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.16 107.41 22.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 36.2 p -108.88 178.87 4.34 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.78 -16.88 64.33 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.948 0.404 . . . . 0.0 110.818 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.3 m -87.88 -4.7 58.83 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.9 -151.7 18.17 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.592 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.577 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.5 pt? -84.28 108.53 17.19 Favored 'General case' 0 N--CA 1.394 -3.253 0 CA-C-O 122.016 0.912 . . . . 0.0 109.796 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.4 158.85 23.73 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.496 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.46 131.87 54.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -116.49 151.1 46.61 Favored Pre-proline 0 C--N 1.273 -2.731 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.11 125.16 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.893 1.728 . . . . 0.0 109.902 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.74 151.52 20.21 Favored Glycine 0 C--N 1.278 -2.64 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 122.47 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.08 -168.44 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.5 136.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 69.4 p -95.42 -46.94 6.49 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.453 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -146.58 146.88 30.6 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 56.4 tp -127.78 125.44 39.88 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.3 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.17 130.59 26.94 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.416 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 50.6 Cg_exo -57.52 126.28 21.41 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.148 1.899 . . . . 0.0 110.24 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.66 -14.9 41.91 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.64 146.02 28.16 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.44 ' H ' HD21 ' A' ' 172' ' ' LEU . 34.6 tp -53.96 -34.42 59.66 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 123.927 0.891 . . . . 0.0 113.271 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.457 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -69.37 -35.26 75.65 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.8 tp10 -77.04 -35.52 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 36.4 m -61.73 -33.11 73.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.486 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.3 m -67.12 -39.89 86.73 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.46 -32.27 2.61 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.941 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.89 -19.25 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 123.74 0.816 . . . . 0.0 110.189 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.456 HD13 ' CB ' ' A' ' 159' ' ' ARG . 71.1 mt -109.42 141.84 41.24 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.476 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.3 163.06 27.63 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 124.622 1.169 . . . . 0.0 110.128 -177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.86 -26.74 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.816 0.846 . . . . 0.0 112.579 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.12 -23.55 64.0 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.504 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.1 m-20 -63.66 159.13 19.71 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.52 148.46 24.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.919 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -101.56 139.02 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.829 0.852 . . . . 0.0 109.477 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.7 mp -116.12 -50.64 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.401 ' HB2' ' HG1' ' A' ' 248' ' ' THR . 47.6 mt-10 -136.22 152.44 50.76 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' A' ' 245' ' ' LEU . 50.4 t -119.84 106.82 19.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.811 -1.54 . . . . 0.0 107.975 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 70.25 -69.01 0.18 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.475 1.11 . . . . 0.0 110.49 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -166.0 21.19 0.11 Allowed Glycine 0 C--N 1.291 -1.926 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.582 HG23 ' SD ' ' A' ' 237' ' ' MET . 13.2 mt -113.19 124.91 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.8 143.48 41.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 118.621 0.646 . . . . 0.0 109.664 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.9 m -96.15 -5.19 10.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.682 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.04 123.05 19.98 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.172 0.511 . . . . 0.0 111.684 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.7 7.4 75.13 Favored Glycine 0 CA--C 1.499 -0.907 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.201 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' OE1' ' A' ' 233' ' ' GLN . 23.3 ttmm -107.47 156.29 19.13 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.439 ' O ' HG22 ' A' ' 234' ' ' VAL . 87.1 m -77.14 157.47 30.97 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 50.0 tp -62.45 -44.3 96.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.42 -35.4 70.02 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.035 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 237' ' ' MET . 79.2 mt-30 -73.34 -42.47 62.23 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.946 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 230' ' ' THR . 61.1 t -64.75 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.596 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.0 p -65.87 -41.63 91.36 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.615 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.39 -44.88 95.41 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.1 0.476 . . . . 0.0 110.463 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 33.8 mtm -60.14 -42.9 95.83 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.8 -17.92 62.13 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.395 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 235' ' ' THR . 85.0 t -85.39 -36.73 11.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.24 -25.22 67.7 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.534 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -129.92 28.76 5.04 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.687 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.9 t -59.16 -35.57 73.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.459 1.103 . . . . 0.0 111.953 -175.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.454 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 22.8 t -70.36 -20.5 62.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.216 0.532 . . . . 0.0 110.759 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -130.15 37.12 3.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.401 ' CD2' HG13 ' A' ' 221' ' ' VAL . 3.2 tm? -85.02 123.01 30.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.829 0.823 . . . . 0.0 112.219 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 61.6 mt -129.02 119.61 49.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.317 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 161' ' ' VAL . 10.8 tt -109.66 131.99 59.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.584 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.401 ' HG1' ' HB2' ' A' ' 220' ' ' GLU . 33.4 m -95.46 120.15 35.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.093 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.53 149.97 26.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.582 0.551 . . . . 0.0 110.208 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.405 ' CB ' HD13 ' A' ' 219' ' ' ILE . 0.5 OUTLIER -134.77 126.06 17.73 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.504 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 77.7 Cg_exo -52.56 132.06 43.76 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.659 2.906 . . . . 0.0 114.494 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -101.78 8.15 41.53 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -83.25 66.32 8.71 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.152 -1.386 . . . . 0.0 108.122 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -90.95 152.39 20.73 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.613 -0.722 . . . . 0.0 112.144 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? . . . . . 0 C--N 1.294 -1.846 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 179.701 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.106 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.8 m -150.17 157.51 43.18 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 117.365 0.583 . . . . 0.0 109.801 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -75.06 127.79 34.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.1 t -75.53 134.07 40.85 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -130.76 166.04 21.63 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -175.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.26 111.59 52.59 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.0 108.39 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.635 1.557 . . . . 0.0 108.736 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 t -92.85 85.82 5.3 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.315 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.59 119.6 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.1 m -145.24 91.31 2.12 Favored 'General case' 1 C--N 1.235 -4.401 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -116.63 108.15 45.47 Favored Pre-proline 0 N--CA 1.424 -1.734 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.178 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.16 123.92 12.63 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 N-CA-C 106.504 -2.152 . . . . 0.0 106.504 172.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.38 112.14 20.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.388 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 142' ' ' PHE . 11.6 m-20 -107.22 118.85 37.81 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 141' ' ' ASP . 48.6 t80 166.66 93.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 O-C-N 125.029 1.455 . . . . 0.0 107.217 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -108.33 7.31 27.13 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.178 0.989 . . . . 0.0 109.357 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -89.3 160.08 17.07 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.152 -1.385 . . . . 0.0 107.328 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.1 m -77.65 154.0 5.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.3 m -71.09 114.04 8.74 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -112.86 147.2 37.5 Favored 'General case' 0 N--CA 1.401 -2.902 0 CA-C-O 121.455 0.645 . . . . 0.0 111.866 -169.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.8 mt 46.3 64.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 126.608 1.963 . . . . 0.0 113.665 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 149' ' ' ILE . 2.5 pp -106.79 140.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.58 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.8 t70 62.73 91.47 0.07 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.436 1.112 . . . . 0.0 110.523 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.71 -72.99 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.019 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -76.41 107.53 8.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 154' ' ' VAL 0.326 9.0 tt 40.29 -92.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.909 1.684 . . . . 0.0 113.839 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.526 ' H ' HG23 ' A' ' 153' ' ' ILE . 7.5 p -129.47 115.02 18.29 Favored Pre-proline 0 N--CA 1.417 -2.097 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.49 146.66 13.77 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.338 2.025 . . . . 0.0 113.381 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.452 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 2.4 mp0 -83.0 72.32 10.08 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.717 177.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -106.07 138.53 42.09 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -126.08 135.91 52.3 Favored 'General case' 0 CA--C 1.469 -2.136 0 CA-C-O 121.147 0.498 . . . . 0.0 112.082 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -113.65 115.76 28.4 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.416 ' O ' ' HD2' ' A' ' 160' ' ' ARG 0.334 4.0 ppt_? -97.97 103.81 15.78 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 122.162 0.982 . . . . 0.0 110.659 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.31 125.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.916 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -95.55 126.68 41.0 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.305 0.574 . . . . 0.0 109.862 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.01 121.43 38.89 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.512 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.28 105.16 15.75 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.322 1.058 . . . . 0.0 110.639 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -74.98 136.28 41.31 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.441 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.449 ' HB2' ' H ' ' A' ' 170' ' ' LYS . 88.3 m-70 -139.53 -75.63 0.35 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.556 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.2 -10.96 58.46 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.251 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.7 m -134.01 25.5 3.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 122.123 0.963 . . . . 0.0 108.476 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -165.14 -70.48 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.161 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 166' ' ' HIS . 12.7 mptt -123.79 114.27 28.37 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -84.31 -40.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.037 1.825 . . . . 0.0 110.234 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.95 159.16 36.21 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 125.618 1.567 . . . . 0.0 107.153 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -122.73 17.81 8.18 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.584 -1.293 . . . . 0.0 112.449 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -165.68 143.67 5.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.414 ' CE2' HG23 ' A' ' 201' ' ' VAL . 76.1 m-85 -108.99 136.03 49.2 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.973 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.409 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -134.44 140.31 46.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -137.82 159.9 40.74 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.29 145.08 44.26 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.947 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.1 109.72 0.43 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 m -93.3 143.76 25.96 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 51.0 m -126.24 133.79 51.38 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.4 p -108.65 125.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.484 ' HB2' ' OE1' ' A' ' 190' ' ' GLU . 72.7 mtp180 -124.72 162.21 24.71 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.428 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.98 113.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.893 0.854 . . . . 0.0 108.856 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 57.0 p -113.8 178.24 4.35 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.498 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.48 -10.88 59.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 109.916 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.2 m -94.55 -4.19 48.39 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.219 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.08 -159.6 14.27 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.527 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -83.98 129.13 34.93 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 117.593 0.697 . . . . 0.0 110.272 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.484 ' OE1' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -137.78 161.82 35.57 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.761 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 181' ' ' SER . 98.3 mttt -121.64 150.15 42.15 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -131.13 139.0 34.17 Favored Pre-proline 0 N--CA 1.414 -2.23 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.7 133.74 8.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.546 2.164 . . . . 0.0 110.854 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.23 153.7 25.5 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.869 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.57 123.1 63.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -127.56 163.97 23.01 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.6 114.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -84.52 -49.59 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.064 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.11 155.41 50.22 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.743 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -113.57 140.62 48.01 Favored 'General case' 0 N--CA 1.395 -3.2 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 178.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.414 HG23 ' CE2' ' A' ' 175' ' ' TYR . 40.1 t -96.54 129.69 32.5 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.15 126.05 17.8 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 121.939 1.76 . . . . 0.0 109.236 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.07 -6.56 83.1 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.39 156.3 53.29 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.89 -25.88 65.72 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.46 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.496 ' N ' HD22 ' A' ' 200' ' ' LEU . 42.8 tt0 -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.0 m -54.81 -31.27 58.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.288 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.4 p -60.75 -43.12 98.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.96 29.28 74.39 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.9 tp -145.43 -46.47 0.22 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.011 -1.095 . . . . 0.0 110.458 -172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 71.9 mt -115.4 110.43 19.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.445 0.641 . . . . 0.0 111.3 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.69 134.01 44.27 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.613 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 71.2 t 43.22 -72.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -23.6 65.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.613 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -67.41 153.2 44.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.363 -173.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -101.29 156.44 17.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.63 143.3 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.491 0.717 . . . . 0.0 109.964 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.8 mp -121.69 -45.52 2.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 111.968 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.452 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 35.9 mt-10 -135.58 150.85 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.768 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.4 t -121.87 101.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 123.804 0.69 . . . . 0.0 109.338 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.502 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 39.2 t-20 69.59 -72.09 0.11 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 0.0 111.269 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.54 12.18 0.4 Allowed Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.592 HG23 ' SD ' ' A' ' 237' ' ' MET . 19.9 mt -105.21 133.06 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.92 146.3 28.12 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.432 ' HA ' ' CG ' ' A' ' 229' ' ' LYS . 12.7 m -91.63 -4.94 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.945 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.76 112.34 7.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.575 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 4.29 50.76 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.5 mmpt? -96.79 163.04 13.16 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -104.57 168.7 8.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -57.59 -47.59 81.71 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -68.31 -40.99 81.53 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.237 0.541 . . . . 0.0 110.529 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.672 ' O ' ' HG3' ' A' ' 237' ' ' MET . 35.5 tt0 -59.09 -43.59 91.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.309 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.49 -46.86 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.483 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.0 p -65.97 -31.01 71.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.888 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.65 -42.79 77.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.18 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.672 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 24.6 mtm -59.3 -46.35 88.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.68 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.3 ptp -67.15 -23.15 65.76 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.967 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 235' ' ' THR . 58.8 t -90.14 -27.05 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.557 0.694 . . . . 0.0 109.161 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.02 71.95 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.449 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.58 -70.17 0.72 Allowed 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.28 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.2 t 60.16 -41.28 0.09 Allowed 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 42.5 m -68.6 -73.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.885 0.766 . . . . 0.0 111.588 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.52 81.17 2.92 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -95.87 129.1 43.21 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.207 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 3.3 mp -127.46 134.5 65.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 220' ' ' GLU . 7.2 tp -124.18 131.17 73.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.59 . . . . 0.0 110.001 178.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 28.5 m -98.03 120.22 38.04 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.052 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.06 149.37 24.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.278 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 80.7 tttt -127.72 141.07 39.88 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 124.001 0.92 . . . . 0.0 109.258 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.613 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.5 Cg_endo -64.39 130.09 25.84 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 121.626 1.551 . . . . 0.0 111.039 175.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -95.48 -35.15 11.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.928 0.871 . . . . 0.0 109.07 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 45.1 m-80 56.43 8.81 0.46 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.932 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -121.72 130.11 53.21 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.288 0.566 . . . . 0.0 110.552 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? . . . . . 0 C--N 1.283 -2.285 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.571 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.749 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.2 p -127.57 142.47 51.36 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-O 120.941 0.4 . . . . 0.0 111.313 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -151.14 130.11 12.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.2 t -76.06 139.29 41.33 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.532 0.682 . . . . 0.0 110.734 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -94.38 122.03 36.53 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.394 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.5 113.07 64.6 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.28 133.2 31.93 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.736 1.624 . . . . 0.0 110.093 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.9 t -96.32 96.31 8.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.404 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.57 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.3 t -161.95 93.21 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.23 114.18 61.44 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.32 123.0 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.313 2.008 . . . . 0.0 112.286 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -98.44 132.26 44.03 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.83 157.17 17.66 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -96.27 138.91 33.18 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -154.48 92.87 1.53 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 122.106 0.955 . . . . 0.0 109.005 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -84.11 140.19 31.96 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.061 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.6 m -78.93 124.43 37.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.217 0.532 . . . . 0.0 110.14 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.9 m -86.56 115.7 24.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.749 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.27 105.26 16.33 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.1 mp -88.28 96.89 6.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -106.03 151.76 7.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.173 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -92.17 -173.41 3.43 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.405 0.621 . . . . 0.0 110.34 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.85 120.0 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.01 120.97 11.27 Favored 'General case' 1 C--N 1.243 -4.056 0 CA-C-N 114.11 -1.404 . . . . 0.0 114.452 -170.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.1 tt -154.87 151.03 11.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 253' ' ' ASN . 41.3 t -114.03 104.56 54.89 Favored Pre-proline 0 C--N 1.288 -2.082 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.16 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 154' ' ' VAL . 35.1 Cg_endo -65.04 151.79 84.55 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.391 2.061 . . . . 0.0 109.266 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 78.64 0.22 Allowed 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.8 p -81.84 96.96 7.79 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -66.04 116.39 7.1 Favored 'General case' 0 CA--C 1.457 -2.622 0 CA-C-O 121.861 0.838 . . . . 0.0 112.42 -175.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -110.12 116.7 32.01 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.67 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 30.7 ptt180 -99.14 113.62 25.95 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.92 132.32 41.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 19.6 ptt180 -112.13 148.79 33.24 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.001 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 2.5 tm? -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 171.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.46 HD11 ' H ' ' A' ' 164' ' ' LEU 0.273 0.0 OUTLIER -108.04 101.33 10.58 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-O 121.956 0.884 . . . . 0.0 112.72 179.39 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -71.91 131.83 43.52 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.817 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.26 79.07 0.52 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.801 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.95 17.62 69.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -102.94 113.89 27.72 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 114.616 -0.792 . . . . 0.0 111.049 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.14 4.24 7.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.769 1.271 . . . . 0.0 107.687 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -74.2 169.19 20.32 Favored Pre-proline 0 C--O 1.246 0.869 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -56.07 146.17 71.32 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.257 1.972 . . . . 0.0 110.523 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.72 -47.23 80.44 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.442 0.639 . . . . 0.0 111.853 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 115.83 -18.78 14.47 Favored Glycine 0 CA--C 1.487 -1.692 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -132.67 133.36 43.47 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 114.275 -0.962 . . . . 0.0 108.857 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -138.04 148.08 44.74 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 123.524 0.515 . . . . 0.0 111.926 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.6 pt -124.71 143.14 39.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.992 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -140.24 159.39 42.28 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.841 0.353 . . . . 0.0 111.43 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.65 135.78 35.53 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.932 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -142.17 175.01 22.98 Favored Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.5 m -95.04 133.42 38.84 Favored 'General case' 0 C--N 1.27 -2.881 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.725 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.3 t -103.88 119.12 38.25 Favored 'General case' 0 C--N 1.252 -3.668 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.41 123.16 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.544 0.688 . . . . 0.0 109.168 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.89 51.65 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.529 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.82 107.41 21.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.28 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.3 p -111.87 179.11 4.1 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.753 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.12 -15.21 62.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.2 m -87.62 -5.32 58.78 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.95 -157.36 15.04 Favored Glycine 0 C--O 1.214 -1.119 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 189' ' ' LEU . 4.0 pp -88.19 129.97 35.19 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 118.346 1.073 . . . . 0.0 109.203 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.69 147.78 44.82 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.507 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -121.34 130.12 53.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -142.21 154.83 64.83 Favored Pre-proline 0 C--N 1.279 -2.486 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.69 121.56 6.39 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 109.23 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.41 139.35 10.71 Favored Glycine 0 C--N 1.276 -2.791 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.8 pt -100.6 126.58 54.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-O 121.532 0.682 . . . . 0.0 112.164 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -120.19 174.47 6.48 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.952 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.9 mt -68.33 135.7 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.3 t -121.23 -59.29 1.73 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.593 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -122.86 147.01 47.05 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.442 -173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 206' ' ' ALA . 12.9 mt -127.36 134.11 49.98 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.464 174.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.7 129.38 27.71 Favored Pre-proline 0 C--N 1.275 -2.632 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.66 126.45 19.73 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.334 2.023 . . . . 0.0 110.682 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.04 72.5 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.214 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 158.35 47.48 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -55.95 -39.32 71.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.474 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -74.01 -26.98 60.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.171 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.0 -45.46 57.79 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 m -55.36 -32.22 62.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.263 1.025 . . . . 0.0 111.846 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.527 HG21 ' HG ' ' A' ' 211' ' ' LEU . 27.6 m -62.58 -43.49 98.69 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.033 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 77.59 -27.64 1.85 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.387 0.915 . . . . 0.0 115.387 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 209' ' ' THR . 4.2 pp -97.56 7.98 45.47 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 94.9 mt -116.0 145.05 43.28 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.938 0.399 . . . . 0.0 110.045 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.47 161.89 26.1 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 120.889 0.376 . . . . 0.0 111.75 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.61 -19.41 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-O 121.547 0.689 . . . . 0.0 111.114 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.77 -25.07 58.82 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.528 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.598 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 51.8 m-20 -70.98 156.67 39.35 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.245 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.47 165.74 18.54 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.628 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.6 m -82.77 142.88 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.234 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.511 HG13 ' HG3' ' A' ' 250' ' ' LYS . 42.8 mm -116.06 -47.43 4.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.069 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.479 ' H ' ' HB ' ' A' ' 248' ' ' THR . 39.1 mt-10 -145.99 159.49 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.42 HG23 ' CG1' ' A' ' 226' ' ' VAL . 77.2 t -123.38 97.26 4.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 169.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.3 t30 68.3 -70.17 0.13 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.36 17.56 0.68 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.419 HG23 ' SD ' ' A' ' 237' ' ' MET . 9.0 mt -120.3 142.33 36.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -86.12 153.83 21.8 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.991 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' A' ' 221' ' ' VAL . 16.3 m -118.03 -3.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.94 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -86.27 121.77 29.32 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.81 -10.22 72.52 Favored Glycine 0 C--N 1.318 -0.441 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -91.95 153.79 19.25 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 124.48 1.112 . . . . 0.0 109.153 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.4 m -74.92 156.28 36.53 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.65 -36.82 85.49 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.686 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.37 -36.85 76.53 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.75 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.645 ' O ' ' HG3' ' A' ' 237' ' ' MET . 5.8 tp-100 -72.42 -48.52 40.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.422 ' HA ' ' HE1' ' A' ' 237' ' ' MET . 95.6 t -56.74 -48.97 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.932 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.615 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.5 p -65.0 -34.0 77.39 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.32 -38.58 81.69 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.99 0.424 . . . . 0.0 110.276 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.645 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 20.2 mtm -57.8 -45.6 85.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.84 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.28 -15.01 60.54 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.465 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 235' ' ' THR . 65.9 t -78.82 -38.72 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.251 0.548 . . . . 0.0 110.028 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.27 -29.06 68.57 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.281 0.563 . . . . 0.0 110.806 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -110.79 32.13 5.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.8 p -60.02 -27.52 66.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.2 p -46.9 -63.55 1.0 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.137 0.575 . . . . 0.0 111.564 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 40.1 m-80 -129.96 87.68 2.56 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.9 pp -90.33 131.99 35.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.453 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.3 mp -106.7 125.29 62.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.094 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.1 tt -111.37 128.27 67.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 110.649 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.1 m -106.44 129.44 54.42 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.315 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.66 165.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.511 ' HG3' HG13 ' A' ' 219' ' ' ILE . 43.9 mtpt -126.42 129.02 24.25 Favored Pre-proline 0 CA--C 1.482 -1.637 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.55 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.598 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 50.0 Cg_exo -58.62 127.23 23.79 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.811 1.674 . . . . 0.0 110.164 172.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.12 9.69 21.83 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.125 0.964 . . . . 0.0 109.712 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.439 ' HB2' ' HB ' ' A' ' 154' ' ' VAL . 24.8 m-80 -93.7 15.78 15.53 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.29 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -90.99 144.64 25.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.266 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 C--N 1.302 -1.472 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.863 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.601 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.4 m 79.05 5.6 2.25 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.754 1.221 . . . . 0.0 113.48 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -97.93 88.14 4.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.7 p -93.45 142.42 27.35 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.206 0.527 . . . . 0.0 112.392 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -110.33 100.06 8.98 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -112.22 117.84 46.92 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 147.82 91.87 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.26 1.973 . . . . 0.0 111.263 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.3 m -79.7 85.85 5.36 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.47 0.652 . . . . 0.0 110.614 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.9 mm -99.81 144.18 12.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m 58.26 73.93 0.45 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.141 0.977 . . . . 0.0 111.148 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.79 119.43 70.56 Favored Pre-proline 0 N--CA 1.421 -1.896 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.815 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.17 121.82 10.22 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.464 2.11 . . . . 0.0 112.114 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -101.94 161.19 13.86 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.759 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -83.52 149.44 26.6 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.704 -0.398 . . . . 0.0 109.944 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -103.45 -37.72 7.48 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -150.02 89.95 1.64 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 121.118 0.485 . . . . 0.0 110.647 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -72.47 125.36 27.21 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.7 140.91 16.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.851 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.1 m -94.25 147.99 22.65 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.77 103.96 16.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.264 0.554 . . . . 0.0 110.81 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.0 tp -102.48 98.71 7.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pp -101.39 152.28 5.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.407 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -77.6 109.72 11.81 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.528 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 153' ' ' ILE . 57.2 t -77.0 -37.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.6 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.92 123.74 21.03 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 151' ' ' VAL . 68.0 mt -133.4 127.58 53.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.252 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.66 102.04 20.31 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 169.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.75 131.2 1.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.049 1.833 . . . . 0.0 112.283 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.505 ' HA ' ' HG2' ' A' ' 251' ' ' PRO . 42.2 mt-10 -84.27 85.57 7.35 Favored 'General case' 0 N--CA 1.403 -2.811 0 CA-C-O 121.387 0.613 . . . . 0.0 112.109 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -91.0 100.45 13.31 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -88.61 105.01 17.38 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -126.36 116.11 20.7 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.25 129.58 34.6 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.997 0.427 . . . . 0.0 110.074 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.3 t -89.71 115.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -106.28 137.61 43.93 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 111.836 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.72 141.49 48.56 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.356 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.43 115.3 23.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 121.822 0.82 . . . . 0.0 110.801 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.56 130.08 38.92 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.345 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 169' ' ' ASP . 0.5 OUTLIER -164.99 76.33 0.28 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.99 -178.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.37 17.35 76.32 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.009 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.0 m 67.58 97.0 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.587 1.155 . . . . 0.0 111.154 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.455 ' HB2' ' CD2' ' A' ' 166' ' ' HIS . 19.2 t70 -86.56 -49.56 7.46 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.926 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -145.17 150.35 44.86 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.76 -61.93 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 121.312 1.341 . . . . 0.0 109.756 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.04 -65.56 0.39 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.511 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.445 ' HA3' ' H ' ' A' ' 205' ' ' LEU . . . 92.65 11.48 59.22 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.46 156.92 26.74 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -137.27 136.1 37.75 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 123.339 0.399 . . . . 0.0 110.326 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 176' ' ' ILE . 2.3 pp -128.81 141.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.307 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -141.31 158.08 44.36 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.498 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -96.95 130.41 44.26 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -122.2 158.89 16.89 Favored Glycine 0 CA--C 1.47 -2.751 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 m -92.91 131.45 37.91 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.72 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -111.43 140.2 46.22 Favored 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.463 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.4 123.15 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.86 152.52 21.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.0 104.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.1 p -117.74 179.03 4.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.97 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.39 -15.89 63.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 109.656 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.6 m -87.25 -4.13 59.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.208 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.54 -142.3 15.52 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.06 123.28 33.79 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -117.2 146.18 43.4 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.58 133.52 55.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.065 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -146.93 147.61 30.05 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.514 ' O ' ' HA2' ' A' ' 228' ' ' GLY . 13.9 Cg_exo -69.12 133.29 26.37 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.414 2.076 . . . . 0.0 111.512 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -129.82 127.19 5.32 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.446 HG21 ' HB ' ' A' ' 218' ' ' VAL . 10.5 tt -91.19 124.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-O 121.25 0.548 . . . . 0.0 110.881 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.58 173.11 10.56 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.47 131.99 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 37.3 t -90.69 -54.31 4.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.223 0.535 . . . . 0.0 110.83 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -155.65 155.66 33.61 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 53.5 tp -127.33 139.63 52.75 Favored 'General case' 0 N--CA 1.403 -2.819 0 O-C-N 123.317 0.386 . . . . 0.0 110.228 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.37 128.62 32.62 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.481 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 29.6 Cg_exo -63.36 126.27 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 108.934 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.6 73.45 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.51 158.42 41.43 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.445 ' H ' ' HA3' ' A' ' 173' ' ' GLY . 27.4 tp -57.95 -38.8 76.66 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.71 -29.27 63.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.512 0.672 . . . . 0.0 109.963 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.481 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -76.72 -34.07 58.14 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -58.84 -33.54 70.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.9 m -77.16 -45.59 26.24 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.27 -6.0 0.87 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.02 -14.95 58.88 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.218 0.607 . . . . 0.0 111.287 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.418 ' CD1' HG23 ' A' ' 249' ' ' VAL . 94.1 mt -119.22 146.89 44.83 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.146 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.2 161.28 13.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.961 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 51.7 t -67.36 -18.65 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.669 0.747 . . . . 0.0 110.239 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.99 -24.58 59.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.144 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.596 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 73.7 m-20 -66.06 157.2 31.64 Favored 'General case' 0 C--O 1.248 1.026 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -172.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.81 150.4 22.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.576 0.703 . . . . 0.0 112.425 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.446 ' HB ' HG21 ' A' ' 195' ' ' ILE . 57.1 t -94.32 136.94 24.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.465 HG21 ' HG3' ' A' ' 220' ' ' GLU . 31.4 mm -115.6 -53.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.543 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.484 ' H ' ' HB ' ' A' ' 248' ' ' THR . 41.5 mt-10 -143.55 159.79 41.8 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.42 0.629 . . . . 0.0 111.594 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.498 ' HB ' ' HE3' ' A' ' 237' ' ' MET . 93.6 t -117.4 104.8 16.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 169.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.0 t30 65.97 -74.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.801 1.24 . . . . 0.0 110.612 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -147.23 3.4 0.89 Allowed Glycine 0 C--N 1.306 -1.113 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.3 mt -100.38 117.94 46.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.51 131.75 42.11 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.386 0.612 . . . . 0.0 109.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.3 m -117.17 7.19 7.09 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.204 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.38 3.39 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.706 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 193' ' ' PRO . . . 102.56 -3.09 49.7 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.292 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -87.54 170.04 11.67 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.15 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.486 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 20.9 m -101.39 159.38 15.32 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.476 ' HA ' HG12 ' A' ' 234' ' ' VAL . 2.4 pt? -52.9 -45.26 67.48 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.09 -46.48 88.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.584 0.707 . . . . 0.0 110.074 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.486 ' OE1' ' HB ' ' A' ' 230' ' ' THR . 2.0 mp0 -66.1 -37.94 86.99 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.34 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 231' ' ' LEU . 9.8 p -74.8 -45.08 44.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.672 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.472 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 14.6 t -68.92 -38.62 79.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.88 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.55 -37.46 87.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.856 0.836 . . . . 0.0 108.8 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.498 ' HE3' ' HB ' ' A' ' 221' ' ' VAL . 10.9 tmm? -69.16 -49.26 58.38 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.418 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.472 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 18.4 ptp -67.29 -22.58 65.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.62 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 235' ' ' THR . 89.7 t -83.12 -33.0 9.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.731 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.11 -35.05 70.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.31 -79.21 0.18 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.731 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.5 t 59.59 -37.31 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.77 1.628 . . . . 0.0 114.871 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.4 p -55.75 -68.52 0.19 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.482 0.713 . . . . 0.0 110.271 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -100.55 80.5 2.22 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.54 103.89 16.05 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.05 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.4 135.77 62.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.441 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.0 tp -118.49 134.18 62.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.316 0.579 . . . . 0.0 110.245 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 25.2 m -103.39 119.62 39.24 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.553 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 212' ' ' LEU . 4.3 m -127.73 137.07 58.7 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 96.6 mttt -134.8 143.57 46.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.168 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.596 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 93.2 Cg_exo -45.79 132.3 13.57 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.362 2.708 . . . . 0.0 112.05 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' A' ' 254' ' ' GLN . . . -66.04 -16.88 64.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 68.47 -31.32 0.19 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.627 1.571 . . . . 0.0 114.33 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 252' ' ' ALA . 54.8 tp60 -85.08 120.89 27.1 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 . . . . . 0 C--N 1.272 -2.8 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.51 -178.776 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.0 m -72.14 141.75 49.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 130' ' ' LYS . 2.9 mptp? -79.39 151.05 31.16 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.065 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.8 m -75.34 114.12 13.51 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.763 0.792 . . . . 0.0 112.192 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -90.69 130.52 36.68 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.405 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.15 132.93 78.82 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.02 118.6 2.45 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.692 2.928 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.2 m -83.52 89.73 7.12 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.853 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -63.66 131.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.678 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m -151.73 102.45 2.85 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.214 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.4 tt -87.89 133.66 37.03 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.58 127.59 22.18 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.008 1.806 . . . . 0.0 110.268 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -98.48 157.35 16.27 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.68 157.18 22.29 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.279 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -134.61 139.58 45.43 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 69.22 98.02 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.98 0.912 . . . . 0.0 110.885 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -73.13 111.02 7.87 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.559 0.695 . . . . 0.0 111.247 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.93 130.49 41.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.338 0.589 . . . . 0.0 111.432 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.8 p -101.42 153.98 19.21 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.701 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.52 104.55 17.04 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.457 0.646 . . . . 0.0 112.169 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.1 mp -109.82 102.06 13.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.7 pt -95.47 116.19 36.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.016 0.912 . . . . 0.0 112.837 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -118.17 -25.95 6.49 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.039 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.1 t -74.86 -39.02 44.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.782 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.02 116.65 7.36 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.506 0.67 . . . . 0.0 111.851 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.4 tt -140.25 161.72 25.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.6 t -94.64 112.93 59.75 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.57 136.42 30.8 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.967 1.778 . . . . 0.0 110.726 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.05 76.15 2.24 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-O 121.608 0.718 . . . . 0.0 111.694 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 41.1 m -83.72 103.85 13.35 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 173.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.408 ' CE1' ' HG3' ' A' ' 250' ' ' LYS . 13.0 m170 -69.06 122.53 18.91 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 121.901 0.858 . . . . 0.0 110.984 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.56 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 4.1 mmp_? -105.27 116.62 32.25 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.786 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -107.88 107.11 17.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 247' ' ' ILE . 38.5 t -89.09 125.65 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.568 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.82 138.41 32.65 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.229 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -123.33 129.25 51.07 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.661 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.04 120.02 39.19 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.48 123.89 20.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 122.672 1.225 . . . . 0.0 113.259 -173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -123.84 29.95 6.34 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 113.013 -1.903 . . . . 0.0 108.677 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.26 -10.34 56.58 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.198 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.2 m 60.95 21.15 11.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.42 0.688 . . . . 0.0 111.705 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.96 -55.34 7.62 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.999 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 171' ' ' PRO . 83.8 tttt -99.4 128.22 32.27 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 21.4 Cg_exo -67.96 156.83 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.062 1.841 . . . . 0.0 110.342 172.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.97 -8.03 54.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.509 0.671 . . . . 0.0 111.137 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.23 0.52 7.47 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.024 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -103.95 144.62 31.29 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.24 136.86 38.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.02 135.93 58.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 79.9 ttt180 -142.07 150.43 41.2 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.151 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.471 ' CB ' ' HB3' ' A' ' 231' ' ' LEU . 20.4 t70 -92.59 134.23 35.2 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.411 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -135.28 166.79 24.36 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 191' ' ' LYS . 1.6 m -92.71 131.36 37.85 Favored 'General case' 0 C--N 1.27 -2.86 0 C-N-CA 117.394 -1.723 . . . . 0.0 107.972 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 25.3 m -100.8 134.8 43.23 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.43 128.62 75.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.979 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.2 mtt180 -117.47 154.37 31.54 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.9 109.94 30.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.574 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 74.7 p -107.03 177.89 4.72 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.12 -20.95 62.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.225 0.536 . . . . 0.0 109.874 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.6 p -86.51 -3.8 59.07 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.434 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.95 -171.55 14.54 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.737 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.479 ' CD2' ' H ' ' A' ' 189' ' ' LEU . 1.6 pt? -84.95 133.75 34.27 Favored 'General case' 0 N--CA 1.4 -2.951 0 O-C-N 122.306 -0.526 . . . . 0.0 110.298 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.47 156.72 46.24 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.373 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.462 ' HB3' HG21 ' A' ' 180' ' ' THR . 96.9 mttt -121.36 150.33 41.63 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.84 161.48 62.51 Favored Pre-proline 0 N--CA 1.426 -1.654 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.627 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.55 142.68 85.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.94 89.96 0.15 Allowed Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.586 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 218' ' ' VAL . 12.1 tt -95.97 117.66 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-O 121.77 0.795 . . . . 0.0 109.998 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -132.46 179.16 6.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.283 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.416 HD13 ' HB2' ' A' ' 216' ' ' ASP . 44.9 mt -68.7 122.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 26.1 p -96.33 -32.89 12.16 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 120.905 0.383 . . . . 0.0 111.887 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -153.34 148.79 27.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.47 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.9 tt -124.54 136.73 54.22 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 71.3 t -99.57 124.42 44.44 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.12 127.23 24.14 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.477 2.118 . . . . 0.0 111.353 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.42 63.15 Favored Glycine 0 C--N 1.309 -0.953 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.39 161.4 44.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.736 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.35 -39.68 64.34 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.8 0.84 . . . . 0.0 110.862 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 212' ' ' LEU . . . -55.47 -42.14 73.91 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.3 -36.12 54.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.1 m -54.45 -34.74 62.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.435 0.694 . . . . 0.0 112.816 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 73.1 p -60.17 -41.26 92.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 111.557 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.83 3.16 90.68 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.452 HD13 ' HG ' ' A' ' 212' ' ' LEU . 2.7 pp -127.96 -2.32 5.86 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.517 ' HA ' ' OD2' ' A' ' 216' ' ' ASP . 97.2 mt -108.55 130.58 55.29 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.237 0.541 . . . . 0.0 110.305 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.95 164.36 25.51 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 125.318 1.447 . . . . 0.0 109.663 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.0 p -52.49 -20.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.733 0.777 . . . . 0.0 112.435 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -68.79 -25.29 64.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.929 -0.482 . . . . 0.0 111.898 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.8 m-20 -61.3 159.34 12.53 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -114.96 144.87 42.9 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.15 -1.841 . . . . 0.0 110.448 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 195' ' ' ILE . 7.7 p -96.61 140.4 17.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.053 0.454 . . . . 0.0 109.819 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.409 HG21 ' HG3' ' A' ' 220' ' ' GLU . 40.2 mm -110.44 -52.92 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.189 0.519 . . . . 0.0 111.803 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.531 ' H ' ' HB ' ' A' ' 248' ' ' THR . 45.1 mt-10 -134.73 142.74 46.85 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.57 0.7 . . . . 0.0 112.646 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.6 t -115.62 113.5 43.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.213 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 70.6 -66.19 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.221 1.008 . . . . 0.0 110.327 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -169.34 12.91 0.05 OUTLIER Glycine 0 C--N 1.292 -1.891 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.529 HG23 ' SD ' ' A' ' 237' ' ' MET . 28.9 mt -105.37 125.49 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -176.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -77.48 141.64 39.57 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.453 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 33.6 m -100.91 14.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.08 104.01 2.46 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.276 0.56 . . . . 0.0 111.02 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.78 12.32 55.71 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.231 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 6.0 mmpt? -91.8 152.36 20.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 234' ' ' VAL . 38.7 p -86.94 159.46 19.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.471 ' HB3' ' CB ' ' A' ' 178' ' ' ASP . 1.9 pt? -60.26 -38.07 82.38 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.596 0.236 . . . . 0.0 111.288 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.87 -46.5 87.66 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.854 0.861 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.572 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.6 tp-100 -63.48 -51.05 67.23 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.144 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 230' ' ' THR . 75.0 t -56.93 -49.03 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 239' ' ' VAL . 9.9 t -66.86 -38.47 86.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.801 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.92 -46.88 88.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.159 0.504 . . . . 0.0 109.969 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.572 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 40.7 mtm -62.3 -42.94 99.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.066 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 13.0 ptp -71.1 -18.44 62.53 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.121 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 235' ' ' THR . 84.8 t -89.12 -33.57 6.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.772 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.22 79.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.44 0.638 . . . . 0.0 109.392 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -105.52 23.27 14.08 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.233 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 239' ' ' VAL . 55.4 p -60.63 -26.44 67.03 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.813 0.445 . . . . 0.0 111.66 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m -51.15 -51.26 55.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -130.15 89.42 2.79 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 246' ' ' ILE . 2.8 tm? -96.71 130.04 44.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.721 0.772 . . . . 0.0 110.801 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 245' ' ' LEU . 73.0 mt -127.6 128.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.419 ' CG2' ' HB ' ' A' ' 161' ' ' VAL . 8.1 tp -119.86 126.38 75.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.632 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.531 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 28.4 m -103.99 119.84 39.78 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.745 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.92 149.31 23.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.367 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 158' ' ' HIS . 10.0 tmtt? -135.8 128.06 17.65 Favored Pre-proline 0 C--N 1.286 -2.168 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.326 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 50.3 Cg_exo -57.69 127.3 24.72 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.627 2.218 . . . . 0.0 113.041 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -106.58 4.1 27.68 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.972 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -83.89 69.04 10.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -119.26 129.48 54.94 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.984 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 4.6 tpm_? . . . . . 0 C--N 1.294 -1.845 0 CA-C-O 118.316 -0.849 . . . . 0.0 108.855 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.857 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.7 m 64.03 107.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -71.35 99.34 1.94 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.676 0.75 . . . . 0.0 111.004 178.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.7 p -79.49 149.91 31.37 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.58 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -105.52 172.59 6.71 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.57 116.46 59.61 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.67 149.19 73.32 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.475 2.117 . . . . 0.0 113.052 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -86.15 91.43 8.43 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.1 pt -64.71 113.21 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.118 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.2 m -90.85 77.73 6.17 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-O 121.955 0.883 . . . . 0.0 109.887 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -109.65 125.38 31.41 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.911 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.88 134.12 33.62 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.135 1.89 . . . . 0.0 110.852 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -101.27 139.49 36.88 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.06 135.72 34.74 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -101.83 -64.64 1.04 Allowed 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.484 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -175.77 102.33 0.07 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.03 112.76 10.48 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.2 p -78.2 122.73 33.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.07 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.4 t -101.4 149.72 23.76 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.522 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.16 123.87 51.24 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.055 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.7 tp -62.12 115.84 2.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.145 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.31 136.99 38.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.4 t70 72.63 117.43 0.05 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 125.586 1.554 . . . . 0.0 114.636 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.1 m -145.5 144.37 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.91 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -106.22 142.24 36.24 Favored 'General case' 0 C--N 1.26 -3.304 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.409 ' N ' HD11 ' A' ' 153' ' ' ILE . 2.2 mp -80.92 -81.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.009 0.433 . . . . 0.0 110.412 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.03 102.11 17.7 Favored Pre-proline 0 C--N 1.295 -1.799 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.059 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.26 142.31 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.057 1.838 . . . . 0.0 110.666 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.5 82.15 5.66 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 121.339 0.59 . . . . 0.0 110.285 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.3 p -85.05 108.87 17.84 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -82.3 99.22 9.21 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -96.5 131.94 42.59 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.029 -163.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.495 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 22.1 ptt180 -105.14 112.74 25.97 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.16 133.41 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.865 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.551 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -98.44 134.8 40.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.627 0.727 . . . . 0.0 112.659 -176.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 45.0 tp -98.53 122.4 41.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.024 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.75 100.68 9.39 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-O 122.106 0.955 . . . . 0.0 112.21 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.466 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 64.2 pttt -74.61 147.31 41.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.376 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -100.62 20.5 14.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.49 -11.35 59.01 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.9 t -162.16 131.36 4.39 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 71.23 108.06 0.06 Allowed 'General case' 0 C--O 1.248 1.006 0 O-C-N 124.442 1.089 . . . . 0.0 112.014 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.466 ' HG3' ' HB3' ' A' ' 165' ' ' LYS . 3.5 mppt? -90.62 121.96 67.65 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -81.21 70.0 7.64 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.964 1.776 . . . . 0.0 112.55 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -69.92 112.99 6.72 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.393 0.616 . . . . 0.0 110.992 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -104.93 33.78 6.3 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -158.85 145.25 16.96 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -137.11 135.81 37.75 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -135.37 139.6 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -141.88 158.65 43.53 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.142 0.577 . . . . 0.0 112.185 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.487 ' H ' HD21 ' A' ' 231' ' ' LEU . 13.0 t70 -74.5 139.41 43.83 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.173 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.05 179.23 36.64 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 m -99.44 141.59 32.03 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.739 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 43.4 t -112.46 146.82 37.74 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.002 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.04 123.86 71.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.9 mtt180 -123.5 160.64 26.53 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.35 106.45 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 43.7 p -111.1 179.61 3.99 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.0 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.27 -18.16 65.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.0 m -92.06 4.97 51.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.589 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.26 -152.54 19.26 Favored Glycine 0 C--O 1.212 -1.274 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.5 pt? -85.88 121.26 28.27 Favored 'General case' 0 N--CA 1.395 -3.199 0 CA-C-N 117.34 0.57 . . . . 0.0 110.034 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.03 159.98 35.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.846 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 181' ' ' SER . 68.1 mttm -106.93 143.76 34.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.648 0.592 . . . . 0.0 109.722 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -136.31 154.09 76.88 Favored Pre-proline 0 N--CA 1.426 -1.626 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.09 129.44 6.87 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.047 1.832 . . . . 0.0 109.397 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.63 -177.82 24.9 Favored Glycine 0 C--N 1.287 -2.157 0 C-N-CA 120.611 -0.805 . . . . 0.0 111.718 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.447 HG21 ' HB ' ' A' ' 218' ' ' VAL . 12.0 tt -129.48 122.24 55.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.526 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -114.48 173.15 6.61 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.087 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.4 126.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.3 t -89.53 -45.58 9.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.753 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -146.62 153.65 40.57 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 49.1 tp -127.73 137.78 52.57 Favored 'General case' 0 N--CA 1.407 -2.601 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.47 137.3 19.21 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.84 126.45 18.14 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.765 1.643 . . . . 0.0 108.913 172.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.64 1.33 66.05 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.16 162.75 40.72 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.435 ' H ' HD21 ' A' ' 205' ' ' LEU . 2.1 mm? -63.99 -36.32 83.59 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 112.144 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -76.6 -27.9 55.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.611 0.719 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.41 -37.65 56.79 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.29 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.3 m -57.9 -33.63 68.96 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 120.773 0.321 . . . . 0.0 111.568 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 211' ' ' LEU . 4.3 m -68.06 -39.98 82.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.79 -33.6 2.36 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.25 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 209' ' ' THR . 27.1 mt -77.84 -8.1 57.58 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.62 ' HA ' ' OD2' ' A' ' 216' ' ' ASP . 82.7 mt -108.63 127.85 54.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.964 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.53 163.85 25.06 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.65 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -54.41 -26.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 C-N-CA 123.502 0.721 . . . . 0.0 112.123 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.08 -23.64 64.04 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.62 ' OD2' ' HA ' ' A' ' 212' ' ' LEU . 34.7 m-20 -66.73 166.01 13.92 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.135 0.574 . . . . 0.0 112.077 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.526 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -134.0 169.56 16.94 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.447 ' HB ' HG21 ' A' ' 195' ' ' ILE . 87.7 t -89.47 136.45 23.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.279 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.427 HD13 ' HB2' ' A' ' 250' ' ' LYS . 31.2 mt -96.68 -58.76 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.483 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.8 mt-10 -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.895 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.7 110.26 31.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.36 -77.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.752 0.821 . . . . 0.0 110.366 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -151.88 10.39 0.67 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.514 HG23 ' SD ' ' A' ' 237' ' ' MET . 3.0 mp -107.58 133.14 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.18 158.57 27.65 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.0 m -116.37 6.91 7.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.321 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -57.59 109.07 0.64 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.769 0.668 . . . . 0.0 111.554 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.99 5.37 47.23 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.53 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.411 ' HD2' ' HB3' ' A' ' 233' ' ' GLN . 35.9 mtmm -110.53 174.99 5.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 234' ' ' VAL . 31.8 m -118.69 163.42 16.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.691 -1.595 . . . . 0.0 108.866 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.632 HD11 ' N ' ' A' ' 232' ' ' ASP . 2.7 pp -50.53 -41.5 53.92 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.632 ' N ' HD11 ' A' ' 231' ' ' LEU . 29.6 t70 -61.3 -51.03 70.58 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.267 0.556 . . . . 0.0 110.482 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 237' ' ' MET . 48.1 mt-30 -58.53 -45.12 89.52 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.774 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 230' ' ' THR . 71.5 t -66.59 -49.07 78.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.48 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 45.5 p -59.63 -37.11 77.76 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.3 -44.13 97.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.066 0.46 . . . . 0.0 109.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.514 ' SD ' HG23 ' A' ' 224' ' ' ILE . 30.7 mtm -64.11 -49.62 71.5 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.546 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.48 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 24.0 ptm -67.88 -23.44 65.13 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.325 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 60.7 t -79.41 -30.93 14.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.499 0.666 . . . . 0.0 109.933 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.77 -15.04 57.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -132.56 27.44 4.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 37.0 t -65.95 -18.68 65.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -172.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.2 t -52.08 -64.46 0.81 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 90.76 3.3 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.4 tm? -91.18 126.88 36.4 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.495 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.1 mp -110.82 119.04 58.67 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.77 139.01 34.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.483 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.2 m -108.51 120.11 41.46 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.111 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.7 m -122.67 157.5 27.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 120.733 0.302 . . . . 0.0 110.915 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.51 ' HB3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -130.09 124.92 21.71 Favored Pre-proline 0 N--CA 1.432 -1.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.112 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.587 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.1 Cg_endo -65.36 134.12 37.58 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.821 2.347 . . . . 0.0 113.329 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.71 4.68 43.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 75.16 83.74 0.1 Allowed 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 113.386 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -120.68 148.09 44.4 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.551 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 . . . . . 0 C--N 1.298 -1.644 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.196 -179.844 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 m -89.89 -38.25 13.84 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.754 0.312 . . . . 0.0 110.311 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -153.95 -76.86 0.11 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.193 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.4 m -100.57 130.27 46.61 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.073 0.463 . . . . 0.0 110.357 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -83.94 98.7 9.93 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.89 136.25 24.78 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.63 123.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.457 2.105 . . . . 0.0 112.032 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.0 t -89.93 89.85 7.91 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.2 mt -91.1 161.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.7 t -162.05 170.79 18.62 Favored 'General case' 0 N--CA 1.38 -3.934 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.6 120.84 69.56 Favored Pre-proline 0 C--N 1.257 -3.454 0 CA-C-O 120.988 0.423 . . . . 0.0 110.367 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -72.7 131.08 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.646 2.231 . . . . 0.0 111.654 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -101.15 113.9 27.37 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.531 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 143' ' ' ARG . 13.8 t70 -84.41 157.69 21.32 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 144' ' ' GLN . 69.0 t80 -48.93 -46.88 43.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 141' ' ' ASP . 37.9 ptt180 40.89 24.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 127.204 2.202 . . . . 0.0 116.103 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 53.4 tt0 -84.04 144.61 28.98 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.9 m -73.18 136.13 26.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.426 0.632 . . . . 0.0 111.401 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.3 p -80.66 128.13 33.27 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.988 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.76 121.52 40.81 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.2 tp -76.12 87.94 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 122.05 0.928 . . . . 0.0 111.558 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.48 142.26 18.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.96 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -130.17 164.58 24.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -75.08 -37.88 41.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.413 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -106.43 110.65 22.93 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 122.007 -0.433 . . . . 0.0 110.339 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tp -133.28 95.99 2.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.675 0.75 . . . . 0.0 111.808 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.66 116.21 19.49 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.52 131.22 9.32 Favored 'Trans proline' 0 C--O 1.253 1.255 0 C-N-CA 121.629 1.552 . . . . 0.0 110.949 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -72.82 91.84 1.54 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -83.16 97.69 8.95 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.852 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -81.57 99.28 8.74 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.433 ' HB3' HD13 ' A' ' 212' ' ' LEU . 26.7 tpt180 -109.87 136.07 49.75 Favored 'General case' 0 C--N 1.257 -3.423 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.932 -165.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.461 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 4.6 ptp180 -114.44 116.79 29.44 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.904 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.97 129.88 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -109.59 133.25 53.32 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.754 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.45 120.46 42.5 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.718 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -115.12 110.23 19.22 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -72.59 121.22 19.36 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.935 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -126.9 124.75 40.26 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.84 16.29 77.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.239 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m 63.36 26.6 15.05 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 109.796 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -111.82 95.14 5.31 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -81.91 111.73 29.15 Favored Pre-proline 0 C--N 1.268 -2.967 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.551 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -73.79 -36.54 3.57 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.316 2.011 . . . . 0.0 111.123 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 35.9 tp 63.62 -91.31 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.455 1.102 . . . . 0.0 110.35 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 79.19 19.61 71.73 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.296 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -161.33 149.17 15.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -136.96 135.79 38.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -141.08 142.13 30.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.935 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.424 HH11 HD11 ' A' ' 231' ' ' LEU . 36.7 mmt180 -138.21 158.35 44.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.05 138.31 31.7 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.327 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -129.77 152.61 19.68 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -93.08 129.92 38.88 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 117.691 0.746 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -129.67 137.26 50.53 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.7 123.96 67.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.316 0.579 . . . . 0.0 110.203 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.15 160.38 18.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.045 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -103.3 113.23 39.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.234 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.3 p -110.23 178.62 4.34 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.794 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.95 -14.35 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.321 0.581 . . . . 0.0 109.752 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.0 m -89.27 -4.99 57.95 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 109.53 -161.07 13.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.558 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -84.14 124.5 31.21 Favored 'General case' 0 N--CA 1.396 -3.139 0 CA-C-N 117.877 0.839 . . . . 0.0 110.921 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -126.63 150.57 48.85 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.721 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.89 134.77 54.6 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.427 0.632 . . . . 0.0 110.125 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -130.03 149.56 73.52 Favored Pre-proline 0 C--N 1.265 -3.07 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.631 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.64 121.8 2.6 Favored 'Trans proline' 0 N--CA 1.429 -2.31 0 C-N-CA 122.084 1.856 . . . . 0.0 110.369 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -114.03 131.23 9.78 Favored Glycine 0 C--N 1.275 -2.845 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 66.2 mt -96.51 118.58 43.17 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -119.67 160.03 23.31 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 123.109 0.256 . . . . 0.0 110.984 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 67.8 mt -68.47 119.36 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.7 m -91.1 -35.21 14.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.053 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -150.82 140.05 21.24 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 47.4 tp -128.2 134.7 49.07 Favored 'General case' 0 N--CA 1.383 -3.824 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.896 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.36 128.26 25.74 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.66 128.5 28.42 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.538 2.159 . . . . 0.0 109.783 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.49 -10.87 61.35 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 155.11 34.61 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -27.99 69.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -73.94 -33.9 64.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.732 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.53 -37.59 56.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.2 t -54.08 -31.79 52.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.951 1.3 . . . . 0.0 112.137 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 79.4 p -59.55 -41.6 90.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.845 0.355 . . . . 0.0 111.434 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.24 -25.56 4.84 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.394 -0.367 . . . . 0.0 113.293 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.3 -18.56 26.72 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.338 0.59 . . . . 0.0 110.184 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.47 HD11 ' CG2' ' A' ' 249' ' ' VAL . 35.7 mt -113.28 145.6 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.758 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.71 163.23 26.6 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.376 1.07 . . . . 0.0 110.627 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.585 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 47.0 t -48.28 -35.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.316 1.046 . . . . 0.0 113.627 -176.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.67 -25.12 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.533 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.2 m-20 -62.42 159.63 15.09 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -114.74 165.3 12.96 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 195' ' ' ILE . 93.4 t -95.19 142.52 13.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 124.694 1.197 . . . . 0.0 110.805 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.423 HD13 ' HB2' ' A' ' 250' ' ' LYS . 35.8 mt -109.71 -59.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.049 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.524 ' H ' ' HB ' ' A' ' 248' ' ' THR . 50.1 mt-10 -135.98 159.11 42.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.564 -173.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.1 t -122.42 118.83 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.974 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.43 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.5 t-20 70.28 -62.85 0.42 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.467 1.107 . . . . 0.0 110.739 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 178.77 24.64 0.04 OUTLIER Glycine 0 C--N 1.281 -2.487 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.33 133.27 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.71 141.87 48.2 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.914 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -117.66 20.17 6.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.718 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.67 129.88 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.692 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.06 1.91 59.48 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' A' ' 233' ' ' GLN . 28.7 mmmt -99.08 153.67 18.7 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.331 0.652 . . . . 0.0 109.933 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.499 ' O ' HG22 ' A' ' 234' ' ' VAL . 17.2 m -101.91 161.35 13.73 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.424 HD11 HH11 ' A' ' 177' ' ' ARG . 1.7 pt? -49.43 -46.28 47.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.19 -38.86 78.88 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.823 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.462 ' HB3' ' HE3' ' A' ' 229' ' ' LYS . 47.5 mt-30 -58.12 -44.88 87.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.086 175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 230' ' ' THR . 61.7 t -66.66 -43.89 90.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 O-C-N 123.494 0.496 . . . . 0.0 111.122 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.4 p -70.35 -34.67 72.91 Favored 'General case' 0 C--O 1.206 -1.218 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.42 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.1 -41.2 99.33 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.019 0.914 . . . . 0.0 109.485 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 234' ' ' VAL . 8.5 tpt -56.78 -48.66 77.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.96 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 235' ' ' THR . 22.2 ptm -76.11 -17.97 59.37 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.913 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 235' ' ' THR . 70.0 t -88.7 -25.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.42 0.629 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.83 -20.78 16.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.628 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -121.13 -69.43 0.84 Allowed 'General case' 0 N--CA 1.389 -3.516 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.767 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 32.2 t 61.04 -39.76 0.11 Allowed 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.7 m -58.36 -39.77 80.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.811 0.844 . . . . 0.0 110.276 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -129.24 90.37 3.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 238' ' ' MET . 3.2 tm? -99.88 124.35 45.1 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.315 0.579 . . . . 0.0 110.088 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 60.7 mt -127.24 123.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.8 tp -109.42 122.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.727 0.775 . . . . 0.0 108.97 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.524 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.6 m -106.29 127.23 53.09 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.641 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.47 ' CG2' HD11 ' A' ' 212' ' ' LEU . 18.5 m -129.29 162.91 35.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.267 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 26.4 ttmt -130.45 136.58 29.19 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 124.759 1.224 . . . . 0.0 108.307 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.533 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 27.6 Cg_exo -65.03 127.4 18.39 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.494 1.463 . . . . 0.0 110.569 173.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -85.34 -27.55 25.8 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.223 0.535 . . . . 0.0 109.83 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.8 m120 61.0 27.74 17.6 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.836 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -98.79 31.65 2.87 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.674 0.75 . . . . 0.0 110.987 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 . . . . . 0 C--N 1.281 -2.37 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.43 179.17 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.0 t -136.26 143.41 44.24 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -132.85 138.58 47.09 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.958 0.409 . . . . 0.0 110.155 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -108.1 121.65 45.27 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.27 149.56 27.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 120.908 0.385 . . . . 0.0 110.964 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.55 106.46 32.46 Favored Pre-proline 0 N--CA 1.43 -1.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.387 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.1 -39.74 88.67 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.74 2.293 . . . . 0.0 109.862 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.4 p -147.0 112.97 5.77 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.96 119.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.537 1.16 . . . . 0.0 113.044 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 96.28 3.97 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.576 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.6 tp -95.31 133.69 25.61 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.197 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.06 126.88 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.933 1.755 . . . . 0.0 110.293 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -82.88 164.15 20.68 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.857 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.89 121.73 25.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.437 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -152.8 -55.53 0.12 Allowed 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.651 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -97.43 71.62 2.34 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 122.509 1.147 . . . . 0.0 109.595 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -64.64 118.81 9.42 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.982 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.7 m -81.19 152.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.563 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.1 t -97.94 137.97 35.98 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.18 104.35 11.6 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.306 0.574 . . . . 0.0 110.832 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.5 tt -82.88 133.06 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.247 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.39 141.76 15.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.2 t70 72.07 94.72 0.07 Allowed 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 124.451 1.1 . . . . 0.0 112.018 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 68.0 t -132.2 -39.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.479 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -73.53 108.5 6.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.023 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 tp -154.07 136.88 7.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.64 101.47 48.4 Favored Pre-proline 0 C--N 1.294 -1.846 0 CA-C-O 121.311 0.577 . . . . 0.0 110.742 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.2 150.83 23.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.586 2.191 . . . . 0.0 111.453 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 158' ' ' HIS . 41.4 mt-10 -75.34 84.37 2.48 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 120.967 0.413 . . . . 0.0 112.092 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -91.88 100.5 13.17 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 78.5 m80 -75.26 112.48 11.59 Favored 'General case' 0 CA--C 1.47 -2.108 0 CA-C-O 121.782 0.801 . . . . 0.0 109.292 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -110.53 135.16 51.62 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.106 -1.407 . . . . 0.0 107.578 -170.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 85.2 mtm180 -114.3 140.95 48.2 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.037 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.87 132.11 57.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.457 ' C ' HD12 ' A' ' 163' ' ' LEU . 6.6 mpt_? -105.9 138.72 41.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.072 0.463 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 162' ' ' ARG . 8.2 mp -126.77 124.69 40.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.89 0.876 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.48 107.74 18.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 122.064 0.935 . . . . 0.0 113.022 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.455 ' HD2' ' OG ' ' A' ' 242' ' ' SER . 88.5 tttt -78.23 142.87 37.59 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.288 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -106.24 26.44 9.8 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.323 0.582 . . . . 0.0 110.414 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.95 -11.54 65.98 Favored Glycine 0 CA--C 1.498 -0.974 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -164.08 146.68 9.28 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 125.624 1.57 . . . . 0.0 106.868 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.256 6.8 m-20 49.69 96.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 175.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.495 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -84.25 127.06 67.91 Favored Pre-proline 0 C--N 1.299 -1.616 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.065 174.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.422 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 26.1 Cg_endo -62.06 102.83 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.835 2.357 . . . . 0.0 112.614 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.61 144.25 28.91 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.824 0.821 . . . . 0.0 112.459 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.6 38.19 1.53 Allowed Glycine 0 C--N 1.286 -2.238 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.406 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -158.58 151.89 22.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -137.0 135.14 37.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.9 pt -137.49 148.64 25.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.517 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 13.2 ptm180 -142.56 158.5 43.61 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.22 145.47 30.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 0.0 109.727 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.85 -172.5 13.48 Favored Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.462 ' CG2' ' HB3' ' A' ' 191' ' ' LYS . 6.5 m -126.54 142.93 51.37 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 117.836 0.818 . . . . 0.0 109.003 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.0 m -114.9 131.32 56.91 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.7 122.46 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -121.85 155.16 35.97 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.279 0.561 . . . . 0.0 110.504 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 120.47 54.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.639 -174.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.3 p -115.73 177.66 4.59 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.05 -2.9 49.99 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.707 0.765 . . . . 0.0 109.317 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.4 m -97.34 -4.37 38.67 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.82 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.73 -156.25 15.74 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.49 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.434 ' N ' HD21 ' A' ' 189' ' ' LEU . 2.0 mm? -88.96 135.32 33.61 Favored 'General case' 0 N--CA 1.403 -2.819 0 C-N-CA 122.747 0.419 . . . . 0.0 109.979 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.28 150.13 46.37 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.832 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.462 ' HB3' ' CG2' ' A' ' 180' ' ' THR . 50.9 mtmt -108.14 142.76 37.86 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.998 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -134.76 141.98 40.7 Favored Pre-proline 0 N--CA 1.413 -2.319 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.666 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.46 129.05 12.45 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 110.895 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.32 137.41 8.55 Favored Glycine 0 C--N 1.287 -2.172 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 57.3 mt -97.41 125.32 50.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 89.8 m-85 -118.63 167.01 12.04 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.945 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.53 136.51 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.404 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 30.5 p -117.05 -44.07 2.82 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.978 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -137.63 145.17 42.41 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 206' ' ' ALA . 4.8 mt -127.74 137.69 52.52 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.829 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.67 130.1 27.39 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -59.94 126.77 21.24 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.763 1.642 . . . . 0.0 110.079 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 90.74 -7.66 80.95 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.779 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.2 160.94 52.46 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -56.66 -45.09 81.85 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.472 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -70.71 -28.94 65.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.325 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' A' ' 200' ' ' LEU . 8.7 tp10 -76.37 -42.46 44.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.516 0.675 . . . . 0.0 109.209 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 39.7 t -60.56 -33.3 72.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.812 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.417 HG21 ' HG ' ' A' ' 211' ' ' LEU . 29.1 m -62.61 -41.5 99.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.112 0.482 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.86 -45.85 3.58 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 121.171 -0.538 . . . . 0.0 114.372 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.417 ' HG ' HG21 ' A' ' 209' ' ' THR . 4.3 pp -74.39 -4.25 35.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.68 143.97 38.7 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -128.87 163.06 26.07 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 124.311 1.044 . . . . 0.0 109.204 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.71 -21.3 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 123.82 0.848 . . . . 0.0 112.99 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 254' ' ' GLN . 41.3 t30 -71.87 -29.24 64.16 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.059 0.544 . . . . 0.0 111.559 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.689 ' HB3' ' O ' ' A' ' 250' ' ' LYS . 74.5 m-20 -68.03 163.09 23.1 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -169.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 0.5 OUTLIER -116.37 167.06 11.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.243 -0.983 . . . . 0.0 113.231 -173.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 61.0 t -98.88 142.12 15.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.465 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.17 -46.98 6.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.949 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.15 154.3 51.01 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 121.57 0.7 . . . . 0.0 112.085 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.52 101.79 12.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 113.534 -1.666 . . . . 0.0 106.509 166.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.564 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 61.0 t30 71.23 -68.36 0.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.56 1.544 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.05 8.25 0.32 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.414 HG23 ' SD ' ' A' ' 237' ' ' MET . 29.2 mt -107.27 118.2 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.04 142.16 45.72 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.72 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 29.0 m -95.08 18.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.49 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.08 109.46 2.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.08 0.466 . . . . 0.0 110.325 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.59 61.95 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.637 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -84.42 169.16 14.85 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 85.3 m -121.29 158.73 27.51 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.37 -1.741 . . . . 0.0 106.696 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.477 ' HA ' HG12 ' A' ' 234' ' ' VAL . 57.8 tp -67.1 -46.82 73.07 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.984 0.811 . . . . 0.0 111.894 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.06 -37.96 75.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.13 0.49 . . . . 0.0 111.251 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.5 mp0 -74.42 -44.52 51.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 231' ' ' LEU . 8.9 p -66.25 -38.47 81.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.689 0.28 . . . . 0.0 110.833 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 239' ' ' VAL . 10.8 t -66.12 -32.13 73.4 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.91 -43.5 83.19 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 22.7 mtm -62.4 -43.78 98.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.193 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.521 ' SD ' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptm -75.58 -13.89 60.37 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.828 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.531 ' HA ' ' HB2' ' A' ' 242' ' ' SER . 66.0 t -87.78 -37.25 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 109.829 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.88 69.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.492 0.663 . . . . 0.0 110.281 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -108.66 21.25 17.51 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.423 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 36.9 t -67.05 -24.5 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -174.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 31.7 m -52.12 -51.63 56.63 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.559 0.537 . . . . 0.0 110.59 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -128.75 87.98 2.66 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.3 tm? -93.43 131.36 38.7 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.969 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 71.1 mt -127.43 139.48 51.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 9.3 tt -129.62 134.53 63.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.144 174.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 39.4 m -102.31 120.63 40.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.213 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.35 155.25 15.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 36.2 tttm -138.34 140.29 27.88 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.422 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.515 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 36.6 Cg_endo -68.75 127.46 15.44 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 121.626 1.55 . . . . 0.0 110.157 172.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -4.67 58.65 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 122.596 0.358 . . . . 0.0 111.454 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.453 ' N ' HD21 ' A' ' 253' ' ' ASN . 0.7 OUTLIER 66.35 102.35 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.591 ' HA ' ' ND2' ' A' ' 215' ' ' ASN . 19.4 tm0? -61.9 109.03 1.13 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.733 1.254 . . . . 0.0 112.483 -172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 . . . . . 0 C--N 1.281 -2.386 0 CA-C-N 112.212 -2.267 . . . . 0.0 105.953 179.486 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.705 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.0 t -154.09 116.21 4.29 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -104.05 118.45 36.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -77.01 137.16 38.82 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.528 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -105.33 92.0 4.02 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.728 0.775 . . . . 0.0 109.854 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.27 110.23 37.94 Favored Pre-proline 0 C--N 1.301 -1.513 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.632 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.79 111.92 2.94 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.161 1.907 . . . . 0.0 108.962 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.8 p -101.9 103.27 13.94 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.54 0.686 . . . . 0.0 112.566 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 62.2 mt 68.15 147.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.822 1.649 . . . . 0.0 112.23 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -156.33 91.37 1.25 Allowed 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.5 tt -120.68 103.98 42.9 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-O 121.539 0.685 . . . . 0.0 112.599 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -84.47 137.84 7.11 Favored 'Trans proline' 0 N--CA 1.429 -2.283 0 C-N-CA 121.667 1.578 . . . . 0.0 109.711 174.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -82.48 114.39 20.87 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.88 124.4 34.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -170.87 96.46 0.21 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -138.37 85.87 2.12 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -82.0 110.2 17.03 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.041 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.5 m -73.74 125.02 32.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.215 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.1 m -74.94 113.97 12.86 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.11 108.47 18.18 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.435 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.08 97.56 5.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.0 pt -85.15 115.97 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.814 0.816 . . . . 0.0 110.31 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -112.61 100.13 8.49 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-O 122.273 1.035 . . . . 0.0 110.589 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.03 -45.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.158 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 153' ' ' ILE . 26.6 t70 -77.96 130.82 37.01 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.259 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.449 HG12 ' H ' ' A' ' 154' ' ' VAL . 12.2 tt 56.74 170.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 126.969 2.107 . . . . 0.0 112.274 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.449 ' H ' HG12 ' A' ' 153' ' ' ILE . 6.7 p -101.98 105.62 43.04 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.668 -0.645 . . . . 0.0 109.382 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.15 150.25 29.15 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.114 1.876 . . . . 0.0 110.04 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.51 69.07 6.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.327 0.584 . . . . 0.0 112.506 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.2 t -91.33 128.39 37.14 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -99.74 128.27 45.85 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.23 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -96.76 120.81 37.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.914 -169.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -106.33 107.84 19.05 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.23 132.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -108.88 149.08 29.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.92 130.37 43.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.401 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.85 111.61 18.18 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 121.591 0.71 . . . . 0.0 111.203 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -68.25 146.72 53.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.619 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -121.41 76.85 1.28 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.46 -2.67 84.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.522 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.4 t 58.63 72.77 0.51 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.56 1.144 . . . . 0.0 110.3 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -103.92 -49.77 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.97 150.24 47.25 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.562 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 -162.93 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 110.992 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.435 HD22 ' CZ ' ' A' ' 174' ' ' PHE . 4.9 mp -92.94 144.32 25.38 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -89.9 25.47 11.73 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.61 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.435 ' CZ ' HD22 ' A' ' 172' ' ' LEU . 41.9 p90 -158.7 147.32 18.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -132.31 142.83 49.5 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.2 pt -133.16 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.327 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.539 ' HG2' ' N ' ' A' ' 178' ' ' ASP . 78.1 ttt180 -141.23 159.87 41.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.539 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 7.7 p-10 -72.99 157.71 36.88 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.878 0.847 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.32 149.91 18.01 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -93.86 140.76 29.29 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -131.23 134.22 46.23 Favored 'General case' 0 C--N 1.261 -3.279 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.84 123.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.95 107.69 21.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.3 p -115.18 177.72 4.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.14 59.92 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.448 0.642 . . . . 0.0 109.416 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.1 m -89.51 -4.42 57.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.528 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.64 -154.48 16.86 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.494 HD21 ' H ' ' A' ' 189' ' ' LEU . 2.1 pt? -84.35 118.35 24.17 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-O 122.001 0.905 . . . . 0.0 109.962 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -120.89 144.88 48.18 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.059 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -101.42 143.87 30.91 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 41.6 tt0 -133.08 144.2 51.68 Favored Pre-proline 0 C--N 1.281 -2.412 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.266 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 1.6 Cg_endo -83.12 128.62 5.03 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 C-N-CA 122.519 2.146 . . . . 0.0 109.298 171.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 178' ' ' ASP . . . -140.31 163.06 26.45 Favored Glycine 0 C--N 1.277 -2.725 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.797 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.414 ' O ' HG21 ' A' ' 218' ' ' VAL . 63.0 mt -116.89 119.64 62.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 56.6 m-85 -118.95 167.04 12.11 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.998 -175.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.0 122.73 18.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.513 ' C ' ' HD2' ' A' ' 199' ' ' ARG . 76.6 p -96.04 -67.36 0.85 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.867 0.365 . . . . 0.0 111.494 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.513 ' HD2' ' C ' ' A' ' 198' ' ' SER . 7.2 mpt_? -124.88 154.19 41.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.938 0.495 . . . . 0.0 110.351 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.74 139.44 52.68 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.966 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -99.25 126.86 36.37 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.87 126.44 20.43 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.108 1.872 . . . . 0.0 109.946 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.9 -6.86 54.66 Favored Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.26 151.46 34.86 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.65 -29.9 70.37 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.19 70.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.224 0.535 . . . . 0.0 110.568 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -77.34 -43.47 32.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 m -55.24 -33.61 63.27 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.615 ' OG1' ' HG ' ' A' ' 211' ' ' LEU . 5.2 t -69.61 -44.92 69.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.744 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 -12.75 4.52 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.469 -0.872 . . . . 0.0 114.39 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.615 ' HG ' ' OG1' ' A' ' 209' ' ' THR . 3.8 pp -89.67 -3.93 58.0 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 118.836 1.318 . . . . 0.0 111.494 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 88.5 mt -109.54 146.11 35.19 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.617 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.69 162.68 16.92 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 123.671 0.788 . . . . 0.0 110.533 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.16 -16.82 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-O 122.454 1.121 . . . . 0.0 110.425 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -75.52 -23.67 56.71 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.301 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.548 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.8 m-20 -63.75 156.43 27.17 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -171.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.485 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 31.1 mt-10 -109.51 150.84 27.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.929 -170.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 195' ' ' ILE . 23.2 m -98.58 143.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 43.1 mt -109.33 -56.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.489 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.4 mt-10 -130.27 149.86 51.77 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.633 -172.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.405 HG12 ' HB3' ' A' ' 238' ' ' MET . 67.5 t -116.02 112.48 39.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 67.73 -70.14 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.26 1.024 . . . . 0.0 110.014 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.84 11.09 0.1 OUTLIER Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.53 135.78 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.25 159.18 29.83 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.287 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.414 HG22 HG23 ' A' ' 218' ' ' VAL . 20.6 m -102.95 3.63 10.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.867 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -55.21 108.9 0.46 Allowed 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.993 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.49 90.53 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.465 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -87.17 160.12 18.62 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.8 m -81.55 158.28 24.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.537 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 178' ' ' ASP . 4.1 mp -70.55 -41.39 72.53 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 118.425 0.557 . . . . 0.0 109.98 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.73 -39.26 73.62 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.378 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 237' ' ' MET . 21.1 tp60 -67.74 -47.16 70.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.294 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.29 -45.42 86.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.048 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.459 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 8.8 t -64.59 -29.11 70.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.14 -48.91 77.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.292 0.567 . . . . 0.0 109.478 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 29.4 mtm -62.67 -40.18 96.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.129 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.459 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 15.4 ptm -76.24 -20.27 57.57 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.695 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 79.8 t -91.7 -36.8 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.352 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.42 69.94 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -109.23 23.24 14.79 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.323 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 63.7 m -64.97 -18.82 65.6 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -67.52 -39.66 85.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -129.45 79.66 1.92 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -99.41 129.59 45.61 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.535 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.06 132.28 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 6.9 tp -118.24 120.8 65.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.029 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.489 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.3 m -92.35 119.32 31.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.359 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -120.45 139.43 47.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.802 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.65 123.46 23.91 Favored Pre-proline 0 N--CA 1.413 -2.305 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.092 -173.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.548 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 31.6 Cg_exo -58.25 133.72 57.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.866 2.377 . . . . 0.0 113.515 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -94.92 3.1 55.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -90.58 81.1 5.92 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -131.73 135.23 46.67 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.002 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 119.15 -0.453 . . . . 0.0 110.097 -177.226 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.827 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.1 p -164.0 161.93 22.94 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 122.24 0.216 . . . . 0.0 110.84 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.516 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -161.79 132.98 5.25 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.511 0.725 . . . . 0.0 110.994 175.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 28.5 m -102.06 122.65 44.51 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -134.23 152.58 51.89 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.89 117.52 66.33 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.42 -34.86 75.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.343 2.028 . . . . 0.0 110.61 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.7 t -121.06 108.02 13.32 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.72 154.36 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.1 t -91.83 83.45 5.25 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.58 112.61 32.43 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.449 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.74 133.05 45.86 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.306 2.004 . . . . 0.0 110.733 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -100.17 114.54 28.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.31 153.4 18.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.786 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -92.68 79.74 4.79 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -116.43 20.31 14.24 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.275 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.6 162.51 18.12 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.345 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.28 116.52 13.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 122.385 1.088 . . . . 0.0 110.969 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -89.99 153.86 20.27 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.962 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.92 116.54 31.38 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tp -79.3 123.61 36.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.905 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.2 tp -91.17 138.08 20.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.516 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.95 121.65 0.03 OUTLIER 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.932 1.293 . . . . 0.0 113.88 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.37 136.39 36.59 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.34 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.583 ' O ' HG23 ' A' ' 153' ' ' ILE . 22.4 t70 -85.35 138.66 32.14 Favored 'General case' 0 C--N 1.258 -3.408 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 152' ' ' ASP . 9.7 tt 63.93 165.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 126.381 1.872 . . . . 0.0 109.114 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.7 t -96.87 104.79 19.85 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.349 -0.844 . . . . 0.0 108.921 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 30.7 Cg_exo -62.79 151.44 83.99 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 122.769 2.313 . . . . 0.0 109.232 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.54 80.35 0.1 Allowed 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 121.936 0.874 . . . . 0.0 113.322 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.1 m -92.96 85.11 5.03 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -98.81 113.54 25.7 Favored 'General case' 0 CA--C 1.467 -2.228 0 CA-C-O 121.391 0.615 . . . . 0.0 109.845 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 4.1 tpm_? -100.25 123.69 44.79 Favored 'General case' 0 C--N 1.271 -2.847 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.283 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.536 ' HB3' ' CG2' ' A' ' 246' ' ' ILE . 67.9 mtm180 -99.92 112.33 24.6 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.92 125.75 42.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 39.6 ptt180 -102.87 142.24 34.32 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.07 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -116.77 123.1 46.32 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.497 HD11 ' O ' ' A' ' 164' ' ' LEU . 2.9 pp -111.05 100.87 9.47 Favored 'General case' 0 N--CA 1.398 -3.038 0 CA-C-O 122.499 1.142 . . . . 0.0 112.049 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 243' ' ' SER . 12.8 tmtt? -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.811 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 14.2 p80 179.8 117.9 0.05 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.326 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.75 0.41 66.63 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.115 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 t -171.88 148.56 2.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.98 -39.87 83.23 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt 62.89 121.38 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.027 1.331 . . . . 0.0 113.629 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.42 22.94 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.365 2.71 . . . . 0.0 113.108 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp 66.5 -73.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.798 1.239 . . . . 0.0 112.854 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 108.89 -12.71 34.8 Favored Glycine 0 CA--C 1.497 -1.06 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -128.12 143.9 51.08 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.17 161.07 35.42 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 123.185 0.303 . . . . 0.0 110.813 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 176' ' ' ILE . 2.3 pp -130.62 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -141.66 147.95 38.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 12.2 p-10 -102.46 127.12 49.63 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.532 0.682 . . . . 0.0 111.521 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -112.23 117.32 4.35 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 23.5 p -92.72 143.19 26.54 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 117.722 0.761 . . . . 0.0 112.363 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.0 t -127.42 132.4 50.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.16 124.0 49.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -120.97 157.09 30.7 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 63.2 t -102.64 116.6 46.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.8 p -115.62 177.81 4.53 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.701 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.37 -14.57 62.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.204 0.526 . . . . 0.0 109.918 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.3 p -91.94 -0.24 57.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.056 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.83 -165.35 12.04 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.536 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.7 pt? -84.83 106.47 16.38 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.314 1.054 . . . . 0.0 110.712 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -104.31 152.44 22.23 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.266 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -121.3 133.39 55.13 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -116.7 143.91 32.3 Favored Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.358 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.18 126.51 2.0 Allowed 'Trans proline' 0 N--CA 1.427 -2.428 0 C-N-CA 122.227 1.951 . . . . 0.0 112.734 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.67 86.32 0.45 Allowed Glycine 0 C--N 1.279 -2.617 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 12.1 tt -82.11 133.66 28.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 120.597 0.237 . . . . 0.0 110.438 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -142.87 177.56 8.26 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.542 0.737 . . . . 0.0 110.74 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.2 mt -71.99 134.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 68.3 p -109.84 -59.95 1.85 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.8 147.87 47.19 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.059 0.457 . . . . 0.0 111.043 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 206' ' ' ALA . 11.2 mt -127.06 138.3 53.19 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.646 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.89 132.63 20.71 Favored Pre-proline 0 C--N 1.286 -2.16 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.96 126.79 23.74 Favored 'Trans proline' 0 C--O 1.251 1.125 0 C-N-CA 121.808 1.672 . . . . 0.0 110.057 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.89 60.78 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.83 149.14 51.13 Favored Glycine 0 C--O 1.214 -1.144 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -56.73 -35.61 68.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.505 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -73.42 -28.08 61.79 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.738 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.19 -43.33 43.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.1 m -54.7 -32.9 60.15 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.223 1.009 . . . . 0.0 112.222 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.488 HG21 ' HG ' ' A' ' 211' ' ' LEU . 25.5 m -63.94 -43.28 96.36 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.845 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.8 -56.72 3.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.433 -0.349 . . . . 0.0 113.857 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.488 ' HG ' HG21 ' A' ' 209' ' ' THR . 4.1 pp -70.93 2.23 4.6 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.625 1.17 . . . . 0.0 113.292 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CG2' ' A' ' 249' ' ' VAL . 25.7 tp -119.99 145.74 46.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.82 161.64 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.245 0.545 . . . . 0.0 112.062 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.63 -24.66 13.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.844 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -68.93 -24.6 64.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.348 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.667 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 70.5 m-20 -60.13 139.96 57.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.249 0.62 . . . . 0.0 111.878 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.66 145.08 26.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -170.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.406 ' HB ' HG21 ' A' ' 195' ' ' ILE . 84.1 t -78.0 135.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.886 1.274 . . . . 0.0 110.993 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.8 mm -122.23 -43.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.134 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.49 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.5 mt-10 -136.58 151.33 49.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.484 0.659 . . . . 0.0 112.045 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.49 109.12 26.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.533 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 69.82 -66.62 0.26 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.452 1.101 . . . . 0.0 111.229 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.93 15.78 0.09 OUTLIER Glycine 0 C--N 1.294 -1.765 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.92 133.55 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 44.6 mt-10 -82.33 149.42 27.76 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.57 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.56 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 19.1 m -89.62 14.1 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.021 -177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -88.73 109.36 20.08 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.4 15.09 26.27 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.737 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 1.1 pptp? -104.85 174.36 5.91 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 26.3 m -106.06 158.64 16.66 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.646 ' O ' HG12 ' A' ' 234' ' ' VAL . 4.7 tt -60.44 -47.49 85.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.859 0.464 . . . . 0.0 110.798 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.15 -36.42 74.74 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.281 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.71 -37.86 80.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 231' ' ' LEU . 7.5 p -58.18 -44.67 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.409 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.7 p -70.54 -35.47 73.15 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.341 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.35 -43.36 81.69 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.815 0.817 . . . . 0.0 110.327 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 76.1 mtp -61.92 -44.59 96.46 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.701 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 25.7 ptm -70.54 -24.4 62.8 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 235' ' ' THR . 96.8 t -83.24 -32.26 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 0.0 109.798 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.64 68.75 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.618 0.723 . . . . 0.0 109.844 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -107.98 22.24 16.24 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 68.4 m -54.45 -31.46 55.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 34.2 t -50.83 -58.16 6.65 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.736 0.303 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -130.58 89.61 2.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.4 tm? -101.14 130.88 47.29 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 160' ' ' ARG . 68.1 mt -118.32 123.81 72.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.85 118.79 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 122.098 0.951 . . . . 0.0 109.565 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.49 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 19.8 m -95.82 120.15 35.58 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.942 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.576 ' CG2' HD22 ' A' ' 212' ' ' LEU . 29.8 m -129.34 149.53 33.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -127.03 128.49 24.16 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.667 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.9 Cg_exo -39.23 126.9 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.07 3.18 . . . . 0.0 115.009 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.25 8.49 32.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.535 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -83.36 -6.42 59.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.415 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -119.32 125.29 48.69 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.012 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 . . . . . 0 C--N 1.282 -2.352 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.736 -175.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.817 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.4 m -88.81 -3.35 58.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.157 0.503 . . . . 0.0 111.007 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -129.46 124.29 33.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -75.43 142.23 43.04 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.76 0.314 . . . . 0.0 110.216 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -91.22 112.59 24.56 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.93 99.29 34.3 Favored Pre-proline 0 C--N 1.289 -2.05 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.949 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.86 110.56 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.237 1.958 . . . . 0.0 110.189 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 m -80.15 99.06 7.58 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.7 tt -54.02 135.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.728 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.7 p -129.25 88.93 2.77 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.039 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.95 138.77 19.65 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.766 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.12 123.13 11.26 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.373 2.049 . . . . 0.0 111.021 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -90.29 152.64 20.95 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.828 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.33 121.96 33.53 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -113.12 -52.35 2.78 Favored 'General case' 0 C--N 1.261 -3.274 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 58.9 89.71 0.06 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.839 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -76.38 111.71 12.13 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.7 m -101.15 140.54 19.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 t -88.02 114.88 25.08 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.3 103.11 13.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 tt -121.4 96.51 4.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.799 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.38 117.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.084 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -101.73 -2.71 29.58 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.815 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.93 -49.46 79.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -102.72 118.86 37.77 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 153' ' ' ILE . 2.2 mp -71.98 -46.3 60.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.83 102.05 19.82 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -81.32 148.71 16.68 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.202 1.935 . . . . 0.0 109.259 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -74.81 85.71 2.2 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.547 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.7 p -81.73 114.94 20.73 Favored 'General case' 0 N--CA 1.408 -2.566 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.399 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -87.74 99.7 12.28 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.415 ' HG3' HG12 ' A' ' 161' ' ' VAL . 32.9 tpt180 -103.24 125.72 50.05 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.054 -170.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.484 ' HG2' ' OG1' ' A' ' 248' ' ' THR . 88.2 mtt180 -103.3 105.0 15.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.698 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.415 HG12 ' HG3' ' A' ' 159' ' ' ARG . 23.0 m -104.69 132.53 51.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 120.96 0.409 . . . . 0.0 110.94 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -103.06 142.76 33.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.1 mt -133.39 145.42 50.31 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.828 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -120.4 120.43 35.94 Favored 'General case' 0 N--CA 1.404 -2.744 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.578 172.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -65.98 143.48 57.35 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.538 -178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 169' ' ' ASP . 37.5 m80 -110.86 -37.34 5.43 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.494 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.53 -11.69 37.71 Favored Glycine 0 N--CA 1.459 0.183 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.959 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 3.13 15.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 25.2 t70 171.68 117.19 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.413 2.285 . . . . 0.0 105.916 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 169' ' ' ASP . 56.7 mttp 66.77 86.59 0.13 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 124.949 1.3 . . . . 0.0 112.478 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -75.84 -32.27 4.59 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.168 1.912 . . . . 0.0 107.915 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 174' ' ' PHE . 1.8 pt? -152.95 127.12 9.12 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.118 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -95.65 48.11 1.87 Allowed Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.443 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.449 ' CE1' ' HB2' ' A' ' 172' ' ' LEU . 54.1 p90 -169.75 156.82 6.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 67.6 m-85 -137.73 135.41 36.37 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 169.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.593 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.0 pt -132.78 144.71 35.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -136.4 136.63 39.75 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.729 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -87.21 123.16 31.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.847 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -131.1 174.72 19.82 Favored Glycine 0 C--N 1.276 -2.789 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 141.84 32.63 Favored 'General case' 0 C--N 1.271 -2.81 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.322 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t -123.09 136.87 54.98 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.44 124.03 63.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -116.19 154.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-O 121.019 0.438 . . . . 0.0 110.254 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.37 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.7 p -115.6 177.29 4.72 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.098 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.36 -16.86 61.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.6 p -91.85 5.75 48.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.17 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 -156.26 15.66 Favored Glycine 0 C--O 1.214 -1.154 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.882 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.509 HD21 ' H ' ' A' ' 189' ' ' LEU . 0.5 OUTLIER -98.95 106.77 19.06 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.77 0.795 . . . . 0.0 109.373 175.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.21 152.14 23.21 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.697 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -121.09 130.92 53.97 Favored 'General case' 0 N--CA 1.402 -2.852 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -147.76 150.88 37.52 Favored Pre-proline 0 C--N 1.265 -3.09 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.977 -172.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.68 134.96 19.07 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.206 1.937 . . . . 0.0 110.273 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.04 134.65 6.87 Favored Glycine 0 C--N 1.301 -1.391 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.593 ' CG2' ' HB ' ' A' ' 176' ' ' ILE . 58.2 mt -104.61 119.82 54.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.753 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -120.65 156.97 30.58 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 68.5 mt -63.51 123.38 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.602 0.715 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -91.09 -42.46 10.47 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.865 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 68.5 ttt180 -151.65 152.98 33.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.197 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.513 HD22 ' HB2' ' A' ' 206' ' ' ALA . 13.8 mt -128.08 138.76 52.68 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.14 130.21 26.6 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.72 137.25 59.5 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.55 2.22 58.8 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.79 153.09 34.18 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.64 -26.39 61.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.513 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -67.19 -26.87 66.84 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 122.077 0.941 . . . . 0.0 109.224 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.62 -41.36 46.22 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.031 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.1 t -64.78 -36.12 83.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.0 p -62.62 -44.29 96.67 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.95 -51.84 2.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.631 -0.259 . . . . 0.0 113.032 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.3 mt -57.58 -39.77 77.49 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.48 1.112 . . . . 0.0 108.922 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.9 mp -115.37 108.67 16.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.27 116.62 16.38 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.614 -0.434 . . . . 0.0 112.054 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.488 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 70.8 t 57.23 -43.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.067 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 174.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -74.63 -23.82 58.75 Favored 'General case' 0 CA--C 1.484 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 112.465 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.26 173.44 2.54 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.656 0.741 . . . . 0.0 112.566 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -128.65 140.43 51.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.641 -170.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.12 141.4 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.371 0.605 . . . . 0.0 110.086 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.73 -52.62 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.942 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.445 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 36.5 mt-10 -125.49 146.51 49.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.899 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.526 HG13 ' SD ' ' A' ' 238' ' ' MET . 92.2 t -109.18 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 171.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.519 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 25.1 t-20 70.33 -73.83 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.806 0.812 . . . . 0.0 109.788 -174.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.95 12.53 0.1 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 175.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.449 ' CG2' ' HE2' ' A' ' 237' ' ' MET . 9.0 mt -95.45 118.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.24 150.1 33.5 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.981 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 22.5 m -95.84 13.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 120.922 0.391 . . . . 0.0 112.05 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.75 114.52 18.73 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.22 15.07 28.98 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.295 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 0.5 OUTLIER -109.93 175.98 5.24 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.536 -0.391 . . . . 0.0 110.443 -177.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 32.9 m -113.77 160.77 18.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.565 ' O ' HG12 ' A' ' 234' ' ' VAL . 3.0 tm? -55.11 -46.36 75.57 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.177 0.444 . . . . 0.0 111.876 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.47 -35.5 77.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.232 0.539 . . . . 0.0 110.478 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 237' ' ' MET . 97.7 mt-30 -69.96 -39.79 75.81 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.664 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 231' ' ' LEU . 10.4 p -61.17 -42.23 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 118.498 0.59 . . . . 0.0 111.855 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 239' ' ' VAL . 6.7 t -75.27 -28.95 60.01 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.918 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.68 -39.58 88.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 73.1 mtp -56.41 -43.93 79.83 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.455 174.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.598 ' SD ' HD22 ' A' ' 245' ' ' LEU . 24.6 mmt -64.12 -29.38 70.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.062 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.566 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 87.7 t -82.7 -34.85 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.306 0.574 . . . . 0.0 110.755 -175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.55 -23.3 67.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.243 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.7 26.37 5.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.455 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 49.3 m -54.32 -28.66 43.9 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -95.28 -5.51 43.45 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.986 -0.446 . . . . 0.0 111.696 -176.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.27 35.52 4.26 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.598 HD22 ' SD ' ' A' ' 238' ' ' MET . 2.6 tm? -83.22 124.11 30.23 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.506 -167.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 56.6 mt -130.22 129.63 65.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.479 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.68 122.06 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 42.0 m -90.78 119.84 31.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-O 121.118 0.485 . . . . 0.0 111.81 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.482 ' HB3' ' HZ3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -138.04 126.8 14.51 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 123.743 0.817 . . . . 0.0 108.858 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.48 127.71 21.59 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.14 2.56 . . . . 0.0 112.974 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -105.2 19.02 21.31 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.892 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -95.02 76.67 3.53 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 122.905 1.335 . . . . 0.0 108.838 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -76.67 139.53 40.58 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.055 -1.429 . . . . 0.0 112.0 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.393 -3.325 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.075 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -112.95 151.52 30.45 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -132.65 160.88 35.4 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.684 0.278 . . . . 0.0 110.298 -177.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 28.0 m -91.57 135.07 34.13 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -85.77 99.99 11.73 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.94 110.82 28.29 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.52 109.42 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.228 1.952 . . . . 0.0 110.594 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -84.12 73.55 10.39 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 122.001 0.905 . . . . 0.0 109.397 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.5 tt -121.08 156.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.475 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -150.97 130.36 12.88 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 115.47 63.01 Favored Pre-proline 0 C--N 1.284 -2.242 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -85.9 128.71 3.33 Favored 'Trans proline' 0 N--CA 1.429 -2.307 0 C-N-CA 122.359 2.039 . . . . 0.0 109.273 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -79.36 114.01 17.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.91 156.22 22.49 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.607 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -63.59 141.67 58.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.746 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 68.26 89.59 0.1 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.529 0.68 . . . . 0.0 110.584 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -75.0 116.09 15.35 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.671 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.64 145.97 8.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.7 t -83.74 136.89 34.0 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.126 0.489 . . . . 0.0 110.146 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.38 153.46 29.8 Favored 'General case' 0 N--CA 1.407 -2.613 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.03 83.26 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.2 pp -108.1 151.93 10.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 114.256 -1.338 . . . . 0.0 114.21 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -176.62 141.21 0.38 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.84 -43.73 96.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -106.13 107.19 18.07 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.852 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.5 127.39 75.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.481 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.81 120.67 50.63 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-O 121.026 0.441 . . . . 0.0 110.714 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.24 150.3 65.08 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.438 1.425 . . . . 0.0 109.392 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.77 83.36 1.18 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.3 m -83.88 109.78 17.85 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.416 ' NE2' ' HG3' ' A' ' 250' ' ' LYS . 14.0 m-70 -72.0 123.66 23.26 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-O 121.876 0.846 . . . . 0.0 112.116 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.409 ' HD2' HD13 ' A' ' 212' ' ' LEU . 22.1 ttm-85 -113.41 140.26 48.21 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.957 -171.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.454 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 19.8 ptt180 -123.92 119.51 29.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.98 133.82 55.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 122.257 -0.277 . . . . 0.0 111.685 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.4 ' HB3' HG13 ' A' ' 246' ' ' ILE . 26.5 ptt180 -99.6 135.62 40.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.764 0.792 . . . . 0.0 112.832 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.436 ' HB2' HD13 ' A' ' 245' ' ' LEU . 3.5 mm? -124.67 121.42 34.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.574 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.418 HD11 ' O ' ' A' ' 164' ' ' LEU 0.264 1.6 pp -107.01 105.04 14.87 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-O 122.2 1.0 . . . . 0.0 113.295 175.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -100.58 134.52 43.41 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.527 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.401 ' C ' ' H ' ' A' ' 168' ' ' SER . 70.3 m80 -95.06 29.71 2.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 87.11 -11.44 65.12 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 166' ' ' HIS . 30.2 p -175.69 133.53 0.28 Allowed 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 t70 178.46 -57.37 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.534 ' HB3' ' HZ2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -149.04 148.27 26.52 Favored Pre-proline 0 N--CA 1.412 -2.354 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.676 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -86.7 23.73 0.8 Allowed 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 122.466 2.111 . . . . 0.0 110.886 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 87.5 mt 75.01 123.6 0.04 OUTLIER 'General case' 0 C--N 1.347 0.469 0 C-N-CA 125.952 1.701 . . . . 0.0 111.421 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.93 44.08 3.08 Favored Glycine 0 C--O 1.241 0.589 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.991 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -172.2 144.23 1.59 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -135.77 135.42 39.91 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 121.3 0.572 . . . . 0.0 111.111 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -130.94 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.451 -175.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -122.87 158.72 29.71 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -74.27 137.48 42.98 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 123.2 0.313 . . . . 0.0 111.046 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.71 163.92 37.4 Favored Glycine 0 N--CA 1.406 -3.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 m -107.07 143.7 34.81 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.4 t -92.84 125.54 37.5 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.439 HG23 ' HG2' ' A' ' 191' ' ' LYS . 24.0 t -117.3 124.62 73.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.276 -174.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -110.34 151.61 27.22 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.29 106.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-O 122.167 0.984 . . . . 0.0 109.127 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.2 p -116.41 178.28 4.38 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.562 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.7 -15.83 62.74 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 m -88.02 -3.81 58.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.72 -160.04 14.17 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.078 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.497 HD22 ' O ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.77 109.97 18.45 Favored 'General case' 0 N--CA 1.385 -3.716 0 CA-C-O 121.931 0.872 . . . . 0.0 110.783 177.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -101.92 144.02 31.08 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.51 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 181' ' ' SER . 52.7 mtmt -123.29 142.35 51.03 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.439 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.62 154.87 79.83 Favored Pre-proline 0 N--CA 1.42 -1.945 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.83 131.01 17.65 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.752 1.635 . . . . 0.0 109.282 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 178.63 103.63 0.17 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.2 pt -77.47 144.84 10.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.62 158.87 17.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.9 mt -68.89 136.54 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.6 t -136.03 -39.67 0.68 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.744 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -127.11 147.53 50.17 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.874 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 206' ' ' ALA . 30.2 mt -128.31 139.71 52.26 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.441 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.48 132.47 23.15 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 126.86 23.26 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.5 1.467 . . . . 0.0 110.12 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.92 -5.1 57.85 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.79 155.99 53.44 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 74.0 mt -65.94 -35.62 81.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -173.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -75.66 -26.27 57.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.674 0.75 . . . . 0.0 109.294 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.21 -56.17 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.876 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.4 m -62.85 -34.94 78.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.2 p -66.98 -43.76 82.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.689 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.76 10.64 51.14 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 29.3 tp -119.95 15.4 12.51 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 122.711 1.244 . . . . 0.0 109.252 -173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 159' ' ' ARG . 78.7 mt -135.17 129.33 33.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.383 -1.735 . . . . 0.0 106.648 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.31 162.26 13.03 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 -174.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.8 -22.72 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-O 122.629 1.204 . . . . 0.0 108.858 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -74.59 -23.09 58.68 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.432 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.531 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 59.5 m-20 -67.65 154.96 40.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.679 0.792 . . . . 0.0 112.094 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -116.02 163.8 15.38 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.593 0.711 . . . . 0.0 112.866 -172.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.82 137.94 25.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.833 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.563 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.7 mp -107.66 -50.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.67 0.747 . . . . 0.0 110.235 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.469 ' H ' ' HB ' ' A' ' 248' ' ' THR . 43.1 mt-10 -141.35 159.39 42.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.401 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.2 t -106.33 97.61 5.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 44.3 t30 72.99 -73.4 0.1 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 111.261 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.05 18.4 0.73 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.84 111.95 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.85 147.53 53.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 219' ' ' ILE . 15.4 m -98.76 3.67 10.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.147 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.8 103.48 0.11 Allowed 'General case' 0 C--O 1.244 0.773 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.74 7.56 84.01 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.336 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.25 160.03 17.86 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 96.8 m -74.83 156.29 36.64 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.005 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.536 HD11 ' N ' ' A' ' 232' ' ' ASP . 4.1 pp -71.32 -34.93 71.01 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.132 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.536 ' N ' HD11 ' A' ' 231' ' ' LEU . 21.9 t70 -70.1 -37.05 75.3 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.509 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.62 ' O ' ' HG3' ' A' ' 237' ' ' MET . 23.6 tp60 -66.12 -51.01 62.0 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.433 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.28 -48.68 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.532 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.0 p -65.43 -32.42 74.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.973 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.03 -42.95 93.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.62 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 23.6 mtm -58.32 -46.05 86.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.905 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.6 ptp -68.43 -23.19 64.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 235' ' ' THR . 89.4 t -83.56 -33.15 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.5 67.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.067 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -95.82 -63.07 1.19 Allowed 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.457 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.8 t 66.04 -41.31 0.35 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.94 1.829 . . . . 0.0 115.94 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -97.57 -39.29 9.19 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.72 -0.613 . . . . 0.0 112.398 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.18 42.03 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.446 ' C ' HD11 ' A' ' 246' ' ' ILE . 3.2 tm? -85.34 129.67 34.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.99 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -128.42 140.73 48.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.9 tp -122.26 138.18 53.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 118.547 0.612 . . . . 0.0 109.751 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.469 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.8 m -102.82 120.68 41.03 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.958 -174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.74 149.25 29.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 CA-C-O 121.366 0.603 . . . . 0.0 112.411 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.467 ' HB2' HD13 ' A' ' 219' ' ' ILE . 32.1 ttmt -124.35 124.74 25.76 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.822 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.531 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.6 Cg_exo -63.81 126.48 17.47 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.162 1.241 . . . . 0.0 109.07 171.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.6 -0.01 17.41 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.656 -176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 253' ' ' ASN . 0.7 OUTLIER 67.72 99.3 0.05 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.243 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.3 103.66 16.32 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.774 0.797 . . . . 0.0 109.422 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? . . . . . 0 C--N 1.261 -3.274 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.181 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.887 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.3 m -72.0 -21.27 61.58 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 116.855 0.327 . . . . 0.0 111.573 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.96 109.61 4.6 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.788 0.804 . . . . 0.0 109.435 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.6 m -99.16 113.71 26.09 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.978 -175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -98.0 84.27 3.27 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.068 0.937 . . . . 0.0 110.01 178.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.62 155.98 37.93 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.204 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.38 144.77 91.77 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.245 1.963 . . . . 0.0 111.424 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 64.9 m -82.99 100.8 10.68 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 tt -50.71 139.1 6.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.635 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.3 t -160.48 102.93 1.38 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.5 mt -87.68 116.14 65.2 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.284 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.8 123.74 3.76 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.873 2.382 . . . . 0.0 112.243 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.57 132.22 47.35 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.1 156.8 18.11 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.493 ' C ' ' HD2' ' A' ' 143' ' ' ARG . 96.9 m-85 -96.09 122.67 39.17 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.493 ' HD2' ' C ' ' A' ' 142' ' ' PHE . 3.4 mpt_? -128.7 81.57 2.03 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -95.26 150.96 19.66 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.838 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.5 m -76.88 136.21 25.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.221 0.534 . . . . 0.0 111.407 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.9 m -95.26 154.33 17.24 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.882 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.57 104.54 16.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tp -70.31 132.69 32.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.4 pt -106.8 151.97 8.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 120.997 0.427 . . . . 0.0 111.713 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.4 107.94 5.32 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 50.1 t -137.85 -45.44 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.4 -174.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.1 126.7 29.45 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -174.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.1 tt 55.42 148.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 127.497 2.319 . . . . 0.0 113.299 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.27 119.11 66.07 Favored Pre-proline 0 N--CA 1.431 -1.389 0 O-C-N 121.44 -0.788 . . . . 0.0 109.172 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.87 151.63 31.54 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.0 2.467 . . . . 0.0 110.843 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.37 81.35 1.04 Allowed 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 t -79.85 105.26 11.01 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -79.1 99.05 6.77 Favored 'General case' 0 CA--C 1.458 -2.565 0 CA-C-O 122.482 1.134 . . . . 0.0 109.531 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.49 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -96.26 138.2 34.22 Favored 'General case' 0 N--CA 1.39 -3.451 0 CA-C-N 112.5 -2.137 . . . . 0.0 107.007 -174.018 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 77.8 mtm180 -116.57 121.53 42.01 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 121.107 0.48 . . . . 0.0 111.01 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 205' ' ' LEU . 97.0 t -89.01 116.02 29.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -112.5 122.57 48.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.6 0.714 . . . . 0.0 111.494 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.7 121.02 37.35 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.378 -1.283 . . . . 0.0 107.655 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 166' ' ' HIS . 85.5 mt -113.01 111.74 22.7 Favored 'General case' 0 N--CA 1.396 -3.142 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.612 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 168' ' ' SER . 77.5 tttt -80.65 125.02 29.5 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.832 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' A' ' 164' ' ' LEU . 8.8 p80 -150.74 93.93 2.02 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.462 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.89 6.02 89.71 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.098 -0.956 . . . . 0.0 113.283 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.507 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 22.9 t -165.31 143.25 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.58 76.51 8.91 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.451 0.644 . . . . 0.0 110.708 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.21 121.47 85.19 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.18 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -57.48 135.52 70.33 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.688 2.259 . . . . 0.0 111.724 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -53.39 121.2 7.16 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.207 1.003 . . . . 0.0 111.421 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -80.15 46.65 3.23 Favored Glycine 0 C--O 1.246 0.871 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.717 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -174.78 152.26 1.55 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -137.98 140.99 40.47 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.125 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.4 pt -135.46 136.26 50.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 123.663 0.602 . . . . 0.0 109.832 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.52 158.84 43.34 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.931 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.432 ' CB ' ' HB3' ' A' ' 231' ' ' LEU . 8.3 t70 -84.84 125.42 32.59 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.71 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -130.89 117.98 2.33 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 105.247 -3.141 . . . . 0.0 105.247 171.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.8 t -91.32 144.42 25.61 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.295 1.045 . . . . 0.0 112.711 -170.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t -105.04 129.44 53.47 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.919 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.47 125.17 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 CA-C-O 121.382 0.611 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 98.4 mtt180 -120.38 153.22 36.81 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.5 p -109.07 178.28 4.51 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.534 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.38 -16.56 63.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.9 m -89.84 -4.54 57.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.78 -168.31 12.59 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.527 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.6 pt? -83.93 106.29 15.49 Favored 'General case' 0 N--CA 1.402 -2.828 0 CA-C-O 122.127 0.965 . . . . 0.0 109.878 177.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -112.58 149.93 32.06 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.936 -173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -108.46 150.8 26.92 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.321 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -131.82 147.21 65.02 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.66 135.47 69.62 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.979 1.786 . . . . 0.0 109.986 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.66 76.72 0.39 Allowed Glycine 0 C--N 1.284 -2.33 0 C-N-CA 120.025 -1.084 . . . . 0.0 111.69 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.86 117.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.27 175.91 8.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 54.7 mt -66.05 122.43 17.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.3 p -102.02 -55.28 2.52 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -137.07 155.98 48.96 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.856 0.36 . . . . 0.0 110.268 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.504 HD22 ' HB2' ' A' ' 206' ' ' ALA . 18.4 mt -129.13 140.51 51.51 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.8 t -98.58 124.04 47.83 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.4 127.02 24.21 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.166 1.911 . . . . 0.0 109.986 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.89 21.28 12.31 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.406 -0.902 . . . . 0.0 110.943 -173.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.26 159.57 16.23 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.471 ' HB2' HG12 ' A' ' 161' ' ' VAL . 87.7 mt -70.21 -25.97 63.66 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.807 -0.82 . . . . 0.0 113.117 -176.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.504 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -67.24 -38.22 84.85 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.288 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.412 ' HB3' HD13 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -77.56 -33.95 53.89 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.945 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.2 t -68.0 -33.68 75.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.018 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.1 p -71.57 -43.95 65.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.72 -42.93 1.58 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.9 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.459 ' CD1' ' HG ' ' A' ' 212' ' ' LEU . 1.0 OUTLIER -65.87 -13.56 59.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.351 1.061 . . . . 0.0 113.633 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.459 ' HG ' ' CD1' ' A' ' 211' ' ' LEU . 96.8 mt -108.79 145.77 34.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.44 163.39 25.96 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.027 0.441 . . . . 0.0 111.804 -171.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 58.4 t -54.7 -22.03 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.619 0.768 . . . . 0.0 111.535 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -74.55 -24.08 58.89 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.55 ' HB3' ' N ' ' A' ' 252' ' ' ALA 0.655 0.4 OUTLIER -65.41 158.5 26.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 119.249 3.055 . . . . 0.0 119.249 -176.819 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.02 146.31 34.13 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.07 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.75 142.58 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.922 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.428 HG21 ' HG3' ' A' ' 220' ' ' GLU . 40.0 mm -110.78 -56.59 4.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.048 0.451 . . . . 0.0 110.297 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG3' HG21 ' A' ' 219' ' ' ILE . 44.3 mt-10 -138.4 155.59 48.36 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.383 0.611 . . . . 0.0 112.418 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.7 t -127.54 110.68 22.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 124.657 1.183 . . . . 0.0 107.887 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 69.52 -70.6 0.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.965 1.306 . . . . 0.0 110.471 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -161.95 16.14 0.15 Allowed Glycine 0 C--N 1.299 -1.492 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 19.6 mt -112.49 131.38 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -85.35 167.99 15.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.214 0.531 . . . . 0.0 110.329 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.03 9.71 9.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.378 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.0 102.58 0.08 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.047 -176.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.61 13.16 80.6 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.838 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -97.56 164.03 12.6 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 98.9 m -91.13 157.89 16.96 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 113.046 -1.888 . . . . 0.0 108.955 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 178' ' ' ASP . 1.9 pt? -63.33 -42.1 98.94 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.681 0.277 . . . . 0.0 111.313 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.37 -49.99 72.84 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.312 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.25 -46.4 89.92 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.443 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.487 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 91.2 t -67.57 -45.95 84.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.901 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 10.6 t -68.02 -29.91 69.03 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.68 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.98 -48.53 52.8 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.394 0.616 . . . . 0.0 109.988 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.487 ' HG2' ' HA ' ' A' ' 234' ' ' VAL . 21.5 ptt? -65.0 -33.54 76.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -175.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.405 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 14.7 ptp -73.15 -25.21 60.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.481 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.612 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 93.6 t -85.33 -37.44 12.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.608 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.51 67.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.939 175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.03 21.98 15.32 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 73.0 m -59.25 -20.81 57.32 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 15.1 m -53.62 -50.65 65.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.685 0.794 . . . . 0.0 109.647 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -125.69 75.44 1.49 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.9 tp -103.2 104.3 14.42 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.139 0.971 . . . . 0.0 112.728 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.58 118.11 55.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.575 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 10.8 tt -111.23 133.32 57.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.512 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 21.8 m -100.15 125.02 46.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.034 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.49 163.36 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 123.3 0.375 . . . . 0.0 110.475 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -133.79 123.48 17.2 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.78 135.82 71.43 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.484 2.79 . . . . 0.0 113.544 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.55 ' N ' ' HB3' ' A' ' 216' ' ' ASP . . . -116.78 20.86 13.74 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -63.74 -21.3 66.34 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.335 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -135.75 139.95 43.97 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.288 -2.071 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.113 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.1 m 64.41 86.81 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.84 0.856 . . . . 0.0 112.313 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -94.07 87.61 5.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.6 m -81.87 118.3 22.82 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.811 -173.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -88.72 142.3 27.79 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.19 111.04 38.24 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.9 101.84 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.21 1.94 . . . . 0.0 111.749 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -88.93 85.05 6.65 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.42 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 136' ' ' ILE . 2.5 pp -86.11 136.77 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.3 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.4 m -102.98 90.9 3.91 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.3 tt -87.83 123.0 69.91 Favored Pre-proline 0 C--N 1.29 -1.978 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.131 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -66.8 122.12 9.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.695 1.597 . . . . 0.0 110.362 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -94.19 120.34 34.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.455 -177.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.62 130.32 53.68 Favored 'General case' 0 CA--C 1.484 -1.583 0 CA-C-O 120.82 0.343 . . . . 0.0 110.718 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -153.24 86.44 1.23 Allowed 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -137.9 85.68 2.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.327 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -96.55 109.57 22.14 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.1 m -107.29 150.17 10.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.299 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.4 m -101.42 153.49 19.64 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.28 104.28 16.65 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.66 90.54 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.9 pt -107.29 151.62 9.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.028 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.02 111.73 22.85 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.381 0.61 . . . . 0.0 109.955 175.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.8 t -106.48 -60.44 2.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.95 107.17 18.26 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.4 tp -168.93 117.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-O 121.386 0.613 . . . . 0.0 111.252 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.3 t -101.12 122.71 47.58 Favored Pre-proline 0 C--N 1.292 -1.923 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.05 130.41 16.23 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.033 2.489 . . . . 0.0 113.955 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.78 -7.35 49.83 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.668 0.747 . . . . 0.0 109.722 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.3 t -75.3 102.22 4.98 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -91.19 143.91 26.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.858 -173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -97.87 121.34 39.67 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.97 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -99.86 104.35 16.01 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.74 117.32 32.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 120.956 0.408 . . . . 0.0 110.376 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.418 ' HG2' HG12 ' A' ' 246' ' ' ILE . 58.3 mtp180 -88.75 136.66 32.89 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 171' ' ' PRO . 3.4 tm? -120.38 121.3 38.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.62 99.78 9.45 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.8 145.76 46.79 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -101.78 -12.2 18.5 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.377 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.94 44.63 Favored Glycine 0 N--CA 1.46 0.233 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.085 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.7 t -149.33 128.63 12.9 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.3 t70 72.2 -42.5 0.53 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.832 1.253 . . . . 0.0 113.172 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -122.05 94.77 47.92 Favored Pre-proline 0 C--O 1.254 1.319 0 CA-C-O 120.671 0.272 . . . . 0.0 110.399 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.403 ' O ' HD12 ' A' ' 163' ' ' LEU . 4.3 Cg_exo -83.46 -69.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.063 2.509 . . . . 0.0 112.123 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 pp -157.19 157.39 34.3 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.342 0.657 . . . . 0.0 110.597 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -128.57 48.2 0.98 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.515 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -160.47 147.58 15.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -138.54 146.21 41.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.52 152.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 123.441 0.463 . . . . 0.0 111.868 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 79.2 ttt180 -141.82 149.9 40.95 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.86 133.98 44.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.974 0.416 . . . . 0.0 110.595 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.36 165.99 15.92 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.8 p -93.11 120.4 33.36 Favored 'General case' 0 N--CA 1.391 -3.413 0 CA-C-N 117.986 0.893 . . . . 0.0 111.181 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.6 t -118.7 132.42 56.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.6 p -98.34 127.2 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.623 0.725 . . . . 0.0 109.177 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -112.85 153.43 27.9 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.68 107.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.1 p -110.18 178.15 4.48 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.19 -13.6 61.19 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.4 m -87.99 -4.6 58.79 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.588 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.55 -159.19 13.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.477 HD11 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.89 128.31 34.56 Favored 'General case' 0 N--CA 1.379 -3.977 0 CA-C-N 117.154 0.477 . . . . 0.0 110.003 175.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.38 153.49 48.67 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -119.89 140.27 51.11 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-O 121.311 0.577 . . . . 0.0 109.618 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -139.62 144.74 40.55 Favored Pre-proline 0 C--N 1.277 -2.554 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.81 119.52 5.93 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.246 1.964 . . . . 0.0 110.288 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.61 118.01 5.67 Favored Glycine 0 C--N 1.276 -2.758 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 177' ' ' ARG . 2.6 pt -96.5 117.53 41.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.598 0.713 . . . . 0.0 112.2 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -119.77 169.9 9.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.684 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.61 131.06 34.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.0 p -114.26 -56.02 2.43 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -123.55 142.01 51.45 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.486 HD22 ' HB2' ' A' ' 206' ' ' ALA . 18.2 mt -128.15 139.12 52.66 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.33 123.25 49.18 Favored Pre-proline 0 N--CA 1.416 -2.142 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -50.51 130.59 30.11 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.616 2.211 . . . . 0.0 112.215 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.62 5.14 65.12 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.34 146.06 41.84 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 114.785 -0.708 . . . . 0.0 112.779 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.425 HD13 ' H ' ' A' ' 205' ' ' LEU . 5.0 mp -55.4 -33.65 63.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.414 1.086 . . . . 0.0 113.14 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.486 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -66.13 -41.14 90.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.194 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.9 -34.97 57.68 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.9 m -54.87 -30.58 58.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.064 0.946 . . . . 0.0 112.558 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 205' ' ' LEU . 80.8 p -58.26 -43.24 87.79 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.636 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.73 21.18 72.83 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 tp -138.2 -35.42 0.62 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.154 -1.023 . . . . 0.0 110.804 -173.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.0 mm? -108.23 139.15 43.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.83 0.824 . . . . 0.0 111.179 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.38 162.28 13.15 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.393 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.83 -24.89 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-O 121.514 0.673 . . . . 0.0 110.983 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 254' ' ' GLN . 8.2 t30 -73.28 -23.88 60.36 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.292 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.559 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 64.1 m-20 -62.45 158.73 17.04 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.448 0.699 . . . . 0.0 112.079 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.36 157.32 25.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.57 130.59 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.921 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.81 -42.96 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.179 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.447 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 34.2 mt-10 -137.68 152.7 49.56 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.341 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.58 96.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.467 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.494 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 67.13 1.15 2.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.164 1.386 . . . . 0.0 112.583 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 123.8 -4.29 9.21 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.68 134.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.14 147.36 31.39 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.842 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 195' ' ' ILE . 25.8 m -117.19 10.64 7.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.083 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -61.48 105.82 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.067 0.46 . . . . 0.0 110.806 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.33 2.64 53.95 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.942 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.526 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.0 mmpt? -88.95 141.67 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.582 -0.364 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.476 ' O ' HG22 ' A' ' 234' ' ' VAL . 11.7 t -85.57 164.75 17.57 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.454 ' O ' HG22 ' A' ' 235' ' ' THR . 1.7 pt? -55.78 -41.66 74.42 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.278 0.49 . . . . 0.0 112.203 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.418 ' H ' HD23 ' A' ' 231' ' ' LEU . 25.0 t70 -59.89 -40.57 89.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.543 0.687 . . . . 0.0 110.677 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 11.9 mm-40 -69.22 -47.04 65.88 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.462 177.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 230' ' ' THR . 58.9 t -61.09 -43.74 96.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.54 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 239' ' ' VAL . 8.4 t -65.36 -40.09 93.13 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.095 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.62 -45.0 85.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.238 0.542 . . . . 0.0 110.517 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 77.3 mtp -56.43 -49.24 75.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.461 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.426 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.1 ptp -76.79 -9.76 58.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.183 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.654 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 70.4 t -83.07 -31.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.626 0.727 . . . . 0.0 109.171 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.5 -13.12 61.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.496 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -130.86 29.16 4.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.128 0.571 . . . . 0.0 110.848 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.654 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 68.1 m -61.99 -28.26 69.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -173.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.3 m -51.85 -61.92 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.169 0.509 . . . . 0.0 110.836 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -129.69 88.42 2.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 245' ' ' LEU . 3.6 pp -92.02 133.47 35.69 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 62.6 mt -114.37 119.52 61.61 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.296 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.1 tt -109.89 118.69 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 111.134 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 38.5 m -90.51 119.71 31.0 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.456 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 15.7 m -114.93 144.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.407 ' HD3' ' C ' ' A' ' 250' ' ' LYS . 13.1 tmtt? -125.62 125.42 25.0 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.978 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 18.7 Cg_endo -68.02 127.24 15.68 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.34 2.027 . . . . 0.0 114.097 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.436 ' HB2' HD21 ' A' ' 215' ' ' ASN . . . -106.42 -35.32 7.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 43.37 79.94 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 112.75 -2.023 . . . . 0.0 113.197 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.448 ' HB3' ' ND2' ' A' ' 215' ' ' ASN . 47.0 tt0 -137.23 125.93 23.87 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.597 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 . . . . . 0 C--N 1.282 -2.34 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.622 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 70.6 p -146.16 143.36 29.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -99.99 130.75 46.19 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 75.0 m -80.85 120.4 24.64 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.58 112.54 20.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.849 0.357 . . . . 0.0 111.282 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.34 106.84 47.9 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.98 102.82 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.848 2.365 . . . . 0.0 112.773 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 m -86.37 91.77 8.61 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.1 mm -71.59 140.51 18.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 23.0 t -94.61 96.07 9.19 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.7 tt -94.19 107.96 32.48 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.8 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 137' ' ' SER . 12.2 Cg_exo -71.24 136.35 28.94 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.139 1.893 . . . . 0.0 109.507 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -101.37 113.87 27.35 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -95.55 128.63 42.57 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.279 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -134.39 99.16 4.29 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -131.75 89.86 2.75 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.49 115.16 5.43 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.204 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.16 126.65 39.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 121.318 0.58 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.5 m -84.42 119.15 24.79 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.307 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.96 104.56 16.61 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.938 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.53 105.5 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.6 tp -98.01 134.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 121.441 0.639 . . . . 0.0 111.447 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -148.23 141.18 24.81 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.6 -66.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.175 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.33 108.78 16.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.278 0.561 . . . . 0.0 111.937 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -127.61 94.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-O 121.793 0.806 . . . . 0.0 110.493 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.9 t -124.36 101.28 34.55 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -82.73 142.34 11.35 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.074 1.849 . . . . 0.0 109.257 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.2 96.84 0.11 Allowed 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.195 0.521 . . . . 0.0 112.025 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.8 m -88.07 93.51 9.51 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -82.22 113.26 19.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -132.86 138.12 46.93 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.106 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.582 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 0.0 OUTLIER -110.94 114.49 27.85 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 205' ' ' LEU . 21.8 t -100.64 132.39 46.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.415 ' HG2' HG13 ' A' ' 246' ' ' ILE . 97.4 mtt180 -94.63 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.106 0.479 . . . . 0.0 112.089 -176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.6 tm? -127.31 125.43 40.8 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.405 HD11 ' O ' ' A' ' 164' ' ' LEU 0.276 2.1 pp -112.36 101.68 9.86 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-O 122.442 1.115 . . . . 0.0 112.232 176.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -100.8 120.72 40.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.93 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -151.45 92.12 1.74 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.942 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.01 88.03 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.734 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 p -110.73 137.43 48.4 Favored 'General case' 0 N--CA 1.392 -3.34 0 C-N-CA 123.711 0.804 . . . . 0.0 109.699 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -125.18 82.75 2.09 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.938 0.875 . . . . 0.0 108.783 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -129.0 143.79 50.12 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.383 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.84 141.77 95.72 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.058 1.838 . . . . 0.0 111.226 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.75 123.56 21.25 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.42 46.43 2.52 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.152 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.577 ' HE1' ' SD ' ' A' ' 238' ' ' MET . 50.7 p90 -174.7 134.04 0.37 Allowed 'General case' 0 N--CA 1.416 -2.139 0 C-N-CA 125.803 1.641 . . . . 0.0 107.711 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.4 141.33 51.08 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 176' ' ' ILE . 2.3 pp -126.11 140.92 47.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.873 -177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 231' ' ' LEU . 55.9 ttt180 -142.19 148.05 37.58 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.754 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.85 145.37 29.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -132.26 163.94 23.9 Favored Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.7 m -104.65 131.78 51.68 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.041 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.9 m -106.13 136.02 46.57 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.518 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.2 128.93 60.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.514 0.674 . . . . 0.0 111.408 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -114.01 152.75 30.49 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.45 115.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 120.724 0.297 . . . . 0.0 110.464 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.9 p -113.08 169.86 8.63 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.42 61.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.017 0.437 . . . . 0.0 111.034 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.0 m -93.65 -3.81 51.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.546 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.78 -168.86 22.19 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.339 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.505 HD21 ' H ' ' A' ' 189' ' ' LEU . 2.1 pt? -85.24 130.37 34.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.427 0.632 . . . . 0.0 111.127 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -108.55 155.63 20.42 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.323 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -119.8 148.8 43.0 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -139.63 153.47 70.31 Favored Pre-proline 0 N--CA 1.411 -2.408 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.52 138.57 21.96 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.34 2.027 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.1 107.03 0.57 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.4 tt -105.51 118.52 53.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.649 0.738 . . . . 0.0 111.369 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.408 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 70.4 m-85 -125.81 165.56 18.44 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.458 -175.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.4 mt -70.68 127.8 33.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 172.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.5 p -102.45 -39.93 6.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -150.24 147.75 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.427 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 206' ' ' ALA . 15.4 mt -114.56 139.34 49.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.246 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.0 t -103.99 128.76 26.53 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.85 126.41 21.87 Favored 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.032 1.821 . . . . 0.0 110.67 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.57 13.45 58.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.43 160.24 24.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.7 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.415 ' HB3' HG11 ' A' ' 161' ' ' VAL . 85.6 mt -54.35 -46.2 72.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.573 1.149 . . . . 0.0 113.906 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.501 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -68.45 -27.18 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.858 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.76 -42.22 50.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.9 m -56.38 -31.56 63.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.2 p -61.08 -44.36 97.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.37 -47.65 1.73 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 121.474 0.486 . . . . 0.0 112.767 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.53 -23.96 65.5 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.039 1.336 . . . . 0.0 111.167 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.2 mm? -108.02 146.0 33.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.174 0.511 . . . . 0.0 109.728 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -92.39 158.32 16.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.05 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 23.6 t -67.0 -27.33 39.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.603 -178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.87 58.89 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 89.4 m-20 -48.75 161.03 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -169.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.408 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 41.5 mt-10 -93.41 154.28 18.03 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.302 -172.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.22 134.81 45.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.416 HG21 ' HG3' ' A' ' 220' ' ' GLU . 46.7 mm -111.0 -44.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.867 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.541 ' H ' ' HB ' ' A' ' 248' ' ' THR . 40.4 mt-10 -141.07 154.32 45.89 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.371 0.605 . . . . 0.0 111.591 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 65.9 t -128.75 108.34 17.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.588 172.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 70.56 -9.96 0.74 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.524 0.678 . . . . 0.0 111.937 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 127.98 -9.37 6.72 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.455 HG23 ' SD ' ' A' ' 237' ' ' MET . 48.5 mt -84.01 121.01 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -75.65 137.76 40.93 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.045 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.5 m -91.75 17.41 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.837 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.7 109.32 2.38 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.115 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.55 9.69 64.39 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.877 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 10.4 mmpt? -93.93 168.43 10.97 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 234' ' ' VAL . 9.9 t -120.02 163.46 17.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 232' ' ' ASP . 0.0 OUTLIER -50.5 -46.77 57.34 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -171.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.512 ' N ' HD23 ' A' ' 231' ' ' LEU . 23.5 t70 -74.29 -40.55 62.21 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.304 0.574 . . . . 0.0 109.828 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.555 ' O ' ' HG3' ' A' ' 237' ' ' MET . 36.1 tt0 -59.24 -43.28 92.39 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.93 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 230' ' ' THR . 97.7 t -70.25 -46.61 71.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.984 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.462 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 21.4 p -60.97 -37.8 83.71 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.155 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.45 -44.61 84.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 37.6 mtm -64.28 -47.06 80.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.402 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.577 ' SD ' ' HE1' ' A' ' 174' ' ' PHE . 20.9 ptp -67.27 -25.71 66.2 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.01 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.78 -28.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.901 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.58 75.12 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 121.664 0.745 . . . . 0.0 109.268 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.91 -62.06 1.67 Allowed 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.575 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 38.1 t 64.6 -40.97 0.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.309 1.444 . . . . 0.0 114.176 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 -46.47 51.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.27 75.39 0.98 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 238' ' ' MET . 4.3 tt -92.89 116.34 28.95 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 3.3 mp -127.16 127.92 69.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.4 pt -109.43 118.67 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.541 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 64.7 m -92.2 120.16 32.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.417 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 20.8 m -113.89 141.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.963 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.15 129.0 14.43 Favored Pre-proline 0 N--CA 1.42 -1.936 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.614 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 12.3 Cg_endo -56.03 130.9 42.77 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.24 2.626 . . . . 0.0 114.811 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.43 -7.39 44.66 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 68.44 101.91 0.05 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.953 -1.93 . . . . 0.0 112.45 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.11 118.79 37.2 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 . . . . . 0 C--N 1.27 -2.858 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.821 -177.14 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.159 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.5 p -88.88 -13.2 39.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.701 0.762 . . . . 0.0 110.398 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -87.51 156.57 19.47 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.705 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.2 m -88.54 114.05 24.75 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 133' ' ' ALA . 1.0 OUTLIER -107.81 132.76 53.07 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.43 ' N ' ' HD3' ' A' ' 132' ' ' LYS . . . -105.86 113.1 64.17 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.3 -159.91 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.05 2.5 . . . . 0.0 110.633 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.1 p -82.61 87.08 6.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.56 153.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.9 p -103.05 103.64 13.75 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.0 tt -92.83 114.73 63.41 Favored Pre-proline 0 C--N 1.275 -2.648 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.577 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.58 145.25 37.12 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.477 2.118 . . . . 0.0 111.727 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -97.73 114.45 26.45 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.694 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 4.0 p30 -90.24 154.08 20.0 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.4 t80 53.65 -145.37 0.6 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -110.37 69.15 0.68 Allowed 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 166.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.694 ' HG2' ' O ' ' A' ' 141' ' ' ASP . 77.2 mm-40 -71.88 110.49 6.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 174.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.64 131.22 43.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.862 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.7 p -73.81 126.89 31.41 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.915 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.56 103.3 15.42 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 121.211 0.529 . . . . 0.0 110.493 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 5.0 tp -75.9 99.25 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 25.8 pt -85.42 151.24 3.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.556 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -88.43 132.69 34.36 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.476 -176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 m -76.25 89.45 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-O 123.504 1.621 . . . . 0.0 109.733 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -78.7 132.44 36.99 Favored 'General case' 0 C--N 1.252 -3.664 0 CA-C-N 112.29 -2.232 . . . . 0.0 111.973 -172.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.609 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 9.7 tp -82.12 158.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.2 t -97.36 106.67 33.85 Favored Pre-proline 0 C--N 1.316 -0.864 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 39.5 Cg_exo -65.47 151.97 83.34 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 123.26 2.64 . . . . 0.0 109.509 172.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.529 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 13.1 pt-20 -58.7 88.07 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -93.08 116.0 28.63 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 171.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -91.56 109.51 20.81 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.495 ' HD3' ' N ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -120.74 134.87 55.26 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.495 ' N ' ' HD3' ' A' ' 159' ' ' ARG . 37.8 ptt180 -113.92 123.03 48.77 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.647 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.422 HG22 ' NH1' ' A' ' 159' ' ' ARG . 47.4 t -90.03 115.69 30.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.439 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -96.11 145.15 25.73 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.975 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.8 mt -126.44 121.56 32.77 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.936 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 164' ' ' LEU . 1.7 pp -106.91 101.07 10.53 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-O 122.727 1.251 . . . . 0.0 108.689 169.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 165' ' ' LYS 0.259 0.0 OUTLIER -75.47 127.84 34.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -172.242 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -105.7 112.26 25.26 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.759 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.79 -4.2 80.41 Favored Glycine 0 C--O 1.222 -0.645 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.714 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.4 m 61.8 20.98 11.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.748 0.819 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.59 102.46 3.81 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.331 0.586 . . . . 0.0 109.605 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -160.41 131.26 3.74 Favored Pre-proline 0 C--N 1.275 -2.64 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.098 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.88 141.42 93.15 Favored 'Trans proline' 0 C--O 1.254 1.319 0 C-N-CA 122.861 2.374 . . . . 0.0 112.698 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.6 130.85 38.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.107 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -87.03 -23.57 40.77 Favored Glycine 0 C--N 1.289 -2.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -108.27 144.85 35.2 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -134.95 147.41 49.76 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.528 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.5 149.41 30.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.517 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 75.4 ttt180 -134.06 153.14 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.508 ' HA ' HG23 ' A' ' 195' ' ' ILE . 19.6 m-20 -74.73 151.73 39.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.073 0.463 . . . . 0.0 111.302 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.36 161.32 26.6 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 p -101.98 136.44 41.81 Favored 'General case' 0 N--CA 1.394 -3.242 0 CA-C-O 121.125 0.488 . . . . 0.0 111.62 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.4 t -111.6 120.3 41.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.0 p -91.16 123.59 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.668 0.746 . . . . 0.0 111.144 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.02 158.55 24.76 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.2 t -100.23 116.57 43.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.9 p -115.17 177.54 4.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.53 -21.4 61.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.044 0.45 . . . . 0.0 109.857 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.6 p -87.17 -1.27 57.77 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.61 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.75 -168.9 13.69 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.953 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.515 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.07 106.17 15.51 Favored 'General case' 0 N--CA 1.384 -3.737 0 CA-C-O 122.899 1.333 . . . . 0.0 110.593 175.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -111.46 155.42 23.23 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.387 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 7.7 mptt -116.93 127.2 53.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.48 153.58 47.69 Favored Pre-proline 0 C--N 1.263 -3.176 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.466 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 14.2 Cg_exo -68.11 113.4 3.04 Favored 'Trans proline' 0 N--CA 1.423 -2.629 0 C-N-CA 121.343 1.362 . . . . 0.0 109.013 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -132.31 92.06 0.27 Allowed Glycine 0 CA--C 1.457 -3.567 0 N-CA-C 106.889 -2.484 . . . . 0.0 106.889 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 178' ' ' ASP . 23.4 pt -77.22 135.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.34 -172.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.05 166.9 10.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.258 -173.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.3 mt -67.44 130.77 33.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.517 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 67.6 p -98.73 -36.46 9.83 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.507 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -151.01 146.02 25.93 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.557 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.451 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 52.4 tp -127.43 124.93 39.62 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.91 128.9 29.74 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.42 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 50.7 Cg_exo -57.63 126.86 23.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.16 1.907 . . . . 0.0 109.451 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.75 -9.87 60.46 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.87 149.87 24.66 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.82 -26.09 65.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -173.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -74.73 -32.36 62.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.009 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.449 ' N ' HD11 ' A' ' 200' ' ' LEU . 3.6 tm-20 -76.45 -38.85 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.0 m -57.88 -32.03 67.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.355 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.0 m -61.56 -43.55 98.66 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 78.52 -14.44 12.58 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.854 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 53.4 mt -85.93 -36.83 19.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.097 0.475 . . . . 0.0 111.099 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 81.0 mt -115.33 146.92 41.06 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.34 163.84 17.24 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.666 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 13.7 p -45.84 -33.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.24 -24.26 66.24 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -69.29 165.91 19.62 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.28 142.18 45.08 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -171.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 195' ' ' ILE . 14.1 m -95.82 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.469 HD13 ' CD ' ' A' ' 250' ' ' LYS . 25.1 pt -120.06 -41.9 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.418 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 39.6 mt-10 -133.55 151.25 51.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.581 0.705 . . . . 0.0 112.75 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.76 108.73 23.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.516 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.1 t-20 70.22 -71.1 0.13 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.165 0.986 . . . . 0.0 110.72 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.14 21.75 0.13 Allowed Glycine 0 C--N 1.298 -1.574 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.452 ' CG2' ' HE2' ' A' ' 237' ' ' MET . 15.8 mt -116.73 121.77 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.11 151.08 37.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 118.806 0.73 . . . . 0.0 111.5 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.55 -6.39 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.995 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.45 121.33 15.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.314 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.466 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 93.12 10.3 59.82 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.101 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -111.13 173.35 6.38 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 234' ' ' VAL . 90.4 m -100.9 158.52 15.92 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.007 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.37 -46.19 86.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.441 0.296 . . . . 0.0 111.62 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.25 -41.79 89.59 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.327 0.584 . . . . 0.0 110.286 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.58 -49.34 75.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.946 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 230' ' ' THR . 85.1 t -59.88 -45.92 94.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.946 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.474 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 12.1 t -69.17 -37.13 78.02 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -42.56 90.56 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.452 ' HE2' ' CG2' ' A' ' 224' ' ' ILE . 52.4 mtp -56.5 -51.08 69.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.761 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.474 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptp -73.19 -15.03 61.46 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.356 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.581 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 98.1 t -91.4 -27.01 4.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.89 66.17 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.461 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -142.94 32.72 1.38 Allowed 'General case' 0 N--CA 1.419 -1.997 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.933 -173.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 61.7 m -54.19 -27.98 37.67 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 t -72.29 -29.62 64.04 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -126.22 56.48 1.44 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.8 122.65 29.44 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.733 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.516 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 67.0 mt -130.22 125.11 59.24 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.658 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.16 121.42 64.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.768 0.794 . . . . 0.0 110.513 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 15.3 m -94.15 128.57 40.65 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.21 -175.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.431 HG12 HG13 ' A' ' 218' ' ' VAL . 4.9 m -124.88 148.46 29.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.469 ' CD ' HD13 ' A' ' 219' ' ' ILE . 58.1 mtpt -130.28 138.24 32.62 Favored Pre-proline 0 CA--C 1.508 -0.658 0 C-N-CA 124.394 1.078 . . . . 0.0 109.366 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.579 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 26.5 Cg_endo -64.76 126.86 17.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.628 1.552 . . . . 0.0 111.423 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.4 -28.18 19.93 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 121.833 0.825 . . . . 0.0 109.721 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 44.1 m-80 49.07 69.84 0.53 Allowed 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.113 -1.858 . . . . 0.0 112.024 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.88 126.76 35.83 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 . . . . . 0 C--N 1.287 -2.114 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.191 -178.573 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.726 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 53.8 m -93.69 157.16 16.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.207 0.504 . . . . 0.0 109.922 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 157.9 17.74 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.8 p -75.82 113.68 13.57 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.389 0.614 . . . . 0.0 112.25 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -94.61 110.83 22.62 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.19 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.45 104.16 55.82 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -93.48 12.51 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.887 2.392 . . . . 0.0 112.487 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m 68.36 94.89 0.07 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.927 0.891 . . . . 0.0 111.75 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.5 mt -81.48 157.12 4.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.4 m 71.58 96.02 0.07 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.582 -176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.1 tt -102.55 136.74 19.3 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.259 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 129.8 37.05 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.297 1.998 . . . . 0.0 109.953 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -98.13 161.02 13.92 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.267 0.556 . . . . 0.0 112.335 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.89 156.04 22.59 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -80.49 -29.12 37.35 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.038 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' A' ' 143' ' ' ARG . 1.7 mmp_? 64.08 62.49 0.86 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.008 0.923 . . . . 0.0 108.898 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -81.6 157.33 24.77 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.415 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.27 117.06 29.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 p -84.01 146.14 28.13 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.333 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.41 104.14 16.72 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.962 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.5 tp -66.97 157.48 5.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 149' ' ' ILE . 2.3 pp -83.54 134.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.873 0.845 . . . . 0.0 112.489 -177.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -113.42 -152.16 0.5 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . 0.333 15.4 m 50.45 92.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 C-N-CA 125.735 1.614 . . . . 0.0 114.24 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.03 122.27 14.53 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.564 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tp -139.73 116.75 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-O 122.033 0.92 . . . . 0.0 111.662 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 p -100.72 114.08 65.73 Favored Pre-proline 0 N--CA 1.421 -1.894 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 130.74 41.77 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.547 2.164 . . . . 0.0 113.727 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.94 8.99 43.23 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.637 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -74.15 99.91 3.51 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.575 ' CE1' ' HE3' ' A' ' 250' ' ' LYS . 30.3 m170 -70.13 130.06 41.09 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.463 0.649 . . . . 0.0 112.423 -169.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -102.54 116.78 33.3 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.395 -167.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -100.73 135.81 41.58 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.72 128.53 56.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.538 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.42 ' CB ' HG12 ' A' ' 246' ' ' ILE . 36.8 ptt180 -108.62 126.88 53.45 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.81 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.2 mt -107.91 121.23 44.34 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.428 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.76 107.34 19.76 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.819 0.818 . . . . 0.0 111.662 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -88.27 120.47 29.66 Favored 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.919 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -152.5 102.33 2.73 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.432 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.75 63.66 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.113 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -130.26 178.23 6.73 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.67 -49.21 3.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.743 0.306 . . . . 0.0 110.689 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -166.58 100.13 0.68 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.5 44.44 1.24 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 123.481 2.787 . . . . 0.0 113.768 -175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . 0.342 0.6 OUTLIER -69.59 90.78 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -178.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -97.84 38.93 2.91 Favored Glycine 0 C--N 1.308 -0.986 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.98 150.49 24.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 77.9 m-85 -136.71 134.88 37.66 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.794 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.2 pt -133.71 142.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.626 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.09 159.7 41.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.44 1.096 . . . . 0.0 108.094 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -91.44 122.24 33.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.461 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -119.38 114.89 2.89 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 104.584 -3.407 . . . . 0.0 104.584 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -89.0 128.23 35.7 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.614 -165.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -92.85 127.52 38.39 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.855 -172.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.02 138.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.928 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -121.23 152.77 38.46 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.44 107.99 24.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.2 p -115.42 177.31 4.71 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.422 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.71 -6.09 54.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.276 0.56 . . . . 0.0 109.577 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.1 m -88.04 -4.49 58.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.77 -142.4 17.44 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.488 HD21 ' H ' ' A' ' 189' ' ' LEU . 0.4 OUTLIER -101.86 115.59 30.88 Favored 'General case' 0 N--CA 1.392 -3.372 0 CA-C-O 121.169 0.509 . . . . 0.0 109.971 176.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.66 152.04 30.96 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.924 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -122.22 146.44 47.26 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.734 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -127.07 147.91 63.67 Favored Pre-proline 0 N--CA 1.417 -2.125 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.36 137.04 64.39 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.949 2.433 . . . . 0.0 111.542 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -138.85 73.7 0.41 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.337 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 11.9 tt -84.21 116.39 27.91 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.746 0.784 . . . . 0.0 109.091 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.617 ' CE2' ' HG2' ' A' ' 217' ' ' GLU . 87.2 m-85 -130.18 172.1 12.15 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.908 -175.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.2 136.18 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 47.1 m -126.17 -16.89 5.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.345 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 50.9 ttt180 -158.98 142.96 15.29 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.436 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 206' ' ' ALA . 18.5 mt -128.4 139.31 52.44 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.94 124.59 45.06 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.88 129.47 32.22 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.689 1.593 . . . . 0.0 109.857 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.19 -9.83 57.98 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.02 153.25 46.62 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.15 -38.94 80.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -68.64 -33.45 74.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.035 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.21 -43.5 42.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.204 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.4 m -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 m -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.92 -12.21 9.41 Favored Glycine 0 N--CA 1.465 0.58 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.935 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 36.7 mt -93.84 -15.78 24.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 71.9 mt -108.92 143.56 38.01 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.791 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.65 163.45 27.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.812 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.33 -14.44 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 121.582 0.706 . . . . 0.0 111.768 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.18 -22.35 58.09 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.659 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 58.9 m-20 -63.41 157.37 23.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -174.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.617 ' HG2' ' CE2' ' A' ' 196' ' ' PHE . 37.6 mt-10 -106.69 145.37 32.09 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.681 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.36 134.36 29.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.466 HG13 ' CD ' ' A' ' 250' ' ' LYS . 50.3 mm -116.2 -49.87 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.42 ' H ' ' HB ' ' A' ' 248' ' ' THR . 44.0 mt-10 -125.38 147.79 49.03 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.413 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.558 ' HB ' ' HE3' ' A' ' 237' ' ' MET . 67.3 t -111.0 96.72 4.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 105.655 -1.979 . . . . 0.0 105.655 165.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 45.3 t30 68.41 -77.62 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 124.392 1.077 . . . . 0.0 111.333 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -146.0 10.27 1.59 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.502 ' CG2' ' HE2' ' A' ' 237' ' ' MET . 10.8 mt -107.14 133.05 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -81.32 149.77 28.78 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.11 2.24 8.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.519 0.676 . . . . 0.0 109.881 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.33 109.26 2.2 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.966 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 6.51 48.24 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 9.4 mmpt? -103.4 166.89 10.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 234' ' ' VAL . 16.9 m -118.59 159.77 22.99 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.37 -46.92 56.28 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.23 -37.15 84.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.3 0.571 . . . . 0.0 110.894 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.411 ' NE2' ' HB ' ' A' ' 230' ' ' THR . 1.9 mp0 -70.3 -37.82 74.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.215 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 230' ' ' THR . 96.8 t -63.09 -44.19 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 0.0 110.974 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.546 ' O ' HG23 ' A' ' 239' ' ' VAL . 11.7 t -67.89 -35.28 78.23 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.841 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.35 -43.15 86.86 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.948 0.88 . . . . 0.0 109.167 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.558 ' HE3' ' HB ' ' A' ' 221' ' ' VAL . 16.9 ttt -56.59 -45.82 81.18 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.372 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 19.1 ptp -76.28 -16.46 59.78 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.765 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 75.3 t -81.02 -33.78 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.277 0.56 . . . . 0.0 109.547 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.47 -22.48 43.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.188 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -132.91 30.24 4.03 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.243 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.765 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 67.8 m -74.1 -18.83 60.76 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 38.5 m -58.77 -48.04 82.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.37 0.605 . . . . 0.0 109.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -124.23 79.32 1.73 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.934 -2.246 . . . . 0.0 104.934 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.8 tp -86.4 118.65 25.97 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.349 -1.751 . . . . 0.0 111.06 -170.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.42 HG12 ' CB ' ' A' ' 162' ' ' ARG . 59.8 mt -127.03 133.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.843 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.3 tt -131.8 132.09 61.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 121.317 0.58 . . . . 0.0 111.981 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.42 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 61.8 m -102.35 125.68 49.13 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.872 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.23 139.98 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 158' ' ' HIS . 57.4 mtpt -110.91 122.57 37.68 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.659 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 14.5 Cg_endo -60.27 133.12 47.63 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 122.645 2.23 . . . . 0.0 113.766 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -97.27 8.75 43.94 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -72.88 86.14 1.27 Allowed 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.731 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.83 144.89 37.05 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.836 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.571 ' HE ' ' C ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.487 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.792 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.9 m -97.21 101.84 13.48 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.279 0.561 . . . . 0.0 111.146 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -110.68 -45.27 3.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 t -108.27 145.02 34.98 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 175.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' A' ' 132' ' ' LYS . 7.5 mtpm? -112.2 87.03 2.47 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.692 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.41 108.86 31.31 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.473 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.37 115.61 3.44 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 122.41 2.073 . . . . 0.0 111.079 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -75.69 94.52 3.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.271 0.558 . . . . 0.0 109.592 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.8 mt 72.51 138.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 125.662 1.585 . . . . 0.0 110.721 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t -120.98 100.7 7.22 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.902 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.2 tt -94.71 123.19 58.74 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.82 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -68.03 131.19 23.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.848 1.699 . . . . 0.0 109.048 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -76.32 150.24 36.94 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.26 155.85 23.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.95 117.54 25.75 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -85.68 70.84 10.75 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 122.382 1.087 . . . . 0.0 110.106 -175.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -90.01 160.16 16.5 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.005 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.1 154.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.5 t -66.28 114.81 5.62 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.48 111.3 23.8 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.229 0.538 . . . . 0.0 112.419 -171.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.0 tp -84.36 124.87 40.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.0 mm -87.6 151.71 3.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 71.83 105.91 0.07 Allowed 'General case' 0 N--CA 1.412 -2.332 0 C-N-CA 125.994 1.718 . . . . 0.0 111.892 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -59.88 -42.02 87.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.614 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -94.11 106.96 18.92 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.485 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 67.8 mt -95.64 122.39 47.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.12 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p -105.9 101.17 31.88 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-O 121.43 0.633 . . . . 0.0 110.338 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 7.9 Cg_exo -74.55 152.7 43.51 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.941 2.428 . . . . 0.0 109.601 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -63.93 83.29 0.03 OUTLIER 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 121.426 0.632 . . . . 0.0 109.898 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.1 m -82.82 111.09 18.41 Favored 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -82.32 110.86 17.86 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HB3' HG11 ' A' ' 249' ' ' VAL . 77.8 ttt180 -94.3 116.78 29.22 Favored 'General case' 0 C--N 1.267 -2.992 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.89 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -125.66 109.62 12.83 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.588 -173.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.7 m -105.29 132.32 52.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.434 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -114.89 147.96 39.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -170.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 90.5 mt -126.34 120.02 28.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.313 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.33 108.19 13.85 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.586 175.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.624 ' HD2' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.73 121.36 21.6 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -173.99 105.66 0.12 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.133 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.434 ' C ' ' HG ' ' A' ' 168' ' ' SER . . . 96.42 -10.42 67.11 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.685 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.434 ' HG ' ' C ' ' A' ' 167' ' ' GLY . 51.0 m -157.93 164.14 37.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -106.53 85.51 2.18 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.445 ' HD3' ' HB3' ' A' ' 242' ' ' SER . 24.5 pttm 38.5 97.45 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.663 1.985 . . . . 0.0 116.272 170.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 100.73 1.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.861 1.708 . . . . 0.0 110.461 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.81 99.69 2.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.546 0.689 . . . . 0.0 111.35 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -93.59 43.99 2.44 Favored Glycine 0 C--N 1.282 -2.425 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.007 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -170.29 145.69 2.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.889 0.876 . . . . 0.0 108.729 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.1 143.94 42.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.702 0.287 . . . . 0.0 111.051 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.444 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 2.3 pp -124.71 154.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.258 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -141.26 158.78 43.43 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.006 0.522 . . . . 0.0 110.321 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.8 131.96 36.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.26 -172.38 18.14 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 191' ' ' LYS . 3.1 m -126.43 143.19 51.27 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.332 -0.947 . . . . 0.0 108.734 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t -120.3 119.77 34.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.68 123.38 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.791 0.805 . . . . 0.0 110.652 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 16.2 ptp180 -117.37 160.06 21.76 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.351 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -99.22 108.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.135 0.969 . . . . 0.0 110.811 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.8 p -108.13 178.21 4.57 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.82 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.91 -17.32 63.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.057 0.456 . . . . 0.0 109.944 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.7 m -87.9 -4.74 58.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.367 0.603 . . . . 0.0 109.424 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.04 -158.47 14.3 Favored Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 183' ' ' ARG 0.266 1.1 pp -84.6 106.9 16.51 Favored 'General case' 0 N--CA 1.4 -2.942 0 CA-C-O 122.224 1.012 . . . . 0.0 112.642 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -109.95 155.39 21.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.052 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 180' ' ' THR . 7.3 ptpp? -106.21 139.69 40.32 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 121.516 0.674 . . . . 0.0 111.362 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.436 ' NE2' ' HD2' ' A' ' 193' ' ' PRO . 56.3 tp60 -127.95 141.63 41.78 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -177.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.436 ' HD2' ' NE2' ' A' ' 192' ' ' GLN . 16.9 Cg_exo -66.16 125.58 14.31 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.654 2.236 . . . . 0.0 109.699 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -140.6 135.32 6.94 Favored Glycine 0 C--N 1.28 -2.559 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.629 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.444 ' CG2' ' HB ' ' A' ' 176' ' ' ILE . 49.7 mm -93.04 122.21 44.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -107.84 162.23 14.19 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.01 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.6 mt -73.16 136.67 24.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.7 t -118.38 -61.02 1.72 Allowed 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.129 -1.029 . . . . 0.0 112.172 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -123.12 155.65 36.56 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 206' ' ' ALA . 17.0 mt -126.65 138.74 53.46 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.874 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.3 t -99.6 128.45 31.36 Favored Pre-proline 0 C--N 1.283 -2.313 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.29 126.81 22.59 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 121.952 1.768 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.37 40.16 6.55 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 -172.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.31 162.39 12.61 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.902 -0.649 . . . . 0.0 112.794 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.92 -43.43 68.28 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.086 0.555 . . . . 0.0 111.494 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.478 ' HB2' HD21 ' A' ' 200' ' ' LEU . . . -72.41 -26.64 61.94 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.932 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -67.64 -45.28 75.8 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.8 t -64.49 -38.23 90.3 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.281 0.563 . . . . 0.0 110.314 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 206' ' ' ALA . 17.1 p -79.19 -6.18 55.97 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 52.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 125.412 1.482 . . . . 0.0 116.518 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.55 -19.96 15.27 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.459 ' HB3' ' OD2' ' A' ' 216' ' ' ASP . 6.7 mp -109.69 149.91 29.05 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.479 -2.146 . . . . 0.0 107.261 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.13 162.36 16.77 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.467 0.651 . . . . 0.0 111.461 -170.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.49 -15.82 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.486 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -69.78 -23.63 63.38 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.55 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.571 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.2 m-20 -61.79 159.75 13.14 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -106.23 145.32 31.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.515 -170.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 195' ' ' ILE . 35.2 m -89.55 143.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.6 mp -115.27 -51.87 4.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -174.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.438 ' H ' ' HB ' ' A' ' 248' ' ' THR . 41.9 mt-10 -135.44 153.31 51.82 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.561 0.696 . . . . 0.0 112.597 -172.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 92.6 t -117.02 98.28 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.424 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 49.1 t-20 65.82 -78.53 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.522 1.129 . . . . 0.0 110.522 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -137.0 -0.52 2.77 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.9 mt -101.79 129.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -82.08 150.85 27.31 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.254 0.479 . . . . 0.0 110.409 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.582 HG11 ' SD ' ' A' ' 237' ' ' MET . 12.5 m -117.02 6.49 7.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.207 0.527 . . . . 0.0 109.627 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.7 101.89 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.896 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.68 0.52 59.12 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.535 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 226' ' ' VAL . 47.3 mtmt -89.26 166.51 13.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.724 0.762 . . . . 0.0 112.729 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 34.2 m -87.58 158.59 18.86 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -59.33 -45.12 92.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.8 -45.98 88.64 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.506 0.67 . . . . 0.0 110.515 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.467 ' OE1' ' HD2' ' A' ' 229' ' ' LYS . 33.8 tt0 -64.6 -39.0 92.93 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.97 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 94.4 t -73.95 -36.41 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 9.1 t -74.46 -35.16 63.3 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.761 -1.175 . . . . 0.0 110.483 177.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.62 -48.38 77.57 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.429 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.582 ' SD ' HG11 ' A' ' 226' ' ' VAL . 26.2 ptm -62.06 -39.16 91.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.229 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.42 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.7 ptp -72.29 -21.09 61.41 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.15 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.697 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 91.8 t -85.91 -32.5 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.01 66.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.899 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.88 21.69 13.62 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.722 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.6 m -60.91 -18.71 58.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.403 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 21.9 p -56.74 -48.79 76.99 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.0 0.428 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -129.93 90.37 2.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.1 tm? -99.7 122.76 43.17 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.29 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 58.2 mt -129.92 119.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.5 tp -109.78 129.63 64.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.131 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.438 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 15.2 m -103.56 131.52 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.35 -174.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' ' 159' ' ' ARG 0.28 0.4 OUTLIER -134.44 139.3 48.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 123.308 0.643 . . . . 0.0 112.457 176.92 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.509 ' CB ' HD13 ' A' ' 219' ' ' ILE . 87.3 tttt -124.01 138.87 31.39 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.589 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.571 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 16.8 Cg_endo -56.0 126.8 23.6 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.708 2.272 . . . . 0.0 112.896 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.66 -30.73 16.96 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 55.96 40.96 30.38 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.766 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -65.14 128.15 34.61 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.618 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 . . . . . 0 C--N 1.285 -2.199 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -178.752 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.774 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -160.13 146.99 16.04 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -113.69 128.42 56.42 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.7 m -90.97 119.24 31.0 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 120.894 0.378 . . . . 0.0 110.938 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -151.03 156.5 41.25 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.04 99.57 40.84 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 120.374 -0.53 . . . . 0.0 112.23 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.7 105.23 1.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.258 1.972 . . . . 0.0 108.956 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.6 t -86.77 95.5 9.85 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 121.714 0.769 . . . . 0.0 111.52 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.4 148.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.6 t -160.65 123.95 3.4 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.0 tt -91.98 125.69 56.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-O 120.653 0.264 . . . . 0.0 110.776 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.12 122.83 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.878 1.719 . . . . 0.0 110.135 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -89.13 120.76 30.81 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -83.76 156.76 22.39 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -59.63 -57.22 13.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 51.96 83.38 0.06 Allowed 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.782 0.676 . . . . 0.0 110.346 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -80.99 109.29 15.43 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.78 117.01 29.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.079 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.8 m -101.43 123.79 46.06 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.84 103.37 8.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tp -82.36 105.01 11.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.556 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.1 mm -105.62 116.25 49.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 151' ' ' VAL . 13.7 t70 -151.01 -154.75 0.57 Allowed 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -175.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.424 ' H ' ' CG ' ' A' ' 150' ' ' ASP 0.312 14.1 m 48.7 94.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 C-N-CA 127.311 2.244 . . . . 0.0 116.182 179.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -101.56 108.29 19.81 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.6 tt -153.42 171.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.599 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.87 110.48 49.87 Favored Pre-proline 0 C--N 1.295 -1.803 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 152.4 74.55 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.151 2.567 . . . . 0.0 110.779 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 3.4 mp0 -56.33 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.568 0.747 . . . . 0.0 111.359 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.476 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.5 m -98.0 147.82 24.11 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -126.61 113.54 16.87 Favored 'General case' 0 CA--C 1.474 -1.966 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.45 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 0.5 OUTLIER -98.76 114.97 27.74 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -177.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -97.44 100.99 12.43 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.45 ' HA ' ' NH1' ' A' ' 159' ' ' ARG . 7.3 p -89.38 110.44 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 121.731 0.777 . . . . 0.0 108.911 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.44 ' HB3' HG12 ' A' ' 246' ' ' ILE . 30.9 ptt180 -118.68 142.14 47.94 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.771 -173.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.581 ' O ' HD21 ' A' ' 245' ' ' LEU . 4.8 tt -129.94 141.85 50.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.487 ' N ' HD21 ' A' ' 163' ' ' LEU 0.26 0.7 OUTLIER -112.34 101.19 9.41 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 179.096 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.59 120.87 25.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 164' ' ' LEU . 39.6 m80 -153.21 25.74 0.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 123.364 0.666 . . . . 0.0 109.625 -177.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.58 -11.46 57.99 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.4 t -100.66 101.05 11.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.8 80.91 1.36 Allowed 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.889 0.852 . . . . 0.0 111.894 -170.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.28 151.76 41.84 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.273 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.48 167.3 27.4 Favored 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 122.877 2.384 . . . . 0.0 113.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -102.33 143.06 32.57 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.163 177.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -114.45 56.37 0.5 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.573 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.32 145.39 23.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.35 145.62 43.56 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.166 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.97 152.32 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 40.2 ttm180 -141.13 153.25 45.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -96.83 144.12 27.09 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.792 0.683 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.09 27.75 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 p -94.74 121.95 36.85 Favored 'General case' 0 N--CA 1.385 -3.72 0 CA-C-N 117.158 0.479 . . . . 0.0 110.375 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 t -110.67 119.38 38.95 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.03 123.36 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -107.33 155.16 20.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.79 110.26 31.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.182 0.515 . . . . 0.0 109.955 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 39.7 p -111.22 178.72 4.25 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.49 -3.25 32.92 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.288 0.566 . . . . 0.0 109.794 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.8 m -98.62 -4.43 33.95 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.89 -152.83 17.97 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -92.32 134.41 34.93 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-N 117.164 0.482 . . . . 0.0 109.746 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -132.59 148.99 52.38 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -107.4 127.73 53.85 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.982 0.896 . . . . 0.0 111.03 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.34 160.06 54.51 Favored Pre-proline 0 C--N 1.259 -3.36 0 CA-C-N 113.595 -1.639 . . . . 0.0 108.618 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.02 122.66 6.84 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.158 1.906 . . . . 0.0 108.569 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.61 111.43 3.03 Favored Glycine 0 C--N 1.271 -3.033 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.331 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -98.97 116.68 42.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 14.1 p90 -131.59 172.3 12.4 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.386 -175.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mt -67.6 123.48 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 79.2 p -87.08 -41.98 13.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -162.22 156.02 21.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.996 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 48.7 tp -122.91 138.53 54.64 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.536 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.07 133.69 20.51 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.53 130.21 25.96 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.256 1.971 . . . . 0.0 110.511 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.79 2.64 81.28 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -175.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.23 30.21 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.6 mt -55.37 -38.58 69.02 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 200' ' ' LEU . . . -76.45 -30.38 57.32 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.402 ' N ' HD11 ' A' ' 200' ' ' LEU . 4.8 tm-20 -75.93 -34.03 59.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.0 m -55.53 -32.21 62.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.911 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 m -77.21 -44.89 28.39 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.501 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.97 21.65 63.81 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 114.006 0.362 . . . . 0.0 114.006 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt -107.48 -39.19 5.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.359 0.599 . . . . 0.0 111.001 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . 6.8 mp -109.13 146.55 33.89 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.665 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.08 162.69 17.04 Favored 'General case' 0 C--O 1.198 -1.643 0 O-C-N 123.612 0.57 . . . . 0.0 112.086 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -50.16 -25.94 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -72.06 -25.26 61.71 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.617 -0.677 . . . . 0.0 111.722 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 212' ' ' LEU 0.457 0.8 OUTLIER -73.76 170.79 14.57 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.232 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.1 pt-20 -135.26 165.56 25.15 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -164.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 248' ' ' THR . 58.0 t -80.02 132.85 30.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.22 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.413 HG21 ' HG3' ' A' ' 220' ' ' GLU . 43.5 mm -112.72 -60.6 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.733 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.609 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.7 mt-10 -125.92 153.48 44.17 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.852 0.834 . . . . 0.0 111.947 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.418 HG22 HG11 ' A' ' 234' ' ' VAL . 92.1 t -119.45 103.36 14.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.977 174.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.491 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.4 t-20 68.2 -69.34 0.15 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.847 0.859 . . . . 0.0 111.04 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.31 7.62 0.45 Allowed Glycine 0 C--N 1.308 -1.012 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.2 mt -104.43 120.81 55.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.3 158.4 31.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.01 7.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.744 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.33 108.07 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.43 . . . . 0.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.75 2.66 46.38 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.105 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.469 ' HE3' ' SD ' ' A' ' 237' ' ' MET . 34.8 mtmm -107.46 158.98 16.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 234' ' ' VAL . 55.1 m -85.26 158.47 20.31 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.224 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.52 HD11 ' N ' ' A' ' 232' ' ' ASP 0.254 1.2 pp -68.74 -31.99 71.45 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.52 ' N ' HD11 ' A' ' 231' ' ' LEU . 10.8 m-20 -64.21 -34.84 79.02 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.286 0.565 . . . . 0.0 110.052 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.567 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.0 tp-100 -69.51 -47.77 62.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 230' ' ' THR . 82.2 t -57.47 -49.47 80.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.931 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 239' ' ' VAL . 40.1 p -67.05 -36.59 82.4 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.199 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.08 -42.53 98.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.022 0.439 . . . . 0.0 109.99 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.3 mtm -59.63 -48.63 80.92 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.868 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 235' ' ' THR . 4.6 ppp? -71.26 -16.92 62.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.651 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 235' ' ' THR . 98.3 t -84.73 -33.04 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.337 0.589 . . . . 0.0 109.574 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.9 -12.02 61.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.891 0.853 . . . . 0.0 109.806 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.43 27.61 8.2 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.757 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 245' ' ' LEU . 69.4 m -57.59 -20.44 32.6 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.8 m -50.55 -56.96 9.36 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -131.6 84.9 2.21 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 163' ' ' LEU . 1.4 pt? -86.7 121.56 29.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.382 0.61 . . . . 0.0 110.403 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 32.0 mt -122.35 124.52 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.478 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 19.1 mm -110.24 139.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.609 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 30.1 m -117.63 125.3 50.5 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.457 HG23 HD23 ' A' ' 212' ' ' LEU . 17.0 m -114.59 148.73 17.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 216' ' ' ASP . 1.0 OUTLIER -139.46 131.18 14.97 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.438 -176.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 157' ' ' THR . 6.6 Cg_endo -47.44 136.09 20.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.309 3.339 . . . . 0.0 113.066 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -80.83 4.2 19.98 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.861 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.3 m120 65.88 88.38 0.11 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.837 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -75.53 124.06 26.54 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.583 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.428 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 5.5 tpm_? . . . . . 0 C--N 1.301 -1.506 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.26 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.69 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.8 m -137.07 148.29 46.66 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -113.28 118.25 34.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.8 t -91.94 136.34 33.23 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 132' ' ' LYS . 11.0 mptt -90.31 91.5 8.52 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.463 0.649 . . . . 0.0 111.771 -175.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.06 91.22 50.0 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.494 173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -96.14 162.37 1.31 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 122.36 2.04 . . . . 0.0 111.429 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.5 p -90.35 97.67 11.32 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.26 133.7 30.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.627 0.727 . . . . 0.0 109.237 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.4 t 177.85 108.98 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -86.68 120.92 72.13 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.894 -172.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.53 124.33 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.277 1.985 . . . . 0.0 109.154 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -78.18 124.95 28.66 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.06 -174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.6 157.6 22.22 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.142 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -51.18 122.08 7.15 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 124.002 0.814 . . . . 0.0 110.521 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.419 ' HD3' ' C ' ' A' ' 143' ' ' ARG . 1.7 tmt_? -97.33 79.46 2.79 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 122.48 1.133 . . . . 0.0 108.243 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -88.85 145.25 25.68 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.057 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.6 m -75.22 116.55 18.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.265 0.555 . . . . 0.0 110.501 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -66.26 113.11 4.34 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.01 -176.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.56 103.88 11.46 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.9 mm -136.1 125.08 38.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 152' ' ' ASP . 26.0 pt -101.82 114.41 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-O 121.586 0.708 . . . . 0.0 110.306 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -120.75 -30.69 4.4 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.708 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.95 -39.73 15.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.543 ' O ' ' HB ' ' A' ' 149' ' ' ILE . 32.5 t70 -100.0 111.53 23.83 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.582 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 14.7 tt -156.61 -173.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.508 ' H ' HG12 ' A' ' 153' ' ' ILE . 51.7 t -96.86 101.6 9.78 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 6.1 Cg_endo -87.5 152.36 7.72 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.139 2.559 . . . . 0.0 109.535 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.579 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 1.6 mp0 -70.05 84.47 0.52 Allowed 'General case' 0 N--CA 1.418 -2.05 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.51 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 101.71 12.73 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -80.72 94.22 6.33 Favored 'General case' 0 CA--C 1.463 -2.404 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -115.22 126.78 54.96 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.592 -169.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.547 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.7 ptt180 -95.74 94.32 7.62 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.16 133.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.759 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 18.9 ptp180 -99.52 155.74 17.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.77 126.72 37.1 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . 0.258 1.1 pp -105.32 101.54 11.07 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-O 122.152 0.977 . . . . 0.0 113.039 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.613 ' HE2' ' O ' ' A' ' 168' ' ' SER . 12.6 tmtt? -65.2 121.01 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.597 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -162.23 132.89 4.9 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.62 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.37 90.12 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 114.548 0.579 . . . . 0.0 114.548 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.613 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 47.9 m -158.52 153.6 25.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.53 -47.63 69.35 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.702 0.626 . . . . 0.0 109.832 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.498 ' HB3' ' HZ1' ' A' ' 170' ' ' LYS . 6.8 ttpm? -137.56 83.72 24.62 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.416 ' HB3' ' HB2' ' A' ' 168' ' ' SER . 88.8 Cg_endo -91.91 25.08 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.236 2.624 . . . . 0.0 112.576 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.08 109.31 6.52 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.78 53.66 4.84 Favored Glycine 0 C--N 1.305 -1.176 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.529 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -170.41 142.26 2.11 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.25 158.89 42.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 176' ' ' ILE . 2.5 pp -131.08 143.31 41.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.181 0.515 . . . . 0.0 112.257 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -142.22 157.41 44.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -74.12 131.75 41.6 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.967 0.792 . . . . 0.0 110.62 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -144.8 125.91 2.51 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 24.5 p -92.59 139.07 30.95 Favored 'General case' 0 N--CA 1.383 -3.777 0 CA-C-N 117.367 0.583 . . . . 0.0 111.959 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.2 m -110.86 130.54 55.55 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.31 128.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -109.66 155.4 21.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.07 118.86 56.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.255 0.55 . . . . 0.0 110.466 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 41.5 p -115.24 177.83 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.332 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.03 58.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.57 0.7 . . . . 0.0 109.99 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.0 m -101.1 7.47 43.28 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.558 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.18 -141.58 12.94 Favored Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.764 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 189' ' ' LEU . 2.9 pp -125.08 137.86 54.19 Favored 'General case' 0 N--CA 1.388 -3.549 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 153.11 46.56 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.76 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.402 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 38.3 ttpt -121.27 144.09 48.81 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 121.394 0.616 . . . . 0.0 112.027 -172.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 19.8 pt20 -122.2 140.51 32.57 Favored Pre-proline 0 N--CA 1.41 -2.43 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.346 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 6.3 Cg_exo -75.08 134.79 18.1 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.214 1.942 . . . . 0.0 109.203 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.86 154.35 22.65 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.764 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.91 117.09 49.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -119.37 166.53 12.93 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 62.6 mt -67.09 129.79 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 39.7 p -96.68 -51.68 4.21 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -137.5 143.54 41.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.362 0.601 . . . . 0.0 111.122 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 138.85 49.73 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.62 138.33 20.74 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -59.8 126.38 20.31 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 121.669 1.579 . . . . 0.0 109.339 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.7 16.36 68.4 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 156.5 29.81 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.862 -0.669 . . . . 0.0 113.218 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.28 -46.08 76.16 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 124.799 1.239 . . . . 0.0 111.446 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.31 -30.14 70.96 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.158 0.504 . . . . 0.0 111.077 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.44 -33.72 54.72 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.364 0.666 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.3 t -55.02 -32.85 62.14 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.375 1.07 . . . . 0.0 113.843 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.404 ' OG1' ' HG ' ' A' ' 211' ' ' LEU . 2.9 t -79.86 -44.02 21.26 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.38 -23.18 5.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.631 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.404 ' HG ' ' OG1' ' A' ' 209' ' ' THR . 46.7 mt -75.85 -40.34 54.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.938 0.875 . . . . 0.0 109.383 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 86.3 mt -109.64 147.37 33.2 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.568 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.05 162.89 17.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.016 0.436 . . . . 0.0 111.289 -174.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 14.3 p -62.2 -15.45 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-O 121.987 0.899 . . . . 0.0 111.323 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -71.88 -24.02 61.6 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.822 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.4 m-20 -64.56 173.39 2.17 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -116.46 147.75 41.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.242 -172.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.67 142.69 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.065 0.546 . . . . 0.0 110.43 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.5 mp -112.04 -51.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 110.456 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.479 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.3 mt-10 -140.48 149.74 42.9 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.56 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.0 t -113.62 108.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.494 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 6.9 t30 69.87 -68.82 0.18 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.332 1.453 . . . . 0.0 110.939 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.73 26.36 0.19 Allowed Glycine 0 C--N 1.301 -1.388 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.414 ' CG2' ' HE2' ' A' ' 237' ' ' MET . 13.1 mt -123.52 119.1 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 225' ' ' GLU . 1.2 pm0 -75.53 145.91 40.93 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-O 121.007 0.432 . . . . 0.0 111.985 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 219' ' ' ILE . 20.3 m -94.11 9.31 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.892 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -64.54 106.11 1.09 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.834 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.25 12.2 58.95 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.497 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 70.6 mmtt -87.03 170.58 11.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.27 1.033 . . . . 0.0 113.327 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 234' ' ' VAL . 86.0 m -110.26 157.09 19.83 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 113.363 -1.744 . . . . 0.0 106.65 174.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.67 -34.35 78.08 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.34 -49.48 55.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.551 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -60.48 -40.57 91.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.681 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.546 ' HA ' ' SD ' ' A' ' 237' ' ' MET . 92.0 t -57.53 -43.31 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 O-C-N 123.266 0.354 . . . . 0.0 111.439 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 239' ' ' VAL . 60.2 p -65.19 -28.89 69.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.5 -40.75 63.83 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.546 ' SD ' ' HA ' ' A' ' 234' ' ' VAL . 54.3 mtp -55.84 -50.16 71.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.02 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 20.7 ptm -76.49 -10.67 59.57 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.046 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.683 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 59.0 t -91.81 -34.96 6.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.045 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.43 -22.07 66.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.643 0.735 . . . . 0.0 109.902 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -114.32 21.83 14.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.1 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.683 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 75.2 m -63.92 -32.0 73.38 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.8 m -51.94 -53.08 45.42 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 0.0 110.815 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -129.81 86.17 2.38 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.1 tm? -97.09 131.45 43.86 Favored 'General case' 0 C--O 1.191 -1.993 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.722 -174.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -117.07 118.86 60.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.42 130.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.922 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 18.7 m -97.35 120.18 37.23 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.93 150.4 29.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 123.781 0.675 . . . . 0.0 112.251 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.526 ' HB3' ' HZ3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -139.04 130.36 15.11 Favored Pre-proline 0 C--O 1.247 0.921 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.682 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.8 Cg_endo -62.41 132.2 37.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.024 2.483 . . . . 0.0 115.119 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.58 -4.48 15.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.655 -1.157 . . . . 0.0 107.919 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -89.03 -1.8 58.28 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.766 -177.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.39 123.35 22.87 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.696 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 . . . . . 0 C--N 1.295 -1.778 0 O-C-N 124.25 0.969 . . . . 0.0 109.119 178.762 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.784 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.21 -45.37 7.64 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 122.85 2.367 . . . . 0.0 112.405 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -119.9 103.17 9.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.254 0.55 . . . . 0.0 110.678 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.0 mt -110.45 142.92 21.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.5 t -134.52 93.36 3.04 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.91 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.1 tt -115.06 92.26 30.36 Favored Pre-proline 0 N--CA 1.415 -2.193 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.06 122.63 3.83 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.152 1.901 . . . . 0.0 111.446 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -94.59 114.57 26.55 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -83.23 119.93 25.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.297 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -179.17 92.24 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.595 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 . . . . . 0 C--N 1.301 -1.525 0 CA-C-O 122.535 1.16 . . . . 0.0 108.107 178.536 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.82 150.37 78.67 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 122.548 2.166 . . . . 0.0 111.69 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 77.3 4.33 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.2 p -74.39 101.76 4.2 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.452 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -76.4 95.65 3.86 Favored 'General case' 0 CA--C 1.466 -2.277 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.485 ' CB ' HD11 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -96.08 117.3 30.42 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.324 -167.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 30.3 ptt180 -87.25 99.49 12.0 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.724 0.773 . . . . 0.0 109.716 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 247' ' ' ILE . 62.5 t -88.94 105.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.417 ' HE ' HD21 ' A' ' 164' ' ' LEU . 14.6 ptm180 -105.69 139.42 40.3 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.322 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.19 121.34 44.96 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.417 HD21 ' HE ' ' A' ' 162' ' ' ARG . 89.7 mt -100.82 100.21 10.83 Favored 'General case' 0 N--CA 1.403 -2.783 0 CA-C-O 121.752 0.787 . . . . 0.0 109.729 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER -90.64 120.58 31.83 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.282 176.38 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -152.31 89.32 1.42 Allowed 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.113 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.07 -10.37 41.58 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.36 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 32.9 t -141.61 135.04 29.6 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.509 ' OD2' ' HG3' ' A' ' 165' ' ' LYS . 13.4 t70 -130.42 87.04 2.45 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -119.01 147.51 42.71 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.563 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 112.4 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 107.886 -1.621 . . . . 0.0 107.886 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.503 HD22 ' H ' ' A' ' 205' ' ' LEU . 4.9 tt -62.73 -29.2 70.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.357 0.599 . . . . 0.0 109.607 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.76 -4.91 1.71 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.337 -1.411 . . . . 0.0 113.468 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -103.06 147.56 26.81 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.417 ' HB2' ' H ' ' A' ' 199' ' ' ARG . 81.7 m-85 -137.93 158.51 44.19 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.404 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.1 pt -117.57 149.17 19.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.476 0.655 . . . . 0.0 112.377 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 60.1 ttt180 -125.45 152.33 45.03 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.124 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 8.7 t70 -115.59 123.23 47.92 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.39 179.68 29.55 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.288 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.9 p -93.41 120.61 33.9 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.163 0.506 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.8 t -101.7 124.45 47.37 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.46 123.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 121.381 0.61 . . . . 0.0 110.445 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -124.76 161.57 26.13 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.272 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.16 107.41 22.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 36.2 p -108.88 178.87 4.34 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.78 -16.88 64.33 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.948 0.404 . . . . 0.0 110.818 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.3 m -87.88 -4.7 58.83 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.9 -151.7 18.17 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.592 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.5 pt? -84.28 108.53 17.19 Favored 'General case' 0 N--CA 1.394 -3.253 0 CA-C-O 122.016 0.912 . . . . 0.0 109.796 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.4 158.85 23.73 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.496 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.46 131.87 54.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -116.49 151.1 46.61 Favored Pre-proline 0 C--N 1.273 -2.731 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.11 125.16 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.893 1.728 . . . . 0.0 109.902 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.74 151.52 20.21 Favored Glycine 0 C--N 1.278 -2.64 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 122.47 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.08 -168.44 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.5 136.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 69.4 p -95.42 -46.94 6.49 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.453 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.417 ' H ' ' HB2' ' A' ' 175' ' ' TYR . 72.7 ttt180 -146.58 146.88 30.6 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 56.4 tp -127.78 125.44 39.88 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.3 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.17 130.59 26.94 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 50.6 Cg_exo -57.52 126.28 21.41 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.148 1.899 . . . . 0.0 110.24 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.66 -14.9 41.91 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.64 146.02 28.16 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.503 ' H ' HD22 ' A' ' 172' ' ' LEU . 34.6 tp -53.96 -34.42 59.66 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 123.927 0.891 . . . . 0.0 113.271 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -69.37 -35.26 75.65 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.8 tp10 -77.04 -35.52 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 36.4 m -61.73 -33.11 73.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.486 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.3 m -67.12 -39.89 86.73 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.46 -32.27 2.61 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.941 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.89 -19.25 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 123.74 0.816 . . . . 0.0 110.189 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.485 HD11 ' CB ' ' A' ' 159' ' ' ARG . 71.1 mt -109.42 141.84 41.24 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.476 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.3 163.06 27.63 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 124.622 1.169 . . . . 0.0 110.128 -177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.86 -26.74 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.816 0.846 . . . . 0.0 112.579 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.12 -23.55 64.0 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.1 m-20 -63.66 159.13 19.71 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.52 148.46 24.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.919 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -101.56 139.02 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.829 0.852 . . . . 0.0 109.477 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 219' ' ' ILE . 2.7 mp -116.12 -50.64 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.468 ' HG3' HG22 ' A' ' 219' ' ' ILE . 47.6 mt-10 -136.22 152.44 50.76 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.413 HG13 ' CD2' ' A' ' 245' ' ' LEU . 50.4 t -119.84 106.82 19.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.811 -1.54 . . . . 0.0 107.975 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 70.25 -69.01 0.18 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.475 1.11 . . . . 0.0 110.49 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -166.0 21.19 0.11 Allowed Glycine 0 C--N 1.291 -1.926 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.583 HG21 ' SD ' ' A' ' 237' ' ' MET . 13.2 mt -113.19 124.91 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.8 143.48 41.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 118.621 0.646 . . . . 0.0 109.664 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.9 m -96.15 -5.19 10.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.682 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.04 123.05 19.98 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.172 0.511 . . . . 0.0 111.684 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.7 7.4 75.13 Favored Glycine 0 CA--C 1.499 -0.907 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.201 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.442 ' HG3' ' OE1' ' A' ' 233' ' ' GLN . 23.3 ttmm -107.47 156.29 19.13 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 234' ' ' VAL . 87.1 m -77.14 157.47 30.97 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 50.0 tp -62.45 -44.3 96.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.42 -35.4 70.02 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.035 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.651 ' O ' ' HG3' ' A' ' 237' ' ' MET . 79.2 mt-30 -73.34 -42.47 62.23 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.946 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 230' ' ' THR . 61.1 t -64.75 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.596 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.0 p -65.87 -41.63 91.36 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.615 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.39 -44.88 95.41 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.1 0.476 . . . . 0.0 110.463 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 33.8 mtm -60.14 -42.9 95.83 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.8 -17.92 62.13 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.395 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 235' ' ' THR . 85.0 t -85.39 -36.73 11.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.24 -25.22 67.7 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.534 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -129.92 28.76 5.04 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.687 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.9 t -59.16 -35.57 73.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.459 1.103 . . . . 0.0 111.953 -175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 22.8 t -70.36 -20.5 62.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.216 0.532 . . . . 0.0 110.759 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -130.15 37.12 3.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.413 ' CD2' HG13 ' A' ' 221' ' ' VAL . 3.2 tm? -85.02 123.01 30.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.829 0.823 . . . . 0.0 112.219 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 61.6 mt -129.02 119.61 49.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.317 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.455 HG23 ' HB ' ' A' ' 161' ' ' VAL . 10.8 tt -109.66 131.99 59.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.584 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.4 m -95.46 120.15 35.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.093 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 212' ' ' LEU . 17.4 m -122.53 149.97 26.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.582 0.551 . . . . 0.0 110.208 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.451 ' CB ' HD11 ' A' ' 219' ' ' ILE . 0.5 OUTLIER -134.77 126.06 17.73 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 77.7 Cg_exo -52.56 132.06 43.76 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.659 2.906 . . . . 0.0 114.494 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -101.78 8.15 41.53 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 114.152 -1.386 . . . . 0.0 108.122 179.546 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.92 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.0 108.39 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.635 1.557 . . . . 0.0 108.736 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 t -92.85 85.82 5.3 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.315 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.59 119.6 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.1 m -145.24 91.31 2.12 Favored 'General case' 1 C--N 1.235 -4.401 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -116.63 108.15 45.47 Favored Pre-proline 0 N--CA 1.424 -1.734 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.178 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.16 123.92 12.63 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 N-CA-C 106.504 -2.152 . . . . 0.0 106.504 172.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.38 112.14 20.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.388 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 142' ' ' PHE . 11.6 m-20 -107.22 118.85 37.81 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 141' ' ' ASP . 48.6 t80 166.66 93.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 O-C-N 125.029 1.455 . . . . 0.0 107.217 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 122.178 0.989 . . . . 0.0 109.357 -179.111 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.417 -2.097 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.49 146.66 13.77 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.338 2.025 . . . . 0.0 113.381 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.494 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 2.4 mp0 -83.0 72.32 10.08 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.717 177.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -106.07 138.53 42.09 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -126.08 135.91 52.3 Favored 'General case' 0 CA--C 1.469 -2.136 0 CA-C-O 121.147 0.498 . . . . 0.0 112.082 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -113.65 115.76 28.4 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.432 ' O ' ' HD2' ' A' ' 160' ' ' ARG 0.334 4.0 ppt_? -97.97 103.81 15.78 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 122.162 0.982 . . . . 0.0 110.659 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.31 125.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.916 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -95.55 126.68 41.0 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.305 0.574 . . . . 0.0 109.862 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.01 121.43 38.89 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.512 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.28 105.16 15.75 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.322 1.058 . . . . 0.0 110.639 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -74.98 136.28 41.31 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.441 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.542 ' HB2' ' H ' ' A' ' 170' ' ' LYS . 88.3 m-70 -139.53 -75.63 0.35 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.556 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.2 -10.96 58.46 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.251 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.7 m -134.01 25.5 3.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 122.123 0.963 . . . . 0.0 108.476 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.402 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 19.4 t70 -165.14 -70.48 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.161 -174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.542 ' H ' ' HB2' ' A' ' 166' ' ' HIS . 12.7 mptt -123.79 114.27 28.37 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -84.31 -40.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.037 1.825 . . . . 0.0 110.234 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.95 159.16 36.21 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 125.618 1.567 . . . . 0.0 107.153 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -122.73 17.81 8.18 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.584 -1.293 . . . . 0.0 112.449 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -165.68 143.67 5.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.424 ' CE2' HG22 ' A' ' 201' ' ' VAL . 76.1 m-85 -108.99 136.03 49.2 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.973 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.478 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -134.44 140.31 46.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -137.82 159.9 40.74 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.29 145.08 44.26 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.947 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.1 109.72 0.43 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 m -93.3 143.76 25.96 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 51.0 m -126.24 133.79 51.38 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.4 p -108.65 125.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.49 ' HB2' ' OE1' ' A' ' 190' ' ' GLU . 72.7 mtp180 -124.72 162.21 24.71 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.428 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.98 113.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.893 0.854 . . . . 0.0 108.856 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 57.0 p -113.8 178.24 4.35 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.498 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.48 -10.88 59.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 109.916 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.2 m -94.55 -4.19 48.39 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.219 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.08 -159.6 14.27 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -83.98 129.13 34.93 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 117.593 0.697 . . . . 0.0 110.272 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -137.78 161.82 35.57 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.761 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 181' ' ' SER . 98.3 mttt -121.64 150.15 42.15 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 18.6 pt20 -131.13 139.0 34.17 Favored Pre-proline 0 N--CA 1.414 -2.23 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.1 Cg_endo -81.7 133.74 8.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.546 2.164 . . . . 0.0 110.854 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.23 153.7 25.5 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.869 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 231' ' ' LEU . 2.7 mp -125.57 123.1 63.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -127.56 163.97 23.01 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 67.7 mt -74.6 114.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -84.52 -49.59 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.064 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.11 155.41 50.22 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.743 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -113.57 140.62 48.01 Favored 'General case' 0 N--CA 1.395 -3.2 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 178.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 175' ' ' TYR . 40.1 t -96.54 129.69 32.5 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.15 126.05 17.8 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 121.939 1.76 . . . . 0.0 109.236 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.07 -6.56 83.1 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.39 156.3 53.29 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.89 -25.88 65.72 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.46 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' N ' HD21 ' A' ' 200' ' ' LEU . 42.8 tt0 -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.0 m -54.81 -31.27 58.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.288 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.4 p -60.75 -43.12 98.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.96 29.28 74.39 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.9 tp -145.43 -46.47 0.22 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.011 -1.095 . . . . 0.0 110.458 -172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.442 HD12 HG23 ' A' ' 249' ' ' VAL . 71.9 mt -115.4 110.43 19.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.445 0.641 . . . . 0.0 111.3 -176.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.69 134.01 44.27 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.613 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 71.2 t 43.22 -72.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 173.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -23.6 65.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -67.41 153.2 44.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.363 -173.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -101.29 156.44 17.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.63 143.3 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.491 0.717 . . . . 0.0 109.964 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.513 HD11 ' CB ' ' A' ' 250' ' ' LYS . 2.8 mp -121.69 -45.52 2.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 111.968 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.451 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 35.9 mt-10 -135.58 150.85 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.768 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.4 t -121.87 101.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 123.804 0.69 . . . . 0.0 109.338 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.522 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 39.2 t-20 69.59 -72.09 0.11 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 0.0 111.269 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.54 12.18 0.4 Allowed Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.584 HG21 ' SD ' ' A' ' 237' ' ' MET . 19.9 mt -105.21 133.06 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.92 146.3 28.12 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.47 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 12.7 m -91.63 -4.94 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.945 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.76 112.34 7.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.575 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 4.29 50.76 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.546 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 10.5 mmpt? -96.79 163.04 13.16 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -104.57 168.7 8.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 231' ' ' LEU . 1.9 pt? -57.59 -47.59 81.71 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -68.31 -40.99 81.53 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.237 0.541 . . . . 0.0 110.529 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.684 ' O ' ' HG3' ' A' ' 237' ' ' MET . 35.5 tt0 -59.09 -43.59 91.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.309 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.49 -46.86 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.483 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.0 p -65.97 -31.01 71.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.888 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.65 -42.79 77.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.18 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.684 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 24.6 mtm -59.3 -46.35 88.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.68 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.3 ptp -67.15 -23.15 65.76 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.967 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 235' ' ' THR . 58.8 t -90.14 -27.05 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.557 0.694 . . . . 0.0 109.161 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.02 71.95 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.449 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.58 -70.17 0.72 Allowed 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.28 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.2 t 60.16 -41.28 0.09 Allowed 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 42.5 m -68.6 -73.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.885 0.766 . . . . 0.0 111.588 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.52 81.17 2.92 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -95.87 129.1 43.21 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.207 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 3.3 mp -127.46 134.5 65.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 220' ' ' GLU . 7.2 tp -124.18 131.17 73.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.59 . . . . 0.0 110.001 178.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 28.5 m -98.03 120.22 38.04 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.052 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG23 HD12 ' A' ' 212' ' ' LEU . 10.5 m -121.06 149.37 24.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.278 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.513 ' CB ' HD11 ' A' ' 219' ' ' ILE . 80.7 tttt -127.72 141.07 39.88 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 124.001 0.92 . . . . 0.0 109.258 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.631 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.5 Cg_endo -64.39 130.09 25.84 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 121.626 1.551 . . . . 0.0 111.039 175.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -95.48 -35.15 11.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.928 0.871 . . . . 0.0 109.07 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.9 m120 . . . . . 0 N--CA 1.495 1.796 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.932 -177.647 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.579 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.28 133.2 31.93 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.736 1.624 . . . . 0.0 110.093 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.9 t -96.32 96.31 8.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.404 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.57 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.3 t -161.95 93.21 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 73.0 mt -92.23 114.18 61.44 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 6.9 Cg_exo -72.32 123.0 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.313 2.008 . . . . 0.0 112.286 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -98.44 132.26 44.03 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.83 157.17 17.66 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -96.27 138.91 33.18 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 122.106 0.955 . . . . 0.0 109.005 -177.108 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 253' ' ' ASN . 41.3 t . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.04 151.79 84.55 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.391 2.061 . . . . 0.0 109.266 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 78.64 0.22 Allowed 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.8 p -81.84 96.96 7.79 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.411 ' NE2' ' HG2' ' A' ' 250' ' ' LYS . 12.0 m170 -66.04 116.39 7.1 Favored 'General case' 0 CA--C 1.457 -2.622 0 CA-C-O 121.861 0.838 . . . . 0.0 112.42 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.458 ' HG2' HG21 ' A' ' 209' ' ' THR . 10.7 tpt180 -110.12 116.7 32.01 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.67 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.497 ' HB2' HG23 ' A' ' 246' ' ' ILE . 30.7 ptt180 -99.14 113.62 25.95 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.92 132.32 41.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 19.6 ptt180 -112.13 148.79 33.24 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.001 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 2.5 tm? -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 171.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 164' ' ' LEU 0.273 0.0 OUTLIER -108.04 101.33 10.58 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-O 121.956 0.884 . . . . 0.0 112.72 179.39 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -71.91 131.83 43.52 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.817 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.26 79.07 0.52 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.801 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.95 17.62 69.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -102.94 113.89 27.72 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 114.616 -0.792 . . . . 0.0 111.049 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.14 4.24 7.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.769 1.271 . . . . 0.0 107.687 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -74.2 169.19 20.32 Favored Pre-proline 0 C--O 1.246 0.869 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -56.07 146.17 71.32 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.257 1.972 . . . . 0.0 110.523 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.72 -47.23 80.44 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.442 0.639 . . . . 0.0 111.853 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 115.83 -18.78 14.47 Favored Glycine 0 CA--C 1.487 -1.692 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -132.67 133.36 43.47 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 114.275 -0.962 . . . . 0.0 108.857 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 199' ' ' ARG . 77.4 m-85 -138.04 148.08 44.74 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 123.524 0.515 . . . . 0.0 111.926 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.425 HG21 HG11 ' A' ' 218' ' ' VAL . 31.6 pt -124.71 143.14 39.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.992 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -140.24 159.39 42.28 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.841 0.353 . . . . 0.0 111.43 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.65 135.78 35.53 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.932 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -142.17 175.01 22.98 Favored Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.5 m -95.04 133.42 38.84 Favored 'General case' 0 C--N 1.27 -2.881 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.725 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.3 t -103.88 119.12 38.25 Favored 'General case' 0 C--N 1.252 -3.668 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.1 p -108.41 123.16 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.544 0.688 . . . . 0.0 109.168 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.89 51.65 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.529 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.82 107.41 21.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.28 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.3 p -111.87 179.11 4.1 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.753 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.12 -15.21 62.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.2 m -87.62 -5.32 58.78 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.95 -157.36 15.04 Favored Glycine 0 C--O 1.214 -1.119 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 189' ' ' LEU . 4.0 pp -88.19 129.97 35.19 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 118.346 1.073 . . . . 0.0 109.203 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 41.7 mt-10 -120.69 147.78 44.82 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.507 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -121.34 130.12 53.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -142.21 154.83 64.83 Favored Pre-proline 0 C--N 1.279 -2.486 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.69 121.56 6.39 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 109.23 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.41 139.35 10.71 Favored Glycine 0 C--N 1.276 -2.791 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.8 pt -100.6 126.58 54.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-O 121.532 0.682 . . . . 0.0 112.164 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -120.19 174.47 6.48 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.952 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 176' ' ' ILE . 59.9 mt -68.33 135.7 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.3 t -121.23 -59.29 1.73 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.593 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.42 ' HB2' ' HB2' ' A' ' 175' ' ' TYR . 93.1 mtt180 -122.86 147.01 47.05 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.442 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 206' ' ' ALA . 12.9 mt -127.36 134.11 49.98 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.464 174.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.402 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 57.7 t -100.7 129.38 27.71 Favored Pre-proline 0 C--N 1.275 -2.632 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 172.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.66 126.45 19.73 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.334 2.023 . . . . 0.0 110.682 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.04 72.5 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.214 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 158.35 47.48 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -55.95 -39.32 71.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.771 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -74.01 -26.98 60.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.171 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.428 ' HB2' HD22 ' A' ' 200' ' ' LEU . 7.7 tp10 -73.0 -45.46 57.79 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 m -55.36 -32.22 62.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.263 1.025 . . . . 0.0 111.846 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.559 HG22 ' HG ' ' A' ' 211' ' ' LEU . 27.6 m -62.58 -43.49 98.69 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.033 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 77.59 -27.64 1.85 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.387 0.915 . . . . 0.0 115.387 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.559 ' HG ' HG22 ' A' ' 209' ' ' THR . 4.2 pp -97.56 7.98 45.47 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 249' ' ' VAL . 94.9 mt -116.0 145.05 43.28 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.938 0.399 . . . . 0.0 110.045 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.47 161.89 26.1 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 120.889 0.376 . . . . 0.0 111.75 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.61 -19.41 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-O 121.547 0.689 . . . . 0.0 111.114 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.77 -25.07 58.82 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.528 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.617 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 51.8 m-20 -70.98 156.67 39.35 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.245 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.47 165.74 18.54 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.628 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 176' ' ' ILE . 19.6 m -82.77 142.88 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.234 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.59 HG13 ' HG3' ' A' ' 250' ' ' LYS . 42.8 mm -116.06 -47.43 4.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.069 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.544 ' H ' ' HB ' ' A' ' 248' ' ' THR . 39.1 mt-10 -145.99 159.49 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' A' ' 226' ' ' VAL . 77.2 t -123.38 97.26 4.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 169.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.3 t30 68.3 -70.17 0.13 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.36 17.56 0.68 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.426 HG21 ' SD ' ' A' ' 237' ' ' MET . 9.0 mt -120.3 142.33 36.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -86.12 153.83 21.8 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.991 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.424 ' CG1' HG23 ' A' ' 221' ' ' VAL . 16.3 m -118.03 -3.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.94 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -86.27 121.77 29.32 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.81 -10.22 72.52 Favored Glycine 0 C--N 1.318 -0.441 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 233' ' ' GLN . 37.5 ttmt -91.95 153.79 19.25 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 124.48 1.112 . . . . 0.0 109.153 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.4 m -74.92 156.28 36.53 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 231' ' ' LEU . 2.2 pt? -64.65 -36.82 85.49 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.686 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.37 -36.85 76.53 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.75 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 237' ' ' MET . 5.8 tp-100 -72.42 -48.52 40.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.459 ' HA ' ' HE2' ' A' ' 237' ' ' MET . 95.6 t -56.74 -48.97 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.932 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.5 p -65.0 -34.0 77.39 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.32 -38.58 81.69 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.99 0.424 . . . . 0.0 110.276 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.659 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 20.2 mtm -57.8 -45.6 85.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.84 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.28 -15.01 60.54 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.465 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 235' ' ' THR . 65.9 t -78.82 -38.72 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.251 0.548 . . . . 0.0 110.028 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.27 -29.06 68.57 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.281 0.563 . . . . 0.0 110.806 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -110.79 32.13 5.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.8 p -60.02 -27.52 66.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.2 p -46.9 -63.55 1.0 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.137 0.575 . . . . 0.0 111.564 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 40.1 m-80 -129.96 87.68 2.56 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.9 pp -90.33 131.99 35.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 160' ' ' ARG . 2.3 mp -106.7 125.29 62.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.094 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.1 tt -111.37 128.27 67.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 110.649 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.544 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.1 m -106.44 129.44 54.42 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.315 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 212' ' ' LEU . 27.8 m -135.66 165.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.59 ' HG3' HG13 ' A' ' 219' ' ' ILE . 43.9 mtpt -126.42 129.02 24.25 Favored Pre-proline 0 CA--C 1.482 -1.637 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.55 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 50.0 Cg_exo -58.62 127.23 23.79 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.811 1.674 . . . . 0.0 110.164 172.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.12 9.69 21.83 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.125 0.964 . . . . 0.0 109.712 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' A' ' 154' ' ' VAL . 24.8 m-80 . . . . . 0 C--N 1.306 -1.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.29 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 147.82 91.87 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.26 1.973 . . . . 0.0 111.263 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.3 m -79.7 85.85 5.36 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.47 0.652 . . . . 0.0 110.614 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.9 mm -99.81 144.18 12.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m 58.26 73.93 0.45 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.141 0.977 . . . . 0.0 111.148 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.79 119.43 70.56 Favored Pre-proline 0 N--CA 1.421 -1.896 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.815 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.17 121.82 10.22 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.464 2.11 . . . . 0.0 112.114 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -101.94 161.19 13.86 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.759 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -83.52 149.44 26.6 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.704 -0.398 . . . . 0.0 109.944 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -103.45 -37.72 7.48 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? . . . . . 0 N--CA 1.429 -1.516 0 CA-C-O 121.118 0.485 . . . . 0.0 110.647 -176.192 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.75 131.2 1.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.049 1.833 . . . . 0.0 112.283 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.55 ' HA ' ' HG2' ' A' ' 251' ' ' PRO . 42.2 mt-10 -84.27 85.57 7.35 Favored 'General case' 0 N--CA 1.403 -2.811 0 CA-C-O 121.387 0.613 . . . . 0.0 112.109 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -91.0 100.45 13.31 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -88.61 105.01 17.38 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -126.36 116.11 20.7 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.25 129.58 34.6 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.997 0.427 . . . . 0.0 110.074 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.3 t -89.71 115.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -106.28 137.61 43.93 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 111.836 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.72 141.49 48.56 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.356 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.43 115.3 23.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 121.822 0.82 . . . . 0.0 110.801 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.56 130.08 38.92 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.345 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 169' ' ' ASP . 0.5 OUTLIER -164.99 76.33 0.28 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.99 -178.66 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.37 17.35 76.32 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.009 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.0 m 67.58 97.0 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.587 1.155 . . . . 0.0 111.154 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 166' ' ' HIS . 19.2 t70 -86.56 -49.56 7.46 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.926 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -145.17 150.35 44.86 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.76 -61.93 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 121.312 1.341 . . . . 0.0 109.756 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.04 -65.56 0.39 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.511 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 205' ' ' LEU . . . 92.65 11.48 59.22 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.46 156.92 26.74 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -137.27 136.1 37.75 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 123.339 0.399 . . . . 0.0 110.326 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.483 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -128.81 141.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.307 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -141.31 158.08 44.36 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.498 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -96.95 130.41 44.26 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -122.2 158.89 16.89 Favored Glycine 0 CA--C 1.47 -2.751 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 m -92.91 131.45 37.91 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.72 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -111.43 140.2 46.22 Favored 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.463 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.4 123.15 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.86 152.52 21.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.0 104.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.1 p -117.74 179.03 4.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.97 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.39 -15.89 63.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 109.656 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.6 m -87.25 -4.13 59.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.208 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.54 -142.3 15.52 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.06 123.28 33.79 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -117.2 146.18 43.4 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.58 133.52 55.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.065 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -146.93 147.61 30.05 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.525 ' O ' ' HA2' ' A' ' 228' ' ' GLY . 13.9 Cg_exo -69.12 133.29 26.37 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.414 2.076 . . . . 0.0 111.512 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -129.82 127.19 5.32 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.529 HG23 ' HB ' ' A' ' 218' ' ' VAL . 10.5 tt -91.19 124.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-O 121.25 0.548 . . . . 0.0 110.881 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.58 173.11 10.56 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.47 131.99 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 37.3 t -90.69 -54.31 4.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.223 0.535 . . . . 0.0 110.83 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -155.65 155.66 33.61 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 53.5 tp -127.33 139.63 52.75 Favored 'General case' 0 N--CA 1.403 -2.819 0 O-C-N 123.317 0.386 . . . . 0.0 110.228 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.37 128.62 32.62 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.524 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 29.6 Cg_exo -63.36 126.27 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 108.934 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.6 73.45 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.51 158.42 41.43 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.497 ' H ' ' HA3' ' A' ' 173' ' ' GLY . 27.4 tp -57.95 -38.8 76.66 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -72.71 -29.27 63.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.512 0.672 . . . . 0.0 109.963 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -76.72 -34.07 58.14 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -58.84 -33.54 70.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.9 m -77.16 -45.59 26.24 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.27 -6.0 0.87 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.02 -14.95 58.88 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.218 0.607 . . . . 0.0 111.287 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.471 ' CD1' HG23 ' A' ' 249' ' ' VAL . 94.1 mt -119.22 146.89 44.83 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.146 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.2 161.28 13.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.961 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 51.7 t -67.36 -18.65 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.669 0.747 . . . . 0.0 110.239 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.99 -24.58 59.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.144 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.649 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 73.7 m-20 -66.06 157.2 31.64 Favored 'General case' 0 C--O 1.248 1.026 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -172.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.81 150.4 22.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.576 0.703 . . . . 0.0 112.425 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 195' ' ' ILE . 57.1 t -94.32 136.94 24.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.602 HG22 ' HG3' ' A' ' 220' ' ' GLU . 31.4 mm -115.6 -53.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.543 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.602 ' HG3' HG22 ' A' ' 219' ' ' ILE . 41.5 mt-10 -143.55 159.79 41.8 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.42 0.629 . . . . 0.0 111.594 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.4 104.8 16.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.0 t30 65.97 -74.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.801 1.24 . . . . 0.0 110.612 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -147.23 3.4 0.89 Allowed Glycine 0 C--N 1.306 -1.113 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.3 mt -100.38 117.94 46.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.51 131.75 42.11 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.386 0.612 . . . . 0.0 109.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 234' ' ' VAL . 35.3 m -117.17 7.19 7.09 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.204 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.38 3.39 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.706 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 193' ' ' PRO . . . 102.56 -3.09 49.7 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.292 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -87.54 170.04 11.67 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.15 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.486 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 20.9 m -101.39 159.38 15.32 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 234' ' ' VAL . 2.4 pt? -52.9 -45.26 67.48 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.09 -46.48 88.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.584 0.707 . . . . 0.0 110.074 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 237' ' ' MET . 2.0 mp0 -66.1 -37.94 86.99 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.34 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 231' ' ' LEU . 9.8 p -74.8 -45.08 44.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.672 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 14.6 t -68.92 -38.62 79.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.88 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.55 -37.46 87.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.856 0.836 . . . . 0.0 108.8 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 10.9 tmm? -69.16 -49.26 58.38 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.418 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 18.4 ptp -67.29 -22.58 65.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.62 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 235' ' ' THR . 89.7 t -83.12 -33.0 9.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.731 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.11 -35.05 70.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.31 -79.21 0.18 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.731 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.5 t 59.59 -37.31 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.77 1.628 . . . . 0.0 114.871 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.4 p -55.75 -68.52 0.19 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.482 0.713 . . . . 0.0 110.271 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -100.55 80.5 2.22 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.54 103.89 16.05 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.05 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.4 135.77 62.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.441 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.431 HD11 ' CG1' ' A' ' 218' ' ' VAL . 8.0 tp -118.49 134.18 62.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.316 0.579 . . . . 0.0 110.245 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.559 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 25.2 m -103.39 119.62 39.24 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.553 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.488 HG12 HG22 ' A' ' 218' ' ' VAL . 4.3 m -127.73 137.07 58.7 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.454 ' HD2' HG13 ' A' ' 219' ' ' ILE . 96.6 mttt -134.8 143.57 46.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.168 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.649 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 93.2 Cg_exo -45.79 132.3 13.57 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.362 2.708 . . . . 0.0 112.05 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.04 -16.88 64.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 . . . . . 0 N--CA 1.497 1.891 0 C-N-CA 125.627 1.571 . . . . 0.0 114.33 -178.586 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.02 118.6 2.45 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.692 2.928 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.2 m -83.52 89.73 7.12 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.853 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -63.66 131.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.678 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m -151.73 102.45 2.85 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.214 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.4 tt -87.89 133.66 37.03 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.58 127.59 22.18 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.008 1.806 . . . . 0.0 110.268 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -98.48 157.35 16.27 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.68 157.18 22.29 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.279 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -134.61 139.58 45.43 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 . . . . . 0 N--CA 1.466 0.358 0 C-N-CA 123.98 0.912 . . . . 0.0 110.885 -178.383 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 N--CA 1.426 -1.649 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.57 136.42 30.8 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.967 1.778 . . . . 0.0 110.726 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.05 76.15 2.24 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-O 121.608 0.718 . . . . 0.0 111.694 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 41.1 m -83.72 103.85 13.35 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 173.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.401 ' CE1' ' HG3' ' A' ' 250' ' ' LYS . 13.0 m170 -69.06 122.53 18.91 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 121.901 0.858 . . . . 0.0 110.984 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.498 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 4.1 mmp_? -105.27 116.62 32.25 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.786 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -107.88 107.11 17.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.432 ' HB ' ' CG2' ' A' ' 247' ' ' ILE . 38.5 t -89.09 125.65 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.697 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.82 138.41 32.65 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.229 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 3.7 mm? -123.33 129.25 51.07 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.661 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.04 120.02 39.19 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 167' ' ' GLY . 88.4 tttt -65.48 123.89 20.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 122.672 1.225 . . . . 0.0 113.259 -173.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -123.84 29.95 6.34 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 113.013 -1.903 . . . . 0.0 108.677 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 165' ' ' LYS . . . 102.26 -10.34 56.58 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.198 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.2 m 60.95 21.15 11.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.42 0.688 . . . . 0.0 111.705 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.96 -55.34 7.62 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.999 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 171' ' ' PRO . 83.8 tttt -99.4 128.22 32.27 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 21.4 Cg_exo -67.96 156.83 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.062 1.841 . . . . 0.0 110.342 172.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.97 -8.03 54.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.509 0.671 . . . . 0.0 111.137 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.23 0.52 7.47 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.024 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -103.95 144.62 31.29 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.24 136.86 38.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.02 135.93 58.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 79.9 ttt180 -142.07 150.43 41.2 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.151 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 231' ' ' LEU . 20.4 t70 -92.59 134.23 35.2 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.411 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -135.28 166.79 24.36 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 191' ' ' LYS . 1.6 m -92.71 131.36 37.85 Favored 'General case' 0 C--N 1.27 -2.86 0 C-N-CA 117.394 -1.723 . . . . 0.0 107.972 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 25.3 m -100.8 134.8 43.23 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.43 128.62 75.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.979 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.2 mtt180 -117.47 154.37 31.54 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.9 109.94 30.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.574 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 74.7 p -107.03 177.89 4.72 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.12 -20.95 62.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.225 0.536 . . . . 0.0 109.874 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.6 p -86.51 -3.8 59.07 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.434 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.95 -171.55 14.54 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.737 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.6 pt? -84.95 133.75 34.27 Favored 'General case' 0 N--CA 1.4 -2.951 0 O-C-N 122.306 -0.526 . . . . 0.0 110.298 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -132.47 156.72 46.24 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.373 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.562 ' HB3' HG22 ' A' ' 180' ' ' THR . 96.9 mttt -121.36 150.33 41.63 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.84 161.48 62.51 Favored Pre-proline 0 N--CA 1.426 -1.654 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.627 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.55 142.68 85.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.94 89.96 0.15 Allowed Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.586 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 218' ' ' VAL . 12.1 tt -95.97 117.66 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-O 121.77 0.795 . . . . 0.0 109.998 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -132.46 179.16 6.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.283 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 216' ' ' ASP . 44.9 mt -68.7 122.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 26.1 p -96.33 -32.89 12.16 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 120.905 0.383 . . . . 0.0 111.887 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -153.34 148.79 27.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.47 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.9 tt -124.54 136.73 54.22 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 71.3 t -99.57 124.42 44.44 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.12 127.23 24.14 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.477 2.118 . . . . 0.0 111.353 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.42 63.15 Favored Glycine 0 C--N 1.309 -0.953 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.39 161.4 44.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.736 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 205' ' ' LEU . 2.8 tm? -53.35 -39.68 64.34 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.8 0.84 . . . . 0.0 110.862 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 212' ' ' LEU . . . -55.47 -42.14 73.91 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.3 -36.12 54.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.1 m -54.45 -34.74 62.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.435 0.694 . . . . 0.0 112.816 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 73.1 p -60.17 -41.26 92.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 111.557 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.83 3.16 90.68 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.533 HD12 ' HG ' ' A' ' 212' ' ' LEU . 2.7 pp -127.96 -2.32 5.86 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.533 ' HG ' HD12 ' A' ' 211' ' ' LEU . 97.2 mt -108.55 130.58 55.29 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.237 0.541 . . . . 0.0 110.305 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.95 164.36 25.51 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 125.318 1.447 . . . . 0.0 109.663 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.0 p -52.49 -20.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.733 0.777 . . . . 0.0 112.435 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -68.79 -25.29 64.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.929 -0.482 . . . . 0.0 111.898 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.8 m-20 -61.3 159.34 12.53 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -114.96 144.87 42.9 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.15 -1.841 . . . . 0.0 110.448 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 195' ' ' ILE . 7.7 p -96.61 140.4 17.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.053 0.454 . . . . 0.0 109.819 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.48 HG22 ' HG3' ' A' ' 220' ' ' GLU . 40.2 mm -110.44 -52.92 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.189 0.519 . . . . 0.0 111.803 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.635 ' H ' ' HB ' ' A' ' 248' ' ' THR . 45.1 mt-10 -134.73 142.74 46.85 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.57 0.7 . . . . 0.0 112.646 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.453 HG21 HG13 ' A' ' 234' ' ' VAL . 57.6 t -115.62 113.5 43.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.213 172.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 70.6 -66.19 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.221 1.008 . . . . 0.0 110.327 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -169.34 12.91 0.05 OUTLIER Glycine 0 C--N 1.292 -1.891 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.538 HG21 ' SD ' ' A' ' 237' ' ' MET . 28.9 mt -105.37 125.49 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -176.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -77.48 141.64 39.57 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 33.6 m -100.91 14.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.08 104.01 2.46 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.276 0.56 . . . . 0.0 111.02 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.78 12.32 55.71 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.231 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.582 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 6.0 mmpt? -91.8 152.36 20.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 234' ' ' VAL . 38.7 p -86.94 159.46 19.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 178' ' ' ASP . 1.9 pt? -60.26 -38.07 82.38 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.596 0.236 . . . . 0.0 111.288 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.87 -46.5 87.66 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.854 0.861 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.575 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.6 tp-100 -63.48 -51.05 67.23 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.144 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 221' ' ' VAL . 75.0 t -56.93 -49.03 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.468 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 9.9 t -66.86 -38.47 86.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.801 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.92 -46.88 88.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.159 0.504 . . . . 0.0 109.969 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.575 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 40.7 mtm -62.3 -42.94 99.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.066 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.468 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 13.0 ptp -71.1 -18.44 62.53 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.121 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 235' ' ' THR . 84.8 t -89.12 -33.57 6.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.772 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.22 79.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.44 0.638 . . . . 0.0 109.392 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -105.52 23.27 14.08 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.233 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 55.4 p -60.63 -26.44 67.03 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.813 0.445 . . . . 0.0 111.66 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m -51.15 -51.26 55.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -130.15 89.42 2.79 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tm? -96.71 130.04 44.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.721 0.772 . . . . 0.0 110.801 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 245' ' ' LEU . 73.0 mt -127.6 128.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.432 ' CG2' ' HB ' ' A' ' 161' ' ' VAL . 8.1 tp -119.86 126.38 75.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.632 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.635 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 28.4 m -103.99 119.84 39.78 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.745 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 159' ' ' ARG . 19.5 m -120.92 149.31 23.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.367 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 251' ' ' PRO . 10.0 tmtt? -135.8 128.06 17.65 Favored Pre-proline 0 C--N 1.286 -2.168 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.326 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 50.3 Cg_exo -57.69 127.3 24.72 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.627 2.218 . . . . 0.0 113.041 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -106.58 4.1 27.68 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.972 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 . . . . . 0 C--N 1.312 -1.028 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.485 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.872 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.67 149.19 73.32 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.475 2.117 . . . . 0.0 113.052 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -86.15 91.43 8.43 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.1 pt -64.71 113.21 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.118 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.2 m -90.85 77.73 6.17 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-O 121.955 0.883 . . . . 0.0 109.887 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 10.8 tt -109.65 125.38 31.41 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.911 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 17.6 Cg_exo -66.88 134.12 33.62 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.135 1.89 . . . . 0.0 110.852 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -101.27 139.49 36.88 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.06 135.72 34.74 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -101.83 -64.64 1.04 Allowed 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.484 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 . . . . . 0 C--N 1.308 -1.23 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.484 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.434 -1.254 0 CA-C-O 121.234 0.54 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.26 142.31 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.057 1.838 . . . . 0.0 110.666 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.5 82.15 5.66 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 121.339 0.59 . . . . 0.0 110.285 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.3 p -85.05 108.87 17.84 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.3 99.22 9.21 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -96.5 131.94 42.59 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.029 -163.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.509 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 22.1 ptt180 -105.14 112.74 25.97 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.16 133.41 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.865 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.655 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -98.44 134.8 40.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.627 0.727 . . . . 0.0 112.659 -176.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 45.0 tp -98.53 122.4 41.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.024 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.75 100.68 9.39 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-O 122.106 0.955 . . . . 0.0 112.21 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 64.2 pttt -74.61 147.31 41.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.376 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -100.62 20.5 14.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.49 -11.35 59.01 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.9 t -162.16 131.36 4.39 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 71.23 108.06 0.06 Allowed 'General case' 0 C--O 1.248 1.006 0 O-C-N 124.442 1.089 . . . . 0.0 112.014 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 165' ' ' LYS . 3.5 mppt? -90.62 121.96 67.65 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -81.21 70.0 7.64 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.964 1.776 . . . . 0.0 112.55 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -69.92 112.99 6.72 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.393 0.616 . . . . 0.0 110.992 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.443 ' HA2' ' CG1' ' A' ' 201' ' ' VAL . . . -104.93 33.78 6.3 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -158.85 145.25 16.96 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -137.11 135.81 37.75 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -135.37 139.6 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -141.88 158.65 43.53 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.142 0.577 . . . . 0.0 112.185 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.572 ' H ' HD23 ' A' ' 231' ' ' LEU . 13.0 t70 -74.5 139.41 43.83 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.173 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.05 179.23 36.64 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 m -99.44 141.59 32.03 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.739 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 43.4 t -112.46 146.82 37.74 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.002 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.04 123.86 71.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.9 mtt180 -123.5 160.64 26.53 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.35 106.45 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 43.7 p -111.1 179.61 3.99 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.0 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.27 -18.16 65.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.0 m -92.06 4.97 51.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.589 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.26 -152.54 19.26 Favored Glycine 0 C--O 1.212 -1.274 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.5 pt? -85.88 121.26 28.27 Favored 'General case' 0 N--CA 1.395 -3.199 0 CA-C-N 117.34 0.57 . . . . 0.0 110.034 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.03 159.98 35.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.846 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 181' ' ' SER . 68.1 mttm -106.93 143.76 34.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.648 0.592 . . . . 0.0 109.722 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -136.31 154.09 76.88 Favored Pre-proline 0 N--CA 1.426 -1.626 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.09 129.44 6.87 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.047 1.832 . . . . 0.0 109.397 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.63 -177.82 24.9 Favored Glycine 0 C--N 1.287 -2.157 0 C-N-CA 120.611 -0.805 . . . . 0.0 111.718 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.498 HG23 ' HB ' ' A' ' 218' ' ' VAL . 12.0 tt -129.48 122.24 55.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -114.48 173.15 6.61 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.087 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.4 126.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.3 t -89.53 -45.58 9.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.753 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -146.62 153.65 40.57 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 206' ' ' ALA . 49.1 tp -127.73 137.78 52.57 Favored 'General case' 0 N--CA 1.407 -2.601 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.443 ' CG1' ' HA2' ' A' ' 173' ' ' GLY . 8.2 p -103.47 137.3 19.21 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.84 126.45 18.14 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.765 1.643 . . . . 0.0 108.913 172.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.64 1.33 66.05 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.16 162.75 40.72 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.507 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.1 mm? -63.99 -36.32 83.59 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 112.144 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 200' ' ' LEU . . . -76.6 -27.9 55.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.611 0.719 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.41 -37.65 56.79 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.29 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.3 m -57.9 -33.63 68.96 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 120.773 0.321 . . . . 0.0 111.568 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 211' ' ' LEU . 4.3 m -68.06 -39.98 82.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.79 -33.6 2.36 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.25 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.401 ' H ' ' C ' ' A' ' 209' ' ' THR . 27.1 mt -77.84 -8.1 57.58 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.647 ' HA ' ' OD2' ' A' ' 216' ' ' ASP . 82.7 mt -108.63 127.85 54.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.964 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.53 163.85 25.06 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.65 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -54.41 -26.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 C-N-CA 123.502 0.721 . . . . 0.0 112.123 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.08 -23.64 64.04 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.647 ' OD2' ' HA ' ' A' ' 212' ' ' LEU . 34.7 m-20 -66.73 166.01 13.92 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.135 0.574 . . . . 0.0 112.077 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.539 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -134.0 169.56 16.94 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.498 ' HB ' HG23 ' A' ' 195' ' ' ILE . 87.7 t -89.47 136.45 23.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.279 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 250' ' ' LYS . 31.2 mt -96.68 -58.76 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.566 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.8 mt-10 -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.895 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.462 HG21 HG13 ' A' ' 234' ' ' VAL . 75.5 t -114.7 110.26 31.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.36 -77.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.752 0.821 . . . . 0.0 110.366 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -151.88 10.39 0.67 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.506 HG21 ' SD ' ' A' ' 237' ' ' MET . 3.0 mp -107.58 133.14 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.18 158.57 27.65 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.0 m -116.37 6.91 7.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.321 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -57.59 109.07 0.64 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.769 0.668 . . . . 0.0 111.554 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.99 5.37 47.23 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.53 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 233' ' ' GLN . 35.9 mtmm -110.53 174.99 5.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 234' ' ' VAL . 31.8 m -118.69 163.42 16.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.691 -1.595 . . . . 0.0 108.866 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 232' ' ' ASP . 2.7 pp -50.53 -41.5 53.92 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 231' ' ' LEU . 29.6 t70 -61.3 -51.03 70.58 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.267 0.556 . . . . 0.0 110.482 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 237' ' ' MET . 48.1 mt-30 -58.53 -45.12 89.52 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.774 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 230' ' ' THR . 71.5 t -66.59 -49.07 78.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 45.5 p -59.63 -37.11 77.76 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.3 -44.13 97.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.066 0.46 . . . . 0.0 109.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.7 mtm -64.11 -49.62 71.5 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.546 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.507 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 24.0 ptm -67.88 -23.44 65.13 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.325 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 235' ' ' THR . 60.7 t -79.41 -30.93 14.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.499 0.666 . . . . 0.0 109.933 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.77 -15.04 57.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -132.56 27.44 4.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 37.0 t -65.95 -18.68 65.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -172.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.2 t -52.08 -64.46 0.81 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -124.74 90.76 3.3 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 3.4 tm? -91.18 126.88 36.4 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.509 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.1 mp -110.82 119.04 58.67 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.77 139.01 34.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.566 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.2 m -108.51 120.11 41.46 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.111 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.7 m -122.67 157.5 27.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 120.733 0.302 . . . . 0.0 110.915 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.531 ' HB3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -130.09 124.92 21.71 Favored Pre-proline 0 N--CA 1.432 -1.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.112 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.1 Cg_endo -65.36 134.12 37.58 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.821 2.347 . . . . 0.0 113.329 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.71 4.68 43.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 CA--C 1.504 -0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 113.386 175.443 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.63 123.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.457 2.105 . . . . 0.0 112.032 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.0 t -89.93 89.85 7.91 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.2 mt -91.1 161.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.7 t -162.05 170.79 18.62 Favored 'General case' 0 N--CA 1.38 -3.934 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.6 120.84 69.56 Favored Pre-proline 0 C--N 1.257 -3.454 0 CA-C-O 120.988 0.423 . . . . 0.0 110.367 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -72.7 131.08 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.646 2.231 . . . . 0.0 111.654 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -101.15 113.9 27.37 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.531 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 143' ' ' ARG . 13.8 t70 -84.41 157.69 21.32 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -48.93 -46.88 43.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 141' ' ' ASP . 37.9 ptt180 . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 127.204 2.202 . . . . 0.0 116.103 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.52 131.22 9.32 Favored 'Trans proline' 0 C--O 1.253 1.255 0 C-N-CA 121.629 1.552 . . . . 0.0 110.949 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -72.82 91.84 1.54 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -83.16 97.69 8.95 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.852 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -81.57 99.28 8.74 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.522 ' HB3' HD11 ' A' ' 212' ' ' LEU . 26.7 tpt180 -109.87 136.07 49.75 Favored 'General case' 0 C--N 1.257 -3.423 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.932 -165.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 4.6 ptp180 -114.44 116.79 29.44 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.904 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.97 129.88 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -109.59 133.25 53.32 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.754 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 245' ' ' LEU . 4.0 mm? -110.45 120.46 42.5 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.718 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -115.12 110.23 19.22 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -72.59 121.22 19.36 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.935 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -126.9 124.75 40.26 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.84 16.29 77.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.239 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m 63.36 26.6 15.05 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 109.796 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -111.82 95.14 5.31 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -81.91 111.73 29.15 Favored Pre-proline 0 C--N 1.268 -2.967 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.551 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -73.79 -36.54 3.57 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.316 2.011 . . . . 0.0 111.123 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 35.9 tp 63.62 -91.31 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.455 1.102 . . . . 0.0 110.35 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 79.19 19.61 71.73 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.296 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -161.33 149.17 15.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -136.96 135.79 38.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -141.08 142.13 30.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.935 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.452 HH11 HD12 ' A' ' 231' ' ' LEU . 36.7 mmt180 -138.21 158.35 44.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.05 138.31 31.7 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.327 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -129.77 152.61 19.68 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -93.08 129.92 38.88 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 117.691 0.746 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -129.67 137.26 50.53 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.7 123.96 67.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.316 0.579 . . . . 0.0 110.203 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.15 160.38 18.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.045 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -103.3 113.23 39.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.234 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.3 p -110.23 178.62 4.34 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.794 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.95 -14.35 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.321 0.581 . . . . 0.0 109.752 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.0 m -89.27 -4.99 57.95 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 109.53 -161.07 13.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -84.14 124.5 31.21 Favored 'General case' 0 N--CA 1.396 -3.139 0 CA-C-N 117.877 0.839 . . . . 0.0 110.921 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -126.63 150.57 48.85 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.721 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.89 134.77 54.6 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.427 0.632 . . . . 0.0 110.125 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 24.6 mp0 -130.03 149.56 73.52 Favored Pre-proline 0 C--N 1.265 -3.07 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.631 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 3.3 Cg_exo -84.64 121.8 2.6 Favored 'Trans proline' 0 N--CA 1.429 -2.31 0 C-N-CA 122.084 1.856 . . . . 0.0 110.369 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -114.03 131.23 9.78 Favored Glycine 0 C--N 1.275 -2.845 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 66.2 mt -96.51 118.58 43.17 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -119.67 160.03 23.31 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 123.109 0.256 . . . . 0.0 110.984 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 67.8 mt -68.47 119.36 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.7 m -91.1 -35.21 14.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.053 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -150.82 140.05 21.24 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.486 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 47.4 tp -128.2 134.7 49.07 Favored 'General case' 0 N--CA 1.383 -3.824 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.896 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.36 128.26 25.74 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 51.3 Cg_exo -58.66 128.5 28.42 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.538 2.159 . . . . 0.0 109.783 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.49 -10.87 61.35 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 155.11 34.61 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -27.99 69.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.486 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -73.94 -33.9 64.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.732 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.6 tm-20 -76.53 -37.59 56.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.2 t -54.08 -31.79 52.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.951 1.3 . . . . 0.0 112.137 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 79.4 p -59.55 -41.6 90.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.845 0.355 . . . . 0.0 111.434 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.24 -25.56 4.84 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.394 -0.367 . . . . 0.0 113.293 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.3 -18.56 26.72 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.338 0.59 . . . . 0.0 110.184 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 159' ' ' ARG . 35.7 mt -113.28 145.6 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.758 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.71 163.23 26.6 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.376 1.07 . . . . 0.0 110.627 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.593 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 47.0 t -48.28 -35.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.316 1.046 . . . . 0.0 113.627 -176.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -65.67 -25.12 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.55 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.2 m-20 -62.42 159.63 15.09 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -114.74 165.3 12.96 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 195' ' ' ILE . 93.4 t -95.19 142.52 13.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 124.694 1.197 . . . . 0.0 110.805 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 250' ' ' LYS . 35.8 mt -109.71 -59.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.049 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.612 ' H ' ' HB ' ' A' ' 248' ' ' THR . 50.1 mt-10 -135.98 159.11 42.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.564 -173.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.1 t -122.42 118.83 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.974 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.5 t-20 70.28 -62.85 0.42 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.467 1.107 . . . . 0.0 110.739 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 178.77 24.64 0.04 OUTLIER Glycine 0 C--N 1.281 -2.487 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.33 133.27 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.71 141.87 48.2 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.914 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -117.66 20.17 6.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.718 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.67 129.88 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.692 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.06 1.91 59.48 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 233' ' ' GLN . 28.7 mmmt -99.08 153.67 18.7 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.331 0.652 . . . . 0.0 109.933 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 234' ' ' VAL . 17.2 m -101.91 161.35 13.73 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 230' ' ' THR . 1.7 pt? -49.43 -46.28 47.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.19 -38.86 78.88 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.823 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.564 ' HB3' ' HE3' ' A' ' 229' ' ' LYS . 47.5 mt-30 -58.12 -44.88 87.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.086 175.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 230' ' ' THR . 61.7 t -66.66 -43.89 90.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 O-C-N 123.494 0.496 . . . . 0.0 111.122 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.4 p -70.35 -34.67 72.91 Favored 'General case' 0 C--O 1.206 -1.218 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.42 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.1 -41.2 99.33 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.019 0.914 . . . . 0.0 109.485 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.504 ' HB3' ' O ' ' A' ' 234' ' ' VAL . 8.5 tpt -56.78 -48.66 77.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.96 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.459 ' HB2' ' CD2' ' A' ' 245' ' ' LEU . 22.2 ptm -76.11 -17.97 59.37 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.913 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 235' ' ' THR . 70.0 t -88.7 -25.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.42 0.629 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.83 -20.78 16.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.628 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -121.13 -69.43 0.84 Allowed 'General case' 0 N--CA 1.389 -3.516 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.767 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 32.2 t 61.04 -39.76 0.11 Allowed 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.7 m -58.36 -39.77 80.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.811 0.844 . . . . 0.0 110.276 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -129.24 90.37 3.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 238' ' ' MET . 3.2 tm? -99.88 124.35 45.1 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.315 0.579 . . . . 0.0 110.088 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 60.7 mt -127.24 123.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.8 tp -109.42 122.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.727 0.775 . . . . 0.0 108.97 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.612 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.6 m -106.29 127.23 53.09 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.641 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 212' ' ' LEU . 18.5 m -129.29 162.91 35.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.267 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.469 ' HB2' HD11 ' A' ' 219' ' ' ILE . 26.4 ttmt -130.45 136.58 29.19 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 124.759 1.224 . . . . 0.0 108.307 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 27.6 Cg_exo -65.03 127.4 18.39 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.494 1.463 . . . . 0.0 110.569 173.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -85.34 -27.55 25.8 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.223 0.535 . . . . 0.0 109.83 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 . . . . . 0 C--N 1.301 -1.514 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.836 178.093 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.425 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.1 -39.74 88.67 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.74 2.293 . . . . 0.0 109.862 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.4 p -147.0 112.97 5.77 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.96 119.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.537 1.16 . . . . 0.0 113.044 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 96.28 3.97 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.576 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.439 HD12 ' HD2' ' A' ' 139' ' ' PRO . 8.6 tp -95.31 133.69 25.61 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.197 -175.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 138' ' ' ILE . 33.6 Cg_exo -63.06 126.88 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.933 1.755 . . . . 0.0 110.293 176.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -82.88 164.15 20.68 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.857 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.89 121.73 25.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.437 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -152.8 -55.53 0.12 Allowed 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.651 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 . . . . . 0 N--CA 1.426 -1.653 0 CA-C-O 122.509 1.147 . . . . 0.0 109.595 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.433 -1.281 0 CA-C-O 121.311 0.577 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.2 150.83 23.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.586 2.191 . . . . 0.0 111.453 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB3' ' CE1' ' A' ' 158' ' ' HIS . 41.4 mt-10 -75.34 84.37 2.48 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 120.967 0.413 . . . . 0.0 112.092 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -91.88 100.5 13.17 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 78.5 m80 -75.26 112.48 11.59 Favored 'General case' 0 CA--C 1.47 -2.108 0 CA-C-O 121.782 0.801 . . . . 0.0 109.292 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.466 ' HG3' HG21 ' A' ' 209' ' ' THR . 1.7 tmt_? -110.53 135.16 51.62 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.106 -1.407 . . . . 0.0 107.578 -170.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 85.2 mtm180 -114.3 140.95 48.2 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.037 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.87 132.11 57.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 163' ' ' LEU . 6.6 mpt_? -105.9 138.72 41.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.072 0.463 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 8.2 mp -126.77 124.69 40.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.89 0.876 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.48 107.74 18.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 122.064 0.935 . . . . 0.0 113.022 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.469 ' HD2' ' OG ' ' A' ' 242' ' ' SER . 88.5 tttt -78.23 142.87 37.59 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.288 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -106.24 26.44 9.8 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.323 0.582 . . . . 0.0 110.414 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 165' ' ' LYS . . . 96.95 -11.54 65.98 Favored Glycine 0 CA--C 1.498 -0.974 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -164.08 146.68 9.28 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 125.624 1.57 . . . . 0.0 106.868 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.256 6.8 m-20 49.69 96.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 175.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -84.25 127.06 67.91 Favored Pre-proline 0 C--N 1.299 -1.616 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.065 174.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.408 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 26.1 Cg_endo -62.06 102.83 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.835 2.357 . . . . 0.0 112.614 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.61 144.25 28.91 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.824 0.821 . . . . 0.0 112.459 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.6 38.19 1.53 Allowed Glycine 0 C--N 1.286 -2.238 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.406 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -158.58 151.89 22.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.424 ' HB2' ' HB2' ' A' ' 199' ' ' ARG . 97.7 m-85 -137.0 135.14 37.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.9 pt -137.49 148.64 25.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.517 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.47 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 13.2 ptm180 -142.56 158.5 43.61 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.22 145.47 30.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 0.0 109.727 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.85 -172.5 13.48 Favored Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 191' ' ' LYS . 6.5 m -126.54 142.93 51.37 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 117.836 0.818 . . . . 0.0 109.003 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.0 m -114.9 131.32 56.91 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.7 122.46 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -121.85 155.16 35.97 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.279 0.561 . . . . 0.0 110.504 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 120.47 54.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.639 -174.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.3 p -115.73 177.66 4.59 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.05 -2.9 49.99 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.707 0.765 . . . . 0.0 109.317 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.4 m -97.34 -4.37 38.67 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.82 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.73 -156.25 15.74 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.49 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 189' ' ' LEU . 2.0 mm? -88.96 135.32 33.61 Favored 'General case' 0 N--CA 1.403 -2.819 0 C-N-CA 122.747 0.419 . . . . 0.0 109.979 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.28 150.13 46.37 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.832 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.476 ' HB3' ' CG2' ' A' ' 180' ' ' THR . 50.9 mtmt -108.14 142.76 37.86 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.998 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 13.9 pt20 -134.76 141.98 40.7 Favored Pre-proline 0 N--CA 1.413 -2.319 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.666 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.8 Cg_exo -74.46 129.05 12.45 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 110.895 177.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.32 137.41 8.55 Favored Glycine 0 C--N 1.287 -2.172 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.421 HD12 ' HB ' ' A' ' 226' ' ' VAL . 57.3 mt -97.41 125.32 50.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 89.8 m-85 -118.63 167.01 12.04 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.945 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.53 136.51 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 30.5 p -117.05 -44.07 2.82 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.978 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.424 ' HB2' ' HB2' ' A' ' 175' ' ' TYR . 98.8 mtt180 -137.63 145.17 42.41 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 206' ' ' ALA . 4.8 mt -127.74 137.69 52.52 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.829 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.67 130.1 27.39 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -59.94 126.77 21.24 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.763 1.642 . . . . 0.0 110.079 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 90.74 -7.66 80.95 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.779 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.2 160.94 52.46 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.6 mm? -56.66 -45.09 81.85 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.775 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -70.71 -28.94 65.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.325 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.56 ' HB2' HD22 ' A' ' 200' ' ' LEU . 8.7 tp10 -76.37 -42.46 44.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.516 0.675 . . . . 0.0 109.209 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 39.7 t -60.56 -33.3 72.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.812 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.474 HG22 ' HG ' ' A' ' 211' ' ' LEU . 29.1 m -62.61 -41.5 99.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.112 0.482 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.86 -45.85 3.58 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 121.171 -0.538 . . . . 0.0 114.372 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.482 HD12 HD22 ' A' ' 212' ' ' LEU . 4.3 pp -74.39 -4.25 35.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 211' ' ' LEU . 2.7 mm? -109.68 143.97 38.7 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -128.87 163.06 26.07 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 124.311 1.044 . . . . 0.0 109.204 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.71 -21.3 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 123.82 0.848 . . . . 0.0 112.99 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -71.87 -29.24 64.16 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.059 0.544 . . . . 0.0 111.559 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.689 ' HB3' ' O ' ' A' ' 250' ' ' LYS . 74.5 m-20 -68.03 163.09 23.1 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -169.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 0.5 OUTLIER -116.37 167.06 11.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.243 -0.983 . . . . 0.0 113.231 -173.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 61.0 t -98.88 142.12 15.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.465 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.17 -46.98 6.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.949 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.449 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.6 mt-10 -136.15 154.3 51.01 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 121.57 0.7 . . . . 0.0 112.085 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 238' ' ' MET . 59.5 t -118.52 101.79 12.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 113.534 -1.666 . . . . 0.0 106.509 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.589 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 61.0 t30 71.23 -68.36 0.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.56 1.544 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.05 8.25 0.32 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.418 HG21 ' SD ' ' A' ' 237' ' ' MET . 29.2 mt -107.27 118.2 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 46.9 mt-10 -74.04 142.16 45.72 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.72 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.421 ' HB ' HD12 ' A' ' 195' ' ' ILE . 29.0 m -95.08 18.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.49 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.08 109.46 2.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.08 0.466 . . . . 0.0 110.325 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.59 61.95 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.637 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -84.42 169.16 14.85 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 85.3 m -121.29 158.73 27.51 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.37 -1.741 . . . . 0.0 106.696 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 234' ' ' VAL . 57.8 tp -67.1 -46.82 73.07 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.984 0.811 . . . . 0.0 111.894 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.06 -37.96 75.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.13 0.49 . . . . 0.0 111.251 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.5 mp0 -74.42 -44.52 51.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 231' ' ' LEU . 8.9 p -66.25 -38.47 81.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.689 0.28 . . . . 0.0 110.833 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.539 ' HA ' ' SD ' ' A' ' 238' ' ' MET . 10.8 t -66.12 -32.13 73.4 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.91 -43.5 83.19 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 22.7 mtm -62.4 -43.78 98.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.193 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptm -75.58 -13.89 60.37 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.828 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 242' ' ' SER . 66.0 t -87.78 -37.25 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 109.829 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.88 69.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.492 0.663 . . . . 0.0 110.281 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -108.66 21.25 17.51 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.423 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 36.9 t -67.05 -24.5 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 31.7 m -52.12 -51.63 56.63 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.559 0.537 . . . . 0.0 110.59 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -128.75 87.98 2.66 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.3 tm? -93.43 131.36 38.7 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.969 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 71.1 mt -127.43 139.48 51.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 9.3 tt -129.62 134.53 63.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.144 174.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 39.4 m -102.31 120.63 40.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.213 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.35 155.25 15.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 36.2 tttm -138.34 140.29 27.88 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.422 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 36.6 Cg_endo -68.75 127.46 15.44 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 121.626 1.55 . . . . 0.0 110.157 172.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -4.67 58.65 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 122.596 0.358 . . . . 0.0 111.454 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.072 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 120.471 0.177 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.79 111.92 2.94 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.161 1.907 . . . . 0.0 108.962 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.8 p -101.9 103.27 13.94 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.54 0.686 . . . . 0.0 112.566 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 62.2 mt 68.15 147.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.822 1.649 . . . . 0.0 112.23 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -156.33 91.37 1.25 Allowed 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.5 tt -120.68 103.98 42.9 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-O 121.539 0.685 . . . . 0.0 112.599 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -84.47 137.84 7.11 Favored 'Trans proline' 0 N--CA 1.429 -2.283 0 C-N-CA 121.667 1.578 . . . . 0.0 109.711 174.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -82.48 114.39 20.87 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.88 124.4 34.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -170.87 96.46 0.21 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 . . . . . 0 C--N 1.275 -2.665 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.517 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.15 150.25 29.15 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.114 1.876 . . . . 0.0 110.04 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.51 69.07 6.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.327 0.584 . . . . 0.0 112.506 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.2 t -91.33 128.39 37.14 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.441 ' CE1' ' HG2' ' A' ' 250' ' ' LYS . 30.3 m170 -99.74 128.27 45.85 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.23 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -96.76 120.81 37.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.914 -169.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -106.33 107.84 19.05 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.23 132.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -108.88 149.08 29.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.92 130.37 43.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.401 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.85 111.61 18.18 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 121.591 0.71 . . . . 0.0 111.203 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -68.25 146.72 53.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.619 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -121.41 76.85 1.28 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.46 -2.67 84.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.522 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.4 t 58.63 72.77 0.51 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.56 1.144 . . . . 0.0 110.3 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -103.92 -49.77 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.97 150.24 47.25 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.562 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 -162.93 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 110.992 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.442 HD23 ' CZ ' ' A' ' 174' ' ' PHE . 4.9 mp -92.94 144.32 25.38 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -89.9 25.47 11.73 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.61 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.442 ' CZ ' HD23 ' A' ' 172' ' ' LEU . 41.9 p90 -158.7 147.32 18.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -132.31 142.83 49.5 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.468 HG21 HG11 ' A' ' 218' ' ' VAL . 29.2 pt -133.16 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.327 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.561 ' HG2' ' N ' ' A' ' 178' ' ' ASP . 78.1 ttt180 -141.23 159.87 41.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.561 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 7.7 p-10 -72.99 157.71 36.88 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.878 0.847 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.32 149.91 18.01 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -93.86 140.76 29.29 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -131.23 134.22 46.23 Favored 'General case' 0 C--N 1.261 -3.279 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.84 123.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.95 107.69 21.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.3 p -115.18 177.72 4.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.14 59.92 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.448 0.642 . . . . 0.0 109.416 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.1 m -89.51 -4.42 57.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.528 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.64 -154.48 16.86 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 189' ' ' LEU . 2.1 pt? -84.35 118.35 24.17 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-O 122.001 0.905 . . . . 0.0 109.962 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -120.89 144.88 48.18 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.059 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -101.42 143.87 30.91 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -133.08 144.2 51.68 Favored Pre-proline 0 C--N 1.281 -2.412 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.266 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.12 128.62 5.03 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 C-N-CA 122.519 2.146 . . . . 0.0 109.298 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 178' ' ' ASP . . . -140.31 163.06 26.45 Favored Glycine 0 C--N 1.277 -2.725 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.797 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 218' ' ' VAL . 63.0 mt -116.89 119.64 62.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 56.6 m-85 -118.95 167.04 12.11 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.998 -175.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.0 122.73 18.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.514 ' C ' ' HD2' ' A' ' 199' ' ' ARG . 76.6 p -96.04 -67.36 0.85 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.867 0.365 . . . . 0.0 111.494 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.514 ' HD2' ' C ' ' A' ' 198' ' ' SER . 7.2 mpt_? -124.88 154.19 41.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.938 0.495 . . . . 0.0 110.351 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.74 139.44 52.68 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.966 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -99.25 126.86 36.37 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.87 126.44 20.43 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.108 1.872 . . . . 0.0 109.946 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.9 -6.86 54.66 Favored Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.26 151.46 34.86 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.65 -29.9 70.37 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.19 70.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.224 0.535 . . . . 0.0 110.568 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -77.34 -43.47 32.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 m -55.24 -33.61 63.27 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.613 ' OG1' ' HG ' ' A' ' 211' ' ' LEU . 5.2 t -69.61 -44.92 69.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.744 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 -12.75 4.52 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.469 -0.872 . . . . 0.0 114.39 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.613 ' HG ' ' OG1' ' A' ' 209' ' ' THR . 3.8 pp -89.67 -3.93 58.0 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 118.836 1.318 . . . . 0.0 111.494 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.494 ' HG ' HD12 ' A' ' 211' ' ' LEU . 88.5 mt -109.54 146.11 35.19 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.617 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.69 162.68 16.92 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 123.671 0.788 . . . . 0.0 110.533 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.16 -16.82 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-O 122.454 1.121 . . . . 0.0 110.425 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -75.52 -23.67 56.71 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.301 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.581 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.8 m-20 -63.75 156.43 27.17 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -171.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.501 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 31.1 mt-10 -109.51 150.84 27.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.929 -170.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.506 HG23 HG21 ' A' ' 226' ' ' VAL . 23.2 m -98.58 143.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.453 HG22 ' HG3' ' A' ' 220' ' ' GLU . 43.1 mt -109.33 -56.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.586 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.4 mt-10 -130.27 149.86 51.77 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.633 -172.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 238' ' ' MET . 67.5 t -116.02 112.48 39.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 67.73 -70.14 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.26 1.024 . . . . 0.0 110.014 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.84 11.09 0.1 OUTLIER Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.53 135.78 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.25 159.18 29.83 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.287 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.506 HG21 HG23 ' A' ' 218' ' ' VAL . 20.6 m -102.95 3.63 10.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.867 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -55.21 108.9 0.46 Allowed 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.993 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.49 90.53 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.465 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -87.17 160.12 18.62 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.8 m -81.55 158.28 24.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.537 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 178' ' ' ASP . 4.1 mp -70.55 -41.39 72.53 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 118.425 0.557 . . . . 0.0 109.98 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.73 -39.26 73.62 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.378 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 237' ' ' MET . 21.1 tp60 -67.74 -47.16 70.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.294 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.407 ' HA ' ' HE2' ' A' ' 237' ' ' MET . 97.2 t -67.29 -45.42 86.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.048 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.485 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 8.8 t -64.59 -29.11 70.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.14 -48.91 77.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.292 0.567 . . . . 0.0 109.478 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 29.4 mtm -62.67 -40.18 96.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.129 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.513 ' HB3' HG11 ' A' ' 221' ' ' VAL . 15.4 ptm -76.24 -20.27 57.57 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.681 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 79.8 t -91.7 -36.8 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.352 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.42 69.94 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -109.23 23.24 14.79 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.323 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.681 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 63.7 m -64.97 -18.82 65.6 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -67.52 -39.66 85.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -129.45 79.66 1.92 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 3.3 tm? -99.41 129.59 45.61 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.535 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.06 132.28 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 6.9 tp -118.24 120.8 65.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.029 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.586 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.3 m -92.35 119.32 31.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.359 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.428 HG12 HG12 ' A' ' 218' ' ' VAL . 3.1 m -120.45 139.43 47.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.802 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 158' ' ' HIS . 0.4 OUTLIER -126.65 123.46 23.91 Favored Pre-proline 0 N--CA 1.413 -2.305 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.092 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.581 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 31.6 Cg_exo -58.25 133.72 57.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.866 2.377 . . . . 0.0 113.515 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -94.92 3.1 55.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 11.3 m120 . . . . . 0 CA--C 1.487 -1.478 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.196 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.42 -34.86 75.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.343 2.028 . . . . 0.0 110.61 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.7 t -121.06 108.02 13.32 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.72 154.36 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.1 t -91.83 83.45 5.25 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.58 112.61 32.43 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.449 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.74 133.05 45.86 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.306 2.004 . . . . 0.0 110.733 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -100.17 114.54 28.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.31 153.4 18.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.786 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -92.68 79.74 4.79 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 . . . . . 0 C--N 1.297 -1.687 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.275 177.652 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 N--CA 1.439 -1.024 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.79 151.44 83.99 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 122.769 2.313 . . . . 0.0 109.232 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.54 80.35 0.1 Allowed 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 121.936 0.874 . . . . 0.0 113.322 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.1 m -92.96 85.11 5.03 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -98.81 113.54 25.7 Favored 'General case' 0 CA--C 1.467 -2.228 0 CA-C-O 121.391 0.615 . . . . 0.0 109.845 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.488 ' HG2' HG21 ' A' ' 209' ' ' THR . 4.1 tpm_? -100.25 123.69 44.79 Favored 'General case' 0 C--N 1.271 -2.847 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.283 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HB3' ' CG2' ' A' ' 246' ' ' ILE . 67.9 mtm180 -99.92 112.33 24.6 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.92 125.75 42.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 39.6 ptt180 -102.87 142.24 34.32 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.07 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.9 tm? -116.77 123.1 46.32 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 164' ' ' LEU . 2.9 pp -111.05 100.87 9.47 Favored 'General case' 0 N--CA 1.398 -3.038 0 CA-C-O 122.499 1.142 . . . . 0.0 112.049 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 243' ' ' SER . 12.8 tmtt? -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.811 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 14.2 p80 179.8 117.9 0.05 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.326 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.75 0.41 66.63 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.115 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 t -171.88 148.56 2.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.98 -39.87 83.23 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 170' ' ' LYS . 39.5 ttmt 62.89 121.38 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.027 1.331 . . . . 0.0 113.629 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.42 22.94 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.365 2.71 . . . . 0.0 113.108 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp 66.5 -73.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.798 1.239 . . . . 0.0 112.854 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 108.89 -12.71 34.8 Favored Glycine 0 CA--C 1.497 -1.06 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -128.12 143.9 51.08 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.17 161.07 35.42 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 123.185 0.303 . . . . 0.0 110.813 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -130.62 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.41 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 14.4 ttp180 -141.66 147.95 38.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 12.2 p-10 -102.46 127.12 49.63 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.532 0.682 . . . . 0.0 111.521 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -112.23 117.32 4.35 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 23.5 p -92.72 143.19 26.54 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 117.722 0.761 . . . . 0.0 112.363 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.0 t -127.42 132.4 50.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.16 124.0 49.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -120.97 157.09 30.7 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 63.2 t -102.64 116.6 46.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.8 p -115.62 177.81 4.53 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.701 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.37 -14.57 62.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.204 0.526 . . . . 0.0 109.918 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.3 p -91.94 -0.24 57.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.056 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.83 -165.35 12.04 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.7 pt? -84.83 106.47 16.38 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.314 1.054 . . . . 0.0 110.712 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -104.31 152.44 22.23 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.266 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 39.6 ttpt -121.3 133.39 55.13 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 29.9 pt20 -116.7 143.91 32.3 Favored Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.358 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 9.8 Cg_endo -88.18 126.51 2.0 Allowed 'Trans proline' 0 N--CA 1.427 -2.428 0 C-N-CA 122.227 1.951 . . . . 0.0 112.734 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.67 86.32 0.45 Allowed Glycine 0 C--N 1.279 -2.617 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 12.1 tt -82.11 133.66 28.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 120.597 0.237 . . . . 0.0 110.438 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -142.87 177.56 8.26 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.542 0.737 . . . . 0.0 110.74 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.2 mt -71.99 134.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.41 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 68.3 p -109.84 -59.95 1.85 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.8 147.87 47.19 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.059 0.457 . . . . 0.0 111.043 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.816 HD21 ' HB3' ' A' ' 206' ' ' ALA . 11.2 mt -127.06 138.3 53.19 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.646 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.89 132.63 20.71 Favored Pre-proline 0 C--N 1.286 -2.16 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.96 126.79 23.74 Favored 'Trans proline' 0 C--O 1.251 1.125 0 C-N-CA 121.808 1.672 . . . . 0.0 110.057 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.89 60.78 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.83 149.14 51.13 Favored Glycine 0 C--O 1.214 -1.144 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.415 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.8 mm? -56.73 -35.61 68.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.816 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -73.42 -28.08 61.79 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.738 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.19 -43.33 43.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.1 m -54.7 -32.9 60.15 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.223 1.009 . . . . 0.0 112.222 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.491 HG22 ' HG ' ' A' ' 211' ' ' LEU . 25.5 m -63.94 -43.28 96.36 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.845 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.8 -56.72 3.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.433 -0.349 . . . . 0.0 113.857 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 209' ' ' THR . 4.1 pp -70.93 2.23 4.6 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.625 1.17 . . . . 0.0 113.292 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.593 HD21 ' CG2' ' A' ' 249' ' ' VAL . 25.7 tp -119.99 145.74 46.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.82 161.64 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.245 0.545 . . . . 0.0 112.062 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.63 -24.66 13.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.844 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -68.93 -24.6 64.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.348 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 70.5 m-20 -60.13 139.96 57.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.249 0.62 . . . . 0.0 111.878 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.66 145.08 26.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -170.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 195' ' ' ILE . 84.1 t -78.0 135.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.886 1.274 . . . . 0.0 110.993 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.43 HG13 ' HD2' ' A' ' 250' ' ' LYS . 44.8 mm -122.23 -43.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.134 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.571 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.5 mt-10 -136.58 151.33 49.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.484 0.659 . . . . 0.0 112.045 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.49 109.12 26.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.533 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 69.82 -66.62 0.26 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.452 1.101 . . . . 0.0 111.229 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.93 15.78 0.09 OUTLIER Glycine 0 C--N 1.294 -1.765 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.92 133.55 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 44.6 mt-10 -82.33 149.42 27.76 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.57 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.574 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 19.1 m -89.62 14.1 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.021 -177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -88.73 109.36 20.08 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.4 15.09 26.27 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.737 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 1.1 pptp? -104.85 174.36 5.91 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 26.3 m -106.06 158.64 16.66 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.654 ' O ' HG12 ' A' ' 234' ' ' VAL . 4.7 tt -60.44 -47.49 85.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.859 0.464 . . . . 0.0 110.798 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.15 -36.42 74.74 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.281 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.71 -37.86 80.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 231' ' ' LEU . 7.5 p -58.18 -44.67 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.409 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.7 p -70.54 -35.47 73.15 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.341 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.35 -43.36 81.69 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.815 0.817 . . . . 0.0 110.327 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 76.1 mtp -61.92 -44.59 96.46 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.701 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.409 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 25.7 ptm -70.54 -24.4 62.8 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 235' ' ' THR . 96.8 t -83.24 -32.26 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 0.0 109.798 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.64 68.75 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.618 0.723 . . . . 0.0 109.844 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -107.98 22.24 16.24 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 68.4 m -54.45 -31.46 55.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 34.2 t -50.83 -58.16 6.65 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.736 0.303 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -130.58 89.61 2.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.4 tm? -101.14 130.88 47.29 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' ' 160' ' ' ARG . 68.1 mt -118.32 123.81 72.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.85 118.79 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 122.098 0.951 . . . . 0.0 109.565 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.571 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 19.8 m -95.82 120.15 35.58 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.942 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.593 ' CG2' HD21 ' A' ' 212' ' ' LEU . 29.8 m -129.34 149.53 33.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.43 ' HD2' HG13 ' A' ' 219' ' ' ILE . 97.2 mttt -127.03 128.49 24.16 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.683 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.9 Cg_exo -39.23 126.9 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.07 3.18 . . . . 0.0 115.009 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.25 8.49 32.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.535 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.415 176.708 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.801 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.86 110.56 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.237 1.958 . . . . 0.0 110.189 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 m -80.15 99.06 7.58 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.7 tt -54.02 135.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.728 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.7 p -129.25 88.93 2.77 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.039 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.95 138.77 19.65 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.766 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.12 123.13 11.26 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.373 2.049 . . . . 0.0 111.021 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -90.29 152.64 20.95 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.828 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.33 121.96 33.53 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -113.12 -52.35 2.78 Favored 'General case' 0 C--N 1.261 -3.274 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 . . . . . 0 C--O 1.238 0.464 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.839 177.169 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.232 0.134 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -81.32 148.71 16.68 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.202 1.935 . . . . 0.0 109.259 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -74.81 85.71 2.2 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.547 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.7 p -81.73 114.94 20.73 Favored 'General case' 0 N--CA 1.408 -2.566 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.399 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.74 99.7 12.28 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.477 ' HG3' HG13 ' A' ' 161' ' ' VAL . 32.9 tpt180 -103.24 125.72 50.05 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.054 -170.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.498 ' HG2' ' OG1' ' A' ' 248' ' ' THR . 88.2 mtt180 -103.3 105.0 15.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.698 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.477 HG13 ' HG3' ' A' ' 159' ' ' ARG . 23.0 m -104.69 132.53 51.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 120.96 0.409 . . . . 0.0 110.94 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -103.06 142.76 33.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.457 HD13 ' H ' ' A' ' 173' ' ' GLY . 72.1 mt -133.39 145.42 50.31 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.828 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 164' ' ' LEU . 1.0 OUTLIER -120.4 120.43 35.94 Favored 'General case' 0 N--CA 1.404 -2.744 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.578 172.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.548 ' HG2' ' HB3' ' A' ' 242' ' ' SER . 0.0 OUTLIER -65.98 143.48 57.35 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.538 -178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 169' ' ' ASP . 37.5 m80 -110.86 -37.34 5.43 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.494 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.53 -11.69 37.71 Favored Glycine 0 N--CA 1.459 0.183 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.959 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 3.13 15.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 25.2 t70 171.68 117.19 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.413 2.285 . . . . 0.0 105.916 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.425 ' HG3' ' OD2' ' A' ' 169' ' ' ASP . 56.7 mttp 66.77 86.59 0.13 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 124.949 1.3 . . . . 0.0 112.478 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -75.84 -32.27 4.59 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.168 1.912 . . . . 0.0 107.915 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 174' ' ' PHE . 1.8 pt? -152.95 127.12 9.12 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.118 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.457 ' H ' HD13 ' A' ' 163' ' ' LEU . . . -95.65 48.11 1.87 Allowed Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.443 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 172' ' ' LEU . 54.1 p90 -169.75 156.82 6.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 67.6 m-85 -137.73 135.41 36.37 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 169.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.605 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.0 pt -132.78 144.71 35.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -136.4 136.63 39.75 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.729 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.483 ' H ' HD23 ' A' ' 231' ' ' LEU . 17.8 t70 -87.21 123.16 31.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.847 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -131.1 174.72 19.82 Favored Glycine 0 C--N 1.276 -2.789 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 141.84 32.63 Favored 'General case' 0 C--N 1.271 -2.81 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.322 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t -123.09 136.87 54.98 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.44 124.03 63.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -116.19 154.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-O 121.019 0.438 . . . . 0.0 110.254 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.37 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.7 p -115.6 177.29 4.72 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.098 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.36 -16.86 61.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.6 p -91.85 5.75 48.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.17 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 -156.26 15.66 Favored Glycine 0 C--O 1.214 -1.154 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.882 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 189' ' ' LEU . 0.5 OUTLIER -98.95 106.77 19.06 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.77 0.795 . . . . 0.0 109.373 175.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.21 152.14 23.21 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.697 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -121.09 130.92 53.97 Favored 'General case' 0 N--CA 1.402 -2.852 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -147.76 150.88 37.52 Favored Pre-proline 0 C--N 1.265 -3.09 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.977 -172.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.68 134.96 19.07 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.206 1.937 . . . . 0.0 110.273 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.04 134.65 6.87 Favored Glycine 0 C--N 1.301 -1.391 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.605 ' CG2' ' HB ' ' A' ' 176' ' ' ILE . 58.2 mt -104.61 119.82 54.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.753 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -120.65 156.97 30.58 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.665 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 68.5 mt -63.51 123.38 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.602 0.715 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -91.09 -42.46 10.47 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.865 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 68.5 ttt180 -151.65 152.98 33.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.197 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 206' ' ' ALA . 13.8 mt -128.08 138.76 52.68 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.14 130.21 26.6 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.72 137.25 59.5 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.55 2.22 58.8 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.79 153.09 34.18 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.64 -26.39 61.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.644 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -67.19 -26.87 66.84 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 122.077 0.941 . . . . 0.0 109.224 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.62 -41.36 46.22 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.031 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.1 t -64.78 -36.12 83.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.0 p -62.62 -44.29 96.67 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.95 -51.84 2.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.631 -0.259 . . . . 0.0 113.032 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 212' ' ' LEU . 51.3 mt -57.58 -39.77 77.49 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.48 1.112 . . . . 0.0 108.922 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.439 HD22 HG23 ' A' ' 249' ' ' VAL . 3.9 mp -115.37 108.67 16.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.27 116.62 16.38 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.614 -0.434 . . . . 0.0 112.054 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.665 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 70.8 t 57.23 -43.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.067 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 174.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -74.63 -23.82 58.75 Favored 'General case' 0 CA--C 1.484 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 112.465 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.26 173.44 2.54 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.656 0.741 . . . . 0.0 112.566 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -128.65 140.43 51.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.641 -170.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.12 141.4 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.371 0.605 . . . . 0.0 110.086 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.73 -52.62 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.942 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.513 ' H ' ' HB ' ' A' ' 248' ' ' THR . 36.5 mt-10 -125.49 146.51 49.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.899 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.531 HG13 ' SD ' ' A' ' 238' ' ' MET . 92.2 t -109.18 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 171.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.514 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 25.1 t-20 70.33 -73.83 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.806 0.812 . . . . 0.0 109.788 -174.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.95 12.53 0.1 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 175.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 9.0 mt -95.45 118.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.24 150.1 33.5 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.981 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.635 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 22.5 m -95.84 13.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 120.922 0.391 . . . . 0.0 112.05 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.75 114.52 18.73 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.22 15.07 28.98 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.295 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 0.5 OUTLIER -109.93 175.98 5.24 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.536 -0.391 . . . . 0.0 110.443 -177.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 32.9 m -113.77 160.77 18.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.568 ' O ' HG12 ' A' ' 234' ' ' VAL . 3.0 tm? -55.11 -46.36 75.57 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.177 0.444 . . . . 0.0 111.876 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.47 -35.5 77.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.232 0.539 . . . . 0.0 110.478 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 237' ' ' MET . 97.7 mt-30 -69.96 -39.79 75.81 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.664 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 231' ' ' LEU . 10.4 p -61.17 -42.23 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 118.498 0.59 . . . . 0.0 111.855 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 239' ' ' VAL . 6.7 t -75.27 -28.95 60.01 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.918 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.68 -39.58 88.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 73.1 mtp -56.41 -43.93 79.83 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.455 174.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.614 ' SD ' HD21 ' A' ' 245' ' ' LEU . 24.6 mmt -64.12 -29.38 70.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.062 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.548 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 87.7 t -82.7 -34.85 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.306 0.574 . . . . 0.0 110.755 -175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.55 -23.3 67.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.243 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.7 26.37 5.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.455 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.548 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 49.3 m -54.32 -28.66 43.9 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -95.28 -5.51 43.45 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.986 -0.446 . . . . 0.0 111.696 -176.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.27 35.52 4.26 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.614 HD21 ' SD ' ' A' ' 238' ' ' MET . 2.6 tm? -83.22 124.11 30.23 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.506 -167.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 56.6 mt -130.22 129.63 65.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.479 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.68 122.06 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.513 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 42.0 m -90.78 119.84 31.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.439 HG23 HD22 ' A' ' 212' ' ' LEU . 12.9 m -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-O 121.118 0.485 . . . . 0.0 111.81 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.457 ' NZ ' ' HB3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -138.04 126.8 14.51 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 123.743 0.817 . . . . 0.0 108.858 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.48 127.71 21.59 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.14 2.56 . . . . 0.0 112.974 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -105.2 19.02 21.31 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.892 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 N--CA 1.432 -1.326 0 CA-C-O 122.905 1.335 . . . . 0.0 108.838 176.779 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.52 109.42 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.228 1.952 . . . . 0.0 110.594 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -84.12 73.55 10.39 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 122.001 0.905 . . . . 0.0 109.397 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.5 tt -121.08 156.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.475 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -150.97 130.36 12.88 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 115.47 63.01 Favored Pre-proline 0 C--N 1.284 -2.242 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -85.9 128.71 3.33 Favored 'Trans proline' 0 N--CA 1.429 -2.307 0 C-N-CA 122.359 2.039 . . . . 0.0 109.273 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -79.36 114.01 17.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.91 156.22 22.49 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.607 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -63.59 141.67 58.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.746 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.529 0.68 . . . . 0.0 110.584 -176.134 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.437 -1.117 0 CA-C-O 121.026 0.441 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.24 150.3 65.08 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.438 1.425 . . . . 0.0 109.392 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.77 83.36 1.18 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.3 m -83.88 109.78 17.85 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.415 ' NE2' ' HG3' ' A' ' 250' ' ' LYS . 14.0 m-70 -72.0 123.66 23.26 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-O 121.876 0.846 . . . . 0.0 112.116 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.441 ' HD2' HD11 ' A' ' 212' ' ' LEU . 22.1 ttm-85 -113.41 140.26 48.21 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.957 -171.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.465 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 19.8 ptt180 -123.92 119.51 29.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 205' ' ' LEU . 27.1 m -110.98 133.82 55.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 122.257 -0.277 . . . . 0.0 111.685 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' HG13 ' A' ' 246' ' ' ILE . 26.5 ptt180 -99.6 135.62 40.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.764 0.792 . . . . 0.0 112.832 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.475 ' HB2' HD12 ' A' ' 245' ' ' LEU . 3.5 mm? -124.67 121.42 34.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.574 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 164' ' ' LEU 0.264 1.6 pp -107.01 105.04 14.87 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-O 122.2 1.0 . . . . 0.0 113.295 175.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -100.58 134.52 43.41 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.527 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -95.06 29.71 2.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 87.11 -11.44 65.12 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.2 p -175.69 133.53 0.28 Allowed 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 t70 178.46 -57.37 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' NZ ' ' HB3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -149.04 148.27 26.52 Favored Pre-proline 0 N--CA 1.412 -2.354 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.676 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -86.7 23.73 0.8 Allowed 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 122.466 2.111 . . . . 0.0 110.886 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 87.5 mt 75.01 123.6 0.04 OUTLIER 'General case' 0 C--N 1.347 0.469 0 C-N-CA 125.952 1.701 . . . . 0.0 111.421 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.93 44.08 3.08 Favored Glycine 0 C--O 1.241 0.589 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.991 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -172.2 144.23 1.59 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -135.77 135.42 39.91 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 121.3 0.572 . . . . 0.0 111.111 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.52 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -130.94 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.451 -175.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 177' ' ' ARG . 3.5 mmp_? -122.87 158.72 29.71 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.47 ' HA ' HG22 ' A' ' 195' ' ' ILE . 26.5 t70 -74.27 137.48 42.98 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 123.2 0.313 . . . . 0.0 111.046 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.71 163.92 37.4 Favored Glycine 0 N--CA 1.406 -3.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 m -107.07 143.7 34.81 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.4 t -92.84 125.54 37.5 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 191' ' ' LYS . 24.0 t -117.3 124.62 73.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.276 -174.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -110.34 151.61 27.22 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.29 106.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-O 122.167 0.984 . . . . 0.0 109.127 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.2 p -116.41 178.28 4.38 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.562 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.7 -15.83 62.74 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 m -88.02 -3.81 58.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.72 -160.04 14.17 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.078 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.77 109.97 18.45 Favored 'General case' 0 N--CA 1.385 -3.716 0 CA-C-O 121.931 0.872 . . . . 0.0 110.783 177.119 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -101.92 144.02 31.08 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.51 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 181' ' ' SER . 52.7 mtmt -123.29 142.35 51.03 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.439 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.62 154.87 79.83 Favored Pre-proline 0 N--CA 1.42 -1.945 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.83 131.01 17.65 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.752 1.635 . . . . 0.0 109.282 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 178.63 103.63 0.17 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 178' ' ' ASP . 27.2 pt -77.47 144.84 10.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.62 158.87 17.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.9 mt -68.89 136.54 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.6 t -136.03 -39.67 0.68 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.744 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -127.11 147.53 50.17 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.874 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 206' ' ' ALA . 30.2 mt -128.31 139.71 52.26 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.441 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.48 132.47 23.15 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 126.86 23.26 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.5 1.467 . . . . 0.0 110.12 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.92 -5.1 57.85 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.79 155.99 53.44 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.428 HD13 ' HB ' ' A' ' 161' ' ' VAL . 74.0 mt -65.94 -35.62 81.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.742 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -75.66 -26.27 57.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.674 0.75 . . . . 0.0 109.294 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB2' HD22 ' A' ' 200' ' ' LEU . 2.4 tm-20 -76.21 -56.17 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.876 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.4 m -62.85 -34.94 78.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.2 p -66.98 -43.76 82.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.689 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.76 10.64 51.14 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.409 HD23 HH22 ' A' ' 159' ' ' ARG . 29.3 tp -119.95 15.4 12.51 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 122.711 1.244 . . . . 0.0 109.252 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.441 HD11 ' HD2' ' A' ' 159' ' ' ARG . 78.7 mt -135.17 129.33 33.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.383 -1.735 . . . . 0.0 106.648 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.31 162.26 13.03 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 -174.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.8 -22.72 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-O 122.629 1.204 . . . . 0.0 108.858 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -74.59 -23.09 58.68 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.432 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 59.5 m-20 -67.65 154.96 40.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.679 0.792 . . . . 0.0 112.094 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -116.02 163.8 15.38 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.593 0.711 . . . . 0.0 112.866 -172.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 176' ' ' ILE . 72.6 t -99.82 137.94 25.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.833 174.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 250' ' ' LYS . 2.7 mp -107.66 -50.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.67 0.747 . . . . 0.0 110.235 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.54 ' H ' ' HB ' ' A' ' 248' ' ' THR . 43.1 mt-10 -141.35 159.39 42.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.401 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.2 t -106.33 97.61 5.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 44.3 t30 72.99 -73.4 0.1 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 111.261 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.05 18.4 0.73 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.84 111.95 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.85 147.53 53.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 219' ' ' ILE . 15.4 m -98.76 3.67 10.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.147 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.8 103.48 0.11 Allowed 'General case' 0 C--O 1.244 0.773 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.74 7.56 84.01 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.336 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.25 160.03 17.86 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 232' ' ' ASP . 96.8 m -74.83 156.29 36.64 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.005 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 232' ' ' ASP . 4.1 pp -71.32 -34.93 71.01 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.132 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.546 ' N ' HD12 ' A' ' 231' ' ' LEU . 21.9 t70 -70.1 -37.05 75.3 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.509 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 237' ' ' MET . 23.6 tp60 -66.12 -51.01 62.0 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.433 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.28 -48.68 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.532 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.0 p -65.43 -32.42 74.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.973 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.03 -42.95 93.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.638 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 23.6 mtm -58.32 -46.05 86.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.905 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.6 ptp -68.43 -23.19 64.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 235' ' ' THR . 89.4 t -83.56 -33.15 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.5 67.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.067 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -95.82 -63.07 1.19 Allowed 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.457 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.8 t 66.04 -41.31 0.35 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.94 1.829 . . . . 0.0 115.94 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -97.57 -39.29 9.19 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.72 -0.613 . . . . 0.0 112.398 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.18 42.03 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 163' ' ' LEU . 3.2 tm? -85.34 129.67 34.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.99 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -128.42 140.73 48.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.429 HD11 ' CG1' ' A' ' 218' ' ' VAL . 8.9 tp -122.26 138.18 53.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 118.547 0.612 . . . . 0.0 109.751 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.54 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.8 m -102.82 120.68 41.03 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.958 -174.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.74 149.25 29.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 CA-C-O 121.366 0.603 . . . . 0.0 112.411 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.599 ' HB2' HD11 ' A' ' 219' ' ' ILE . 32.1 ttmt -124.35 124.74 25.76 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.822 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.6 Cg_exo -63.81 126.48 17.47 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.162 1.241 . . . . 0.0 109.07 171.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.6 -0.01 17.41 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.656 -176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.48 1.035 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.243 179.013 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.38 144.77 91.77 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.245 1.963 . . . . 0.0 111.424 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 64.9 m -82.99 100.8 10.68 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 tt -50.71 139.1 6.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.635 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.3 t -160.48 102.93 1.38 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 61.5 mt -87.68 116.14 65.2 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.284 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 1.4 Cg_endo -82.8 123.74 3.76 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.873 2.382 . . . . 0.0 112.243 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.57 132.22 47.35 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.1 156.8 18.11 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.504 ' C ' ' HD2' ' A' ' 143' ' ' ARG . 96.9 m-85 -96.09 122.67 39.17 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.504 ' HD2' ' C ' ' A' ' 142' ' ' PHE . 3.4 mpt_? . . . . . 0 CA--C 1.485 -1.523 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.431 -1.389 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.87 151.63 31.54 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.0 2.467 . . . . 0.0 110.843 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.37 81.35 1.04 Allowed 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 t -79.85 105.26 11.01 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -79.1 99.05 6.77 Favored 'General case' 0 CA--C 1.458 -2.565 0 CA-C-O 122.482 1.134 . . . . 0.0 109.531 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.503 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -96.26 138.2 34.22 Favored 'General case' 0 N--CA 1.39 -3.451 0 CA-C-N 112.5 -2.137 . . . . 0.0 107.007 -174.018 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 77.8 mtm180 -116.57 121.53 42.01 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 121.107 0.48 . . . . 0.0 111.01 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 205' ' ' LEU . 97.0 t -89.01 116.02 29.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -112.5 122.57 48.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.6 0.714 . . . . 0.0 111.494 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.7 121.02 37.35 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.378 -1.283 . . . . 0.0 107.655 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.5 mt -113.01 111.74 22.7 Favored 'General case' 0 N--CA 1.396 -3.142 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.612 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 168' ' ' SER . 77.5 tttt -80.65 125.02 29.5 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.832 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -150.74 93.93 2.02 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.462 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.89 6.02 89.71 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.098 -0.956 . . . . 0.0 113.283 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.518 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 22.9 t -165.31 143.25 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.58 76.51 8.91 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.451 0.644 . . . . 0.0 110.708 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.21 121.47 85.19 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.18 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -57.48 135.52 70.33 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.688 2.259 . . . . 0.0 111.724 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 172' ' ' LEU . 1.6 pt? -53.39 121.2 7.16 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.207 1.003 . . . . 0.0 111.421 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -80.15 46.65 3.23 Favored Glycine 0 C--O 1.246 0.871 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.717 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -174.78 152.26 1.55 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -137.98 140.99 40.47 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.125 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.456 HG21 HG11 ' A' ' 218' ' ' VAL . 46.4 pt -135.46 136.26 50.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 123.663 0.602 . . . . 0.0 109.832 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.52 158.84 43.34 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.931 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.443 ' CB ' ' HB3' ' A' ' 231' ' ' LEU . 8.3 t70 -84.84 125.42 32.59 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.71 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -130.89 117.98 2.33 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 105.247 -3.141 . . . . 0.0 105.247 171.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.8 t -91.32 144.42 25.61 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.295 1.045 . . . . 0.0 112.711 -170.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t -105.04 129.44 53.47 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.919 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.47 125.17 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 CA-C-O 121.382 0.611 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 98.4 mtt180 -120.38 153.22 36.81 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.5 p -109.07 178.28 4.51 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.534 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.38 -16.56 63.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.9 m -89.84 -4.54 57.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.78 -168.31 12.59 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.6 pt? -83.93 106.29 15.49 Favored 'General case' 0 N--CA 1.402 -2.828 0 CA-C-O 122.127 0.965 . . . . 0.0 109.878 177.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -112.58 149.93 32.06 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.936 -173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -108.46 150.8 26.92 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.321 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -131.82 147.21 65.02 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.66 135.47 69.62 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.979 1.786 . . . . 0.0 109.986 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.66 76.72 0.39 Allowed Glycine 0 C--N 1.284 -2.33 0 C-N-CA 120.025 -1.084 . . . . 0.0 111.69 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.86 117.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.27 175.91 8.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 54.7 mt -66.05 122.43 17.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.3 p -102.02 -55.28 2.52 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -137.07 155.98 48.96 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.856 0.36 . . . . 0.0 110.268 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.759 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.4 mt -129.13 140.51 51.51 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.8 t -98.58 124.04 47.83 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.4 127.02 24.21 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.166 1.911 . . . . 0.0 109.986 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.89 21.28 12.31 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.406 -0.902 . . . . 0.0 110.943 -173.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.26 159.57 16.23 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.569 ' HB2' HG13 ' A' ' 161' ' ' VAL . 87.7 mt -70.21 -25.97 63.66 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.807 -0.82 . . . . 0.0 113.117 -176.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.759 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -67.24 -38.22 84.85 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.288 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.497 ' HB3' HD13 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -77.56 -33.95 53.89 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.945 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.2 t -68.0 -33.68 75.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.018 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.1 p -71.57 -43.95 65.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.72 -42.93 1.58 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.9 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.529 HD12 ' HG ' ' A' ' 212' ' ' LEU . 1.0 OUTLIER -65.87 -13.56 59.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.351 1.061 . . . . 0.0 113.633 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.529 ' HG ' HD12 ' A' ' 211' ' ' LEU . 96.8 mt -108.79 145.77 34.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.44 163.39 25.96 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.027 0.441 . . . . 0.0 111.804 -171.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 58.4 t -54.7 -22.03 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.619 0.768 . . . . 0.0 111.535 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -74.55 -24.08 58.89 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.576 ' HB3' ' N ' ' A' ' 252' ' ' ALA 0.655 0.4 OUTLIER -65.41 158.5 26.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 119.249 3.055 . . . . 0.0 119.249 -176.819 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.02 146.31 34.13 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.07 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 226' ' ' VAL . 31.3 m -89.75 142.58 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.922 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 220' ' ' GLU . 40.0 mm -110.78 -56.59 4.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.048 0.451 . . . . 0.0 110.297 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HG3' HG22 ' A' ' 219' ' ' ILE . 44.3 mt-10 -138.4 155.59 48.36 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.383 0.611 . . . . 0.0 112.418 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 238' ' ' MET . 90.7 t -127.54 110.68 22.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 124.657 1.183 . . . . 0.0 107.887 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 69.52 -70.6 0.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.965 1.306 . . . . 0.0 110.471 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -161.95 16.14 0.15 Allowed Glycine 0 C--N 1.299 -1.492 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 19.6 mt -112.49 131.38 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -85.35 167.99 15.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.214 0.531 . . . . 0.0 110.329 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 218' ' ' VAL . 28.8 m -104.03 9.71 9.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.378 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.0 102.58 0.08 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.047 -176.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.61 13.16 80.6 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.838 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -97.56 164.03 12.6 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 98.9 m -91.13 157.89 16.96 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 113.046 -1.888 . . . . 0.0 108.955 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 178' ' ' ASP . 1.9 pt? -63.33 -42.1 98.94 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.681 0.277 . . . . 0.0 111.313 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.37 -49.99 72.84 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.312 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.25 -46.4 89.92 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.443 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.525 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 91.2 t -67.57 -45.95 84.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.901 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.6 t -68.02 -29.91 69.03 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.68 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.98 -48.53 52.8 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.394 0.616 . . . . 0.0 109.988 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 234' ' ' VAL . 21.5 ptt? -65.0 -33.54 76.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -175.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.455 ' HB3' HG11 ' A' ' 221' ' ' VAL . 14.7 ptp -73.15 -25.21 60.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.481 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.59 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 93.6 t -85.33 -37.44 12.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.608 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.51 67.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.939 175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.03 21.98 15.32 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.656 ' HA ' ' HB2' ' A' ' 245' ' ' LEU . 73.0 m -59.25 -20.81 57.32 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 15.1 m -53.62 -50.65 65.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.685 0.794 . . . . 0.0 109.647 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -125.69 75.44 1.49 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.656 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.9 tp -103.2 104.3 14.42 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.139 0.971 . . . . 0.0 112.728 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.58 118.11 55.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.575 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 10.8 tt -111.23 133.32 57.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.512 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 21.8 m -100.15 125.02 46.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.034 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 212' ' ' LEU . 28.0 m -122.49 163.36 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 123.3 0.375 . . . . 0.0 110.475 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -133.79 123.48 17.2 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.78 135.82 71.43 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.484 2.79 . . . . 0.0 113.544 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.576 ' N ' ' HB3' ' A' ' 216' ' ' ASP . . . -116.78 20.86 13.74 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 N--CA 1.472 0.658 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.335 179.401 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.9 101.84 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.21 1.94 . . . . 0.0 111.749 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -88.93 85.05 6.65 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.42 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.487 ' O ' HD12 ' A' ' 136' ' ' ILE . 2.5 pp -86.11 136.77 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.3 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.4 m -102.98 90.9 3.91 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 10.3 tt -87.83 123.0 69.91 Favored Pre-proline 0 C--N 1.29 -1.978 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.131 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 12.4 Cg_exo -66.8 122.12 9.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.695 1.597 . . . . 0.0 110.362 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -94.19 120.34 34.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.455 -177.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.62 130.32 53.68 Favored 'General case' 0 CA--C 1.484 -1.583 0 CA-C-O 120.82 0.343 . . . . 0.0 110.718 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -153.24 86.44 1.23 Allowed 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 . . . . . 0 C--N 1.3 -1.578 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.327 -178.869 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 N--CA 1.426 -1.663 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.05 130.41 16.23 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.033 2.489 . . . . 0.0 113.955 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.78 -7.35 49.83 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.668 0.747 . . . . 0.0 109.722 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.3 t -75.3 102.22 4.98 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -91.19 143.91 26.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.858 -173.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -97.87 121.34 39.67 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.97 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -99.86 104.35 16.01 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 247' ' ' ILE . 59.6 t -89.74 117.32 32.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 120.956 0.408 . . . . 0.0 110.376 -176.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HG2' HG12 ' A' ' 246' ' ' ILE . 58.3 mtp180 -88.75 136.66 32.89 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 171' ' ' PRO . 3.4 tm? -120.38 121.3 38.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.62 99.78 9.45 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.8 145.76 46.79 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -101.78 -12.2 18.5 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.377 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.94 44.63 Favored Glycine 0 N--CA 1.46 0.233 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.085 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.7 t -149.33 128.63 12.9 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.3 t70 72.2 -42.5 0.53 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.832 1.253 . . . . 0.0 113.172 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -122.05 94.77 47.92 Favored Pre-proline 0 C--O 1.254 1.319 0 CA-C-O 120.671 0.272 . . . . 0.0 110.399 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.413 ' O ' HD11 ' A' ' 163' ' ' LEU . 4.3 Cg_exo -83.46 -69.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.063 2.509 . . . . 0.0 112.123 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 pp -157.19 157.39 34.3 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.342 0.657 . . . . 0.0 110.597 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -128.57 48.2 0.98 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.515 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 245' ' ' LEU . 54.0 p90 -160.47 147.58 15.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -138.54 146.21 41.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.52 152.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 123.441 0.463 . . . . 0.0 111.868 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 79.2 ttt180 -141.82 149.9 40.95 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.86 133.98 44.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.974 0.416 . . . . 0.0 110.595 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.36 165.99 15.92 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 2.8 p -93.11 120.4 33.36 Favored 'General case' 0 N--CA 1.391 -3.413 0 CA-C-N 117.986 0.893 . . . . 0.0 111.181 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.6 t -118.7 132.42 56.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.6 p -98.34 127.2 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.623 0.725 . . . . 0.0 109.177 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -112.85 153.43 27.9 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.68 107.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.1 p -110.18 178.15 4.48 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.19 -13.6 61.19 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.4 m -87.99 -4.6 58.79 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.588 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.55 -159.19 13.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.89 128.31 34.56 Favored 'General case' 0 N--CA 1.379 -3.977 0 CA-C-N 117.154 0.477 . . . . 0.0 110.003 175.089 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.38 153.49 48.67 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.411 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 36.9 ttpt -119.89 140.27 51.11 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-O 121.311 0.577 . . . . 0.0 109.618 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 5.5 tp-100 -139.62 144.74 40.55 Favored Pre-proline 0 C--N 1.277 -2.554 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.9 Cg_exo -73.81 119.52 5.93 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.246 1.964 . . . . 0.0 110.288 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.61 118.01 5.67 Favored Glycine 0 C--N 1.276 -2.758 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 177' ' ' ARG . 2.6 pt -96.5 117.53 41.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.598 0.713 . . . . 0.0 112.2 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 217' ' ' GLU . 59.4 m-85 -119.77 169.9 9.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.684 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.61 131.06 34.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.0 p -114.26 -56.02 2.43 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -123.55 142.01 51.45 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.2 mt -128.15 139.12 52.66 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.33 123.25 49.18 Favored Pre-proline 0 N--CA 1.416 -2.142 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -50.51 130.59 30.11 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.616 2.211 . . . . 0.0 112.215 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.62 5.14 65.12 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.34 146.06 41.84 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 114.785 -0.708 . . . . 0.0 112.779 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 205' ' ' LEU . 5.0 mp -55.4 -33.65 63.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.414 1.086 . . . . 0.0 113.14 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.628 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -66.13 -41.14 90.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.194 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.412 ' HB2' HD13 ' A' ' 200' ' ' LEU . 3.2 tm-20 -76.9 -34.97 57.68 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.9 m -54.87 -30.58 58.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.064 0.946 . . . . 0.0 112.558 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 205' ' ' LEU . 80.8 p -58.26 -43.24 87.79 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.636 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.73 21.18 72.83 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 tp -138.2 -35.42 0.62 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.154 -1.023 . . . . 0.0 110.804 -173.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.459 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.0 mm? -108.23 139.15 43.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.83 0.824 . . . . 0.0 111.179 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.38 162.28 13.15 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.393 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.83 -24.89 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-O 121.514 0.673 . . . . 0.0 110.983 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -73.28 -23.88 60.36 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.292 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.566 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 64.1 m-20 -62.45 158.73 17.04 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.448 0.699 . . . . 0.0 112.079 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.409 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 12.3 pt-20 -116.36 157.32 25.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -171.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.57 130.59 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.921 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.81 -42.96 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.179 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.478 ' H ' ' HB ' ' A' ' 248' ' ' THR . 34.2 mt-10 -137.68 152.7 49.56 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.341 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.58 96.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.467 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.533 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 67.13 1.15 2.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.164 1.386 . . . . 0.0 112.583 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 123.8 -4.29 9.21 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.68 134.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.14 147.36 31.39 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.842 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.411 ' CG2' HD11 ' A' ' 195' ' ' ILE . 25.8 m -117.19 10.64 7.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.083 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -61.48 105.82 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.067 0.46 . . . . 0.0 110.806 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.402 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.33 2.64 53.95 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.942 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 10.0 mmpt? -88.95 141.67 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.582 -0.364 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 234' ' ' VAL . 11.7 t -85.57 164.75 17.57 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 235' ' ' THR . 1.7 pt? -55.78 -41.66 74.42 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.278 0.49 . . . . 0.0 112.203 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.407 ' H ' HD23 ' A' ' 231' ' ' LEU . 25.0 t70 -59.89 -40.57 89.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.543 0.687 . . . . 0.0 110.677 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 11.9 mm-40 -69.22 -47.04 65.88 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.462 177.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 230' ' ' THR . 58.9 t -61.09 -43.74 96.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.54 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 239' ' ' VAL . 8.4 t -65.36 -40.09 93.13 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.095 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.62 -45.0 85.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.238 0.542 . . . . 0.0 110.517 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 77.3 mtp -56.43 -49.24 75.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.461 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.1 ptp -76.79 -9.76 58.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.183 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.627 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 70.4 t -83.07 -31.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.626 0.727 . . . . 0.0 109.171 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.5 -13.12 61.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.496 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -130.86 29.16 4.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.128 0.571 . . . . 0.0 110.848 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 68.1 m -61.99 -28.26 69.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -173.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.3 m -51.85 -61.92 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.169 0.509 . . . . 0.0 110.836 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -129.69 88.42 2.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 174' ' ' PHE . 3.6 pp -92.02 133.47 35.69 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 62.6 mt -114.37 119.52 61.61 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.296 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 161' ' ' VAL . 7.1 tt -109.89 118.69 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 111.134 177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 38.5 m -90.51 119.71 31.0 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.459 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 15.7 m -114.93 144.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.411 ' C ' ' HD3' ' A' ' 250' ' ' LYS . 13.1 tmtt? -125.62 125.42 25.0 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.978 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.566 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 18.7 Cg_endo -68.02 127.24 15.68 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.34 2.027 . . . . 0.0 114.097 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -106.42 -35.32 7.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 C--N 1.308 -1.222 0 CA-C-N 112.75 -2.023 . . . . 0.0 113.197 -178.731 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.98 102.82 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.848 2.365 . . . . 0.0 112.773 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 m -86.37 91.77 8.61 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.1 mm -71.59 140.51 18.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.455 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 23.0 t -94.61 96.07 9.19 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.7 tt -94.19 107.96 32.48 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.8 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 137' ' ' SER . 12.2 Cg_exo -71.24 136.35 28.94 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.139 1.893 . . . . 0.0 109.507 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -101.37 113.87 27.35 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -95.55 128.63 42.57 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.279 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -134.39 99.16 4.29 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 . . . . . 0 N--CA 1.41 -2.442 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.343 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -82.73 142.34 11.35 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.074 1.849 . . . . 0.0 109.257 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 46.8 mt-10 -63.2 96.84 0.11 Allowed 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.195 0.521 . . . . 0.0 112.025 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.8 m -88.07 93.51 9.51 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.442 ' CD2' ' HB3' ' A' ' 156' ' ' GLU . 12.8 m170 -82.22 113.26 19.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -132.86 138.12 46.93 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.106 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.625 ' HD3' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -110.94 114.49 27.85 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.408 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 205' ' ' LEU . 21.8 t -100.64 132.39 46.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG2' HG13 ' A' ' 246' ' ' ILE . 97.4 mtt180 -94.63 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.106 0.479 . . . . 0.0 112.089 -176.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.6 tm? -127.31 125.43 40.8 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 164' ' ' LEU 0.276 2.1 pp -112.36 101.68 9.86 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-O 122.442 1.115 . . . . 0.0 112.232 176.272 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -100.8 120.72 40.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.93 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -151.45 92.12 1.74 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.942 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.01 88.03 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.734 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 p -110.73 137.43 48.4 Favored 'General case' 0 N--CA 1.392 -3.34 0 C-N-CA 123.711 0.804 . . . . 0.0 109.699 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -125.18 82.75 2.09 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.938 0.875 . . . . 0.0 108.783 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -129.0 143.79 50.12 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.383 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.84 141.77 95.72 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.058 1.838 . . . . 0.0 111.226 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.75 123.56 21.25 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . -77.42 46.43 2.52 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.152 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.577 ' HE1' ' SD ' ' A' ' 238' ' ' MET . 50.7 p90 -174.7 134.04 0.37 Allowed 'General case' 0 N--CA 1.416 -2.139 0 C-N-CA 125.803 1.641 . . . . 0.0 107.711 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.4 141.33 51.08 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -126.11 140.92 47.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.873 -177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 231' ' ' LEU . 55.9 ttt180 -142.19 148.05 37.58 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.754 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 5.7 p-10 -101.85 145.37 29.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -132.26 163.94 23.9 Favored Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.7 m -104.65 131.78 51.68 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.041 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.9 m -106.13 136.02 46.57 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.518 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.2 128.93 60.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.514 0.674 . . . . 0.0 111.408 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -114.01 152.75 30.49 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.45 115.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 120.724 0.297 . . . . 0.0 110.464 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.9 p -113.08 169.86 8.63 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.42 61.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.017 0.437 . . . . 0.0 111.034 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.0 m -93.65 -3.81 51.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.546 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.78 -168.86 22.19 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.339 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 189' ' ' LEU . 2.1 pt? -85.24 130.37 34.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.427 0.632 . . . . 0.0 111.127 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -108.55 155.63 20.42 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.323 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -119.8 148.8 43.0 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -139.63 153.47 70.31 Favored Pre-proline 0 N--CA 1.411 -2.408 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.52 138.57 21.96 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.34 2.027 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.1 107.03 0.57 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 10.4 tt -105.51 118.52 53.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.649 0.738 . . . . 0.0 111.369 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 70.4 m-85 -125.81 165.56 18.44 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.458 -175.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.4 mt -70.68 127.8 33.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 172.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.5 p -102.45 -39.93 6.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -150.24 147.75 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.427 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 206' ' ' ALA . 15.4 mt -114.56 139.34 49.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.246 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.406 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 78.0 t -103.99 128.76 26.53 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.85 126.41 21.87 Favored 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.032 1.821 . . . . 0.0 110.67 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.57 13.45 58.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.43 160.24 24.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.7 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.476 ' HB3' HG11 ' A' ' 161' ' ' VAL . 85.6 mt -54.35 -46.2 72.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.573 1.149 . . . . 0.0 113.906 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.783 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -68.45 -27.18 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.858 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.76 -42.22 50.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.9 m -56.38 -31.56 63.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.2 p -61.08 -44.36 97.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.37 -47.65 1.73 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 121.474 0.486 . . . . 0.0 112.767 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.405 ' HB2' HD22 ' A' ' 212' ' ' LEU . 58.4 mt -67.53 -23.96 65.5 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.039 1.336 . . . . 0.0 111.167 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.2 mm? -108.02 146.0 33.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.174 0.511 . . . . 0.0 109.728 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -92.39 158.32 16.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.05 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 23.6 t -67.0 -27.33 39.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.603 -178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -74.98 -21.87 58.89 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.652 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 89.4 m-20 -48.75 161.03 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -169.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 41.5 mt-10 -93.41 154.28 18.03 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.302 -172.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.22 134.81 45.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.459 HG22 ' HG3' ' A' ' 220' ' ' GLU . 46.7 mm -111.0 -44.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.867 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.625 ' H ' ' HB ' ' A' ' 248' ' ' THR . 40.4 mt-10 -141.07 154.32 45.89 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.371 0.605 . . . . 0.0 111.591 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 65.9 t -128.75 108.34 17.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.588 172.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 70.56 -9.96 0.74 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.524 0.678 . . . . 0.0 111.937 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 127.98 -9.37 6.72 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.462 HG21 ' SD ' ' A' ' 237' ' ' MET . 48.5 mt -84.01 121.01 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -75.65 137.76 40.93 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.045 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.417 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 35.5 m -91.75 17.41 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.837 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.7 109.32 2.38 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.115 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.55 9.69 64.39 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.877 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 10.4 mmpt? -93.93 168.43 10.97 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 234' ' ' VAL . 9.9 t -120.02 163.46 17.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 232' ' ' ASP . 0.0 OUTLIER -50.5 -46.77 57.34 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -171.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.519 ' N ' HD22 ' A' ' 231' ' ' LEU . 23.5 t70 -74.29 -40.55 62.21 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.304 0.574 . . . . 0.0 109.828 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.569 ' O ' ' HG3' ' A' ' 237' ' ' MET . 36.1 tt0 -59.24 -43.28 92.39 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.93 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 230' ' ' THR . 97.7 t -70.25 -46.61 71.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.984 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.494 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 21.4 p -60.97 -37.8 83.71 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.155 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.45 -44.61 84.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 37.6 mtm -64.28 -47.06 80.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.402 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.577 ' SD ' ' HE1' ' A' ' 174' ' ' PHE . 20.9 ptp -67.27 -25.71 66.2 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.01 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.78 -28.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.901 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.58 75.12 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 121.664 0.745 . . . . 0.0 109.268 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.91 -62.06 1.67 Allowed 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.575 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 38.1 t 64.6 -40.97 0.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.309 1.444 . . . . 0.0 114.176 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 -46.47 51.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.27 75.39 0.98 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 238' ' ' MET . 4.3 tt -92.89 116.34 28.95 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 3.3 mp -127.16 127.92 69.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 247' ' ' ILE . 36.4 pt -109.43 118.67 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.625 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 64.7 m -92.2 120.16 32.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.432 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 20.8 m -113.89 141.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.963 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.15 129.0 14.43 Favored Pre-proline 0 N--CA 1.42 -1.936 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.652 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 12.3 Cg_endo -56.03 130.9 42.77 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.24 2.626 . . . . 0.0 114.811 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.43 -7.39 44.66 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 112.953 -1.93 . . . . 0.0 112.45 179.068 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.3 -159.91 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.05 2.5 . . . . 0.0 110.633 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.1 p -82.61 87.08 6.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.56 153.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.9 p -103.05 103.64 13.75 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.0 tt -92.83 114.73 63.41 Favored Pre-proline 0 C--N 1.275 -2.648 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.577 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.58 145.25 37.12 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.477 2.118 . . . . 0.0 111.727 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -97.73 114.45 26.45 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -90.24 154.08 20.0 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.4 t80 53.65 -145.37 0.6 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? . . . . . 0 C--N 1.278 -2.514 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 166.804 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -65.47 151.97 83.34 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 123.26 2.64 . . . . 0.0 109.509 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.547 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 13.1 pt-20 -58.7 88.07 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -93.08 116.0 28.63 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 171.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -91.56 109.51 20.81 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.495 ' HD3' ' N ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -120.74 134.87 55.26 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.499 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.8 ptt180 -113.92 123.03 48.77 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.647 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.429 HG22 ' NH1' ' A' ' 159' ' ' ARG . 47.4 t -90.03 115.69 30.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.439 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -96.11 145.15 25.73 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.975 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.8 mt -126.44 121.56 32.77 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.936 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 164' ' ' LEU . 1.7 pp -106.91 101.07 10.53 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-O 122.727 1.251 . . . . 0.0 108.689 169.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.468 ' O ' ' HD2' ' A' ' 165' ' ' LYS 0.259 0.0 OUTLIER -75.47 127.84 34.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -172.242 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -105.7 112.26 25.26 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.759 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.79 -4.2 80.41 Favored Glycine 0 C--O 1.222 -0.645 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.714 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.4 m 61.8 20.98 11.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.748 0.819 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.59 102.46 3.81 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.331 0.586 . . . . 0.0 109.605 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -160.41 131.26 3.74 Favored Pre-proline 0 C--N 1.275 -2.64 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.098 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.88 141.42 93.15 Favored 'Trans proline' 0 C--O 1.254 1.319 0 C-N-CA 122.861 2.374 . . . . 0.0 112.698 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.6 130.85 38.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.107 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . -87.03 -23.57 40.77 Favored Glycine 0 C--N 1.289 -2.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -108.27 144.85 35.2 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -134.95 147.41 49.76 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.528 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 176' ' ' ILE . 2.8 mp -125.5 149.41 30.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 75.4 ttt180 -134.06 153.14 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.66 ' HA ' HG22 ' A' ' 195' ' ' ILE . 19.6 m-20 -74.73 151.73 39.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.073 0.463 . . . . 0.0 111.302 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.36 161.32 26.6 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 p -101.98 136.44 41.81 Favored 'General case' 0 N--CA 1.394 -3.242 0 CA-C-O 121.125 0.488 . . . . 0.0 111.62 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.4 t -111.6 120.3 41.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.0 p -91.16 123.59 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.668 0.746 . . . . 0.0 111.144 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.02 158.55 24.76 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.2 t -100.23 116.57 43.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.9 p -115.17 177.54 4.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.53 -21.4 61.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.044 0.45 . . . . 0.0 109.857 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.6 p -87.17 -1.27 57.77 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.61 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.75 -168.9 13.69 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.953 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.61 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.07 106.17 15.51 Favored 'General case' 0 N--CA 1.384 -3.737 0 CA-C-O 122.899 1.333 . . . . 0.0 110.593 175.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -111.46 155.42 23.23 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.387 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 191' ' ' LYS . 7.7 mptt -116.93 127.2 53.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.48 153.58 47.69 Favored Pre-proline 0 C--N 1.263 -3.176 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.595 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 14.2 Cg_exo -68.11 113.4 3.04 Favored 'Trans proline' 0 N--CA 1.423 -2.629 0 C-N-CA 121.343 1.362 . . . . 0.0 109.013 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -132.31 92.06 0.27 Allowed Glycine 0 CA--C 1.457 -3.567 0 N-CA-C 106.889 -2.484 . . . . 0.0 106.889 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 178' ' ' ASP . 23.4 pt -77.22 135.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.34 -172.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.05 166.9 10.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.258 -173.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.3 mt -67.44 130.77 33.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 67.6 p -98.73 -36.46 9.83 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.507 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -151.01 146.02 25.93 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.557 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 52.4 tp -127.43 124.93 39.62 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.91 128.9 29.74 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 50.7 Cg_exo -57.63 126.86 23.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.16 1.907 . . . . 0.0 109.451 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.75 -9.87 60.46 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -84.87 149.87 24.66 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.82 -26.09 65.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -173.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -74.73 -32.36 62.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.009 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' N ' HD11 ' A' ' 200' ' ' LEU . 3.6 tm-20 -76.45 -38.85 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.0 m -57.88 -32.03 67.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.355 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.0 m -61.56 -43.55 98.66 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 78.52 -14.44 12.58 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.854 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 53.4 mt -85.93 -36.83 19.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.097 0.475 . . . . 0.0 111.099 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 249' ' ' VAL . 81.0 mt -115.33 146.92 41.06 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.34 163.84 17.24 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.666 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 13.7 p -45.84 -33.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -61.24 -24.26 66.24 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.612 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -69.29 165.91 19.62 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.28 142.18 45.08 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -171.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 14.1 m -95.82 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.487 HD13 ' HD2' ' A' ' 250' ' ' LYS . 25.1 pt -120.06 -41.9 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.432 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 39.6 mt-10 -133.55 151.25 51.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.581 0.705 . . . . 0.0 112.75 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.76 108.73 23.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.54 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.1 t-20 70.22 -71.1 0.13 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.165 0.986 . . . . 0.0 110.72 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.14 21.75 0.13 Allowed Glycine 0 C--N 1.298 -1.574 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 15.8 mt -116.73 121.77 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 47.7 mt-10 -76.11 151.08 37.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 118.806 0.73 . . . . 0.0 111.5 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.55 -6.39 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.995 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.45 121.33 15.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.314 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.595 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 93.12 10.3 59.82 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.101 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -111.13 173.35 6.38 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 234' ' ' VAL . 90.4 m -100.9 158.52 15.92 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.007 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.37 -46.19 86.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.441 0.296 . . . . 0.0 111.62 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.25 -41.79 89.59 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.327 0.584 . . . . 0.0 110.286 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.58 -49.34 75.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.946 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 230' ' ' THR . 85.1 t -59.88 -45.92 94.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.946 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.511 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 12.1 t -69.17 -37.13 78.02 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -42.56 90.56 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 52.4 mtp -56.5 -51.08 69.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.761 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptp -73.19 -15.03 61.46 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.356 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.561 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 98.1 t -91.4 -27.01 4.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.89 66.17 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.461 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -142.94 32.72 1.38 Allowed 'General case' 0 N--CA 1.419 -1.997 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.933 -173.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.561 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 61.7 m -54.19 -27.98 37.67 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 t -72.29 -29.62 64.04 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -126.22 56.48 1.44 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.8 122.65 29.44 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.733 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 67.0 mt -130.22 125.11 59.24 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.658 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.16 121.42 64.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.768 0.794 . . . . 0.0 110.513 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.432 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 15.3 m -94.15 128.57 40.65 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.21 -175.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 4.9 m -124.88 148.46 29.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.487 ' HD2' HD13 ' A' ' 219' ' ' ILE . 58.1 mtpt -130.28 138.24 32.62 Favored Pre-proline 0 CA--C 1.508 -0.658 0 C-N-CA 124.394 1.078 . . . . 0.0 109.366 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 26.5 Cg_endo -64.76 126.86 17.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.628 1.552 . . . . 0.0 111.423 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.4 -28.18 19.93 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 121.833 0.825 . . . . 0.0 109.721 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 44.1 m-80 . . . . . 0 C--N 1.289 -2.032 0 CA-C-N 113.113 -1.858 . . . . 0.0 112.024 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -93.48 12.51 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.887 2.392 . . . . 0.0 112.487 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m 68.36 94.89 0.07 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.927 0.891 . . . . 0.0 111.75 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.5 mt -81.48 157.12 4.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.4 m 71.58 96.02 0.07 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.582 -176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.1 tt -102.55 136.74 19.3 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.259 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 129.8 37.05 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.297 1.998 . . . . 0.0 109.953 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -98.13 161.02 13.92 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.267 0.556 . . . . 0.0 112.335 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.89 156.04 22.59 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -80.49 -29.12 37.35 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.038 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.549 ' HA ' ' HE ' ' A' ' 143' ' ' ARG . 1.7 mmp_? . . . . . 0 N--CA 1.443 -0.816 0 C-N-CA 124.008 0.923 . . . . 0.0 108.898 -177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.421 -1.894 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 130.74 41.77 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.547 2.164 . . . . 0.0 113.727 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.94 8.99 43.23 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.637 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -74.15 99.91 3.51 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -70.13 130.06 41.09 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.463 0.649 . . . . 0.0 112.423 -169.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -102.54 116.78 33.3 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.395 -167.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -100.73 135.81 41.58 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 205' ' ' LEU . 7.7 p -103.72 128.53 56.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.538 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 246' ' ' ILE . 36.8 ptt180 -108.62 126.88 53.45 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.81 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.2 mt -107.91 121.23 44.34 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.428 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.76 107.34 19.76 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.819 0.818 . . . . 0.0 111.662 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -88.27 120.47 29.66 Favored 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.919 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -152.5 102.33 2.73 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.432 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.75 63.66 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.113 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -130.26 178.23 6.73 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.67 -49.21 3.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.743 0.306 . . . . 0.0 110.689 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -166.58 100.13 0.68 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.5 44.44 1.24 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 123.481 2.787 . . . . 0.0 113.768 -175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . 0.342 0.6 OUTLIER -69.59 90.78 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -178.753 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -97.84 38.93 2.91 Favored Glycine 0 C--N 1.308 -0.986 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.98 150.49 24.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 77.9 m-85 -136.71 134.88 37.66 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.794 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.497 HD12 HD11 ' A' ' 195' ' ' ILE . 20.2 pt -133.71 142.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.626 -176.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.09 159.7 41.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.44 1.096 . . . . 0.0 108.094 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.463 ' H ' HD22 ' A' ' 231' ' ' LEU . 15.4 t70 -91.44 122.24 33.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.461 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -119.38 114.89 2.89 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 104.584 -3.407 . . . . 0.0 104.584 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 191' ' ' LYS . 1.8 m -89.0 128.23 35.7 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.614 -165.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -92.85 127.52 38.39 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.855 -172.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.02 138.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.928 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 183' ' ' ARG . 27.6 mmt180 -121.23 152.77 38.46 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.44 107.99 24.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.2 p -115.42 177.31 4.71 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.422 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.71 -6.09 54.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.276 0.56 . . . . 0.0 109.577 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.1 m -88.04 -4.49 58.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.77 -142.4 17.44 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 189' ' ' LEU . 0.4 OUTLIER -101.86 115.59 30.88 Favored 'General case' 0 N--CA 1.392 -3.372 0 CA-C-O 121.169 0.509 . . . . 0.0 109.971 176.301 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.66 152.04 30.96 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.924 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.453 ' HB3' HG22 ' A' ' 180' ' ' THR . 95.7 mttt -122.22 146.44 47.26 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.734 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -127.07 147.91 63.67 Favored Pre-proline 0 N--CA 1.417 -2.125 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.36 137.04 64.39 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.949 2.433 . . . . 0.0 111.542 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -138.85 73.7 0.41 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.337 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 176' ' ' ILE . 11.9 tt -84.21 116.39 27.91 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.746 0.784 . . . . 0.0 109.091 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.64 ' CE2' ' HG2' ' A' ' 217' ' ' GLU . 87.2 m-85 -130.18 172.1 12.15 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.908 -175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.2 136.18 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 47.1 m -126.17 -16.89 5.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.345 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 50.9 ttt180 -158.98 142.96 15.29 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.436 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.5 mt -128.4 139.31 52.44 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.94 124.59 45.06 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.88 129.47 32.22 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.689 1.593 . . . . 0.0 109.857 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.19 -9.83 57.98 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.02 153.25 46.62 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' A' ' 161' ' ' VAL . 2.6 mm? -59.15 -38.94 80.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.726 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -68.64 -33.45 74.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.035 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 200' ' ' LEU . 3.2 tm-20 -76.21 -43.5 42.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.204 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.4 m -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 m -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.92 -12.21 9.41 Favored Glycine 0 N--CA 1.465 0.58 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.935 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 36.7 mt -93.84 -15.78 24.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 71.9 mt -108.92 143.56 38.01 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.791 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.65 163.45 27.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.812 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.33 -14.44 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 121.582 0.706 . . . . 0.0 111.768 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.18 -22.35 58.09 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 58.9 m-20 -63.41 157.37 23.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -174.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.64 ' HG2' ' CE2' ' A' ' 196' ' ' PHE . 37.6 mt-10 -106.69 145.37 32.09 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.681 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.36 134.36 29.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.508 HG13 ' HD3' ' A' ' 250' ' ' LYS . 50.3 mm -116.2 -49.87 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.503 ' H ' ' HB ' ' A' ' 248' ' ' THR . 44.0 mt-10 -125.38 147.79 49.03 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.413 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.0 96.72 4.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 105.655 -1.979 . . . . 0.0 105.655 165.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.478 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 45.3 t30 68.41 -77.62 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 124.392 1.077 . . . . 0.0 111.333 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -146.0 10.27 1.59 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.562 ' HB ' ' HE2' ' A' ' 237' ' ' MET . 10.8 mt -107.14 133.05 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -81.32 149.77 28.78 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.11 2.24 8.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.519 0.676 . . . . 0.0 109.881 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.33 109.26 2.2 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.966 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 6.51 48.24 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 9.4 mmpt? -103.4 166.89 10.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 234' ' ' VAL . 16.9 m -118.59 159.77 22.99 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.463 HD22 ' H ' ' A' ' 178' ' ' ASP . 65.5 tp -50.37 -46.92 56.28 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.23 -37.15 84.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.3 0.571 . . . . 0.0 110.894 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.3 -37.82 74.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.215 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 230' ' ' THR . 96.8 t -63.09 -44.19 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 0.0 110.974 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 239' ' ' VAL . 11.7 t -67.89 -35.28 78.23 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.841 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.35 -43.15 86.86 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.948 0.88 . . . . 0.0 109.167 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.562 ' HE2' ' HB ' ' A' ' 224' ' ' ILE . 16.9 ttt -56.59 -45.82 81.18 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.372 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.467 ' HB2' HD11 ' A' ' 245' ' ' LEU . 19.1 ptp -76.28 -16.46 59.78 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.753 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 75.3 t -81.02 -33.78 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.277 0.56 . . . . 0.0 109.547 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.47 -22.48 43.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.188 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -132.91 30.24 4.03 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.243 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.753 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 67.8 m -74.1 -18.83 60.76 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 38.5 m -58.77 -48.04 82.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.37 0.605 . . . . 0.0 109.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -124.23 79.32 1.73 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.934 -2.246 . . . . 0.0 104.934 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.8 tp -86.4 118.65 25.97 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.349 -1.751 . . . . 0.0 111.06 -170.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 59.8 mt -127.03 133.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.843 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.3 tt -131.8 132.09 61.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 121.317 0.58 . . . . 0.0 111.981 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.503 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 61.8 m -102.35 125.68 49.13 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.872 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.23 139.98 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.508 ' HD3' HG13 ' A' ' 219' ' ' ILE . 57.4 mtpt -110.91 122.57 37.68 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.675 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 14.5 Cg_endo -60.27 133.12 47.63 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 122.645 2.23 . . . . 0.0 113.766 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -97.27 8.75 43.94 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 . . . . . 0 N--CA 1.425 -1.685 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.731 178.149 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.29 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.37 115.61 3.44 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 122.41 2.073 . . . . 0.0 111.079 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -75.69 94.52 3.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.271 0.558 . . . . 0.0 109.592 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.8 mt 72.51 138.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 125.662 1.585 . . . . 0.0 110.721 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t -120.98 100.7 7.22 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.902 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.2 tt -94.71 123.19 58.74 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.82 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -68.03 131.19 23.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.848 1.699 . . . . 0.0 109.048 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -76.32 150.24 36.94 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.26 155.85 23.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.95 117.54 25.75 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 . . . . . 0 N--CA 1.432 -1.352 0 CA-C-O 122.382 1.087 . . . . 0.0 110.106 -175.768 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.427 -1.621 0 CA-C-O 121.43 0.633 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.55 152.7 43.51 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.941 2.428 . . . . 0.0 109.601 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -63.93 83.29 0.03 OUTLIER 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 121.426 0.632 . . . . 0.0 109.898 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.1 m -82.82 111.09 18.41 Favored 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -82.32 110.86 17.86 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.531 ' HB3' HG13 ' A' ' 249' ' ' VAL . 77.8 ttt180 -94.3 116.78 29.22 Favored 'General case' 0 C--N 1.267 -2.992 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.89 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -125.66 109.62 12.83 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.588 -173.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 205' ' ' LEU . 27.7 m -105.29 132.32 52.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.434 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.407 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.2 mtm180 -114.89 147.96 39.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -170.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 90.5 mt -126.34 120.02 28.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.313 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.33 108.19 13.85 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.586 175.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.633 ' O ' ' HD2' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.73 121.36 21.6 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -173.99 105.66 0.12 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.133 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.42 67.11 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.685 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -157.93 164.14 37.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -106.53 85.51 2.18 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.503 ' HD3' ' HB3' ' A' ' 242' ' ' SER . 24.5 pttm 38.5 97.45 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.663 1.985 . . . . 0.0 116.272 170.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 100.73 1.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.861 1.708 . . . . 0.0 110.461 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.81 99.69 2.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.546 0.689 . . . . 0.0 111.35 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -93.59 43.99 2.44 Favored Glycine 0 C--N 1.282 -2.425 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.007 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -170.29 145.69 2.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.889 0.876 . . . . 0.0 108.729 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.1 143.94 42.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.702 0.287 . . . . 0.0 111.051 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.463 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 2.3 pp -124.71 154.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.258 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -141.26 158.78 43.43 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.006 0.522 . . . . 0.0 110.321 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.8 131.96 36.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.26 -172.38 18.14 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.429 ' CG2' ' HB2' ' A' ' 191' ' ' LYS . 3.1 m -126.43 143.19 51.27 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.332 -0.947 . . . . 0.0 108.734 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t -120.3 119.77 34.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.68 123.38 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.791 0.805 . . . . 0.0 110.652 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 16.2 ptp180 -117.37 160.06 21.76 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.351 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -99.22 108.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.135 0.969 . . . . 0.0 110.811 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.8 p -108.13 178.21 4.57 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.82 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.91 -17.32 63.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.057 0.456 . . . . 0.0 109.944 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.7 m -87.9 -4.74 58.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.367 0.603 . . . . 0.0 109.424 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.04 -158.47 14.3 Favored Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 183' ' ' ARG 0.266 1.1 pp -84.6 106.9 16.51 Favored 'General case' 0 N--CA 1.4 -2.942 0 CA-C-O 122.224 1.012 . . . . 0.0 112.642 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -109.95 155.39 21.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.052 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 180' ' ' THR . 7.3 ptpp? -106.21 139.69 40.32 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 121.516 0.674 . . . . 0.0 111.362 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.447 ' NE2' ' HD2' ' A' ' 193' ' ' PRO . 56.3 tp60 -127.95 141.63 41.78 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -177.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.447 ' HD2' ' NE2' ' A' ' 192' ' ' GLN . 16.9 Cg_exo -66.16 125.58 14.31 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.654 2.236 . . . . 0.0 109.699 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -140.6 135.32 6.94 Favored Glycine 0 C--N 1.28 -2.559 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.629 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.469 HG13 HG21 ' A' ' 234' ' ' VAL . 49.7 mm -93.04 122.21 44.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -107.84 162.23 14.19 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.01 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 249' ' ' VAL . 58.6 mt -73.16 136.67 24.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.7 t -118.38 -61.02 1.72 Allowed 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.129 -1.029 . . . . 0.0 112.172 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -123.12 155.65 36.56 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 206' ' ' ALA . 17.0 mt -126.65 138.74 53.46 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.874 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.3 t -99.6 128.45 31.36 Favored Pre-proline 0 C--N 1.283 -2.313 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.29 126.81 22.59 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 121.952 1.768 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.37 40.16 6.55 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 -172.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.31 162.39 12.61 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.902 -0.649 . . . . 0.0 112.794 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 161' ' ' VAL . 92.8 mt -70.92 -43.43 68.28 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.086 0.555 . . . . 0.0 111.494 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -72.41 -26.64 61.94 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.932 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -67.64 -45.28 75.8 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.8 t -64.49 -38.23 90.3 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.281 0.563 . . . . 0.0 110.314 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 206' ' ' ALA . 17.1 p -79.19 -6.18 55.97 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 52.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 125.412 1.482 . . . . 0.0 116.518 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.55 -19.96 15.27 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.49 ' HB3' ' OD2' ' A' ' 216' ' ' ASP . 6.7 mp -109.69 149.91 29.05 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.479 -2.146 . . . . 0.0 107.261 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.13 162.36 16.77 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.467 0.651 . . . . 0.0 111.461 -170.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.49 -15.82 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.486 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -69.78 -23.63 63.38 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.55 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.592 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.2 m-20 -61.79 159.75 13.14 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -106.23 145.32 31.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.515 -170.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 195' ' ' ILE . 35.2 m -89.55 143.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.539 HD11 ' CB ' ' A' ' 250' ' ' LYS . 2.6 mp -115.27 -51.87 4.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -174.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.511 ' H ' ' HB ' ' A' ' 248' ' ' THR . 41.9 mt-10 -135.44 153.31 51.82 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.561 0.696 . . . . 0.0 112.597 -172.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 92.6 t -117.02 98.28 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.463 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 49.1 t-20 65.82 -78.53 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.522 1.129 . . . . 0.0 110.522 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -137.0 -0.52 2.77 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.9 mt -101.79 129.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -82.08 150.85 27.31 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.254 0.479 . . . . 0.0 110.409 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.603 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 12.5 m -117.02 6.49 7.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.207 0.527 . . . . 0.0 109.627 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.7 101.89 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.896 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.68 0.52 59.12 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.535 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 226' ' ' VAL . 47.3 mtmt -89.26 166.51 13.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.724 0.762 . . . . 0.0 112.729 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.459 HG22 HD23 ' A' ' 231' ' ' LEU . 34.2 m -87.58 158.59 18.86 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 -176.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 230' ' ' THR . 1.9 pt? -59.33 -45.12 92.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.8 -45.98 88.64 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.506 0.67 . . . . 0.0 110.515 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.486 ' OE1' ' HD2' ' A' ' 229' ' ' LYS . 33.8 tt0 -64.6 -39.0 92.93 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.97 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.546 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 94.4 t -73.95 -36.41 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 239' ' ' VAL . 9.1 t -74.46 -35.16 63.3 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.761 -1.175 . . . . 0.0 110.483 177.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.62 -48.38 77.57 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.429 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.582 ' SD ' HG12 ' A' ' 226' ' ' VAL . 26.2 ptm -62.06 -39.16 91.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.229 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.432 ' HB2' HD21 ' A' ' 245' ' ' LEU . 20.7 ptp -72.29 -21.09 61.41 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.15 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.658 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 91.8 t -85.91 -32.5 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.01 66.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.899 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.88 21.69 13.62 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.722 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.6 m -60.91 -18.71 58.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.494 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 21.9 p -56.74 -48.79 76.99 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.0 0.428 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -129.93 90.37 2.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.1 tm? -99.7 122.76 43.17 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.29 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.2 mt -129.92 119.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.45 HD11 ' HB ' ' A' ' 218' ' ' VAL . 7.5 tp -109.78 129.63 64.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.131 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.511 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 15.2 m -103.56 131.52 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.35 -174.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 159' ' ' ARG 0.28 0.4 OUTLIER -134.44 139.3 48.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 123.308 0.643 . . . . 0.0 112.457 176.92 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.539 ' CB ' HD11 ' A' ' 219' ' ' ILE . 87.3 tttt -124.01 138.87 31.39 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.589 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.592 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 16.8 Cg_endo -56.0 126.8 23.6 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.708 2.272 . . . . 0.0 112.896 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.66 -30.73 16.96 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 C--N 1.301 -1.528 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.766 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.7 105.23 1.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.258 1.972 . . . . 0.0 108.956 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.6 t -86.77 95.5 9.85 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 121.714 0.769 . . . . 0.0 111.52 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.4 148.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.6 t -160.65 123.95 3.4 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.0 tt -91.98 125.69 56.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-O 120.653 0.264 . . . . 0.0 110.776 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.12 122.83 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.878 1.719 . . . . 0.0 110.135 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -89.13 120.76 30.81 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -83.76 156.76 22.39 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -59.63 -57.22 13.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 . . . . . 0 C--O 1.242 0.705 0 O-C-N 123.782 0.676 . . . . 0.0 110.346 -176.759 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 152.4 74.55 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.151 2.567 . . . . 0.0 110.779 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.491 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 3.4 mp0 -56.33 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.568 0.747 . . . . 0.0 111.359 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.493 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.5 m -98.0 147.82 24.11 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -126.61 113.54 16.87 Favored 'General case' 0 CA--C 1.474 -1.966 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.474 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 0.5 OUTLIER -98.76 114.97 27.74 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -177.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -97.44 100.99 12.43 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.474 ' HA ' ' NH1' ' A' ' 159' ' ' ARG . 7.3 p -89.38 110.44 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 121.731 0.777 . . . . 0.0 108.911 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.518 ' HB3' HG12 ' A' ' 246' ' ' ILE . 30.9 ptt180 -118.68 142.14 47.94 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.771 -173.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 245' ' ' LEU . 4.8 tt -129.94 141.85 50.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 166' ' ' HIS 0.26 0.7 OUTLIER -112.34 101.19 9.41 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 179.096 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.59 120.87 25.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.536 ' CE1' ' HB2' ' A' ' 164' ' ' LEU . 39.6 m80 -153.21 25.74 0.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 123.364 0.666 . . . . 0.0 109.625 -177.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.58 -11.46 57.99 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.4 t -100.66 101.05 11.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.8 80.91 1.36 Allowed 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.889 0.852 . . . . 0.0 111.894 -170.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.28 151.76 41.84 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.273 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.48 167.3 27.4 Favored 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 122.877 2.384 . . . . 0.0 113.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -102.33 143.06 32.57 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.163 177.393 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -114.45 56.37 0.5 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.573 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.32 145.39 23.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.35 145.62 43.56 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.166 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.97 152.32 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 40.2 ttm180 -141.13 153.25 45.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -96.83 144.12 27.09 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.792 0.683 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.09 27.75 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 p -94.74 121.95 36.85 Favored 'General case' 0 N--CA 1.385 -3.72 0 CA-C-N 117.158 0.479 . . . . 0.0 110.375 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 t -110.67 119.38 38.95 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.03 123.36 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -107.33 155.16 20.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.79 110.26 31.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.182 0.515 . . . . 0.0 109.955 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 39.7 p -111.22 178.72 4.25 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.49 -3.25 32.92 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.288 0.566 . . . . 0.0 109.794 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.8 m -98.62 -4.43 33.95 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.89 -152.83 17.97 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -92.32 134.41 34.93 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-N 117.164 0.482 . . . . 0.0 109.746 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -132.59 148.99 52.38 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -107.4 127.73 53.85 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.982 0.896 . . . . 0.0 111.03 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -124.34 160.06 54.51 Favored Pre-proline 0 C--N 1.259 -3.36 0 CA-C-N 113.595 -1.639 . . . . 0.0 108.618 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.02 122.66 6.84 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.158 1.906 . . . . 0.0 108.569 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.61 111.43 3.03 Favored Glycine 0 C--N 1.271 -3.033 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.331 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -98.97 116.68 42.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 14.1 p90 -131.59 172.3 12.4 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.386 -175.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mt -67.6 123.48 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 79.2 p -87.08 -41.98 13.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -162.22 156.02 21.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.996 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 48.7 tp -122.91 138.53 54.64 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.536 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.07 133.69 20.51 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.3 Cg_endo -64.53 130.21 25.96 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.256 1.971 . . . . 0.0 110.511 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.79 2.64 81.28 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -175.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.23 30.21 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.6 mt -55.37 -38.58 69.02 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -76.45 -30.38 57.32 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.8 tm-20 -75.93 -34.03 59.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.0 m -55.53 -32.21 62.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.911 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 m -77.21 -44.89 28.39 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.501 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.97 21.65 63.81 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 114.006 0.362 . . . . 0.0 114.006 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt -107.48 -39.19 5.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.359 0.599 . . . . 0.0 111.001 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.56 HD22 HG23 ' A' ' 249' ' ' VAL . 6.8 mp -109.13 146.55 33.89 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.665 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.08 162.69 17.04 Favored 'General case' 0 C--O 1.198 -1.643 0 O-C-N 123.612 0.57 . . . . 0.0 112.086 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -50.16 -25.94 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -72.06 -25.26 61.71 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.617 -0.677 . . . . 0.0 111.722 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 250' ' ' LYS 0.457 0.8 OUTLIER -73.76 170.79 14.57 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.232 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.1 pt-20 -135.26 165.56 25.15 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -164.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 248' ' ' THR . 58.0 t -80.02 132.85 30.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.22 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.538 HG22 ' HG3' ' A' ' 220' ' ' GLU . 43.5 mm -112.72 -60.6 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.733 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.688 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.7 mt-10 -125.92 153.48 44.17 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.852 0.834 . . . . 0.0 111.947 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 234' ' ' VAL . 92.1 t -119.45 103.36 14.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.977 174.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.563 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.4 t-20 68.2 -69.34 0.15 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.847 0.859 . . . . 0.0 111.04 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.31 7.62 0.45 Allowed Glycine 0 C--N 1.308 -1.012 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.2 mt -104.43 120.81 55.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 43.3 mt-10 -76.3 158.4 31.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.01 7.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.744 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.33 108.07 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.43 . . . . 0.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.75 2.66 46.38 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.105 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.473 ' HE3' ' SD ' ' A' ' 237' ' ' MET . 34.8 mtmm -107.46 158.98 16.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 234' ' ' VAL . 55.1 m -85.26 158.47 20.31 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.224 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 232' ' ' ASP 0.254 1.2 pp -68.74 -31.99 71.45 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.536 ' N ' HD12 ' A' ' 231' ' ' LEU . 10.8 m-20 -64.21 -34.84 79.02 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.286 0.565 . . . . 0.0 110.052 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.584 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.0 tp-100 -69.51 -47.77 62.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 230' ' ' THR . 82.2 t -57.47 -49.47 80.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.931 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 239' ' ' VAL . 40.1 p -67.05 -36.59 82.4 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.199 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.08 -42.53 98.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.022 0.439 . . . . 0.0 109.99 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.3 mtm -59.63 -48.63 80.92 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.868 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 235' ' ' THR . 4.6 ppp? -71.26 -16.92 62.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.651 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 235' ' ' THR . 98.3 t -84.73 -33.04 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.337 0.589 . . . . 0.0 109.574 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.9 -12.02 61.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.891 0.853 . . . . 0.0 109.806 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.43 27.61 8.2 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.757 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 245' ' ' LEU . 69.4 m -57.59 -20.44 32.6 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.8 m -50.55 -56.96 9.36 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -131.6 84.9 2.21 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 245' ' ' LEU . 1.4 pt? -86.7 121.56 29.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.382 0.61 . . . . 0.0 110.403 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 32.0 mt -122.35 124.52 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.478 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 19.1 mm -110.24 139.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.688 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 30.1 m -117.63 125.3 50.5 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.56 HG23 HD22 ' A' ' 212' ' ' LEU . 17.0 m -114.59 148.73 17.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 216' ' ' ASP . 1.0 OUTLIER -139.46 131.18 14.97 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.438 -176.195 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 157' ' ' THR . 6.6 Cg_endo -47.44 136.09 20.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.309 3.339 . . . . 0.0 113.066 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -80.83 4.2 19.98 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.861 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.3 m120 . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.837 -176.908 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -96.14 162.37 1.31 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 122.36 2.04 . . . . 0.0 111.429 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.5 p -90.35 97.67 11.32 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 136' ' ' ILE . 2.7 mp -76.26 133.7 30.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.627 0.727 . . . . 0.0 109.237 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.4 t 177.85 108.98 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -86.68 120.92 72.13 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.894 -172.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.53 124.33 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.277 1.985 . . . . 0.0 109.154 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -78.18 124.95 28.66 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.06 -174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.6 157.6 22.22 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.142 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -51.18 122.08 7.15 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 124.002 0.814 . . . . 0.0 110.521 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.421 ' C ' ' HD3' ' A' ' 143' ' ' ARG . 1.7 tmt_? . . . . . 0 N--CA 1.417 -2.103 0 CA-C-O 122.48 1.133 . . . . 0.0 108.243 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -87.5 152.36 7.72 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.139 2.559 . . . . 0.0 109.535 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 1.6 mp0 -70.05 84.47 0.52 Allowed 'General case' 0 N--CA 1.418 -2.05 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.51 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 101.71 12.73 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -80.72 94.22 6.33 Favored 'General case' 0 CA--C 1.463 -2.404 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -115.22 126.78 54.96 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.592 -169.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.556 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.7 ptt180 -95.74 94.32 7.62 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.16 133.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.759 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 18.9 ptp180 -99.52 155.74 17.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.77 126.72 37.1 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . 0.258 1.1 pp -105.32 101.54 11.07 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-O 122.152 0.977 . . . . 0.0 113.039 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.618 ' HE2' ' O ' ' A' ' 168' ' ' SER . 12.6 tmtt? -65.2 121.01 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.597 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -162.23 132.89 4.9 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.62 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.37 90.12 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 114.548 0.579 . . . . 0.0 114.548 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.618 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 47.9 m -158.52 153.6 25.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.53 -47.63 69.35 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.702 0.626 . . . . 0.0 109.832 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.442 ' HG3' HD13 ' A' ' 172' ' ' LEU . 6.8 ttpm? -137.56 83.72 24.62 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 168' ' ' SER . 88.8 Cg_endo -91.91 25.08 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.236 2.624 . . . . 0.0 112.576 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 170' ' ' LYS . 5.6 mp -73.08 109.31 6.52 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.78 53.66 4.84 Favored Glycine 0 C--N 1.305 -1.176 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.529 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -170.41 142.26 2.11 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.25 158.89 42.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.46 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.5 pp -131.08 143.31 41.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.181 0.515 . . . . 0.0 112.257 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 16.2 ttm180 -142.22 157.41 44.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -74.12 131.75 41.6 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.967 0.792 . . . . 0.0 110.62 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -144.8 125.91 2.51 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 24.5 p -92.59 139.07 30.95 Favored 'General case' 0 N--CA 1.383 -3.777 0 CA-C-N 117.367 0.583 . . . . 0.0 111.959 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.2 m -110.86 130.54 55.55 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.31 128.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -109.66 155.4 21.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.07 118.86 56.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.255 0.55 . . . . 0.0 110.466 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 41.5 p -115.24 177.83 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.332 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.03 58.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.57 0.7 . . . . 0.0 109.99 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.0 m -101.1 7.47 43.28 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.558 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.18 -141.58 12.94 Favored Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.764 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 189' ' ' LEU . 2.9 pp -125.08 137.86 54.19 Favored 'General case' 0 N--CA 1.388 -3.549 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 153.11 46.56 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.76 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.461 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 38.3 ttpt -121.27 144.09 48.81 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 121.394 0.616 . . . . 0.0 112.027 -172.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -122.2 140.51 32.57 Favored Pre-proline 0 N--CA 1.41 -2.43 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.346 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.08 134.79 18.1 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.214 1.942 . . . . 0.0 109.203 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.86 154.35 22.65 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.764 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.91 117.09 49.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -119.37 166.53 12.93 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 62.6 mt -67.09 129.79 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 39.7 p -96.68 -51.68 4.21 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -137.5 143.54 41.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.362 0.601 . . . . 0.0 111.122 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 138.85 49.73 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.62 138.33 20.74 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -59.8 126.38 20.31 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 121.669 1.579 . . . . 0.0 109.339 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.7 16.36 68.4 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 156.5 29.81 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.862 -0.669 . . . . 0.0 113.218 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.28 -46.08 76.16 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 124.799 1.239 . . . . 0.0 111.446 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.31 -30.14 70.96 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.158 0.504 . . . . 0.0 111.077 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.44 -33.72 54.72 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.364 0.666 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.3 t -55.02 -32.85 62.14 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.375 1.07 . . . . 0.0 113.843 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.9 t -79.86 -44.02 21.26 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.38 -23.18 5.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.631 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.85 -40.34 54.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.938 0.875 . . . . 0.0 109.383 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.505 HD13 HG23 ' A' ' 249' ' ' VAL . 86.3 mt -109.64 147.37 33.2 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.568 -175.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.05 162.89 17.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.016 0.436 . . . . 0.0 111.289 -174.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.521 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 14.3 p -62.2 -15.45 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-O 121.987 0.899 . . . . 0.0 111.323 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -71.88 -24.02 61.6 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.822 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.684 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.4 m-20 -64.56 173.39 2.17 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -116.46 147.75 41.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.242 -172.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.67 142.69 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.065 0.546 . . . . 0.0 110.43 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 220' ' ' GLU . 2.5 mp -112.04 -51.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 110.456 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.557 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.3 mt-10 -140.48 149.74 42.9 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.56 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.0 t -113.62 108.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.505 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 6.9 t30 69.87 -68.82 0.18 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.332 1.453 . . . . 0.0 110.939 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.73 26.36 0.19 Allowed Glycine 0 C--N 1.301 -1.388 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.52 119.1 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 225' ' ' GLU . 1.2 pm0 -75.53 145.91 40.93 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-O 121.007 0.432 . . . . 0.0 111.985 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 219' ' ' ILE . 20.3 m -94.11 9.31 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.892 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -64.54 106.11 1.09 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.834 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.25 12.2 58.95 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.497 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 70.6 mmtt -87.03 170.58 11.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.27 1.033 . . . . 0.0 113.327 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 234' ' ' VAL . 86.0 m -110.26 157.09 19.83 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 113.363 -1.744 . . . . 0.0 106.65 174.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 231' ' ' LEU . 1.9 pt? -64.67 -34.35 78.08 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.34 -49.48 55.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.551 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -60.48 -40.57 91.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.681 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.559 ' HA ' ' SD ' ' A' ' 237' ' ' MET . 92.0 t -57.53 -43.31 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 O-C-N 123.266 0.354 . . . . 0.0 111.439 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 239' ' ' VAL . 60.2 p -65.19 -28.89 69.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.5 -40.75 63.83 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.559 ' SD ' ' HA ' ' A' ' 234' ' ' VAL . 54.3 mtp -55.84 -50.16 71.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.02 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.7 ptm -76.49 -10.67 59.57 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.046 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.673 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 59.0 t -91.81 -34.96 6.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.045 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.43 -22.07 66.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.643 0.735 . . . . 0.0 109.902 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -114.32 21.83 14.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.1 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 75.2 m -63.92 -32.0 73.38 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.8 m -51.94 -53.08 45.42 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 0.0 110.815 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -129.81 86.17 2.38 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.1 tm? -97.09 131.45 43.86 Favored 'General case' 0 C--O 1.191 -1.993 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.722 -174.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -117.07 118.86 60.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.42 130.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.922 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.557 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 18.7 m -97.35 120.18 37.23 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.505 HG23 HD13 ' A' ' 212' ' ' LEU . 5.4 m -124.93 150.4 29.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 123.781 0.675 . . . . 0.0 112.251 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.491 ' CB ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.04 130.36 15.11 Favored Pre-proline 0 C--O 1.247 0.921 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.684 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.8 Cg_endo -62.41 132.2 37.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.024 2.483 . . . . 0.0 115.119 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.58 -4.48 15.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.655 -1.157 . . . . 0.0 107.919 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.2 p30 . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.766 -177.496 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.078 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 m 69.0 149.68 0.07 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.314 1.045 . . . . 0.0 112.317 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -116.95 73.41 0.86 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.4 p -109.73 112.37 24.38 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.545 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -159.34 -174.65 4.79 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.32 90.89 35.67 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 166.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.21 -45.37 7.64 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 122.85 2.367 . . . . 0.0 112.405 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -119.9 103.17 9.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.254 0.55 . . . . 0.0 110.678 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.0 mt -110.45 142.92 21.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.5 t -134.52 93.36 3.04 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.91 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.1 tt -115.06 92.26 30.36 Favored Pre-proline 0 N--CA 1.415 -2.193 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.06 122.63 3.83 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.152 1.901 . . . . 0.0 111.446 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -94.59 114.57 26.55 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -83.23 119.93 25.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.297 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -179.17 92.24 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.595 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -112.3 7.51 19.36 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.535 1.16 . . . . 0.0 108.107 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.02 154.1 42.36 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.618 -1.628 . . . . 0.0 107.927 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.29 125.53 32.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 p -68.6 114.86 7.36 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 121.68 0.753 . . . . 0.0 113.021 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.41 153.97 27.72 Favored 'General case' 0 N--CA 1.403 -2.806 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.2 tt -67.04 88.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 CA-C-O 122.324 1.059 . . . . 0.0 113.503 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.1 mm -105.89 115.57 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -120.04 113.54 20.66 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 121.525 0.679 . . . . 0.0 112.754 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 51.9 t -136.32 -68.3 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.219 -1.355 . . . . 0.0 107.948 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -107.51 107.39 18.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.056 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.9 mp 59.06 125.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.69 115.75 65.81 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.82 150.37 78.67 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 122.548 2.166 . . . . 0.0 111.69 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 77.3 4.33 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.2 p -74.39 101.76 4.2 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.452 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -76.4 95.65 3.86 Favored 'General case' 0 CA--C 1.466 -2.277 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.485 ' CB ' HD11 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -96.08 117.3 30.42 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.324 -167.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 30.3 ptt180 -87.25 99.49 12.0 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.724 0.773 . . . . 0.0 109.716 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 247' ' ' ILE . 62.5 t -88.94 105.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.417 ' HE ' HD21 ' A' ' 164' ' ' LEU . 14.6 ptm180 -105.69 139.42 40.3 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.322 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.19 121.34 44.96 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.417 HD21 ' HE ' ' A' ' 162' ' ' ARG . 89.7 mt -100.82 100.21 10.83 Favored 'General case' 0 N--CA 1.403 -2.783 0 CA-C-O 121.752 0.787 . . . . 0.0 109.729 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER -90.64 120.58 31.83 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.282 176.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -152.31 89.32 1.42 Allowed 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.113 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.07 -10.37 41.58 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.36 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 32.9 t -141.61 135.04 29.6 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.509 ' OD2' ' HG3' ' A' ' 165' ' ' LYS . 13.4 t70 -130.42 87.04 2.45 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -119.01 147.51 42.71 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.563 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 112.4 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 107.886 -1.621 . . . . 0.0 107.886 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.503 HD22 ' H ' ' A' ' 205' ' ' LEU . 4.9 tt -62.73 -29.2 70.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.357 0.599 . . . . 0.0 109.607 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.76 -4.91 1.71 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.337 -1.411 . . . . 0.0 113.468 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -103.06 147.56 26.81 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.417 ' HB2' ' H ' ' A' ' 199' ' ' ARG . 81.7 m-85 -137.93 158.51 44.19 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.404 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.1 pt -117.57 149.17 19.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.476 0.655 . . . . 0.0 112.377 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 60.1 ttt180 -125.45 152.33 45.03 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.124 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 8.7 t70 -115.59 123.23 47.92 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.39 179.68 29.55 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.288 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.9 p -93.41 120.61 33.9 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.163 0.506 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.8 t -101.7 124.45 47.37 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.46 123.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 121.381 0.61 . . . . 0.0 110.445 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -124.76 161.57 26.13 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.272 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.16 107.41 22.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 36.2 p -108.88 178.87 4.34 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.78 -16.88 64.33 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.948 0.404 . . . . 0.0 110.818 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.3 m -87.88 -4.7 58.83 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.9 -151.7 18.17 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.592 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.5 pt? -84.28 108.53 17.19 Favored 'General case' 0 N--CA 1.394 -3.253 0 CA-C-O 122.016 0.912 . . . . 0.0 109.796 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.4 158.85 23.73 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.496 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.46 131.87 54.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -116.49 151.1 46.61 Favored Pre-proline 0 C--N 1.273 -2.731 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.11 125.16 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.893 1.728 . . . . 0.0 109.902 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.74 151.52 20.21 Favored Glycine 0 C--N 1.278 -2.64 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 122.47 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.08 -168.44 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.5 136.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 69.4 p -95.42 -46.94 6.49 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.453 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.417 ' H ' ' HB2' ' A' ' 175' ' ' TYR . 72.7 ttt180 -146.58 146.88 30.6 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 56.4 tp -127.78 125.44 39.88 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.3 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.17 130.59 26.94 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 50.6 Cg_exo -57.52 126.28 21.41 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.148 1.899 . . . . 0.0 110.24 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.66 -14.9 41.91 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.64 146.02 28.16 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.503 ' H ' HD22 ' A' ' 172' ' ' LEU . 34.6 tp -53.96 -34.42 59.66 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 123.927 0.891 . . . . 0.0 113.271 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -69.37 -35.26 75.65 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.8 tp10 -77.04 -35.52 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 36.4 m -61.73 -33.11 73.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.486 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.3 m -67.12 -39.89 86.73 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.46 -32.27 2.61 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.941 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.89 -19.25 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 123.74 0.816 . . . . 0.0 110.189 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.485 HD11 ' CB ' ' A' ' 159' ' ' ARG . 71.1 mt -109.42 141.84 41.24 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.476 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.3 163.06 27.63 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 124.622 1.169 . . . . 0.0 110.128 -177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.86 -26.74 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.816 0.846 . . . . 0.0 112.579 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.12 -23.55 64.0 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.1 m-20 -63.66 159.13 19.71 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.52 148.46 24.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.919 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -101.56 139.02 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.829 0.852 . . . . 0.0 109.477 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 219' ' ' ILE . 2.7 mp -116.12 -50.64 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.468 ' HG3' HG22 ' A' ' 219' ' ' ILE . 47.6 mt-10 -136.22 152.44 50.76 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.413 HG13 ' CD2' ' A' ' 245' ' ' LEU . 50.4 t -119.84 106.82 19.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.811 -1.54 . . . . 0.0 107.975 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 70.25 -69.01 0.18 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.475 1.11 . . . . 0.0 110.49 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -166.0 21.19 0.11 Allowed Glycine 0 C--N 1.291 -1.926 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.583 HG21 ' SD ' ' A' ' 237' ' ' MET . 13.2 mt -113.19 124.91 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.8 143.48 41.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 118.621 0.646 . . . . 0.0 109.664 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.9 m -96.15 -5.19 10.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.682 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.04 123.05 19.98 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.172 0.511 . . . . 0.0 111.684 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.7 7.4 75.13 Favored Glycine 0 CA--C 1.499 -0.907 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.201 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.442 ' HG3' ' OE1' ' A' ' 233' ' ' GLN . 23.3 ttmm -107.47 156.29 19.13 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 234' ' ' VAL . 87.1 m -77.14 157.47 30.97 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 50.0 tp -62.45 -44.3 96.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.42 -35.4 70.02 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.035 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.651 ' O ' ' HG3' ' A' ' 237' ' ' MET . 79.2 mt-30 -73.34 -42.47 62.23 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.946 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 230' ' ' THR . 61.1 t -64.75 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.596 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.0 p -65.87 -41.63 91.36 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.615 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.39 -44.88 95.41 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.1 0.476 . . . . 0.0 110.463 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 33.8 mtm -60.14 -42.9 95.83 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.8 -17.92 62.13 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.395 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 235' ' ' THR . 85.0 t -85.39 -36.73 11.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.24 -25.22 67.7 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.534 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -129.92 28.76 5.04 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.687 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.9 t -59.16 -35.57 73.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.459 1.103 . . . . 0.0 111.953 -175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 22.8 t -70.36 -20.5 62.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.216 0.532 . . . . 0.0 110.759 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -130.15 37.12 3.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.413 ' CD2' HG13 ' A' ' 221' ' ' VAL . 3.2 tm? -85.02 123.01 30.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.829 0.823 . . . . 0.0 112.219 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 61.6 mt -129.02 119.61 49.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.317 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.455 HG23 ' HB ' ' A' ' 161' ' ' VAL . 10.8 tt -109.66 131.99 59.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.584 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.4 m -95.46 120.15 35.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.093 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 212' ' ' LEU . 17.4 m -122.53 149.97 26.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.582 0.551 . . . . 0.0 110.208 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.451 ' CB ' HD11 ' A' ' 219' ' ' ILE . 0.5 OUTLIER -134.77 126.06 17.73 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 77.7 Cg_exo -52.56 132.06 43.76 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.659 2.906 . . . . 0.0 114.494 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -101.78 8.15 41.53 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -83.25 66.32 8.71 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.152 -1.386 . . . . 0.0 108.122 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -90.95 152.39 20.73 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.613 -0.722 . . . . 0.0 112.144 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? . . . . . 0 C--N 1.294 -1.846 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 179.701 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.106 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.8 m -150.17 157.51 43.18 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 117.365 0.583 . . . . 0.0 109.801 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -75.06 127.79 34.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.1 t -75.53 134.07 40.85 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -130.76 166.04 21.63 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -175.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.26 111.59 52.59 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.0 108.39 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.635 1.557 . . . . 0.0 108.736 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 t -92.85 85.82 5.3 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.315 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.59 119.6 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.1 m -145.24 91.31 2.12 Favored 'General case' 1 C--N 1.235 -4.401 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -116.63 108.15 45.47 Favored Pre-proline 0 N--CA 1.424 -1.734 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.178 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.16 123.92 12.63 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 N-CA-C 106.504 -2.152 . . . . 0.0 106.504 172.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.38 112.14 20.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.388 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 142' ' ' PHE . 11.6 m-20 -107.22 118.85 37.81 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 141' ' ' ASP . 48.6 t80 166.66 93.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 O-C-N 125.029 1.455 . . . . 0.0 107.217 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -108.33 7.31 27.13 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.178 0.989 . . . . 0.0 109.357 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -89.3 160.08 17.07 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.152 -1.385 . . . . 0.0 107.328 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.1 m -77.65 154.0 5.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.3 m -71.09 114.04 8.74 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -112.86 147.2 37.5 Favored 'General case' 0 N--CA 1.401 -2.902 0 CA-C-O 121.455 0.645 . . . . 0.0 111.866 -169.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.8 mt 46.3 64.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 126.608 1.963 . . . . 0.0 113.665 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 149' ' ' ILE . 2.5 pp -106.79 140.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.58 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.8 t70 62.73 91.47 0.07 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.436 1.112 . . . . 0.0 110.523 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.71 -72.99 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.019 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -76.41 107.53 8.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.574 HG23 ' H ' ' A' ' 154' ' ' VAL 0.326 9.0 tt 40.29 -92.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.909 1.684 . . . . 0.0 113.839 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.574 ' H ' HG23 ' A' ' 153' ' ' ILE . 7.5 p -129.47 115.02 18.29 Favored Pre-proline 0 N--CA 1.417 -2.097 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.49 146.66 13.77 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.338 2.025 . . . . 0.0 113.381 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.494 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 2.4 mp0 -83.0 72.32 10.08 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.717 177.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -106.07 138.53 42.09 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -126.08 135.91 52.3 Favored 'General case' 0 CA--C 1.469 -2.136 0 CA-C-O 121.147 0.498 . . . . 0.0 112.082 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -113.65 115.76 28.4 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.432 ' O ' ' HD2' ' A' ' 160' ' ' ARG 0.334 4.0 ppt_? -97.97 103.81 15.78 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 122.162 0.982 . . . . 0.0 110.659 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.31 125.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.916 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -95.55 126.68 41.0 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.305 0.574 . . . . 0.0 109.862 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.01 121.43 38.89 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.512 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.28 105.16 15.75 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.322 1.058 . . . . 0.0 110.639 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -74.98 136.28 41.31 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.441 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.542 ' HB2' ' H ' ' A' ' 170' ' ' LYS . 88.3 m-70 -139.53 -75.63 0.35 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.556 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.2 -10.96 58.46 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.251 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.7 m -134.01 25.5 3.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 122.123 0.963 . . . . 0.0 108.476 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.402 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 19.4 t70 -165.14 -70.48 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.161 -174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.542 ' H ' ' HB2' ' A' ' 166' ' ' HIS . 12.7 mptt -123.79 114.27 28.37 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -84.31 -40.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.037 1.825 . . . . 0.0 110.234 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.95 159.16 36.21 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 125.618 1.567 . . . . 0.0 107.153 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -122.73 17.81 8.18 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.584 -1.293 . . . . 0.0 112.449 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -165.68 143.67 5.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.424 ' CE2' HG22 ' A' ' 201' ' ' VAL . 76.1 m-85 -108.99 136.03 49.2 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.973 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.478 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -134.44 140.31 46.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -137.82 159.9 40.74 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.29 145.08 44.26 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.947 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.1 109.72 0.43 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 m -93.3 143.76 25.96 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 51.0 m -126.24 133.79 51.38 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.4 p -108.65 125.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.49 ' HB2' ' OE1' ' A' ' 190' ' ' GLU . 72.7 mtp180 -124.72 162.21 24.71 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.428 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.98 113.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.893 0.854 . . . . 0.0 108.856 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 57.0 p -113.8 178.24 4.35 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.498 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.48 -10.88 59.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 109.916 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.2 m -94.55 -4.19 48.39 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.219 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.08 -159.6 14.27 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -83.98 129.13 34.93 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 117.593 0.697 . . . . 0.0 110.272 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -137.78 161.82 35.57 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.761 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 181' ' ' SER . 98.3 mttt -121.64 150.15 42.15 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 18.6 pt20 -131.13 139.0 34.17 Favored Pre-proline 0 N--CA 1.414 -2.23 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.1 Cg_endo -81.7 133.74 8.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.546 2.164 . . . . 0.0 110.854 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.23 153.7 25.5 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.869 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 231' ' ' LEU . 2.7 mp -125.57 123.1 63.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -127.56 163.97 23.01 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 67.7 mt -74.6 114.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -84.52 -49.59 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.064 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.11 155.41 50.22 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.743 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -113.57 140.62 48.01 Favored 'General case' 0 N--CA 1.395 -3.2 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 178.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 175' ' ' TYR . 40.1 t -96.54 129.69 32.5 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.15 126.05 17.8 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 121.939 1.76 . . . . 0.0 109.236 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.07 -6.56 83.1 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.39 156.3 53.29 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.89 -25.88 65.72 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.46 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' N ' HD21 ' A' ' 200' ' ' LEU . 42.8 tt0 -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.0 m -54.81 -31.27 58.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.288 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.4 p -60.75 -43.12 98.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.96 29.28 74.39 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.9 tp -145.43 -46.47 0.22 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.011 -1.095 . . . . 0.0 110.458 -172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.442 HD12 HG23 ' A' ' 249' ' ' VAL . 71.9 mt -115.4 110.43 19.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.445 0.641 . . . . 0.0 111.3 -176.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.69 134.01 44.27 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.613 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 71.2 t 43.22 -72.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 173.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -23.6 65.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -67.41 153.2 44.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.363 -173.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -101.29 156.44 17.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.63 143.3 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.491 0.717 . . . . 0.0 109.964 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.513 HD11 ' CB ' ' A' ' 250' ' ' LYS . 2.8 mp -121.69 -45.52 2.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 111.968 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.451 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 35.9 mt-10 -135.58 150.85 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.768 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.4 t -121.87 101.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 123.804 0.69 . . . . 0.0 109.338 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.522 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 39.2 t-20 69.59 -72.09 0.11 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 0.0 111.269 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.54 12.18 0.4 Allowed Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.584 HG21 ' SD ' ' A' ' 237' ' ' MET . 19.9 mt -105.21 133.06 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.92 146.3 28.12 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.47 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 12.7 m -91.63 -4.94 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.945 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.76 112.34 7.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.575 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 4.29 50.76 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.546 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 10.5 mmpt? -96.79 163.04 13.16 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -104.57 168.7 8.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 231' ' ' LEU . 1.9 pt? -57.59 -47.59 81.71 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -68.31 -40.99 81.53 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.237 0.541 . . . . 0.0 110.529 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.684 ' O ' ' HG3' ' A' ' 237' ' ' MET . 35.5 tt0 -59.09 -43.59 91.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.309 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.49 -46.86 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.483 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.0 p -65.97 -31.01 71.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.888 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.65 -42.79 77.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.18 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.684 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 24.6 mtm -59.3 -46.35 88.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.68 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.3 ptp -67.15 -23.15 65.76 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.967 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 235' ' ' THR . 58.8 t -90.14 -27.05 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.557 0.694 . . . . 0.0 109.161 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.02 71.95 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.449 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.58 -70.17 0.72 Allowed 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.28 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.2 t 60.16 -41.28 0.09 Allowed 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 42.5 m -68.6 -73.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.885 0.766 . . . . 0.0 111.588 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.52 81.17 2.92 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -95.87 129.1 43.21 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.207 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 3.3 mp -127.46 134.5 65.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 220' ' ' GLU . 7.2 tp -124.18 131.17 73.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.59 . . . . 0.0 110.001 178.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 28.5 m -98.03 120.22 38.04 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.052 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG23 HD12 ' A' ' 212' ' ' LEU . 10.5 m -121.06 149.37 24.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.278 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.513 ' CB ' HD11 ' A' ' 219' ' ' ILE . 80.7 tttt -127.72 141.07 39.88 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 124.001 0.92 . . . . 0.0 109.258 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.631 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.5 Cg_endo -64.39 130.09 25.84 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 121.626 1.551 . . . . 0.0 111.039 175.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -95.48 -35.15 11.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.928 0.871 . . . . 0.0 109.07 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.43 8.81 0.46 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.932 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -121.72 130.11 53.21 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.288 0.566 . . . . 0.0 110.552 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 5.9 tpm_? . . . . . 0 C--N 1.283 -2.285 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.749 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.2 p -127.57 142.47 51.36 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-O 120.941 0.4 . . . . 0.0 111.313 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -151.14 130.11 12.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.2 t -76.06 139.29 41.33 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.532 0.682 . . . . 0.0 110.734 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -94.38 122.03 36.53 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.394 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.5 113.07 64.6 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.28 133.2 31.93 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.736 1.624 . . . . 0.0 110.093 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.9 t -96.32 96.31 8.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.404 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.57 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.3 t -161.95 93.21 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 73.0 mt -92.23 114.18 61.44 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 6.9 Cg_exo -72.32 123.0 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.313 2.008 . . . . 0.0 112.286 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -98.44 132.26 44.03 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.83 157.17 17.66 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -96.27 138.91 33.18 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -154.48 92.87 1.53 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 122.106 0.955 . . . . 0.0 109.005 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -84.11 140.19 31.96 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.061 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.6 m -78.93 124.43 37.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.217 0.532 . . . . 0.0 110.14 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.9 m -86.56 115.7 24.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.749 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.27 105.26 16.33 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.1 mp -88.28 96.89 6.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.664 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -106.03 151.76 7.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.173 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -92.17 -173.41 3.43 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.405 0.621 . . . . 0.0 110.34 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.85 120.0 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.01 120.97 11.27 Favored 'General case' 1 C--N 1.243 -4.056 0 CA-C-N 114.11 -1.404 . . . . 0.0 114.452 -170.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.1 tt -154.87 151.03 11.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 253' ' ' ASN . 41.3 t -114.03 104.56 54.89 Favored Pre-proline 0 C--N 1.288 -2.082 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.16 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.04 151.79 84.55 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.391 2.061 . . . . 0.0 109.266 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 78.64 0.22 Allowed 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.8 p -81.84 96.96 7.79 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.411 ' NE2' ' HG2' ' A' ' 250' ' ' LYS . 12.0 m170 -66.04 116.39 7.1 Favored 'General case' 0 CA--C 1.457 -2.622 0 CA-C-O 121.861 0.838 . . . . 0.0 112.42 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.458 ' HG2' HG21 ' A' ' 209' ' ' THR . 10.7 tpt180 -110.12 116.7 32.01 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.67 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.497 ' HB2' HG23 ' A' ' 246' ' ' ILE . 30.7 ptt180 -99.14 113.62 25.95 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.92 132.32 41.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 19.6 ptt180 -112.13 148.79 33.24 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.001 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 2.5 tm? -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 171.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 164' ' ' LEU 0.273 0.0 OUTLIER -108.04 101.33 10.58 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-O 121.956 0.884 . . . . 0.0 112.72 179.39 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -71.91 131.83 43.52 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.817 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.26 79.07 0.52 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.801 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.95 17.62 69.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -102.94 113.89 27.72 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 114.616 -0.792 . . . . 0.0 111.049 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.14 4.24 7.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.769 1.271 . . . . 0.0 107.687 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -74.2 169.19 20.32 Favored Pre-proline 0 C--O 1.246 0.869 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -56.07 146.17 71.32 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.257 1.972 . . . . 0.0 110.523 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.72 -47.23 80.44 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.442 0.639 . . . . 0.0 111.853 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 115.83 -18.78 14.47 Favored Glycine 0 CA--C 1.487 -1.692 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -132.67 133.36 43.47 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 114.275 -0.962 . . . . 0.0 108.857 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 199' ' ' ARG . 77.4 m-85 -138.04 148.08 44.74 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 123.524 0.515 . . . . 0.0 111.926 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.425 HG21 HG11 ' A' ' 218' ' ' VAL . 31.6 pt -124.71 143.14 39.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.992 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -140.24 159.39 42.28 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.841 0.353 . . . . 0.0 111.43 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.65 135.78 35.53 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.932 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -142.17 175.01 22.98 Favored Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.5 m -95.04 133.42 38.84 Favored 'General case' 0 C--N 1.27 -2.881 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.725 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.3 t -103.88 119.12 38.25 Favored 'General case' 0 C--N 1.252 -3.668 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.1 p -108.41 123.16 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.544 0.688 . . . . 0.0 109.168 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.89 51.65 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.529 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.82 107.41 21.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.28 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.3 p -111.87 179.11 4.1 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.753 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.12 -15.21 62.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.2 m -87.62 -5.32 58.78 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.95 -157.36 15.04 Favored Glycine 0 C--O 1.214 -1.119 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 189' ' ' LEU . 4.0 pp -88.19 129.97 35.19 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 118.346 1.073 . . . . 0.0 109.203 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 41.7 mt-10 -120.69 147.78 44.82 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.507 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -121.34 130.12 53.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -142.21 154.83 64.83 Favored Pre-proline 0 C--N 1.279 -2.486 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.69 121.56 6.39 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 109.23 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.41 139.35 10.71 Favored Glycine 0 C--N 1.276 -2.791 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.8 pt -100.6 126.58 54.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-O 121.532 0.682 . . . . 0.0 112.164 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -120.19 174.47 6.48 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.952 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 176' ' ' ILE . 59.9 mt -68.33 135.7 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.3 t -121.23 -59.29 1.73 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.593 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.42 ' HB2' ' HB2' ' A' ' 175' ' ' TYR . 93.1 mtt180 -122.86 147.01 47.05 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.442 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 206' ' ' ALA . 12.9 mt -127.36 134.11 49.98 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.464 174.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.402 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 57.7 t -100.7 129.38 27.71 Favored Pre-proline 0 C--N 1.275 -2.632 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 172.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.66 126.45 19.73 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.334 2.023 . . . . 0.0 110.682 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.04 72.5 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.214 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 158.35 47.48 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -55.95 -39.32 71.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.771 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -74.01 -26.98 60.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.171 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.428 ' HB2' HD22 ' A' ' 200' ' ' LEU . 7.7 tp10 -73.0 -45.46 57.79 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 m -55.36 -32.22 62.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.263 1.025 . . . . 0.0 111.846 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.559 HG22 ' HG ' ' A' ' 211' ' ' LEU . 27.6 m -62.58 -43.49 98.69 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.033 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 77.59 -27.64 1.85 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.387 0.915 . . . . 0.0 115.387 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.559 ' HG ' HG22 ' A' ' 209' ' ' THR . 4.2 pp -97.56 7.98 45.47 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 249' ' ' VAL . 94.9 mt -116.0 145.05 43.28 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.938 0.399 . . . . 0.0 110.045 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.47 161.89 26.1 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 120.889 0.376 . . . . 0.0 111.75 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.61 -19.41 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-O 121.547 0.689 . . . . 0.0 111.114 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.77 -25.07 58.82 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.528 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.617 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 51.8 m-20 -70.98 156.67 39.35 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.245 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.47 165.74 18.54 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.628 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 176' ' ' ILE . 19.6 m -82.77 142.88 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.234 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.59 HG13 ' HG3' ' A' ' 250' ' ' LYS . 42.8 mm -116.06 -47.43 4.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.069 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.544 ' H ' ' HB ' ' A' ' 248' ' ' THR . 39.1 mt-10 -145.99 159.49 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' A' ' 226' ' ' VAL . 77.2 t -123.38 97.26 4.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 169.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.3 t30 68.3 -70.17 0.13 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.36 17.56 0.68 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.426 HG21 ' SD ' ' A' ' 237' ' ' MET . 9.0 mt -120.3 142.33 36.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -86.12 153.83 21.8 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.991 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.424 ' CG1' HG23 ' A' ' 221' ' ' VAL . 16.3 m -118.03 -3.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.94 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -86.27 121.77 29.32 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.81 -10.22 72.52 Favored Glycine 0 C--N 1.318 -0.441 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 233' ' ' GLN . 37.5 ttmt -91.95 153.79 19.25 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 124.48 1.112 . . . . 0.0 109.153 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.4 m -74.92 156.28 36.53 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 231' ' ' LEU . 2.2 pt? -64.65 -36.82 85.49 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.686 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.37 -36.85 76.53 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.75 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 237' ' ' MET . 5.8 tp-100 -72.42 -48.52 40.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.459 ' HA ' ' HE2' ' A' ' 237' ' ' MET . 95.6 t -56.74 -48.97 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.932 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.5 p -65.0 -34.0 77.39 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.32 -38.58 81.69 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.99 0.424 . . . . 0.0 110.276 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.659 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 20.2 mtm -57.8 -45.6 85.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.84 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.28 -15.01 60.54 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.465 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 235' ' ' THR . 65.9 t -78.82 -38.72 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.251 0.548 . . . . 0.0 110.028 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.27 -29.06 68.57 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.281 0.563 . . . . 0.0 110.806 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -110.79 32.13 5.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.8 p -60.02 -27.52 66.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.2 p -46.9 -63.55 1.0 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.137 0.575 . . . . 0.0 111.564 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 40.1 m-80 -129.96 87.68 2.56 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.9 pp -90.33 131.99 35.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 160' ' ' ARG . 2.3 mp -106.7 125.29 62.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.094 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.1 tt -111.37 128.27 67.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 110.649 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.544 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.1 m -106.44 129.44 54.42 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.315 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 212' ' ' LEU . 27.8 m -135.66 165.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.59 ' HG3' HG13 ' A' ' 219' ' ' ILE . 43.9 mtpt -126.42 129.02 24.25 Favored Pre-proline 0 CA--C 1.482 -1.637 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.55 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 50.0 Cg_exo -58.62 127.23 23.79 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.811 1.674 . . . . 0.0 110.164 172.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.12 9.69 21.83 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.125 0.964 . . . . 0.0 109.712 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' A' ' 154' ' ' VAL . 24.8 m-80 -93.7 15.78 15.53 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.29 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -90.99 144.64 25.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.266 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 C--N 1.302 -1.472 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.863 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.601 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.4 m 79.05 5.6 2.25 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.754 1.221 . . . . 0.0 113.48 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -97.93 88.14 4.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.7 p -93.45 142.42 27.35 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.206 0.527 . . . . 0.0 112.392 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -110.33 100.06 8.98 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -112.22 117.84 46.92 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 147.82 91.87 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.26 1.973 . . . . 0.0 111.263 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.3 m -79.7 85.85 5.36 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.47 0.652 . . . . 0.0 110.614 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.9 mm -99.81 144.18 12.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m 58.26 73.93 0.45 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.141 0.977 . . . . 0.0 111.148 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.79 119.43 70.56 Favored Pre-proline 0 N--CA 1.421 -1.896 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.815 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.17 121.82 10.22 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.464 2.11 . . . . 0.0 112.114 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -101.94 161.19 13.86 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.759 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -83.52 149.44 26.6 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.704 -0.398 . . . . 0.0 109.944 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -103.45 -37.72 7.48 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -150.02 89.95 1.64 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 121.118 0.485 . . . . 0.0 110.647 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -72.47 125.36 27.21 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.7 140.91 16.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.851 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.1 m -94.25 147.99 22.65 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.77 103.96 16.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.264 0.554 . . . . 0.0 110.81 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.0 tp -102.48 98.71 7.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pp -101.39 152.28 5.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.407 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -77.6 109.72 11.81 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.528 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 153' ' ' ILE . 57.2 t -77.0 -37.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.6 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.92 123.74 21.03 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 151' ' ' VAL . 68.0 mt -133.4 127.58 53.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.252 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.66 102.04 20.31 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 169.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.75 131.2 1.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.049 1.833 . . . . 0.0 112.283 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.55 ' HA ' ' HG2' ' A' ' 251' ' ' PRO . 42.2 mt-10 -84.27 85.57 7.35 Favored 'General case' 0 N--CA 1.403 -2.811 0 CA-C-O 121.387 0.613 . . . . 0.0 112.109 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -91.0 100.45 13.31 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -88.61 105.01 17.38 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -126.36 116.11 20.7 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.25 129.58 34.6 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.997 0.427 . . . . 0.0 110.074 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.3 t -89.71 115.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -106.28 137.61 43.93 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 111.836 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.72 141.49 48.56 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.356 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.43 115.3 23.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 121.822 0.82 . . . . 0.0 110.801 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.56 130.08 38.92 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.345 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 169' ' ' ASP . 0.5 OUTLIER -164.99 76.33 0.28 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.99 -178.66 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.37 17.35 76.32 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.009 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.0 m 67.58 97.0 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.587 1.155 . . . . 0.0 111.154 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 166' ' ' HIS . 19.2 t70 -86.56 -49.56 7.46 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.926 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -145.17 150.35 44.86 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.76 -61.93 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 121.312 1.341 . . . . 0.0 109.756 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.04 -65.56 0.39 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.511 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 205' ' ' LEU . . . 92.65 11.48 59.22 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.46 156.92 26.74 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -137.27 136.1 37.75 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 123.339 0.399 . . . . 0.0 110.326 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.483 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -128.81 141.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.307 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -141.31 158.08 44.36 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.498 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -96.95 130.41 44.26 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -122.2 158.89 16.89 Favored Glycine 0 CA--C 1.47 -2.751 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 m -92.91 131.45 37.91 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.72 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -111.43 140.2 46.22 Favored 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.463 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.4 123.15 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.86 152.52 21.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.0 104.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.1 p -117.74 179.03 4.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.97 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.39 -15.89 63.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 109.656 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.6 m -87.25 -4.13 59.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.208 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.54 -142.3 15.52 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.06 123.28 33.79 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -117.2 146.18 43.4 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.58 133.52 55.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.065 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -146.93 147.61 30.05 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.525 ' O ' ' HA2' ' A' ' 228' ' ' GLY . 13.9 Cg_exo -69.12 133.29 26.37 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.414 2.076 . . . . 0.0 111.512 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -129.82 127.19 5.32 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.529 HG23 ' HB ' ' A' ' 218' ' ' VAL . 10.5 tt -91.19 124.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-O 121.25 0.548 . . . . 0.0 110.881 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.58 173.11 10.56 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.47 131.99 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 37.3 t -90.69 -54.31 4.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.223 0.535 . . . . 0.0 110.83 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -155.65 155.66 33.61 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 53.5 tp -127.33 139.63 52.75 Favored 'General case' 0 N--CA 1.403 -2.819 0 O-C-N 123.317 0.386 . . . . 0.0 110.228 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.37 128.62 32.62 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.524 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 29.6 Cg_exo -63.36 126.27 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 108.934 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.6 73.45 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.51 158.42 41.43 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.497 ' H ' ' HA3' ' A' ' 173' ' ' GLY . 27.4 tp -57.95 -38.8 76.66 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -72.71 -29.27 63.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.512 0.672 . . . . 0.0 109.963 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -76.72 -34.07 58.14 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -58.84 -33.54 70.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.9 m -77.16 -45.59 26.24 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.27 -6.0 0.87 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.02 -14.95 58.88 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.218 0.607 . . . . 0.0 111.287 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.471 ' CD1' HG23 ' A' ' 249' ' ' VAL . 94.1 mt -119.22 146.89 44.83 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.146 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.2 161.28 13.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.961 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 51.7 t -67.36 -18.65 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.669 0.747 . . . . 0.0 110.239 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.99 -24.58 59.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.144 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.649 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 73.7 m-20 -66.06 157.2 31.64 Favored 'General case' 0 C--O 1.248 1.026 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -172.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.81 150.4 22.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.576 0.703 . . . . 0.0 112.425 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 195' ' ' ILE . 57.1 t -94.32 136.94 24.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.602 HG22 ' HG3' ' A' ' 220' ' ' GLU . 31.4 mm -115.6 -53.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.543 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.602 ' HG3' HG22 ' A' ' 219' ' ' ILE . 41.5 mt-10 -143.55 159.79 41.8 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.42 0.629 . . . . 0.0 111.594 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.4 104.8 16.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.0 t30 65.97 -74.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.801 1.24 . . . . 0.0 110.612 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -147.23 3.4 0.89 Allowed Glycine 0 C--N 1.306 -1.113 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.3 mt -100.38 117.94 46.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.51 131.75 42.11 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.386 0.612 . . . . 0.0 109.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 234' ' ' VAL . 35.3 m -117.17 7.19 7.09 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.204 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.38 3.39 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.706 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 193' ' ' PRO . . . 102.56 -3.09 49.7 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.292 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -87.54 170.04 11.67 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.15 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.486 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 20.9 m -101.39 159.38 15.32 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 234' ' ' VAL . 2.4 pt? -52.9 -45.26 67.48 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.09 -46.48 88.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.584 0.707 . . . . 0.0 110.074 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 237' ' ' MET . 2.0 mp0 -66.1 -37.94 86.99 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.34 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 231' ' ' LEU . 9.8 p -74.8 -45.08 44.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.672 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 14.6 t -68.92 -38.62 79.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.88 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.55 -37.46 87.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.856 0.836 . . . . 0.0 108.8 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 10.9 tmm? -69.16 -49.26 58.38 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.418 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 18.4 ptp -67.29 -22.58 65.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.62 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 235' ' ' THR . 89.7 t -83.12 -33.0 9.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.731 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.11 -35.05 70.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.31 -79.21 0.18 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.731 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.5 t 59.59 -37.31 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.77 1.628 . . . . 0.0 114.871 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.4 p -55.75 -68.52 0.19 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.482 0.713 . . . . 0.0 110.271 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -100.55 80.5 2.22 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.54 103.89 16.05 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.05 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.4 135.77 62.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.441 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.431 HD11 ' CG1' ' A' ' 218' ' ' VAL . 8.0 tp -118.49 134.18 62.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.316 0.579 . . . . 0.0 110.245 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.559 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 25.2 m -103.39 119.62 39.24 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.553 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.488 HG12 HG22 ' A' ' 218' ' ' VAL . 4.3 m -127.73 137.07 58.7 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.454 ' HD2' HG13 ' A' ' 219' ' ' ILE . 96.6 mttt -134.8 143.57 46.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.168 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.649 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 93.2 Cg_exo -45.79 132.3 13.57 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.362 2.708 . . . . 0.0 112.05 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 254' ' ' GLN . . . -66.04 -16.88 64.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 68.47 -31.32 0.19 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.627 1.571 . . . . 0.0 114.33 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 252' ' ' ALA . 54.8 tp60 -85.08 120.89 27.1 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 . . . . . 0 C--N 1.272 -2.8 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.51 -178.776 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.0 m -72.14 141.75 49.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 130' ' ' LYS . 2.9 mptp? -79.39 151.05 31.16 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.065 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.8 m -75.34 114.12 13.51 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.763 0.792 . . . . 0.0 112.192 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -90.69 130.52 36.68 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.405 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.15 132.93 78.82 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.02 118.6 2.45 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.692 2.928 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.2 m -83.52 89.73 7.12 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.853 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -63.66 131.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.678 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m -151.73 102.45 2.85 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.214 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.4 tt -87.89 133.66 37.03 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.58 127.59 22.18 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.008 1.806 . . . . 0.0 110.268 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -98.48 157.35 16.27 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.68 157.18 22.29 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.279 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -134.61 139.58 45.43 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 69.22 98.02 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.98 0.912 . . . . 0.0 110.885 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -73.13 111.02 7.87 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.559 0.695 . . . . 0.0 111.247 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.93 130.49 41.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.338 0.589 . . . . 0.0 111.432 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.8 p -101.42 153.98 19.21 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.701 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.52 104.55 17.04 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.457 0.646 . . . . 0.0 112.169 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.1 mp -109.82 102.06 13.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.7 pt -95.47 116.19 36.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.016 0.912 . . . . 0.0 112.837 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -118.17 -25.95 6.49 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.039 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.1 t -74.86 -39.02 44.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.782 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.02 116.65 7.36 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.506 0.67 . . . . 0.0 111.851 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.4 tt -140.25 161.72 25.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.6 t -94.64 112.93 59.75 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.57 136.42 30.8 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.967 1.778 . . . . 0.0 110.726 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.05 76.15 2.24 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-O 121.608 0.718 . . . . 0.0 111.694 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 41.1 m -83.72 103.85 13.35 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 173.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.401 ' CE1' ' HG3' ' A' ' 250' ' ' LYS . 13.0 m170 -69.06 122.53 18.91 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 121.901 0.858 . . . . 0.0 110.984 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.498 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 4.1 mmp_? -105.27 116.62 32.25 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.786 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -107.88 107.11 17.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.432 ' HB ' ' CG2' ' A' ' 247' ' ' ILE . 38.5 t -89.09 125.65 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.697 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.82 138.41 32.65 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.229 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 3.7 mm? -123.33 129.25 51.07 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.661 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.04 120.02 39.19 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 167' ' ' GLY . 88.4 tttt -65.48 123.89 20.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 122.672 1.225 . . . . 0.0 113.259 -173.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -123.84 29.95 6.34 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 113.013 -1.903 . . . . 0.0 108.677 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 165' ' ' LYS . . . 102.26 -10.34 56.58 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.198 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.2 m 60.95 21.15 11.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.42 0.688 . . . . 0.0 111.705 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.96 -55.34 7.62 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.999 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 171' ' ' PRO . 83.8 tttt -99.4 128.22 32.27 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 21.4 Cg_exo -67.96 156.83 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.062 1.841 . . . . 0.0 110.342 172.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.97 -8.03 54.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.509 0.671 . . . . 0.0 111.137 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.23 0.52 7.47 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.024 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -103.95 144.62 31.29 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.24 136.86 38.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.02 135.93 58.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 79.9 ttt180 -142.07 150.43 41.2 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.151 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 231' ' ' LEU . 20.4 t70 -92.59 134.23 35.2 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.411 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -135.28 166.79 24.36 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 191' ' ' LYS . 1.6 m -92.71 131.36 37.85 Favored 'General case' 0 C--N 1.27 -2.86 0 C-N-CA 117.394 -1.723 . . . . 0.0 107.972 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 25.3 m -100.8 134.8 43.23 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.43 128.62 75.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.979 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.2 mtt180 -117.47 154.37 31.54 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.9 109.94 30.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.574 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 74.7 p -107.03 177.89 4.72 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.12 -20.95 62.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.225 0.536 . . . . 0.0 109.874 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.6 p -86.51 -3.8 59.07 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.434 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.95 -171.55 14.54 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.737 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.6 pt? -84.95 133.75 34.27 Favored 'General case' 0 N--CA 1.4 -2.951 0 O-C-N 122.306 -0.526 . . . . 0.0 110.298 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -132.47 156.72 46.24 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.373 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.562 ' HB3' HG22 ' A' ' 180' ' ' THR . 96.9 mttt -121.36 150.33 41.63 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.84 161.48 62.51 Favored Pre-proline 0 N--CA 1.426 -1.654 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.627 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.55 142.68 85.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.94 89.96 0.15 Allowed Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.586 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 218' ' ' VAL . 12.1 tt -95.97 117.66 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-O 121.77 0.795 . . . . 0.0 109.998 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -132.46 179.16 6.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.283 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 216' ' ' ASP . 44.9 mt -68.7 122.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 26.1 p -96.33 -32.89 12.16 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 120.905 0.383 . . . . 0.0 111.887 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -153.34 148.79 27.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.47 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.9 tt -124.54 136.73 54.22 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 71.3 t -99.57 124.42 44.44 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.12 127.23 24.14 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.477 2.118 . . . . 0.0 111.353 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.42 63.15 Favored Glycine 0 C--N 1.309 -0.953 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.39 161.4 44.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.736 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 205' ' ' LEU . 2.8 tm? -53.35 -39.68 64.34 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.8 0.84 . . . . 0.0 110.862 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 212' ' ' LEU . . . -55.47 -42.14 73.91 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.3 -36.12 54.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.1 m -54.45 -34.74 62.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.435 0.694 . . . . 0.0 112.816 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 73.1 p -60.17 -41.26 92.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 111.557 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.83 3.16 90.68 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.533 HD12 ' HG ' ' A' ' 212' ' ' LEU . 2.7 pp -127.96 -2.32 5.86 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.533 ' HG ' HD12 ' A' ' 211' ' ' LEU . 97.2 mt -108.55 130.58 55.29 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.237 0.541 . . . . 0.0 110.305 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.95 164.36 25.51 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 125.318 1.447 . . . . 0.0 109.663 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.0 p -52.49 -20.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.733 0.777 . . . . 0.0 112.435 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -68.79 -25.29 64.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.929 -0.482 . . . . 0.0 111.898 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.8 m-20 -61.3 159.34 12.53 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -114.96 144.87 42.9 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.15 -1.841 . . . . 0.0 110.448 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 195' ' ' ILE . 7.7 p -96.61 140.4 17.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.053 0.454 . . . . 0.0 109.819 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.48 HG22 ' HG3' ' A' ' 220' ' ' GLU . 40.2 mm -110.44 -52.92 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.189 0.519 . . . . 0.0 111.803 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.635 ' H ' ' HB ' ' A' ' 248' ' ' THR . 45.1 mt-10 -134.73 142.74 46.85 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.57 0.7 . . . . 0.0 112.646 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.453 HG21 HG13 ' A' ' 234' ' ' VAL . 57.6 t -115.62 113.5 43.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.213 172.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 70.6 -66.19 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.221 1.008 . . . . 0.0 110.327 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -169.34 12.91 0.05 OUTLIER Glycine 0 C--N 1.292 -1.891 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.538 HG21 ' SD ' ' A' ' 237' ' ' MET . 28.9 mt -105.37 125.49 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -176.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -77.48 141.64 39.57 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 33.6 m -100.91 14.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.08 104.01 2.46 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.276 0.56 . . . . 0.0 111.02 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.78 12.32 55.71 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.231 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.582 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 6.0 mmpt? -91.8 152.36 20.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 234' ' ' VAL . 38.7 p -86.94 159.46 19.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 178' ' ' ASP . 1.9 pt? -60.26 -38.07 82.38 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.596 0.236 . . . . 0.0 111.288 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.87 -46.5 87.66 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.854 0.861 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.575 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.6 tp-100 -63.48 -51.05 67.23 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.144 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 221' ' ' VAL . 75.0 t -56.93 -49.03 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.468 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 9.9 t -66.86 -38.47 86.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.801 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.92 -46.88 88.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.159 0.504 . . . . 0.0 109.969 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.575 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 40.7 mtm -62.3 -42.94 99.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.066 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.468 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 13.0 ptp -71.1 -18.44 62.53 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.121 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 235' ' ' THR . 84.8 t -89.12 -33.57 6.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.772 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.22 79.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.44 0.638 . . . . 0.0 109.392 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -105.52 23.27 14.08 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.233 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 55.4 p -60.63 -26.44 67.03 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.813 0.445 . . . . 0.0 111.66 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m -51.15 -51.26 55.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -130.15 89.42 2.79 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tm? -96.71 130.04 44.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.721 0.772 . . . . 0.0 110.801 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 245' ' ' LEU . 73.0 mt -127.6 128.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.432 ' CG2' ' HB ' ' A' ' 161' ' ' VAL . 8.1 tp -119.86 126.38 75.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.632 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.635 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 28.4 m -103.99 119.84 39.78 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.745 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 159' ' ' ARG . 19.5 m -120.92 149.31 23.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.367 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 251' ' ' PRO . 10.0 tmtt? -135.8 128.06 17.65 Favored Pre-proline 0 C--N 1.286 -2.168 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.326 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 50.3 Cg_exo -57.69 127.3 24.72 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.627 2.218 . . . . 0.0 113.041 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -106.58 4.1 27.68 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.972 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -83.89 69.04 10.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -119.26 129.48 54.94 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.984 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 4.6 tpm_? . . . . . 0 C--N 1.294 -1.845 0 CA-C-O 118.316 -0.849 . . . . 0.0 108.855 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.857 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.7 m 64.03 107.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.627 ' H ' ' HD3' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -71.35 99.34 1.94 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.676 0.75 . . . . 0.0 111.004 178.321 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.7 p -79.49 149.91 31.37 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.58 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -105.52 172.59 6.71 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.57 116.46 59.61 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.67 149.19 73.32 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.475 2.117 . . . . 0.0 113.052 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -86.15 91.43 8.43 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.1 pt -64.71 113.21 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.118 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.2 m -90.85 77.73 6.17 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-O 121.955 0.883 . . . . 0.0 109.887 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 10.8 tt -109.65 125.38 31.41 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.911 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 17.6 Cg_exo -66.88 134.12 33.62 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.135 1.89 . . . . 0.0 110.852 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -101.27 139.49 36.88 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.06 135.72 34.74 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -101.83 -64.64 1.04 Allowed 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.484 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -175.77 102.33 0.07 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.03 112.76 10.48 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.2 p -78.2 122.73 33.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.07 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.4 t -101.4 149.72 23.76 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.522 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.16 123.87 51.24 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.055 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.7 tp -62.12 115.84 2.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.145 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.31 136.99 38.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.4 t70 72.63 117.43 0.05 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 125.586 1.554 . . . . 0.0 114.636 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.1 m -145.5 144.37 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.91 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -106.22 142.24 36.24 Favored 'General case' 0 C--N 1.26 -3.304 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 153' ' ' ILE . 2.2 mp -80.92 -81.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.009 0.433 . . . . 0.0 110.412 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.03 102.11 17.7 Favored Pre-proline 0 C--N 1.295 -1.799 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.059 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.26 142.31 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.057 1.838 . . . . 0.0 110.666 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.5 82.15 5.66 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 121.339 0.59 . . . . 0.0 110.285 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.3 p -85.05 108.87 17.84 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.3 99.22 9.21 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -96.5 131.94 42.59 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.029 -163.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.509 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 22.1 ptt180 -105.14 112.74 25.97 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.16 133.41 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.865 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.655 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -98.44 134.8 40.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.627 0.727 . . . . 0.0 112.659 -176.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 45.0 tp -98.53 122.4 41.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.024 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.75 100.68 9.39 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-O 122.106 0.955 . . . . 0.0 112.21 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 64.2 pttt -74.61 147.31 41.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.376 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -100.62 20.5 14.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.49 -11.35 59.01 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.9 t -162.16 131.36 4.39 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 71.23 108.06 0.06 Allowed 'General case' 0 C--O 1.248 1.006 0 O-C-N 124.442 1.089 . . . . 0.0 112.014 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 165' ' ' LYS . 3.5 mppt? -90.62 121.96 67.65 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -81.21 70.0 7.64 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.964 1.776 . . . . 0.0 112.55 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -69.92 112.99 6.72 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.393 0.616 . . . . 0.0 110.992 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.443 ' HA2' ' CG1' ' A' ' 201' ' ' VAL . . . -104.93 33.78 6.3 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -158.85 145.25 16.96 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -137.11 135.81 37.75 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -135.37 139.6 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -141.88 158.65 43.53 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.142 0.577 . . . . 0.0 112.185 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.572 ' H ' HD23 ' A' ' 231' ' ' LEU . 13.0 t70 -74.5 139.41 43.83 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.173 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.05 179.23 36.64 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 m -99.44 141.59 32.03 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.739 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 43.4 t -112.46 146.82 37.74 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.002 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.04 123.86 71.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.9 mtt180 -123.5 160.64 26.53 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.35 106.45 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 43.7 p -111.1 179.61 3.99 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.0 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.27 -18.16 65.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.0 m -92.06 4.97 51.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.589 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.26 -152.54 19.26 Favored Glycine 0 C--O 1.212 -1.274 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.5 pt? -85.88 121.26 28.27 Favored 'General case' 0 N--CA 1.395 -3.199 0 CA-C-N 117.34 0.57 . . . . 0.0 110.034 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.03 159.98 35.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.846 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 181' ' ' SER . 68.1 mttm -106.93 143.76 34.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.648 0.592 . . . . 0.0 109.722 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -136.31 154.09 76.88 Favored Pre-proline 0 N--CA 1.426 -1.626 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.09 129.44 6.87 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.047 1.832 . . . . 0.0 109.397 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.63 -177.82 24.9 Favored Glycine 0 C--N 1.287 -2.157 0 C-N-CA 120.611 -0.805 . . . . 0.0 111.718 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.498 HG23 ' HB ' ' A' ' 218' ' ' VAL . 12.0 tt -129.48 122.24 55.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -114.48 173.15 6.61 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.087 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.4 126.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.3 t -89.53 -45.58 9.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.753 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -146.62 153.65 40.57 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 206' ' ' ALA . 49.1 tp -127.73 137.78 52.57 Favored 'General case' 0 N--CA 1.407 -2.601 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.443 ' CG1' ' HA2' ' A' ' 173' ' ' GLY . 8.2 p -103.47 137.3 19.21 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.84 126.45 18.14 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.765 1.643 . . . . 0.0 108.913 172.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.64 1.33 66.05 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.16 162.75 40.72 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.507 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.1 mm? -63.99 -36.32 83.59 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 112.144 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 200' ' ' LEU . . . -76.6 -27.9 55.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.611 0.719 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.41 -37.65 56.79 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.29 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.3 m -57.9 -33.63 68.96 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 120.773 0.321 . . . . 0.0 111.568 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 211' ' ' LEU . 4.3 m -68.06 -39.98 82.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.79 -33.6 2.36 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.25 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.401 ' H ' ' C ' ' A' ' 209' ' ' THR . 27.1 mt -77.84 -8.1 57.58 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.647 ' HA ' ' OD2' ' A' ' 216' ' ' ASP . 82.7 mt -108.63 127.85 54.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.964 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.53 163.85 25.06 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.65 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -54.41 -26.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 C-N-CA 123.502 0.721 . . . . 0.0 112.123 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.08 -23.64 64.04 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.647 ' OD2' ' HA ' ' A' ' 212' ' ' LEU . 34.7 m-20 -66.73 166.01 13.92 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.135 0.574 . . . . 0.0 112.077 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.539 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -134.0 169.56 16.94 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.498 ' HB ' HG23 ' A' ' 195' ' ' ILE . 87.7 t -89.47 136.45 23.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.279 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 250' ' ' LYS . 31.2 mt -96.68 -58.76 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.566 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.8 mt-10 -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.895 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.462 HG21 HG13 ' A' ' 234' ' ' VAL . 75.5 t -114.7 110.26 31.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.36 -77.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.752 0.821 . . . . 0.0 110.366 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -151.88 10.39 0.67 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.506 HG21 ' SD ' ' A' ' 237' ' ' MET . 3.0 mp -107.58 133.14 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.18 158.57 27.65 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.0 m -116.37 6.91 7.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.321 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -57.59 109.07 0.64 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.769 0.668 . . . . 0.0 111.554 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.99 5.37 47.23 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.53 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 233' ' ' GLN . 35.9 mtmm -110.53 174.99 5.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 234' ' ' VAL . 31.8 m -118.69 163.42 16.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.691 -1.595 . . . . 0.0 108.866 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 232' ' ' ASP . 2.7 pp -50.53 -41.5 53.92 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 231' ' ' LEU . 29.6 t70 -61.3 -51.03 70.58 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.267 0.556 . . . . 0.0 110.482 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 237' ' ' MET . 48.1 mt-30 -58.53 -45.12 89.52 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.774 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 230' ' ' THR . 71.5 t -66.59 -49.07 78.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 45.5 p -59.63 -37.11 77.76 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.3 -44.13 97.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.066 0.46 . . . . 0.0 109.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.7 mtm -64.11 -49.62 71.5 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.546 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.507 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 24.0 ptm -67.88 -23.44 65.13 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.325 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 235' ' ' THR . 60.7 t -79.41 -30.93 14.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.499 0.666 . . . . 0.0 109.933 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.77 -15.04 57.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -132.56 27.44 4.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 37.0 t -65.95 -18.68 65.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -172.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.2 t -52.08 -64.46 0.81 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -124.74 90.76 3.3 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 3.4 tm? -91.18 126.88 36.4 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.509 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.1 mp -110.82 119.04 58.67 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.77 139.01 34.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.566 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.2 m -108.51 120.11 41.46 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.111 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.7 m -122.67 157.5 27.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 120.733 0.302 . . . . 0.0 110.915 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.531 ' HB3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -130.09 124.92 21.71 Favored Pre-proline 0 N--CA 1.432 -1.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.112 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.1 Cg_endo -65.36 134.12 37.58 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.821 2.347 . . . . 0.0 113.329 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.71 4.68 43.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 75.16 83.74 0.1 Allowed 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 113.386 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -120.68 148.09 44.4 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.551 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 . . . . . 0 C--N 1.298 -1.644 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.196 -179.844 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 m -89.89 -38.25 13.84 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.754 0.312 . . . . 0.0 110.311 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -153.95 -76.86 0.11 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.193 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.4 m -100.57 130.27 46.61 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.073 0.463 . . . . 0.0 110.357 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -83.94 98.7 9.93 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.89 136.25 24.78 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.63 123.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.457 2.105 . . . . 0.0 112.032 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.0 t -89.93 89.85 7.91 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.2 mt -91.1 161.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.7 t -162.05 170.79 18.62 Favored 'General case' 0 N--CA 1.38 -3.934 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.6 120.84 69.56 Favored Pre-proline 0 C--N 1.257 -3.454 0 CA-C-O 120.988 0.423 . . . . 0.0 110.367 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -72.7 131.08 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.646 2.231 . . . . 0.0 111.654 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -101.15 113.9 27.37 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.531 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 143' ' ' ARG . 13.8 t70 -84.41 157.69 21.32 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 144' ' ' GLN . 69.0 t80 -48.93 -46.88 43.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 141' ' ' ASP . 37.9 ptt180 40.89 24.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 127.204 2.202 . . . . 0.0 116.103 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 53.4 tt0 -84.04 144.61 28.98 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.9 m -73.18 136.13 26.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.426 0.632 . . . . 0.0 111.401 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.3 p -80.66 128.13 33.27 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.988 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.76 121.52 40.81 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.2 tp -76.12 87.94 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 122.05 0.928 . . . . 0.0 111.558 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.48 142.26 18.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.96 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -130.17 164.58 24.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -75.08 -37.88 41.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.413 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -106.43 110.65 22.93 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 122.007 -0.433 . . . . 0.0 110.339 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tp -133.28 95.99 2.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.675 0.75 . . . . 0.0 111.808 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.66 116.21 19.49 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.52 131.22 9.32 Favored 'Trans proline' 0 C--O 1.253 1.255 0 C-N-CA 121.629 1.552 . . . . 0.0 110.949 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -72.82 91.84 1.54 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -83.16 97.69 8.95 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.852 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -81.57 99.28 8.74 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.522 ' HB3' HD11 ' A' ' 212' ' ' LEU . 26.7 tpt180 -109.87 136.07 49.75 Favored 'General case' 0 C--N 1.257 -3.423 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.932 -165.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 4.6 ptp180 -114.44 116.79 29.44 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.904 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.97 129.88 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -109.59 133.25 53.32 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.754 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 245' ' ' LEU . 4.0 mm? -110.45 120.46 42.5 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.718 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -115.12 110.23 19.22 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -72.59 121.22 19.36 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.935 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -126.9 124.75 40.26 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.84 16.29 77.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.239 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m 63.36 26.6 15.05 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 109.796 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -111.82 95.14 5.31 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -81.91 111.73 29.15 Favored Pre-proline 0 C--N 1.268 -2.967 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.551 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -73.79 -36.54 3.57 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.316 2.011 . . . . 0.0 111.123 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 35.9 tp 63.62 -91.31 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.455 1.102 . . . . 0.0 110.35 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 79.19 19.61 71.73 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.296 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -161.33 149.17 15.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -136.96 135.79 38.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -141.08 142.13 30.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.935 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.452 HH11 HD12 ' A' ' 231' ' ' LEU . 36.7 mmt180 -138.21 158.35 44.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.05 138.31 31.7 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.327 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -129.77 152.61 19.68 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -93.08 129.92 38.88 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 117.691 0.746 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -129.67 137.26 50.53 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.7 123.96 67.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.316 0.579 . . . . 0.0 110.203 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.15 160.38 18.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.045 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -103.3 113.23 39.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.234 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.3 p -110.23 178.62 4.34 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.794 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.95 -14.35 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.321 0.581 . . . . 0.0 109.752 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.0 m -89.27 -4.99 57.95 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 109.53 -161.07 13.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -84.14 124.5 31.21 Favored 'General case' 0 N--CA 1.396 -3.139 0 CA-C-N 117.877 0.839 . . . . 0.0 110.921 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -126.63 150.57 48.85 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.721 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.89 134.77 54.6 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.427 0.632 . . . . 0.0 110.125 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 24.6 mp0 -130.03 149.56 73.52 Favored Pre-proline 0 C--N 1.265 -3.07 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.631 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 3.3 Cg_exo -84.64 121.8 2.6 Favored 'Trans proline' 0 N--CA 1.429 -2.31 0 C-N-CA 122.084 1.856 . . . . 0.0 110.369 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -114.03 131.23 9.78 Favored Glycine 0 C--N 1.275 -2.845 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 66.2 mt -96.51 118.58 43.17 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -119.67 160.03 23.31 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 123.109 0.256 . . . . 0.0 110.984 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 67.8 mt -68.47 119.36 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.7 m -91.1 -35.21 14.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.053 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -150.82 140.05 21.24 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.486 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 47.4 tp -128.2 134.7 49.07 Favored 'General case' 0 N--CA 1.383 -3.824 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.896 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.36 128.26 25.74 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 51.3 Cg_exo -58.66 128.5 28.42 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.538 2.159 . . . . 0.0 109.783 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.49 -10.87 61.35 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 155.11 34.61 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -27.99 69.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.486 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -73.94 -33.9 64.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.732 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.6 tm-20 -76.53 -37.59 56.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.2 t -54.08 -31.79 52.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.951 1.3 . . . . 0.0 112.137 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 79.4 p -59.55 -41.6 90.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.845 0.355 . . . . 0.0 111.434 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.24 -25.56 4.84 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.394 -0.367 . . . . 0.0 113.293 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.3 -18.56 26.72 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.338 0.59 . . . . 0.0 110.184 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 159' ' ' ARG . 35.7 mt -113.28 145.6 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.758 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.71 163.23 26.6 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.376 1.07 . . . . 0.0 110.627 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.593 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 47.0 t -48.28 -35.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.316 1.046 . . . . 0.0 113.627 -176.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.67 -25.12 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.55 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.2 m-20 -62.42 159.63 15.09 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -114.74 165.3 12.96 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 195' ' ' ILE . 93.4 t -95.19 142.52 13.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 124.694 1.197 . . . . 0.0 110.805 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 250' ' ' LYS . 35.8 mt -109.71 -59.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.049 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.612 ' H ' ' HB ' ' A' ' 248' ' ' THR . 50.1 mt-10 -135.98 159.11 42.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.564 -173.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.1 t -122.42 118.83 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.974 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.5 t-20 70.28 -62.85 0.42 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.467 1.107 . . . . 0.0 110.739 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 178.77 24.64 0.04 OUTLIER Glycine 0 C--N 1.281 -2.487 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.33 133.27 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.71 141.87 48.2 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.914 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -117.66 20.17 6.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.718 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.67 129.88 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.692 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.06 1.91 59.48 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 233' ' ' GLN . 28.7 mmmt -99.08 153.67 18.7 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.331 0.652 . . . . 0.0 109.933 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 234' ' ' VAL . 17.2 m -101.91 161.35 13.73 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 230' ' ' THR . 1.7 pt? -49.43 -46.28 47.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.19 -38.86 78.88 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.823 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.564 ' HB3' ' HE3' ' A' ' 229' ' ' LYS . 47.5 mt-30 -58.12 -44.88 87.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.086 175.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 230' ' ' THR . 61.7 t -66.66 -43.89 90.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 O-C-N 123.494 0.496 . . . . 0.0 111.122 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.4 p -70.35 -34.67 72.91 Favored 'General case' 0 C--O 1.206 -1.218 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.42 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.1 -41.2 99.33 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.019 0.914 . . . . 0.0 109.485 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.504 ' HB3' ' O ' ' A' ' 234' ' ' VAL . 8.5 tpt -56.78 -48.66 77.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.96 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.459 ' HB2' ' CD2' ' A' ' 245' ' ' LEU . 22.2 ptm -76.11 -17.97 59.37 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.913 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 235' ' ' THR . 70.0 t -88.7 -25.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.42 0.629 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.83 -20.78 16.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.628 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -121.13 -69.43 0.84 Allowed 'General case' 0 N--CA 1.389 -3.516 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.767 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 32.2 t 61.04 -39.76 0.11 Allowed 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.7 m -58.36 -39.77 80.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.811 0.844 . . . . 0.0 110.276 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -129.24 90.37 3.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 238' ' ' MET . 3.2 tm? -99.88 124.35 45.1 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.315 0.579 . . . . 0.0 110.088 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 60.7 mt -127.24 123.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.8 tp -109.42 122.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.727 0.775 . . . . 0.0 108.97 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.612 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.6 m -106.29 127.23 53.09 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.641 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 212' ' ' LEU . 18.5 m -129.29 162.91 35.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.267 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.469 ' HB2' HD11 ' A' ' 219' ' ' ILE . 26.4 ttmt -130.45 136.58 29.19 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 124.759 1.224 . . . . 0.0 108.307 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 27.6 Cg_exo -65.03 127.4 18.39 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.494 1.463 . . . . 0.0 110.569 173.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -85.34 -27.55 25.8 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.223 0.535 . . . . 0.0 109.83 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 61.0 27.74 17.6 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.836 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -98.79 31.65 2.87 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.674 0.75 . . . . 0.0 110.987 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 . . . . . 0 C--N 1.281 -2.37 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.43 179.17 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.0 t -136.26 143.41 44.24 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -132.85 138.58 47.09 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.958 0.409 . . . . 0.0 110.155 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -108.1 121.65 45.27 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -154.27 149.56 27.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 120.908 0.385 . . . . 0.0 110.964 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.55 106.46 32.46 Favored Pre-proline 0 N--CA 1.43 -1.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.387 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.1 -39.74 88.67 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.74 2.293 . . . . 0.0 109.862 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.4 p -147.0 112.97 5.77 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.96 119.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.537 1.16 . . . . 0.0 113.044 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 96.28 3.97 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.576 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.439 HD12 ' HD2' ' A' ' 139' ' ' PRO . 8.6 tp -95.31 133.69 25.61 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.197 -175.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 138' ' ' ILE . 33.6 Cg_exo -63.06 126.88 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.933 1.755 . . . . 0.0 110.293 176.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -82.88 164.15 20.68 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.857 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.89 121.73 25.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.437 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -152.8 -55.53 0.12 Allowed 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.651 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -97.43 71.62 2.34 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 122.509 1.147 . . . . 0.0 109.595 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -64.64 118.81 9.42 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.982 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.7 m -81.19 152.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.563 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.1 t -97.94 137.97 35.98 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.18 104.35 11.6 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.306 0.574 . . . . 0.0 110.832 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.5 tt -82.88 133.06 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.247 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.39 141.76 15.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.2 t70 72.07 94.72 0.07 Allowed 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 124.451 1.1 . . . . 0.0 112.018 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 68.0 t -132.2 -39.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.479 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -73.53 108.5 6.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.023 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 tp -154.07 136.88 7.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.64 101.47 48.4 Favored Pre-proline 0 C--N 1.294 -1.846 0 CA-C-O 121.311 0.577 . . . . 0.0 110.742 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.2 150.83 23.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.586 2.191 . . . . 0.0 111.453 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB3' ' CE1' ' A' ' 158' ' ' HIS . 41.4 mt-10 -75.34 84.37 2.48 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 120.967 0.413 . . . . 0.0 112.092 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -91.88 100.5 13.17 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 78.5 m80 -75.26 112.48 11.59 Favored 'General case' 0 CA--C 1.47 -2.108 0 CA-C-O 121.782 0.801 . . . . 0.0 109.292 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.466 ' HG3' HG21 ' A' ' 209' ' ' THR . 1.7 tmt_? -110.53 135.16 51.62 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.106 -1.407 . . . . 0.0 107.578 -170.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 85.2 mtm180 -114.3 140.95 48.2 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.037 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.87 132.11 57.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 163' ' ' LEU . 6.6 mpt_? -105.9 138.72 41.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.072 0.463 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 8.2 mp -126.77 124.69 40.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.89 0.876 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.48 107.74 18.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 122.064 0.935 . . . . 0.0 113.022 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.469 ' HD2' ' OG ' ' A' ' 242' ' ' SER . 88.5 tttt -78.23 142.87 37.59 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.288 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -106.24 26.44 9.8 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.323 0.582 . . . . 0.0 110.414 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 165' ' ' LYS . . . 96.95 -11.54 65.98 Favored Glycine 0 CA--C 1.498 -0.974 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -164.08 146.68 9.28 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 125.624 1.57 . . . . 0.0 106.868 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.256 6.8 m-20 49.69 96.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 175.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -84.25 127.06 67.91 Favored Pre-proline 0 C--N 1.299 -1.616 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.065 174.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.408 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 26.1 Cg_endo -62.06 102.83 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.835 2.357 . . . . 0.0 112.614 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.61 144.25 28.91 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.824 0.821 . . . . 0.0 112.459 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.6 38.19 1.53 Allowed Glycine 0 C--N 1.286 -2.238 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.406 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -158.58 151.89 22.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.424 ' HB2' ' HB2' ' A' ' 199' ' ' ARG . 97.7 m-85 -137.0 135.14 37.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.9 pt -137.49 148.64 25.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.517 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.47 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 13.2 ptm180 -142.56 158.5 43.61 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.22 145.47 30.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 0.0 109.727 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.85 -172.5 13.48 Favored Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 191' ' ' LYS . 6.5 m -126.54 142.93 51.37 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 117.836 0.818 . . . . 0.0 109.003 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.0 m -114.9 131.32 56.91 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.7 122.46 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -121.85 155.16 35.97 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.279 0.561 . . . . 0.0 110.504 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 120.47 54.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.639 -174.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.3 p -115.73 177.66 4.59 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.05 -2.9 49.99 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.707 0.765 . . . . 0.0 109.317 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.4 m -97.34 -4.37 38.67 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.82 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.73 -156.25 15.74 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.49 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 189' ' ' LEU . 2.0 mm? -88.96 135.32 33.61 Favored 'General case' 0 N--CA 1.403 -2.819 0 C-N-CA 122.747 0.419 . . . . 0.0 109.979 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.28 150.13 46.37 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.832 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.476 ' HB3' ' CG2' ' A' ' 180' ' ' THR . 50.9 mtmt -108.14 142.76 37.86 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.998 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 13.9 pt20 -134.76 141.98 40.7 Favored Pre-proline 0 N--CA 1.413 -2.319 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.666 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.8 Cg_exo -74.46 129.05 12.45 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 110.895 177.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.32 137.41 8.55 Favored Glycine 0 C--N 1.287 -2.172 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.421 HD12 ' HB ' ' A' ' 226' ' ' VAL . 57.3 mt -97.41 125.32 50.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 89.8 m-85 -118.63 167.01 12.04 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.945 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.53 136.51 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 30.5 p -117.05 -44.07 2.82 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.978 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.424 ' HB2' ' HB2' ' A' ' 175' ' ' TYR . 98.8 mtt180 -137.63 145.17 42.41 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 206' ' ' ALA . 4.8 mt -127.74 137.69 52.52 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.829 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.67 130.1 27.39 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -59.94 126.77 21.24 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.763 1.642 . . . . 0.0 110.079 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 90.74 -7.66 80.95 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.779 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.2 160.94 52.46 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.6 mm? -56.66 -45.09 81.85 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.775 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -70.71 -28.94 65.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.325 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.56 ' HB2' HD22 ' A' ' 200' ' ' LEU . 8.7 tp10 -76.37 -42.46 44.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.516 0.675 . . . . 0.0 109.209 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 39.7 t -60.56 -33.3 72.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.812 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.474 HG22 ' HG ' ' A' ' 211' ' ' LEU . 29.1 m -62.61 -41.5 99.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.112 0.482 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.86 -45.85 3.58 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 121.171 -0.538 . . . . 0.0 114.372 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.482 HD12 HD22 ' A' ' 212' ' ' LEU . 4.3 pp -74.39 -4.25 35.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 211' ' ' LEU . 2.7 mm? -109.68 143.97 38.7 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -128.87 163.06 26.07 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 124.311 1.044 . . . . 0.0 109.204 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.71 -21.3 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 123.82 0.848 . . . . 0.0 112.99 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 254' ' ' GLN . 5.4 t-20 -71.87 -29.24 64.16 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.059 0.544 . . . . 0.0 111.559 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.689 ' HB3' ' O ' ' A' ' 250' ' ' LYS . 74.5 m-20 -68.03 163.09 23.1 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -169.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 0.5 OUTLIER -116.37 167.06 11.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.243 -0.983 . . . . 0.0 113.231 -173.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 61.0 t -98.88 142.12 15.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.465 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.17 -46.98 6.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.949 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.449 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.6 mt-10 -136.15 154.3 51.01 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 121.57 0.7 . . . . 0.0 112.085 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 238' ' ' MET . 59.5 t -118.52 101.79 12.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 113.534 -1.666 . . . . 0.0 106.509 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.589 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 61.0 t30 71.23 -68.36 0.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.56 1.544 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.05 8.25 0.32 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.418 HG21 ' SD ' ' A' ' 237' ' ' MET . 29.2 mt -107.27 118.2 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 46.9 mt-10 -74.04 142.16 45.72 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.72 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.421 ' HB ' HD12 ' A' ' 195' ' ' ILE . 29.0 m -95.08 18.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.49 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.08 109.46 2.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.08 0.466 . . . . 0.0 110.325 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.59 61.95 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.637 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -84.42 169.16 14.85 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 85.3 m -121.29 158.73 27.51 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.37 -1.741 . . . . 0.0 106.696 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 234' ' ' VAL . 57.8 tp -67.1 -46.82 73.07 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.984 0.811 . . . . 0.0 111.894 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.06 -37.96 75.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.13 0.49 . . . . 0.0 111.251 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.5 mp0 -74.42 -44.52 51.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 231' ' ' LEU . 8.9 p -66.25 -38.47 81.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.689 0.28 . . . . 0.0 110.833 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.539 ' HA ' ' SD ' ' A' ' 238' ' ' MET . 10.8 t -66.12 -32.13 73.4 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.91 -43.5 83.19 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 22.7 mtm -62.4 -43.78 98.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.193 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptm -75.58 -13.89 60.37 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.828 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 242' ' ' SER . 66.0 t -87.78 -37.25 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 109.829 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.88 69.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.492 0.663 . . . . 0.0 110.281 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -108.66 21.25 17.51 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.423 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 36.9 t -67.05 -24.5 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 31.7 m -52.12 -51.63 56.63 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.559 0.537 . . . . 0.0 110.59 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -128.75 87.98 2.66 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.3 tm? -93.43 131.36 38.7 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.969 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 71.1 mt -127.43 139.48 51.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 9.3 tt -129.62 134.53 63.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.144 174.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 39.4 m -102.31 120.63 40.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.213 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.35 155.25 15.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 36.2 tttm -138.34 140.29 27.88 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.422 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 36.6 Cg_endo -68.75 127.46 15.44 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 121.626 1.55 . . . . 0.0 110.157 172.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -4.67 58.65 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 122.596 0.358 . . . . 0.0 111.454 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 66.35 102.35 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.445 ' HA ' ' OD1' ' A' ' 215' ' ' ASN . 19.4 tm0? -61.9 109.03 1.13 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.733 1.254 . . . . 0.0 112.483 -172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 . . . . . 0 C--N 1.281 -2.386 0 CA-C-N 112.212 -2.267 . . . . 0.0 105.953 179.486 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.705 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.0 t -154.09 116.21 4.29 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -104.05 118.45 36.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -77.01 137.16 38.82 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.625 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -105.33 92.0 4.02 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.728 0.775 . . . . 0.0 109.854 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.27 110.23 37.94 Favored Pre-proline 0 C--N 1.301 -1.513 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.632 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.79 111.92 2.94 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.161 1.907 . . . . 0.0 108.962 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.8 p -101.9 103.27 13.94 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.54 0.686 . . . . 0.0 112.566 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 62.2 mt 68.15 147.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.822 1.649 . . . . 0.0 112.23 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -156.33 91.37 1.25 Allowed 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.5 tt -120.68 103.98 42.9 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-O 121.539 0.685 . . . . 0.0 112.599 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -84.47 137.84 7.11 Favored 'Trans proline' 0 N--CA 1.429 -2.283 0 C-N-CA 121.667 1.578 . . . . 0.0 109.711 174.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -82.48 114.39 20.87 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.88 124.4 34.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -170.87 96.46 0.21 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -138.37 85.87 2.12 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -82.0 110.2 17.03 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.041 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.5 m -73.74 125.02 32.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.215 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.1 m -74.94 113.97 12.86 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.11 108.47 18.18 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.435 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.08 97.56 5.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.0 pt -85.15 115.97 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.814 0.816 . . . . 0.0 110.31 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -112.61 100.13 8.49 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-O 122.273 1.035 . . . . 0.0 110.589 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.03 -45.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.158 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 153' ' ' ILE . 26.6 t70 -77.96 130.82 37.01 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.259 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.495 HG12 ' H ' ' A' ' 154' ' ' VAL . 12.2 tt 56.74 170.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 126.969 2.107 . . . . 0.0 112.274 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.495 ' H ' HG12 ' A' ' 153' ' ' ILE . 6.7 p -101.98 105.62 43.04 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.668 -0.645 . . . . 0.0 109.382 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.15 150.25 29.15 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.114 1.876 . . . . 0.0 110.04 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.51 69.07 6.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.327 0.584 . . . . 0.0 112.506 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.2 t -91.33 128.39 37.14 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.441 ' CE1' ' HG2' ' A' ' 250' ' ' LYS . 30.3 m170 -99.74 128.27 45.85 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.23 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -96.76 120.81 37.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.914 -169.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -106.33 107.84 19.05 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.23 132.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -108.88 149.08 29.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.92 130.37 43.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.401 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.85 111.61 18.18 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 121.591 0.71 . . . . 0.0 111.203 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -68.25 146.72 53.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.619 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -121.41 76.85 1.28 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.46 -2.67 84.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.522 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.4 t 58.63 72.77 0.51 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.56 1.144 . . . . 0.0 110.3 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -103.92 -49.77 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.97 150.24 47.25 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.562 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 -162.93 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 110.992 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.442 HD23 ' CZ ' ' A' ' 174' ' ' PHE . 4.9 mp -92.94 144.32 25.38 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -89.9 25.47 11.73 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.61 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.442 ' CZ ' HD23 ' A' ' 172' ' ' LEU . 41.9 p90 -158.7 147.32 18.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -132.31 142.83 49.5 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.468 HG21 HG11 ' A' ' 218' ' ' VAL . 29.2 pt -133.16 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.327 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.561 ' HG2' ' N ' ' A' ' 178' ' ' ASP . 78.1 ttt180 -141.23 159.87 41.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.561 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 7.7 p-10 -72.99 157.71 36.88 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.878 0.847 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.32 149.91 18.01 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -93.86 140.76 29.29 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -131.23 134.22 46.23 Favored 'General case' 0 C--N 1.261 -3.279 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.84 123.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.95 107.69 21.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.3 p -115.18 177.72 4.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.14 59.92 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.448 0.642 . . . . 0.0 109.416 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.1 m -89.51 -4.42 57.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.528 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.64 -154.48 16.86 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 189' ' ' LEU . 2.1 pt? -84.35 118.35 24.17 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-O 122.001 0.905 . . . . 0.0 109.962 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -120.89 144.88 48.18 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.059 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -101.42 143.87 30.91 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -133.08 144.2 51.68 Favored Pre-proline 0 C--N 1.281 -2.412 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.266 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.12 128.62 5.03 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 C-N-CA 122.519 2.146 . . . . 0.0 109.298 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 178' ' ' ASP . . . -140.31 163.06 26.45 Favored Glycine 0 C--N 1.277 -2.725 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.797 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 218' ' ' VAL . 63.0 mt -116.89 119.64 62.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 56.6 m-85 -118.95 167.04 12.11 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.998 -175.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.0 122.73 18.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.514 ' C ' ' HD2' ' A' ' 199' ' ' ARG . 76.6 p -96.04 -67.36 0.85 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.867 0.365 . . . . 0.0 111.494 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.514 ' HD2' ' C ' ' A' ' 198' ' ' SER . 7.2 mpt_? -124.88 154.19 41.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.938 0.495 . . . . 0.0 110.351 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.74 139.44 52.68 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.966 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -99.25 126.86 36.37 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.87 126.44 20.43 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.108 1.872 . . . . 0.0 109.946 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.9 -6.86 54.66 Favored Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.26 151.46 34.86 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.65 -29.9 70.37 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.19 70.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.224 0.535 . . . . 0.0 110.568 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -77.34 -43.47 32.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 m -55.24 -33.61 63.27 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.613 ' OG1' ' HG ' ' A' ' 211' ' ' LEU . 5.2 t -69.61 -44.92 69.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.744 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 -12.75 4.52 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.469 -0.872 . . . . 0.0 114.39 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.613 ' HG ' ' OG1' ' A' ' 209' ' ' THR . 3.8 pp -89.67 -3.93 58.0 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 118.836 1.318 . . . . 0.0 111.494 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.494 ' HG ' HD12 ' A' ' 211' ' ' LEU . 88.5 mt -109.54 146.11 35.19 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.617 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.69 162.68 16.92 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 123.671 0.788 . . . . 0.0 110.533 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.16 -16.82 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-O 122.454 1.121 . . . . 0.0 110.425 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -75.52 -23.67 56.71 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.301 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.581 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.8 m-20 -63.75 156.43 27.17 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -171.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.501 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 31.1 mt-10 -109.51 150.84 27.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.929 -170.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.506 HG23 HG21 ' A' ' 226' ' ' VAL . 23.2 m -98.58 143.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.453 HG22 ' HG3' ' A' ' 220' ' ' GLU . 43.1 mt -109.33 -56.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.586 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.4 mt-10 -130.27 149.86 51.77 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.633 -172.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 238' ' ' MET . 67.5 t -116.02 112.48 39.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 67.73 -70.14 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.26 1.024 . . . . 0.0 110.014 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.84 11.09 0.1 OUTLIER Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.53 135.78 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.25 159.18 29.83 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.287 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.506 HG21 HG23 ' A' ' 218' ' ' VAL . 20.6 m -102.95 3.63 10.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.867 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -55.21 108.9 0.46 Allowed 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.993 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.49 90.53 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.465 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -87.17 160.12 18.62 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.8 m -81.55 158.28 24.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.537 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 178' ' ' ASP . 4.1 mp -70.55 -41.39 72.53 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 118.425 0.557 . . . . 0.0 109.98 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.73 -39.26 73.62 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.378 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 237' ' ' MET . 21.1 tp60 -67.74 -47.16 70.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.294 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.407 ' HA ' ' HE2' ' A' ' 237' ' ' MET . 97.2 t -67.29 -45.42 86.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.048 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.485 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 8.8 t -64.59 -29.11 70.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.14 -48.91 77.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.292 0.567 . . . . 0.0 109.478 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 29.4 mtm -62.67 -40.18 96.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.129 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.513 ' HB3' HG11 ' A' ' 221' ' ' VAL . 15.4 ptm -76.24 -20.27 57.57 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.681 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 79.8 t -91.7 -36.8 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.352 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.42 69.94 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -109.23 23.24 14.79 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.323 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.681 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 63.7 m -64.97 -18.82 65.6 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -67.52 -39.66 85.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -129.45 79.66 1.92 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 3.3 tm? -99.41 129.59 45.61 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.535 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.06 132.28 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 6.9 tp -118.24 120.8 65.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.029 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.586 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.3 m -92.35 119.32 31.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.359 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.428 HG12 HG12 ' A' ' 218' ' ' VAL . 3.1 m -120.45 139.43 47.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.802 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 158' ' ' HIS . 0.4 OUTLIER -126.65 123.46 23.91 Favored Pre-proline 0 N--CA 1.413 -2.305 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.092 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.581 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 31.6 Cg_exo -58.25 133.72 57.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.866 2.377 . . . . 0.0 113.515 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -94.92 3.1 55.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -90.58 81.1 5.92 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -131.73 135.23 46.67 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.002 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 119.15 -0.453 . . . . 0.0 110.097 -177.226 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.827 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.1 p -164.0 161.93 22.94 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 122.24 0.216 . . . . 0.0 110.84 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.521 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -161.79 132.98 5.25 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.511 0.725 . . . . 0.0 110.994 175.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 28.5 m -102.06 122.65 44.51 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -134.23 152.58 51.89 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.89 117.52 66.33 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.42 -34.86 75.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.343 2.028 . . . . 0.0 110.61 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.7 t -121.06 108.02 13.32 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.72 154.36 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.1 t -91.83 83.45 5.25 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.58 112.61 32.43 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.449 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.74 133.05 45.86 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.306 2.004 . . . . 0.0 110.733 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -100.17 114.54 28.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.31 153.4 18.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.786 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 69.1 t80 -92.68 79.74 4.79 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -116.43 20.31 14.24 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.275 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 142' ' ' PHE . 2.0 mp0 -65.6 162.51 18.12 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.345 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.28 116.52 13.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 122.385 1.088 . . . . 0.0 110.969 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -89.99 153.86 20.27 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.962 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.92 116.54 31.38 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tp -79.3 123.61 36.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.905 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.2 tp -91.17 138.08 20.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.516 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.95 121.65 0.03 OUTLIER 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.932 1.293 . . . . 0.0 113.88 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.37 136.39 36.59 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.34 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.589 ' O ' HG22 ' A' ' 153' ' ' ILE . 22.4 t70 -85.35 138.66 32.14 Favored 'General case' 0 C--N 1.258 -3.408 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 152' ' ' ASP . 9.7 tt 63.93 165.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 126.381 1.872 . . . . 0.0 109.114 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.7 t -96.87 104.79 19.85 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.349 -0.844 . . . . 0.0 108.921 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 30.7 Cg_exo -62.79 151.44 83.99 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 122.769 2.313 . . . . 0.0 109.232 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.54 80.35 0.1 Allowed 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 121.936 0.874 . . . . 0.0 113.322 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.1 m -92.96 85.11 5.03 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -98.81 113.54 25.7 Favored 'General case' 0 CA--C 1.467 -2.228 0 CA-C-O 121.391 0.615 . . . . 0.0 109.845 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.488 ' HG2' HG21 ' A' ' 209' ' ' THR . 4.1 tpm_? -100.25 123.69 44.79 Favored 'General case' 0 C--N 1.271 -2.847 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.283 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HB3' ' CG2' ' A' ' 246' ' ' ILE . 67.9 mtm180 -99.92 112.33 24.6 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.92 125.75 42.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 39.6 ptt180 -102.87 142.24 34.32 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.07 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.9 tm? -116.77 123.1 46.32 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 164' ' ' LEU . 2.9 pp -111.05 100.87 9.47 Favored 'General case' 0 N--CA 1.398 -3.038 0 CA-C-O 122.499 1.142 . . . . 0.0 112.049 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 243' ' ' SER . 12.8 tmtt? -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.811 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 14.2 p80 179.8 117.9 0.05 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.326 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.75 0.41 66.63 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.115 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 t -171.88 148.56 2.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.98 -39.87 83.23 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 170' ' ' LYS . 39.5 ttmt 62.89 121.38 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.027 1.331 . . . . 0.0 113.629 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.42 22.94 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.365 2.71 . . . . 0.0 113.108 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp 66.5 -73.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.798 1.239 . . . . 0.0 112.854 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 108.89 -12.71 34.8 Favored Glycine 0 CA--C 1.497 -1.06 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -128.12 143.9 51.08 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.17 161.07 35.42 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 123.185 0.303 . . . . 0.0 110.813 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -130.62 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.41 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 14.4 ttp180 -141.66 147.95 38.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 12.2 p-10 -102.46 127.12 49.63 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.532 0.682 . . . . 0.0 111.521 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -112.23 117.32 4.35 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 23.5 p -92.72 143.19 26.54 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 117.722 0.761 . . . . 0.0 112.363 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.0 t -127.42 132.4 50.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.16 124.0 49.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -120.97 157.09 30.7 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 63.2 t -102.64 116.6 46.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.8 p -115.62 177.81 4.53 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.701 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.37 -14.57 62.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.204 0.526 . . . . 0.0 109.918 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.3 p -91.94 -0.24 57.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.056 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.83 -165.35 12.04 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.7 pt? -84.83 106.47 16.38 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.314 1.054 . . . . 0.0 110.712 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -104.31 152.44 22.23 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.266 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 39.6 ttpt -121.3 133.39 55.13 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 29.9 pt20 -116.7 143.91 32.3 Favored Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.358 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 9.8 Cg_endo -88.18 126.51 2.0 Allowed 'Trans proline' 0 N--CA 1.427 -2.428 0 C-N-CA 122.227 1.951 . . . . 0.0 112.734 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.67 86.32 0.45 Allowed Glycine 0 C--N 1.279 -2.617 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 12.1 tt -82.11 133.66 28.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 120.597 0.237 . . . . 0.0 110.438 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -142.87 177.56 8.26 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.542 0.737 . . . . 0.0 110.74 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.2 mt -71.99 134.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.41 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 68.3 p -109.84 -59.95 1.85 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.8 147.87 47.19 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.059 0.457 . . . . 0.0 111.043 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.816 HD21 ' HB3' ' A' ' 206' ' ' ALA . 11.2 mt -127.06 138.3 53.19 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.646 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.89 132.63 20.71 Favored Pre-proline 0 C--N 1.286 -2.16 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.96 126.79 23.74 Favored 'Trans proline' 0 C--O 1.251 1.125 0 C-N-CA 121.808 1.672 . . . . 0.0 110.057 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.89 60.78 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.83 149.14 51.13 Favored Glycine 0 C--O 1.214 -1.144 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.415 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.8 mm? -56.73 -35.61 68.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.816 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -73.42 -28.08 61.79 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.738 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.19 -43.33 43.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.1 m -54.7 -32.9 60.15 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.223 1.009 . . . . 0.0 112.222 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.491 HG22 ' HG ' ' A' ' 211' ' ' LEU . 25.5 m -63.94 -43.28 96.36 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.845 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.8 -56.72 3.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.433 -0.349 . . . . 0.0 113.857 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 209' ' ' THR . 4.1 pp -70.93 2.23 4.6 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.625 1.17 . . . . 0.0 113.292 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.593 HD21 ' CG2' ' A' ' 249' ' ' VAL . 25.7 tp -119.99 145.74 46.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.82 161.64 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.245 0.545 . . . . 0.0 112.062 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.63 -24.66 13.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.844 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -68.93 -24.6 64.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.348 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 70.5 m-20 -60.13 139.96 57.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.249 0.62 . . . . 0.0 111.878 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.66 145.08 26.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -170.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 195' ' ' ILE . 84.1 t -78.0 135.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.886 1.274 . . . . 0.0 110.993 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.43 HG13 ' HD2' ' A' ' 250' ' ' LYS . 44.8 mm -122.23 -43.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.134 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.571 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.5 mt-10 -136.58 151.33 49.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.484 0.659 . . . . 0.0 112.045 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.49 109.12 26.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.533 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 69.82 -66.62 0.26 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.452 1.101 . . . . 0.0 111.229 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.93 15.78 0.09 OUTLIER Glycine 0 C--N 1.294 -1.765 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.92 133.55 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 44.6 mt-10 -82.33 149.42 27.76 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.57 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.574 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 19.1 m -89.62 14.1 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.021 -177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -88.73 109.36 20.08 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.4 15.09 26.27 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.737 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 1.1 pptp? -104.85 174.36 5.91 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 26.3 m -106.06 158.64 16.66 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.654 ' O ' HG12 ' A' ' 234' ' ' VAL . 4.7 tt -60.44 -47.49 85.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.859 0.464 . . . . 0.0 110.798 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.15 -36.42 74.74 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.281 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.71 -37.86 80.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 231' ' ' LEU . 7.5 p -58.18 -44.67 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.409 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.7 p -70.54 -35.47 73.15 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.341 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.35 -43.36 81.69 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.815 0.817 . . . . 0.0 110.327 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 76.1 mtp -61.92 -44.59 96.46 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.701 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.409 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 25.7 ptm -70.54 -24.4 62.8 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 235' ' ' THR . 96.8 t -83.24 -32.26 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 0.0 109.798 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.64 68.75 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.618 0.723 . . . . 0.0 109.844 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -107.98 22.24 16.24 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 68.4 m -54.45 -31.46 55.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 34.2 t -50.83 -58.16 6.65 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.736 0.303 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -130.58 89.61 2.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.4 tm? -101.14 130.88 47.29 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' ' 160' ' ' ARG . 68.1 mt -118.32 123.81 72.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.85 118.79 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 122.098 0.951 . . . . 0.0 109.565 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.571 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 19.8 m -95.82 120.15 35.58 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.942 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.593 ' CG2' HD21 ' A' ' 212' ' ' LEU . 29.8 m -129.34 149.53 33.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.43 ' HD2' HG13 ' A' ' 219' ' ' ILE . 97.2 mttt -127.03 128.49 24.16 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.683 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.9 Cg_exo -39.23 126.9 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.07 3.18 . . . . 0.0 115.009 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.25 8.49 32.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.535 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -83.36 -6.42 59.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.415 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.444 ' HA ' ' OE1' ' A' ' 254' ' ' GLN . 5.5 tp60 -119.32 125.29 48.69 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.012 174.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 . . . . . 0 C--N 1.282 -2.352 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.736 -175.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.817 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.4 m -88.81 -3.35 58.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.157 0.503 . . . . 0.0 111.007 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -129.46 124.29 33.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -75.43 142.23 43.04 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.76 0.314 . . . . 0.0 110.216 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 134' ' ' PRO . 25.3 pttm -91.22 112.59 24.56 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.93 99.29 34.3 Favored Pre-proline 0 C--N 1.289 -2.05 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.949 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 132' ' ' LYS . 31.8 Cg_exo -61.86 110.56 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.237 1.958 . . . . 0.0 110.189 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 m -80.15 99.06 7.58 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.7 tt -54.02 135.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.728 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.7 p -129.25 88.93 2.77 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.039 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.95 138.77 19.65 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.766 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.12 123.13 11.26 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.373 2.049 . . . . 0.0 111.021 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -90.29 152.64 20.95 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.828 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.33 121.96 33.53 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -113.12 -52.35 2.78 Favored 'General case' 0 C--N 1.261 -3.274 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 58.9 89.71 0.06 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.839 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -76.38 111.71 12.13 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.7 m -101.15 140.54 19.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 t -88.02 114.88 25.08 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.3 103.11 13.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 tt -121.4 96.51 4.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.799 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.38 117.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.084 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -101.73 -2.71 29.58 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.815 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.93 -49.46 79.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -102.72 118.86 37.77 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 153' ' ' ILE . 2.2 mp -71.98 -46.3 60.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.83 102.05 19.82 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -81.32 148.71 16.68 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.202 1.935 . . . . 0.0 109.259 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -74.81 85.71 2.2 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.547 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.7 p -81.73 114.94 20.73 Favored 'General case' 0 N--CA 1.408 -2.566 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.399 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.74 99.7 12.28 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.477 ' HG3' HG13 ' A' ' 161' ' ' VAL . 32.9 tpt180 -103.24 125.72 50.05 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.054 -170.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.498 ' HG2' ' OG1' ' A' ' 248' ' ' THR . 88.2 mtt180 -103.3 105.0 15.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.698 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.477 HG13 ' HG3' ' A' ' 159' ' ' ARG . 23.0 m -104.69 132.53 51.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 120.96 0.409 . . . . 0.0 110.94 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -103.06 142.76 33.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.457 HD13 ' H ' ' A' ' 173' ' ' GLY . 72.1 mt -133.39 145.42 50.31 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.828 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 164' ' ' LEU . 1.0 OUTLIER -120.4 120.43 35.94 Favored 'General case' 0 N--CA 1.404 -2.744 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.578 172.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.548 ' HG2' ' HB3' ' A' ' 242' ' ' SER . 0.0 OUTLIER -65.98 143.48 57.35 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.538 -178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 169' ' ' ASP . 37.5 m80 -110.86 -37.34 5.43 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.494 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.53 -11.69 37.71 Favored Glycine 0 N--CA 1.459 0.183 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.959 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 3.13 15.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 25.2 t70 171.68 117.19 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.413 2.285 . . . . 0.0 105.916 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.425 ' HG3' ' OD2' ' A' ' 169' ' ' ASP . 56.7 mttp 66.77 86.59 0.13 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 124.949 1.3 . . . . 0.0 112.478 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -75.84 -32.27 4.59 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.168 1.912 . . . . 0.0 107.915 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 174' ' ' PHE . 1.8 pt? -152.95 127.12 9.12 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.118 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.457 ' H ' HD13 ' A' ' 163' ' ' LEU . . . -95.65 48.11 1.87 Allowed Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.443 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 172' ' ' LEU . 54.1 p90 -169.75 156.82 6.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 67.6 m-85 -137.73 135.41 36.37 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 169.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.605 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.0 pt -132.78 144.71 35.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -136.4 136.63 39.75 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.729 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.483 ' H ' HD23 ' A' ' 231' ' ' LEU . 17.8 t70 -87.21 123.16 31.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.847 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -131.1 174.72 19.82 Favored Glycine 0 C--N 1.276 -2.789 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 141.84 32.63 Favored 'General case' 0 C--N 1.271 -2.81 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.322 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t -123.09 136.87 54.98 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.44 124.03 63.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -116.19 154.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-O 121.019 0.438 . . . . 0.0 110.254 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.37 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.7 p -115.6 177.29 4.72 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.098 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.36 -16.86 61.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.6 p -91.85 5.75 48.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.17 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 -156.26 15.66 Favored Glycine 0 C--O 1.214 -1.154 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.882 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 189' ' ' LEU . 0.5 OUTLIER -98.95 106.77 19.06 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.77 0.795 . . . . 0.0 109.373 175.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.21 152.14 23.21 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.697 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -121.09 130.92 53.97 Favored 'General case' 0 N--CA 1.402 -2.852 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -147.76 150.88 37.52 Favored Pre-proline 0 C--N 1.265 -3.09 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.977 -172.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.68 134.96 19.07 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.206 1.937 . . . . 0.0 110.273 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.04 134.65 6.87 Favored Glycine 0 C--N 1.301 -1.391 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.605 ' CG2' ' HB ' ' A' ' 176' ' ' ILE . 58.2 mt -104.61 119.82 54.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.753 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -120.65 156.97 30.58 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.665 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 68.5 mt -63.51 123.38 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.602 0.715 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -91.09 -42.46 10.47 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.865 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 68.5 ttt180 -151.65 152.98 33.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.197 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 206' ' ' ALA . 13.8 mt -128.08 138.76 52.68 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.14 130.21 26.6 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.72 137.25 59.5 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.55 2.22 58.8 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.79 153.09 34.18 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.64 -26.39 61.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.644 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -67.19 -26.87 66.84 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 122.077 0.941 . . . . 0.0 109.224 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.62 -41.36 46.22 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.031 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.1 t -64.78 -36.12 83.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.0 p -62.62 -44.29 96.67 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.95 -51.84 2.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.631 -0.259 . . . . 0.0 113.032 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 212' ' ' LEU . 51.3 mt -57.58 -39.77 77.49 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.48 1.112 . . . . 0.0 108.922 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.439 HD22 HG23 ' A' ' 249' ' ' VAL . 3.9 mp -115.37 108.67 16.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.27 116.62 16.38 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.614 -0.434 . . . . 0.0 112.054 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.665 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 70.8 t 57.23 -43.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.067 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 174.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -74.63 -23.82 58.75 Favored 'General case' 0 CA--C 1.484 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 112.465 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.26 173.44 2.54 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.656 0.741 . . . . 0.0 112.566 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -128.65 140.43 51.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.641 -170.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.12 141.4 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.371 0.605 . . . . 0.0 110.086 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.73 -52.62 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.942 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.513 ' H ' ' HB ' ' A' ' 248' ' ' THR . 36.5 mt-10 -125.49 146.51 49.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.899 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.531 HG13 ' SD ' ' A' ' 238' ' ' MET . 92.2 t -109.18 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 171.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.514 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 25.1 t-20 70.33 -73.83 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.806 0.812 . . . . 0.0 109.788 -174.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.95 12.53 0.1 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 175.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 9.0 mt -95.45 118.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.24 150.1 33.5 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.981 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.635 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 22.5 m -95.84 13.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 120.922 0.391 . . . . 0.0 112.05 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.75 114.52 18.73 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.22 15.07 28.98 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.295 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 0.5 OUTLIER -109.93 175.98 5.24 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.536 -0.391 . . . . 0.0 110.443 -177.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 32.9 m -113.77 160.77 18.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.568 ' O ' HG12 ' A' ' 234' ' ' VAL . 3.0 tm? -55.11 -46.36 75.57 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.177 0.444 . . . . 0.0 111.876 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.47 -35.5 77.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.232 0.539 . . . . 0.0 110.478 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 237' ' ' MET . 97.7 mt-30 -69.96 -39.79 75.81 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.664 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 231' ' ' LEU . 10.4 p -61.17 -42.23 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 118.498 0.59 . . . . 0.0 111.855 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 239' ' ' VAL . 6.7 t -75.27 -28.95 60.01 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.918 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.68 -39.58 88.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 73.1 mtp -56.41 -43.93 79.83 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.455 174.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.614 ' SD ' HD21 ' A' ' 245' ' ' LEU . 24.6 mmt -64.12 -29.38 70.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.062 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.548 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 87.7 t -82.7 -34.85 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.306 0.574 . . . . 0.0 110.755 -175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.55 -23.3 67.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.243 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.7 26.37 5.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.455 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.548 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 49.3 m -54.32 -28.66 43.9 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -95.28 -5.51 43.45 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.986 -0.446 . . . . 0.0 111.696 -176.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.27 35.52 4.26 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.614 HD21 ' SD ' ' A' ' 238' ' ' MET . 2.6 tm? -83.22 124.11 30.23 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.506 -167.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 56.6 mt -130.22 129.63 65.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.479 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.68 122.06 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.513 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 42.0 m -90.78 119.84 31.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.439 HG23 HD22 ' A' ' 212' ' ' LEU . 12.9 m -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-O 121.118 0.485 . . . . 0.0 111.81 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.457 ' NZ ' ' HB3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -138.04 126.8 14.51 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 123.743 0.817 . . . . 0.0 108.858 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.48 127.71 21.59 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.14 2.56 . . . . 0.0 112.974 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -105.2 19.02 21.31 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.892 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -95.02 76.67 3.53 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 122.905 1.335 . . . . 0.0 108.838 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -76.67 139.53 40.58 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.055 -1.429 . . . . 0.0 112.0 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.393 -3.325 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.075 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -112.95 151.52 30.45 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' H ' ' HD3' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -132.65 160.88 35.4 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.684 0.278 . . . . 0.0 110.298 -177.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 28.0 m -91.57 135.07 34.13 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -85.77 99.99 11.73 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.94 110.82 28.29 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.52 109.42 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.228 1.952 . . . . 0.0 110.594 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -84.12 73.55 10.39 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 122.001 0.905 . . . . 0.0 109.397 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.5 tt -121.08 156.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.475 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -150.97 130.36 12.88 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 115.47 63.01 Favored Pre-proline 0 C--N 1.284 -2.242 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -85.9 128.71 3.33 Favored 'Trans proline' 0 N--CA 1.429 -2.307 0 C-N-CA 122.359 2.039 . . . . 0.0 109.273 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -79.36 114.01 17.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.91 156.22 22.49 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.607 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -63.59 141.67 58.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.746 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 68.26 89.59 0.1 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.529 0.68 . . . . 0.0 110.584 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -75.0 116.09 15.35 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.671 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.64 145.97 8.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.7 t -83.74 136.89 34.0 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.126 0.489 . . . . 0.0 110.146 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.38 153.46 29.8 Favored 'General case' 0 N--CA 1.407 -2.613 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.03 83.26 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.2 pp -108.1 151.93 10.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 114.256 -1.338 . . . . 0.0 114.21 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.447 ' HB3' HD11 ' A' ' 153' ' ' ILE . 13.4 t70 -176.62 141.21 0.38 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 173.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.84 -43.73 96.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -106.13 107.19 18.07 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.852 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 150' ' ' ASP . 37.6 mm -121.5 127.39 75.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.481 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.81 120.67 50.63 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-O 121.026 0.441 . . . . 0.0 110.714 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.24 150.3 65.08 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.438 1.425 . . . . 0.0 109.392 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.77 83.36 1.18 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.3 m -83.88 109.78 17.85 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.415 ' NE2' ' HG3' ' A' ' 250' ' ' LYS . 14.0 m-70 -72.0 123.66 23.26 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-O 121.876 0.846 . . . . 0.0 112.116 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.441 ' HD2' HD11 ' A' ' 212' ' ' LEU . 22.1 ttm-85 -113.41 140.26 48.21 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.957 -171.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.465 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 19.8 ptt180 -123.92 119.51 29.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 205' ' ' LEU . 27.1 m -110.98 133.82 55.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 122.257 -0.277 . . . . 0.0 111.685 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' HG13 ' A' ' 246' ' ' ILE . 26.5 ptt180 -99.6 135.62 40.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.764 0.792 . . . . 0.0 112.832 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.475 ' HB2' HD12 ' A' ' 245' ' ' LEU . 3.5 mm? -124.67 121.42 34.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.574 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 164' ' ' LEU 0.264 1.6 pp -107.01 105.04 14.87 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-O 122.2 1.0 . . . . 0.0 113.295 175.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -100.58 134.52 43.41 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.527 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -95.06 29.71 2.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 87.11 -11.44 65.12 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.2 p -175.69 133.53 0.28 Allowed 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 t70 178.46 -57.37 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' NZ ' ' HB3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -149.04 148.27 26.52 Favored Pre-proline 0 N--CA 1.412 -2.354 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.676 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -86.7 23.73 0.8 Allowed 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 122.466 2.111 . . . . 0.0 110.886 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 87.5 mt 75.01 123.6 0.04 OUTLIER 'General case' 0 C--N 1.347 0.469 0 C-N-CA 125.952 1.701 . . . . 0.0 111.421 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.93 44.08 3.08 Favored Glycine 0 C--O 1.241 0.589 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.991 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -172.2 144.23 1.59 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -135.77 135.42 39.91 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 121.3 0.572 . . . . 0.0 111.111 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.52 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -130.94 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.451 -175.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 177' ' ' ARG . 3.5 mmp_? -122.87 158.72 29.71 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.47 ' HA ' HG22 ' A' ' 195' ' ' ILE . 26.5 t70 -74.27 137.48 42.98 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 123.2 0.313 . . . . 0.0 111.046 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.71 163.92 37.4 Favored Glycine 0 N--CA 1.406 -3.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 m -107.07 143.7 34.81 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.4 t -92.84 125.54 37.5 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 191' ' ' LYS . 24.0 t -117.3 124.62 73.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.276 -174.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -110.34 151.61 27.22 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.29 106.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-O 122.167 0.984 . . . . 0.0 109.127 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.2 p -116.41 178.28 4.38 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.562 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.7 -15.83 62.74 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 m -88.02 -3.81 58.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.72 -160.04 14.17 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.078 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.77 109.97 18.45 Favored 'General case' 0 N--CA 1.385 -3.716 0 CA-C-O 121.931 0.872 . . . . 0.0 110.783 177.119 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -101.92 144.02 31.08 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.51 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 181' ' ' SER . 52.7 mtmt -123.29 142.35 51.03 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.439 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.62 154.87 79.83 Favored Pre-proline 0 N--CA 1.42 -1.945 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.83 131.01 17.65 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.752 1.635 . . . . 0.0 109.282 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 178.63 103.63 0.17 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 178' ' ' ASP . 27.2 pt -77.47 144.84 10.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.62 158.87 17.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.9 mt -68.89 136.54 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.6 t -136.03 -39.67 0.68 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.744 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -127.11 147.53 50.17 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.874 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 206' ' ' ALA . 30.2 mt -128.31 139.71 52.26 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.441 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.48 132.47 23.15 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 126.86 23.26 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.5 1.467 . . . . 0.0 110.12 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.92 -5.1 57.85 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.79 155.99 53.44 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.428 HD13 ' HB ' ' A' ' 161' ' ' VAL . 74.0 mt -65.94 -35.62 81.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.742 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -75.66 -26.27 57.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.674 0.75 . . . . 0.0 109.294 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB2' HD22 ' A' ' 200' ' ' LEU . 2.4 tm-20 -76.21 -56.17 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.876 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.4 m -62.85 -34.94 78.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.2 p -66.98 -43.76 82.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.689 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.76 10.64 51.14 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.409 HD23 HH22 ' A' ' 159' ' ' ARG . 29.3 tp -119.95 15.4 12.51 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 122.711 1.244 . . . . 0.0 109.252 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.441 HD11 ' HD2' ' A' ' 159' ' ' ARG . 78.7 mt -135.17 129.33 33.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.383 -1.735 . . . . 0.0 106.648 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.31 162.26 13.03 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 -174.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.8 -22.72 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-O 122.629 1.204 . . . . 0.0 108.858 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -74.59 -23.09 58.68 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.432 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 59.5 m-20 -67.65 154.96 40.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.679 0.792 . . . . 0.0 112.094 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -116.02 163.8 15.38 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.593 0.711 . . . . 0.0 112.866 -172.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 176' ' ' ILE . 72.6 t -99.82 137.94 25.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.833 174.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 250' ' ' LYS . 2.7 mp -107.66 -50.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.67 0.747 . . . . 0.0 110.235 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.54 ' H ' ' HB ' ' A' ' 248' ' ' THR . 43.1 mt-10 -141.35 159.39 42.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.401 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.2 t -106.33 97.61 5.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 44.3 t30 72.99 -73.4 0.1 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 111.261 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.05 18.4 0.73 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.84 111.95 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.85 147.53 53.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 219' ' ' ILE . 15.4 m -98.76 3.67 10.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.147 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.8 103.48 0.11 Allowed 'General case' 0 C--O 1.244 0.773 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.74 7.56 84.01 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.336 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.25 160.03 17.86 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 232' ' ' ASP . 96.8 m -74.83 156.29 36.64 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.005 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 232' ' ' ASP . 4.1 pp -71.32 -34.93 71.01 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.132 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.546 ' N ' HD12 ' A' ' 231' ' ' LEU . 21.9 t70 -70.1 -37.05 75.3 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.509 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 237' ' ' MET . 23.6 tp60 -66.12 -51.01 62.0 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.433 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.28 -48.68 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.532 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.0 p -65.43 -32.42 74.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.973 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.03 -42.95 93.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.638 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 23.6 mtm -58.32 -46.05 86.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.905 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.6 ptp -68.43 -23.19 64.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 235' ' ' THR . 89.4 t -83.56 -33.15 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.5 67.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.067 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -95.82 -63.07 1.19 Allowed 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.457 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.8 t 66.04 -41.31 0.35 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.94 1.829 . . . . 0.0 115.94 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -97.57 -39.29 9.19 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.72 -0.613 . . . . 0.0 112.398 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.18 42.03 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 163' ' ' LEU . 3.2 tm? -85.34 129.67 34.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.99 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -128.42 140.73 48.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.429 HD11 ' CG1' ' A' ' 218' ' ' VAL . 8.9 tp -122.26 138.18 53.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 118.547 0.612 . . . . 0.0 109.751 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.54 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.8 m -102.82 120.68 41.03 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.958 -174.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.74 149.25 29.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 CA-C-O 121.366 0.603 . . . . 0.0 112.411 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.599 ' HB2' HD11 ' A' ' 219' ' ' ILE . 32.1 ttmt -124.35 124.74 25.76 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.822 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.6 Cg_exo -63.81 126.48 17.47 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.162 1.241 . . . . 0.0 109.07 171.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.6 -0.01 17.41 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.656 -176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.491 ' N ' HD22 ' A' ' 253' ' ' ASN . 0.7 OUTLIER 67.72 99.3 0.05 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.243 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.3 103.66 16.32 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.774 0.797 . . . . 0.0 109.422 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? . . . . . 0 C--N 1.261 -3.274 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.181 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.887 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.3 m -72.0 -21.27 61.58 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 116.855 0.327 . . . . 0.0 111.573 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.96 109.61 4.6 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.788 0.804 . . . . 0.0 109.435 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.6 m -99.16 113.71 26.09 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.978 -175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.622 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -98.0 84.27 3.27 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.068 0.937 . . . . 0.0 110.01 178.02 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.62 155.98 37.93 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.204 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.38 144.77 91.77 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.245 1.963 . . . . 0.0 111.424 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 64.9 m -82.99 100.8 10.68 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 tt -50.71 139.1 6.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.635 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.3 t -160.48 102.93 1.38 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 61.5 mt -87.68 116.14 65.2 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.284 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 1.4 Cg_endo -82.8 123.74 3.76 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.873 2.382 . . . . 0.0 112.243 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.57 132.22 47.35 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.1 156.8 18.11 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.504 ' C ' ' HD2' ' A' ' 143' ' ' ARG . 96.9 m-85 -96.09 122.67 39.17 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.504 ' HD2' ' C ' ' A' ' 142' ' ' PHE . 3.4 mpt_? -128.7 81.57 2.03 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -95.26 150.96 19.66 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.838 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.5 m -76.88 136.21 25.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.221 0.534 . . . . 0.0 111.407 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.9 m -95.26 154.33 17.24 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.882 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.57 104.54 16.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tp -70.31 132.69 32.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.4 pt -106.8 151.97 8.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 120.997 0.427 . . . . 0.0 111.713 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.4 107.94 5.32 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 50.1 t -137.85 -45.44 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.4 -174.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.1 126.7 29.45 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -174.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.1 tt 55.42 148.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 127.497 2.319 . . . . 0.0 113.299 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.27 119.11 66.07 Favored Pre-proline 0 N--CA 1.431 -1.389 0 O-C-N 121.44 -0.788 . . . . 0.0 109.172 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.87 151.63 31.54 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.0 2.467 . . . . 0.0 110.843 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.37 81.35 1.04 Allowed 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 t -79.85 105.26 11.01 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -79.1 99.05 6.77 Favored 'General case' 0 CA--C 1.458 -2.565 0 CA-C-O 122.482 1.134 . . . . 0.0 109.531 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.503 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -96.26 138.2 34.22 Favored 'General case' 0 N--CA 1.39 -3.451 0 CA-C-N 112.5 -2.137 . . . . 0.0 107.007 -174.018 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 77.8 mtm180 -116.57 121.53 42.01 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 121.107 0.48 . . . . 0.0 111.01 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 205' ' ' LEU . 97.0 t -89.01 116.02 29.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -112.5 122.57 48.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.6 0.714 . . . . 0.0 111.494 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.7 121.02 37.35 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.378 -1.283 . . . . 0.0 107.655 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.5 mt -113.01 111.74 22.7 Favored 'General case' 0 N--CA 1.396 -3.142 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.612 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 168' ' ' SER . 77.5 tttt -80.65 125.02 29.5 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.832 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -150.74 93.93 2.02 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.462 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.89 6.02 89.71 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.098 -0.956 . . . . 0.0 113.283 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.518 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 22.9 t -165.31 143.25 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.58 76.51 8.91 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.451 0.644 . . . . 0.0 110.708 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.21 121.47 85.19 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.18 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -57.48 135.52 70.33 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.688 2.259 . . . . 0.0 111.724 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 172' ' ' LEU . 1.6 pt? -53.39 121.2 7.16 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.207 1.003 . . . . 0.0 111.421 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -80.15 46.65 3.23 Favored Glycine 0 C--O 1.246 0.871 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.717 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -174.78 152.26 1.55 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -137.98 140.99 40.47 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.125 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.456 HG21 HG11 ' A' ' 218' ' ' VAL . 46.4 pt -135.46 136.26 50.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 123.663 0.602 . . . . 0.0 109.832 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.52 158.84 43.34 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.931 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.443 ' CB ' ' HB3' ' A' ' 231' ' ' LEU . 8.3 t70 -84.84 125.42 32.59 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.71 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -130.89 117.98 2.33 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 105.247 -3.141 . . . . 0.0 105.247 171.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.8 t -91.32 144.42 25.61 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.295 1.045 . . . . 0.0 112.711 -170.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t -105.04 129.44 53.47 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.919 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.47 125.17 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 CA-C-O 121.382 0.611 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 98.4 mtt180 -120.38 153.22 36.81 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.5 p -109.07 178.28 4.51 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.534 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.38 -16.56 63.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.9 m -89.84 -4.54 57.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.78 -168.31 12.59 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.6 pt? -83.93 106.29 15.49 Favored 'General case' 0 N--CA 1.402 -2.828 0 CA-C-O 122.127 0.965 . . . . 0.0 109.878 177.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -112.58 149.93 32.06 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.936 -173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -108.46 150.8 26.92 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.321 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -131.82 147.21 65.02 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.66 135.47 69.62 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.979 1.786 . . . . 0.0 109.986 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.66 76.72 0.39 Allowed Glycine 0 C--N 1.284 -2.33 0 C-N-CA 120.025 -1.084 . . . . 0.0 111.69 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.86 117.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.27 175.91 8.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 54.7 mt -66.05 122.43 17.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.3 p -102.02 -55.28 2.52 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -137.07 155.98 48.96 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.856 0.36 . . . . 0.0 110.268 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.759 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.4 mt -129.13 140.51 51.51 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.8 t -98.58 124.04 47.83 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.4 127.02 24.21 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.166 1.911 . . . . 0.0 109.986 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.89 21.28 12.31 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.406 -0.902 . . . . 0.0 110.943 -173.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.26 159.57 16.23 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.569 ' HB2' HG13 ' A' ' 161' ' ' VAL . 87.7 mt -70.21 -25.97 63.66 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.807 -0.82 . . . . 0.0 113.117 -176.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.759 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -67.24 -38.22 84.85 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.288 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.497 ' HB3' HD13 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -77.56 -33.95 53.89 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.945 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.2 t -68.0 -33.68 75.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.018 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.1 p -71.57 -43.95 65.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.72 -42.93 1.58 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.9 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.529 HD12 ' HG ' ' A' ' 212' ' ' LEU . 1.0 OUTLIER -65.87 -13.56 59.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.351 1.061 . . . . 0.0 113.633 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.529 ' HG ' HD12 ' A' ' 211' ' ' LEU . 96.8 mt -108.79 145.77 34.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.44 163.39 25.96 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.027 0.441 . . . . 0.0 111.804 -171.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 58.4 t -54.7 -22.03 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.619 0.768 . . . . 0.0 111.535 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -74.55 -24.08 58.89 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.576 ' HB3' ' N ' ' A' ' 252' ' ' ALA 0.655 0.4 OUTLIER -65.41 158.5 26.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 119.249 3.055 . . . . 0.0 119.249 -176.819 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.02 146.31 34.13 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.07 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 226' ' ' VAL . 31.3 m -89.75 142.58 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.922 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 220' ' ' GLU . 40.0 mm -110.78 -56.59 4.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.048 0.451 . . . . 0.0 110.297 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HG3' HG22 ' A' ' 219' ' ' ILE . 44.3 mt-10 -138.4 155.59 48.36 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.383 0.611 . . . . 0.0 112.418 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 238' ' ' MET . 90.7 t -127.54 110.68 22.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 124.657 1.183 . . . . 0.0 107.887 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 69.52 -70.6 0.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.965 1.306 . . . . 0.0 110.471 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -161.95 16.14 0.15 Allowed Glycine 0 C--N 1.299 -1.492 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 19.6 mt -112.49 131.38 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -85.35 167.99 15.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.214 0.531 . . . . 0.0 110.329 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 218' ' ' VAL . 28.8 m -104.03 9.71 9.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.378 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.0 102.58 0.08 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.047 -176.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.61 13.16 80.6 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.838 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -97.56 164.03 12.6 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 98.9 m -91.13 157.89 16.96 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 113.046 -1.888 . . . . 0.0 108.955 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 178' ' ' ASP . 1.9 pt? -63.33 -42.1 98.94 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.681 0.277 . . . . 0.0 111.313 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.37 -49.99 72.84 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.312 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.25 -46.4 89.92 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.443 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.525 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 91.2 t -67.57 -45.95 84.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.901 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.6 t -68.02 -29.91 69.03 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.68 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.98 -48.53 52.8 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.394 0.616 . . . . 0.0 109.988 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 234' ' ' VAL . 21.5 ptt? -65.0 -33.54 76.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -175.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.455 ' HB3' HG11 ' A' ' 221' ' ' VAL . 14.7 ptp -73.15 -25.21 60.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.481 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.59 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 93.6 t -85.33 -37.44 12.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.608 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.51 67.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.939 175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.03 21.98 15.32 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.656 ' HA ' ' HB2' ' A' ' 245' ' ' LEU . 73.0 m -59.25 -20.81 57.32 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 15.1 m -53.62 -50.65 65.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.685 0.794 . . . . 0.0 109.647 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -125.69 75.44 1.49 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.656 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.9 tp -103.2 104.3 14.42 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.139 0.971 . . . . 0.0 112.728 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.58 118.11 55.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.575 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 10.8 tt -111.23 133.32 57.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.512 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 21.8 m -100.15 125.02 46.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.034 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 212' ' ' LEU . 28.0 m -122.49 163.36 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 123.3 0.375 . . . . 0.0 110.475 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -133.79 123.48 17.2 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.78 135.82 71.43 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.484 2.79 . . . . 0.0 113.544 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.576 ' N ' ' HB3' ' A' ' 216' ' ' ASP . . . -116.78 20.86 13.74 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -63.74 -21.3 66.34 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.335 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -135.75 139.95 43.97 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.288 -2.071 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.113 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.1 m 64.41 86.81 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.84 0.856 . . . . 0.0 112.313 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -94.07 87.61 5.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.6 m -81.87 118.3 22.82 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.811 -173.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -88.72 142.3 27.79 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.19 111.04 38.24 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.9 101.84 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.21 1.94 . . . . 0.0 111.749 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -88.93 85.05 6.65 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.42 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.487 ' O ' HD12 ' A' ' 136' ' ' ILE . 2.5 pp -86.11 136.77 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.3 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.4 m -102.98 90.9 3.91 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 10.3 tt -87.83 123.0 69.91 Favored Pre-proline 0 C--N 1.29 -1.978 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.131 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 12.4 Cg_exo -66.8 122.12 9.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.695 1.597 . . . . 0.0 110.362 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -94.19 120.34 34.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.455 -177.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.62 130.32 53.68 Favored 'General case' 0 CA--C 1.484 -1.583 0 CA-C-O 120.82 0.343 . . . . 0.0 110.718 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -153.24 86.44 1.23 Allowed 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -137.9 85.68 2.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.327 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -96.55 109.57 22.14 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.1 m -107.29 150.17 10.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.299 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.4 m -101.42 153.49 19.64 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.28 104.28 16.65 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.66 90.54 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.9 pt -107.29 151.62 9.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.028 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.02 111.73 22.85 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.381 0.61 . . . . 0.0 109.955 175.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.8 t -106.48 -60.44 2.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.95 107.17 18.26 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.4 tp -168.93 117.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-O 121.386 0.613 . . . . 0.0 111.252 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.3 t -101.12 122.71 47.58 Favored Pre-proline 0 C--N 1.292 -1.923 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.05 130.41 16.23 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.033 2.489 . . . . 0.0 113.955 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.78 -7.35 49.83 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.668 0.747 . . . . 0.0 109.722 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.3 t -75.3 102.22 4.98 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -91.19 143.91 26.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.858 -173.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -97.87 121.34 39.67 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.97 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -99.86 104.35 16.01 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 247' ' ' ILE . 59.6 t -89.74 117.32 32.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 120.956 0.408 . . . . 0.0 110.376 -176.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HG2' HG12 ' A' ' 246' ' ' ILE . 58.3 mtp180 -88.75 136.66 32.89 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 171' ' ' PRO . 3.4 tm? -120.38 121.3 38.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.62 99.78 9.45 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.8 145.76 46.79 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -101.78 -12.2 18.5 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.377 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.94 44.63 Favored Glycine 0 N--CA 1.46 0.233 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.085 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.7 t -149.33 128.63 12.9 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.3 t70 72.2 -42.5 0.53 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.832 1.253 . . . . 0.0 113.172 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -122.05 94.77 47.92 Favored Pre-proline 0 C--O 1.254 1.319 0 CA-C-O 120.671 0.272 . . . . 0.0 110.399 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.413 ' O ' HD11 ' A' ' 163' ' ' LEU . 4.3 Cg_exo -83.46 -69.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.063 2.509 . . . . 0.0 112.123 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 pp -157.19 157.39 34.3 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.342 0.657 . . . . 0.0 110.597 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -128.57 48.2 0.98 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.515 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 245' ' ' LEU . 54.0 p90 -160.47 147.58 15.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -138.54 146.21 41.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.52 152.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 123.441 0.463 . . . . 0.0 111.868 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 79.2 ttt180 -141.82 149.9 40.95 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.86 133.98 44.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.974 0.416 . . . . 0.0 110.595 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.36 165.99 15.92 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 2.8 p -93.11 120.4 33.36 Favored 'General case' 0 N--CA 1.391 -3.413 0 CA-C-N 117.986 0.893 . . . . 0.0 111.181 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.6 t -118.7 132.42 56.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.6 p -98.34 127.2 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.623 0.725 . . . . 0.0 109.177 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -112.85 153.43 27.9 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.68 107.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.1 p -110.18 178.15 4.48 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.19 -13.6 61.19 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.4 m -87.99 -4.6 58.79 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.588 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.55 -159.19 13.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.89 128.31 34.56 Favored 'General case' 0 N--CA 1.379 -3.977 0 CA-C-N 117.154 0.477 . . . . 0.0 110.003 175.089 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.38 153.49 48.67 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.411 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 36.9 ttpt -119.89 140.27 51.11 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-O 121.311 0.577 . . . . 0.0 109.618 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 5.5 tp-100 -139.62 144.74 40.55 Favored Pre-proline 0 C--N 1.277 -2.554 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.9 Cg_exo -73.81 119.52 5.93 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.246 1.964 . . . . 0.0 110.288 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.61 118.01 5.67 Favored Glycine 0 C--N 1.276 -2.758 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 177' ' ' ARG . 2.6 pt -96.5 117.53 41.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.598 0.713 . . . . 0.0 112.2 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 217' ' ' GLU . 59.4 m-85 -119.77 169.9 9.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.684 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.61 131.06 34.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.0 p -114.26 -56.02 2.43 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -123.55 142.01 51.45 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.2 mt -128.15 139.12 52.66 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.33 123.25 49.18 Favored Pre-proline 0 N--CA 1.416 -2.142 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -50.51 130.59 30.11 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.616 2.211 . . . . 0.0 112.215 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.62 5.14 65.12 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.34 146.06 41.84 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 114.785 -0.708 . . . . 0.0 112.779 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 205' ' ' LEU . 5.0 mp -55.4 -33.65 63.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.414 1.086 . . . . 0.0 113.14 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.628 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -66.13 -41.14 90.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.194 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.412 ' HB2' HD13 ' A' ' 200' ' ' LEU . 3.2 tm-20 -76.9 -34.97 57.68 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.9 m -54.87 -30.58 58.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.064 0.946 . . . . 0.0 112.558 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 205' ' ' LEU . 80.8 p -58.26 -43.24 87.79 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.636 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.73 21.18 72.83 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 tp -138.2 -35.42 0.62 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.154 -1.023 . . . . 0.0 110.804 -173.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.459 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.0 mm? -108.23 139.15 43.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.83 0.824 . . . . 0.0 111.179 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.38 162.28 13.15 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.393 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.83 -24.89 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-O 121.514 0.673 . . . . 0.0 110.983 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -73.28 -23.88 60.36 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.292 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.566 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 64.1 m-20 -62.45 158.73 17.04 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.448 0.699 . . . . 0.0 112.079 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.409 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 12.3 pt-20 -116.36 157.32 25.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -171.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.57 130.59 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.921 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.81 -42.96 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.179 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.478 ' H ' ' HB ' ' A' ' 248' ' ' THR . 34.2 mt-10 -137.68 152.7 49.56 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.341 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.58 96.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.467 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.533 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 67.13 1.15 2.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.164 1.386 . . . . 0.0 112.583 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 123.8 -4.29 9.21 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.68 134.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.14 147.36 31.39 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.842 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.411 ' CG2' HD11 ' A' ' 195' ' ' ILE . 25.8 m -117.19 10.64 7.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.083 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -61.48 105.82 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.067 0.46 . . . . 0.0 110.806 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.402 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.33 2.64 53.95 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.942 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 10.0 mmpt? -88.95 141.67 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.582 -0.364 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 234' ' ' VAL . 11.7 t -85.57 164.75 17.57 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 235' ' ' THR . 1.7 pt? -55.78 -41.66 74.42 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.278 0.49 . . . . 0.0 112.203 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.407 ' H ' HD23 ' A' ' 231' ' ' LEU . 25.0 t70 -59.89 -40.57 89.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.543 0.687 . . . . 0.0 110.677 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 11.9 mm-40 -69.22 -47.04 65.88 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.462 177.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 230' ' ' THR . 58.9 t -61.09 -43.74 96.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.54 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 239' ' ' VAL . 8.4 t -65.36 -40.09 93.13 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.095 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.62 -45.0 85.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.238 0.542 . . . . 0.0 110.517 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 77.3 mtp -56.43 -49.24 75.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.461 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.1 ptp -76.79 -9.76 58.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.183 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.627 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 70.4 t -83.07 -31.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.626 0.727 . . . . 0.0 109.171 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.5 -13.12 61.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.496 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -130.86 29.16 4.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.128 0.571 . . . . 0.0 110.848 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 68.1 m -61.99 -28.26 69.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -173.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.3 m -51.85 -61.92 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.169 0.509 . . . . 0.0 110.836 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -129.69 88.42 2.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 174' ' ' PHE . 3.6 pp -92.02 133.47 35.69 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 62.6 mt -114.37 119.52 61.61 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.296 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 161' ' ' VAL . 7.1 tt -109.89 118.69 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 111.134 177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 38.5 m -90.51 119.71 31.0 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.459 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 15.7 m -114.93 144.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.411 ' C ' ' HD3' ' A' ' 250' ' ' LYS . 13.1 tmtt? -125.62 125.42 25.0 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.978 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.566 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 18.7 Cg_endo -68.02 127.24 15.68 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.34 2.027 . . . . 0.0 114.097 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -106.42 -35.32 7.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 43.37 79.94 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 112.75 -2.023 . . . . 0.0 113.197 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -137.23 125.93 23.87 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.597 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 . . . . . 0 C--N 1.282 -2.34 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.913 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.622 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 70.6 p -146.16 143.36 29.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -99.99 130.75 46.19 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 75.0 m -80.85 120.4 24.64 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.58 112.54 20.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.849 0.357 . . . . 0.0 111.282 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.34 106.84 47.9 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.98 102.82 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.848 2.365 . . . . 0.0 112.773 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 m -86.37 91.77 8.61 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.1 mm -71.59 140.51 18.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.455 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 23.0 t -94.61 96.07 9.19 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.7 tt -94.19 107.96 32.48 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.8 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 137' ' ' SER . 12.2 Cg_exo -71.24 136.35 28.94 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.139 1.893 . . . . 0.0 109.507 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -101.37 113.87 27.35 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -95.55 128.63 42.57 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.279 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -134.39 99.16 4.29 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -131.75 89.86 2.75 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.49 115.16 5.43 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.204 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.16 126.65 39.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 121.318 0.58 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.5 m -84.42 119.15 24.79 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.307 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.96 104.56 16.61 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.938 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 148' ' ' ILE . 2.3 mp -70.53 105.5 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.6 tp -98.01 134.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 121.441 0.639 . . . . 0.0 111.447 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -148.23 141.18 24.81 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.6 -66.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.175 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.33 108.78 16.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.278 0.561 . . . . 0.0 111.937 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -127.61 94.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-O 121.793 0.806 . . . . 0.0 110.493 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.9 t -124.36 101.28 34.55 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -82.73 142.34 11.35 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.074 1.849 . . . . 0.0 109.257 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 46.8 mt-10 -63.2 96.84 0.11 Allowed 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.195 0.521 . . . . 0.0 112.025 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.8 m -88.07 93.51 9.51 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.442 ' CD2' ' HB3' ' A' ' 156' ' ' GLU . 12.8 m170 -82.22 113.26 19.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -132.86 138.12 46.93 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.106 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.625 ' HD3' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -110.94 114.49 27.85 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 205' ' ' LEU . 21.8 t -100.64 132.39 46.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG2' HG13 ' A' ' 246' ' ' ILE . 97.4 mtt180 -94.63 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.106 0.479 . . . . 0.0 112.089 -176.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.6 tm? -127.31 125.43 40.8 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 164' ' ' LEU 0.276 2.1 pp -112.36 101.68 9.86 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-O 122.442 1.115 . . . . 0.0 112.232 176.272 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -100.8 120.72 40.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.93 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -151.45 92.12 1.74 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.942 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.01 88.03 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.734 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 p -110.73 137.43 48.4 Favored 'General case' 0 N--CA 1.392 -3.34 0 C-N-CA 123.711 0.804 . . . . 0.0 109.699 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -125.18 82.75 2.09 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.938 0.875 . . . . 0.0 108.783 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -129.0 143.79 50.12 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.383 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.84 141.77 95.72 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.058 1.838 . . . . 0.0 111.226 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.75 123.56 21.25 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . -77.42 46.43 2.52 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.152 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.577 ' HE1' ' SD ' ' A' ' 238' ' ' MET . 50.7 p90 -174.7 134.04 0.37 Allowed 'General case' 0 N--CA 1.416 -2.139 0 C-N-CA 125.803 1.641 . . . . 0.0 107.711 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.4 141.33 51.08 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -126.11 140.92 47.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.873 -177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 231' ' ' LEU . 55.9 ttt180 -142.19 148.05 37.58 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.754 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 5.7 p-10 -101.85 145.37 29.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -132.26 163.94 23.9 Favored Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.7 m -104.65 131.78 51.68 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.041 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.9 m -106.13 136.02 46.57 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.518 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.2 128.93 60.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.514 0.674 . . . . 0.0 111.408 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -114.01 152.75 30.49 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.45 115.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 120.724 0.297 . . . . 0.0 110.464 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.9 p -113.08 169.86 8.63 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.42 61.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.017 0.437 . . . . 0.0 111.034 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.0 m -93.65 -3.81 51.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.546 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.78 -168.86 22.19 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.339 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 189' ' ' LEU . 2.1 pt? -85.24 130.37 34.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.427 0.632 . . . . 0.0 111.127 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -108.55 155.63 20.42 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.323 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -119.8 148.8 43.0 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -139.63 153.47 70.31 Favored Pre-proline 0 N--CA 1.411 -2.408 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.52 138.57 21.96 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.34 2.027 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.1 107.03 0.57 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 10.4 tt -105.51 118.52 53.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.649 0.738 . . . . 0.0 111.369 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 70.4 m-85 -125.81 165.56 18.44 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.458 -175.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.4 mt -70.68 127.8 33.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 172.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.5 p -102.45 -39.93 6.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -150.24 147.75 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.427 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 206' ' ' ALA . 15.4 mt -114.56 139.34 49.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.246 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.406 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 78.0 t -103.99 128.76 26.53 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.85 126.41 21.87 Favored 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.032 1.821 . . . . 0.0 110.67 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.57 13.45 58.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.43 160.24 24.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.7 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.476 ' HB3' HG11 ' A' ' 161' ' ' VAL . 85.6 mt -54.35 -46.2 72.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.573 1.149 . . . . 0.0 113.906 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.783 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -68.45 -27.18 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.858 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.76 -42.22 50.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.9 m -56.38 -31.56 63.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.2 p -61.08 -44.36 97.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.37 -47.65 1.73 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 121.474 0.486 . . . . 0.0 112.767 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.405 ' HB2' HD22 ' A' ' 212' ' ' LEU . 58.4 mt -67.53 -23.96 65.5 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.039 1.336 . . . . 0.0 111.167 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.2 mm? -108.02 146.0 33.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.174 0.511 . . . . 0.0 109.728 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -92.39 158.32 16.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.05 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 23.6 t -67.0 -27.33 39.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.603 -178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -74.98 -21.87 58.89 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.652 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 89.4 m-20 -48.75 161.03 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -169.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 41.5 mt-10 -93.41 154.28 18.03 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.302 -172.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.22 134.81 45.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.459 HG22 ' HG3' ' A' ' 220' ' ' GLU . 46.7 mm -111.0 -44.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.867 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.625 ' H ' ' HB ' ' A' ' 248' ' ' THR . 40.4 mt-10 -141.07 154.32 45.89 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.371 0.605 . . . . 0.0 111.591 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 65.9 t -128.75 108.34 17.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.588 172.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 70.56 -9.96 0.74 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.524 0.678 . . . . 0.0 111.937 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 127.98 -9.37 6.72 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.462 HG21 ' SD ' ' A' ' 237' ' ' MET . 48.5 mt -84.01 121.01 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -75.65 137.76 40.93 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.045 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.417 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 35.5 m -91.75 17.41 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.837 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.7 109.32 2.38 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.115 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.55 9.69 64.39 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.877 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 10.4 mmpt? -93.93 168.43 10.97 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 234' ' ' VAL . 9.9 t -120.02 163.46 17.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 232' ' ' ASP . 0.0 OUTLIER -50.5 -46.77 57.34 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -171.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.519 ' N ' HD22 ' A' ' 231' ' ' LEU . 23.5 t70 -74.29 -40.55 62.21 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.304 0.574 . . . . 0.0 109.828 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.569 ' O ' ' HG3' ' A' ' 237' ' ' MET . 36.1 tt0 -59.24 -43.28 92.39 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.93 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 230' ' ' THR . 97.7 t -70.25 -46.61 71.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.984 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.494 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 21.4 p -60.97 -37.8 83.71 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.155 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.45 -44.61 84.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 37.6 mtm -64.28 -47.06 80.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.402 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.577 ' SD ' ' HE1' ' A' ' 174' ' ' PHE . 20.9 ptp -67.27 -25.71 66.2 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.01 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.78 -28.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.901 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.58 75.12 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 121.664 0.745 . . . . 0.0 109.268 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.91 -62.06 1.67 Allowed 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.575 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 38.1 t 64.6 -40.97 0.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.309 1.444 . . . . 0.0 114.176 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 -46.47 51.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.27 75.39 0.98 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 238' ' ' MET . 4.3 tt -92.89 116.34 28.95 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 3.3 mp -127.16 127.92 69.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 247' ' ' ILE . 36.4 pt -109.43 118.67 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.625 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 64.7 m -92.2 120.16 32.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.432 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 20.8 m -113.89 141.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.963 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.15 129.0 14.43 Favored Pre-proline 0 N--CA 1.42 -1.936 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.652 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 12.3 Cg_endo -56.03 130.9 42.77 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.24 2.626 . . . . 0.0 114.811 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.43 -7.39 44.66 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 68.44 101.91 0.05 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.953 -1.93 . . . . 0.0 112.45 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.11 118.79 37.2 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 . . . . . 0 C--N 1.27 -2.858 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.821 -177.14 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.159 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.5 p -88.88 -13.2 39.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.701 0.762 . . . . 0.0 110.398 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -87.51 156.57 19.47 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.705 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.2 m -88.54 114.05 24.75 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 133' ' ' ALA . 1.0 OUTLIER -107.81 132.76 53.07 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.13 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.442 ' N ' ' HD3' ' A' ' 132' ' ' LYS . . . -105.86 113.1 64.17 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.3 -159.91 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.05 2.5 . . . . 0.0 110.633 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.1 p -82.61 87.08 6.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.56 153.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.9 p -103.05 103.64 13.75 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.0 tt -92.83 114.73 63.41 Favored Pre-proline 0 C--N 1.275 -2.648 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.577 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.58 145.25 37.12 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.477 2.118 . . . . 0.0 111.727 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -97.73 114.45 26.45 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.706 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 4.0 p30 -90.24 154.08 20.0 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.4 t80 53.65 -145.37 0.6 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -110.37 69.15 0.68 Allowed 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 166.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 141' ' ' ASP . 77.2 mm-40 -71.88 110.49 6.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 174.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.64 131.22 43.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.862 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.7 p -73.81 126.89 31.41 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.915 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.56 103.3 15.42 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 121.211 0.529 . . . . 0.0 110.493 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 5.0 tp -75.9 99.25 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 25.8 pt -85.42 151.24 3.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.556 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -88.43 132.69 34.36 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.476 -176.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 m -76.25 89.45 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-O 123.504 1.621 . . . . 0.0 109.733 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -78.7 132.44 36.99 Favored 'General case' 0 C--N 1.252 -3.664 0 CA-C-N 112.29 -2.232 . . . . 0.0 111.973 -172.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.626 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 9.7 tp -82.12 158.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.2 t -97.36 106.67 33.85 Favored Pre-proline 0 C--N 1.316 -0.864 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 39.5 Cg_exo -65.47 151.97 83.34 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 123.26 2.64 . . . . 0.0 109.509 172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.547 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 13.1 pt-20 -58.7 88.07 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -93.08 116.0 28.63 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 171.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -91.56 109.51 20.81 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.495 ' HD3' ' N ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -120.74 134.87 55.26 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.499 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.8 ptt180 -113.92 123.03 48.77 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.647 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.429 HG22 ' NH1' ' A' ' 159' ' ' ARG . 47.4 t -90.03 115.69 30.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.439 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -96.11 145.15 25.73 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.975 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.8 mt -126.44 121.56 32.77 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.936 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 164' ' ' LEU . 1.7 pp -106.91 101.07 10.53 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-O 122.727 1.251 . . . . 0.0 108.689 169.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.468 ' O ' ' HD2' ' A' ' 165' ' ' LYS 0.259 0.0 OUTLIER -75.47 127.84 34.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -172.242 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -105.7 112.26 25.26 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.759 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.79 -4.2 80.41 Favored Glycine 0 C--O 1.222 -0.645 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.714 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.4 m 61.8 20.98 11.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.748 0.819 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.59 102.46 3.81 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.331 0.586 . . . . 0.0 109.605 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -160.41 131.26 3.74 Favored Pre-proline 0 C--N 1.275 -2.64 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.098 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.88 141.42 93.15 Favored 'Trans proline' 0 C--O 1.254 1.319 0 C-N-CA 122.861 2.374 . . . . 0.0 112.698 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.6 130.85 38.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.107 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . -87.03 -23.57 40.77 Favored Glycine 0 C--N 1.289 -2.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -108.27 144.85 35.2 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -134.95 147.41 49.76 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.528 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 176' ' ' ILE . 2.8 mp -125.5 149.41 30.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 75.4 ttt180 -134.06 153.14 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.66 ' HA ' HG22 ' A' ' 195' ' ' ILE . 19.6 m-20 -74.73 151.73 39.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.073 0.463 . . . . 0.0 111.302 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.36 161.32 26.6 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 p -101.98 136.44 41.81 Favored 'General case' 0 N--CA 1.394 -3.242 0 CA-C-O 121.125 0.488 . . . . 0.0 111.62 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.4 t -111.6 120.3 41.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.0 p -91.16 123.59 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.668 0.746 . . . . 0.0 111.144 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.02 158.55 24.76 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.2 t -100.23 116.57 43.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.9 p -115.17 177.54 4.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.53 -21.4 61.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.044 0.45 . . . . 0.0 109.857 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.6 p -87.17 -1.27 57.77 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.61 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.75 -168.9 13.69 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.953 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.61 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.07 106.17 15.51 Favored 'General case' 0 N--CA 1.384 -3.737 0 CA-C-O 122.899 1.333 . . . . 0.0 110.593 175.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -111.46 155.42 23.23 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.387 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 191' ' ' LYS . 7.7 mptt -116.93 127.2 53.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.48 153.58 47.69 Favored Pre-proline 0 C--N 1.263 -3.176 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.595 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 14.2 Cg_exo -68.11 113.4 3.04 Favored 'Trans proline' 0 N--CA 1.423 -2.629 0 C-N-CA 121.343 1.362 . . . . 0.0 109.013 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -132.31 92.06 0.27 Allowed Glycine 0 CA--C 1.457 -3.567 0 N-CA-C 106.889 -2.484 . . . . 0.0 106.889 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 178' ' ' ASP . 23.4 pt -77.22 135.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.34 -172.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.05 166.9 10.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.258 -173.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.3 mt -67.44 130.77 33.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 67.6 p -98.73 -36.46 9.83 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.507 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -151.01 146.02 25.93 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.557 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 52.4 tp -127.43 124.93 39.62 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.91 128.9 29.74 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 50.7 Cg_exo -57.63 126.86 23.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.16 1.907 . . . . 0.0 109.451 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.75 -9.87 60.46 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -84.87 149.87 24.66 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.82 -26.09 65.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -173.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -74.73 -32.36 62.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.009 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' N ' HD11 ' A' ' 200' ' ' LEU . 3.6 tm-20 -76.45 -38.85 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.0 m -57.88 -32.03 67.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.355 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.0 m -61.56 -43.55 98.66 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 78.52 -14.44 12.58 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.854 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 53.4 mt -85.93 -36.83 19.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.097 0.475 . . . . 0.0 111.099 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 249' ' ' VAL . 81.0 mt -115.33 146.92 41.06 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.34 163.84 17.24 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.666 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 13.7 p -45.84 -33.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.24 -24.26 66.24 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.612 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -69.29 165.91 19.62 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.28 142.18 45.08 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -171.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 14.1 m -95.82 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.487 HD13 ' HD2' ' A' ' 250' ' ' LYS . 25.1 pt -120.06 -41.9 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.432 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 39.6 mt-10 -133.55 151.25 51.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.581 0.705 . . . . 0.0 112.75 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.76 108.73 23.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.54 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.1 t-20 70.22 -71.1 0.13 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.165 0.986 . . . . 0.0 110.72 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.14 21.75 0.13 Allowed Glycine 0 C--N 1.298 -1.574 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 15.8 mt -116.73 121.77 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 47.7 mt-10 -76.11 151.08 37.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 118.806 0.73 . . . . 0.0 111.5 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.55 -6.39 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.995 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.45 121.33 15.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.314 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.595 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 93.12 10.3 59.82 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.101 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -111.13 173.35 6.38 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 234' ' ' VAL . 90.4 m -100.9 158.52 15.92 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.007 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.37 -46.19 86.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.441 0.296 . . . . 0.0 111.62 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.25 -41.79 89.59 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.327 0.584 . . . . 0.0 110.286 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.58 -49.34 75.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.946 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 230' ' ' THR . 85.1 t -59.88 -45.92 94.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.946 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.511 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 12.1 t -69.17 -37.13 78.02 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -42.56 90.56 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 52.4 mtp -56.5 -51.08 69.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.761 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptp -73.19 -15.03 61.46 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.356 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.561 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 98.1 t -91.4 -27.01 4.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.89 66.17 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.461 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -142.94 32.72 1.38 Allowed 'General case' 0 N--CA 1.419 -1.997 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.933 -173.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.561 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 61.7 m -54.19 -27.98 37.67 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 t -72.29 -29.62 64.04 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -126.22 56.48 1.44 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.8 122.65 29.44 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.733 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 67.0 mt -130.22 125.11 59.24 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.658 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.16 121.42 64.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.768 0.794 . . . . 0.0 110.513 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.432 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 15.3 m -94.15 128.57 40.65 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.21 -175.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 4.9 m -124.88 148.46 29.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.487 ' HD2' HD13 ' A' ' 219' ' ' ILE . 58.1 mtpt -130.28 138.24 32.62 Favored Pre-proline 0 CA--C 1.508 -0.658 0 C-N-CA 124.394 1.078 . . . . 0.0 109.366 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 26.5 Cg_endo -64.76 126.86 17.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.628 1.552 . . . . 0.0 111.423 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.4 -28.18 19.93 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 121.833 0.825 . . . . 0.0 109.721 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 44.1 m-80 49.07 69.84 0.53 Allowed 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.113 -1.858 . . . . 0.0 112.024 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.88 126.76 35.83 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 . . . . . 0 C--N 1.287 -2.114 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.191 -178.573 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.726 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 53.8 m -93.69 157.16 16.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.207 0.504 . . . . 0.0 109.922 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 157.9 17.74 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.8 p -75.82 113.68 13.57 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.389 0.614 . . . . 0.0 112.25 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -94.61 110.83 22.62 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.19 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.45 104.16 55.82 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -93.48 12.51 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.887 2.392 . . . . 0.0 112.487 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m 68.36 94.89 0.07 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.927 0.891 . . . . 0.0 111.75 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.5 mt -81.48 157.12 4.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.4 m 71.58 96.02 0.07 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.582 -176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.1 tt -102.55 136.74 19.3 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.259 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 129.8 37.05 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.297 1.998 . . . . 0.0 109.953 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -98.13 161.02 13.92 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.267 0.556 . . . . 0.0 112.335 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.89 156.04 22.59 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -80.49 -29.12 37.35 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.038 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.549 ' HA ' ' HE ' ' A' ' 143' ' ' ARG . 1.7 mmp_? 64.08 62.49 0.86 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.008 0.923 . . . . 0.0 108.898 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -81.6 157.33 24.77 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.415 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.27 117.06 29.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 p -84.01 146.14 28.13 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.333 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.41 104.14 16.72 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.962 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.5 tp -66.97 157.48 5.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 149' ' ' ILE . 2.3 pp -83.54 134.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.873 0.845 . . . . 0.0 112.489 -177.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 151' ' ' VAL . 16.8 t70 -113.42 -152.16 0.5 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.403 ' H ' ' CG ' ' A' ' 150' ' ' ASP 0.333 15.4 m 50.45 92.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 C-N-CA 125.735 1.614 . . . . 0.0 114.24 -176.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.03 122.27 14.53 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.564 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tp -139.73 116.75 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-O 122.033 0.92 . . . . 0.0 111.662 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 p -100.72 114.08 65.73 Favored Pre-proline 0 N--CA 1.421 -1.894 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 130.74 41.77 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.547 2.164 . . . . 0.0 113.727 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.94 8.99 43.23 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.637 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -74.15 99.91 3.51 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -70.13 130.06 41.09 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.463 0.649 . . . . 0.0 112.423 -169.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -102.54 116.78 33.3 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.395 -167.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -100.73 135.81 41.58 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 205' ' ' LEU . 7.7 p -103.72 128.53 56.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.538 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 246' ' ' ILE . 36.8 ptt180 -108.62 126.88 53.45 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.81 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.2 mt -107.91 121.23 44.34 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.428 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.76 107.34 19.76 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.819 0.818 . . . . 0.0 111.662 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -88.27 120.47 29.66 Favored 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.919 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -152.5 102.33 2.73 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.432 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.75 63.66 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.113 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -130.26 178.23 6.73 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.67 -49.21 3.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.743 0.306 . . . . 0.0 110.689 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -166.58 100.13 0.68 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.5 44.44 1.24 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 123.481 2.787 . . . . 0.0 113.768 -175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . 0.342 0.6 OUTLIER -69.59 90.78 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -178.753 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -97.84 38.93 2.91 Favored Glycine 0 C--N 1.308 -0.986 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.98 150.49 24.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 77.9 m-85 -136.71 134.88 37.66 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.794 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.497 HD12 HD11 ' A' ' 195' ' ' ILE . 20.2 pt -133.71 142.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.626 -176.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.09 159.7 41.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.44 1.096 . . . . 0.0 108.094 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.463 ' H ' HD22 ' A' ' 231' ' ' LEU . 15.4 t70 -91.44 122.24 33.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.461 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -119.38 114.89 2.89 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 104.584 -3.407 . . . . 0.0 104.584 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 191' ' ' LYS . 1.8 m -89.0 128.23 35.7 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.614 -165.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -92.85 127.52 38.39 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.855 -172.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.02 138.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.928 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 183' ' ' ARG . 27.6 mmt180 -121.23 152.77 38.46 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.44 107.99 24.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.2 p -115.42 177.31 4.71 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.422 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.71 -6.09 54.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.276 0.56 . . . . 0.0 109.577 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.1 m -88.04 -4.49 58.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.77 -142.4 17.44 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 189' ' ' LEU . 0.4 OUTLIER -101.86 115.59 30.88 Favored 'General case' 0 N--CA 1.392 -3.372 0 CA-C-O 121.169 0.509 . . . . 0.0 109.971 176.301 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.66 152.04 30.96 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.924 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.453 ' HB3' HG22 ' A' ' 180' ' ' THR . 95.7 mttt -122.22 146.44 47.26 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.734 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -127.07 147.91 63.67 Favored Pre-proline 0 N--CA 1.417 -2.125 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.36 137.04 64.39 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.949 2.433 . . . . 0.0 111.542 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -138.85 73.7 0.41 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.337 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 176' ' ' ILE . 11.9 tt -84.21 116.39 27.91 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.746 0.784 . . . . 0.0 109.091 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.64 ' CE2' ' HG2' ' A' ' 217' ' ' GLU . 87.2 m-85 -130.18 172.1 12.15 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.908 -175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.2 136.18 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 47.1 m -126.17 -16.89 5.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.345 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 50.9 ttt180 -158.98 142.96 15.29 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.436 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.5 mt -128.4 139.31 52.44 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.94 124.59 45.06 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.88 129.47 32.22 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.689 1.593 . . . . 0.0 109.857 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.19 -9.83 57.98 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.02 153.25 46.62 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' A' ' 161' ' ' VAL . 2.6 mm? -59.15 -38.94 80.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.726 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -68.64 -33.45 74.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.035 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 200' ' ' LEU . 3.2 tm-20 -76.21 -43.5 42.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.204 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.4 m -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 m -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.92 -12.21 9.41 Favored Glycine 0 N--CA 1.465 0.58 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.935 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 36.7 mt -93.84 -15.78 24.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 71.9 mt -108.92 143.56 38.01 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.791 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.65 163.45 27.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.812 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.33 -14.44 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 121.582 0.706 . . . . 0.0 111.768 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.18 -22.35 58.09 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 58.9 m-20 -63.41 157.37 23.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -174.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.64 ' HG2' ' CE2' ' A' ' 196' ' ' PHE . 37.6 mt-10 -106.69 145.37 32.09 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.681 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.36 134.36 29.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.508 HG13 ' HD3' ' A' ' 250' ' ' LYS . 50.3 mm -116.2 -49.87 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.503 ' H ' ' HB ' ' A' ' 248' ' ' THR . 44.0 mt-10 -125.38 147.79 49.03 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.413 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.0 96.72 4.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 105.655 -1.979 . . . . 0.0 105.655 165.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.478 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 45.3 t30 68.41 -77.62 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 124.392 1.077 . . . . 0.0 111.333 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -146.0 10.27 1.59 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.562 ' HB ' ' HE2' ' A' ' 237' ' ' MET . 10.8 mt -107.14 133.05 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -81.32 149.77 28.78 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.11 2.24 8.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.519 0.676 . . . . 0.0 109.881 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.33 109.26 2.2 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.966 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 6.51 48.24 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 229' ' ' LYS . 9.4 mmpt? -103.4 166.89 10.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 234' ' ' VAL . 16.9 m -118.59 159.77 22.99 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.463 HD22 ' H ' ' A' ' 178' ' ' ASP . 65.5 tp -50.37 -46.92 56.28 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.23 -37.15 84.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.3 0.571 . . . . 0.0 110.894 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.3 -37.82 74.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.215 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 230' ' ' THR . 96.8 t -63.09 -44.19 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 0.0 110.974 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 239' ' ' VAL . 11.7 t -67.89 -35.28 78.23 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.841 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.35 -43.15 86.86 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.948 0.88 . . . . 0.0 109.167 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.562 ' HE2' ' HB ' ' A' ' 224' ' ' ILE . 16.9 ttt -56.59 -45.82 81.18 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.372 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.467 ' HB2' HD11 ' A' ' 245' ' ' LEU . 19.1 ptp -76.28 -16.46 59.78 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.753 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 75.3 t -81.02 -33.78 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.277 0.56 . . . . 0.0 109.547 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.47 -22.48 43.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.188 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -132.91 30.24 4.03 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.243 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.753 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 67.8 m -74.1 -18.83 60.76 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 38.5 m -58.77 -48.04 82.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.37 0.605 . . . . 0.0 109.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -124.23 79.32 1.73 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.934 -2.246 . . . . 0.0 104.934 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.8 tp -86.4 118.65 25.97 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.349 -1.751 . . . . 0.0 111.06 -170.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 59.8 mt -127.03 133.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.843 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.3 tt -131.8 132.09 61.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 121.317 0.58 . . . . 0.0 111.981 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.503 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 61.8 m -102.35 125.68 49.13 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.872 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.23 139.98 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.508 ' HD3' HG13 ' A' ' 219' ' ' ILE . 57.4 mtpt -110.91 122.57 37.68 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.675 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 14.5 Cg_endo -60.27 133.12 47.63 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 122.645 2.23 . . . . 0.0 113.766 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -97.27 8.75 43.94 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -72.88 86.14 1.27 Allowed 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.731 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.83 144.89 37.05 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.836 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.589 ' C ' ' HE ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.487 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.792 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.9 m -97.21 101.84 13.48 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.279 0.561 . . . . 0.0 111.146 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -110.68 -45.27 3.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 t -108.27 145.02 34.98 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 175.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' A' ' 132' ' ' LYS . 7.5 mtpm? -112.2 87.03 2.47 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.692 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.41 108.86 31.31 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.473 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.37 115.61 3.44 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 122.41 2.073 . . . . 0.0 111.079 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -75.69 94.52 3.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.271 0.558 . . . . 0.0 109.592 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.8 mt 72.51 138.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 125.662 1.585 . . . . 0.0 110.721 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t -120.98 100.7 7.22 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.902 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.2 tt -94.71 123.19 58.74 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.82 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -68.03 131.19 23.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.848 1.699 . . . . 0.0 109.048 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -76.32 150.24 36.94 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.26 155.85 23.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.95 117.54 25.75 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -85.68 70.84 10.75 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 122.382 1.087 . . . . 0.0 110.106 -175.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -90.01 160.16 16.5 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.005 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.1 154.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.5 t -66.28 114.81 5.62 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.48 111.3 23.8 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.229 0.538 . . . . 0.0 112.419 -171.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.0 tp -84.36 124.87 40.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.0 mm -87.6 151.71 3.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 71.83 105.91 0.07 Allowed 'General case' 0 N--CA 1.412 -2.332 0 C-N-CA 125.994 1.718 . . . . 0.0 111.892 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -59.88 -42.02 87.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.614 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -94.11 106.96 18.92 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.508 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 67.8 mt -95.64 122.39 47.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.12 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p -105.9 101.17 31.88 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-O 121.43 0.633 . . . . 0.0 110.338 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 7.9 Cg_exo -74.55 152.7 43.51 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.941 2.428 . . . . 0.0 109.601 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -63.93 83.29 0.03 OUTLIER 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 121.426 0.632 . . . . 0.0 109.898 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.1 m -82.82 111.09 18.41 Favored 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -82.32 110.86 17.86 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.531 ' HB3' HG13 ' A' ' 249' ' ' VAL . 77.8 ttt180 -94.3 116.78 29.22 Favored 'General case' 0 C--N 1.267 -2.992 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.89 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -125.66 109.62 12.83 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.588 -173.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 205' ' ' LEU . 27.7 m -105.29 132.32 52.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.434 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.407 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.2 mtm180 -114.89 147.96 39.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -170.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 90.5 mt -126.34 120.02 28.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.313 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.33 108.19 13.85 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.586 175.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.633 ' O ' ' HD2' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.73 121.36 21.6 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -173.99 105.66 0.12 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.133 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.42 67.11 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.685 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -157.93 164.14 37.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -106.53 85.51 2.18 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.503 ' HD3' ' HB3' ' A' ' 242' ' ' SER . 24.5 pttm 38.5 97.45 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.663 1.985 . . . . 0.0 116.272 170.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 100.73 1.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.861 1.708 . . . . 0.0 110.461 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.81 99.69 2.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.546 0.689 . . . . 0.0 111.35 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -93.59 43.99 2.44 Favored Glycine 0 C--N 1.282 -2.425 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.007 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -170.29 145.69 2.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.889 0.876 . . . . 0.0 108.729 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.1 143.94 42.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.702 0.287 . . . . 0.0 111.051 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.463 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 2.3 pp -124.71 154.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.258 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -141.26 158.78 43.43 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.006 0.522 . . . . 0.0 110.321 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.8 131.96 36.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.26 -172.38 18.14 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.429 ' CG2' ' HB2' ' A' ' 191' ' ' LYS . 3.1 m -126.43 143.19 51.27 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.332 -0.947 . . . . 0.0 108.734 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t -120.3 119.77 34.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.68 123.38 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.791 0.805 . . . . 0.0 110.652 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 16.2 ptp180 -117.37 160.06 21.76 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.351 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -99.22 108.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.135 0.969 . . . . 0.0 110.811 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.8 p -108.13 178.21 4.57 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.82 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.91 -17.32 63.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.057 0.456 . . . . 0.0 109.944 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.7 m -87.9 -4.74 58.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.367 0.603 . . . . 0.0 109.424 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.04 -158.47 14.3 Favored Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 183' ' ' ARG 0.266 1.1 pp -84.6 106.9 16.51 Favored 'General case' 0 N--CA 1.4 -2.942 0 CA-C-O 122.224 1.012 . . . . 0.0 112.642 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -109.95 155.39 21.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.052 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 180' ' ' THR . 7.3 ptpp? -106.21 139.69 40.32 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 121.516 0.674 . . . . 0.0 111.362 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.447 ' NE2' ' HD2' ' A' ' 193' ' ' PRO . 56.3 tp60 -127.95 141.63 41.78 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -177.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.447 ' HD2' ' NE2' ' A' ' 192' ' ' GLN . 16.9 Cg_exo -66.16 125.58 14.31 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.654 2.236 . . . . 0.0 109.699 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -140.6 135.32 6.94 Favored Glycine 0 C--N 1.28 -2.559 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.629 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.469 HG13 HG21 ' A' ' 234' ' ' VAL . 49.7 mm -93.04 122.21 44.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -107.84 162.23 14.19 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.01 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 249' ' ' VAL . 58.6 mt -73.16 136.67 24.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.7 t -118.38 -61.02 1.72 Allowed 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.129 -1.029 . . . . 0.0 112.172 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -123.12 155.65 36.56 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 206' ' ' ALA . 17.0 mt -126.65 138.74 53.46 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.874 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.3 t -99.6 128.45 31.36 Favored Pre-proline 0 C--N 1.283 -2.313 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.29 126.81 22.59 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 121.952 1.768 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.37 40.16 6.55 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 -172.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.31 162.39 12.61 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.902 -0.649 . . . . 0.0 112.794 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 161' ' ' VAL . 92.8 mt -70.92 -43.43 68.28 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.086 0.555 . . . . 0.0 111.494 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -72.41 -26.64 61.94 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.932 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -67.64 -45.28 75.8 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.8 t -64.49 -38.23 90.3 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.281 0.563 . . . . 0.0 110.314 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 206' ' ' ALA . 17.1 p -79.19 -6.18 55.97 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 52.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 125.412 1.482 . . . . 0.0 116.518 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.55 -19.96 15.27 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.49 ' HB3' ' OD2' ' A' ' 216' ' ' ASP . 6.7 mp -109.69 149.91 29.05 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.479 -2.146 . . . . 0.0 107.261 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.13 162.36 16.77 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.467 0.651 . . . . 0.0 111.461 -170.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.49 -15.82 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.486 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -69.78 -23.63 63.38 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.55 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.592 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.2 m-20 -61.79 159.75 13.14 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -106.23 145.32 31.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.515 -170.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 195' ' ' ILE . 35.2 m -89.55 143.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.539 HD11 ' CB ' ' A' ' 250' ' ' LYS . 2.6 mp -115.27 -51.87 4.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -174.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.511 ' H ' ' HB ' ' A' ' 248' ' ' THR . 41.9 mt-10 -135.44 153.31 51.82 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.561 0.696 . . . . 0.0 112.597 -172.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 92.6 t -117.02 98.28 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.463 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 49.1 t-20 65.82 -78.53 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.522 1.129 . . . . 0.0 110.522 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -137.0 -0.52 2.77 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.9 mt -101.79 129.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -82.08 150.85 27.31 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.254 0.479 . . . . 0.0 110.409 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.603 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 12.5 m -117.02 6.49 7.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.207 0.527 . . . . 0.0 109.627 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.7 101.89 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.896 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.68 0.52 59.12 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.535 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 226' ' ' VAL . 47.3 mtmt -89.26 166.51 13.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.724 0.762 . . . . 0.0 112.729 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.459 HG22 HD23 ' A' ' 231' ' ' LEU . 34.2 m -87.58 158.59 18.86 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 -176.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 230' ' ' THR . 1.9 pt? -59.33 -45.12 92.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.8 -45.98 88.64 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.506 0.67 . . . . 0.0 110.515 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.486 ' OE1' ' HD2' ' A' ' 229' ' ' LYS . 33.8 tt0 -64.6 -39.0 92.93 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.97 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.546 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 94.4 t -73.95 -36.41 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 239' ' ' VAL . 9.1 t -74.46 -35.16 63.3 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.761 -1.175 . . . . 0.0 110.483 177.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.62 -48.38 77.57 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.429 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.582 ' SD ' HG12 ' A' ' 226' ' ' VAL . 26.2 ptm -62.06 -39.16 91.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.229 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.432 ' HB2' HD21 ' A' ' 245' ' ' LEU . 20.7 ptp -72.29 -21.09 61.41 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.15 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.658 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 91.8 t -85.91 -32.5 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.01 66.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.899 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.88 21.69 13.62 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.722 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.6 m -60.91 -18.71 58.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.494 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 21.9 p -56.74 -48.79 76.99 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.0 0.428 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -129.93 90.37 2.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.1 tm? -99.7 122.76 43.17 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.29 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.2 mt -129.92 119.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.45 HD11 ' HB ' ' A' ' 218' ' ' VAL . 7.5 tp -109.78 129.63 64.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.131 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.511 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 15.2 m -103.56 131.52 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.35 -174.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 159' ' ' ARG 0.28 0.4 OUTLIER -134.44 139.3 48.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 123.308 0.643 . . . . 0.0 112.457 176.92 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.539 ' CB ' HD11 ' A' ' 219' ' ' ILE . 87.3 tttt -124.01 138.87 31.39 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.589 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.592 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 16.8 Cg_endo -56.0 126.8 23.6 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.708 2.272 . . . . 0.0 112.896 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.66 -30.73 16.96 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 55.96 40.96 30.38 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.766 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -65.14 128.15 34.61 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.618 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 . . . . . 0 C--N 1.285 -2.199 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -178.752 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.774 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -160.13 146.99 16.04 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -113.69 128.42 56.42 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.7 m -90.97 119.24 31.0 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 120.894 0.378 . . . . 0.0 110.938 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -151.03 156.5 41.25 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.04 99.57 40.84 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 120.374 -0.53 . . . . 0.0 112.23 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.7 105.23 1.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.258 1.972 . . . . 0.0 108.956 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.6 t -86.77 95.5 9.85 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 121.714 0.769 . . . . 0.0 111.52 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.4 148.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.6 t -160.65 123.95 3.4 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.0 tt -91.98 125.69 56.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-O 120.653 0.264 . . . . 0.0 110.776 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.12 122.83 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.878 1.719 . . . . 0.0 110.135 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -89.13 120.76 30.81 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -83.76 156.76 22.39 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -59.63 -57.22 13.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 51.96 83.38 0.06 Allowed 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.782 0.676 . . . . 0.0 110.346 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -80.99 109.29 15.43 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.78 117.01 29.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.079 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.8 m -101.43 123.79 46.06 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.84 103.37 8.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tp -82.36 105.01 11.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.556 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.1 mm -105.62 116.25 49.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 151' ' ' VAL . 13.7 t70 -151.01 -154.75 0.57 Allowed 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -175.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.464 ' H ' ' CG ' ' A' ' 150' ' ' ASP 0.312 14.1 m 48.7 94.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 C-N-CA 127.311 2.244 . . . . 0.0 116.182 179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -101.56 108.29 19.81 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.6 tt -153.42 171.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.599 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.87 110.48 49.87 Favored Pre-proline 0 C--N 1.295 -1.803 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 152.4 74.55 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.151 2.567 . . . . 0.0 110.779 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.491 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 3.4 mp0 -56.33 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.568 0.747 . . . . 0.0 111.359 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.493 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.5 m -98.0 147.82 24.11 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -126.61 113.54 16.87 Favored 'General case' 0 CA--C 1.474 -1.966 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.474 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 0.5 OUTLIER -98.76 114.97 27.74 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -177.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -97.44 100.99 12.43 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.474 ' HA ' ' NH1' ' A' ' 159' ' ' ARG . 7.3 p -89.38 110.44 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 121.731 0.777 . . . . 0.0 108.911 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.518 ' HB3' HG12 ' A' ' 246' ' ' ILE . 30.9 ptt180 -118.68 142.14 47.94 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.771 -173.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 245' ' ' LEU . 4.8 tt -129.94 141.85 50.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 166' ' ' HIS 0.26 0.7 OUTLIER -112.34 101.19 9.41 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 179.096 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.59 120.87 25.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.536 ' CE1' ' HB2' ' A' ' 164' ' ' LEU . 39.6 m80 -153.21 25.74 0.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 123.364 0.666 . . . . 0.0 109.625 -177.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.58 -11.46 57.99 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.4 t -100.66 101.05 11.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.8 80.91 1.36 Allowed 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.889 0.852 . . . . 0.0 111.894 -170.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.28 151.76 41.84 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.273 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.48 167.3 27.4 Favored 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 122.877 2.384 . . . . 0.0 113.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -102.33 143.06 32.57 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.163 177.393 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -114.45 56.37 0.5 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.573 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.32 145.39 23.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.35 145.62 43.56 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.166 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.97 152.32 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 40.2 ttm180 -141.13 153.25 45.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -96.83 144.12 27.09 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.792 0.683 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.09 27.75 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 p -94.74 121.95 36.85 Favored 'General case' 0 N--CA 1.385 -3.72 0 CA-C-N 117.158 0.479 . . . . 0.0 110.375 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 t -110.67 119.38 38.95 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.03 123.36 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -107.33 155.16 20.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.79 110.26 31.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.182 0.515 . . . . 0.0 109.955 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 39.7 p -111.22 178.72 4.25 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.49 -3.25 32.92 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.288 0.566 . . . . 0.0 109.794 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.8 m -98.62 -4.43 33.95 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.89 -152.83 17.97 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 189' ' ' LEU . 1.8 pt? -92.32 134.41 34.93 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-N 117.164 0.482 . . . . 0.0 109.746 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -132.59 148.99 52.38 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -107.4 127.73 53.85 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.982 0.896 . . . . 0.0 111.03 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -124.34 160.06 54.51 Favored Pre-proline 0 C--N 1.259 -3.36 0 CA-C-N 113.595 -1.639 . . . . 0.0 108.618 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.02 122.66 6.84 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.158 1.906 . . . . 0.0 108.569 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.61 111.43 3.03 Favored Glycine 0 C--N 1.271 -3.033 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.331 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -98.97 116.68 42.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 14.1 p90 -131.59 172.3 12.4 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.386 -175.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mt -67.6 123.48 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 79.2 p -87.08 -41.98 13.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -162.22 156.02 21.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.996 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 48.7 tp -122.91 138.53 54.64 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.536 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.07 133.69 20.51 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.3 Cg_endo -64.53 130.21 25.96 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.256 1.971 . . . . 0.0 110.511 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.79 2.64 81.28 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -175.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.23 30.21 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.6 mt -55.37 -38.58 69.02 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -76.45 -30.38 57.32 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.8 tm-20 -75.93 -34.03 59.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.0 m -55.53 -32.21 62.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.911 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 m -77.21 -44.89 28.39 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.501 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.97 21.65 63.81 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 114.006 0.362 . . . . 0.0 114.006 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt -107.48 -39.19 5.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.359 0.599 . . . . 0.0 111.001 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.56 HD22 HG23 ' A' ' 249' ' ' VAL . 6.8 mp -109.13 146.55 33.89 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.665 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.08 162.69 17.04 Favored 'General case' 0 C--O 1.198 -1.643 0 O-C-N 123.612 0.57 . . . . 0.0 112.086 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -50.16 -25.94 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -72.06 -25.26 61.71 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.617 -0.677 . . . . 0.0 111.722 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 250' ' ' LYS 0.457 0.8 OUTLIER -73.76 170.79 14.57 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.232 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.1 pt-20 -135.26 165.56 25.15 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -164.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 248' ' ' THR . 58.0 t -80.02 132.85 30.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.22 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.538 HG22 ' HG3' ' A' ' 220' ' ' GLU . 43.5 mm -112.72 -60.6 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.733 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.688 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.7 mt-10 -125.92 153.48 44.17 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.852 0.834 . . . . 0.0 111.947 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 234' ' ' VAL . 92.1 t -119.45 103.36 14.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.977 174.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.563 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.4 t-20 68.2 -69.34 0.15 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.847 0.859 . . . . 0.0 111.04 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.31 7.62 0.45 Allowed Glycine 0 C--N 1.308 -1.012 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.2 mt -104.43 120.81 55.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 43.3 mt-10 -76.3 158.4 31.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.01 7.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.744 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.33 108.07 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.43 . . . . 0.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.75 2.66 46.38 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.105 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.473 ' HE3' ' SD ' ' A' ' 237' ' ' MET . 34.8 mtmm -107.46 158.98 16.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 234' ' ' VAL . 55.1 m -85.26 158.47 20.31 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.224 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 232' ' ' ASP 0.254 1.2 pp -68.74 -31.99 71.45 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.536 ' N ' HD12 ' A' ' 231' ' ' LEU . 10.8 m-20 -64.21 -34.84 79.02 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.286 0.565 . . . . 0.0 110.052 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.584 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.0 tp-100 -69.51 -47.77 62.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 230' ' ' THR . 82.2 t -57.47 -49.47 80.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.931 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 239' ' ' VAL . 40.1 p -67.05 -36.59 82.4 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.199 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.08 -42.53 98.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.022 0.439 . . . . 0.0 109.99 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.3 mtm -59.63 -48.63 80.92 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.868 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 235' ' ' THR . 4.6 ppp? -71.26 -16.92 62.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.651 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 235' ' ' THR . 98.3 t -84.73 -33.04 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.337 0.589 . . . . 0.0 109.574 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.9 -12.02 61.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.891 0.853 . . . . 0.0 109.806 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.43 27.61 8.2 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.757 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 245' ' ' LEU . 69.4 m -57.59 -20.44 32.6 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.8 m -50.55 -56.96 9.36 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -131.6 84.9 2.21 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 245' ' ' LEU . 1.4 pt? -86.7 121.56 29.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.382 0.61 . . . . 0.0 110.403 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 32.0 mt -122.35 124.52 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.478 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 19.1 mm -110.24 139.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.688 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 30.1 m -117.63 125.3 50.5 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.56 HG23 HD22 ' A' ' 212' ' ' LEU . 17.0 m -114.59 148.73 17.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 216' ' ' ASP . 1.0 OUTLIER -139.46 131.18 14.97 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.438 -176.195 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 157' ' ' THR . 6.6 Cg_endo -47.44 136.09 20.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.309 3.339 . . . . 0.0 113.066 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -80.83 4.2 19.98 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.861 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.3 m120 65.88 88.38 0.11 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.837 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -75.53 124.06 26.54 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.583 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.442 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 5.5 tpm_? . . . . . 0 C--N 1.301 -1.506 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.26 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.69 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.8 m -137.07 148.29 46.66 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -113.28 118.25 34.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.8 t -91.94 136.34 33.23 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 132' ' ' LYS . 11.0 mptt -90.31 91.5 8.52 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.463 0.649 . . . . 0.0 111.771 -175.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.06 91.22 50.0 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.494 173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -96.14 162.37 1.31 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 122.36 2.04 . . . . 0.0 111.429 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.5 p -90.35 97.67 11.32 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 136' ' ' ILE . 2.7 mp -76.26 133.7 30.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.627 0.727 . . . . 0.0 109.237 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.4 t 177.85 108.98 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -86.68 120.92 72.13 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.894 -172.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.53 124.33 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.277 1.985 . . . . 0.0 109.154 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -78.18 124.95 28.66 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.06 -174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.6 157.6 22.22 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.142 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -51.18 122.08 7.15 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 124.002 0.814 . . . . 0.0 110.521 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.421 ' C ' ' HD3' ' A' ' 143' ' ' ARG . 1.7 tmt_? -97.33 79.46 2.79 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 122.48 1.133 . . . . 0.0 108.243 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -88.85 145.25 25.68 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.057 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.6 m -75.22 116.55 18.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.265 0.555 . . . . 0.0 110.501 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -66.26 113.11 4.34 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.01 -176.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.56 103.88 11.46 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.9 mm -136.1 125.08 38.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 152' ' ' ASP . 26.0 pt -101.82 114.41 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-O 121.586 0.708 . . . . 0.0 110.306 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -120.75 -30.69 4.4 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.708 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.95 -39.73 15.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 149' ' ' ILE . 32.5 t70 -100.0 111.53 23.83 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.582 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 14.7 tt -156.61 -173.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.554 ' H ' HG12 ' A' ' 153' ' ' ILE . 51.7 t -96.86 101.6 9.78 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 6.1 Cg_endo -87.5 152.36 7.72 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.139 2.559 . . . . 0.0 109.535 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 1.6 mp0 -70.05 84.47 0.52 Allowed 'General case' 0 N--CA 1.418 -2.05 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.51 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 101.71 12.73 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -80.72 94.22 6.33 Favored 'General case' 0 CA--C 1.463 -2.404 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -115.22 126.78 54.96 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.592 -169.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.556 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.7 ptt180 -95.74 94.32 7.62 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.16 133.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.759 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 18.9 ptp180 -99.52 155.74 17.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.77 126.72 37.1 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . 0.258 1.1 pp -105.32 101.54 11.07 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-O 122.152 0.977 . . . . 0.0 113.039 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.618 ' HE2' ' O ' ' A' ' 168' ' ' SER . 12.6 tmtt? -65.2 121.01 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.597 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -162.23 132.89 4.9 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.62 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.37 90.12 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 114.548 0.579 . . . . 0.0 114.548 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.618 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 47.9 m -158.52 153.6 25.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.53 -47.63 69.35 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.702 0.626 . . . . 0.0 109.832 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.442 ' HG3' HD13 ' A' ' 172' ' ' LEU . 6.8 ttpm? -137.56 83.72 24.62 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 168' ' ' SER . 88.8 Cg_endo -91.91 25.08 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.236 2.624 . . . . 0.0 112.576 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 170' ' ' LYS . 5.6 mp -73.08 109.31 6.52 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.78 53.66 4.84 Favored Glycine 0 C--N 1.305 -1.176 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.529 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -170.41 142.26 2.11 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.25 158.89 42.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.46 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.5 pp -131.08 143.31 41.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.181 0.515 . . . . 0.0 112.257 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 16.2 ttm180 -142.22 157.41 44.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -74.12 131.75 41.6 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.967 0.792 . . . . 0.0 110.62 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -144.8 125.91 2.51 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 24.5 p -92.59 139.07 30.95 Favored 'General case' 0 N--CA 1.383 -3.777 0 CA-C-N 117.367 0.583 . . . . 0.0 111.959 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.2 m -110.86 130.54 55.55 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.31 128.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -109.66 155.4 21.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.07 118.86 56.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.255 0.55 . . . . 0.0 110.466 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 41.5 p -115.24 177.83 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.332 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.03 58.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.57 0.7 . . . . 0.0 109.99 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.0 m -101.1 7.47 43.28 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.558 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.18 -141.58 12.94 Favored Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.764 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 189' ' ' LEU . 2.9 pp -125.08 137.86 54.19 Favored 'General case' 0 N--CA 1.388 -3.549 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 153.11 46.56 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.76 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.461 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 38.3 ttpt -121.27 144.09 48.81 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 121.394 0.616 . . . . 0.0 112.027 -172.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -122.2 140.51 32.57 Favored Pre-proline 0 N--CA 1.41 -2.43 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.346 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.08 134.79 18.1 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.214 1.942 . . . . 0.0 109.203 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.86 154.35 22.65 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.764 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.91 117.09 49.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -119.37 166.53 12.93 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 62.6 mt -67.09 129.79 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 39.7 p -96.68 -51.68 4.21 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -137.5 143.54 41.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.362 0.601 . . . . 0.0 111.122 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 138.85 49.73 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.62 138.33 20.74 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -59.8 126.38 20.31 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 121.669 1.579 . . . . 0.0 109.339 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.7 16.36 68.4 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 156.5 29.81 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.862 -0.669 . . . . 0.0 113.218 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.28 -46.08 76.16 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 124.799 1.239 . . . . 0.0 111.446 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.31 -30.14 70.96 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.158 0.504 . . . . 0.0 111.077 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.44 -33.72 54.72 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.364 0.666 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.3 t -55.02 -32.85 62.14 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.375 1.07 . . . . 0.0 113.843 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.9 t -79.86 -44.02 21.26 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.38 -23.18 5.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.631 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.85 -40.34 54.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.938 0.875 . . . . 0.0 109.383 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.505 HD13 HG23 ' A' ' 249' ' ' VAL . 86.3 mt -109.64 147.37 33.2 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.568 -175.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.05 162.89 17.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.016 0.436 . . . . 0.0 111.289 -174.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.521 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 14.3 p -62.2 -15.45 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-O 121.987 0.899 . . . . 0.0 111.323 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -71.88 -24.02 61.6 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.822 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.684 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.4 m-20 -64.56 173.39 2.17 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -116.46 147.75 41.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.242 -172.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.67 142.69 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.065 0.546 . . . . 0.0 110.43 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 220' ' ' GLU . 2.5 mp -112.04 -51.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 110.456 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.557 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.3 mt-10 -140.48 149.74 42.9 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.56 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.0 t -113.62 108.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.505 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 6.9 t30 69.87 -68.82 0.18 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.332 1.453 . . . . 0.0 110.939 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.73 26.36 0.19 Allowed Glycine 0 C--N 1.301 -1.388 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.52 119.1 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 225' ' ' GLU . 1.2 pm0 -75.53 145.91 40.93 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-O 121.007 0.432 . . . . 0.0 111.985 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 219' ' ' ILE . 20.3 m -94.11 9.31 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.892 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -64.54 106.11 1.09 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.834 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.25 12.2 58.95 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.497 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 70.6 mmtt -87.03 170.58 11.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.27 1.033 . . . . 0.0 113.327 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 234' ' ' VAL . 86.0 m -110.26 157.09 19.83 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 113.363 -1.744 . . . . 0.0 106.65 174.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 231' ' ' LEU . 1.9 pt? -64.67 -34.35 78.08 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.34 -49.48 55.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.551 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -60.48 -40.57 91.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.681 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.559 ' HA ' ' SD ' ' A' ' 237' ' ' MET . 92.0 t -57.53 -43.31 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 O-C-N 123.266 0.354 . . . . 0.0 111.439 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 239' ' ' VAL . 60.2 p -65.19 -28.89 69.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.5 -40.75 63.83 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.559 ' SD ' ' HA ' ' A' ' 234' ' ' VAL . 54.3 mtp -55.84 -50.16 71.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.02 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.7 ptm -76.49 -10.67 59.57 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.046 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.673 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 59.0 t -91.81 -34.96 6.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.045 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.43 -22.07 66.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.643 0.735 . . . . 0.0 109.902 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -114.32 21.83 14.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.1 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 75.2 m -63.92 -32.0 73.38 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.8 m -51.94 -53.08 45.42 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 0.0 110.815 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -129.81 86.17 2.38 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.1 tm? -97.09 131.45 43.86 Favored 'General case' 0 C--O 1.191 -1.993 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.722 -174.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -117.07 118.86 60.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.42 130.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.922 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.557 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 18.7 m -97.35 120.18 37.23 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.505 HG23 HD13 ' A' ' 212' ' ' LEU . 5.4 m -124.93 150.4 29.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 123.781 0.675 . . . . 0.0 112.251 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.491 ' CB ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.04 130.36 15.11 Favored Pre-proline 0 C--O 1.247 0.921 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.684 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.8 Cg_endo -62.41 132.2 37.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.024 2.483 . . . . 0.0 115.119 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.58 -4.48 15.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.655 -1.157 . . . . 0.0 107.919 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -89.03 -1.8 58.28 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.766 -177.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.39 123.35 22.87 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.696 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 . . . . . 0 C--N 1.295 -1.778 0 O-C-N 124.25 0.969 . . . . 0.0 109.119 178.762 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.784 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.21 -45.37 7.64 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 122.85 2.367 . . . . 0.0 112.405 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -119.9 103.17 9.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.254 0.55 . . . . 0.0 110.678 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.0 mt -110.45 142.92 21.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.5 t -134.52 93.36 3.04 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.91 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.1 tt -115.06 92.26 30.36 Favored Pre-proline 0 N--CA 1.415 -2.193 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.06 122.63 3.83 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.152 1.901 . . . . 0.0 111.446 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -94.59 114.57 26.55 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -83.23 119.93 25.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.297 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -179.17 92.24 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.595 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 . . . . . 0 C--N 1.301 -1.525 0 CA-C-O 122.535 1.16 . . . . 0.0 108.107 178.536 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.82 150.37 78.67 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 122.548 2.166 . . . . 0.0 111.69 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 77.3 4.33 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.2 p -74.39 101.76 4.2 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.452 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -76.4 95.65 3.86 Favored 'General case' 0 CA--C 1.466 -2.277 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.485 ' CB ' HD11 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -96.08 117.3 30.42 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.324 -167.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 30.3 ptt180 -87.25 99.49 12.0 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.724 0.773 . . . . 0.0 109.716 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 247' ' ' ILE . 62.5 t -88.94 105.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.417 ' HE ' HD21 ' A' ' 164' ' ' LEU . 14.6 ptm180 -105.69 139.42 40.3 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.322 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.19 121.34 44.96 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.417 HD21 ' HE ' ' A' ' 162' ' ' ARG . 89.7 mt -100.82 100.21 10.83 Favored 'General case' 0 N--CA 1.403 -2.783 0 CA-C-O 121.752 0.787 . . . . 0.0 109.729 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER -90.64 120.58 31.83 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.282 176.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -152.31 89.32 1.42 Allowed 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.113 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.07 -10.37 41.58 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.36 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 32.9 t -141.61 135.04 29.6 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.509 ' OD2' ' HG3' ' A' ' 165' ' ' LYS . 13.4 t70 -130.42 87.04 2.45 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -119.01 147.51 42.71 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.563 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 112.4 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 107.886 -1.621 . . . . 0.0 107.886 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.503 HD22 ' H ' ' A' ' 205' ' ' LEU . 4.9 tt -62.73 -29.2 70.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.357 0.599 . . . . 0.0 109.607 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.76 -4.91 1.71 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.337 -1.411 . . . . 0.0 113.468 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -103.06 147.56 26.81 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.417 ' HB2' ' H ' ' A' ' 199' ' ' ARG . 81.7 m-85 -137.93 158.51 44.19 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.404 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.1 pt -117.57 149.17 19.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.476 0.655 . . . . 0.0 112.377 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 60.1 ttt180 -125.45 152.33 45.03 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.124 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 8.7 t70 -115.59 123.23 47.92 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.39 179.68 29.55 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.288 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.9 p -93.41 120.61 33.9 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.163 0.506 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.8 t -101.7 124.45 47.37 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.46 123.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 121.381 0.61 . . . . 0.0 110.445 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -124.76 161.57 26.13 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.272 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.16 107.41 22.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 36.2 p -108.88 178.87 4.34 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.78 -16.88 64.33 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.948 0.404 . . . . 0.0 110.818 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.3 m -87.88 -4.7 58.83 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.9 -151.7 18.17 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.592 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.707 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.5 pt? -84.28 108.53 17.19 Favored 'General case' 0 N--CA 1.394 -3.253 0 CA-C-O 122.016 0.912 . . . . 0.0 109.796 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.4 158.85 23.73 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.496 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.46 131.87 54.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -116.49 151.1 46.61 Favored Pre-proline 0 C--N 1.273 -2.731 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.11 125.16 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.893 1.728 . . . . 0.0 109.902 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.74 151.52 20.21 Favored Glycine 0 C--N 1.278 -2.64 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 122.47 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.08 -168.44 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.5 136.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 69.4 p -95.42 -46.94 6.49 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.453 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.417 ' H ' ' HB2' ' A' ' 175' ' ' TYR . 72.7 ttt180 -146.58 146.88 30.6 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 56.4 tp -127.78 125.44 39.88 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.3 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.17 130.59 26.94 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 50.6 Cg_exo -57.52 126.28 21.41 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.148 1.899 . . . . 0.0 110.24 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.66 -14.9 41.91 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.64 146.02 28.16 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.503 ' H ' HD22 ' A' ' 172' ' ' LEU . 34.6 tp -53.96 -34.42 59.66 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 123.927 0.891 . . . . 0.0 113.271 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -69.37 -35.26 75.65 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.8 tp10 -77.04 -35.52 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 36.4 m -61.73 -33.11 73.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.486 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.3 m -67.12 -39.89 86.73 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.46 -32.27 2.61 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.941 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.89 -19.25 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 123.74 0.816 . . . . 0.0 110.189 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.485 HD11 ' CB ' ' A' ' 159' ' ' ARG . 71.1 mt -109.42 141.84 41.24 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.476 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.3 163.06 27.63 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 124.622 1.169 . . . . 0.0 110.128 -177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.86 -26.74 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.816 0.846 . . . . 0.0 112.579 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.12 -23.55 64.0 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.1 m-20 -63.66 159.13 19.71 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.52 148.46 24.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.919 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -101.56 139.02 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.829 0.852 . . . . 0.0 109.477 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.7 mp -116.12 -50.64 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.468 ' HG3' HG22 ' A' ' 219' ' ' ILE . 47.6 mt-10 -136.22 152.44 50.76 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.413 HG13 ' CD2' ' A' ' 245' ' ' LEU . 50.4 t -119.84 106.82 19.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.811 -1.54 . . . . 0.0 107.975 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 70.25 -69.01 0.18 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.475 1.11 . . . . 0.0 110.49 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -166.0 21.19 0.11 Allowed Glycine 0 C--N 1.291 -1.926 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.583 HG21 ' SD ' ' A' ' 237' ' ' MET . 13.2 mt -113.19 124.91 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.8 143.48 41.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 118.621 0.646 . . . . 0.0 109.664 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.9 m -96.15 -5.19 10.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.682 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.04 123.05 19.98 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.172 0.511 . . . . 0.0 111.684 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.7 7.4 75.13 Favored Glycine 0 CA--C 1.499 -0.907 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.201 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.442 ' HG3' ' OE1' ' A' ' 233' ' ' GLN . 23.3 ttmm -107.47 156.29 19.13 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 234' ' ' VAL . 87.1 m -77.14 157.47 30.97 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 50.0 tp -62.45 -44.3 96.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.42 -35.4 70.02 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.035 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.651 ' O ' ' HG3' ' A' ' 237' ' ' MET . 79.2 mt-30 -73.34 -42.47 62.23 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.946 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 230' ' ' THR . 61.1 t -64.75 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.596 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.0 p -65.87 -41.63 91.36 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.615 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.39 -44.88 95.41 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.1 0.476 . . . . 0.0 110.463 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 33.8 mtm -60.14 -42.9 95.83 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.8 -17.92 62.13 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.395 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 235' ' ' THR . 85.0 t -85.39 -36.73 11.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.24 -25.22 67.7 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.534 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -129.92 28.76 5.04 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.687 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.9 t -59.16 -35.57 73.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.459 1.103 . . . . 0.0 111.953 -175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 22.8 t -70.36 -20.5 62.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.216 0.532 . . . . 0.0 110.759 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -130.15 37.12 3.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.413 ' CD2' HG13 ' A' ' 221' ' ' VAL . 3.2 tm? -85.02 123.01 30.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.829 0.823 . . . . 0.0 112.219 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 61.6 mt -129.02 119.61 49.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.317 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.455 HG23 ' HB ' ' A' ' 161' ' ' VAL . 10.8 tt -109.66 131.99 59.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.584 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.4 m -95.46 120.15 35.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.093 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 212' ' ' LEU . 17.4 m -122.53 149.97 26.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.582 0.551 . . . . 0.0 110.208 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.451 ' CB ' HD11 ' A' ' 219' ' ' ILE . 0.5 OUTLIER -134.77 126.06 17.73 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 77.7 Cg_exo -52.56 132.06 43.76 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.659 2.906 . . . . 0.0 114.494 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -101.78 8.15 41.53 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 114.152 -1.386 . . . . 0.0 108.122 179.546 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.92 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.0 108.39 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.635 1.557 . . . . 0.0 108.736 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 t -92.85 85.82 5.3 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.315 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.59 119.6 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.1 m -145.24 91.31 2.12 Favored 'General case' 1 C--N 1.235 -4.401 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -116.63 108.15 45.47 Favored Pre-proline 0 N--CA 1.424 -1.734 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.178 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.16 123.92 12.63 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 N-CA-C 106.504 -2.152 . . . . 0.0 106.504 172.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.38 112.14 20.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.388 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 142' ' ' PHE . 11.6 m-20 -107.22 118.85 37.81 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 141' ' ' ASP . 48.6 t80 166.66 93.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 O-C-N 125.029 1.455 . . . . 0.0 107.217 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 122.178 0.989 . . . . 0.0 109.357 -179.111 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.45 HG23 HD22 ' A' ' 253' ' ' ASN . 7.5 p . . . . . 0 N--CA 1.417 -2.097 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.49 146.66 13.77 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.338 2.025 . . . . 0.0 113.381 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.494 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 2.4 mp0 -83.0 72.32 10.08 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.717 177.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -106.07 138.53 42.09 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -126.08 135.91 52.3 Favored 'General case' 0 CA--C 1.469 -2.136 0 CA-C-O 121.147 0.498 . . . . 0.0 112.082 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -113.65 115.76 28.4 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.432 ' O ' ' HD2' ' A' ' 160' ' ' ARG 0.334 4.0 ppt_? -97.97 103.81 15.78 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 122.162 0.982 . . . . 0.0 110.659 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.31 125.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.916 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -95.55 126.68 41.0 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.305 0.574 . . . . 0.0 109.862 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.01 121.43 38.89 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.512 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.28 105.16 15.75 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.322 1.058 . . . . 0.0 110.639 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -74.98 136.28 41.31 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.441 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.542 ' HB2' ' H ' ' A' ' 170' ' ' LYS . 88.3 m-70 -139.53 -75.63 0.35 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.556 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.2 -10.96 58.46 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.251 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.7 m -134.01 25.5 3.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 122.123 0.963 . . . . 0.0 108.476 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.402 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 19.4 t70 -165.14 -70.48 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.161 -174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.542 ' H ' ' HB2' ' A' ' 166' ' ' HIS . 12.7 mptt -123.79 114.27 28.37 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -84.31 -40.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.037 1.825 . . . . 0.0 110.234 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.95 159.16 36.21 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 125.618 1.567 . . . . 0.0 107.153 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -122.73 17.81 8.18 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.584 -1.293 . . . . 0.0 112.449 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -165.68 143.67 5.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.424 ' CE2' HG22 ' A' ' 201' ' ' VAL . 76.1 m-85 -108.99 136.03 49.2 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.973 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.478 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -134.44 140.31 46.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -137.82 159.9 40.74 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.29 145.08 44.26 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.947 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.1 109.72 0.43 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 m -93.3 143.76 25.96 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 51.0 m -126.24 133.79 51.38 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.4 p -108.65 125.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.49 ' HB2' ' OE1' ' A' ' 190' ' ' GLU . 72.7 mtp180 -124.72 162.21 24.71 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.428 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.98 113.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.893 0.854 . . . . 0.0 108.856 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 57.0 p -113.8 178.24 4.35 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.498 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.48 -10.88 59.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 109.916 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.2 m -94.55 -4.19 48.39 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.219 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.08 -159.6 14.27 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.645 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.8 pt? -83.98 129.13 34.93 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 117.593 0.697 . . . . 0.0 110.272 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -137.78 161.82 35.57 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.761 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 181' ' ' SER . 98.3 mttt -121.64 150.15 42.15 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 18.6 pt20 -131.13 139.0 34.17 Favored Pre-proline 0 N--CA 1.414 -2.23 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.1 Cg_endo -81.7 133.74 8.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.546 2.164 . . . . 0.0 110.854 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.23 153.7 25.5 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.869 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 231' ' ' LEU . 2.7 mp -125.57 123.1 63.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -127.56 163.97 23.01 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 67.7 mt -74.6 114.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -84.52 -49.59 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.064 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.11 155.41 50.22 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.743 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -113.57 140.62 48.01 Favored 'General case' 0 N--CA 1.395 -3.2 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 178.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 175' ' ' TYR . 40.1 t -96.54 129.69 32.5 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.15 126.05 17.8 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 121.939 1.76 . . . . 0.0 109.236 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.07 -6.56 83.1 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.39 156.3 53.29 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.89 -25.88 65.72 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.46 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' N ' HD21 ' A' ' 200' ' ' LEU . 42.8 tt0 -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.0 m -54.81 -31.27 58.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.288 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.4 p -60.75 -43.12 98.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.96 29.28 74.39 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.9 tp -145.43 -46.47 0.22 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.011 -1.095 . . . . 0.0 110.458 -172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.442 HD12 HG23 ' A' ' 249' ' ' VAL . 71.9 mt -115.4 110.43 19.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.445 0.641 . . . . 0.0 111.3 -176.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.69 134.01 44.27 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.613 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 71.2 t 43.22 -72.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 173.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -23.6 65.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -67.41 153.2 44.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.363 -173.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -101.29 156.44 17.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.63 143.3 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.491 0.717 . . . . 0.0 109.964 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.513 HD11 ' CB ' ' A' ' 250' ' ' LYS . 2.8 mp -121.69 -45.52 2.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 111.968 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.451 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 35.9 mt-10 -135.58 150.85 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.768 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.4 t -121.87 101.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 123.804 0.69 . . . . 0.0 109.338 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.522 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 39.2 t-20 69.59 -72.09 0.11 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 0.0 111.269 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.54 12.18 0.4 Allowed Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.584 HG21 ' SD ' ' A' ' 237' ' ' MET . 19.9 mt -105.21 133.06 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.92 146.3 28.12 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.47 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 12.7 m -91.63 -4.94 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.945 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.76 112.34 7.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.575 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 4.29 50.76 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.5 mmpt? -96.79 163.04 13.16 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -104.57 168.7 8.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 231' ' ' LEU . 1.9 pt? -57.59 -47.59 81.71 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -68.31 -40.99 81.53 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.237 0.541 . . . . 0.0 110.529 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.684 ' O ' ' HG3' ' A' ' 237' ' ' MET . 35.5 tt0 -59.09 -43.59 91.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.309 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.49 -46.86 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.483 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.0 p -65.97 -31.01 71.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.888 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.65 -42.79 77.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.18 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.684 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 24.6 mtm -59.3 -46.35 88.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.68 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.3 ptp -67.15 -23.15 65.76 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.967 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 235' ' ' THR . 58.8 t -90.14 -27.05 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.557 0.694 . . . . 0.0 109.161 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.02 71.95 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.449 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.58 -70.17 0.72 Allowed 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.28 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.2 t 60.16 -41.28 0.09 Allowed 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 42.5 m -68.6 -73.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.885 0.766 . . . . 0.0 111.588 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.52 81.17 2.92 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -95.87 129.1 43.21 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.207 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 3.3 mp -127.46 134.5 65.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 220' ' ' GLU . 7.2 tp -124.18 131.17 73.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.59 . . . . 0.0 110.001 178.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 28.5 m -98.03 120.22 38.04 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.052 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG23 HD12 ' A' ' 212' ' ' LEU . 10.5 m -121.06 149.37 24.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.278 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.513 ' CB ' HD11 ' A' ' 219' ' ' ILE . 80.7 tttt -127.72 141.07 39.88 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 124.001 0.92 . . . . 0.0 109.258 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.631 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.5 Cg_endo -64.39 130.09 25.84 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 121.626 1.551 . . . . 0.0 111.039 175.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -95.48 -35.15 11.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.928 0.871 . . . . 0.0 109.07 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.535 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 45.1 m-80 . . . . . 0 N--CA 1.495 1.796 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.932 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.579 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.28 133.2 31.93 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.736 1.624 . . . . 0.0 110.093 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.9 t -96.32 96.31 8.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.404 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.57 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.3 t -161.95 93.21 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 73.0 mt -92.23 114.18 61.44 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 6.9 Cg_exo -72.32 123.0 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.313 2.008 . . . . 0.0 112.286 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -98.44 132.26 44.03 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.83 157.17 17.66 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -96.27 138.91 33.18 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 122.106 0.955 . . . . 0.0 109.005 -177.108 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 253' ' ' ASN . 41.3 t . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.04 151.79 84.55 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.391 2.061 . . . . 0.0 109.266 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 78.64 0.22 Allowed 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.8 p -81.84 96.96 7.79 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.411 ' NE2' ' HG2' ' A' ' 250' ' ' LYS . 12.0 m170 -66.04 116.39 7.1 Favored 'General case' 0 CA--C 1.457 -2.622 0 CA-C-O 121.861 0.838 . . . . 0.0 112.42 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.458 ' HG2' HG21 ' A' ' 209' ' ' THR . 10.7 tpt180 -110.12 116.7 32.01 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.67 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.497 ' HB2' HG23 ' A' ' 246' ' ' ILE . 30.7 ptt180 -99.14 113.62 25.95 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.92 132.32 41.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 19.6 ptt180 -112.13 148.79 33.24 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.001 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 2.5 tm? -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 171.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 164' ' ' LEU 0.273 0.0 OUTLIER -108.04 101.33 10.58 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-O 121.956 0.884 . . . . 0.0 112.72 179.39 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -71.91 131.83 43.52 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.817 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.26 79.07 0.52 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.801 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.95 17.62 69.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -102.94 113.89 27.72 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 114.616 -0.792 . . . . 0.0 111.049 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.14 4.24 7.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.769 1.271 . . . . 0.0 107.687 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -74.2 169.19 20.32 Favored Pre-proline 0 C--O 1.246 0.869 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -56.07 146.17 71.32 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.257 1.972 . . . . 0.0 110.523 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.72 -47.23 80.44 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.442 0.639 . . . . 0.0 111.853 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 115.83 -18.78 14.47 Favored Glycine 0 CA--C 1.487 -1.692 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -132.67 133.36 43.47 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 114.275 -0.962 . . . . 0.0 108.857 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 199' ' ' ARG . 77.4 m-85 -138.04 148.08 44.74 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 123.524 0.515 . . . . 0.0 111.926 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.425 HG21 HG11 ' A' ' 218' ' ' VAL . 31.6 pt -124.71 143.14 39.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.992 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -140.24 159.39 42.28 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.841 0.353 . . . . 0.0 111.43 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.65 135.78 35.53 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.932 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -142.17 175.01 22.98 Favored Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.5 m -95.04 133.42 38.84 Favored 'General case' 0 C--N 1.27 -2.881 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.725 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.3 t -103.88 119.12 38.25 Favored 'General case' 0 C--N 1.252 -3.668 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.1 p -108.41 123.16 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.544 0.688 . . . . 0.0 109.168 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.89 51.65 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.529 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.82 107.41 21.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.28 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.3 p -111.87 179.11 4.1 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.753 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.12 -15.21 62.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.2 m -87.62 -5.32 58.78 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.95 -157.36 15.04 Favored Glycine 0 C--O 1.214 -1.119 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 189' ' ' LEU . 4.0 pp -88.19 129.97 35.19 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 118.346 1.073 . . . . 0.0 109.203 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 41.7 mt-10 -120.69 147.78 44.82 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.507 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -121.34 130.12 53.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -142.21 154.83 64.83 Favored Pre-proline 0 C--N 1.279 -2.486 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.69 121.56 6.39 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 109.23 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.41 139.35 10.71 Favored Glycine 0 C--N 1.276 -2.791 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.8 pt -100.6 126.58 54.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-O 121.532 0.682 . . . . 0.0 112.164 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -120.19 174.47 6.48 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.952 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 176' ' ' ILE . 59.9 mt -68.33 135.7 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.3 t -121.23 -59.29 1.73 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.593 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.42 ' HB2' ' HB2' ' A' ' 175' ' ' TYR . 93.1 mtt180 -122.86 147.01 47.05 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.442 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 206' ' ' ALA . 12.9 mt -127.36 134.11 49.98 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.464 174.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.402 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 57.7 t -100.7 129.38 27.71 Favored Pre-proline 0 C--N 1.275 -2.632 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 172.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.66 126.45 19.73 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.334 2.023 . . . . 0.0 110.682 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.04 72.5 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.214 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 158.35 47.48 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -55.95 -39.32 71.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.771 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -74.01 -26.98 60.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.171 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.428 ' HB2' HD22 ' A' ' 200' ' ' LEU . 7.7 tp10 -73.0 -45.46 57.79 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 m -55.36 -32.22 62.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.263 1.025 . . . . 0.0 111.846 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.559 HG22 ' HG ' ' A' ' 211' ' ' LEU . 27.6 m -62.58 -43.49 98.69 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.033 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 77.59 -27.64 1.85 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.387 0.915 . . . . 0.0 115.387 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.559 ' HG ' HG22 ' A' ' 209' ' ' THR . 4.2 pp -97.56 7.98 45.47 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 249' ' ' VAL . 94.9 mt -116.0 145.05 43.28 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.938 0.399 . . . . 0.0 110.045 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.47 161.89 26.1 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 120.889 0.376 . . . . 0.0 111.75 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.61 -19.41 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-O 121.547 0.689 . . . . 0.0 111.114 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.77 -25.07 58.82 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.528 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.617 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 51.8 m-20 -70.98 156.67 39.35 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.245 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.47 165.74 18.54 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.628 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 176' ' ' ILE . 19.6 m -82.77 142.88 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.234 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.59 HG13 ' HG3' ' A' ' 250' ' ' LYS . 42.8 mm -116.06 -47.43 4.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.069 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.544 ' H ' ' HB ' ' A' ' 248' ' ' THR . 39.1 mt-10 -145.99 159.49 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' A' ' 226' ' ' VAL . 77.2 t -123.38 97.26 4.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 169.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.3 t30 68.3 -70.17 0.13 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.36 17.56 0.68 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.426 HG21 ' SD ' ' A' ' 237' ' ' MET . 9.0 mt -120.3 142.33 36.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -86.12 153.83 21.8 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.991 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.424 ' CG1' HG23 ' A' ' 221' ' ' VAL . 16.3 m -118.03 -3.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.94 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -86.27 121.77 29.32 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.81 -10.22 72.52 Favored Glycine 0 C--N 1.318 -0.441 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 233' ' ' GLN . 37.5 ttmt -91.95 153.79 19.25 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 124.48 1.112 . . . . 0.0 109.153 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.4 m -74.92 156.28 36.53 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 231' ' ' LEU . 2.2 pt? -64.65 -36.82 85.49 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.686 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.37 -36.85 76.53 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.75 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 237' ' ' MET . 5.8 tp-100 -72.42 -48.52 40.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.459 ' HA ' ' HE2' ' A' ' 237' ' ' MET . 95.6 t -56.74 -48.97 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.932 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.5 p -65.0 -34.0 77.39 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.32 -38.58 81.69 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.99 0.424 . . . . 0.0 110.276 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.659 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 20.2 mtm -57.8 -45.6 85.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.84 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.28 -15.01 60.54 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.465 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 235' ' ' THR . 65.9 t -78.82 -38.72 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.251 0.548 . . . . 0.0 110.028 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.27 -29.06 68.57 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.281 0.563 . . . . 0.0 110.806 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -110.79 32.13 5.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.8 p -60.02 -27.52 66.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.2 p -46.9 -63.55 1.0 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.137 0.575 . . . . 0.0 111.564 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 40.1 m-80 -129.96 87.68 2.56 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.9 pp -90.33 131.99 35.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 160' ' ' ARG . 2.3 mp -106.7 125.29 62.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.094 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.1 tt -111.37 128.27 67.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 110.649 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.544 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.1 m -106.44 129.44 54.42 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.315 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 212' ' ' LEU . 27.8 m -135.66 165.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.59 ' HG3' HG13 ' A' ' 219' ' ' ILE . 43.9 mtpt -126.42 129.02 24.25 Favored Pre-proline 0 CA--C 1.482 -1.637 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.55 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 50.0 Cg_exo -58.62 127.23 23.79 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.811 1.674 . . . . 0.0 110.164 172.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.12 9.69 21.83 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.125 0.964 . . . . 0.0 109.712 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' A' ' 154' ' ' VAL . 24.8 m-80 . . . . . 0 C--N 1.306 -1.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.29 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 147.82 91.87 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.26 1.973 . . . . 0.0 111.263 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.3 m -79.7 85.85 5.36 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.47 0.652 . . . . 0.0 110.614 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.9 mm -99.81 144.18 12.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m 58.26 73.93 0.45 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.141 0.977 . . . . 0.0 111.148 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.79 119.43 70.56 Favored Pre-proline 0 N--CA 1.421 -1.896 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.815 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.17 121.82 10.22 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.464 2.11 . . . . 0.0 112.114 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -101.94 161.19 13.86 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.759 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -83.52 149.44 26.6 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.704 -0.398 . . . . 0.0 109.944 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -103.45 -37.72 7.48 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? . . . . . 0 N--CA 1.429 -1.516 0 CA-C-O 121.118 0.485 . . . . 0.0 110.647 -176.192 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.75 131.2 1.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.049 1.833 . . . . 0.0 112.283 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.55 ' HA ' ' HG2' ' A' ' 251' ' ' PRO . 42.2 mt-10 -84.27 85.57 7.35 Favored 'General case' 0 N--CA 1.403 -2.811 0 CA-C-O 121.387 0.613 . . . . 0.0 112.109 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -91.0 100.45 13.31 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -88.61 105.01 17.38 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -126.36 116.11 20.7 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.25 129.58 34.6 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.997 0.427 . . . . 0.0 110.074 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.3 t -89.71 115.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -106.28 137.61 43.93 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 111.836 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.72 141.49 48.56 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.356 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.43 115.3 23.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 121.822 0.82 . . . . 0.0 110.801 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.56 130.08 38.92 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.345 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 169' ' ' ASP . 0.5 OUTLIER -164.99 76.33 0.28 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.99 -178.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.37 17.35 76.32 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.009 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.0 m 67.58 97.0 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.587 1.155 . . . . 0.0 111.154 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 166' ' ' HIS . 19.2 t70 -86.56 -49.56 7.46 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.926 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -145.17 150.35 44.86 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.76 -61.93 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 121.312 1.341 . . . . 0.0 109.756 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.04 -65.56 0.39 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.511 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 205' ' ' LEU . . . 92.65 11.48 59.22 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.46 156.92 26.74 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -137.27 136.1 37.75 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 123.339 0.399 . . . . 0.0 110.326 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.483 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -128.81 141.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.307 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -141.31 158.08 44.36 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.498 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -96.95 130.41 44.26 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -122.2 158.89 16.89 Favored Glycine 0 CA--C 1.47 -2.751 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 m -92.91 131.45 37.91 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.72 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -111.43 140.2 46.22 Favored 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.463 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.4 123.15 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.86 152.52 21.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.0 104.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.1 p -117.74 179.03 4.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.97 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.39 -15.89 63.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 109.656 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.6 m -87.25 -4.13 59.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.208 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.54 -142.3 15.52 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.06 123.28 33.79 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -117.2 146.18 43.4 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.58 133.52 55.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.065 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -146.93 147.61 30.05 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.525 ' O ' ' HA2' ' A' ' 228' ' ' GLY . 13.9 Cg_exo -69.12 133.29 26.37 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.414 2.076 . . . . 0.0 111.512 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -129.82 127.19 5.32 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.529 HG23 ' HB ' ' A' ' 218' ' ' VAL . 10.5 tt -91.19 124.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-O 121.25 0.548 . . . . 0.0 110.881 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.58 173.11 10.56 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.47 131.99 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 37.3 t -90.69 -54.31 4.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.223 0.535 . . . . 0.0 110.83 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -155.65 155.66 33.61 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 53.5 tp -127.33 139.63 52.75 Favored 'General case' 0 N--CA 1.403 -2.819 0 O-C-N 123.317 0.386 . . . . 0.0 110.228 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.37 128.62 32.62 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.524 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 29.6 Cg_exo -63.36 126.27 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 108.934 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.6 73.45 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.51 158.42 41.43 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.497 ' H ' ' HA3' ' A' ' 173' ' ' GLY . 27.4 tp -57.95 -38.8 76.66 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -72.71 -29.27 63.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.512 0.672 . . . . 0.0 109.963 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -76.72 -34.07 58.14 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -58.84 -33.54 70.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.9 m -77.16 -45.59 26.24 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.27 -6.0 0.87 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.02 -14.95 58.88 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.218 0.607 . . . . 0.0 111.287 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.471 ' CD1' HG23 ' A' ' 249' ' ' VAL . 94.1 mt -119.22 146.89 44.83 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.146 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.2 161.28 13.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.961 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 51.7 t -67.36 -18.65 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.669 0.747 . . . . 0.0 110.239 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.99 -24.58 59.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.144 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.649 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 73.7 m-20 -66.06 157.2 31.64 Favored 'General case' 0 C--O 1.248 1.026 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -172.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.81 150.4 22.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.576 0.703 . . . . 0.0 112.425 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 195' ' ' ILE . 57.1 t -94.32 136.94 24.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.602 HG22 ' HG3' ' A' ' 220' ' ' GLU . 31.4 mm -115.6 -53.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.543 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.602 ' HG3' HG22 ' A' ' 219' ' ' ILE . 41.5 mt-10 -143.55 159.79 41.8 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.42 0.629 . . . . 0.0 111.594 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.4 104.8 16.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.0 t30 65.97 -74.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.801 1.24 . . . . 0.0 110.612 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -147.23 3.4 0.89 Allowed Glycine 0 C--N 1.306 -1.113 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.3 mt -100.38 117.94 46.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.51 131.75 42.11 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.386 0.612 . . . . 0.0 109.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 234' ' ' VAL . 35.3 m -117.17 7.19 7.09 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.204 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.38 3.39 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.706 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 193' ' ' PRO . . . 102.56 -3.09 49.7 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.292 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -87.54 170.04 11.67 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.15 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.486 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 20.9 m -101.39 159.38 15.32 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 234' ' ' VAL . 2.4 pt? -52.9 -45.26 67.48 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.09 -46.48 88.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.584 0.707 . . . . 0.0 110.074 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 237' ' ' MET . 2.0 mp0 -66.1 -37.94 86.99 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.34 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 231' ' ' LEU . 9.8 p -74.8 -45.08 44.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.672 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 14.6 t -68.92 -38.62 79.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.88 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.55 -37.46 87.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.856 0.836 . . . . 0.0 108.8 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 10.9 tmm? -69.16 -49.26 58.38 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.418 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 18.4 ptp -67.29 -22.58 65.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.62 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 235' ' ' THR . 89.7 t -83.12 -33.0 9.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.731 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.11 -35.05 70.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.31 -79.21 0.18 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.731 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.5 t 59.59 -37.31 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.77 1.628 . . . . 0.0 114.871 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.4 p -55.75 -68.52 0.19 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.482 0.713 . . . . 0.0 110.271 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -100.55 80.5 2.22 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.54 103.89 16.05 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.05 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.4 135.77 62.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.441 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.431 HD11 ' CG1' ' A' ' 218' ' ' VAL . 8.0 tp -118.49 134.18 62.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.316 0.579 . . . . 0.0 110.245 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.559 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 25.2 m -103.39 119.62 39.24 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.553 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.488 HG12 HG22 ' A' ' 218' ' ' VAL . 4.3 m -127.73 137.07 58.7 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.454 ' HD2' HG13 ' A' ' 219' ' ' ILE . 96.6 mttt -134.8 143.57 46.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.168 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.649 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 93.2 Cg_exo -45.79 132.3 13.57 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.362 2.708 . . . . 0.0 112.05 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.04 -16.88 64.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 . . . . . 0 N--CA 1.497 1.891 0 C-N-CA 125.627 1.571 . . . . 0.0 114.33 -178.586 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.02 118.6 2.45 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.692 2.928 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.2 m -83.52 89.73 7.12 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.853 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -63.66 131.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.678 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m -151.73 102.45 2.85 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.214 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.4 tt -87.89 133.66 37.03 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.58 127.59 22.18 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.008 1.806 . . . . 0.0 110.268 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -98.48 157.35 16.27 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.68 157.18 22.29 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.279 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -134.61 139.58 45.43 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 . . . . . 0 N--CA 1.466 0.358 0 C-N-CA 123.98 0.912 . . . . 0.0 110.885 -178.383 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 N--CA 1.426 -1.649 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.57 136.42 30.8 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.967 1.778 . . . . 0.0 110.726 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.05 76.15 2.24 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-O 121.608 0.718 . . . . 0.0 111.694 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 41.1 m -83.72 103.85 13.35 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 173.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.401 ' CE1' ' HG3' ' A' ' 250' ' ' LYS . 13.0 m170 -69.06 122.53 18.91 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 121.901 0.858 . . . . 0.0 110.984 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.498 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 4.1 mmp_? -105.27 116.62 32.25 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.786 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -107.88 107.11 17.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.432 ' HB ' ' CG2' ' A' ' 247' ' ' ILE . 38.5 t -89.09 125.65 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.697 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.82 138.41 32.65 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.229 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 3.7 mm? -123.33 129.25 51.07 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.661 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.04 120.02 39.19 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 167' ' ' GLY . 88.4 tttt -65.48 123.89 20.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 122.672 1.225 . . . . 0.0 113.259 -173.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -123.84 29.95 6.34 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 113.013 -1.903 . . . . 0.0 108.677 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 165' ' ' LYS . . . 102.26 -10.34 56.58 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.198 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.2 m 60.95 21.15 11.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.42 0.688 . . . . 0.0 111.705 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.96 -55.34 7.62 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.999 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 171' ' ' PRO . 83.8 tttt -99.4 128.22 32.27 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 21.4 Cg_exo -67.96 156.83 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.062 1.841 . . . . 0.0 110.342 172.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.97 -8.03 54.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.509 0.671 . . . . 0.0 111.137 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.23 0.52 7.47 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.024 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -103.95 144.62 31.29 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.24 136.86 38.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.02 135.93 58.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 79.9 ttt180 -142.07 150.43 41.2 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.151 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 231' ' ' LEU . 20.4 t70 -92.59 134.23 35.2 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.411 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -135.28 166.79 24.36 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 191' ' ' LYS . 1.6 m -92.71 131.36 37.85 Favored 'General case' 0 C--N 1.27 -2.86 0 C-N-CA 117.394 -1.723 . . . . 0.0 107.972 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 25.3 m -100.8 134.8 43.23 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.43 128.62 75.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.979 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.2 mtt180 -117.47 154.37 31.54 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.9 109.94 30.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.574 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 74.7 p -107.03 177.89 4.72 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.12 -20.95 62.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.225 0.536 . . . . 0.0 109.874 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.6 p -86.51 -3.8 59.07 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.434 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.95 -171.55 14.54 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.737 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.6 pt? -84.95 133.75 34.27 Favored 'General case' 0 N--CA 1.4 -2.951 0 O-C-N 122.306 -0.526 . . . . 0.0 110.298 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -132.47 156.72 46.24 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.373 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.562 ' HB3' HG22 ' A' ' 180' ' ' THR . 96.9 mttt -121.36 150.33 41.63 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.84 161.48 62.51 Favored Pre-proline 0 N--CA 1.426 -1.654 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.627 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.55 142.68 85.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.94 89.96 0.15 Allowed Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.586 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 218' ' ' VAL . 12.1 tt -95.97 117.66 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-O 121.77 0.795 . . . . 0.0 109.998 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -132.46 179.16 6.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.283 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 216' ' ' ASP . 44.9 mt -68.7 122.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 26.1 p -96.33 -32.89 12.16 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 120.905 0.383 . . . . 0.0 111.887 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -153.34 148.79 27.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.47 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.9 tt -124.54 136.73 54.22 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 71.3 t -99.57 124.42 44.44 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.12 127.23 24.14 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.477 2.118 . . . . 0.0 111.353 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.42 63.15 Favored Glycine 0 C--N 1.309 -0.953 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.39 161.4 44.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.736 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 205' ' ' LEU . 2.8 tm? -53.35 -39.68 64.34 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.8 0.84 . . . . 0.0 110.862 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 212' ' ' LEU . . . -55.47 -42.14 73.91 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.3 -36.12 54.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.1 m -54.45 -34.74 62.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.435 0.694 . . . . 0.0 112.816 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 73.1 p -60.17 -41.26 92.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 111.557 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.83 3.16 90.68 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.533 HD12 ' HG ' ' A' ' 212' ' ' LEU . 2.7 pp -127.96 -2.32 5.86 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.533 ' HG ' HD12 ' A' ' 211' ' ' LEU . 97.2 mt -108.55 130.58 55.29 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.237 0.541 . . . . 0.0 110.305 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.95 164.36 25.51 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 125.318 1.447 . . . . 0.0 109.663 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.0 p -52.49 -20.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.733 0.777 . . . . 0.0 112.435 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -68.79 -25.29 64.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.929 -0.482 . . . . 0.0 111.898 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.8 m-20 -61.3 159.34 12.53 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -114.96 144.87 42.9 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.15 -1.841 . . . . 0.0 110.448 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 195' ' ' ILE . 7.7 p -96.61 140.4 17.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.053 0.454 . . . . 0.0 109.819 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.48 HG22 ' HG3' ' A' ' 220' ' ' GLU . 40.2 mm -110.44 -52.92 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.189 0.519 . . . . 0.0 111.803 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.635 ' H ' ' HB ' ' A' ' 248' ' ' THR . 45.1 mt-10 -134.73 142.74 46.85 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.57 0.7 . . . . 0.0 112.646 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.453 HG21 HG13 ' A' ' 234' ' ' VAL . 57.6 t -115.62 113.5 43.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.213 172.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 70.6 -66.19 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.221 1.008 . . . . 0.0 110.327 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -169.34 12.91 0.05 OUTLIER Glycine 0 C--N 1.292 -1.891 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.538 HG21 ' SD ' ' A' ' 237' ' ' MET . 28.9 mt -105.37 125.49 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -176.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -77.48 141.64 39.57 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 33.6 m -100.91 14.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.08 104.01 2.46 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.276 0.56 . . . . 0.0 111.02 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.78 12.32 55.71 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.231 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.582 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 6.0 mmpt? -91.8 152.36 20.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 234' ' ' VAL . 38.7 p -86.94 159.46 19.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 178' ' ' ASP . 1.9 pt? -60.26 -38.07 82.38 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.596 0.236 . . . . 0.0 111.288 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.87 -46.5 87.66 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.854 0.861 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.575 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.6 tp-100 -63.48 -51.05 67.23 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.144 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 221' ' ' VAL . 75.0 t -56.93 -49.03 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.468 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 9.9 t -66.86 -38.47 86.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.801 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.92 -46.88 88.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.159 0.504 . . . . 0.0 109.969 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.575 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 40.7 mtm -62.3 -42.94 99.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.066 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.468 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 13.0 ptp -71.1 -18.44 62.53 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.121 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 235' ' ' THR . 84.8 t -89.12 -33.57 6.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.772 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.22 79.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.44 0.638 . . . . 0.0 109.392 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -105.52 23.27 14.08 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.233 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 55.4 p -60.63 -26.44 67.03 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.813 0.445 . . . . 0.0 111.66 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m -51.15 -51.26 55.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -130.15 89.42 2.79 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tm? -96.71 130.04 44.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.721 0.772 . . . . 0.0 110.801 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 245' ' ' LEU . 73.0 mt -127.6 128.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.432 ' CG2' ' HB ' ' A' ' 161' ' ' VAL . 8.1 tp -119.86 126.38 75.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.632 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.635 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 28.4 m -103.99 119.84 39.78 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.745 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 159' ' ' ARG . 19.5 m -120.92 149.31 23.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.367 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 251' ' ' PRO . 10.0 tmtt? -135.8 128.06 17.65 Favored Pre-proline 0 C--N 1.286 -2.168 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.326 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 50.3 Cg_exo -57.69 127.3 24.72 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.627 2.218 . . . . 0.0 113.041 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -106.58 4.1 27.68 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.972 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 . . . . . 0 C--N 1.312 -1.028 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.485 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.872 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.67 149.19 73.32 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.475 2.117 . . . . 0.0 113.052 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -86.15 91.43 8.43 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.1 pt -64.71 113.21 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.118 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.2 m -90.85 77.73 6.17 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-O 121.955 0.883 . . . . 0.0 109.887 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 10.8 tt -109.65 125.38 31.41 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.911 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 17.6 Cg_exo -66.88 134.12 33.62 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.135 1.89 . . . . 0.0 110.852 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -101.27 139.49 36.88 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.06 135.72 34.74 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -101.83 -64.64 1.04 Allowed 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.484 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 . . . . . 0 C--N 1.308 -1.23 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.484 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.434 -1.254 0 CA-C-O 121.234 0.54 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.26 142.31 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.057 1.838 . . . . 0.0 110.666 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.5 82.15 5.66 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 121.339 0.59 . . . . 0.0 110.285 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.3 p -85.05 108.87 17.84 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -82.3 99.22 9.21 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -96.5 131.94 42.59 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.029 -163.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.509 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 22.1 ptt180 -105.14 112.74 25.97 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.16 133.41 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.865 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.655 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -98.44 134.8 40.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.627 0.727 . . . . 0.0 112.659 -176.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 45.0 tp -98.53 122.4 41.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.024 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.75 100.68 9.39 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-O 122.106 0.955 . . . . 0.0 112.21 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 64.2 pttt -74.61 147.31 41.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.376 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -100.62 20.5 14.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.49 -11.35 59.01 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.9 t -162.16 131.36 4.39 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 71.23 108.06 0.06 Allowed 'General case' 0 C--O 1.248 1.006 0 O-C-N 124.442 1.089 . . . . 0.0 112.014 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 165' ' ' LYS . 3.5 mppt? -90.62 121.96 67.65 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -81.21 70.0 7.64 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.964 1.776 . . . . 0.0 112.55 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -69.92 112.99 6.72 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.393 0.616 . . . . 0.0 110.992 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.443 ' HA2' ' CG1' ' A' ' 201' ' ' VAL . . . -104.93 33.78 6.3 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -158.85 145.25 16.96 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -137.11 135.81 37.75 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -135.37 139.6 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -141.88 158.65 43.53 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.142 0.577 . . . . 0.0 112.185 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.572 ' H ' HD23 ' A' ' 231' ' ' LEU . 13.0 t70 -74.5 139.41 43.83 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.173 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.05 179.23 36.64 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 m -99.44 141.59 32.03 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.739 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 43.4 t -112.46 146.82 37.74 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.002 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.04 123.86 71.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.9 mtt180 -123.5 160.64 26.53 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.35 106.45 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 43.7 p -111.1 179.61 3.99 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.0 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.27 -18.16 65.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.0 m -92.06 4.97 51.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.589 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.26 -152.54 19.26 Favored Glycine 0 C--O 1.212 -1.274 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.5 pt? -85.88 121.26 28.27 Favored 'General case' 0 N--CA 1.395 -3.199 0 CA-C-N 117.34 0.57 . . . . 0.0 110.034 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.03 159.98 35.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.846 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 181' ' ' SER . 68.1 mttm -106.93 143.76 34.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.648 0.592 . . . . 0.0 109.722 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -136.31 154.09 76.88 Favored Pre-proline 0 N--CA 1.426 -1.626 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.09 129.44 6.87 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.047 1.832 . . . . 0.0 109.397 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.63 -177.82 24.9 Favored Glycine 0 C--N 1.287 -2.157 0 C-N-CA 120.611 -0.805 . . . . 0.0 111.718 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.498 HG23 ' HB ' ' A' ' 218' ' ' VAL . 12.0 tt -129.48 122.24 55.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -114.48 173.15 6.61 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.087 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.4 126.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.3 t -89.53 -45.58 9.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.753 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -146.62 153.65 40.57 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 206' ' ' ALA . 49.1 tp -127.73 137.78 52.57 Favored 'General case' 0 N--CA 1.407 -2.601 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.443 ' CG1' ' HA2' ' A' ' 173' ' ' GLY . 8.2 p -103.47 137.3 19.21 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.84 126.45 18.14 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.765 1.643 . . . . 0.0 108.913 172.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.64 1.33 66.05 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.16 162.75 40.72 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.507 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.1 mm? -63.99 -36.32 83.59 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 112.144 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 200' ' ' LEU . . . -76.6 -27.9 55.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.611 0.719 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.41 -37.65 56.79 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.29 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.3 m -57.9 -33.63 68.96 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 120.773 0.321 . . . . 0.0 111.568 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 211' ' ' LEU . 4.3 m -68.06 -39.98 82.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.79 -33.6 2.36 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.25 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.401 ' H ' ' C ' ' A' ' 209' ' ' THR . 27.1 mt -77.84 -8.1 57.58 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.647 ' HA ' ' OD2' ' A' ' 216' ' ' ASP . 82.7 mt -108.63 127.85 54.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.964 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.53 163.85 25.06 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.65 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -54.41 -26.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 C-N-CA 123.502 0.721 . . . . 0.0 112.123 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.08 -23.64 64.04 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.647 ' OD2' ' HA ' ' A' ' 212' ' ' LEU . 34.7 m-20 -66.73 166.01 13.92 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.135 0.574 . . . . 0.0 112.077 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.539 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -134.0 169.56 16.94 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.498 ' HB ' HG23 ' A' ' 195' ' ' ILE . 87.7 t -89.47 136.45 23.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.279 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 250' ' ' LYS . 31.2 mt -96.68 -58.76 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.566 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.8 mt-10 -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.895 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.462 HG21 HG13 ' A' ' 234' ' ' VAL . 75.5 t -114.7 110.26 31.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.36 -77.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.752 0.821 . . . . 0.0 110.366 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -151.88 10.39 0.67 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.506 HG21 ' SD ' ' A' ' 237' ' ' MET . 3.0 mp -107.58 133.14 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.18 158.57 27.65 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.0 m -116.37 6.91 7.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.321 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -57.59 109.07 0.64 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.769 0.668 . . . . 0.0 111.554 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.99 5.37 47.23 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.53 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 233' ' ' GLN . 35.9 mtmm -110.53 174.99 5.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 234' ' ' VAL . 31.8 m -118.69 163.42 16.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.691 -1.595 . . . . 0.0 108.866 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 232' ' ' ASP . 2.7 pp -50.53 -41.5 53.92 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 231' ' ' LEU . 29.6 t70 -61.3 -51.03 70.58 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.267 0.556 . . . . 0.0 110.482 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 237' ' ' MET . 48.1 mt-30 -58.53 -45.12 89.52 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.774 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 230' ' ' THR . 71.5 t -66.59 -49.07 78.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 45.5 p -59.63 -37.11 77.76 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.3 -44.13 97.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.066 0.46 . . . . 0.0 109.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.7 mtm -64.11 -49.62 71.5 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.546 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.507 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 24.0 ptm -67.88 -23.44 65.13 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.325 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 235' ' ' THR . 60.7 t -79.41 -30.93 14.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.499 0.666 . . . . 0.0 109.933 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.77 -15.04 57.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -132.56 27.44 4.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 37.0 t -65.95 -18.68 65.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -172.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.2 t -52.08 -64.46 0.81 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 90.76 3.3 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 3.4 tm? -91.18 126.88 36.4 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.509 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.1 mp -110.82 119.04 58.67 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.77 139.01 34.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.566 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.2 m -108.51 120.11 41.46 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.111 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.7 m -122.67 157.5 27.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 120.733 0.302 . . . . 0.0 110.915 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.531 ' HB3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -130.09 124.92 21.71 Favored Pre-proline 0 N--CA 1.432 -1.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.112 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.1 Cg_endo -65.36 134.12 37.58 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.821 2.347 . . . . 0.0 113.329 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.71 4.68 43.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 CA--C 1.504 -0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 113.386 175.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.63 123.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.457 2.105 . . . . 0.0 112.032 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.0 t -89.93 89.85 7.91 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.2 mt -91.1 161.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.7 t -162.05 170.79 18.62 Favored 'General case' 0 N--CA 1.38 -3.934 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.6 120.84 69.56 Favored Pre-proline 0 C--N 1.257 -3.454 0 CA-C-O 120.988 0.423 . . . . 0.0 110.367 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -72.7 131.08 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.646 2.231 . . . . 0.0 111.654 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -101.15 113.9 27.37 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.531 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 143' ' ' ARG . 13.8 t70 -84.41 157.69 21.32 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -48.93 -46.88 43.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 141' ' ' ASP . 37.9 ptt180 . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 127.204 2.202 . . . . 0.0 116.103 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.52 131.22 9.32 Favored 'Trans proline' 0 C--O 1.253 1.255 0 C-N-CA 121.629 1.552 . . . . 0.0 110.949 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -72.82 91.84 1.54 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -83.16 97.69 8.95 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.852 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -81.57 99.28 8.74 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.522 ' HB3' HD11 ' A' ' 212' ' ' LEU . 26.7 tpt180 -109.87 136.07 49.75 Favored 'General case' 0 C--N 1.257 -3.423 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.932 -165.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 4.6 ptp180 -114.44 116.79 29.44 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.904 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.97 129.88 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -109.59 133.25 53.32 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.754 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 245' ' ' LEU . 4.0 mm? -110.45 120.46 42.5 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.718 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -115.12 110.23 19.22 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -72.59 121.22 19.36 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.935 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -126.9 124.75 40.26 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.84 16.29 77.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.239 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m 63.36 26.6 15.05 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 109.796 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -111.82 95.14 5.31 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -81.91 111.73 29.15 Favored Pre-proline 0 C--N 1.268 -2.967 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.551 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -73.79 -36.54 3.57 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.316 2.011 . . . . 0.0 111.123 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 35.9 tp 63.62 -91.31 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.455 1.102 . . . . 0.0 110.35 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 79.19 19.61 71.73 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.296 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -161.33 149.17 15.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -136.96 135.79 38.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -141.08 142.13 30.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.935 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.452 HH11 HD12 ' A' ' 231' ' ' LEU . 36.7 mmt180 -138.21 158.35 44.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.05 138.31 31.7 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.327 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -129.77 152.61 19.68 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -93.08 129.92 38.88 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 117.691 0.746 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -129.67 137.26 50.53 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.7 123.96 67.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.316 0.579 . . . . 0.0 110.203 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.15 160.38 18.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.045 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -103.3 113.23 39.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.234 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.3 p -110.23 178.62 4.34 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.794 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.95 -14.35 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.321 0.581 . . . . 0.0 109.752 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.0 m -89.27 -4.99 57.95 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 109.53 -161.07 13.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.8 pt? -84.14 124.5 31.21 Favored 'General case' 0 N--CA 1.396 -3.139 0 CA-C-N 117.877 0.839 . . . . 0.0 110.921 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -126.63 150.57 48.85 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.721 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.89 134.77 54.6 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.427 0.632 . . . . 0.0 110.125 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 24.6 mp0 -130.03 149.56 73.52 Favored Pre-proline 0 C--N 1.265 -3.07 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.631 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 3.3 Cg_exo -84.64 121.8 2.6 Favored 'Trans proline' 0 N--CA 1.429 -2.31 0 C-N-CA 122.084 1.856 . . . . 0.0 110.369 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -114.03 131.23 9.78 Favored Glycine 0 C--N 1.275 -2.845 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 66.2 mt -96.51 118.58 43.17 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -119.67 160.03 23.31 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 123.109 0.256 . . . . 0.0 110.984 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 67.8 mt -68.47 119.36 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.7 m -91.1 -35.21 14.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.053 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -150.82 140.05 21.24 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.486 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 47.4 tp -128.2 134.7 49.07 Favored 'General case' 0 N--CA 1.383 -3.824 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.896 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.36 128.26 25.74 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 51.3 Cg_exo -58.66 128.5 28.42 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.538 2.159 . . . . 0.0 109.783 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.49 -10.87 61.35 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 155.11 34.61 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -27.99 69.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.486 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -73.94 -33.9 64.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.732 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.6 tm-20 -76.53 -37.59 56.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.2 t -54.08 -31.79 52.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.951 1.3 . . . . 0.0 112.137 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 79.4 p -59.55 -41.6 90.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.845 0.355 . . . . 0.0 111.434 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.24 -25.56 4.84 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.394 -0.367 . . . . 0.0 113.293 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.3 -18.56 26.72 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.338 0.59 . . . . 0.0 110.184 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 159' ' ' ARG . 35.7 mt -113.28 145.6 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.758 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.71 163.23 26.6 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.376 1.07 . . . . 0.0 110.627 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.593 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 47.0 t -48.28 -35.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.316 1.046 . . . . 0.0 113.627 -176.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.67 -25.12 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.55 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.2 m-20 -62.42 159.63 15.09 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -114.74 165.3 12.96 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 195' ' ' ILE . 93.4 t -95.19 142.52 13.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 124.694 1.197 . . . . 0.0 110.805 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 250' ' ' LYS . 35.8 mt -109.71 -59.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.049 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.612 ' H ' ' HB ' ' A' ' 248' ' ' THR . 50.1 mt-10 -135.98 159.11 42.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.564 -173.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.1 t -122.42 118.83 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.974 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.5 t-20 70.28 -62.85 0.42 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.467 1.107 . . . . 0.0 110.739 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 178.77 24.64 0.04 OUTLIER Glycine 0 C--N 1.281 -2.487 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.33 133.27 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.71 141.87 48.2 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.914 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -117.66 20.17 6.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.718 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.67 129.88 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.692 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.06 1.91 59.48 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 233' ' ' GLN . 28.7 mmmt -99.08 153.67 18.7 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.331 0.652 . . . . 0.0 109.933 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 234' ' ' VAL . 17.2 m -101.91 161.35 13.73 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 230' ' ' THR . 1.7 pt? -49.43 -46.28 47.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.19 -38.86 78.88 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.823 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.564 ' HB3' ' HE3' ' A' ' 229' ' ' LYS . 47.5 mt-30 -58.12 -44.88 87.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.086 175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 230' ' ' THR . 61.7 t -66.66 -43.89 90.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 O-C-N 123.494 0.496 . . . . 0.0 111.122 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.4 p -70.35 -34.67 72.91 Favored 'General case' 0 C--O 1.206 -1.218 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.42 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.1 -41.2 99.33 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.019 0.914 . . . . 0.0 109.485 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.504 ' HB3' ' O ' ' A' ' 234' ' ' VAL . 8.5 tpt -56.78 -48.66 77.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.96 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.459 ' HB2' ' CD2' ' A' ' 245' ' ' LEU . 22.2 ptm -76.11 -17.97 59.37 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.913 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 235' ' ' THR . 70.0 t -88.7 -25.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.42 0.629 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.83 -20.78 16.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.628 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -121.13 -69.43 0.84 Allowed 'General case' 0 N--CA 1.389 -3.516 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.767 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 32.2 t 61.04 -39.76 0.11 Allowed 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.7 m -58.36 -39.77 80.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.811 0.844 . . . . 0.0 110.276 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -129.24 90.37 3.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 238' ' ' MET . 3.2 tm? -99.88 124.35 45.1 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.315 0.579 . . . . 0.0 110.088 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 60.7 mt -127.24 123.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.8 tp -109.42 122.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.727 0.775 . . . . 0.0 108.97 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.612 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.6 m -106.29 127.23 53.09 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.641 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 212' ' ' LEU . 18.5 m -129.29 162.91 35.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.267 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.469 ' HB2' HD11 ' A' ' 219' ' ' ILE . 26.4 ttmt -130.45 136.58 29.19 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 124.759 1.224 . . . . 0.0 108.307 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 27.6 Cg_exo -65.03 127.4 18.39 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.494 1.463 . . . . 0.0 110.569 173.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -85.34 -27.55 25.8 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.223 0.535 . . . . 0.0 109.83 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 C--N 1.301 -1.514 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.836 178.093 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.425 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.1 -39.74 88.67 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.74 2.293 . . . . 0.0 109.862 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.4 p -147.0 112.97 5.77 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.96 119.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.537 1.16 . . . . 0.0 113.044 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 96.28 3.97 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.576 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.439 HD12 ' HD2' ' A' ' 139' ' ' PRO . 8.6 tp -95.31 133.69 25.61 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.197 -175.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 138' ' ' ILE . 33.6 Cg_exo -63.06 126.88 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.933 1.755 . . . . 0.0 110.293 176.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -82.88 164.15 20.68 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.857 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.89 121.73 25.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.437 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -152.8 -55.53 0.12 Allowed 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.651 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 . . . . . 0 N--CA 1.426 -1.653 0 CA-C-O 122.509 1.147 . . . . 0.0 109.595 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.433 -1.281 0 CA-C-O 121.311 0.577 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.2 150.83 23.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.586 2.191 . . . . 0.0 111.453 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB3' ' CE1' ' A' ' 158' ' ' HIS . 41.4 mt-10 -75.34 84.37 2.48 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 120.967 0.413 . . . . 0.0 112.092 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -91.88 100.5 13.17 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 78.5 m80 -75.26 112.48 11.59 Favored 'General case' 0 CA--C 1.47 -2.108 0 CA-C-O 121.782 0.801 . . . . 0.0 109.292 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.466 ' HG3' HG21 ' A' ' 209' ' ' THR . 1.7 tmt_? -110.53 135.16 51.62 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.106 -1.407 . . . . 0.0 107.578 -170.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 85.2 mtm180 -114.3 140.95 48.2 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.037 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.87 132.11 57.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 163' ' ' LEU . 6.6 mpt_? -105.9 138.72 41.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.072 0.463 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 8.2 mp -126.77 124.69 40.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.89 0.876 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.48 107.74 18.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 122.064 0.935 . . . . 0.0 113.022 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.469 ' HD2' ' OG ' ' A' ' 242' ' ' SER . 88.5 tttt -78.23 142.87 37.59 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.288 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -106.24 26.44 9.8 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.323 0.582 . . . . 0.0 110.414 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 165' ' ' LYS . . . 96.95 -11.54 65.98 Favored Glycine 0 CA--C 1.498 -0.974 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -164.08 146.68 9.28 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 125.624 1.57 . . . . 0.0 106.868 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.256 6.8 m-20 49.69 96.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 175.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -84.25 127.06 67.91 Favored Pre-proline 0 C--N 1.299 -1.616 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.065 174.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.408 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 26.1 Cg_endo -62.06 102.83 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.835 2.357 . . . . 0.0 112.614 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.61 144.25 28.91 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.824 0.821 . . . . 0.0 112.459 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.6 38.19 1.53 Allowed Glycine 0 C--N 1.286 -2.238 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.406 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -158.58 151.89 22.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.424 ' HB2' ' HB2' ' A' ' 199' ' ' ARG . 97.7 m-85 -137.0 135.14 37.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.9 pt -137.49 148.64 25.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.517 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.47 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 13.2 ptm180 -142.56 158.5 43.61 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.22 145.47 30.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 0.0 109.727 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.85 -172.5 13.48 Favored Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 191' ' ' LYS . 6.5 m -126.54 142.93 51.37 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 117.836 0.818 . . . . 0.0 109.003 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.0 m -114.9 131.32 56.91 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.7 122.46 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -121.85 155.16 35.97 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.279 0.561 . . . . 0.0 110.504 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 120.47 54.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.639 -174.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.3 p -115.73 177.66 4.59 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.05 -2.9 49.99 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.707 0.765 . . . . 0.0 109.317 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.4 m -97.34 -4.37 38.67 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.82 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.73 -156.25 15.74 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.49 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 189' ' ' LEU . 2.0 mm? -88.96 135.32 33.61 Favored 'General case' 0 N--CA 1.403 -2.819 0 C-N-CA 122.747 0.419 . . . . 0.0 109.979 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.28 150.13 46.37 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.832 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.476 ' HB3' ' CG2' ' A' ' 180' ' ' THR . 50.9 mtmt -108.14 142.76 37.86 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.998 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 13.9 pt20 -134.76 141.98 40.7 Favored Pre-proline 0 N--CA 1.413 -2.319 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.666 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.8 Cg_exo -74.46 129.05 12.45 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 110.895 177.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.32 137.41 8.55 Favored Glycine 0 C--N 1.287 -2.172 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.421 HD12 ' HB ' ' A' ' 226' ' ' VAL . 57.3 mt -97.41 125.32 50.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 89.8 m-85 -118.63 167.01 12.04 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.945 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.53 136.51 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 30.5 p -117.05 -44.07 2.82 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.978 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.424 ' HB2' ' HB2' ' A' ' 175' ' ' TYR . 98.8 mtt180 -137.63 145.17 42.41 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 206' ' ' ALA . 4.8 mt -127.74 137.69 52.52 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.829 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.67 130.1 27.39 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -59.94 126.77 21.24 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.763 1.642 . . . . 0.0 110.079 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 90.74 -7.66 80.95 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.779 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.2 160.94 52.46 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.6 mm? -56.66 -45.09 81.85 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.775 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -70.71 -28.94 65.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.325 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.56 ' HB2' HD22 ' A' ' 200' ' ' LEU . 8.7 tp10 -76.37 -42.46 44.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.516 0.675 . . . . 0.0 109.209 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 39.7 t -60.56 -33.3 72.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.812 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.474 HG22 ' HG ' ' A' ' 211' ' ' LEU . 29.1 m -62.61 -41.5 99.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.112 0.482 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.86 -45.85 3.58 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 121.171 -0.538 . . . . 0.0 114.372 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.482 HD12 HD22 ' A' ' 212' ' ' LEU . 4.3 pp -74.39 -4.25 35.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 211' ' ' LEU . 2.7 mm? -109.68 143.97 38.7 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -128.87 163.06 26.07 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 124.311 1.044 . . . . 0.0 109.204 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.71 -21.3 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 123.82 0.848 . . . . 0.0 112.99 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -71.87 -29.24 64.16 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.059 0.544 . . . . 0.0 111.559 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.689 ' HB3' ' O ' ' A' ' 250' ' ' LYS . 74.5 m-20 -68.03 163.09 23.1 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -169.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 0.5 OUTLIER -116.37 167.06 11.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.243 -0.983 . . . . 0.0 113.231 -173.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 61.0 t -98.88 142.12 15.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.465 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.17 -46.98 6.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.949 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.449 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.6 mt-10 -136.15 154.3 51.01 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 121.57 0.7 . . . . 0.0 112.085 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 238' ' ' MET . 59.5 t -118.52 101.79 12.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 113.534 -1.666 . . . . 0.0 106.509 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.589 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 61.0 t30 71.23 -68.36 0.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.56 1.544 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.05 8.25 0.32 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.418 HG21 ' SD ' ' A' ' 237' ' ' MET . 29.2 mt -107.27 118.2 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 46.9 mt-10 -74.04 142.16 45.72 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.72 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.421 ' HB ' HD12 ' A' ' 195' ' ' ILE . 29.0 m -95.08 18.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.49 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.08 109.46 2.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.08 0.466 . . . . 0.0 110.325 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.59 61.95 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.637 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -84.42 169.16 14.85 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 85.3 m -121.29 158.73 27.51 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.37 -1.741 . . . . 0.0 106.696 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 234' ' ' VAL . 57.8 tp -67.1 -46.82 73.07 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.984 0.811 . . . . 0.0 111.894 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.06 -37.96 75.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.13 0.49 . . . . 0.0 111.251 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.5 mp0 -74.42 -44.52 51.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 231' ' ' LEU . 8.9 p -66.25 -38.47 81.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.689 0.28 . . . . 0.0 110.833 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.539 ' HA ' ' SD ' ' A' ' 238' ' ' MET . 10.8 t -66.12 -32.13 73.4 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.91 -43.5 83.19 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 22.7 mtm -62.4 -43.78 98.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.193 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptm -75.58 -13.89 60.37 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.828 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 242' ' ' SER . 66.0 t -87.78 -37.25 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 109.829 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.88 69.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.492 0.663 . . . . 0.0 110.281 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -108.66 21.25 17.51 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.423 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 36.9 t -67.05 -24.5 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 31.7 m -52.12 -51.63 56.63 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.559 0.537 . . . . 0.0 110.59 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -128.75 87.98 2.66 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.3 tm? -93.43 131.36 38.7 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.969 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 71.1 mt -127.43 139.48 51.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 9.3 tt -129.62 134.53 63.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.144 174.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 39.4 m -102.31 120.63 40.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.213 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.35 155.25 15.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 36.2 tttm -138.34 140.29 27.88 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.422 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 36.6 Cg_endo -68.75 127.46 15.44 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 121.626 1.55 . . . . 0.0 110.157 172.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -4.67 58.65 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 122.596 0.358 . . . . 0.0 111.454 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 120.471 0.177 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.79 111.92 2.94 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.161 1.907 . . . . 0.0 108.962 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.8 p -101.9 103.27 13.94 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.54 0.686 . . . . 0.0 112.566 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 62.2 mt 68.15 147.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.822 1.649 . . . . 0.0 112.23 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -156.33 91.37 1.25 Allowed 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.5 tt -120.68 103.98 42.9 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-O 121.539 0.685 . . . . 0.0 112.599 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -84.47 137.84 7.11 Favored 'Trans proline' 0 N--CA 1.429 -2.283 0 C-N-CA 121.667 1.578 . . . . 0.0 109.711 174.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -82.48 114.39 20.87 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.88 124.4 34.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -170.87 96.46 0.21 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 . . . . . 0 C--N 1.275 -2.665 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.517 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.15 150.25 29.15 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.114 1.876 . . . . 0.0 110.04 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.51 69.07 6.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.327 0.584 . . . . 0.0 112.506 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.2 t -91.33 128.39 37.14 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.441 ' CE1' ' HG2' ' A' ' 250' ' ' LYS . 30.3 m170 -99.74 128.27 45.85 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.23 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -96.76 120.81 37.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.914 -169.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -106.33 107.84 19.05 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.23 132.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -108.88 149.08 29.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.92 130.37 43.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.401 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.85 111.61 18.18 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 121.591 0.71 . . . . 0.0 111.203 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -68.25 146.72 53.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.619 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -121.41 76.85 1.28 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.46 -2.67 84.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.522 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.4 t 58.63 72.77 0.51 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.56 1.144 . . . . 0.0 110.3 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -103.92 -49.77 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.97 150.24 47.25 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.562 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 -162.93 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 110.992 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.442 HD23 ' CZ ' ' A' ' 174' ' ' PHE . 4.9 mp -92.94 144.32 25.38 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -89.9 25.47 11.73 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.61 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.442 ' CZ ' HD23 ' A' ' 172' ' ' LEU . 41.9 p90 -158.7 147.32 18.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -132.31 142.83 49.5 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.468 HG21 HG11 ' A' ' 218' ' ' VAL . 29.2 pt -133.16 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.327 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.561 ' HG2' ' N ' ' A' ' 178' ' ' ASP . 78.1 ttt180 -141.23 159.87 41.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.561 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 7.7 p-10 -72.99 157.71 36.88 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.878 0.847 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.32 149.91 18.01 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -93.86 140.76 29.29 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -131.23 134.22 46.23 Favored 'General case' 0 C--N 1.261 -3.279 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.84 123.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.95 107.69 21.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.3 p -115.18 177.72 4.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.14 59.92 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.448 0.642 . . . . 0.0 109.416 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.1 m -89.51 -4.42 57.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.528 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.64 -154.48 16.86 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 189' ' ' LEU . 2.1 pt? -84.35 118.35 24.17 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-O 122.001 0.905 . . . . 0.0 109.962 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -120.89 144.88 48.18 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.059 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -101.42 143.87 30.91 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -133.08 144.2 51.68 Favored Pre-proline 0 C--N 1.281 -2.412 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.266 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.12 128.62 5.03 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 C-N-CA 122.519 2.146 . . . . 0.0 109.298 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 178' ' ' ASP . . . -140.31 163.06 26.45 Favored Glycine 0 C--N 1.277 -2.725 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.797 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 218' ' ' VAL . 63.0 mt -116.89 119.64 62.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 56.6 m-85 -118.95 167.04 12.11 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.998 -175.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.0 122.73 18.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.514 ' C ' ' HD2' ' A' ' 199' ' ' ARG . 76.6 p -96.04 -67.36 0.85 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.867 0.365 . . . . 0.0 111.494 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.514 ' HD2' ' C ' ' A' ' 198' ' ' SER . 7.2 mpt_? -124.88 154.19 41.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.938 0.495 . . . . 0.0 110.351 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.74 139.44 52.68 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.966 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -99.25 126.86 36.37 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.87 126.44 20.43 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.108 1.872 . . . . 0.0 109.946 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.9 -6.86 54.66 Favored Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.26 151.46 34.86 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.65 -29.9 70.37 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.19 70.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.224 0.535 . . . . 0.0 110.568 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -77.34 -43.47 32.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 m -55.24 -33.61 63.27 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.613 ' OG1' ' HG ' ' A' ' 211' ' ' LEU . 5.2 t -69.61 -44.92 69.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.744 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 -12.75 4.52 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.469 -0.872 . . . . 0.0 114.39 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.613 ' HG ' ' OG1' ' A' ' 209' ' ' THR . 3.8 pp -89.67 -3.93 58.0 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 118.836 1.318 . . . . 0.0 111.494 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.494 ' HG ' HD12 ' A' ' 211' ' ' LEU . 88.5 mt -109.54 146.11 35.19 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.617 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.69 162.68 16.92 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 123.671 0.788 . . . . 0.0 110.533 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.16 -16.82 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-O 122.454 1.121 . . . . 0.0 110.425 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -75.52 -23.67 56.71 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.301 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.581 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.8 m-20 -63.75 156.43 27.17 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -171.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.501 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 31.1 mt-10 -109.51 150.84 27.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.929 -170.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.506 HG23 HG21 ' A' ' 226' ' ' VAL . 23.2 m -98.58 143.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.453 HG22 ' HG3' ' A' ' 220' ' ' GLU . 43.1 mt -109.33 -56.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.586 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.4 mt-10 -130.27 149.86 51.77 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.633 -172.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 238' ' ' MET . 67.5 t -116.02 112.48 39.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 67.73 -70.14 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.26 1.024 . . . . 0.0 110.014 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.84 11.09 0.1 OUTLIER Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.53 135.78 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.25 159.18 29.83 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.287 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.506 HG21 HG23 ' A' ' 218' ' ' VAL . 20.6 m -102.95 3.63 10.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.867 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -55.21 108.9 0.46 Allowed 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.993 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.49 90.53 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.465 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -87.17 160.12 18.62 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.8 m -81.55 158.28 24.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.537 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 178' ' ' ASP . 4.1 mp -70.55 -41.39 72.53 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 118.425 0.557 . . . . 0.0 109.98 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.73 -39.26 73.62 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.378 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 237' ' ' MET . 21.1 tp60 -67.74 -47.16 70.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.294 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.407 ' HA ' ' HE2' ' A' ' 237' ' ' MET . 97.2 t -67.29 -45.42 86.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.048 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.485 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 8.8 t -64.59 -29.11 70.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.14 -48.91 77.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.292 0.567 . . . . 0.0 109.478 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 29.4 mtm -62.67 -40.18 96.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.129 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.513 ' HB3' HG11 ' A' ' 221' ' ' VAL . 15.4 ptm -76.24 -20.27 57.57 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.681 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 79.8 t -91.7 -36.8 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.352 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.42 69.94 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -109.23 23.24 14.79 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.323 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.681 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 63.7 m -64.97 -18.82 65.6 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -67.52 -39.66 85.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -129.45 79.66 1.92 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 3.3 tm? -99.41 129.59 45.61 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.535 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.06 132.28 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 6.9 tp -118.24 120.8 65.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.029 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.586 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.3 m -92.35 119.32 31.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.359 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.428 HG12 HG12 ' A' ' 218' ' ' VAL . 3.1 m -120.45 139.43 47.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.802 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 158' ' ' HIS . 0.4 OUTLIER -126.65 123.46 23.91 Favored Pre-proline 0 N--CA 1.413 -2.305 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.092 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.581 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 31.6 Cg_exo -58.25 133.72 57.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.866 2.377 . . . . 0.0 113.515 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -94.92 3.1 55.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 . . . . . 0 CA--C 1.487 -1.478 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.196 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.42 -34.86 75.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.343 2.028 . . . . 0.0 110.61 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.7 t -121.06 108.02 13.32 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.72 154.36 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.1 t -91.83 83.45 5.25 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.58 112.61 32.43 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.449 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.74 133.05 45.86 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.306 2.004 . . . . 0.0 110.733 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -100.17 114.54 28.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.31 153.4 18.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.786 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -92.68 79.74 4.79 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 . . . . . 0 C--N 1.297 -1.687 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.275 177.652 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 N--CA 1.439 -1.024 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.79 151.44 83.99 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 122.769 2.313 . . . . 0.0 109.232 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.54 80.35 0.1 Allowed 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 121.936 0.874 . . . . 0.0 113.322 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.1 m -92.96 85.11 5.03 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -98.81 113.54 25.7 Favored 'General case' 0 CA--C 1.467 -2.228 0 CA-C-O 121.391 0.615 . . . . 0.0 109.845 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.488 ' HG2' HG21 ' A' ' 209' ' ' THR . 4.1 tpm_? -100.25 123.69 44.79 Favored 'General case' 0 C--N 1.271 -2.847 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.283 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HB3' ' CG2' ' A' ' 246' ' ' ILE . 67.9 mtm180 -99.92 112.33 24.6 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.92 125.75 42.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 39.6 ptt180 -102.87 142.24 34.32 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.07 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.9 tm? -116.77 123.1 46.32 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 164' ' ' LEU . 2.9 pp -111.05 100.87 9.47 Favored 'General case' 0 N--CA 1.398 -3.038 0 CA-C-O 122.499 1.142 . . . . 0.0 112.049 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 243' ' ' SER . 12.8 tmtt? -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.811 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 14.2 p80 179.8 117.9 0.05 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.326 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.75 0.41 66.63 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.115 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 t -171.88 148.56 2.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.98 -39.87 83.23 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 170' ' ' LYS . 39.5 ttmt 62.89 121.38 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.027 1.331 . . . . 0.0 113.629 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.42 22.94 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.365 2.71 . . . . 0.0 113.108 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp 66.5 -73.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.798 1.239 . . . . 0.0 112.854 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 108.89 -12.71 34.8 Favored Glycine 0 CA--C 1.497 -1.06 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -128.12 143.9 51.08 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.17 161.07 35.42 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 123.185 0.303 . . . . 0.0 110.813 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -130.62 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.41 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 14.4 ttp180 -141.66 147.95 38.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 12.2 p-10 -102.46 127.12 49.63 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.532 0.682 . . . . 0.0 111.521 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -112.23 117.32 4.35 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 23.5 p -92.72 143.19 26.54 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 117.722 0.761 . . . . 0.0 112.363 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.0 t -127.42 132.4 50.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.16 124.0 49.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -120.97 157.09 30.7 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 63.2 t -102.64 116.6 46.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.8 p -115.62 177.81 4.53 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.701 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.37 -14.57 62.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.204 0.526 . . . . 0.0 109.918 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.3 p -91.94 -0.24 57.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.056 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.83 -165.35 12.04 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.7 pt? -84.83 106.47 16.38 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.314 1.054 . . . . 0.0 110.712 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -104.31 152.44 22.23 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.266 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 39.6 ttpt -121.3 133.39 55.13 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 29.9 pt20 -116.7 143.91 32.3 Favored Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.358 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 9.8 Cg_endo -88.18 126.51 2.0 Allowed 'Trans proline' 0 N--CA 1.427 -2.428 0 C-N-CA 122.227 1.951 . . . . 0.0 112.734 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.67 86.32 0.45 Allowed Glycine 0 C--N 1.279 -2.617 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 12.1 tt -82.11 133.66 28.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 120.597 0.237 . . . . 0.0 110.438 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -142.87 177.56 8.26 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.542 0.737 . . . . 0.0 110.74 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.2 mt -71.99 134.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.41 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 68.3 p -109.84 -59.95 1.85 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.8 147.87 47.19 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.059 0.457 . . . . 0.0 111.043 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.816 HD21 ' HB3' ' A' ' 206' ' ' ALA . 11.2 mt -127.06 138.3 53.19 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.646 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.89 132.63 20.71 Favored Pre-proline 0 C--N 1.286 -2.16 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.96 126.79 23.74 Favored 'Trans proline' 0 C--O 1.251 1.125 0 C-N-CA 121.808 1.672 . . . . 0.0 110.057 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.89 60.78 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.83 149.14 51.13 Favored Glycine 0 C--O 1.214 -1.144 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.8 mm? -56.73 -35.61 68.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.816 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -73.42 -28.08 61.79 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.738 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.19 -43.33 43.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.1 m -54.7 -32.9 60.15 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.223 1.009 . . . . 0.0 112.222 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.491 HG22 ' HG ' ' A' ' 211' ' ' LEU . 25.5 m -63.94 -43.28 96.36 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.845 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.8 -56.72 3.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.433 -0.349 . . . . 0.0 113.857 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 209' ' ' THR . 4.1 pp -70.93 2.23 4.6 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.625 1.17 . . . . 0.0 113.292 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.593 HD21 ' CG2' ' A' ' 249' ' ' VAL . 25.7 tp -119.99 145.74 46.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.82 161.64 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.245 0.545 . . . . 0.0 112.062 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.63 -24.66 13.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.844 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -68.93 -24.6 64.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.348 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 70.5 m-20 -60.13 139.96 57.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.249 0.62 . . . . 0.0 111.878 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.66 145.08 26.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -170.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 195' ' ' ILE . 84.1 t -78.0 135.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.886 1.274 . . . . 0.0 110.993 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.43 HG13 ' HD2' ' A' ' 250' ' ' LYS . 44.8 mm -122.23 -43.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.134 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.571 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.5 mt-10 -136.58 151.33 49.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.484 0.659 . . . . 0.0 112.045 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.49 109.12 26.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.533 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 69.82 -66.62 0.26 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.452 1.101 . . . . 0.0 111.229 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.93 15.78 0.09 OUTLIER Glycine 0 C--N 1.294 -1.765 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.92 133.55 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 44.6 mt-10 -82.33 149.42 27.76 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.57 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.574 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 19.1 m -89.62 14.1 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.021 -177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -88.73 109.36 20.08 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.4 15.09 26.27 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.737 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 1.1 pptp? -104.85 174.36 5.91 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 26.3 m -106.06 158.64 16.66 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.654 ' O ' HG12 ' A' ' 234' ' ' VAL . 4.7 tt -60.44 -47.49 85.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.859 0.464 . . . . 0.0 110.798 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.15 -36.42 74.74 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.281 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.71 -37.86 80.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 231' ' ' LEU . 7.5 p -58.18 -44.67 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.409 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.7 p -70.54 -35.47 73.15 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.341 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.35 -43.36 81.69 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.815 0.817 . . . . 0.0 110.327 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 76.1 mtp -61.92 -44.59 96.46 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.701 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.409 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 25.7 ptm -70.54 -24.4 62.8 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 235' ' ' THR . 96.8 t -83.24 -32.26 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 0.0 109.798 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.64 68.75 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.618 0.723 . . . . 0.0 109.844 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -107.98 22.24 16.24 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 68.4 m -54.45 -31.46 55.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 34.2 t -50.83 -58.16 6.65 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.736 0.303 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -130.58 89.61 2.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.4 tm? -101.14 130.88 47.29 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' ' 160' ' ' ARG . 68.1 mt -118.32 123.81 72.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.85 118.79 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 122.098 0.951 . . . . 0.0 109.565 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.571 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 19.8 m -95.82 120.15 35.58 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.942 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.593 ' CG2' HD21 ' A' ' 212' ' ' LEU . 29.8 m -129.34 149.53 33.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.43 ' HD2' HG13 ' A' ' 219' ' ' ILE . 97.2 mttt -127.03 128.49 24.16 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.683 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.9 Cg_exo -39.23 126.9 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.07 3.18 . . . . 0.0 115.009 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.25 8.49 32.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.535 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.415 176.708 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.801 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.86 110.56 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.237 1.958 . . . . 0.0 110.189 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 m -80.15 99.06 7.58 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.7 tt -54.02 135.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.728 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.7 p -129.25 88.93 2.77 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.039 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.95 138.77 19.65 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.766 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.12 123.13 11.26 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.373 2.049 . . . . 0.0 111.021 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -90.29 152.64 20.95 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.828 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.33 121.96 33.53 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -113.12 -52.35 2.78 Favored 'General case' 0 C--N 1.261 -3.274 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 . . . . . 0 C--O 1.238 0.464 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.839 177.169 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.232 0.134 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -81.32 148.71 16.68 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.202 1.935 . . . . 0.0 109.259 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -74.81 85.71 2.2 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.547 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.7 p -81.73 114.94 20.73 Favored 'General case' 0 N--CA 1.408 -2.566 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.399 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -87.74 99.7 12.28 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.477 ' HG3' HG13 ' A' ' 161' ' ' VAL . 32.9 tpt180 -103.24 125.72 50.05 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.054 -170.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.498 ' HG2' ' OG1' ' A' ' 248' ' ' THR . 88.2 mtt180 -103.3 105.0 15.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.698 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.477 HG13 ' HG3' ' A' ' 159' ' ' ARG . 23.0 m -104.69 132.53 51.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 120.96 0.409 . . . . 0.0 110.94 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -103.06 142.76 33.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.457 HD13 ' H ' ' A' ' 173' ' ' GLY . 72.1 mt -133.39 145.42 50.31 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.828 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.507 HD23 ' H ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -120.4 120.43 35.94 Favored 'General case' 0 N--CA 1.404 -2.744 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.578 172.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.548 ' HG2' ' HB3' ' A' ' 242' ' ' SER . 0.0 OUTLIER -65.98 143.48 57.35 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.538 -178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 169' ' ' ASP . 37.5 m80 -110.86 -37.34 5.43 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.494 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.53 -11.69 37.71 Favored Glycine 0 N--CA 1.459 0.183 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.959 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 3.13 15.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 25.2 t70 171.68 117.19 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.413 2.285 . . . . 0.0 105.916 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.425 ' HG3' ' OD2' ' A' ' 169' ' ' ASP . 56.7 mttp 66.77 86.59 0.13 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 124.949 1.3 . . . . 0.0 112.478 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -75.84 -32.27 4.59 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.168 1.912 . . . . 0.0 107.915 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 174' ' ' PHE . 1.8 pt? -152.95 127.12 9.12 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.118 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.457 ' H ' HD13 ' A' ' 163' ' ' LEU . . . -95.65 48.11 1.87 Allowed Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.443 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 172' ' ' LEU . 54.1 p90 -169.75 156.82 6.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 67.6 m-85 -137.73 135.41 36.37 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 169.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.605 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.0 pt -132.78 144.71 35.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -136.4 136.63 39.75 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.729 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.483 ' H ' HD23 ' A' ' 231' ' ' LEU . 17.8 t70 -87.21 123.16 31.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.847 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -131.1 174.72 19.82 Favored Glycine 0 C--N 1.276 -2.789 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 141.84 32.63 Favored 'General case' 0 C--N 1.271 -2.81 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.322 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t -123.09 136.87 54.98 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.44 124.03 63.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -116.19 154.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-O 121.019 0.438 . . . . 0.0 110.254 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.37 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.7 p -115.6 177.29 4.72 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.098 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.36 -16.86 61.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.6 p -91.85 5.75 48.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.17 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 -156.26 15.66 Favored Glycine 0 C--O 1.214 -1.154 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.882 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.576 ' H ' HD23 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -98.95 106.77 19.06 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.77 0.795 . . . . 0.0 109.373 175.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.21 152.14 23.21 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.697 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -121.09 130.92 53.97 Favored 'General case' 0 N--CA 1.402 -2.852 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -147.76 150.88 37.52 Favored Pre-proline 0 C--N 1.265 -3.09 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.977 -172.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.68 134.96 19.07 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.206 1.937 . . . . 0.0 110.273 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.04 134.65 6.87 Favored Glycine 0 C--N 1.301 -1.391 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.605 ' CG2' ' HB ' ' A' ' 176' ' ' ILE . 58.2 mt -104.61 119.82 54.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.753 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -120.65 156.97 30.58 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.665 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 68.5 mt -63.51 123.38 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.602 0.715 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -91.09 -42.46 10.47 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.865 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 68.5 ttt180 -151.65 152.98 33.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.197 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 206' ' ' ALA . 13.8 mt -128.08 138.76 52.68 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.14 130.21 26.6 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.72 137.25 59.5 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.55 2.22 58.8 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.79 153.09 34.18 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.64 -26.39 61.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.644 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -67.19 -26.87 66.84 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 122.077 0.941 . . . . 0.0 109.224 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.62 -41.36 46.22 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.031 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.1 t -64.78 -36.12 83.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.0 p -62.62 -44.29 96.67 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.95 -51.84 2.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.631 -0.259 . . . . 0.0 113.032 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 212' ' ' LEU . 51.3 mt -57.58 -39.77 77.49 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.48 1.112 . . . . 0.0 108.922 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.439 HD22 HG23 ' A' ' 249' ' ' VAL . 3.9 mp -115.37 108.67 16.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.27 116.62 16.38 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.614 -0.434 . . . . 0.0 112.054 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.665 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 70.8 t 57.23 -43.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.067 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 174.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -74.63 -23.82 58.75 Favored 'General case' 0 CA--C 1.484 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 112.465 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.26 173.44 2.54 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.656 0.741 . . . . 0.0 112.566 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -128.65 140.43 51.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.641 -170.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.12 141.4 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.371 0.605 . . . . 0.0 110.086 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.73 -52.62 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.942 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.513 ' H ' ' HB ' ' A' ' 248' ' ' THR . 36.5 mt-10 -125.49 146.51 49.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.899 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.531 HG13 ' SD ' ' A' ' 238' ' ' MET . 92.2 t -109.18 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 171.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.514 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 25.1 t-20 70.33 -73.83 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.806 0.812 . . . . 0.0 109.788 -174.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.95 12.53 0.1 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 175.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 9.0 mt -95.45 118.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.24 150.1 33.5 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.981 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.635 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 22.5 m -95.84 13.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 120.922 0.391 . . . . 0.0 112.05 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.75 114.52 18.73 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.22 15.07 28.98 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.295 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 0.5 OUTLIER -109.93 175.98 5.24 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.536 -0.391 . . . . 0.0 110.443 -177.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 32.9 m -113.77 160.77 18.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.568 ' O ' HG12 ' A' ' 234' ' ' VAL . 3.0 tm? -55.11 -46.36 75.57 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.177 0.444 . . . . 0.0 111.876 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.47 -35.5 77.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.232 0.539 . . . . 0.0 110.478 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 237' ' ' MET . 97.7 mt-30 -69.96 -39.79 75.81 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.664 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 231' ' ' LEU . 10.4 p -61.17 -42.23 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 118.498 0.59 . . . . 0.0 111.855 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 239' ' ' VAL . 6.7 t -75.27 -28.95 60.01 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.918 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.68 -39.58 88.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 73.1 mtp -56.41 -43.93 79.83 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.455 174.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.614 ' SD ' HD21 ' A' ' 245' ' ' LEU . 24.6 mmt -64.12 -29.38 70.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.062 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.548 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 87.7 t -82.7 -34.85 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.306 0.574 . . . . 0.0 110.755 -175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.55 -23.3 67.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.243 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.7 26.37 5.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.455 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.548 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 49.3 m -54.32 -28.66 43.9 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -95.28 -5.51 43.45 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.986 -0.446 . . . . 0.0 111.696 -176.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.27 35.52 4.26 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.614 HD21 ' SD ' ' A' ' 238' ' ' MET . 2.6 tm? -83.22 124.11 30.23 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.506 -167.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 56.6 mt -130.22 129.63 65.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.479 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.68 122.06 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.513 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 42.0 m -90.78 119.84 31.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.439 HG23 HD22 ' A' ' 212' ' ' LEU . 12.9 m -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-O 121.118 0.485 . . . . 0.0 111.81 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.457 ' NZ ' ' HB3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -138.04 126.8 14.51 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 123.743 0.817 . . . . 0.0 108.858 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.48 127.71 21.59 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.14 2.56 . . . . 0.0 112.974 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -105.2 19.02 21.31 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.892 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 N--CA 1.432 -1.326 0 CA-C-O 122.905 1.335 . . . . 0.0 108.838 176.779 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.52 109.42 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.228 1.952 . . . . 0.0 110.594 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -84.12 73.55 10.39 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 122.001 0.905 . . . . 0.0 109.397 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.5 tt -121.08 156.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.475 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -150.97 130.36 12.88 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 115.47 63.01 Favored Pre-proline 0 C--N 1.284 -2.242 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -85.9 128.71 3.33 Favored 'Trans proline' 0 N--CA 1.429 -2.307 0 C-N-CA 122.359 2.039 . . . . 0.0 109.273 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -79.36 114.01 17.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.91 156.22 22.49 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.607 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -63.59 141.67 58.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.746 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.529 0.68 . . . . 0.0 110.584 -176.134 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.437 -1.117 0 CA-C-O 121.026 0.441 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.24 150.3 65.08 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.438 1.425 . . . . 0.0 109.392 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.77 83.36 1.18 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.3 m -83.88 109.78 17.85 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.415 ' NE2' ' HG3' ' A' ' 250' ' ' LYS . 14.0 m-70 -72.0 123.66 23.26 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-O 121.876 0.846 . . . . 0.0 112.116 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.441 ' HD2' HD11 ' A' ' 212' ' ' LEU . 22.1 ttm-85 -113.41 140.26 48.21 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.957 -171.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.465 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 19.8 ptt180 -123.92 119.51 29.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 205' ' ' LEU . 27.1 m -110.98 133.82 55.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 122.257 -0.277 . . . . 0.0 111.685 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' HG13 ' A' ' 246' ' ' ILE . 26.5 ptt180 -99.6 135.62 40.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.764 0.792 . . . . 0.0 112.832 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.475 ' HB2' HD12 ' A' ' 245' ' ' LEU . 3.5 mm? -124.67 121.42 34.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.574 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 164' ' ' LEU 0.264 1.6 pp -107.01 105.04 14.87 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-O 122.2 1.0 . . . . 0.0 113.295 175.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -100.58 134.52 43.41 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.527 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -95.06 29.71 2.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 87.11 -11.44 65.12 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.2 p -175.69 133.53 0.28 Allowed 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 t70 178.46 -57.37 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' NZ ' ' HB3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -149.04 148.27 26.52 Favored Pre-proline 0 N--CA 1.412 -2.354 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.676 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -86.7 23.73 0.8 Allowed 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 122.466 2.111 . . . . 0.0 110.886 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 87.5 mt 75.01 123.6 0.04 OUTLIER 'General case' 0 C--N 1.347 0.469 0 C-N-CA 125.952 1.701 . . . . 0.0 111.421 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.93 44.08 3.08 Favored Glycine 0 C--O 1.241 0.589 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.991 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -172.2 144.23 1.59 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -135.77 135.42 39.91 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 121.3 0.572 . . . . 0.0 111.111 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -130.94 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.451 -175.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 177' ' ' ARG . 3.5 mmp_? -122.87 158.72 29.71 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.47 ' HA ' HG22 ' A' ' 195' ' ' ILE . 26.5 t70 -74.27 137.48 42.98 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 123.2 0.313 . . . . 0.0 111.046 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.71 163.92 37.4 Favored Glycine 0 N--CA 1.406 -3.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 m -107.07 143.7 34.81 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.4 t -92.84 125.54 37.5 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 191' ' ' LYS . 24.0 t -117.3 124.62 73.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.276 -174.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -110.34 151.61 27.22 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.29 106.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-O 122.167 0.984 . . . . 0.0 109.127 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.2 p -116.41 178.28 4.38 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.562 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.7 -15.83 62.74 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 m -88.02 -3.81 58.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.72 -160.04 14.17 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.078 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.77 109.97 18.45 Favored 'General case' 0 N--CA 1.385 -3.716 0 CA-C-O 121.931 0.872 . . . . 0.0 110.783 177.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -101.92 144.02 31.08 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.51 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 181' ' ' SER . 52.7 mtmt -123.29 142.35 51.03 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.439 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.62 154.87 79.83 Favored Pre-proline 0 N--CA 1.42 -1.945 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.83 131.01 17.65 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.752 1.635 . . . . 0.0 109.282 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 178.63 103.63 0.17 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 178' ' ' ASP . 27.2 pt -77.47 144.84 10.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.62 158.87 17.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.9 mt -68.89 136.54 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.6 t -136.03 -39.67 0.68 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.744 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -127.11 147.53 50.17 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.874 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 206' ' ' ALA . 30.2 mt -128.31 139.71 52.26 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.441 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.48 132.47 23.15 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 126.86 23.26 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.5 1.467 . . . . 0.0 110.12 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.92 -5.1 57.85 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.79 155.99 53.44 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.428 HD13 ' HB ' ' A' ' 161' ' ' VAL . 74.0 mt -65.94 -35.62 81.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.742 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -75.66 -26.27 57.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.674 0.75 . . . . 0.0 109.294 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB2' HD22 ' A' ' 200' ' ' LEU . 2.4 tm-20 -76.21 -56.17 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.876 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.4 m -62.85 -34.94 78.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.2 p -66.98 -43.76 82.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.689 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.76 10.64 51.14 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.409 HD23 HH22 ' A' ' 159' ' ' ARG . 29.3 tp -119.95 15.4 12.51 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 122.711 1.244 . . . . 0.0 109.252 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.441 HD11 ' HD2' ' A' ' 159' ' ' ARG . 78.7 mt -135.17 129.33 33.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.383 -1.735 . . . . 0.0 106.648 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.31 162.26 13.03 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 -174.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.8 -22.72 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-O 122.629 1.204 . . . . 0.0 108.858 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -74.59 -23.09 58.68 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.432 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 59.5 m-20 -67.65 154.96 40.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.679 0.792 . . . . 0.0 112.094 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -116.02 163.8 15.38 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.593 0.711 . . . . 0.0 112.866 -172.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 176' ' ' ILE . 72.6 t -99.82 137.94 25.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.833 174.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 250' ' ' LYS . 2.7 mp -107.66 -50.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.67 0.747 . . . . 0.0 110.235 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.54 ' H ' ' HB ' ' A' ' 248' ' ' THR . 43.1 mt-10 -141.35 159.39 42.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.401 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.2 t -106.33 97.61 5.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 44.3 t30 72.99 -73.4 0.1 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 111.261 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.05 18.4 0.73 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.84 111.95 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.85 147.53 53.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 219' ' ' ILE . 15.4 m -98.76 3.67 10.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.147 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.8 103.48 0.11 Allowed 'General case' 0 C--O 1.244 0.773 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.74 7.56 84.01 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.336 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.25 160.03 17.86 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 232' ' ' ASP . 96.8 m -74.83 156.29 36.64 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.005 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 232' ' ' ASP . 4.1 pp -71.32 -34.93 71.01 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.132 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.546 ' N ' HD12 ' A' ' 231' ' ' LEU . 21.9 t70 -70.1 -37.05 75.3 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.509 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 237' ' ' MET . 23.6 tp60 -66.12 -51.01 62.0 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.433 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.28 -48.68 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.532 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.0 p -65.43 -32.42 74.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.973 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.03 -42.95 93.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.638 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 23.6 mtm -58.32 -46.05 86.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.905 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.6 ptp -68.43 -23.19 64.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 235' ' ' THR . 89.4 t -83.56 -33.15 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.5 67.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.067 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -95.82 -63.07 1.19 Allowed 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.457 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.8 t 66.04 -41.31 0.35 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.94 1.829 . . . . 0.0 115.94 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -97.57 -39.29 9.19 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.72 -0.613 . . . . 0.0 112.398 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.18 42.03 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 163' ' ' LEU . 3.2 tm? -85.34 129.67 34.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.99 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -128.42 140.73 48.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.429 HD11 ' CG1' ' A' ' 218' ' ' VAL . 8.9 tp -122.26 138.18 53.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 118.547 0.612 . . . . 0.0 109.751 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.54 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.8 m -102.82 120.68 41.03 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.958 -174.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.74 149.25 29.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 CA-C-O 121.366 0.603 . . . . 0.0 112.411 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.599 ' HB2' HD11 ' A' ' 219' ' ' ILE . 32.1 ttmt -124.35 124.74 25.76 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.822 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.6 Cg_exo -63.81 126.48 17.47 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.162 1.241 . . . . 0.0 109.07 171.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.6 -0.01 17.41 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.656 -176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.491 ' N ' HD22 ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.035 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.243 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.38 144.77 91.77 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.245 1.963 . . . . 0.0 111.424 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 64.9 m -82.99 100.8 10.68 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 tt -50.71 139.1 6.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.635 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.3 t -160.48 102.93 1.38 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 61.5 mt -87.68 116.14 65.2 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.284 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 1.4 Cg_endo -82.8 123.74 3.76 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.873 2.382 . . . . 0.0 112.243 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.57 132.22 47.35 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.1 156.8 18.11 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.504 ' C ' ' HD2' ' A' ' 143' ' ' ARG . 96.9 m-85 -96.09 122.67 39.17 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.504 ' HD2' ' C ' ' A' ' 142' ' ' PHE . 3.4 mpt_? . . . . . 0 CA--C 1.485 -1.523 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.431 -1.389 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.87 151.63 31.54 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.0 2.467 . . . . 0.0 110.843 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.37 81.35 1.04 Allowed 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 t -79.85 105.26 11.01 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -79.1 99.05 6.77 Favored 'General case' 0 CA--C 1.458 -2.565 0 CA-C-O 122.482 1.134 . . . . 0.0 109.531 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.503 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -96.26 138.2 34.22 Favored 'General case' 0 N--CA 1.39 -3.451 0 CA-C-N 112.5 -2.137 . . . . 0.0 107.007 -174.018 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 77.8 mtm180 -116.57 121.53 42.01 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 121.107 0.48 . . . . 0.0 111.01 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 205' ' ' LEU . 97.0 t -89.01 116.02 29.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -112.5 122.57 48.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.6 0.714 . . . . 0.0 111.494 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.7 121.02 37.35 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.378 -1.283 . . . . 0.0 107.655 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.444 ' O ' ' HD2' ' A' ' 166' ' ' HIS . 85.5 mt -113.01 111.74 22.7 Favored 'General case' 0 N--CA 1.396 -3.142 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.612 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 168' ' ' SER . 77.5 tttt -80.65 125.02 29.5 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.832 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.444 ' HD2' ' O ' ' A' ' 164' ' ' LEU . 8.8 p80 -150.74 93.93 2.02 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.462 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.89 6.02 89.71 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.098 -0.956 . . . . 0.0 113.283 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.518 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 22.9 t -165.31 143.25 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.58 76.51 8.91 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.451 0.644 . . . . 0.0 110.708 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.21 121.47 85.19 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.18 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -57.48 135.52 70.33 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.688 2.259 . . . . 0.0 111.724 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 172' ' ' LEU . 1.6 pt? -53.39 121.2 7.16 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.207 1.003 . . . . 0.0 111.421 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -80.15 46.65 3.23 Favored Glycine 0 C--O 1.246 0.871 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.717 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -174.78 152.26 1.55 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -137.98 140.99 40.47 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.125 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.456 HG21 HG11 ' A' ' 218' ' ' VAL . 46.4 pt -135.46 136.26 50.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 123.663 0.602 . . . . 0.0 109.832 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.52 158.84 43.34 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.931 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.443 ' CB ' ' HB3' ' A' ' 231' ' ' LEU . 8.3 t70 -84.84 125.42 32.59 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.71 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -130.89 117.98 2.33 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 105.247 -3.141 . . . . 0.0 105.247 171.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.8 t -91.32 144.42 25.61 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.295 1.045 . . . . 0.0 112.711 -170.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t -105.04 129.44 53.47 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.919 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.47 125.17 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 CA-C-O 121.382 0.611 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 98.4 mtt180 -120.38 153.22 36.81 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.5 p -109.07 178.28 4.51 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.534 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.38 -16.56 63.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.9 m -89.84 -4.54 57.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.78 -168.31 12.59 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.6 pt? -83.93 106.29 15.49 Favored 'General case' 0 N--CA 1.402 -2.828 0 CA-C-O 122.127 0.965 . . . . 0.0 109.878 177.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -112.58 149.93 32.06 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.936 -173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -108.46 150.8 26.92 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.321 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -131.82 147.21 65.02 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.66 135.47 69.62 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.979 1.786 . . . . 0.0 109.986 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.66 76.72 0.39 Allowed Glycine 0 C--N 1.284 -2.33 0 C-N-CA 120.025 -1.084 . . . . 0.0 111.69 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.86 117.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.27 175.91 8.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 54.7 mt -66.05 122.43 17.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.3 p -102.02 -55.28 2.52 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -137.07 155.98 48.96 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.856 0.36 . . . . 0.0 110.268 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.759 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.4 mt -129.13 140.51 51.51 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.8 t -98.58 124.04 47.83 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.4 127.02 24.21 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.166 1.911 . . . . 0.0 109.986 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.89 21.28 12.31 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.406 -0.902 . . . . 0.0 110.943 -173.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.26 159.57 16.23 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.569 ' HB2' HG13 ' A' ' 161' ' ' VAL . 87.7 mt -70.21 -25.97 63.66 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.807 -0.82 . . . . 0.0 113.117 -176.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.759 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -67.24 -38.22 84.85 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.288 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.497 ' HB3' HD13 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -77.56 -33.95 53.89 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.945 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.2 t -68.0 -33.68 75.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.018 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.1 p -71.57 -43.95 65.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.72 -42.93 1.58 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.9 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.529 HD12 ' HG ' ' A' ' 212' ' ' LEU . 1.0 OUTLIER -65.87 -13.56 59.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.351 1.061 . . . . 0.0 113.633 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.529 ' HG ' HD12 ' A' ' 211' ' ' LEU . 96.8 mt -108.79 145.77 34.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.44 163.39 25.96 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.027 0.441 . . . . 0.0 111.804 -171.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 58.4 t -54.7 -22.03 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.619 0.768 . . . . 0.0 111.535 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -74.55 -24.08 58.89 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.576 ' HB3' ' N ' ' A' ' 252' ' ' ALA 0.655 0.4 OUTLIER -65.41 158.5 26.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 119.249 3.055 . . . . 0.0 119.249 -176.819 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.02 146.31 34.13 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.07 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 226' ' ' VAL . 31.3 m -89.75 142.58 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.922 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 220' ' ' GLU . 40.0 mm -110.78 -56.59 4.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.048 0.451 . . . . 0.0 110.297 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HG3' HG22 ' A' ' 219' ' ' ILE . 44.3 mt-10 -138.4 155.59 48.36 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.383 0.611 . . . . 0.0 112.418 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 238' ' ' MET . 90.7 t -127.54 110.68 22.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 124.657 1.183 . . . . 0.0 107.887 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 69.52 -70.6 0.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.965 1.306 . . . . 0.0 110.471 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -161.95 16.14 0.15 Allowed Glycine 0 C--N 1.299 -1.492 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 19.6 mt -112.49 131.38 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -85.35 167.99 15.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.214 0.531 . . . . 0.0 110.329 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 218' ' ' VAL . 28.8 m -104.03 9.71 9.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.378 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.0 102.58 0.08 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.047 -176.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.61 13.16 80.6 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.838 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -97.56 164.03 12.6 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 98.9 m -91.13 157.89 16.96 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 113.046 -1.888 . . . . 0.0 108.955 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 178' ' ' ASP . 1.9 pt? -63.33 -42.1 98.94 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.681 0.277 . . . . 0.0 111.313 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.37 -49.99 72.84 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.312 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.25 -46.4 89.92 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.443 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.525 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 91.2 t -67.57 -45.95 84.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.901 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.6 t -68.02 -29.91 69.03 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.68 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.98 -48.53 52.8 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.394 0.616 . . . . 0.0 109.988 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 234' ' ' VAL . 21.5 ptt? -65.0 -33.54 76.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -175.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.455 ' HB3' HG11 ' A' ' 221' ' ' VAL . 14.7 ptp -73.15 -25.21 60.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.481 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.59 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 93.6 t -85.33 -37.44 12.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.608 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.51 67.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.939 175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.03 21.98 15.32 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.656 ' HA ' ' HB2' ' A' ' 245' ' ' LEU . 73.0 m -59.25 -20.81 57.32 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 15.1 m -53.62 -50.65 65.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.685 0.794 . . . . 0.0 109.647 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -125.69 75.44 1.49 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.656 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.9 tp -103.2 104.3 14.42 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.139 0.971 . . . . 0.0 112.728 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.58 118.11 55.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.575 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 10.8 tt -111.23 133.32 57.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.512 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 21.8 m -100.15 125.02 46.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.034 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 212' ' ' LEU . 28.0 m -122.49 163.36 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 123.3 0.375 . . . . 0.0 110.475 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -133.79 123.48 17.2 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.78 135.82 71.43 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.484 2.79 . . . . 0.0 113.544 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.576 ' N ' ' HB3' ' A' ' 216' ' ' ASP . . . -116.78 20.86 13.74 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 N--CA 1.472 0.658 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.335 179.401 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.9 101.84 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.21 1.94 . . . . 0.0 111.749 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -88.93 85.05 6.65 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.42 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 136' ' ' ILE . 2.5 pp -86.11 136.77 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.3 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.4 m -102.98 90.9 3.91 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 10.3 tt -87.83 123.0 69.91 Favored Pre-proline 0 C--N 1.29 -1.978 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.131 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 12.4 Cg_exo -66.8 122.12 9.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.695 1.597 . . . . 0.0 110.362 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -94.19 120.34 34.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.455 -177.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.62 130.32 53.68 Favored 'General case' 0 CA--C 1.484 -1.583 0 CA-C-O 120.82 0.343 . . . . 0.0 110.718 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -153.24 86.44 1.23 Allowed 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 . . . . . 0 C--N 1.3 -1.578 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.327 -178.869 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 N--CA 1.426 -1.663 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.05 130.41 16.23 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.033 2.489 . . . . 0.0 113.955 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.78 -7.35 49.83 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.668 0.747 . . . . 0.0 109.722 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.3 t -75.3 102.22 4.98 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -91.19 143.91 26.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.858 -173.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -97.87 121.34 39.67 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.97 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -99.86 104.35 16.01 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 247' ' ' ILE . 59.6 t -89.74 117.32 32.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 120.956 0.408 . . . . 0.0 110.376 -176.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HG2' HG12 ' A' ' 246' ' ' ILE . 58.3 mtp180 -88.75 136.66 32.89 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 171' ' ' PRO . 3.4 tm? -120.38 121.3 38.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.62 99.78 9.45 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.8 145.76 46.79 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -101.78 -12.2 18.5 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.377 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.94 44.63 Favored Glycine 0 N--CA 1.46 0.233 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.085 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.7 t -149.33 128.63 12.9 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.3 t70 72.2 -42.5 0.53 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.832 1.253 . . . . 0.0 113.172 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -122.05 94.77 47.92 Favored Pre-proline 0 C--O 1.254 1.319 0 CA-C-O 120.671 0.272 . . . . 0.0 110.399 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.413 ' O ' HD11 ' A' ' 163' ' ' LEU . 4.3 Cg_exo -83.46 -69.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.063 2.509 . . . . 0.0 112.123 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 pp -157.19 157.39 34.3 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.342 0.657 . . . . 0.0 110.597 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -128.57 48.2 0.98 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.515 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 245' ' ' LEU . 54.0 p90 -160.47 147.58 15.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -138.54 146.21 41.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.52 152.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 123.441 0.463 . . . . 0.0 111.868 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 79.2 ttt180 -141.82 149.9 40.95 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.86 133.98 44.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.974 0.416 . . . . 0.0 110.595 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.36 165.99 15.92 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 2.8 p -93.11 120.4 33.36 Favored 'General case' 0 N--CA 1.391 -3.413 0 CA-C-N 117.986 0.893 . . . . 0.0 111.181 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.6 t -118.7 132.42 56.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.6 p -98.34 127.2 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.623 0.725 . . . . 0.0 109.177 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -112.85 153.43 27.9 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.68 107.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.1 p -110.18 178.15 4.48 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.19 -13.6 61.19 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.4 m -87.99 -4.6 58.79 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.588 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.55 -159.19 13.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.89 128.31 34.56 Favored 'General case' 0 N--CA 1.379 -3.977 0 CA-C-N 117.154 0.477 . . . . 0.0 110.003 175.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.38 153.49 48.67 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.411 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 36.9 ttpt -119.89 140.27 51.11 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-O 121.311 0.577 . . . . 0.0 109.618 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 5.5 tp-100 -139.62 144.74 40.55 Favored Pre-proline 0 C--N 1.277 -2.554 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.9 Cg_exo -73.81 119.52 5.93 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.246 1.964 . . . . 0.0 110.288 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.61 118.01 5.67 Favored Glycine 0 C--N 1.276 -2.758 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 177' ' ' ARG . 2.6 pt -96.5 117.53 41.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.598 0.713 . . . . 0.0 112.2 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 217' ' ' GLU . 59.4 m-85 -119.77 169.9 9.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.684 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.61 131.06 34.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.0 p -114.26 -56.02 2.43 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -123.55 142.01 51.45 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.2 mt -128.15 139.12 52.66 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.33 123.25 49.18 Favored Pre-proline 0 N--CA 1.416 -2.142 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -50.51 130.59 30.11 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.616 2.211 . . . . 0.0 112.215 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.62 5.14 65.12 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.34 146.06 41.84 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 114.785 -0.708 . . . . 0.0 112.779 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 205' ' ' LEU . 5.0 mp -55.4 -33.65 63.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.414 1.086 . . . . 0.0 113.14 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.628 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -66.13 -41.14 90.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.194 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.412 ' HB2' HD13 ' A' ' 200' ' ' LEU . 3.2 tm-20 -76.9 -34.97 57.68 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.9 m -54.87 -30.58 58.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.064 0.946 . . . . 0.0 112.558 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 205' ' ' LEU . 80.8 p -58.26 -43.24 87.79 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.636 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.73 21.18 72.83 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 tp -138.2 -35.42 0.62 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.154 -1.023 . . . . 0.0 110.804 -173.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.459 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.0 mm? -108.23 139.15 43.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.83 0.824 . . . . 0.0 111.179 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.38 162.28 13.15 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.393 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.83 -24.89 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-O 121.514 0.673 . . . . 0.0 110.983 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.486 HD22 ' HB3' ' A' ' 252' ' ' ALA . 8.2 t30 -73.28 -23.88 60.36 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.292 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.566 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 64.1 m-20 -62.45 158.73 17.04 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.448 0.699 . . . . 0.0 112.079 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.409 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 12.3 pt-20 -116.36 157.32 25.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -171.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.57 130.59 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.921 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.81 -42.96 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.179 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.478 ' H ' ' HB ' ' A' ' 248' ' ' THR . 34.2 mt-10 -137.68 152.7 49.56 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.341 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.58 96.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.467 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.533 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 67.13 1.15 2.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.164 1.386 . . . . 0.0 112.583 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 123.8 -4.29 9.21 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.68 134.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.14 147.36 31.39 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.842 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.411 ' CG2' HD11 ' A' ' 195' ' ' ILE . 25.8 m -117.19 10.64 7.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.083 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -61.48 105.82 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.067 0.46 . . . . 0.0 110.806 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.402 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.33 2.64 53.95 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.942 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.602 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.0 mmpt? -88.95 141.67 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.582 -0.364 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 234' ' ' VAL . 11.7 t -85.57 164.75 17.57 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 235' ' ' THR . 1.7 pt? -55.78 -41.66 74.42 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.278 0.49 . . . . 0.0 112.203 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.407 ' H ' HD23 ' A' ' 231' ' ' LEU . 25.0 t70 -59.89 -40.57 89.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.543 0.687 . . . . 0.0 110.677 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 11.9 mm-40 -69.22 -47.04 65.88 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.462 177.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 230' ' ' THR . 58.9 t -61.09 -43.74 96.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.54 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 239' ' ' VAL . 8.4 t -65.36 -40.09 93.13 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.095 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.62 -45.0 85.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.238 0.542 . . . . 0.0 110.517 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 77.3 mtp -56.43 -49.24 75.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.461 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.1 ptp -76.79 -9.76 58.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.183 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.627 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 70.4 t -83.07 -31.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.626 0.727 . . . . 0.0 109.171 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.5 -13.12 61.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.496 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -130.86 29.16 4.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.128 0.571 . . . . 0.0 110.848 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 68.1 m -61.99 -28.26 69.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -173.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.3 m -51.85 -61.92 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.169 0.509 . . . . 0.0 110.836 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -129.69 88.42 2.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 174' ' ' PHE . 3.6 pp -92.02 133.47 35.69 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 62.6 mt -114.37 119.52 61.61 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.296 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 161' ' ' VAL . 7.1 tt -109.89 118.69 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 111.134 177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 38.5 m -90.51 119.71 31.0 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.459 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 15.7 m -114.93 144.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 250' ' ' LYS . 13.1 tmtt? -125.62 125.42 25.0 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.978 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.566 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 18.7 Cg_endo -68.02 127.24 15.68 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.34 2.027 . . . . 0.0 114.097 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 215' ' ' ASN . . . -106.42 -35.32 7.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.308 -1.222 0 CA-C-N 112.75 -2.023 . . . . 0.0 113.197 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.98 102.82 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.848 2.365 . . . . 0.0 112.773 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 m -86.37 91.77 8.61 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.1 mm -71.59 140.51 18.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.455 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 23.0 t -94.61 96.07 9.19 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.7 tt -94.19 107.96 32.48 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.8 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 137' ' ' SER . 12.2 Cg_exo -71.24 136.35 28.94 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.139 1.893 . . . . 0.0 109.507 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -101.37 113.87 27.35 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -95.55 128.63 42.57 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.279 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -134.39 99.16 4.29 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 . . . . . 0 N--CA 1.41 -2.442 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.343 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -82.73 142.34 11.35 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.074 1.849 . . . . 0.0 109.257 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 46.8 mt-10 -63.2 96.84 0.11 Allowed 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.195 0.521 . . . . 0.0 112.025 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.8 m -88.07 93.51 9.51 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.442 ' CD2' ' HB3' ' A' ' 156' ' ' GLU . 12.8 m170 -82.22 113.26 19.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -132.86 138.12 46.93 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.106 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.625 ' HD3' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -110.94 114.49 27.85 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 205' ' ' LEU . 21.8 t -100.64 132.39 46.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG2' HG13 ' A' ' 246' ' ' ILE . 97.4 mtt180 -94.63 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.106 0.479 . . . . 0.0 112.089 -176.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.6 tm? -127.31 125.43 40.8 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 164' ' ' LEU 0.276 2.1 pp -112.36 101.68 9.86 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-O 122.442 1.115 . . . . 0.0 112.232 176.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -100.8 120.72 40.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.93 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -151.45 92.12 1.74 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.942 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.01 88.03 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.734 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 p -110.73 137.43 48.4 Favored 'General case' 0 N--CA 1.392 -3.34 0 C-N-CA 123.711 0.804 . . . . 0.0 109.699 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -125.18 82.75 2.09 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.938 0.875 . . . . 0.0 108.783 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -129.0 143.79 50.12 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.383 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.84 141.77 95.72 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.058 1.838 . . . . 0.0 111.226 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.75 123.56 21.25 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . -77.42 46.43 2.52 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.152 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.577 ' HE1' ' SD ' ' A' ' 238' ' ' MET . 50.7 p90 -174.7 134.04 0.37 Allowed 'General case' 0 N--CA 1.416 -2.139 0 C-N-CA 125.803 1.641 . . . . 0.0 107.711 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.4 141.33 51.08 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -126.11 140.92 47.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.873 -177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 231' ' ' LEU . 55.9 ttt180 -142.19 148.05 37.58 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.754 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 5.7 p-10 -101.85 145.37 29.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -132.26 163.94 23.9 Favored Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.7 m -104.65 131.78 51.68 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.041 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.9 m -106.13 136.02 46.57 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.518 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.2 128.93 60.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.514 0.674 . . . . 0.0 111.408 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -114.01 152.75 30.49 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.45 115.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 120.724 0.297 . . . . 0.0 110.464 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.9 p -113.08 169.86 8.63 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.42 61.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.017 0.437 . . . . 0.0 111.034 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.0 m -93.65 -3.81 51.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.546 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.78 -168.86 22.19 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.339 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.624 ' H ' HD23 ' A' ' 189' ' ' LEU . 2.1 pt? -85.24 130.37 34.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.427 0.632 . . . . 0.0 111.127 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -108.55 155.63 20.42 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.323 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -119.8 148.8 43.0 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -139.63 153.47 70.31 Favored Pre-proline 0 N--CA 1.411 -2.408 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.52 138.57 21.96 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.34 2.027 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.1 107.03 0.57 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 10.4 tt -105.51 118.52 53.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.649 0.738 . . . . 0.0 111.369 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 70.4 m-85 -125.81 165.56 18.44 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.458 -175.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.4 mt -70.68 127.8 33.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 172.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.5 p -102.45 -39.93 6.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -150.24 147.75 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.427 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 206' ' ' ALA . 15.4 mt -114.56 139.34 49.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.246 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.406 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 78.0 t -103.99 128.76 26.53 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.85 126.41 21.87 Favored 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.032 1.821 . . . . 0.0 110.67 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.57 13.45 58.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.43 160.24 24.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.7 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.476 ' HB3' HG11 ' A' ' 161' ' ' VAL . 85.6 mt -54.35 -46.2 72.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.573 1.149 . . . . 0.0 113.906 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.783 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -68.45 -27.18 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.858 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.76 -42.22 50.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.9 m -56.38 -31.56 63.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.2 p -61.08 -44.36 97.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.37 -47.65 1.73 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 121.474 0.486 . . . . 0.0 112.767 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.405 ' HB2' HD22 ' A' ' 212' ' ' LEU . 58.4 mt -67.53 -23.96 65.5 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.039 1.336 . . . . 0.0 111.167 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.2 mm? -108.02 146.0 33.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.174 0.511 . . . . 0.0 109.728 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -92.39 158.32 16.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.05 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 23.6 t -67.0 -27.33 39.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.603 -178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.87 58.89 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.652 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 89.4 m-20 -48.75 161.03 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -169.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 41.5 mt-10 -93.41 154.28 18.03 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.302 -172.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.22 134.81 45.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.459 HG22 ' HG3' ' A' ' 220' ' ' GLU . 46.7 mm -111.0 -44.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.867 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.625 ' H ' ' HB ' ' A' ' 248' ' ' THR . 40.4 mt-10 -141.07 154.32 45.89 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.371 0.605 . . . . 0.0 111.591 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 65.9 t -128.75 108.34 17.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.588 172.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 70.56 -9.96 0.74 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.524 0.678 . . . . 0.0 111.937 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 127.98 -9.37 6.72 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.462 HG21 ' SD ' ' A' ' 237' ' ' MET . 48.5 mt -84.01 121.01 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -75.65 137.76 40.93 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.045 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.417 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 35.5 m -91.75 17.41 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.837 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.7 109.32 2.38 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.115 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.55 9.69 64.39 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.877 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.4 mmpt? -93.93 168.43 10.97 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 234' ' ' VAL . 9.9 t -120.02 163.46 17.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 232' ' ' ASP . 0.0 OUTLIER -50.5 -46.77 57.34 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -171.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.519 ' N ' HD22 ' A' ' 231' ' ' LEU . 23.5 t70 -74.29 -40.55 62.21 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.304 0.574 . . . . 0.0 109.828 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.569 ' O ' ' HG3' ' A' ' 237' ' ' MET . 36.1 tt0 -59.24 -43.28 92.39 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.93 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 230' ' ' THR . 97.7 t -70.25 -46.61 71.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.984 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.494 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 21.4 p -60.97 -37.8 83.71 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.155 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.45 -44.61 84.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 37.6 mtm -64.28 -47.06 80.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.402 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.577 ' SD ' ' HE1' ' A' ' 174' ' ' PHE . 20.9 ptp -67.27 -25.71 66.2 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.01 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.78 -28.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.901 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.58 75.12 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 121.664 0.745 . . . . 0.0 109.268 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.91 -62.06 1.67 Allowed 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.575 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 38.1 t 64.6 -40.97 0.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.309 1.444 . . . . 0.0 114.176 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 -46.47 51.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.27 75.39 0.98 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 238' ' ' MET . 4.3 tt -92.89 116.34 28.95 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 3.3 mp -127.16 127.92 69.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 247' ' ' ILE . 36.4 pt -109.43 118.67 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.625 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 64.7 m -92.2 120.16 32.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.432 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 20.8 m -113.89 141.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.963 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.15 129.0 14.43 Favored Pre-proline 0 N--CA 1.42 -1.936 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.652 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 12.3 Cg_endo -56.03 130.9 42.77 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.24 2.626 . . . . 0.0 114.811 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.43 -7.39 44.66 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 112.953 -1.93 . . . . 0.0 112.45 179.068 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.3 -159.91 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.05 2.5 . . . . 0.0 110.633 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.1 p -82.61 87.08 6.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.56 153.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.9 p -103.05 103.64 13.75 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.0 tt -92.83 114.73 63.41 Favored Pre-proline 0 C--N 1.275 -2.648 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.577 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.58 145.25 37.12 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.477 2.118 . . . . 0.0 111.727 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -97.73 114.45 26.45 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -90.24 154.08 20.0 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.4 t80 53.65 -145.37 0.6 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? . . . . . 0 C--N 1.278 -2.514 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 166.804 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -65.47 151.97 83.34 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 123.26 2.64 . . . . 0.0 109.509 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.547 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 13.1 pt-20 -58.7 88.07 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -93.08 116.0 28.63 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 171.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -91.56 109.51 20.81 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.495 ' HD3' ' N ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -120.74 134.87 55.26 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.499 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.8 ptt180 -113.92 123.03 48.77 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.647 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.429 HG22 ' NH1' ' A' ' 159' ' ' ARG . 47.4 t -90.03 115.69 30.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.439 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -96.11 145.15 25.73 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.975 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.8 mt -126.44 121.56 32.77 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.936 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 164' ' ' LEU . 1.7 pp -106.91 101.07 10.53 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-O 122.727 1.251 . . . . 0.0 108.689 169.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 165' ' ' LYS 0.259 0.0 OUTLIER -75.47 127.84 34.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -172.242 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -105.7 112.26 25.26 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.759 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.79 -4.2 80.41 Favored Glycine 0 C--O 1.222 -0.645 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.714 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.4 m 61.8 20.98 11.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.748 0.819 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.59 102.46 3.81 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.331 0.586 . . . . 0.0 109.605 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -160.41 131.26 3.74 Favored Pre-proline 0 C--N 1.275 -2.64 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.098 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.88 141.42 93.15 Favored 'Trans proline' 0 C--O 1.254 1.319 0 C-N-CA 122.861 2.374 . . . . 0.0 112.698 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.6 130.85 38.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.107 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . -87.03 -23.57 40.77 Favored Glycine 0 C--N 1.289 -2.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -108.27 144.85 35.2 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -134.95 147.41 49.76 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.528 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 176' ' ' ILE . 2.8 mp -125.5 149.41 30.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 75.4 ttt180 -134.06 153.14 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.66 ' HA ' HG22 ' A' ' 195' ' ' ILE . 19.6 m-20 -74.73 151.73 39.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.073 0.463 . . . . 0.0 111.302 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.36 161.32 26.6 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 p -101.98 136.44 41.81 Favored 'General case' 0 N--CA 1.394 -3.242 0 CA-C-O 121.125 0.488 . . . . 0.0 111.62 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.4 t -111.6 120.3 41.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.0 p -91.16 123.59 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.668 0.746 . . . . 0.0 111.144 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.02 158.55 24.76 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.2 t -100.23 116.57 43.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.9 p -115.17 177.54 4.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.53 -21.4 61.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.044 0.45 . . . . 0.0 109.857 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.6 p -87.17 -1.27 57.77 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.61 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.75 -168.9 13.69 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.953 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.61 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.07 106.17 15.51 Favored 'General case' 0 N--CA 1.384 -3.737 0 CA-C-O 122.899 1.333 . . . . 0.0 110.593 175.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -111.46 155.42 23.23 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.387 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 7.7 mptt -116.93 127.2 53.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.48 153.58 47.69 Favored Pre-proline 0 C--N 1.263 -3.176 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.595 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 14.2 Cg_exo -68.11 113.4 3.04 Favored 'Trans proline' 0 N--CA 1.423 -2.629 0 C-N-CA 121.343 1.362 . . . . 0.0 109.013 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -132.31 92.06 0.27 Allowed Glycine 0 CA--C 1.457 -3.567 0 N-CA-C 106.889 -2.484 . . . . 0.0 106.889 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 178' ' ' ASP . 23.4 pt -77.22 135.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.34 -172.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.05 166.9 10.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.258 -173.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.3 mt -67.44 130.77 33.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 67.6 p -98.73 -36.46 9.83 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.507 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -151.01 146.02 25.93 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.557 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 52.4 tp -127.43 124.93 39.62 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.91 128.9 29.74 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 50.7 Cg_exo -57.63 126.86 23.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.16 1.907 . . . . 0.0 109.451 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.75 -9.87 60.46 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -84.87 149.87 24.66 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.82 -26.09 65.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -173.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -74.73 -32.36 62.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.009 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' N ' HD11 ' A' ' 200' ' ' LEU . 3.6 tm-20 -76.45 -38.85 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.0 m -57.88 -32.03 67.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.355 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.0 m -61.56 -43.55 98.66 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 78.52 -14.44 12.58 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.854 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 53.4 mt -85.93 -36.83 19.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.097 0.475 . . . . 0.0 111.099 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 249' ' ' VAL . 81.0 mt -115.33 146.92 41.06 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.34 163.84 17.24 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.666 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 13.7 p -45.84 -33.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.24 -24.26 66.24 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.612 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -69.29 165.91 19.62 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.28 142.18 45.08 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -171.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 14.1 m -95.82 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.487 HD13 ' HD2' ' A' ' 250' ' ' LYS . 25.1 pt -120.06 -41.9 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.432 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 39.6 mt-10 -133.55 151.25 51.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.581 0.705 . . . . 0.0 112.75 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.76 108.73 23.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.54 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.1 t-20 70.22 -71.1 0.13 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.165 0.986 . . . . 0.0 110.72 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.14 21.75 0.13 Allowed Glycine 0 C--N 1.298 -1.574 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 15.8 mt -116.73 121.77 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 47.7 mt-10 -76.11 151.08 37.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 118.806 0.73 . . . . 0.0 111.5 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.55 -6.39 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.995 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.45 121.33 15.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.314 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.595 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 93.12 10.3 59.82 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.101 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -111.13 173.35 6.38 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 234' ' ' VAL . 90.4 m -100.9 158.52 15.92 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.007 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.37 -46.19 86.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.441 0.296 . . . . 0.0 111.62 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.25 -41.79 89.59 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.327 0.584 . . . . 0.0 110.286 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.58 -49.34 75.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.946 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 230' ' ' THR . 85.1 t -59.88 -45.92 94.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.946 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.511 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 12.1 t -69.17 -37.13 78.02 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -42.56 90.56 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 52.4 mtp -56.5 -51.08 69.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.761 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptp -73.19 -15.03 61.46 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.356 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.561 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 98.1 t -91.4 -27.01 4.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.89 66.17 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.461 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -142.94 32.72 1.38 Allowed 'General case' 0 N--CA 1.419 -1.997 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.933 -173.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.561 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 61.7 m -54.19 -27.98 37.67 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 t -72.29 -29.62 64.04 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -126.22 56.48 1.44 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.8 122.65 29.44 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.733 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 67.0 mt -130.22 125.11 59.24 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.658 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.16 121.42 64.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.768 0.794 . . . . 0.0 110.513 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.432 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 15.3 m -94.15 128.57 40.65 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.21 -175.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 4.9 m -124.88 148.46 29.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.487 ' HD2' HD13 ' A' ' 219' ' ' ILE . 58.1 mtpt -130.28 138.24 32.62 Favored Pre-proline 0 CA--C 1.508 -0.658 0 C-N-CA 124.394 1.078 . . . . 0.0 109.366 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 26.5 Cg_endo -64.76 126.86 17.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.628 1.552 . . . . 0.0 111.423 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.4 -28.18 19.93 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 121.833 0.825 . . . . 0.0 109.721 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 44.1 m-80 . . . . . 0 C--N 1.289 -2.032 0 CA-C-N 113.113 -1.858 . . . . 0.0 112.024 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -93.48 12.51 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.887 2.392 . . . . 0.0 112.487 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m 68.36 94.89 0.07 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.927 0.891 . . . . 0.0 111.75 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.5 mt -81.48 157.12 4.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.4 m 71.58 96.02 0.07 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.582 -176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.1 tt -102.55 136.74 19.3 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.259 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 129.8 37.05 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.297 1.998 . . . . 0.0 109.953 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -98.13 161.02 13.92 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.267 0.556 . . . . 0.0 112.335 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.89 156.04 22.59 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -80.49 -29.12 37.35 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.038 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.549 ' HE ' ' HA ' ' A' ' 143' ' ' ARG . 1.7 mmp_? . . . . . 0 N--CA 1.443 -0.816 0 C-N-CA 124.008 0.923 . . . . 0.0 108.898 -177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.421 -1.894 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 130.74 41.77 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.547 2.164 . . . . 0.0 113.727 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.94 8.99 43.23 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.637 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -74.15 99.91 3.51 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.596 ' CE1' ' HE3' ' A' ' 250' ' ' LYS . 30.3 m170 -70.13 130.06 41.09 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.463 0.649 . . . . 0.0 112.423 -169.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -102.54 116.78 33.3 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.395 -167.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -100.73 135.81 41.58 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 205' ' ' LEU . 7.7 p -103.72 128.53 56.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.538 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 246' ' ' ILE . 36.8 ptt180 -108.62 126.88 53.45 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.81 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.2 mt -107.91 121.23 44.34 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.428 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.76 107.34 19.76 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.819 0.818 . . . . 0.0 111.662 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -88.27 120.47 29.66 Favored 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.919 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -152.5 102.33 2.73 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.432 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.75 63.66 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.113 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -130.26 178.23 6.73 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.67 -49.21 3.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.743 0.306 . . . . 0.0 110.689 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -166.58 100.13 0.68 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.5 44.44 1.24 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 123.481 2.787 . . . . 0.0 113.768 -175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . 0.342 0.6 OUTLIER -69.59 90.78 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -178.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -97.84 38.93 2.91 Favored Glycine 0 C--N 1.308 -0.986 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.98 150.49 24.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 77.9 m-85 -136.71 134.88 37.66 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.794 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.497 HD12 HD11 ' A' ' 195' ' ' ILE . 20.2 pt -133.71 142.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.626 -176.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.09 159.7 41.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.44 1.096 . . . . 0.0 108.094 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.463 ' H ' HD22 ' A' ' 231' ' ' LEU . 15.4 t70 -91.44 122.24 33.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.461 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -119.38 114.89 2.89 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 104.584 -3.407 . . . . 0.0 104.584 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 191' ' ' LYS . 1.8 m -89.0 128.23 35.7 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.614 -165.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -92.85 127.52 38.39 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.855 -172.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.02 138.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.928 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 183' ' ' ARG . 27.6 mmt180 -121.23 152.77 38.46 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.44 107.99 24.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.2 p -115.42 177.31 4.71 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.422 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.71 -6.09 54.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.276 0.56 . . . . 0.0 109.577 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.1 m -88.04 -4.49 58.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.77 -142.4 17.44 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 189' ' ' LEU . 0.4 OUTLIER -101.86 115.59 30.88 Favored 'General case' 0 N--CA 1.392 -3.372 0 CA-C-O 121.169 0.509 . . . . 0.0 109.971 176.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.66 152.04 30.96 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.924 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.453 ' HB3' HG22 ' A' ' 180' ' ' THR . 95.7 mttt -122.22 146.44 47.26 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.734 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -127.07 147.91 63.67 Favored Pre-proline 0 N--CA 1.417 -2.125 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.36 137.04 64.39 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.949 2.433 . . . . 0.0 111.542 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -138.85 73.7 0.41 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.337 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 176' ' ' ILE . 11.9 tt -84.21 116.39 27.91 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.746 0.784 . . . . 0.0 109.091 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.64 ' CE2' ' HG2' ' A' ' 217' ' ' GLU . 87.2 m-85 -130.18 172.1 12.15 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.908 -175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.2 136.18 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 47.1 m -126.17 -16.89 5.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.345 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 50.9 ttt180 -158.98 142.96 15.29 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.436 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.5 mt -128.4 139.31 52.44 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.94 124.59 45.06 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.88 129.47 32.22 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.689 1.593 . . . . 0.0 109.857 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.19 -9.83 57.98 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.02 153.25 46.62 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' A' ' 161' ' ' VAL . 2.6 mm? -59.15 -38.94 80.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.726 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -68.64 -33.45 74.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.035 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 200' ' ' LEU . 3.2 tm-20 -76.21 -43.5 42.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.204 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.4 m -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 m -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.92 -12.21 9.41 Favored Glycine 0 N--CA 1.465 0.58 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.935 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 36.7 mt -93.84 -15.78 24.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 71.9 mt -108.92 143.56 38.01 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.791 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.65 163.45 27.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.812 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.33 -14.44 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 121.582 0.706 . . . . 0.0 111.768 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.18 -22.35 58.09 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 58.9 m-20 -63.41 157.37 23.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -174.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.64 ' HG2' ' CE2' ' A' ' 196' ' ' PHE . 37.6 mt-10 -106.69 145.37 32.09 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.681 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.36 134.36 29.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.508 HG13 ' HD3' ' A' ' 250' ' ' LYS . 50.3 mm -116.2 -49.87 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.503 ' H ' ' HB ' ' A' ' 248' ' ' THR . 44.0 mt-10 -125.38 147.79 49.03 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.413 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.0 96.72 4.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 105.655 -1.979 . . . . 0.0 105.655 165.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.478 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 45.3 t30 68.41 -77.62 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 124.392 1.077 . . . . 0.0 111.333 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -146.0 10.27 1.59 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.562 ' HB ' ' HE2' ' A' ' 237' ' ' MET . 10.8 mt -107.14 133.05 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -81.32 149.77 28.78 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.11 2.24 8.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.519 0.676 . . . . 0.0 109.881 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.33 109.26 2.2 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.966 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 6.51 48.24 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.6 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 9.4 mmpt? -103.4 166.89 10.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 234' ' ' VAL . 16.9 m -118.59 159.77 22.99 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.463 HD22 ' H ' ' A' ' 178' ' ' ASP . 65.5 tp -50.37 -46.92 56.28 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.23 -37.15 84.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.3 0.571 . . . . 0.0 110.894 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.3 -37.82 74.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.215 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 230' ' ' THR . 96.8 t -63.09 -44.19 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 0.0 110.974 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 239' ' ' VAL . 11.7 t -67.89 -35.28 78.23 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.841 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.35 -43.15 86.86 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.948 0.88 . . . . 0.0 109.167 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.562 ' HE2' ' HB ' ' A' ' 224' ' ' ILE . 16.9 ttt -56.59 -45.82 81.18 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.372 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.467 ' HB2' HD11 ' A' ' 245' ' ' LEU . 19.1 ptp -76.28 -16.46 59.78 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.753 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 75.3 t -81.02 -33.78 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.277 0.56 . . . . 0.0 109.547 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.47 -22.48 43.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.188 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -132.91 30.24 4.03 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.243 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.753 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 67.8 m -74.1 -18.83 60.76 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 38.5 m -58.77 -48.04 82.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.37 0.605 . . . . 0.0 109.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -124.23 79.32 1.73 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.934 -2.246 . . . . 0.0 104.934 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.8 tp -86.4 118.65 25.97 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.349 -1.751 . . . . 0.0 111.06 -170.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 59.8 mt -127.03 133.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.843 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.3 tt -131.8 132.09 61.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 121.317 0.58 . . . . 0.0 111.981 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.503 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 61.8 m -102.35 125.68 49.13 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.872 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.23 139.98 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.596 ' HE3' ' CE1' ' A' ' 158' ' ' HIS . 57.4 mtpt -110.91 122.57 37.68 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.675 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 14.5 Cg_endo -60.27 133.12 47.63 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 122.645 2.23 . . . . 0.0 113.766 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -97.27 8.75 43.94 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 . . . . . 0 N--CA 1.425 -1.685 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.731 178.149 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.29 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.37 115.61 3.44 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 122.41 2.073 . . . . 0.0 111.079 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -75.69 94.52 3.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.271 0.558 . . . . 0.0 109.592 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.8 mt 72.51 138.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 125.662 1.585 . . . . 0.0 110.721 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t -120.98 100.7 7.22 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.902 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.2 tt -94.71 123.19 58.74 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.82 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -68.03 131.19 23.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.848 1.699 . . . . 0.0 109.048 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -76.32 150.24 36.94 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.26 155.85 23.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.95 117.54 25.75 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 . . . . . 0 N--CA 1.432 -1.352 0 CA-C-O 122.382 1.087 . . . . 0.0 110.106 -175.768 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.427 -1.621 0 CA-C-O 121.43 0.633 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.55 152.7 43.51 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.941 2.428 . . . . 0.0 109.601 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -63.93 83.29 0.03 OUTLIER 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 121.426 0.632 . . . . 0.0 109.898 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.1 m -82.82 111.09 18.41 Favored 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -82.32 110.86 17.86 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.531 ' HB3' HG13 ' A' ' 249' ' ' VAL . 77.8 ttt180 -94.3 116.78 29.22 Favored 'General case' 0 C--N 1.267 -2.992 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.89 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -125.66 109.62 12.83 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.588 -173.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 205' ' ' LEU . 27.7 m -105.29 132.32 52.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.434 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.407 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.2 mtm180 -114.89 147.96 39.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -170.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 90.5 mt -126.34 120.02 28.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.313 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.33 108.19 13.85 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.586 175.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.633 ' HD2' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.73 121.36 21.6 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -173.99 105.66 0.12 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.133 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.42 67.11 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.685 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -157.93 164.14 37.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -106.53 85.51 2.18 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.503 ' HD3' ' HB3' ' A' ' 242' ' ' SER . 24.5 pttm 38.5 97.45 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.663 1.985 . . . . 0.0 116.272 170.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 100.73 1.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.861 1.708 . . . . 0.0 110.461 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.81 99.69 2.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.546 0.689 . . . . 0.0 111.35 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -93.59 43.99 2.44 Favored Glycine 0 C--N 1.282 -2.425 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.007 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -170.29 145.69 2.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.889 0.876 . . . . 0.0 108.729 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.1 143.94 42.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.702 0.287 . . . . 0.0 111.051 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.463 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 2.3 pp -124.71 154.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.258 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -141.26 158.78 43.43 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.006 0.522 . . . . 0.0 110.321 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.8 131.96 36.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.26 -172.38 18.14 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.429 ' CG2' ' HB2' ' A' ' 191' ' ' LYS . 3.1 m -126.43 143.19 51.27 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.332 -0.947 . . . . 0.0 108.734 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t -120.3 119.77 34.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.68 123.38 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.791 0.805 . . . . 0.0 110.652 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 16.2 ptp180 -117.37 160.06 21.76 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.351 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -99.22 108.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.135 0.969 . . . . 0.0 110.811 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.8 p -108.13 178.21 4.57 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.82 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.91 -17.32 63.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.057 0.456 . . . . 0.0 109.944 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.7 m -87.9 -4.74 58.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.367 0.603 . . . . 0.0 109.424 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.04 -158.47 14.3 Favored Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 183' ' ' ARG 0.266 1.1 pp -84.6 106.9 16.51 Favored 'General case' 0 N--CA 1.4 -2.942 0 CA-C-O 122.224 1.012 . . . . 0.0 112.642 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -109.95 155.39 21.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.052 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 180' ' ' THR . 7.3 ptpp? -106.21 139.69 40.32 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 121.516 0.674 . . . . 0.0 111.362 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.447 ' NE2' ' HD2' ' A' ' 193' ' ' PRO . 56.3 tp60 -127.95 141.63 41.78 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -177.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.447 ' HD2' ' NE2' ' A' ' 192' ' ' GLN . 16.9 Cg_exo -66.16 125.58 14.31 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.654 2.236 . . . . 0.0 109.699 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -140.6 135.32 6.94 Favored Glycine 0 C--N 1.28 -2.559 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.629 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.469 HG13 HG21 ' A' ' 234' ' ' VAL . 49.7 mm -93.04 122.21 44.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -107.84 162.23 14.19 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.01 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 249' ' ' VAL . 58.6 mt -73.16 136.67 24.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.7 t -118.38 -61.02 1.72 Allowed 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.129 -1.029 . . . . 0.0 112.172 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -123.12 155.65 36.56 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 206' ' ' ALA . 17.0 mt -126.65 138.74 53.46 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.874 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.3 t -99.6 128.45 31.36 Favored Pre-proline 0 C--N 1.283 -2.313 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.29 126.81 22.59 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 121.952 1.768 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.37 40.16 6.55 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 -172.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.31 162.39 12.61 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.902 -0.649 . . . . 0.0 112.794 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 161' ' ' VAL . 92.8 mt -70.92 -43.43 68.28 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.086 0.555 . . . . 0.0 111.494 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -72.41 -26.64 61.94 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.932 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -67.64 -45.28 75.8 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.8 t -64.49 -38.23 90.3 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.281 0.563 . . . . 0.0 110.314 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 206' ' ' ALA . 17.1 p -79.19 -6.18 55.97 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 52.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 125.412 1.482 . . . . 0.0 116.518 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.55 -19.96 15.27 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.49 ' HB3' ' OD2' ' A' ' 216' ' ' ASP . 6.7 mp -109.69 149.91 29.05 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.479 -2.146 . . . . 0.0 107.261 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.13 162.36 16.77 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.467 0.651 . . . . 0.0 111.461 -170.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.49 -15.82 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.486 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -69.78 -23.63 63.38 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.55 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.592 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.2 m-20 -61.79 159.75 13.14 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -106.23 145.32 31.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.515 -170.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 195' ' ' ILE . 35.2 m -89.55 143.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.539 HD11 ' CB ' ' A' ' 250' ' ' LYS . 2.6 mp -115.27 -51.87 4.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -174.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.511 ' H ' ' HB ' ' A' ' 248' ' ' THR . 41.9 mt-10 -135.44 153.31 51.82 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.561 0.696 . . . . 0.0 112.597 -172.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 92.6 t -117.02 98.28 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.463 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 49.1 t-20 65.82 -78.53 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.522 1.129 . . . . 0.0 110.522 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -137.0 -0.52 2.77 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.9 mt -101.79 129.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -82.08 150.85 27.31 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.254 0.479 . . . . 0.0 110.409 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.603 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 12.5 m -117.02 6.49 7.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.207 0.527 . . . . 0.0 109.627 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.7 101.89 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.896 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.68 0.52 59.12 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.535 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 226' ' ' VAL . 47.3 mtmt -89.26 166.51 13.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.724 0.762 . . . . 0.0 112.729 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.459 HG22 HD23 ' A' ' 231' ' ' LEU . 34.2 m -87.58 158.59 18.86 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 -176.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 230' ' ' THR . 1.9 pt? -59.33 -45.12 92.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.8 -45.98 88.64 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.506 0.67 . . . . 0.0 110.515 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.486 ' OE1' ' HD2' ' A' ' 229' ' ' LYS . 33.8 tt0 -64.6 -39.0 92.93 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.97 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.546 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 94.4 t -73.95 -36.41 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 239' ' ' VAL . 9.1 t -74.46 -35.16 63.3 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.761 -1.175 . . . . 0.0 110.483 177.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.62 -48.38 77.57 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.429 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.582 ' SD ' HG12 ' A' ' 226' ' ' VAL . 26.2 ptm -62.06 -39.16 91.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.229 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.432 ' HB2' HD21 ' A' ' 245' ' ' LEU . 20.7 ptp -72.29 -21.09 61.41 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.15 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.658 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 91.8 t -85.91 -32.5 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.01 66.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.899 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.88 21.69 13.62 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.722 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.6 m -60.91 -18.71 58.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.494 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 21.9 p -56.74 -48.79 76.99 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.0 0.428 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -129.93 90.37 2.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.1 tm? -99.7 122.76 43.17 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.29 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.2 mt -129.92 119.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.45 HD11 ' HB ' ' A' ' 218' ' ' VAL . 7.5 tp -109.78 129.63 64.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.131 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.511 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 15.2 m -103.56 131.52 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.35 -174.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 159' ' ' ARG 0.28 0.4 OUTLIER -134.44 139.3 48.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 123.308 0.643 . . . . 0.0 112.457 176.92 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.539 ' CB ' HD11 ' A' ' 219' ' ' ILE . 87.3 tttt -124.01 138.87 31.39 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.589 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.592 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 16.8 Cg_endo -56.0 126.8 23.6 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.708 2.272 . . . . 0.0 112.896 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.66 -30.73 16.96 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 C--N 1.301 -1.528 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.766 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.7 105.23 1.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.258 1.972 . . . . 0.0 108.956 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.6 t -86.77 95.5 9.85 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 121.714 0.769 . . . . 0.0 111.52 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.4 148.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.6 t -160.65 123.95 3.4 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.0 tt -91.98 125.69 56.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-O 120.653 0.264 . . . . 0.0 110.776 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.12 122.83 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.878 1.719 . . . . 0.0 110.135 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -89.13 120.76 30.81 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -83.76 156.76 22.39 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -59.63 -57.22 13.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 . . . . . 0 C--O 1.242 0.705 0 O-C-N 123.782 0.676 . . . . 0.0 110.346 -176.759 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 152.4 74.55 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.151 2.567 . . . . 0.0 110.779 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.491 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 3.4 mp0 -56.33 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.568 0.747 . . . . 0.0 111.359 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.493 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.5 m -98.0 147.82 24.11 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -126.61 113.54 16.87 Favored 'General case' 0 CA--C 1.474 -1.966 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.474 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 0.5 OUTLIER -98.76 114.97 27.74 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -177.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -97.44 100.99 12.43 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.474 ' HA ' ' NH1' ' A' ' 159' ' ' ARG . 7.3 p -89.38 110.44 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 121.731 0.777 . . . . 0.0 108.911 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.518 ' HB3' HG12 ' A' ' 246' ' ' ILE . 30.9 ptt180 -118.68 142.14 47.94 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.771 -173.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 245' ' ' LEU . 4.8 tt -129.94 141.85 50.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 166' ' ' HIS 0.26 0.7 OUTLIER -112.34 101.19 9.41 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 179.096 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.59 120.87 25.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.536 ' CE1' ' HB2' ' A' ' 164' ' ' LEU . 39.6 m80 -153.21 25.74 0.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 123.364 0.666 . . . . 0.0 109.625 -177.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.58 -11.46 57.99 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.4 t -100.66 101.05 11.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.8 80.91 1.36 Allowed 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.889 0.852 . . . . 0.0 111.894 -170.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.28 151.76 41.84 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.273 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.48 167.3 27.4 Favored 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 122.877 2.384 . . . . 0.0 113.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -102.33 143.06 32.57 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.163 177.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -114.45 56.37 0.5 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.573 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.32 145.39 23.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.35 145.62 43.56 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.166 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.97 152.32 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 40.2 ttm180 -141.13 153.25 45.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -96.83 144.12 27.09 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.792 0.683 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.09 27.75 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 p -94.74 121.95 36.85 Favored 'General case' 0 N--CA 1.385 -3.72 0 CA-C-N 117.158 0.479 . . . . 0.0 110.375 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 t -110.67 119.38 38.95 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.03 123.36 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -107.33 155.16 20.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.79 110.26 31.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.182 0.515 . . . . 0.0 109.955 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 39.7 p -111.22 178.72 4.25 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.49 -3.25 32.92 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.288 0.566 . . . . 0.0 109.794 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.8 m -98.62 -4.43 33.95 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.89 -152.83 17.97 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.8 pt? -92.32 134.41 34.93 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-N 117.164 0.482 . . . . 0.0 109.746 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -132.59 148.99 52.38 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -107.4 127.73 53.85 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.982 0.896 . . . . 0.0 111.03 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.34 160.06 54.51 Favored Pre-proline 0 C--N 1.259 -3.36 0 CA-C-N 113.595 -1.639 . . . . 0.0 108.618 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.02 122.66 6.84 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.158 1.906 . . . . 0.0 108.569 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.61 111.43 3.03 Favored Glycine 0 C--N 1.271 -3.033 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.331 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -98.97 116.68 42.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 14.1 p90 -131.59 172.3 12.4 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.386 -175.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mt -67.6 123.48 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 79.2 p -87.08 -41.98 13.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -162.22 156.02 21.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.996 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 48.7 tp -122.91 138.53 54.64 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.536 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.07 133.69 20.51 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.3 Cg_endo -64.53 130.21 25.96 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.256 1.971 . . . . 0.0 110.511 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.79 2.64 81.28 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -175.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.23 30.21 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.6 mt -55.37 -38.58 69.02 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -76.45 -30.38 57.32 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.8 tm-20 -75.93 -34.03 59.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.0 m -55.53 -32.21 62.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.911 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 m -77.21 -44.89 28.39 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.501 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.97 21.65 63.81 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 114.006 0.362 . . . . 0.0 114.006 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt -107.48 -39.19 5.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.359 0.599 . . . . 0.0 111.001 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.56 HD22 HG23 ' A' ' 249' ' ' VAL . 6.8 mp -109.13 146.55 33.89 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.665 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.08 162.69 17.04 Favored 'General case' 0 C--O 1.198 -1.643 0 O-C-N 123.612 0.57 . . . . 0.0 112.086 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -50.16 -25.94 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -72.06 -25.26 61.71 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.617 -0.677 . . . . 0.0 111.722 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 250' ' ' LYS 0.457 0.8 OUTLIER -73.76 170.79 14.57 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.232 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.1 pt-20 -135.26 165.56 25.15 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -164.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 248' ' ' THR . 58.0 t -80.02 132.85 30.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.22 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.538 HG22 ' HG3' ' A' ' 220' ' ' GLU . 43.5 mm -112.72 -60.6 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.733 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.688 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.7 mt-10 -125.92 153.48 44.17 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.852 0.834 . . . . 0.0 111.947 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 234' ' ' VAL . 92.1 t -119.45 103.36 14.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.977 174.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.563 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.4 t-20 68.2 -69.34 0.15 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.847 0.859 . . . . 0.0 111.04 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.31 7.62 0.45 Allowed Glycine 0 C--N 1.308 -1.012 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.2 mt -104.43 120.81 55.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 43.3 mt-10 -76.3 158.4 31.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.01 7.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.744 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.33 108.07 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.43 . . . . 0.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.75 2.66 46.38 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.105 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.473 ' HE3' ' SD ' ' A' ' 237' ' ' MET . 34.8 mtmm -107.46 158.98 16.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 234' ' ' VAL . 55.1 m -85.26 158.47 20.31 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.224 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 232' ' ' ASP 0.254 1.2 pp -68.74 -31.99 71.45 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.536 ' N ' HD12 ' A' ' 231' ' ' LEU . 10.8 m-20 -64.21 -34.84 79.02 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.286 0.565 . . . . 0.0 110.052 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.584 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.0 tp-100 -69.51 -47.77 62.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 230' ' ' THR . 82.2 t -57.47 -49.47 80.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.931 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 239' ' ' VAL . 40.1 p -67.05 -36.59 82.4 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.199 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.08 -42.53 98.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.022 0.439 . . . . 0.0 109.99 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.3 mtm -59.63 -48.63 80.92 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.868 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 235' ' ' THR . 4.6 ppp? -71.26 -16.92 62.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.651 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 235' ' ' THR . 98.3 t -84.73 -33.04 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.337 0.589 . . . . 0.0 109.574 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.9 -12.02 61.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.891 0.853 . . . . 0.0 109.806 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.43 27.61 8.2 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.757 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 245' ' ' LEU . 69.4 m -57.59 -20.44 32.6 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.8 m -50.55 -56.96 9.36 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -131.6 84.9 2.21 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 245' ' ' LEU . 1.4 pt? -86.7 121.56 29.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.382 0.61 . . . . 0.0 110.403 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 32.0 mt -122.35 124.52 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.478 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 19.1 mm -110.24 139.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.688 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 30.1 m -117.63 125.3 50.5 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.56 HG23 HD22 ' A' ' 212' ' ' LEU . 17.0 m -114.59 148.73 17.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 216' ' ' ASP . 1.0 OUTLIER -139.46 131.18 14.97 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.438 -176.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 157' ' ' THR . 6.6 Cg_endo -47.44 136.09 20.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.309 3.339 . . . . 0.0 113.066 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -80.83 4.2 19.98 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.861 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.3 m120 . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.837 -176.908 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -96.14 162.37 1.31 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 122.36 2.04 . . . . 0.0 111.429 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.5 p -90.35 97.67 11.32 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 136' ' ' ILE . 2.7 mp -76.26 133.7 30.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.627 0.727 . . . . 0.0 109.237 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.4 t 177.85 108.98 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -86.68 120.92 72.13 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.894 -172.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.53 124.33 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.277 1.985 . . . . 0.0 109.154 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -78.18 124.95 28.66 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.06 -174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.6 157.6 22.22 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.142 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -51.18 122.08 7.15 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 124.002 0.814 . . . . 0.0 110.521 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.421 ' HD3' ' C ' ' A' ' 143' ' ' ARG . 1.7 tmt_? . . . . . 0 N--CA 1.417 -2.103 0 CA-C-O 122.48 1.133 . . . . 0.0 108.243 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -87.5 152.36 7.72 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.139 2.559 . . . . 0.0 109.535 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 1.6 mp0 -70.05 84.47 0.52 Allowed 'General case' 0 N--CA 1.418 -2.05 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.51 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 101.71 12.73 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -80.72 94.22 6.33 Favored 'General case' 0 CA--C 1.463 -2.404 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -115.22 126.78 54.96 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.592 -169.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.556 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.7 ptt180 -95.74 94.32 7.62 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.16 133.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.759 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 18.9 ptp180 -99.52 155.74 17.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.77 126.72 37.1 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . 0.258 1.1 pp -105.32 101.54 11.07 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-O 122.152 0.977 . . . . 0.0 113.039 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.618 ' HE2' ' O ' ' A' ' 168' ' ' SER . 12.6 tmtt? -65.2 121.01 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.597 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -162.23 132.89 4.9 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.62 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.37 90.12 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 114.548 0.579 . . . . 0.0 114.548 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.618 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 47.9 m -158.52 153.6 25.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.53 -47.63 69.35 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.702 0.626 . . . . 0.0 109.832 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.442 ' HG3' HD13 ' A' ' 172' ' ' LEU . 6.8 ttpm? -137.56 83.72 24.62 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 168' ' ' SER . 88.8 Cg_endo -91.91 25.08 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.236 2.624 . . . . 0.0 112.576 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 170' ' ' LYS . 5.6 mp -73.08 109.31 6.52 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.78 53.66 4.84 Favored Glycine 0 C--N 1.305 -1.176 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.529 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -170.41 142.26 2.11 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.25 158.89 42.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.46 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.5 pp -131.08 143.31 41.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.181 0.515 . . . . 0.0 112.257 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 16.2 ttm180 -142.22 157.41 44.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -74.12 131.75 41.6 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.967 0.792 . . . . 0.0 110.62 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -144.8 125.91 2.51 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 24.5 p -92.59 139.07 30.95 Favored 'General case' 0 N--CA 1.383 -3.777 0 CA-C-N 117.367 0.583 . . . . 0.0 111.959 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.2 m -110.86 130.54 55.55 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.31 128.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -109.66 155.4 21.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.07 118.86 56.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.255 0.55 . . . . 0.0 110.466 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 41.5 p -115.24 177.83 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.332 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.03 58.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.57 0.7 . . . . 0.0 109.99 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.0 m -101.1 7.47 43.28 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.558 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.18 -141.58 12.94 Favored Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.764 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 189' ' ' LEU . 2.9 pp -125.08 137.86 54.19 Favored 'General case' 0 N--CA 1.388 -3.549 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 153.11 46.56 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.76 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.461 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 38.3 ttpt -121.27 144.09 48.81 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 121.394 0.616 . . . . 0.0 112.027 -172.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -122.2 140.51 32.57 Favored Pre-proline 0 N--CA 1.41 -2.43 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.346 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.08 134.79 18.1 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.214 1.942 . . . . 0.0 109.203 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.86 154.35 22.65 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.764 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.91 117.09 49.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -119.37 166.53 12.93 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 62.6 mt -67.09 129.79 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 39.7 p -96.68 -51.68 4.21 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -137.5 143.54 41.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.362 0.601 . . . . 0.0 111.122 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 138.85 49.73 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.62 138.33 20.74 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -59.8 126.38 20.31 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 121.669 1.579 . . . . 0.0 109.339 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.7 16.36 68.4 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 156.5 29.81 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.862 -0.669 . . . . 0.0 113.218 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.28 -46.08 76.16 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 124.799 1.239 . . . . 0.0 111.446 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.31 -30.14 70.96 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.158 0.504 . . . . 0.0 111.077 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.44 -33.72 54.72 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.364 0.666 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.3 t -55.02 -32.85 62.14 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.375 1.07 . . . . 0.0 113.843 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.9 t -79.86 -44.02 21.26 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.38 -23.18 5.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.631 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.85 -40.34 54.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.938 0.875 . . . . 0.0 109.383 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.505 HD13 HG23 ' A' ' 249' ' ' VAL . 86.3 mt -109.64 147.37 33.2 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.568 -175.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.05 162.89 17.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.016 0.436 . . . . 0.0 111.289 -174.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.521 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 14.3 p -62.2 -15.45 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-O 121.987 0.899 . . . . 0.0 111.323 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -71.88 -24.02 61.6 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.822 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.684 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.4 m-20 -64.56 173.39 2.17 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -116.46 147.75 41.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.242 -172.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.67 142.69 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.065 0.546 . . . . 0.0 110.43 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 220' ' ' GLU . 2.5 mp -112.04 -51.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 110.456 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.557 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.3 mt-10 -140.48 149.74 42.9 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.56 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.0 t -113.62 108.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.505 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 6.9 t30 69.87 -68.82 0.18 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.332 1.453 . . . . 0.0 110.939 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.73 26.36 0.19 Allowed Glycine 0 C--N 1.301 -1.388 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.52 119.1 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.544 ' H ' ' CD ' ' A' ' 225' ' ' GLU . 1.2 pm0 -75.53 145.91 40.93 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-O 121.007 0.432 . . . . 0.0 111.985 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 219' ' ' ILE . 20.3 m -94.11 9.31 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.892 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -64.54 106.11 1.09 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.834 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.25 12.2 58.95 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.497 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 70.6 mmtt -87.03 170.58 11.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.27 1.033 . . . . 0.0 113.327 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 234' ' ' VAL . 86.0 m -110.26 157.09 19.83 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 113.363 -1.744 . . . . 0.0 106.65 174.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 231' ' ' LEU . 1.9 pt? -64.67 -34.35 78.08 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.34 -49.48 55.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.551 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -60.48 -40.57 91.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.681 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.559 ' HA ' ' SD ' ' A' ' 237' ' ' MET . 92.0 t -57.53 -43.31 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 O-C-N 123.266 0.354 . . . . 0.0 111.439 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 239' ' ' VAL . 60.2 p -65.19 -28.89 69.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.5 -40.75 63.83 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.559 ' SD ' ' HA ' ' A' ' 234' ' ' VAL . 54.3 mtp -55.84 -50.16 71.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.02 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.7 ptm -76.49 -10.67 59.57 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.046 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.673 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 59.0 t -91.81 -34.96 6.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.045 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.43 -22.07 66.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.643 0.735 . . . . 0.0 109.902 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -114.32 21.83 14.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.1 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 75.2 m -63.92 -32.0 73.38 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.8 m -51.94 -53.08 45.42 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 0.0 110.815 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -129.81 86.17 2.38 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.1 tm? -97.09 131.45 43.86 Favored 'General case' 0 C--O 1.191 -1.993 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.722 -174.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -117.07 118.86 60.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.42 130.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.922 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.557 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 18.7 m -97.35 120.18 37.23 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.505 HG23 HD13 ' A' ' 212' ' ' LEU . 5.4 m -124.93 150.4 29.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 123.781 0.675 . . . . 0.0 112.251 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.491 ' CB ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.04 130.36 15.11 Favored Pre-proline 0 C--O 1.247 0.921 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.684 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.8 Cg_endo -62.41 132.2 37.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.024 2.483 . . . . 0.0 115.119 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.58 -4.48 15.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.655 -1.157 . . . . 0.0 107.919 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.2 p30 . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.766 -177.496 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.078 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 m 69.0 149.68 0.07 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.314 1.045 . . . . 0.0 112.317 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -116.95 73.41 0.86 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.4 p -109.73 112.37 24.38 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.545 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -159.34 -174.65 4.79 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.32 90.89 35.67 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 166.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.21 -45.37 7.64 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 122.85 2.367 . . . . 0.0 112.405 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -119.9 103.17 9.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.254 0.55 . . . . 0.0 110.678 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.0 mt -110.45 142.92 21.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.5 t -134.52 93.36 3.04 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.91 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.1 tt -115.06 92.26 30.36 Favored Pre-proline 0 N--CA 1.415 -2.193 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.06 122.63 3.83 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.152 1.901 . . . . 0.0 111.446 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -94.59 114.57 26.55 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -83.23 119.93 25.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.297 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -179.17 92.24 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.595 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -112.3 7.51 19.36 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.535 1.16 . . . . 0.0 108.107 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.02 154.1 42.36 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.618 -1.628 . . . . 0.0 107.927 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.29 125.53 32.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 p -68.6 114.86 7.36 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 121.68 0.753 . . . . 0.0 113.021 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.41 153.97 27.72 Favored 'General case' 0 N--CA 1.403 -2.806 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.2 tt -67.04 88.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 CA-C-O 122.324 1.059 . . . . 0.0 113.503 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.1 mm -105.89 115.57 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -120.04 113.54 20.66 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 121.525 0.679 . . . . 0.0 112.754 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 51.9 t -136.32 -68.3 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.219 -1.355 . . . . 0.0 107.948 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -107.51 107.39 18.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.056 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.9 mp 59.06 125.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.69 115.75 65.81 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.82 150.37 78.67 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 122.548 2.166 . . . . 0.0 111.69 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 77.3 4.33 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.2 p -74.39 101.76 4.2 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.452 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -76.4 95.65 3.86 Favored 'General case' 0 CA--C 1.466 -2.277 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.485 ' CB ' HD11 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -96.08 117.3 30.42 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.324 -167.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 30.3 ptt180 -87.25 99.49 12.0 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.724 0.773 . . . . 0.0 109.716 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 247' ' ' ILE . 62.5 t -88.94 105.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.417 ' HE ' HD21 ' A' ' 164' ' ' LEU . 14.6 ptm180 -105.69 139.42 40.3 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.322 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.19 121.34 44.96 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.417 HD21 ' HE ' ' A' ' 162' ' ' ARG . 89.7 mt -100.82 100.21 10.83 Favored 'General case' 0 N--CA 1.403 -2.783 0 CA-C-O 121.752 0.787 . . . . 0.0 109.729 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER -90.64 120.58 31.83 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.282 176.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -152.31 89.32 1.42 Allowed 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.113 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.07 -10.37 41.58 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.36 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 32.9 t -141.61 135.04 29.6 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.509 ' OD2' ' HG3' ' A' ' 165' ' ' LYS . 13.4 t70 -130.42 87.04 2.45 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -119.01 147.51 42.71 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.563 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 112.4 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 107.886 -1.621 . . . . 0.0 107.886 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.503 HD22 ' H ' ' A' ' 205' ' ' LEU . 4.9 tt -62.73 -29.2 70.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.357 0.599 . . . . 0.0 109.607 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.76 -4.91 1.71 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.337 -1.411 . . . . 0.0 113.468 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -103.06 147.56 26.81 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.417 ' HB2' ' H ' ' A' ' 199' ' ' ARG . 81.7 m-85 -137.93 158.51 44.19 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.404 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.1 pt -117.57 149.17 19.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.476 0.655 . . . . 0.0 112.377 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 60.1 ttt180 -125.45 152.33 45.03 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.124 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 8.7 t70 -115.59 123.23 47.92 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.39 179.68 29.55 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.288 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.9 p -93.41 120.61 33.9 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.163 0.506 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.8 t -101.7 124.45 47.37 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.46 123.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 121.381 0.61 . . . . 0.0 110.445 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -124.76 161.57 26.13 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.272 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.16 107.41 22.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 36.2 p -108.88 178.87 4.34 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.78 -16.88 64.33 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.948 0.404 . . . . 0.0 110.818 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.3 m -87.88 -4.7 58.83 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.9 -151.7 18.17 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.592 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.707 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.5 pt? -84.28 108.53 17.19 Favored 'General case' 0 N--CA 1.394 -3.253 0 CA-C-O 122.016 0.912 . . . . 0.0 109.796 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -117.4 158.85 23.73 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.496 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.46 131.87 54.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -116.49 151.1 46.61 Favored Pre-proline 0 C--N 1.273 -2.731 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.11 125.16 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.893 1.728 . . . . 0.0 109.902 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.74 151.52 20.21 Favored Glycine 0 C--N 1.278 -2.64 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 122.47 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.08 -168.44 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.5 136.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 69.4 p -95.42 -46.94 6.49 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.453 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.417 ' H ' ' HB2' ' A' ' 175' ' ' TYR . 72.7 ttt180 -146.58 146.88 30.6 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 56.4 tp -127.78 125.44 39.88 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.3 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.17 130.59 26.94 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 50.6 Cg_exo -57.52 126.28 21.41 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.148 1.899 . . . . 0.0 110.24 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.66 -14.9 41.91 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.64 146.02 28.16 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.503 ' H ' HD22 ' A' ' 172' ' ' LEU . 34.6 tp -53.96 -34.42 59.66 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 123.927 0.891 . . . . 0.0 113.271 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -69.37 -35.26 75.65 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.8 tp10 -77.04 -35.52 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 36.4 m -61.73 -33.11 73.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.486 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.3 m -67.12 -39.89 86.73 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.46 -32.27 2.61 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.941 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.89 -19.25 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 123.74 0.816 . . . . 0.0 110.189 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.485 HD11 ' CB ' ' A' ' 159' ' ' ARG . 71.1 mt -109.42 141.84 41.24 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.476 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.3 163.06 27.63 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 124.622 1.169 . . . . 0.0 110.128 -177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.86 -26.74 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.816 0.846 . . . . 0.0 112.579 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.12 -23.55 64.0 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.1 m-20 -63.66 159.13 19.71 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.52 148.46 24.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.919 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.6 t -101.56 139.02 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.829 0.852 . . . . 0.0 109.477 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 219' ' ' ILE . 2.7 mp -116.12 -50.64 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.468 ' HG3' HG22 ' A' ' 219' ' ' ILE . 47.6 mt-10 -136.22 152.44 50.76 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.413 HG13 ' CD2' ' A' ' 245' ' ' LEU . 50.4 t -119.84 106.82 19.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.811 -1.54 . . . . 0.0 107.975 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 70.25 -69.01 0.18 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.475 1.11 . . . . 0.0 110.49 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -166.0 21.19 0.11 Allowed Glycine 0 C--N 1.291 -1.926 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.583 HG21 ' SD ' ' A' ' 237' ' ' MET . 13.2 mt -113.19 124.91 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.8 143.48 41.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 118.621 0.646 . . . . 0.0 109.664 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.9 m -96.15 -5.19 10.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.682 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.04 123.05 19.98 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.172 0.511 . . . . 0.0 111.684 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.7 7.4 75.13 Favored Glycine 0 CA--C 1.499 -0.907 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.201 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.442 ' HG3' ' OE1' ' A' ' 233' ' ' GLN . 23.3 ttmm -107.47 156.29 19.13 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 234' ' ' VAL . 87.1 m -77.14 157.47 30.97 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 50.0 tp -62.45 -44.3 96.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.42 -35.4 70.02 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.035 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.651 ' O ' ' HG3' ' A' ' 237' ' ' MET . 79.2 mt-30 -73.34 -42.47 62.23 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.946 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 230' ' ' THR . 61.1 t -64.75 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.596 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.0 p -65.87 -41.63 91.36 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.615 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.39 -44.88 95.41 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.1 0.476 . . . . 0.0 110.463 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 33.8 mtm -60.14 -42.9 95.83 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.8 -17.92 62.13 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.395 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 235' ' ' THR . 85.0 t -85.39 -36.73 11.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.24 -25.22 67.7 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.534 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -129.92 28.76 5.04 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.687 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.9 t -59.16 -35.57 73.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.459 1.103 . . . . 0.0 111.953 -175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 22.8 t -70.36 -20.5 62.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.216 0.532 . . . . 0.0 110.759 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -130.15 37.12 3.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.413 ' CD2' HG13 ' A' ' 221' ' ' VAL . 3.2 tm? -85.02 123.01 30.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.829 0.823 . . . . 0.0 112.219 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 61.6 mt -129.02 119.61 49.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.317 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.455 HG23 ' HB ' ' A' ' 161' ' ' VAL . 10.8 tt -109.66 131.99 59.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.584 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.4 m -95.46 120.15 35.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.093 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 212' ' ' LEU . 17.4 m -122.53 149.97 26.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.582 0.551 . . . . 0.0 110.208 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.451 ' CB ' HD11 ' A' ' 219' ' ' ILE . 0.5 OUTLIER -134.77 126.06 17.73 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 77.7 Cg_exo -52.56 132.06 43.76 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.659 2.906 . . . . 0.0 114.494 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -101.78 8.15 41.53 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -83.25 66.32 8.71 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.152 -1.386 . . . . 0.0 108.122 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -90.95 152.39 20.73 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.613 -0.722 . . . . 0.0 112.144 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? . . . . . 0 C--N 1.294 -1.846 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 179.701 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.106 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.8 m -150.17 157.51 43.18 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 117.365 0.583 . . . . 0.0 109.801 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -75.06 127.79 34.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.1 t -75.53 134.07 40.85 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -130.76 166.04 21.63 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -175.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.26 111.59 52.59 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.0 108.39 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.635 1.557 . . . . 0.0 108.736 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 t -92.85 85.82 5.3 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.315 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.59 119.6 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.1 m -145.24 91.31 2.12 Favored 'General case' 1 C--N 1.235 -4.401 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -116.63 108.15 45.47 Favored Pre-proline 0 N--CA 1.424 -1.734 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.178 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.16 123.92 12.63 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 N-CA-C 106.504 -2.152 . . . . 0.0 106.504 172.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.38 112.14 20.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.388 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 142' ' ' PHE . 11.6 m-20 -107.22 118.85 37.81 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 141' ' ' ASP . 48.6 t80 166.66 93.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 O-C-N 125.029 1.455 . . . . 0.0 107.217 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -108.33 7.31 27.13 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.178 0.989 . . . . 0.0 109.357 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -89.3 160.08 17.07 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.152 -1.385 . . . . 0.0 107.328 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.1 m -77.65 154.0 5.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.3 m -71.09 114.04 8.74 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -112.86 147.2 37.5 Favored 'General case' 0 N--CA 1.401 -2.902 0 CA-C-O 121.455 0.645 . . . . 0.0 111.866 -169.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.8 mt 46.3 64.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 126.608 1.963 . . . . 0.0 113.665 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 149' ' ' ILE . 2.5 pp -106.79 140.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.58 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.8 t70 62.73 91.47 0.07 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.436 1.112 . . . . 0.0 110.523 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.71 -72.99 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.019 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -76.41 107.53 8.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.574 HG23 ' H ' ' A' ' 154' ' ' VAL 0.326 9.0 tt 40.29 -92.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.909 1.684 . . . . 0.0 113.839 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.574 ' H ' HG23 ' A' ' 153' ' ' ILE . 7.5 p -129.47 115.02 18.29 Favored Pre-proline 0 N--CA 1.417 -2.097 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.49 146.66 13.77 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.338 2.025 . . . . 0.0 113.381 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.494 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 2.4 mp0 -83.0 72.32 10.08 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.717 177.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -106.07 138.53 42.09 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -126.08 135.91 52.3 Favored 'General case' 0 CA--C 1.469 -2.136 0 CA-C-O 121.147 0.498 . . . . 0.0 112.082 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -113.65 115.76 28.4 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.432 ' O ' ' HD2' ' A' ' 160' ' ' ARG 0.334 4.0 ppt_? -97.97 103.81 15.78 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 122.162 0.982 . . . . 0.0 110.659 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.31 125.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.916 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -95.55 126.68 41.0 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.305 0.574 . . . . 0.0 109.862 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.01 121.43 38.89 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.512 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.28 105.16 15.75 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.322 1.058 . . . . 0.0 110.639 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -74.98 136.28 41.31 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.441 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.542 ' HB2' ' H ' ' A' ' 170' ' ' LYS . 88.3 m-70 -139.53 -75.63 0.35 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.556 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.2 -10.96 58.46 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.251 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.7 m -134.01 25.5 3.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 122.123 0.963 . . . . 0.0 108.476 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.402 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 19.4 t70 -165.14 -70.48 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.161 -174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.542 ' H ' ' HB2' ' A' ' 166' ' ' HIS . 12.7 mptt -123.79 114.27 28.37 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -84.31 -40.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.037 1.825 . . . . 0.0 110.234 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.95 159.16 36.21 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 125.618 1.567 . . . . 0.0 107.153 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -122.73 17.81 8.18 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.584 -1.293 . . . . 0.0 112.449 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -165.68 143.67 5.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.424 ' CE2' HG22 ' A' ' 201' ' ' VAL . 76.1 m-85 -108.99 136.03 49.2 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.973 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.478 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -134.44 140.31 46.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -137.82 159.9 40.74 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.29 145.08 44.26 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.947 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.1 109.72 0.43 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 m -93.3 143.76 25.96 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 51.0 m -126.24 133.79 51.38 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.4 p -108.65 125.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.49 ' HB2' ' OE1' ' A' ' 190' ' ' GLU . 72.7 mtp180 -124.72 162.21 24.71 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.428 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.98 113.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.893 0.854 . . . . 0.0 108.856 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 57.0 p -113.8 178.24 4.35 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.498 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.48 -10.88 59.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 109.916 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.2 m -94.55 -4.19 48.39 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.219 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.08 -159.6 14.27 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.645 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.8 pt? -83.98 129.13 34.93 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 117.593 0.697 . . . . 0.0 110.272 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -137.78 161.82 35.57 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.761 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 181' ' ' SER . 98.3 mttt -121.64 150.15 42.15 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 18.6 pt20 -131.13 139.0 34.17 Favored Pre-proline 0 N--CA 1.414 -2.23 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.1 Cg_endo -81.7 133.74 8.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.546 2.164 . . . . 0.0 110.854 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.23 153.7 25.5 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.869 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 231' ' ' LEU . 2.7 mp -125.57 123.1 63.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -127.56 163.97 23.01 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 67.7 mt -74.6 114.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -84.52 -49.59 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.064 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.11 155.41 50.22 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.743 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -113.57 140.62 48.01 Favored 'General case' 0 N--CA 1.395 -3.2 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 178.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 175' ' ' TYR . 40.1 t -96.54 129.69 32.5 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.15 126.05 17.8 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 121.939 1.76 . . . . 0.0 109.236 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.07 -6.56 83.1 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.39 156.3 53.29 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.89 -25.88 65.72 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.46 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' N ' HD21 ' A' ' 200' ' ' LEU . 42.8 tt0 -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.0 m -54.81 -31.27 58.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.288 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.4 p -60.75 -43.12 98.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.96 29.28 74.39 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.9 tp -145.43 -46.47 0.22 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.011 -1.095 . . . . 0.0 110.458 -172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.442 HD12 HG23 ' A' ' 249' ' ' VAL . 71.9 mt -115.4 110.43 19.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.445 0.641 . . . . 0.0 111.3 -176.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.69 134.01 44.27 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.613 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 71.2 t 43.22 -72.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 173.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -23.6 65.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -67.41 153.2 44.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.363 -173.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -101.29 156.44 17.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.63 143.3 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.491 0.717 . . . . 0.0 109.964 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.513 HD11 ' CB ' ' A' ' 250' ' ' LYS . 2.8 mp -121.69 -45.52 2.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 111.968 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.451 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 35.9 mt-10 -135.58 150.85 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.768 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.4 t -121.87 101.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 123.804 0.69 . . . . 0.0 109.338 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.522 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 39.2 t-20 69.59 -72.09 0.11 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 0.0 111.269 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.54 12.18 0.4 Allowed Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.584 HG21 ' SD ' ' A' ' 237' ' ' MET . 19.9 mt -105.21 133.06 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.92 146.3 28.12 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.47 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 12.7 m -91.63 -4.94 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.945 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.76 112.34 7.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.575 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 4.29 50.76 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.5 mmpt? -96.79 163.04 13.16 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -104.57 168.7 8.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 231' ' ' LEU . 1.9 pt? -57.59 -47.59 81.71 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -68.31 -40.99 81.53 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.237 0.541 . . . . 0.0 110.529 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.684 ' O ' ' HG3' ' A' ' 237' ' ' MET . 35.5 tt0 -59.09 -43.59 91.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.309 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.49 -46.86 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.483 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.0 p -65.97 -31.01 71.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.888 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.65 -42.79 77.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.18 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.684 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 24.6 mtm -59.3 -46.35 88.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.68 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.3 ptp -67.15 -23.15 65.76 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.967 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 235' ' ' THR . 58.8 t -90.14 -27.05 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.557 0.694 . . . . 0.0 109.161 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.02 71.95 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.449 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.58 -70.17 0.72 Allowed 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.28 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.2 t 60.16 -41.28 0.09 Allowed 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 42.5 m -68.6 -73.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.885 0.766 . . . . 0.0 111.588 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.52 81.17 2.92 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -95.87 129.1 43.21 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.207 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 3.3 mp -127.46 134.5 65.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 220' ' ' GLU . 7.2 tp -124.18 131.17 73.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.59 . . . . 0.0 110.001 178.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 28.5 m -98.03 120.22 38.04 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.052 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG23 HD12 ' A' ' 212' ' ' LEU . 10.5 m -121.06 149.37 24.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.278 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.513 ' CB ' HD11 ' A' ' 219' ' ' ILE . 80.7 tttt -127.72 141.07 39.88 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 124.001 0.92 . . . . 0.0 109.258 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.631 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.5 Cg_endo -64.39 130.09 25.84 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 121.626 1.551 . . . . 0.0 111.039 175.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -95.48 -35.15 11.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.928 0.871 . . . . 0.0 109.07 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.535 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 45.1 m-80 56.43 8.81 0.46 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.932 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -121.72 130.11 53.21 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.288 0.566 . . . . 0.0 110.552 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 5.9 tpm_? . . . . . 0 C--N 1.283 -2.285 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.749 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.2 p -127.57 142.47 51.36 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-O 120.941 0.4 . . . . 0.0 111.313 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -151.14 130.11 12.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.2 t -76.06 139.29 41.33 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.532 0.682 . . . . 0.0 110.734 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -94.38 122.03 36.53 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.394 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.5 113.07 64.6 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.28 133.2 31.93 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.736 1.624 . . . . 0.0 110.093 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.9 t -96.32 96.31 8.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.404 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.57 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.3 t -161.95 93.21 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 73.0 mt -92.23 114.18 61.44 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 6.9 Cg_exo -72.32 123.0 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.313 2.008 . . . . 0.0 112.286 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -98.44 132.26 44.03 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.83 157.17 17.66 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -96.27 138.91 33.18 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -154.48 92.87 1.53 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 122.106 0.955 . . . . 0.0 109.005 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -84.11 140.19 31.96 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.061 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.6 m -78.93 124.43 37.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.217 0.532 . . . . 0.0 110.14 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.9 m -86.56 115.7 24.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.749 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.27 105.26 16.33 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.1 mp -88.28 96.89 6.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.664 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -106.03 151.76 7.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.173 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -92.17 -173.41 3.43 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.405 0.621 . . . . 0.0 110.34 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.85 120.0 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.01 120.97 11.27 Favored 'General case' 1 C--N 1.243 -4.056 0 CA-C-N 114.11 -1.404 . . . . 0.0 114.452 -170.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.1 tt -154.87 151.03 11.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 253' ' ' ASN . 41.3 t -114.03 104.56 54.89 Favored Pre-proline 0 C--N 1.288 -2.082 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.16 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.04 151.79 84.55 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.391 2.061 . . . . 0.0 109.266 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 78.64 0.22 Allowed 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.8 p -81.84 96.96 7.79 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.411 ' NE2' ' HG2' ' A' ' 250' ' ' LYS . 12.0 m170 -66.04 116.39 7.1 Favored 'General case' 0 CA--C 1.457 -2.622 0 CA-C-O 121.861 0.838 . . . . 0.0 112.42 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.458 ' HG2' HG21 ' A' ' 209' ' ' THR . 10.7 tpt180 -110.12 116.7 32.01 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.67 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.497 ' HB2' HG23 ' A' ' 246' ' ' ILE . 30.7 ptt180 -99.14 113.62 25.95 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.92 132.32 41.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 19.6 ptt180 -112.13 148.79 33.24 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.001 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 2.5 tm? -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 171.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 164' ' ' LEU 0.273 0.0 OUTLIER -108.04 101.33 10.58 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-O 121.956 0.884 . . . . 0.0 112.72 179.39 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -71.91 131.83 43.52 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.817 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.26 79.07 0.52 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.801 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.95 17.62 69.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -102.94 113.89 27.72 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 114.616 -0.792 . . . . 0.0 111.049 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.14 4.24 7.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.769 1.271 . . . . 0.0 107.687 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -74.2 169.19 20.32 Favored Pre-proline 0 C--O 1.246 0.869 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -56.07 146.17 71.32 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.257 1.972 . . . . 0.0 110.523 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.72 -47.23 80.44 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.442 0.639 . . . . 0.0 111.853 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 115.83 -18.78 14.47 Favored Glycine 0 CA--C 1.487 -1.692 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -132.67 133.36 43.47 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 114.275 -0.962 . . . . 0.0 108.857 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 199' ' ' ARG . 77.4 m-85 -138.04 148.08 44.74 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 123.524 0.515 . . . . 0.0 111.926 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.425 HG21 HG11 ' A' ' 218' ' ' VAL . 31.6 pt -124.71 143.14 39.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.992 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -140.24 159.39 42.28 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.841 0.353 . . . . 0.0 111.43 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.65 135.78 35.53 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.932 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -142.17 175.01 22.98 Favored Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.5 m -95.04 133.42 38.84 Favored 'General case' 0 C--N 1.27 -2.881 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.725 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.3 t -103.88 119.12 38.25 Favored 'General case' 0 C--N 1.252 -3.668 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.1 p -108.41 123.16 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.544 0.688 . . . . 0.0 109.168 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.89 51.65 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.529 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.82 107.41 21.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.28 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.3 p -111.87 179.11 4.1 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.753 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.12 -15.21 62.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.2 m -87.62 -5.32 58.78 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.95 -157.36 15.04 Favored Glycine 0 C--O 1.214 -1.119 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 189' ' ' LEU . 4.0 pp -88.19 129.97 35.19 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 118.346 1.073 . . . . 0.0 109.203 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 41.7 mt-10 -120.69 147.78 44.82 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.507 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -121.34 130.12 53.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -142.21 154.83 64.83 Favored Pre-proline 0 C--N 1.279 -2.486 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.69 121.56 6.39 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 109.23 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.41 139.35 10.71 Favored Glycine 0 C--N 1.276 -2.791 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.8 pt -100.6 126.58 54.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-O 121.532 0.682 . . . . 0.0 112.164 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -120.19 174.47 6.48 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.952 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 176' ' ' ILE . 59.9 mt -68.33 135.7 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.3 t -121.23 -59.29 1.73 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.593 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.42 ' HB2' ' HB2' ' A' ' 175' ' ' TYR . 93.1 mtt180 -122.86 147.01 47.05 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.442 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 206' ' ' ALA . 12.9 mt -127.36 134.11 49.98 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.464 174.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.402 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 57.7 t -100.7 129.38 27.71 Favored Pre-proline 0 C--N 1.275 -2.632 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 172.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.66 126.45 19.73 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.334 2.023 . . . . 0.0 110.682 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.04 72.5 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.214 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 158.35 47.48 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -55.95 -39.32 71.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.771 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -74.01 -26.98 60.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.171 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.428 ' HB2' HD22 ' A' ' 200' ' ' LEU . 7.7 tp10 -73.0 -45.46 57.79 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 m -55.36 -32.22 62.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.263 1.025 . . . . 0.0 111.846 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.559 HG22 ' HG ' ' A' ' 211' ' ' LEU . 27.6 m -62.58 -43.49 98.69 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.033 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 77.59 -27.64 1.85 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.387 0.915 . . . . 0.0 115.387 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.559 ' HG ' HG22 ' A' ' 209' ' ' THR . 4.2 pp -97.56 7.98 45.47 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 249' ' ' VAL . 94.9 mt -116.0 145.05 43.28 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.938 0.399 . . . . 0.0 110.045 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.47 161.89 26.1 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 120.889 0.376 . . . . 0.0 111.75 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.61 -19.41 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-O 121.547 0.689 . . . . 0.0 111.114 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.77 -25.07 58.82 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.528 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.617 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 51.8 m-20 -70.98 156.67 39.35 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.245 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.47 165.74 18.54 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.628 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 176' ' ' ILE . 19.6 m -82.77 142.88 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.234 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.59 HG13 ' HG3' ' A' ' 250' ' ' LYS . 42.8 mm -116.06 -47.43 4.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.069 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.544 ' H ' ' HB ' ' A' ' 248' ' ' THR . 39.1 mt-10 -145.99 159.49 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' A' ' 226' ' ' VAL . 77.2 t -123.38 97.26 4.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 169.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.3 t30 68.3 -70.17 0.13 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.36 17.56 0.68 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.426 HG21 ' SD ' ' A' ' 237' ' ' MET . 9.0 mt -120.3 142.33 36.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -86.12 153.83 21.8 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.991 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.424 ' CG1' HG23 ' A' ' 221' ' ' VAL . 16.3 m -118.03 -3.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.94 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -86.27 121.77 29.32 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.81 -10.22 72.52 Favored Glycine 0 C--N 1.318 -0.441 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 233' ' ' GLN . 37.5 ttmt -91.95 153.79 19.25 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 124.48 1.112 . . . . 0.0 109.153 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.4 m -74.92 156.28 36.53 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 231' ' ' LEU . 2.2 pt? -64.65 -36.82 85.49 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.686 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.37 -36.85 76.53 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.75 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 237' ' ' MET . 5.8 tp-100 -72.42 -48.52 40.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.459 ' HA ' ' HE2' ' A' ' 237' ' ' MET . 95.6 t -56.74 -48.97 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.932 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.5 p -65.0 -34.0 77.39 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.32 -38.58 81.69 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.99 0.424 . . . . 0.0 110.276 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.659 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 20.2 mtm -57.8 -45.6 85.85 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.84 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.28 -15.01 60.54 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.465 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 235' ' ' THR . 65.9 t -78.82 -38.72 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.251 0.548 . . . . 0.0 110.028 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.27 -29.06 68.57 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.281 0.563 . . . . 0.0 110.806 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -110.79 32.13 5.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.8 p -60.02 -27.52 66.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.2 p -46.9 -63.55 1.0 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.137 0.575 . . . . 0.0 111.564 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 40.1 m-80 -129.96 87.68 2.56 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.9 pp -90.33 131.99 35.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 160' ' ' ARG . 2.3 mp -106.7 125.29 62.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.094 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.1 tt -111.37 128.27 67.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 110.649 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.544 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.1 m -106.44 129.44 54.42 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.315 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 212' ' ' LEU . 27.8 m -135.66 165.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.59 ' HG3' HG13 ' A' ' 219' ' ' ILE . 43.9 mtpt -126.42 129.02 24.25 Favored Pre-proline 0 CA--C 1.482 -1.637 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.55 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 50.0 Cg_exo -58.62 127.23 23.79 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.811 1.674 . . . . 0.0 110.164 172.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.12 9.69 21.83 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.125 0.964 . . . . 0.0 109.712 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' A' ' 154' ' ' VAL . 24.8 m-80 -93.7 15.78 15.53 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.29 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -90.99 144.64 25.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.266 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 C--N 1.302 -1.472 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.863 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.601 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.4 m 79.05 5.6 2.25 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.754 1.221 . . . . 0.0 113.48 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -97.93 88.14 4.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.7 p -93.45 142.42 27.35 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.206 0.527 . . . . 0.0 112.392 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -110.33 100.06 8.98 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -112.22 117.84 46.92 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 147.82 91.87 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.26 1.973 . . . . 0.0 111.263 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.3 m -79.7 85.85 5.36 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.47 0.652 . . . . 0.0 110.614 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.9 mm -99.81 144.18 12.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m 58.26 73.93 0.45 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.141 0.977 . . . . 0.0 111.148 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.79 119.43 70.56 Favored Pre-proline 0 N--CA 1.421 -1.896 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.815 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.17 121.82 10.22 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.464 2.11 . . . . 0.0 112.114 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -101.94 161.19 13.86 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.759 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -83.52 149.44 26.6 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.704 -0.398 . . . . 0.0 109.944 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -103.45 -37.72 7.48 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -150.02 89.95 1.64 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 121.118 0.485 . . . . 0.0 110.647 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -72.47 125.36 27.21 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.7 140.91 16.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.851 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.1 m -94.25 147.99 22.65 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.77 103.96 16.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.264 0.554 . . . . 0.0 110.81 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.0 tp -102.48 98.71 7.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pp -101.39 152.28 5.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.407 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -77.6 109.72 11.81 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.528 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 153' ' ' ILE . 57.2 t -77.0 -37.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.6 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.92 123.74 21.03 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 151' ' ' VAL . 68.0 mt -133.4 127.58 53.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.252 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.66 102.04 20.31 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 169.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.75 131.2 1.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.049 1.833 . . . . 0.0 112.283 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.55 ' HA ' ' HG2' ' A' ' 251' ' ' PRO . 42.2 mt-10 -84.27 85.57 7.35 Favored 'General case' 0 N--CA 1.403 -2.811 0 CA-C-O 121.387 0.613 . . . . 0.0 112.109 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -91.0 100.45 13.31 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -88.61 105.01 17.38 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -126.36 116.11 20.7 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.25 129.58 34.6 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.997 0.427 . . . . 0.0 110.074 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.3 t -89.71 115.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -106.28 137.61 43.93 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 111.836 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.72 141.49 48.56 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.356 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.43 115.3 23.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 121.822 0.82 . . . . 0.0 110.801 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.56 130.08 38.92 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.345 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 169' ' ' ASP . 0.5 OUTLIER -164.99 76.33 0.28 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.99 -178.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.37 17.35 76.32 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.009 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.0 m 67.58 97.0 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.587 1.155 . . . . 0.0 111.154 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 166' ' ' HIS . 19.2 t70 -86.56 -49.56 7.46 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.926 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -145.17 150.35 44.86 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.76 -61.93 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 121.312 1.341 . . . . 0.0 109.756 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.04 -65.56 0.39 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.511 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 205' ' ' LEU . . . 92.65 11.48 59.22 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.46 156.92 26.74 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -137.27 136.1 37.75 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 123.339 0.399 . . . . 0.0 110.326 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.483 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -128.81 141.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.307 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -141.31 158.08 44.36 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.498 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -96.95 130.41 44.26 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -122.2 158.89 16.89 Favored Glycine 0 CA--C 1.47 -2.751 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 m -92.91 131.45 37.91 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.72 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -111.43 140.2 46.22 Favored 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.463 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.4 123.15 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.86 152.52 21.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.0 104.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.1 p -117.74 179.03 4.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.97 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.39 -15.89 63.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 109.656 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.6 m -87.25 -4.13 59.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.208 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.54 -142.3 15.52 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.06 123.28 33.79 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -117.2 146.18 43.4 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.58 133.52 55.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.065 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -146.93 147.61 30.05 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.525 ' O ' ' HA2' ' A' ' 228' ' ' GLY . 13.9 Cg_exo -69.12 133.29 26.37 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.414 2.076 . . . . 0.0 111.512 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -129.82 127.19 5.32 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.529 HG23 ' HB ' ' A' ' 218' ' ' VAL . 10.5 tt -91.19 124.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-O 121.25 0.548 . . . . 0.0 110.881 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.58 173.11 10.56 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.47 131.99 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 37.3 t -90.69 -54.31 4.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.223 0.535 . . . . 0.0 110.83 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -155.65 155.66 33.61 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 53.5 tp -127.33 139.63 52.75 Favored 'General case' 0 N--CA 1.403 -2.819 0 O-C-N 123.317 0.386 . . . . 0.0 110.228 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.37 128.62 32.62 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.524 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 29.6 Cg_exo -63.36 126.27 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 108.934 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.6 73.45 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.51 158.42 41.43 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.497 ' H ' ' HA3' ' A' ' 173' ' ' GLY . 27.4 tp -57.95 -38.8 76.66 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -72.71 -29.27 63.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.512 0.672 . . . . 0.0 109.963 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -76.72 -34.07 58.14 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -58.84 -33.54 70.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.9 m -77.16 -45.59 26.24 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.27 -6.0 0.87 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.02 -14.95 58.88 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.218 0.607 . . . . 0.0 111.287 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.471 ' CD1' HG23 ' A' ' 249' ' ' VAL . 94.1 mt -119.22 146.89 44.83 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.146 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.2 161.28 13.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.961 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 51.7 t -67.36 -18.65 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.669 0.747 . . . . 0.0 110.239 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.99 -24.58 59.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.144 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.649 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 73.7 m-20 -66.06 157.2 31.64 Favored 'General case' 0 C--O 1.248 1.026 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -172.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.81 150.4 22.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.576 0.703 . . . . 0.0 112.425 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 195' ' ' ILE . 57.1 t -94.32 136.94 24.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.602 HG22 ' HG3' ' A' ' 220' ' ' GLU . 31.4 mm -115.6 -53.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.543 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.602 ' HG3' HG22 ' A' ' 219' ' ' ILE . 41.5 mt-10 -143.55 159.79 41.8 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.42 0.629 . . . . 0.0 111.594 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.4 104.8 16.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.0 t30 65.97 -74.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.801 1.24 . . . . 0.0 110.612 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -147.23 3.4 0.89 Allowed Glycine 0 C--N 1.306 -1.113 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.3 mt -100.38 117.94 46.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.51 131.75 42.11 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.386 0.612 . . . . 0.0 109.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 234' ' ' VAL . 35.3 m -117.17 7.19 7.09 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.204 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.38 3.39 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.706 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 193' ' ' PRO . . . 102.56 -3.09 49.7 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.292 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -87.54 170.04 11.67 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.15 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.486 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 20.9 m -101.39 159.38 15.32 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 234' ' ' VAL . 2.4 pt? -52.9 -45.26 67.48 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.09 -46.48 88.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.584 0.707 . . . . 0.0 110.074 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 237' ' ' MET . 2.0 mp0 -66.1 -37.94 86.99 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.34 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 231' ' ' LEU . 9.8 p -74.8 -45.08 44.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.672 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 14.6 t -68.92 -38.62 79.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.88 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.55 -37.46 87.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.856 0.836 . . . . 0.0 108.8 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 10.9 tmm? -69.16 -49.26 58.38 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.418 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 18.4 ptp -67.29 -22.58 65.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.62 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 235' ' ' THR . 89.7 t -83.12 -33.0 9.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.731 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.11 -35.05 70.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.31 -79.21 0.18 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.731 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.5 t 59.59 -37.31 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.77 1.628 . . . . 0.0 114.871 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.4 p -55.75 -68.52 0.19 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.482 0.713 . . . . 0.0 110.271 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -100.55 80.5 2.22 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.54 103.89 16.05 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.05 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.4 135.77 62.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.441 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.431 HD11 ' CG1' ' A' ' 218' ' ' VAL . 8.0 tp -118.49 134.18 62.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.316 0.579 . . . . 0.0 110.245 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.559 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 25.2 m -103.39 119.62 39.24 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.553 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.488 HG12 HG22 ' A' ' 218' ' ' VAL . 4.3 m -127.73 137.07 58.7 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.454 ' HD2' HG13 ' A' ' 219' ' ' ILE . 96.6 mttt -134.8 143.57 46.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.168 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.649 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 93.2 Cg_exo -45.79 132.3 13.57 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.362 2.708 . . . . 0.0 112.05 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 254' ' ' GLN . . . -66.04 -16.88 64.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 68.47 -31.32 0.19 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.627 1.571 . . . . 0.0 114.33 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 252' ' ' ALA . 54.8 tp60 -85.08 120.89 27.1 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 . . . . . 0 C--N 1.272 -2.8 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.51 -178.776 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.0 m -72.14 141.75 49.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 130' ' ' LYS . 2.9 mptp? -79.39 151.05 31.16 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.065 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.8 m -75.34 114.12 13.51 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.763 0.792 . . . . 0.0 112.192 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -90.69 130.52 36.68 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.405 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.15 132.93 78.82 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.02 118.6 2.45 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.692 2.928 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.2 m -83.52 89.73 7.12 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.853 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -63.66 131.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.678 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m -151.73 102.45 2.85 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.214 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.4 tt -87.89 133.66 37.03 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.58 127.59 22.18 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.008 1.806 . . . . 0.0 110.268 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -98.48 157.35 16.27 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.68 157.18 22.29 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.279 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -134.61 139.58 45.43 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 69.22 98.02 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.98 0.912 . . . . 0.0 110.885 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -73.13 111.02 7.87 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.559 0.695 . . . . 0.0 111.247 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.93 130.49 41.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.338 0.589 . . . . 0.0 111.432 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.8 p -101.42 153.98 19.21 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.701 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.52 104.55 17.04 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.457 0.646 . . . . 0.0 112.169 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.1 mp -109.82 102.06 13.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.7 pt -95.47 116.19 36.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.016 0.912 . . . . 0.0 112.837 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -118.17 -25.95 6.49 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.039 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.1 t -74.86 -39.02 44.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.782 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.02 116.65 7.36 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.506 0.67 . . . . 0.0 111.851 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.4 tt -140.25 161.72 25.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.6 t -94.64 112.93 59.75 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.57 136.42 30.8 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.967 1.778 . . . . 0.0 110.726 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.05 76.15 2.24 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-O 121.608 0.718 . . . . 0.0 111.694 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 41.1 m -83.72 103.85 13.35 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 173.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.401 ' CE1' ' HG3' ' A' ' 250' ' ' LYS . 13.0 m170 -69.06 122.53 18.91 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 121.901 0.858 . . . . 0.0 110.984 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.498 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 4.1 mmp_? -105.27 116.62 32.25 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.786 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -107.88 107.11 17.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.432 ' HB ' ' CG2' ' A' ' 247' ' ' ILE . 38.5 t -89.09 125.65 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.697 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.82 138.41 32.65 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.229 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 3.7 mm? -123.33 129.25 51.07 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.661 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.04 120.02 39.19 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 167' ' ' GLY . 88.4 tttt -65.48 123.89 20.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 122.672 1.225 . . . . 0.0 113.259 -173.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -123.84 29.95 6.34 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 113.013 -1.903 . . . . 0.0 108.677 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 165' ' ' LYS . . . 102.26 -10.34 56.58 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.198 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.2 m 60.95 21.15 11.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.42 0.688 . . . . 0.0 111.705 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.96 -55.34 7.62 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.999 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 171' ' ' PRO . 83.8 tttt -99.4 128.22 32.27 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 21.4 Cg_exo -67.96 156.83 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.062 1.841 . . . . 0.0 110.342 172.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.97 -8.03 54.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.509 0.671 . . . . 0.0 111.137 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.23 0.52 7.47 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.024 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -103.95 144.62 31.29 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.24 136.86 38.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.02 135.93 58.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 79.9 ttt180 -142.07 150.43 41.2 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.151 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 231' ' ' LEU . 20.4 t70 -92.59 134.23 35.2 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.411 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -135.28 166.79 24.36 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 191' ' ' LYS . 1.6 m -92.71 131.36 37.85 Favored 'General case' 0 C--N 1.27 -2.86 0 C-N-CA 117.394 -1.723 . . . . 0.0 107.972 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 25.3 m -100.8 134.8 43.23 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.43 128.62 75.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.979 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.2 mtt180 -117.47 154.37 31.54 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.9 109.94 30.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.574 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 74.7 p -107.03 177.89 4.72 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.12 -20.95 62.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.225 0.536 . . . . 0.0 109.874 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.6 p -86.51 -3.8 59.07 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.434 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.95 -171.55 14.54 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.737 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.6 pt? -84.95 133.75 34.27 Favored 'General case' 0 N--CA 1.4 -2.951 0 O-C-N 122.306 -0.526 . . . . 0.0 110.298 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -132.47 156.72 46.24 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.373 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.562 ' HB3' HG22 ' A' ' 180' ' ' THR . 96.9 mttt -121.36 150.33 41.63 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.84 161.48 62.51 Favored Pre-proline 0 N--CA 1.426 -1.654 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.627 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.55 142.68 85.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.94 89.96 0.15 Allowed Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.586 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 218' ' ' VAL . 12.1 tt -95.97 117.66 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-O 121.77 0.795 . . . . 0.0 109.998 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -132.46 179.16 6.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.283 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 216' ' ' ASP . 44.9 mt -68.7 122.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 26.1 p -96.33 -32.89 12.16 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 120.905 0.383 . . . . 0.0 111.887 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -153.34 148.79 27.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.47 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.9 tt -124.54 136.73 54.22 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 71.3 t -99.57 124.42 44.44 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.12 127.23 24.14 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.477 2.118 . . . . 0.0 111.353 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.42 63.15 Favored Glycine 0 C--N 1.309 -0.953 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.39 161.4 44.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.736 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 205' ' ' LEU . 2.8 tm? -53.35 -39.68 64.34 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.8 0.84 . . . . 0.0 110.862 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 212' ' ' LEU . . . -55.47 -42.14 73.91 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.3 -36.12 54.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.1 m -54.45 -34.74 62.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.435 0.694 . . . . 0.0 112.816 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 73.1 p -60.17 -41.26 92.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 111.557 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 81.83 3.16 90.68 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.533 HD12 ' HG ' ' A' ' 212' ' ' LEU . 2.7 pp -127.96 -2.32 5.86 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.533 ' HG ' HD12 ' A' ' 211' ' ' LEU . 97.2 mt -108.55 130.58 55.29 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.237 0.541 . . . . 0.0 110.305 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.95 164.36 25.51 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 125.318 1.447 . . . . 0.0 109.663 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.0 p -52.49 -20.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.733 0.777 . . . . 0.0 112.435 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -68.79 -25.29 64.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.929 -0.482 . . . . 0.0 111.898 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.8 m-20 -61.3 159.34 12.53 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -114.96 144.87 42.9 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.15 -1.841 . . . . 0.0 110.448 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 195' ' ' ILE . 7.7 p -96.61 140.4 17.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.053 0.454 . . . . 0.0 109.819 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.48 HG22 ' HG3' ' A' ' 220' ' ' GLU . 40.2 mm -110.44 -52.92 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.189 0.519 . . . . 0.0 111.803 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.635 ' H ' ' HB ' ' A' ' 248' ' ' THR . 45.1 mt-10 -134.73 142.74 46.85 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.57 0.7 . . . . 0.0 112.646 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.453 HG21 HG13 ' A' ' 234' ' ' VAL . 57.6 t -115.62 113.5 43.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.213 172.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 70.6 -66.19 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.221 1.008 . . . . 0.0 110.327 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -169.34 12.91 0.05 OUTLIER Glycine 0 C--N 1.292 -1.891 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.538 HG21 ' SD ' ' A' ' 237' ' ' MET . 28.9 mt -105.37 125.49 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -176.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -77.48 141.64 39.57 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 33.6 m -100.91 14.11 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.08 104.01 2.46 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.276 0.56 . . . . 0.0 111.02 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.78 12.32 55.71 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.231 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.582 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 6.0 mmpt? -91.8 152.36 20.17 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 234' ' ' VAL . 38.7 p -86.94 159.46 19.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 178' ' ' ASP . 1.9 pt? -60.26 -38.07 82.38 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.596 0.236 . . . . 0.0 111.288 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.87 -46.5 87.66 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.854 0.861 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.575 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.6 tp-100 -63.48 -51.05 67.23 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.144 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 221' ' ' VAL . 75.0 t -56.93 -49.03 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.468 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 9.9 t -66.86 -38.47 86.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.801 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.92 -46.88 88.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.159 0.504 . . . . 0.0 109.969 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.575 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 40.7 mtm -62.3 -42.94 99.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.066 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.468 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 13.0 ptp -71.1 -18.44 62.53 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.121 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 235' ' ' THR . 84.8 t -89.12 -33.57 6.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.772 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.22 79.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.44 0.638 . . . . 0.0 109.392 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -105.52 23.27 14.08 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.233 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 55.4 p -60.63 -26.44 67.03 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.813 0.445 . . . . 0.0 111.66 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m -51.15 -51.26 55.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.6 1.16 . . . . 0.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -130.15 89.42 2.79 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tm? -96.71 130.04 44.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.721 0.772 . . . . 0.0 110.801 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 245' ' ' LEU . 73.0 mt -127.6 128.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.432 ' CG2' ' HB ' ' A' ' 161' ' ' VAL . 8.1 tp -119.86 126.38 75.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.632 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.635 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 28.4 m -103.99 119.84 39.78 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.745 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 159' ' ' ARG . 19.5 m -120.92 149.31 23.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.367 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 251' ' ' PRO . 10.0 tmtt? -135.8 128.06 17.65 Favored Pre-proline 0 C--N 1.286 -2.168 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.326 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 50.3 Cg_exo -57.69 127.3 24.72 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.627 2.218 . . . . 0.0 113.041 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -106.58 4.1 27.68 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.972 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -83.89 69.04 10.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -119.26 129.48 54.94 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.984 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.502 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 4.6 tpm_? . . . . . 0 C--N 1.294 -1.845 0 CA-C-O 118.316 -0.849 . . . . 0.0 108.855 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.857 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.7 m 64.03 107.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.627 ' HD3' ' H ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -71.35 99.34 1.94 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.676 0.75 . . . . 0.0 111.004 178.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.7 p -79.49 149.91 31.37 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.58 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -105.52 172.59 6.71 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.57 116.46 59.61 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.67 149.19 73.32 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.475 2.117 . . . . 0.0 113.052 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -86.15 91.43 8.43 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.1 pt -64.71 113.21 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.118 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.2 m -90.85 77.73 6.17 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-O 121.955 0.883 . . . . 0.0 109.887 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 10.8 tt -109.65 125.38 31.41 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.911 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 17.6 Cg_exo -66.88 134.12 33.62 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.135 1.89 . . . . 0.0 110.852 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -101.27 139.49 36.88 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.06 135.72 34.74 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -101.83 -64.64 1.04 Allowed 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.484 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -175.77 102.33 0.07 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.03 112.76 10.48 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.2 p -78.2 122.73 33.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.07 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.4 t -101.4 149.72 23.76 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.522 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.16 123.87 51.24 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.055 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.7 tp -62.12 115.84 2.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.145 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.31 136.99 38.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.4 t70 72.63 117.43 0.05 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 125.586 1.554 . . . . 0.0 114.636 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.1 m -145.5 144.37 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.91 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -106.22 142.24 36.24 Favored 'General case' 0 C--N 1.26 -3.304 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 153' ' ' ILE . 2.2 mp -80.92 -81.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.009 0.433 . . . . 0.0 110.412 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.03 102.11 17.7 Favored Pre-proline 0 C--N 1.295 -1.799 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.059 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.26 142.31 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.057 1.838 . . . . 0.0 110.666 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.5 82.15 5.66 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 121.339 0.59 . . . . 0.0 110.285 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.3 p -85.05 108.87 17.84 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -82.3 99.22 9.21 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -96.5 131.94 42.59 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.029 -163.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.509 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 22.1 ptt180 -105.14 112.74 25.97 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.16 133.41 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.865 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.655 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -98.44 134.8 40.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.627 0.727 . . . . 0.0 112.659 -176.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 45.0 tp -98.53 122.4 41.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.024 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.75 100.68 9.39 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-O 122.106 0.955 . . . . 0.0 112.21 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 64.2 pttt -74.61 147.31 41.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.376 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -100.62 20.5 14.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.49 -11.35 59.01 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.9 t -162.16 131.36 4.39 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 71.23 108.06 0.06 Allowed 'General case' 0 C--O 1.248 1.006 0 O-C-N 124.442 1.089 . . . . 0.0 112.014 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 165' ' ' LYS . 3.5 mppt? -90.62 121.96 67.65 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -81.21 70.0 7.64 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.964 1.776 . . . . 0.0 112.55 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -69.92 112.99 6.72 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.393 0.616 . . . . 0.0 110.992 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.443 ' HA2' ' CG1' ' A' ' 201' ' ' VAL . . . -104.93 33.78 6.3 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -158.85 145.25 16.96 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -137.11 135.81 37.75 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -135.37 139.6 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -141.88 158.65 43.53 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.142 0.577 . . . . 0.0 112.185 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.572 ' H ' HD23 ' A' ' 231' ' ' LEU . 13.0 t70 -74.5 139.41 43.83 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.173 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.05 179.23 36.64 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 m -99.44 141.59 32.03 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.739 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 43.4 t -112.46 146.82 37.74 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.002 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.04 123.86 71.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 97.9 mtt180 -123.5 160.64 26.53 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.35 106.45 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 43.7 p -111.1 179.61 3.99 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.0 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.27 -18.16 65.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.0 m -92.06 4.97 51.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.589 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.26 -152.54 19.26 Favored Glycine 0 C--O 1.212 -1.274 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.5 pt? -85.88 121.26 28.27 Favored 'General case' 0 N--CA 1.395 -3.199 0 CA-C-N 117.34 0.57 . . . . 0.0 110.034 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.03 159.98 35.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.846 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 181' ' ' SER . 68.1 mttm -106.93 143.76 34.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.648 0.592 . . . . 0.0 109.722 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -136.31 154.09 76.88 Favored Pre-proline 0 N--CA 1.426 -1.626 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.09 129.44 6.87 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.047 1.832 . . . . 0.0 109.397 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.63 -177.82 24.9 Favored Glycine 0 C--N 1.287 -2.157 0 C-N-CA 120.611 -0.805 . . . . 0.0 111.718 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.498 HG23 ' HB ' ' A' ' 218' ' ' VAL . 12.0 tt -129.48 122.24 55.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -114.48 173.15 6.61 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.087 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.4 126.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.3 t -89.53 -45.58 9.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.753 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -146.62 153.65 40.57 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 206' ' ' ALA . 49.1 tp -127.73 137.78 52.57 Favored 'General case' 0 N--CA 1.407 -2.601 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.443 ' CG1' ' HA2' ' A' ' 173' ' ' GLY . 8.2 p -103.47 137.3 19.21 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.84 126.45 18.14 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.765 1.643 . . . . 0.0 108.913 172.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.64 1.33 66.05 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.16 162.75 40.72 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.507 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.1 mm? -63.99 -36.32 83.59 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 112.144 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 200' ' ' LEU . . . -76.6 -27.9 55.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.611 0.719 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.41 -37.65 56.79 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.29 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.3 m -57.9 -33.63 68.96 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 120.773 0.321 . . . . 0.0 111.568 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 211' ' ' LEU . 4.3 m -68.06 -39.98 82.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.79 -33.6 2.36 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.25 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.401 ' H ' ' C ' ' A' ' 209' ' ' THR . 27.1 mt -77.84 -8.1 57.58 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.647 ' HA ' ' OD2' ' A' ' 216' ' ' ASP . 82.7 mt -108.63 127.85 54.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.964 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.53 163.85 25.06 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.65 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -54.41 -26.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 C-N-CA 123.502 0.721 . . . . 0.0 112.123 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.08 -23.64 64.04 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.647 ' OD2' ' HA ' ' A' ' 212' ' ' LEU . 34.7 m-20 -66.73 166.01 13.92 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.135 0.574 . . . . 0.0 112.077 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.539 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -134.0 169.56 16.94 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.498 ' HB ' HG23 ' A' ' 195' ' ' ILE . 87.7 t -89.47 136.45 23.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.279 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 250' ' ' LYS . 31.2 mt -96.68 -58.76 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.566 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.8 mt-10 -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.895 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.462 HG21 HG13 ' A' ' 234' ' ' VAL . 75.5 t -114.7 110.26 31.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.36 -77.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.752 0.821 . . . . 0.0 110.366 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -151.88 10.39 0.67 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.506 HG21 ' SD ' ' A' ' 237' ' ' MET . 3.0 mp -107.58 133.14 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.18 158.57 27.65 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.0 m -116.37 6.91 7.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.321 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -57.59 109.07 0.64 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.769 0.668 . . . . 0.0 111.554 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.99 5.37 47.23 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.53 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 233' ' ' GLN . 35.9 mtmm -110.53 174.99 5.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 234' ' ' VAL . 31.8 m -118.69 163.42 16.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.691 -1.595 . . . . 0.0 108.866 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 232' ' ' ASP . 2.7 pp -50.53 -41.5 53.92 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 231' ' ' LEU . 29.6 t70 -61.3 -51.03 70.58 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.267 0.556 . . . . 0.0 110.482 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 237' ' ' MET . 48.1 mt-30 -58.53 -45.12 89.52 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.774 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 230' ' ' THR . 71.5 t -66.59 -49.07 78.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 45.5 p -59.63 -37.11 77.76 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.3 -44.13 97.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.066 0.46 . . . . 0.0 109.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.7 mtm -64.11 -49.62 71.5 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.546 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.507 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 24.0 ptm -67.88 -23.44 65.13 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.325 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 235' ' ' THR . 60.7 t -79.41 -30.93 14.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.499 0.666 . . . . 0.0 109.933 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.77 -15.04 57.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -132.56 27.44 4.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 37.0 t -65.95 -18.68 65.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -172.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.2 t -52.08 -64.46 0.81 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 90.76 3.3 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 3.4 tm? -91.18 126.88 36.4 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.509 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.1 mp -110.82 119.04 58.67 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.77 139.01 34.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.566 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.2 m -108.51 120.11 41.46 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.111 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.7 m -122.67 157.5 27.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 120.733 0.302 . . . . 0.0 110.915 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.531 ' HB3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -130.09 124.92 21.71 Favored Pre-proline 0 N--CA 1.432 -1.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.112 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.1 Cg_endo -65.36 134.12 37.58 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.821 2.347 . . . . 0.0 113.329 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.71 4.68 43.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 75.16 83.74 0.1 Allowed 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 113.386 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -120.68 148.09 44.4 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.551 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 . . . . . 0 C--N 1.298 -1.644 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.196 -179.844 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 m -89.89 -38.25 13.84 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.754 0.312 . . . . 0.0 110.311 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -153.95 -76.86 0.11 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.193 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.4 m -100.57 130.27 46.61 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.073 0.463 . . . . 0.0 110.357 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -83.94 98.7 9.93 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.89 136.25 24.78 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.63 123.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.457 2.105 . . . . 0.0 112.032 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.0 t -89.93 89.85 7.91 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.2 mt -91.1 161.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.7 t -162.05 170.79 18.62 Favored 'General case' 0 N--CA 1.38 -3.934 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.6 120.84 69.56 Favored Pre-proline 0 C--N 1.257 -3.454 0 CA-C-O 120.988 0.423 . . . . 0.0 110.367 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -72.7 131.08 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.646 2.231 . . . . 0.0 111.654 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -101.15 113.9 27.37 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.531 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 143' ' ' ARG . 13.8 t70 -84.41 157.69 21.32 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 144' ' ' GLN . 69.0 t80 -48.93 -46.88 43.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 141' ' ' ASP . 37.9 ptt180 40.89 24.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 127.204 2.202 . . . . 0.0 116.103 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 53.4 tt0 -84.04 144.61 28.98 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.9 m -73.18 136.13 26.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.426 0.632 . . . . 0.0 111.401 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.3 p -80.66 128.13 33.27 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.988 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.76 121.52 40.81 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.2 tp -76.12 87.94 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 122.05 0.928 . . . . 0.0 111.558 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.48 142.26 18.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.96 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -130.17 164.58 24.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -75.08 -37.88 41.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.413 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -106.43 110.65 22.93 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 122.007 -0.433 . . . . 0.0 110.339 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tp -133.28 95.99 2.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.675 0.75 . . . . 0.0 111.808 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.66 116.21 19.49 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.52 131.22 9.32 Favored 'Trans proline' 0 C--O 1.253 1.255 0 C-N-CA 121.629 1.552 . . . . 0.0 110.949 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -72.82 91.84 1.54 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -83.16 97.69 8.95 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.852 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -81.57 99.28 8.74 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.522 ' HB3' HD11 ' A' ' 212' ' ' LEU . 26.7 tpt180 -109.87 136.07 49.75 Favored 'General case' 0 C--N 1.257 -3.423 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.932 -165.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 4.6 ptp180 -114.44 116.79 29.44 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.904 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.97 129.88 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -109.59 133.25 53.32 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.754 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 245' ' ' LEU . 4.0 mm? -110.45 120.46 42.5 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.718 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -115.12 110.23 19.22 Favored 'General case' 0 N--CA 1.404 -2.774 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -72.59 121.22 19.36 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.935 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -126.9 124.75 40.26 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.84 16.29 77.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.239 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m 63.36 26.6 15.05 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 109.796 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -111.82 95.14 5.31 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -81.91 111.73 29.15 Favored Pre-proline 0 C--N 1.268 -2.967 0 CA-C-N 113.32 -1.764 . . . . 0.0 109.551 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -73.79 -36.54 3.57 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.316 2.011 . . . . 0.0 111.123 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 35.9 tp 63.62 -91.31 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.455 1.102 . . . . 0.0 110.35 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 79.19 19.61 71.73 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.296 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -161.33 149.17 15.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -136.96 135.79 38.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -141.08 142.13 30.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.935 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.452 HH11 HD12 ' A' ' 231' ' ' LEU . 36.7 mmt180 -138.21 158.35 44.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.05 138.31 31.7 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.327 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -129.77 152.61 19.68 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -93.08 129.92 38.88 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 117.691 0.746 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -129.67 137.26 50.53 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.7 123.96 67.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.316 0.579 . . . . 0.0 110.203 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.15 160.38 18.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.045 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -103.3 113.23 39.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.234 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.3 p -110.23 178.62 4.34 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.794 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.95 -14.35 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.321 0.581 . . . . 0.0 109.752 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.0 m -89.27 -4.99 57.95 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 109.53 -161.07 13.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.8 pt? -84.14 124.5 31.21 Favored 'General case' 0 N--CA 1.396 -3.139 0 CA-C-N 117.877 0.839 . . . . 0.0 110.921 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -126.63 150.57 48.85 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.721 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -113.89 134.77 54.6 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.427 0.632 . . . . 0.0 110.125 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 24.6 mp0 -130.03 149.56 73.52 Favored Pre-proline 0 C--N 1.265 -3.07 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.631 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 3.3 Cg_exo -84.64 121.8 2.6 Favored 'Trans proline' 0 N--CA 1.429 -2.31 0 C-N-CA 122.084 1.856 . . . . 0.0 110.369 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -114.03 131.23 9.78 Favored Glycine 0 C--N 1.275 -2.845 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 66.2 mt -96.51 118.58 43.17 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -119.67 160.03 23.31 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 123.109 0.256 . . . . 0.0 110.984 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 67.8 mt -68.47 119.36 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.7 m -91.1 -35.21 14.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.053 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -150.82 140.05 21.24 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.486 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 47.4 tp -128.2 134.7 49.07 Favored 'General case' 0 N--CA 1.383 -3.824 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.896 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.36 128.26 25.74 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 51.3 Cg_exo -58.66 128.5 28.42 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.538 2.159 . . . . 0.0 109.783 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.49 -10.87 61.35 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 155.11 34.61 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -27.99 69.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.486 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -73.94 -33.9 64.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.732 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.6 tm-20 -76.53 -37.59 56.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.2 t -54.08 -31.79 52.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.951 1.3 . . . . 0.0 112.137 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 79.4 p -59.55 -41.6 90.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.845 0.355 . . . . 0.0 111.434 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.24 -25.56 4.84 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.394 -0.367 . . . . 0.0 113.293 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.3 -18.56 26.72 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.338 0.59 . . . . 0.0 110.184 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 159' ' ' ARG . 35.7 mt -113.28 145.6 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.758 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.71 163.23 26.6 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.376 1.07 . . . . 0.0 110.627 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.593 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 47.0 t -48.28 -35.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.316 1.046 . . . . 0.0 113.627 -176.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.67 -25.12 67.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.55 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.2 m-20 -62.42 159.63 15.09 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -114.74 165.3 12.96 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 195' ' ' ILE . 93.4 t -95.19 142.52 13.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 124.694 1.197 . . . . 0.0 110.805 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 250' ' ' LYS . 35.8 mt -109.71 -59.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.049 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.612 ' H ' ' HB ' ' A' ' 248' ' ' THR . 50.1 mt-10 -135.98 159.11 42.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.564 -173.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.1 t -122.42 118.83 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.974 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.5 t-20 70.28 -62.85 0.42 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.467 1.107 . . . . 0.0 110.739 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 178.77 24.64 0.04 OUTLIER Glycine 0 C--N 1.281 -2.487 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.33 133.27 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.71 141.87 48.2 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.914 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -117.66 20.17 6.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.718 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.67 129.88 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.692 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.06 1.91 59.48 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 233' ' ' GLN . 28.7 mmmt -99.08 153.67 18.7 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.331 0.652 . . . . 0.0 109.933 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 234' ' ' VAL . 17.2 m -101.91 161.35 13.73 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 230' ' ' THR . 1.7 pt? -49.43 -46.28 47.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.19 -38.86 78.88 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.823 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.564 ' HB3' ' HE3' ' A' ' 229' ' ' LYS . 47.5 mt-30 -58.12 -44.88 87.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.086 175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 230' ' ' THR . 61.7 t -66.66 -43.89 90.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 O-C-N 123.494 0.496 . . . . 0.0 111.122 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.4 p -70.35 -34.67 72.91 Favored 'General case' 0 C--O 1.206 -1.218 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.42 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.1 -41.2 99.33 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.019 0.914 . . . . 0.0 109.485 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.504 ' HB3' ' O ' ' A' ' 234' ' ' VAL . 8.5 tpt -56.78 -48.66 77.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.96 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.459 ' HB2' ' CD2' ' A' ' 245' ' ' LEU . 22.2 ptm -76.11 -17.97 59.37 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.913 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 235' ' ' THR . 70.0 t -88.7 -25.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.42 0.629 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.83 -20.78 16.55 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.628 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -121.13 -69.43 0.84 Allowed 'General case' 0 N--CA 1.389 -3.516 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.767 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 32.2 t 61.04 -39.76 0.11 Allowed 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.7 m -58.36 -39.77 80.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.811 0.844 . . . . 0.0 110.276 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -129.24 90.37 3.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 238' ' ' MET . 3.2 tm? -99.88 124.35 45.1 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.315 0.579 . . . . 0.0 110.088 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 60.7 mt -127.24 123.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.8 tp -109.42 122.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.727 0.775 . . . . 0.0 108.97 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.612 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 11.6 m -106.29 127.23 53.09 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.641 -175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 212' ' ' LEU . 18.5 m -129.29 162.91 35.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.267 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.469 ' HB2' HD11 ' A' ' 219' ' ' ILE . 26.4 ttmt -130.45 136.58 29.19 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 124.759 1.224 . . . . 0.0 108.307 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 27.6 Cg_exo -65.03 127.4 18.39 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.494 1.463 . . . . 0.0 110.569 173.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -85.34 -27.55 25.8 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.223 0.535 . . . . 0.0 109.83 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.8 m120 61.0 27.74 17.6 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.945 -1.48 . . . . 0.0 111.836 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -98.79 31.65 2.87 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.674 0.75 . . . . 0.0 110.987 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 . . . . . 0 C--N 1.281 -2.37 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.43 179.17 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.0 t -136.26 143.41 44.24 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -132.85 138.58 47.09 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.958 0.409 . . . . 0.0 110.155 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -108.1 121.65 45.27 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -154.27 149.56 27.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 120.908 0.385 . . . . 0.0 110.964 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.55 106.46 32.46 Favored Pre-proline 0 N--CA 1.43 -1.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.387 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.1 -39.74 88.67 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.74 2.293 . . . . 0.0 109.862 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.4 p -147.0 112.97 5.77 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.96 119.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.537 1.16 . . . . 0.0 113.044 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 96.28 3.97 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.779 -2.01 . . . . 0.0 107.576 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.439 HD12 ' HD2' ' A' ' 139' ' ' PRO . 8.6 tp -95.31 133.69 25.61 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.197 -175.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 138' ' ' ILE . 33.6 Cg_exo -63.06 126.88 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.933 1.755 . . . . 0.0 110.293 176.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -82.88 164.15 20.68 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.857 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.89 121.73 25.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.437 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -152.8 -55.53 0.12 Allowed 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.651 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -97.43 71.62 2.34 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 122.509 1.147 . . . . 0.0 109.595 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -64.64 118.81 9.42 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.982 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.7 m -81.19 152.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.563 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.1 t -97.94 137.97 35.98 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.18 104.35 11.6 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.306 0.574 . . . . 0.0 110.832 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.5 tt -82.88 133.06 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.247 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.39 141.76 15.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.2 t70 72.07 94.72 0.07 Allowed 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 124.451 1.1 . . . . 0.0 112.018 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 68.0 t -132.2 -39.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.479 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -73.53 108.5 6.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.023 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 tp -154.07 136.88 7.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.64 101.47 48.4 Favored Pre-proline 0 C--N 1.294 -1.846 0 CA-C-O 121.311 0.577 . . . . 0.0 110.742 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.2 150.83 23.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.586 2.191 . . . . 0.0 111.453 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB3' ' CE1' ' A' ' 158' ' ' HIS . 41.4 mt-10 -75.34 84.37 2.48 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 120.967 0.413 . . . . 0.0 112.092 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -91.88 100.5 13.17 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 78.5 m80 -75.26 112.48 11.59 Favored 'General case' 0 CA--C 1.47 -2.108 0 CA-C-O 121.782 0.801 . . . . 0.0 109.292 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.466 ' HG3' HG21 ' A' ' 209' ' ' THR . 1.7 tmt_? -110.53 135.16 51.62 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.106 -1.407 . . . . 0.0 107.578 -170.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 85.2 mtm180 -114.3 140.95 48.2 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.037 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.87 132.11 57.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 163' ' ' LEU . 6.6 mpt_? -105.9 138.72 41.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.072 0.463 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 8.2 mp -126.77 124.69 40.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.89 0.876 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.48 107.74 18.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 122.064 0.935 . . . . 0.0 113.022 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.469 ' HD2' ' OG ' ' A' ' 242' ' ' SER . 88.5 tttt -78.23 142.87 37.59 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.288 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -106.24 26.44 9.8 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.323 0.582 . . . . 0.0 110.414 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 165' ' ' LYS . . . 96.95 -11.54 65.98 Favored Glycine 0 CA--C 1.498 -0.974 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -164.08 146.68 9.28 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 125.624 1.57 . . . . 0.0 106.868 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.256 6.8 m-20 49.69 96.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 175.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -84.25 127.06 67.91 Favored Pre-proline 0 C--N 1.299 -1.616 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.065 174.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.408 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 26.1 Cg_endo -62.06 102.83 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.835 2.357 . . . . 0.0 112.614 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.61 144.25 28.91 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.824 0.821 . . . . 0.0 112.459 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.6 38.19 1.53 Allowed Glycine 0 C--N 1.286 -2.238 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.406 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -158.58 151.89 22.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.424 ' HB2' ' HB2' ' A' ' 199' ' ' ARG . 97.7 m-85 -137.0 135.14 37.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.9 pt -137.49 148.64 25.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.517 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.47 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 13.2 ptm180 -142.56 158.5 43.61 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.22 145.47 30.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 0.0 109.727 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.85 -172.5 13.48 Favored Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 191' ' ' LYS . 6.5 m -126.54 142.93 51.37 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 117.836 0.818 . . . . 0.0 109.003 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.0 m -114.9 131.32 56.91 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.7 122.46 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -121.85 155.16 35.97 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.279 0.561 . . . . 0.0 110.504 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 120.47 54.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.639 -174.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.3 p -115.73 177.66 4.59 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.05 -2.9 49.99 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.707 0.765 . . . . 0.0 109.317 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.4 m -97.34 -4.37 38.67 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.82 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.73 -156.25 15.74 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.49 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 189' ' ' LEU . 2.0 mm? -88.96 135.32 33.61 Favored 'General case' 0 N--CA 1.403 -2.819 0 C-N-CA 122.747 0.419 . . . . 0.0 109.979 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.28 150.13 46.37 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.832 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.476 ' HB3' ' CG2' ' A' ' 180' ' ' THR . 50.9 mtmt -108.14 142.76 37.86 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.998 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 13.9 pt20 -134.76 141.98 40.7 Favored Pre-proline 0 N--CA 1.413 -2.319 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.666 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.8 Cg_exo -74.46 129.05 12.45 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 110.895 177.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.32 137.41 8.55 Favored Glycine 0 C--N 1.287 -2.172 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.421 HD12 ' HB ' ' A' ' 226' ' ' VAL . 57.3 mt -97.41 125.32 50.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 89.8 m-85 -118.63 167.01 12.04 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.945 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.53 136.51 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 30.5 p -117.05 -44.07 2.82 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.978 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.424 ' HB2' ' HB2' ' A' ' 175' ' ' TYR . 98.8 mtt180 -137.63 145.17 42.41 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 206' ' ' ALA . 4.8 mt -127.74 137.69 52.52 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.829 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.67 130.1 27.39 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -59.94 126.77 21.24 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.763 1.642 . . . . 0.0 110.079 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 90.74 -7.66 80.95 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.779 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.2 160.94 52.46 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.6 mm? -56.66 -45.09 81.85 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.775 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -70.71 -28.94 65.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.325 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.56 ' HB2' HD22 ' A' ' 200' ' ' LEU . 8.7 tp10 -76.37 -42.46 44.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.516 0.675 . . . . 0.0 109.209 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 39.7 t -60.56 -33.3 72.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.812 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.474 HG22 ' HG ' ' A' ' 211' ' ' LEU . 29.1 m -62.61 -41.5 99.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.112 0.482 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.86 -45.85 3.58 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 121.171 -0.538 . . . . 0.0 114.372 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.482 HD12 HD22 ' A' ' 212' ' ' LEU . 4.3 pp -74.39 -4.25 35.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 211' ' ' LEU . 2.7 mm? -109.68 143.97 38.7 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -128.87 163.06 26.07 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 124.311 1.044 . . . . 0.0 109.204 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.71 -21.3 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 123.82 0.848 . . . . 0.0 112.99 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 254' ' ' GLN . 41.3 t30 -71.87 -29.24 64.16 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.059 0.544 . . . . 0.0 111.559 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.689 ' HB3' ' O ' ' A' ' 250' ' ' LYS . 74.5 m-20 -68.03 163.09 23.1 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -169.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 0.5 OUTLIER -116.37 167.06 11.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.243 -0.983 . . . . 0.0 113.231 -173.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 61.0 t -98.88 142.12 15.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.465 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.17 -46.98 6.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.949 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.449 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.6 mt-10 -136.15 154.3 51.01 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 121.57 0.7 . . . . 0.0 112.085 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 238' ' ' MET . 59.5 t -118.52 101.79 12.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 113.534 -1.666 . . . . 0.0 106.509 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.589 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 61.0 t30 71.23 -68.36 0.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.56 1.544 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.05 8.25 0.32 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.418 HG21 ' SD ' ' A' ' 237' ' ' MET . 29.2 mt -107.27 118.2 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 46.9 mt-10 -74.04 142.16 45.72 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.72 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.421 ' HB ' HD12 ' A' ' 195' ' ' ILE . 29.0 m -95.08 18.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.49 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.08 109.46 2.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.08 0.466 . . . . 0.0 110.325 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.59 61.95 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.637 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -84.42 169.16 14.85 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 85.3 m -121.29 158.73 27.51 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.37 -1.741 . . . . 0.0 106.696 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 234' ' ' VAL . 57.8 tp -67.1 -46.82 73.07 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.984 0.811 . . . . 0.0 111.894 -177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.06 -37.96 75.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.13 0.49 . . . . 0.0 111.251 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.5 mp0 -74.42 -44.52 51.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 231' ' ' LEU . 8.9 p -66.25 -38.47 81.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.689 0.28 . . . . 0.0 110.833 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.539 ' HA ' ' SD ' ' A' ' 238' ' ' MET . 10.8 t -66.12 -32.13 73.4 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.91 -43.5 83.19 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 22.7 mtm -62.4 -43.78 98.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.193 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptm -75.58 -13.89 60.37 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.828 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 242' ' ' SER . 66.0 t -87.78 -37.25 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 109.829 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.88 69.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.492 0.663 . . . . 0.0 110.281 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -108.66 21.25 17.51 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.423 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 239' ' ' VAL . 36.9 t -67.05 -24.5 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 31.7 m -52.12 -51.63 56.63 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.559 0.537 . . . . 0.0 110.59 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -128.75 87.98 2.66 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.3 tm? -93.43 131.36 38.7 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.969 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 71.1 mt -127.43 139.48 51.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 9.3 tt -129.62 134.53 63.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.144 174.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 39.4 m -102.31 120.63 40.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.213 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.35 155.25 15.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 36.2 tttm -138.34 140.29 27.88 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.422 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 36.6 Cg_endo -68.75 127.46 15.44 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 121.626 1.55 . . . . 0.0 110.157 172.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -4.67 58.65 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 122.596 0.358 . . . . 0.0 111.454 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 253' ' ' ASN . 0.7 OUTLIER 66.35 102.35 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.595 ' HA ' ' ND2' ' A' ' 215' ' ' ASN . 19.4 tm0? -61.9 109.03 1.13 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.733 1.254 . . . . 0.0 112.483 -172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 . . . . . 0 C--N 1.281 -2.386 0 CA-C-N 112.212 -2.267 . . . . 0.0 105.953 179.486 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.705 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.0 t -154.09 116.21 4.29 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -104.05 118.45 36.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -77.01 137.16 38.82 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.625 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -105.33 92.0 4.02 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.728 0.775 . . . . 0.0 109.854 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.27 110.23 37.94 Favored Pre-proline 0 C--N 1.301 -1.513 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.632 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.79 111.92 2.94 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.161 1.907 . . . . 0.0 108.962 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.8 p -101.9 103.27 13.94 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 121.54 0.686 . . . . 0.0 112.566 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 62.2 mt 68.15 147.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.822 1.649 . . . . 0.0 112.23 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -156.33 91.37 1.25 Allowed 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.5 tt -120.68 103.98 42.9 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-O 121.539 0.685 . . . . 0.0 112.599 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -84.47 137.84 7.11 Favored 'Trans proline' 0 N--CA 1.429 -2.283 0 C-N-CA 121.667 1.578 . . . . 0.0 109.711 174.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -82.48 114.39 20.87 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.88 124.4 34.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -170.87 96.46 0.21 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -138.37 85.87 2.12 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -82.0 110.2 17.03 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.041 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.5 m -73.74 125.02 32.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.215 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.1 m -74.94 113.97 12.86 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.11 108.47 18.18 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.435 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.08 97.56 5.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.0 pt -85.15 115.97 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.814 0.816 . . . . 0.0 110.31 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -112.61 100.13 8.49 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-O 122.273 1.035 . . . . 0.0 110.589 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.03 -45.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.158 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 153' ' ' ILE . 26.6 t70 -77.96 130.82 37.01 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.259 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.495 HG12 ' H ' ' A' ' 154' ' ' VAL . 12.2 tt 56.74 170.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 126.969 2.107 . . . . 0.0 112.274 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.495 ' H ' HG12 ' A' ' 153' ' ' ILE . 6.7 p -101.98 105.62 43.04 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.668 -0.645 . . . . 0.0 109.382 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.15 150.25 29.15 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.114 1.876 . . . . 0.0 110.04 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.51 69.07 6.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.327 0.584 . . . . 0.0 112.506 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.2 t -91.33 128.39 37.14 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.441 ' CE1' ' HG2' ' A' ' 250' ' ' LYS . 30.3 m170 -99.74 128.27 45.85 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.23 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -96.76 120.81 37.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.914 -169.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -106.33 107.84 19.05 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.23 132.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -108.88 149.08 29.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.92 130.37 43.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.401 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.85 111.61 18.18 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 121.591 0.71 . . . . 0.0 111.203 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -68.25 146.72 53.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.619 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -121.41 76.85 1.28 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.46 -2.67 84.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.522 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.4 t 58.63 72.77 0.51 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.56 1.144 . . . . 0.0 110.3 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -103.92 -49.77 3.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.97 150.24 47.25 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.562 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 -162.93 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 110.992 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.442 HD23 ' CZ ' ' A' ' 174' ' ' PHE . 4.9 mp -92.94 144.32 25.38 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -89.9 25.47 11.73 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.61 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.442 ' CZ ' HD23 ' A' ' 172' ' ' LEU . 41.9 p90 -158.7 147.32 18.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -132.31 142.83 49.5 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.468 HG21 HG11 ' A' ' 218' ' ' VAL . 29.2 pt -133.16 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.327 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.561 ' HG2' ' N ' ' A' ' 178' ' ' ASP . 78.1 ttt180 -141.23 159.87 41.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.561 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 7.7 p-10 -72.99 157.71 36.88 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.878 0.847 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.32 149.91 18.01 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -93.86 140.76 29.29 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -131.23 134.22 46.23 Favored 'General case' 0 C--N 1.261 -3.279 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.84 123.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.95 107.69 21.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.3 p -115.18 177.72 4.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.14 59.92 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.448 0.642 . . . . 0.0 109.416 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.1 m -89.51 -4.42 57.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.528 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.64 -154.48 16.86 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 189' ' ' LEU . 2.1 pt? -84.35 118.35 24.17 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-O 122.001 0.905 . . . . 0.0 109.962 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -120.89 144.88 48.18 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.059 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -101.42 143.87 30.91 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -133.08 144.2 51.68 Favored Pre-proline 0 C--N 1.281 -2.412 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.266 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.12 128.62 5.03 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 C-N-CA 122.519 2.146 . . . . 0.0 109.298 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 178' ' ' ASP . . . -140.31 163.06 26.45 Favored Glycine 0 C--N 1.277 -2.725 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.797 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 218' ' ' VAL . 63.0 mt -116.89 119.64 62.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 56.6 m-85 -118.95 167.04 12.11 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.998 -175.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.0 122.73 18.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.514 ' C ' ' HD2' ' A' ' 199' ' ' ARG . 76.6 p -96.04 -67.36 0.85 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.867 0.365 . . . . 0.0 111.494 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.514 ' HD2' ' C ' ' A' ' 198' ' ' SER . 7.2 mpt_? -124.88 154.19 41.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 122.938 0.495 . . . . 0.0 110.351 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.74 139.44 52.68 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.966 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -99.25 126.86 36.37 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.87 126.44 20.43 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.108 1.872 . . . . 0.0 109.946 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.9 -6.86 54.66 Favored Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.26 151.46 34.86 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.65 -29.9 70.37 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.19 70.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.224 0.535 . . . . 0.0 110.568 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -77.34 -43.47 32.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 m -55.24 -33.61 63.27 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.613 ' OG1' ' HG ' ' A' ' 211' ' ' LEU . 5.2 t -69.61 -44.92 69.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.744 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 -12.75 4.52 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.469 -0.872 . . . . 0.0 114.39 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.613 ' HG ' ' OG1' ' A' ' 209' ' ' THR . 3.8 pp -89.67 -3.93 58.0 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 118.836 1.318 . . . . 0.0 111.494 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.494 ' HG ' HD12 ' A' ' 211' ' ' LEU . 88.5 mt -109.54 146.11 35.19 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.617 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.69 162.68 16.92 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 123.671 0.788 . . . . 0.0 110.533 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.16 -16.82 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-O 122.454 1.121 . . . . 0.0 110.425 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -75.52 -23.67 56.71 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.301 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.581 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.8 m-20 -63.75 156.43 27.17 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -171.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.501 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 31.1 mt-10 -109.51 150.84 27.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.929 -170.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.506 HG23 HG21 ' A' ' 226' ' ' VAL . 23.2 m -98.58 143.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.453 HG22 ' HG3' ' A' ' 220' ' ' GLU . 43.1 mt -109.33 -56.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.586 ' H ' ' HB ' ' A' ' 248' ' ' THR . 47.4 mt-10 -130.27 149.86 51.77 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.633 -172.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 238' ' ' MET . 67.5 t -116.02 112.48 39.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 67.73 -70.14 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.26 1.024 . . . . 0.0 110.014 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.84 11.09 0.1 OUTLIER Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.53 135.78 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.25 159.18 29.83 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.287 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.506 HG21 HG23 ' A' ' 218' ' ' VAL . 20.6 m -102.95 3.63 10.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.867 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -55.21 108.9 0.46 Allowed 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.993 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.49 90.53 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.465 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -87.17 160.12 18.62 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.8 m -81.55 158.28 24.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.537 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 178' ' ' ASP . 4.1 mp -70.55 -41.39 72.53 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 118.425 0.557 . . . . 0.0 109.98 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.73 -39.26 73.62 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.378 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 237' ' ' MET . 21.1 tp60 -67.74 -47.16 70.08 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.294 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.407 ' HA ' ' HE2' ' A' ' 237' ' ' MET . 97.2 t -67.29 -45.42 86.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.048 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.485 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 8.8 t -64.59 -29.11 70.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.14 -48.91 77.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.292 0.567 . . . . 0.0 109.478 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 29.4 mtm -62.67 -40.18 96.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.129 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.513 ' HB3' HG11 ' A' ' 221' ' ' VAL . 15.4 ptm -76.24 -20.27 57.57 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.681 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 79.8 t -91.7 -36.8 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.352 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.42 69.94 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -109.23 23.24 14.79 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.323 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.681 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 63.7 m -64.97 -18.82 65.6 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -67.52 -39.66 85.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -129.45 79.66 1.92 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 3.3 tm? -99.41 129.59 45.61 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.535 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.06 132.28 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 6.9 tp -118.24 120.8 65.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.029 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.586 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 22.3 m -92.35 119.32 31.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.359 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.428 HG12 HG12 ' A' ' 218' ' ' VAL . 3.1 m -120.45 139.43 47.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.802 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 158' ' ' HIS . 0.4 OUTLIER -126.65 123.46 23.91 Favored Pre-proline 0 N--CA 1.413 -2.305 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.092 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.581 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 31.6 Cg_exo -58.25 133.72 57.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.866 2.377 . . . . 0.0 113.515 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -94.92 3.1 55.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -90.58 81.1 5.92 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -131.73 135.23 46.67 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.002 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 119.15 -0.453 . . . . 0.0 110.097 -177.226 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.827 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.1 p -164.0 161.93 22.94 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 122.24 0.216 . . . . 0.0 110.84 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.521 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -161.79 132.98 5.25 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.511 0.725 . . . . 0.0 110.994 175.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 28.5 m -102.06 122.65 44.51 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -134.23 152.58 51.89 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.89 117.52 66.33 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.42 -34.86 75.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.343 2.028 . . . . 0.0 110.61 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.7 t -121.06 108.02 13.32 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.72 154.36 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.1 t -91.83 83.45 5.25 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.58 112.61 32.43 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.449 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.74 133.05 45.86 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.306 2.004 . . . . 0.0 110.733 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -100.17 114.54 28.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.31 153.4 18.56 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.786 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 69.1 t80 -92.68 79.74 4.79 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -116.43 20.31 14.24 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.275 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 142' ' ' PHE . 2.0 mp0 -65.6 162.51 18.12 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.345 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.28 116.52 13.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 122.385 1.088 . . . . 0.0 110.969 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -89.99 153.86 20.27 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.962 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.92 116.54 31.38 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tp -79.3 123.61 36.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.905 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.2 tp -91.17 138.08 20.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.516 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.95 121.65 0.03 OUTLIER 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.932 1.293 . . . . 0.0 113.88 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.37 136.39 36.59 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.34 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.589 ' O ' HG22 ' A' ' 153' ' ' ILE . 22.4 t70 -85.35 138.66 32.14 Favored 'General case' 0 C--N 1.258 -3.408 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 152' ' ' ASP . 9.7 tt 63.93 165.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 126.381 1.872 . . . . 0.0 109.114 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.7 t -96.87 104.79 19.85 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.349 -0.844 . . . . 0.0 108.921 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 30.7 Cg_exo -62.79 151.44 83.99 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 122.769 2.313 . . . . 0.0 109.232 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.54 80.35 0.1 Allowed 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 121.936 0.874 . . . . 0.0 113.322 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.1 m -92.96 85.11 5.03 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -98.81 113.54 25.7 Favored 'General case' 0 CA--C 1.467 -2.228 0 CA-C-O 121.391 0.615 . . . . 0.0 109.845 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.488 ' HG2' HG21 ' A' ' 209' ' ' THR . 4.1 tpm_? -100.25 123.69 44.79 Favored 'General case' 0 C--N 1.271 -2.847 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.283 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HB3' ' CG2' ' A' ' 246' ' ' ILE . 67.9 mtm180 -99.92 112.33 24.6 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.92 125.75 42.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 39.6 ptt180 -102.87 142.24 34.32 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.07 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.9 tm? -116.77 123.1 46.32 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 164' ' ' LEU . 2.9 pp -111.05 100.87 9.47 Favored 'General case' 0 N--CA 1.398 -3.038 0 CA-C-O 122.499 1.142 . . . . 0.0 112.049 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 243' ' ' SER . 12.8 tmtt? -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.811 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 14.2 p80 179.8 117.9 0.05 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.326 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.75 0.41 66.63 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.115 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 t -171.88 148.56 2.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.98 -39.87 83.23 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 170' ' ' LYS . 39.5 ttmt 62.89 121.38 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.027 1.331 . . . . 0.0 113.629 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.42 22.94 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.365 2.71 . . . . 0.0 113.108 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.8 mp 66.5 -73.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.798 1.239 . . . . 0.0 112.854 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 108.89 -12.71 34.8 Favored Glycine 0 CA--C 1.497 -1.06 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -128.12 143.9 51.08 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.17 161.07 35.42 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 123.185 0.303 . . . . 0.0 110.813 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -130.62 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.41 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 14.4 ttp180 -141.66 147.95 38.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 12.2 p-10 -102.46 127.12 49.63 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.532 0.682 . . . . 0.0 111.521 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -112.23 117.32 4.35 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 23.5 p -92.72 143.19 26.54 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 117.722 0.761 . . . . 0.0 112.363 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.0 t -127.42 132.4 50.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.16 124.0 49.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -120.97 157.09 30.7 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 63.2 t -102.64 116.6 46.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.8 p -115.62 177.81 4.53 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.701 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.37 -14.57 62.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.204 0.526 . . . . 0.0 109.918 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.3 p -91.94 -0.24 57.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.056 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.83 -165.35 12.04 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.7 pt? -84.83 106.47 16.38 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.314 1.054 . . . . 0.0 110.712 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -104.31 152.44 22.23 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.266 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 39.6 ttpt -121.3 133.39 55.13 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 29.9 pt20 -116.7 143.91 32.3 Favored Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.358 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 9.8 Cg_endo -88.18 126.51 2.0 Allowed 'Trans proline' 0 N--CA 1.427 -2.428 0 C-N-CA 122.227 1.951 . . . . 0.0 112.734 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.67 86.32 0.45 Allowed Glycine 0 C--N 1.279 -2.617 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 12.1 tt -82.11 133.66 28.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 120.597 0.237 . . . . 0.0 110.438 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -142.87 177.56 8.26 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.542 0.737 . . . . 0.0 110.74 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.2 mt -71.99 134.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.41 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 68.3 p -109.84 -59.95 1.85 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.8 147.87 47.19 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.059 0.457 . . . . 0.0 111.043 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.816 HD21 ' HB3' ' A' ' 206' ' ' ALA . 11.2 mt -127.06 138.3 53.19 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.646 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.89 132.63 20.71 Favored Pre-proline 0 C--N 1.286 -2.16 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.96 126.79 23.74 Favored 'Trans proline' 0 C--O 1.251 1.125 0 C-N-CA 121.808 1.672 . . . . 0.0 110.057 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.89 60.78 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.83 149.14 51.13 Favored Glycine 0 C--O 1.214 -1.144 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.8 mm? -56.73 -35.61 68.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.816 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -73.42 -28.08 61.79 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.738 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.19 -43.33 43.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.1 m -54.7 -32.9 60.15 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.223 1.009 . . . . 0.0 112.222 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.491 HG22 ' HG ' ' A' ' 211' ' ' LEU . 25.5 m -63.94 -43.28 96.36 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.845 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.8 -56.72 3.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.433 -0.349 . . . . 0.0 113.857 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 209' ' ' THR . 4.1 pp -70.93 2.23 4.6 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.625 1.17 . . . . 0.0 113.292 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.593 HD21 ' CG2' ' A' ' 249' ' ' VAL . 25.7 tp -119.99 145.74 46.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.82 161.64 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.245 0.545 . . . . 0.0 112.062 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.63 -24.66 13.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.844 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -68.93 -24.6 64.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.348 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 70.5 m-20 -60.13 139.96 57.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.249 0.62 . . . . 0.0 111.878 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.66 145.08 26.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -170.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 195' ' ' ILE . 84.1 t -78.0 135.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.886 1.274 . . . . 0.0 110.993 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.43 HG13 ' HD2' ' A' ' 250' ' ' LYS . 44.8 mm -122.23 -43.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.134 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.571 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.5 mt-10 -136.58 151.33 49.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.484 0.659 . . . . 0.0 112.045 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.49 109.12 26.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.533 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 69.82 -66.62 0.26 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.452 1.101 . . . . 0.0 111.229 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.93 15.78 0.09 OUTLIER Glycine 0 C--N 1.294 -1.765 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.92 133.55 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 44.6 mt-10 -82.33 149.42 27.76 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.57 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.574 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 19.1 m -89.62 14.1 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.021 -177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -88.73 109.36 20.08 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.4 15.09 26.27 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.737 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 1.1 pptp? -104.85 174.36 5.91 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 26.3 m -106.06 158.64 16.66 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.654 ' O ' HG12 ' A' ' 234' ' ' VAL . 4.7 tt -60.44 -47.49 85.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.859 0.464 . . . . 0.0 110.798 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.15 -36.42 74.74 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.281 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.71 -37.86 80.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 231' ' ' LEU . 7.5 p -58.18 -44.67 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.409 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.7 p -70.54 -35.47 73.15 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.341 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.35 -43.36 81.69 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.815 0.817 . . . . 0.0 110.327 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 76.1 mtp -61.92 -44.59 96.46 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.701 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.409 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 25.7 ptm -70.54 -24.4 62.8 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 235' ' ' THR . 96.8 t -83.24 -32.26 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 0.0 109.798 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.64 68.75 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.618 0.723 . . . . 0.0 109.844 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -107.98 22.24 16.24 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 68.4 m -54.45 -31.46 55.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 34.2 t -50.83 -58.16 6.65 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.736 0.303 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -130.58 89.61 2.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.4 tm? -101.14 130.88 47.29 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' ' 160' ' ' ARG . 68.1 mt -118.32 123.81 72.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.85 118.79 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 122.098 0.951 . . . . 0.0 109.565 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.571 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 19.8 m -95.82 120.15 35.58 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.942 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.593 ' CG2' HD21 ' A' ' 212' ' ' LEU . 29.8 m -129.34 149.53 33.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.43 ' HD2' HG13 ' A' ' 219' ' ' ILE . 97.2 mttt -127.03 128.49 24.16 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.683 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 38.9 Cg_exo -39.23 126.9 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.07 3.18 . . . . 0.0 115.009 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.25 8.49 32.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.535 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -83.36 -6.42 59.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.415 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 254' ' ' GLN . 5.5 tp60 -119.32 125.29 48.69 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.012 174.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 . . . . . 0 C--N 1.282 -2.352 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.736 -175.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.817 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.4 m -88.81 -3.35 58.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.157 0.503 . . . . 0.0 111.007 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -129.46 124.29 33.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -75.43 142.23 43.04 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.76 0.314 . . . . 0.0 110.216 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 134' ' ' PRO . 25.3 pttm -91.22 112.59 24.56 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.93 99.29 34.3 Favored Pre-proline 0 C--N 1.289 -2.05 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.949 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 132' ' ' LYS . 31.8 Cg_exo -61.86 110.56 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.237 1.958 . . . . 0.0 110.189 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 m -80.15 99.06 7.58 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.7 tt -54.02 135.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.728 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.7 p -129.25 88.93 2.77 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.039 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.95 138.77 19.65 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.766 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.12 123.13 11.26 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.373 2.049 . . . . 0.0 111.021 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -90.29 152.64 20.95 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.828 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.33 121.96 33.53 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -113.12 -52.35 2.78 Favored 'General case' 0 C--N 1.261 -3.274 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 58.9 89.71 0.06 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.839 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -76.38 111.71 12.13 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.7 m -101.15 140.54 19.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 t -88.02 114.88 25.08 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.3 103.11 13.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 tt -121.4 96.51 4.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.799 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.38 117.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.084 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -101.73 -2.71 29.58 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.815 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.93 -49.46 79.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -102.72 118.86 37.77 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 153' ' ' ILE . 2.2 mp -71.98 -46.3 60.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.83 102.05 19.82 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -81.32 148.71 16.68 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.202 1.935 . . . . 0.0 109.259 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -74.81 85.71 2.2 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.547 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.7 p -81.73 114.94 20.73 Favored 'General case' 0 N--CA 1.408 -2.566 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.399 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -87.74 99.7 12.28 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.477 ' HG3' HG13 ' A' ' 161' ' ' VAL . 32.9 tpt180 -103.24 125.72 50.05 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.054 -170.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.498 ' HG2' ' OG1' ' A' ' 248' ' ' THR . 88.2 mtt180 -103.3 105.0 15.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.698 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.477 HG13 ' HG3' ' A' ' 159' ' ' ARG . 23.0 m -104.69 132.53 51.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 120.96 0.409 . . . . 0.0 110.94 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -103.06 142.76 33.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.457 HD13 ' H ' ' A' ' 173' ' ' GLY . 72.1 mt -133.39 145.42 50.31 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.828 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.507 HD23 ' H ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -120.4 120.43 35.94 Favored 'General case' 0 N--CA 1.404 -2.744 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.578 172.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.548 ' HG2' ' HB3' ' A' ' 242' ' ' SER . 0.0 OUTLIER -65.98 143.48 57.35 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.538 -178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 169' ' ' ASP . 37.5 m80 -110.86 -37.34 5.43 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.494 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.53 -11.69 37.71 Favored Glycine 0 N--CA 1.459 0.183 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.959 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 3.13 15.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 25.2 t70 171.68 117.19 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.413 2.285 . . . . 0.0 105.916 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.425 ' HG3' ' OD2' ' A' ' 169' ' ' ASP . 56.7 mttp 66.77 86.59 0.13 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 124.949 1.3 . . . . 0.0 112.478 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -75.84 -32.27 4.59 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.168 1.912 . . . . 0.0 107.915 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 174' ' ' PHE . 1.8 pt? -152.95 127.12 9.12 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.118 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.457 ' H ' HD13 ' A' ' 163' ' ' LEU . . . -95.65 48.11 1.87 Allowed Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.443 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 172' ' ' LEU . 54.1 p90 -169.75 156.82 6.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 67.6 m-85 -137.73 135.41 36.37 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 169.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.605 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.0 pt -132.78 144.71 35.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -136.4 136.63 39.75 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.729 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.483 ' H ' HD23 ' A' ' 231' ' ' LEU . 17.8 t70 -87.21 123.16 31.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.847 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -131.1 174.72 19.82 Favored Glycine 0 C--N 1.276 -2.789 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 141.84 32.63 Favored 'General case' 0 C--N 1.271 -2.81 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.322 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t -123.09 136.87 54.98 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.44 124.03 63.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -116.19 154.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-O 121.019 0.438 . . . . 0.0 110.254 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.37 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.7 p -115.6 177.29 4.72 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.098 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.36 -16.86 61.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.6 p -91.85 5.75 48.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.17 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 -156.26 15.66 Favored Glycine 0 C--O 1.214 -1.154 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.882 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.576 ' H ' HD23 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -98.95 106.77 19.06 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-O 121.77 0.795 . . . . 0.0 109.373 175.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.21 152.14 23.21 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.697 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -121.09 130.92 53.97 Favored 'General case' 0 N--CA 1.402 -2.852 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -147.76 150.88 37.52 Favored Pre-proline 0 C--N 1.265 -3.09 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.977 -172.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.68 134.96 19.07 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.206 1.937 . . . . 0.0 110.273 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.04 134.65 6.87 Favored Glycine 0 C--N 1.301 -1.391 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.605 ' CG2' ' HB ' ' A' ' 176' ' ' ILE . 58.2 mt -104.61 119.82 54.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.753 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -120.65 156.97 30.58 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.665 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 68.5 mt -63.51 123.38 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.602 0.715 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -91.09 -42.46 10.47 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.865 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 68.5 ttt180 -151.65 152.98 33.55 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.197 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 206' ' ' ALA . 13.8 mt -128.08 138.76 52.68 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.14 130.21 26.6 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.72 137.25 59.5 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.55 2.22 58.8 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.79 153.09 34.18 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.64 -26.39 61.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.644 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -67.19 -26.87 66.84 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 122.077 0.941 . . . . 0.0 109.224 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.62 -41.36 46.22 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.031 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.1 t -64.78 -36.12 83.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.0 p -62.62 -44.29 96.67 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.95 -51.84 2.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.631 -0.259 . . . . 0.0 113.032 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 212' ' ' LEU . 51.3 mt -57.58 -39.77 77.49 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.48 1.112 . . . . 0.0 108.922 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.439 HD22 HG23 ' A' ' 249' ' ' VAL . 3.9 mp -115.37 108.67 16.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.27 116.62 16.38 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.614 -0.434 . . . . 0.0 112.054 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.665 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 70.8 t 57.23 -43.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.067 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 174.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -74.63 -23.82 58.75 Favored 'General case' 0 CA--C 1.484 -1.575 0 O-C-N 121.558 -0.714 . . . . 0.0 112.465 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.26 173.44 2.54 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.656 0.741 . . . . 0.0 112.566 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -128.65 140.43 51.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.641 -170.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.12 141.4 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.371 0.605 . . . . 0.0 110.086 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.73 -52.62 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.942 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.513 ' H ' ' HB ' ' A' ' 248' ' ' THR . 36.5 mt-10 -125.49 146.51 49.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.899 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.531 HG13 ' SD ' ' A' ' 238' ' ' MET . 92.2 t -109.18 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 171.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.514 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 25.1 t-20 70.33 -73.83 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.806 0.812 . . . . 0.0 109.788 -174.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -162.95 12.53 0.1 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 175.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 9.0 mt -95.45 118.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.24 150.1 33.5 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.981 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.635 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 22.5 m -95.84 13.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 120.922 0.391 . . . . 0.0 112.05 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.75 114.52 18.73 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.22 15.07 28.98 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.295 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 226' ' ' VAL . 0.5 OUTLIER -109.93 175.98 5.24 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.536 -0.391 . . . . 0.0 110.443 -177.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 32.9 m -113.77 160.77 18.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.568 ' O ' HG12 ' A' ' 234' ' ' VAL . 3.0 tm? -55.11 -46.36 75.57 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.177 0.444 . . . . 0.0 111.876 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.47 -35.5 77.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.232 0.539 . . . . 0.0 110.478 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 237' ' ' MET . 97.7 mt-30 -69.96 -39.79 75.81 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.664 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 231' ' ' LEU . 10.4 p -61.17 -42.23 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 118.498 0.59 . . . . 0.0 111.855 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 239' ' ' VAL . 6.7 t -75.27 -28.95 60.01 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.918 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.68 -39.58 88.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 73.1 mtp -56.41 -43.93 79.83 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.455 174.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.614 ' SD ' HD21 ' A' ' 245' ' ' LEU . 24.6 mmt -64.12 -29.38 70.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.062 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.548 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 87.7 t -82.7 -34.85 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.306 0.574 . . . . 0.0 110.755 -175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.55 -23.3 67.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.243 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.7 26.37 5.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.455 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.548 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 49.3 m -54.32 -28.66 43.9 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -95.28 -5.51 43.45 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.986 -0.446 . . . . 0.0 111.696 -176.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.27 35.52 4.26 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.614 HD21 ' SD ' ' A' ' 238' ' ' MET . 2.6 tm? -83.22 124.11 30.23 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.506 -167.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 56.6 mt -130.22 129.63 65.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.479 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.68 122.06 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.513 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 42.0 m -90.78 119.84 31.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.439 HG23 HD22 ' A' ' 212' ' ' LEU . 12.9 m -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-O 121.118 0.485 . . . . 0.0 111.81 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.457 ' NZ ' ' HB3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -138.04 126.8 14.51 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 123.743 0.817 . . . . 0.0 108.858 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.48 127.71 21.59 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.14 2.56 . . . . 0.0 112.974 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -105.2 19.02 21.31 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.892 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -95.02 76.67 3.53 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 122.905 1.335 . . . . 0.0 108.838 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -76.67 139.53 40.58 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.055 -1.429 . . . . 0.0 112.0 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.393 -3.325 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.075 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -112.95 151.52 30.45 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' HD3' ' H ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -132.65 160.88 35.4 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.684 0.278 . . . . 0.0 110.298 -177.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 28.0 m -91.57 135.07 34.13 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -85.77 99.99 11.73 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.94 110.82 28.29 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.52 109.42 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.228 1.952 . . . . 0.0 110.594 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -84.12 73.55 10.39 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 122.001 0.905 . . . . 0.0 109.397 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.5 tt -121.08 156.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.475 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -150.97 130.36 12.88 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 115.47 63.01 Favored Pre-proline 0 C--N 1.284 -2.242 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -85.9 128.71 3.33 Favored 'Trans proline' 0 N--CA 1.429 -2.307 0 C-N-CA 122.359 2.039 . . . . 0.0 109.273 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -79.36 114.01 17.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.91 156.22 22.49 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.607 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -63.59 141.67 58.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.746 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 68.26 89.59 0.1 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.529 0.68 . . . . 0.0 110.584 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -75.0 116.09 15.35 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.671 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.64 145.97 8.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.7 t -83.74 136.89 34.0 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.126 0.489 . . . . 0.0 110.146 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.38 153.46 29.8 Favored 'General case' 0 N--CA 1.407 -2.613 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.03 83.26 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.2 pp -108.1 151.93 10.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 114.256 -1.338 . . . . 0.0 114.21 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.447 ' HB3' HD11 ' A' ' 153' ' ' ILE . 13.4 t70 -176.62 141.21 0.38 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 173.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.84 -43.73 96.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -106.13 107.19 18.07 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.852 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 150' ' ' ASP . 37.6 mm -121.5 127.39 75.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.481 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.81 120.67 50.63 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-O 121.026 0.441 . . . . 0.0 110.714 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.24 150.3 65.08 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.438 1.425 . . . . 0.0 109.392 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.77 83.36 1.18 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.3 m -83.88 109.78 17.85 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.415 ' NE2' ' HG3' ' A' ' 250' ' ' LYS . 14.0 m-70 -72.0 123.66 23.26 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-O 121.876 0.846 . . . . 0.0 112.116 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.441 ' HD2' HD11 ' A' ' 212' ' ' LEU . 22.1 ttm-85 -113.41 140.26 48.21 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.957 -171.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.465 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 19.8 ptt180 -123.92 119.51 29.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 205' ' ' LEU . 27.1 m -110.98 133.82 55.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 122.257 -0.277 . . . . 0.0 111.685 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' HG13 ' A' ' 246' ' ' ILE . 26.5 ptt180 -99.6 135.62 40.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.764 0.792 . . . . 0.0 112.832 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.475 ' HB2' HD12 ' A' ' 245' ' ' LEU . 3.5 mm? -124.67 121.42 34.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.574 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 164' ' ' LEU 0.264 1.6 pp -107.01 105.04 14.87 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-O 122.2 1.0 . . . . 0.0 113.295 175.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -100.58 134.52 43.41 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.527 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -95.06 29.71 2.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 87.11 -11.44 65.12 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.2 p -175.69 133.53 0.28 Allowed 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 t70 178.46 -57.37 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' NZ ' ' HB3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -149.04 148.27 26.52 Favored Pre-proline 0 N--CA 1.412 -2.354 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.676 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -86.7 23.73 0.8 Allowed 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 122.466 2.111 . . . . 0.0 110.886 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 87.5 mt 75.01 123.6 0.04 OUTLIER 'General case' 0 C--N 1.347 0.469 0 C-N-CA 125.952 1.701 . . . . 0.0 111.421 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.93 44.08 3.08 Favored Glycine 0 C--O 1.241 0.589 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.991 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -172.2 144.23 1.59 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -135.77 135.42 39.91 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 121.3 0.572 . . . . 0.0 111.111 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -130.94 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.451 -175.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 177' ' ' ARG . 3.5 mmp_? -122.87 158.72 29.71 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.47 ' HA ' HG22 ' A' ' 195' ' ' ILE . 26.5 t70 -74.27 137.48 42.98 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 123.2 0.313 . . . . 0.0 111.046 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.71 163.92 37.4 Favored Glycine 0 N--CA 1.406 -3.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 m -107.07 143.7 34.81 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.4 t -92.84 125.54 37.5 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 191' ' ' LYS . 24.0 t -117.3 124.62 73.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.276 -174.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -110.34 151.61 27.22 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.29 106.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-O 122.167 0.984 . . . . 0.0 109.127 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.2 p -116.41 178.28 4.38 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.562 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.7 -15.83 62.74 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 m -88.02 -3.81 58.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.72 -160.04 14.17 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.078 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.77 109.97 18.45 Favored 'General case' 0 N--CA 1.385 -3.716 0 CA-C-O 121.931 0.872 . . . . 0.0 110.783 177.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -101.92 144.02 31.08 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.51 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 181' ' ' SER . 52.7 mtmt -123.29 142.35 51.03 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.439 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.62 154.87 79.83 Favored Pre-proline 0 N--CA 1.42 -1.945 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.83 131.01 17.65 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.752 1.635 . . . . 0.0 109.282 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 178.63 103.63 0.17 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 178' ' ' ASP . 27.2 pt -77.47 144.84 10.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.62 158.87 17.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -172.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.9 mt -68.89 136.54 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.6 t -136.03 -39.67 0.68 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.744 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -127.11 147.53 50.17 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.874 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 206' ' ' ALA . 30.2 mt -128.31 139.71 52.26 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.441 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.48 132.47 23.15 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 126.86 23.26 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.5 1.467 . . . . 0.0 110.12 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.92 -5.1 57.85 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.79 155.99 53.44 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.428 HD13 ' HB ' ' A' ' 161' ' ' VAL . 74.0 mt -65.94 -35.62 81.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.742 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -75.66 -26.27 57.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.674 0.75 . . . . 0.0 109.294 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB2' HD22 ' A' ' 200' ' ' LEU . 2.4 tm-20 -76.21 -56.17 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.876 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.4 m -62.85 -34.94 78.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.2 p -66.98 -43.76 82.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.689 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.76 10.64 51.14 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.409 HD23 HH22 ' A' ' 159' ' ' ARG . 29.3 tp -119.95 15.4 12.51 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 122.711 1.244 . . . . 0.0 109.252 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.441 HD11 ' HD2' ' A' ' 159' ' ' ARG . 78.7 mt -135.17 129.33 33.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.383 -1.735 . . . . 0.0 106.648 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.31 162.26 13.03 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 -174.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.8 -22.72 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-O 122.629 1.204 . . . . 0.0 108.858 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -74.59 -23.09 58.68 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.432 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 59.5 m-20 -67.65 154.96 40.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.679 0.792 . . . . 0.0 112.094 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -116.02 163.8 15.38 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.593 0.711 . . . . 0.0 112.866 -172.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 176' ' ' ILE . 72.6 t -99.82 137.94 25.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.833 174.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 250' ' ' LYS . 2.7 mp -107.66 -50.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.67 0.747 . . . . 0.0 110.235 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.54 ' H ' ' HB ' ' A' ' 248' ' ' THR . 43.1 mt-10 -141.35 159.39 42.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.401 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.2 t -106.33 97.61 5.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 44.3 t30 72.99 -73.4 0.1 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 111.261 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.05 18.4 0.73 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.84 111.95 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.85 147.53 53.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 219' ' ' ILE . 15.4 m -98.76 3.67 10.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.147 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.8 103.48 0.11 Allowed 'General case' 0 C--O 1.244 0.773 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.74 7.56 84.01 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.336 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.25 160.03 17.86 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 232' ' ' ASP . 96.8 m -74.83 156.29 36.64 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.005 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 232' ' ' ASP . 4.1 pp -71.32 -34.93 71.01 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.132 -177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.546 ' N ' HD12 ' A' ' 231' ' ' LEU . 21.9 t70 -70.1 -37.05 75.3 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.509 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 237' ' ' MET . 23.6 tp60 -66.12 -51.01 62.0 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.433 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.28 -48.68 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.532 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.0 p -65.43 -32.42 74.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.973 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.03 -42.95 93.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.597 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.638 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 23.6 mtm -58.32 -46.05 86.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.905 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 19.6 ptp -68.43 -23.19 64.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 235' ' ' THR . 89.4 t -83.56 -33.15 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.5 67.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.067 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -95.82 -63.07 1.19 Allowed 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.457 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 35.8 t 66.04 -41.31 0.35 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.94 1.829 . . . . 0.0 115.94 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -97.57 -39.29 9.19 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.72 -0.613 . . . . 0.0 112.398 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.18 42.03 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 163' ' ' LEU . 3.2 tm? -85.34 129.67 34.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.99 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -128.42 140.73 48.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.429 HD11 ' CG1' ' A' ' 218' ' ' VAL . 8.9 tp -122.26 138.18 53.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 118.547 0.612 . . . . 0.0 109.751 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.54 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.8 m -102.82 120.68 41.03 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.958 -174.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.74 149.25 29.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 CA-C-O 121.366 0.603 . . . . 0.0 112.411 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.599 ' HB2' HD11 ' A' ' 219' ' ' ILE . 32.1 ttmt -124.35 124.74 25.76 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.822 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.6 Cg_exo -63.81 126.48 17.47 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.162 1.241 . . . . 0.0 109.07 171.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.6 -0.01 17.41 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.656 -176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.491 ' N ' HD22 ' A' ' 253' ' ' ASN . 0.7 OUTLIER 67.72 99.3 0.05 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.243 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.3 103.66 16.32 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.774 0.797 . . . . 0.0 109.422 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? . . . . . 0 C--N 1.261 -3.274 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.181 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.887 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.3 m -72.0 -21.27 61.58 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 116.855 0.327 . . . . 0.0 111.573 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.96 109.61 4.6 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.788 0.804 . . . . 0.0 109.435 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.6 m -99.16 113.71 26.09 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.978 -175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.622 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -98.0 84.27 3.27 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.068 0.937 . . . . 0.0 110.01 178.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.62 155.98 37.93 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.204 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.38 144.77 91.77 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.245 1.963 . . . . 0.0 111.424 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 64.9 m -82.99 100.8 10.68 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 tt -50.71 139.1 6.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.635 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.3 t -160.48 102.93 1.38 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 61.5 mt -87.68 116.14 65.2 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.284 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 1.4 Cg_endo -82.8 123.74 3.76 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.873 2.382 . . . . 0.0 112.243 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.57 132.22 47.35 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.1 156.8 18.11 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.504 ' C ' ' HD2' ' A' ' 143' ' ' ARG . 96.9 m-85 -96.09 122.67 39.17 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.504 ' HD2' ' C ' ' A' ' 142' ' ' PHE . 3.4 mpt_? -128.7 81.57 2.03 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -95.26 150.96 19.66 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.838 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.5 m -76.88 136.21 25.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.221 0.534 . . . . 0.0 111.407 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.9 m -95.26 154.33 17.24 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.882 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.57 104.54 16.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tp -70.31 132.69 32.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.4 pt -106.8 151.97 8.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 120.997 0.427 . . . . 0.0 111.713 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.4 107.94 5.32 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 50.1 t -137.85 -45.44 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.4 -174.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.1 126.7 29.45 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -174.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.1 tt 55.42 148.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 127.497 2.319 . . . . 0.0 113.299 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.27 119.11 66.07 Favored Pre-proline 0 N--CA 1.431 -1.389 0 O-C-N 121.44 -0.788 . . . . 0.0 109.172 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.87 151.63 31.54 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.0 2.467 . . . . 0.0 110.843 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.37 81.35 1.04 Allowed 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 t -79.85 105.26 11.01 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -79.1 99.05 6.77 Favored 'General case' 0 CA--C 1.458 -2.565 0 CA-C-O 122.482 1.134 . . . . 0.0 109.531 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.503 ' HA ' ' NE ' ' A' ' 159' ' ' ARG . 1.0 OUTLIER -96.26 138.2 34.22 Favored 'General case' 0 N--CA 1.39 -3.451 0 CA-C-N 112.5 -2.137 . . . . 0.0 107.007 -174.018 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 77.8 mtm180 -116.57 121.53 42.01 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 121.107 0.48 . . . . 0.0 111.01 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 205' ' ' LEU . 97.0 t -89.01 116.02 29.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -112.5 122.57 48.08 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.6 0.714 . . . . 0.0 111.494 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.7 121.02 37.35 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.378 -1.283 . . . . 0.0 107.655 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.444 ' O ' ' HD2' ' A' ' 166' ' ' HIS . 85.5 mt -113.01 111.74 22.7 Favored 'General case' 0 N--CA 1.396 -3.142 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.612 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 168' ' ' SER . 77.5 tttt -80.65 125.02 29.5 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.832 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.444 ' HD2' ' O ' ' A' ' 164' ' ' LEU . 8.8 p80 -150.74 93.93 2.02 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.462 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.89 6.02 89.71 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.098 -0.956 . . . . 0.0 113.283 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.518 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 22.9 t -165.31 143.25 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.58 76.51 8.91 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.451 0.644 . . . . 0.0 110.708 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.21 121.47 85.19 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.18 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -57.48 135.52 70.33 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.688 2.259 . . . . 0.0 111.724 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 172' ' ' LEU . 1.6 pt? -53.39 121.2 7.16 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.207 1.003 . . . . 0.0 111.421 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -80.15 46.65 3.23 Favored Glycine 0 C--O 1.246 0.871 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.717 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -174.78 152.26 1.55 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -137.98 140.99 40.47 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.125 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.456 HG21 HG11 ' A' ' 218' ' ' VAL . 46.4 pt -135.46 136.26 50.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 123.663 0.602 . . . . 0.0 109.832 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.52 158.84 43.34 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.931 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.443 ' CB ' ' HB3' ' A' ' 231' ' ' LEU . 8.3 t70 -84.84 125.42 32.59 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.71 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -130.89 117.98 2.33 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 105.247 -3.141 . . . . 0.0 105.247 171.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.8 t -91.32 144.42 25.61 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.295 1.045 . . . . 0.0 112.711 -170.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t -105.04 129.44 53.47 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.919 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.47 125.17 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 CA-C-O 121.382 0.611 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 98.4 mtt180 -120.38 153.22 36.81 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.5 p -109.07 178.28 4.51 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.534 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.38 -16.56 63.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.9 m -89.84 -4.54 57.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.78 -168.31 12.59 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.6 pt? -83.93 106.29 15.49 Favored 'General case' 0 N--CA 1.402 -2.828 0 CA-C-O 122.127 0.965 . . . . 0.0 109.878 177.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -112.58 149.93 32.06 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.936 -173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -108.46 150.8 26.92 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.321 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -131.82 147.21 65.02 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.66 135.47 69.62 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.979 1.786 . . . . 0.0 109.986 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.66 76.72 0.39 Allowed Glycine 0 C--N 1.284 -2.33 0 C-N-CA 120.025 -1.084 . . . . 0.0 111.69 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.86 117.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.27 175.91 8.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 54.7 mt -66.05 122.43 17.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.3 p -102.02 -55.28 2.52 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -137.07 155.98 48.96 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.856 0.36 . . . . 0.0 110.268 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.759 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.4 mt -129.13 140.51 51.51 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.8 t -98.58 124.04 47.83 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.4 127.02 24.21 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.166 1.911 . . . . 0.0 109.986 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.89 21.28 12.31 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.406 -0.902 . . . . 0.0 110.943 -173.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.26 159.57 16.23 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.569 ' HB2' HG13 ' A' ' 161' ' ' VAL . 87.7 mt -70.21 -25.97 63.66 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.807 -0.82 . . . . 0.0 113.117 -176.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.759 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -67.24 -38.22 84.85 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.288 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.497 ' HB3' HD13 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -77.56 -33.95 53.89 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.945 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.2 t -68.0 -33.68 75.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.018 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.1 p -71.57 -43.95 65.4 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.72 -42.93 1.58 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.9 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.529 HD12 ' HG ' ' A' ' 212' ' ' LEU . 1.0 OUTLIER -65.87 -13.56 59.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.351 1.061 . . . . 0.0 113.633 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.529 ' HG ' HD12 ' A' ' 211' ' ' LEU . 96.8 mt -108.79 145.77 34.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.44 163.39 25.96 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.027 0.441 . . . . 0.0 111.804 -171.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 58.4 t -54.7 -22.03 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.619 0.768 . . . . 0.0 111.535 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -74.55 -24.08 58.89 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.576 ' HB3' ' N ' ' A' ' 252' ' ' ALA 0.655 0.4 OUTLIER -65.41 158.5 26.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 119.249 3.055 . . . . 0.0 119.249 -176.819 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.02 146.31 34.13 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.07 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 226' ' ' VAL . 31.3 m -89.75 142.58 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.922 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 220' ' ' GLU . 40.0 mm -110.78 -56.59 4.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.048 0.451 . . . . 0.0 110.297 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HG3' HG22 ' A' ' 219' ' ' ILE . 44.3 mt-10 -138.4 155.59 48.36 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.383 0.611 . . . . 0.0 112.418 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 238' ' ' MET . 90.7 t -127.54 110.68 22.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 124.657 1.183 . . . . 0.0 107.887 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 69.52 -70.6 0.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.965 1.306 . . . . 0.0 110.471 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -161.95 16.14 0.15 Allowed Glycine 0 C--N 1.299 -1.492 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 19.6 mt -112.49 131.38 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -85.35 167.99 15.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.214 0.531 . . . . 0.0 110.329 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 218' ' ' VAL . 28.8 m -104.03 9.71 9.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.378 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.0 102.58 0.08 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.047 -176.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.61 13.16 80.6 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.838 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -97.56 164.03 12.6 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 98.9 m -91.13 157.89 16.96 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 113.046 -1.888 . . . . 0.0 108.955 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 178' ' ' ASP . 1.9 pt? -63.33 -42.1 98.94 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.681 0.277 . . . . 0.0 111.313 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.37 -49.99 72.84 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.312 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.25 -46.4 89.92 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.443 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.525 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 91.2 t -67.57 -45.95 84.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.901 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.6 t -68.02 -29.91 69.03 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.68 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.98 -48.53 52.8 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.394 0.616 . . . . 0.0 109.988 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 234' ' ' VAL . 21.5 ptt? -65.0 -33.54 76.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -175.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.455 ' HB3' HG11 ' A' ' 221' ' ' VAL . 14.7 ptp -73.15 -25.21 60.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.481 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.59 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 93.6 t -85.33 -37.44 12.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.608 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.51 67.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.939 175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.03 21.98 15.32 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.656 ' HA ' ' HB2' ' A' ' 245' ' ' LEU . 73.0 m -59.25 -20.81 57.32 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 15.1 m -53.62 -50.65 65.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.685 0.794 . . . . 0.0 109.647 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -125.69 75.44 1.49 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.656 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.9 tp -103.2 104.3 14.42 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.139 0.971 . . . . 0.0 112.728 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.58 118.11 55.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.575 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 10.8 tt -111.23 133.32 57.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.512 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 21.8 m -100.15 125.02 46.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.034 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 212' ' ' LEU . 28.0 m -122.49 163.36 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 123.3 0.375 . . . . 0.0 110.475 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -133.79 123.48 17.2 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.78 135.82 71.43 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.484 2.79 . . . . 0.0 113.544 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.576 ' N ' ' HB3' ' A' ' 216' ' ' ASP . . . -116.78 20.86 13.74 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -63.74 -21.3 66.34 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.335 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -135.75 139.95 43.97 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.288 -2.071 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.113 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.1 m 64.41 86.81 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.84 0.856 . . . . 0.0 112.313 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -94.07 87.61 5.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.6 m -81.87 118.3 22.82 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.811 -173.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -88.72 142.3 27.79 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.19 111.04 38.24 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.9 101.84 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.21 1.94 . . . . 0.0 111.749 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -88.93 85.05 6.65 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.42 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 136' ' ' ILE . 2.5 pp -86.11 136.77 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.3 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.4 m -102.98 90.9 3.91 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 10.3 tt -87.83 123.0 69.91 Favored Pre-proline 0 C--N 1.29 -1.978 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.131 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 12.4 Cg_exo -66.8 122.12 9.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.695 1.597 . . . . 0.0 110.362 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -94.19 120.34 34.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.455 -177.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.62 130.32 53.68 Favored 'General case' 0 CA--C 1.484 -1.583 0 CA-C-O 120.82 0.343 . . . . 0.0 110.718 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -153.24 86.44 1.23 Allowed 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -137.9 85.68 2.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.327 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -96.55 109.57 22.14 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.1 m -107.29 150.17 10.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.299 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.4 m -101.42 153.49 19.64 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.28 104.28 16.65 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.66 90.54 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.9 pt -107.29 151.62 9.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.028 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.02 111.73 22.85 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.381 0.61 . . . . 0.0 109.955 175.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.8 t -106.48 -60.44 2.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.95 107.17 18.26 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.4 tp -168.93 117.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-O 121.386 0.613 . . . . 0.0 111.252 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.3 t -101.12 122.71 47.58 Favored Pre-proline 0 C--N 1.292 -1.923 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.05 130.41 16.23 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.033 2.489 . . . . 0.0 113.955 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.78 -7.35 49.83 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.668 0.747 . . . . 0.0 109.722 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.3 t -75.3 102.22 4.98 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -91.19 143.91 26.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.858 -173.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -97.87 121.34 39.67 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.97 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -99.86 104.35 16.01 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 247' ' ' ILE . 59.6 t -89.74 117.32 32.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 120.956 0.408 . . . . 0.0 110.376 -176.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HG2' HG12 ' A' ' 246' ' ' ILE . 58.3 mtp180 -88.75 136.66 32.89 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 171' ' ' PRO . 3.4 tm? -120.38 121.3 38.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.62 99.78 9.45 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.8 145.76 46.79 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -101.78 -12.2 18.5 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.377 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.94 44.63 Favored Glycine 0 N--CA 1.46 0.233 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.085 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.7 t -149.33 128.63 12.9 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.3 t70 72.2 -42.5 0.53 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.832 1.253 . . . . 0.0 113.172 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -122.05 94.77 47.92 Favored Pre-proline 0 C--O 1.254 1.319 0 CA-C-O 120.671 0.272 . . . . 0.0 110.399 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.413 ' O ' HD11 ' A' ' 163' ' ' LEU . 4.3 Cg_exo -83.46 -69.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.063 2.509 . . . . 0.0 112.123 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 pp -157.19 157.39 34.3 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.342 0.657 . . . . 0.0 110.597 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -128.57 48.2 0.98 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.515 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 245' ' ' LEU . 54.0 p90 -160.47 147.58 15.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -138.54 146.21 41.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.52 152.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 123.441 0.463 . . . . 0.0 111.868 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 79.2 ttt180 -141.82 149.9 40.95 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.86 133.98 44.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.974 0.416 . . . . 0.0 110.595 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.36 165.99 15.92 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 2.8 p -93.11 120.4 33.36 Favored 'General case' 0 N--CA 1.391 -3.413 0 CA-C-N 117.986 0.893 . . . . 0.0 111.181 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.6 t -118.7 132.42 56.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.6 p -98.34 127.2 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.623 0.725 . . . . 0.0 109.177 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -112.85 153.43 27.9 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.68 107.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.1 p -110.18 178.15 4.48 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.19 -13.6 61.19 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.4 m -87.99 -4.6 58.79 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.588 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.55 -159.19 13.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.89 128.31 34.56 Favored 'General case' 0 N--CA 1.379 -3.977 0 CA-C-N 117.154 0.477 . . . . 0.0 110.003 175.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.38 153.49 48.67 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.411 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 36.9 ttpt -119.89 140.27 51.11 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-O 121.311 0.577 . . . . 0.0 109.618 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 5.5 tp-100 -139.62 144.74 40.55 Favored Pre-proline 0 C--N 1.277 -2.554 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 2.9 Cg_exo -73.81 119.52 5.93 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.246 1.964 . . . . 0.0 110.288 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.61 118.01 5.67 Favored Glycine 0 C--N 1.276 -2.758 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 177' ' ' ARG . 2.6 pt -96.5 117.53 41.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.598 0.713 . . . . 0.0 112.2 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 217' ' ' GLU . 59.4 m-85 -119.77 169.9 9.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.684 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.61 131.06 34.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.0 p -114.26 -56.02 2.43 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -123.55 142.01 51.45 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.2 mt -128.15 139.12 52.66 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.33 123.25 49.18 Favored Pre-proline 0 N--CA 1.416 -2.142 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -50.51 130.59 30.11 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.616 2.211 . . . . 0.0 112.215 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.62 5.14 65.12 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.34 146.06 41.84 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 114.785 -0.708 . . . . 0.0 112.779 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 205' ' ' LEU . 5.0 mp -55.4 -33.65 63.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.414 1.086 . . . . 0.0 113.14 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.628 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -66.13 -41.14 90.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.194 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.412 ' HB2' HD13 ' A' ' 200' ' ' LEU . 3.2 tm-20 -76.9 -34.97 57.68 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.9 m -54.87 -30.58 58.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.064 0.946 . . . . 0.0 112.558 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 205' ' ' LEU . 80.8 p -58.26 -43.24 87.79 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.636 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.73 21.18 72.83 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 tp -138.2 -35.42 0.62 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.154 -1.023 . . . . 0.0 110.804 -173.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.459 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.0 mm? -108.23 139.15 43.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.83 0.824 . . . . 0.0 111.179 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.38 162.28 13.15 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.393 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.83 -24.89 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-O 121.514 0.673 . . . . 0.0 110.983 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.486 HD22 ' HB3' ' A' ' 252' ' ' ALA . 8.2 t30 -73.28 -23.88 60.36 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.292 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.566 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 64.1 m-20 -62.45 158.73 17.04 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.448 0.699 . . . . 0.0 112.079 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.409 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 12.3 pt-20 -116.36 157.32 25.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -171.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.57 130.59 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.921 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.81 -42.96 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.179 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.478 ' H ' ' HB ' ' A' ' 248' ' ' THR . 34.2 mt-10 -137.68 152.7 49.56 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.341 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.58 96.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.467 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.533 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 67.13 1.15 2.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.164 1.386 . . . . 0.0 112.583 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 123.8 -4.29 9.21 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.68 134.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.14 147.36 31.39 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.842 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.411 ' CG2' HD11 ' A' ' 195' ' ' ILE . 25.8 m -117.19 10.64 7.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.083 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -61.48 105.82 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.067 0.46 . . . . 0.0 110.806 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.402 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.33 2.64 53.95 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.942 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.602 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.0 mmpt? -88.95 141.67 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.582 -0.364 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 234' ' ' VAL . 11.7 t -85.57 164.75 17.57 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 235' ' ' THR . 1.7 pt? -55.78 -41.66 74.42 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.278 0.49 . . . . 0.0 112.203 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.407 ' H ' HD23 ' A' ' 231' ' ' LEU . 25.0 t70 -59.89 -40.57 89.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.543 0.687 . . . . 0.0 110.677 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 11.9 mm-40 -69.22 -47.04 65.88 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.462 177.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 230' ' ' THR . 58.9 t -61.09 -43.74 96.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.54 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 239' ' ' VAL . 8.4 t -65.36 -40.09 93.13 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.095 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.62 -45.0 85.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.238 0.542 . . . . 0.0 110.517 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 77.3 mtp -56.43 -49.24 75.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.461 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.1 ptp -76.79 -9.76 58.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.183 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.627 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 70.4 t -83.07 -31.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.626 0.727 . . . . 0.0 109.171 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.5 -13.12 61.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.496 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -130.86 29.16 4.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.128 0.571 . . . . 0.0 110.848 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 68.1 m -61.99 -28.26 69.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -173.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.3 m -51.85 -61.92 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.169 0.509 . . . . 0.0 110.836 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -129.69 88.42 2.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 174' ' ' PHE . 3.6 pp -92.02 133.47 35.69 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 62.6 mt -114.37 119.52 61.61 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.296 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 161' ' ' VAL . 7.1 tt -109.89 118.69 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 111.134 177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 38.5 m -90.51 119.71 31.0 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.459 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 15.7 m -114.93 144.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 250' ' ' LYS . 13.1 tmtt? -125.62 125.42 25.0 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.978 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.566 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 18.7 Cg_endo -68.02 127.24 15.68 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.34 2.027 . . . . 0.0 114.097 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 215' ' ' ASN . . . -106.42 -35.32 7.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 43.37 79.94 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 112.75 -2.023 . . . . 0.0 113.197 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.465 ' HB3' ' ND2' ' A' ' 215' ' ' ASN . 47.0 tt0 -137.23 125.93 23.87 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.597 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 . . . . . 0 C--N 1.282 -2.34 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.913 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.622 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 70.6 p -146.16 143.36 29.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -99.99 130.75 46.19 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 75.0 m -80.85 120.4 24.64 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.58 112.54 20.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.849 0.357 . . . . 0.0 111.282 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.34 106.84 47.9 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.98 102.82 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.848 2.365 . . . . 0.0 112.773 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 m -86.37 91.77 8.61 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.1 mm -71.59 140.51 18.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.455 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 23.0 t -94.61 96.07 9.19 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.7 tt -94.19 107.96 32.48 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.8 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 137' ' ' SER . 12.2 Cg_exo -71.24 136.35 28.94 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.139 1.893 . . . . 0.0 109.507 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -101.37 113.87 27.35 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -95.55 128.63 42.57 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.279 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -134.39 99.16 4.29 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -131.75 89.86 2.75 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.49 115.16 5.43 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.204 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.16 126.65 39.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 121.318 0.58 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.5 m -84.42 119.15 24.79 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.307 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.96 104.56 16.61 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.938 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 148' ' ' ILE . 2.3 mp -70.53 105.5 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.6 tp -98.01 134.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 121.441 0.639 . . . . 0.0 111.447 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -148.23 141.18 24.81 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.6 -66.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.175 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.33 108.78 16.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.278 0.561 . . . . 0.0 111.937 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -127.61 94.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-O 121.793 0.806 . . . . 0.0 110.493 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.9 t -124.36 101.28 34.55 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -82.73 142.34 11.35 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.074 1.849 . . . . 0.0 109.257 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 46.8 mt-10 -63.2 96.84 0.11 Allowed 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.195 0.521 . . . . 0.0 112.025 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.8 m -88.07 93.51 9.51 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.442 ' CD2' ' HB3' ' A' ' 156' ' ' GLU . 12.8 m170 -82.22 113.26 19.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -132.86 138.12 46.93 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.106 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.625 ' HD3' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -110.94 114.49 27.85 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 205' ' ' LEU . 21.8 t -100.64 132.39 46.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG2' HG13 ' A' ' 246' ' ' ILE . 97.4 mtt180 -94.63 143.63 26.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.106 0.479 . . . . 0.0 112.089 -176.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 2.6 tm? -127.31 125.43 40.8 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 164' ' ' LEU 0.276 2.1 pp -112.36 101.68 9.86 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-O 122.442 1.115 . . . . 0.0 112.232 176.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -100.8 120.72 40.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.93 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -151.45 92.12 1.74 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.942 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.01 88.03 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.734 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 p -110.73 137.43 48.4 Favored 'General case' 0 N--CA 1.392 -3.34 0 C-N-CA 123.711 0.804 . . . . 0.0 109.699 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -125.18 82.75 2.09 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.938 0.875 . . . . 0.0 108.783 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -129.0 143.79 50.12 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.383 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.84 141.77 95.72 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.058 1.838 . . . . 0.0 111.226 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.75 123.56 21.25 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . -77.42 46.43 2.52 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.152 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.577 ' HE1' ' SD ' ' A' ' 238' ' ' MET . 50.7 p90 -174.7 134.04 0.37 Allowed 'General case' 0 N--CA 1.416 -2.139 0 C-N-CA 125.803 1.641 . . . . 0.0 107.711 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.4 141.33 51.08 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.3 pp -126.11 140.92 47.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.873 -177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 231' ' ' LEU . 55.9 ttt180 -142.19 148.05 37.58 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.754 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 195' ' ' ILE . 5.7 p-10 -101.85 145.37 29.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -132.26 163.94 23.9 Favored Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.7 m -104.65 131.78 51.68 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.041 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.9 m -106.13 136.02 46.57 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.518 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.2 128.93 60.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.514 0.674 . . . . 0.0 111.408 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -114.01 152.75 30.49 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.45 115.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 120.724 0.297 . . . . 0.0 110.464 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 77.9 p -113.08 169.86 8.63 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.01 -14.42 61.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.017 0.437 . . . . 0.0 111.034 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.0 m -93.65 -3.81 51.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.546 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.78 -168.86 22.19 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.339 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.624 ' H ' HD23 ' A' ' 189' ' ' LEU . 2.1 pt? -85.24 130.37 34.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.427 0.632 . . . . 0.0 111.127 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -108.55 155.63 20.42 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.323 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -119.8 148.8 43.0 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -139.63 153.47 70.31 Favored Pre-proline 0 N--CA 1.411 -2.408 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.52 138.57 21.96 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.34 2.027 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.1 107.03 0.57 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 178' ' ' ASP . 10.4 tt -105.51 118.52 53.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.649 0.738 . . . . 0.0 111.369 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 217' ' ' GLU . 70.4 m-85 -125.81 165.56 18.44 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.458 -175.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.4 mt -70.68 127.8 33.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 172.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 54.5 p -102.45 -39.93 6.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -150.24 147.75 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.427 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 206' ' ' ALA . 15.4 mt -114.56 139.34 49.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.246 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.406 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 78.0 t -103.99 128.76 26.53 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.85 126.41 21.87 Favored 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.032 1.821 . . . . 0.0 110.67 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.57 13.45 58.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.43 160.24 24.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.7 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.476 ' HB3' HG11 ' A' ' 161' ' ' VAL . 85.6 mt -54.35 -46.2 72.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.573 1.149 . . . . 0.0 113.906 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.783 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -68.45 -27.18 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.858 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.76 -42.22 50.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.9 m -56.38 -31.56 63.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.2 p -61.08 -44.36 97.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.37 -47.65 1.73 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 121.474 0.486 . . . . 0.0 112.767 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.405 ' HB2' HD22 ' A' ' 212' ' ' LEU . 58.4 mt -67.53 -23.96 65.5 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.039 1.336 . . . . 0.0 111.167 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' HG ' ' CG2' ' A' ' 249' ' ' VAL . 3.2 mm? -108.02 146.0 33.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.174 0.511 . . . . 0.0 109.728 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -92.39 158.32 16.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.05 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 23.6 t -67.0 -27.33 39.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.603 -178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.87 58.89 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.652 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 89.4 m-20 -48.75 161.03 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -169.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 196' ' ' PHE . 41.5 mt-10 -93.41 154.28 18.03 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.302 -172.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.22 134.81 45.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.459 HG22 ' HG3' ' A' ' 220' ' ' GLU . 46.7 mm -111.0 -44.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.867 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.625 ' H ' ' HB ' ' A' ' 248' ' ' THR . 40.4 mt-10 -141.07 154.32 45.89 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.371 0.605 . . . . 0.0 111.591 -174.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 65.9 t -128.75 108.34 17.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.588 172.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 70.56 -9.96 0.74 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.524 0.678 . . . . 0.0 111.937 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 127.98 -9.37 6.72 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.462 HG21 ' SD ' ' A' ' 237' ' ' MET . 48.5 mt -84.01 121.01 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -75.65 137.76 40.93 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.045 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.417 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 35.5 m -91.75 17.41 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.837 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.7 109.32 2.38 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.115 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.55 9.69 64.39 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.877 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 10.4 mmpt? -93.93 168.43 10.97 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 234' ' ' VAL . 9.9 t -120.02 163.46 17.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 232' ' ' ASP . 0.0 OUTLIER -50.5 -46.77 57.34 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -171.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.519 ' N ' HD22 ' A' ' 231' ' ' LEU . 23.5 t70 -74.29 -40.55 62.21 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.304 0.574 . . . . 0.0 109.828 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.569 ' O ' ' HG3' ' A' ' 237' ' ' MET . 36.1 tt0 -59.24 -43.28 92.39 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.93 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 230' ' ' THR . 97.7 t -70.25 -46.61 71.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.984 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.494 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 21.4 p -60.97 -37.8 83.71 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.155 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.45 -44.61 84.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 37.6 mtm -64.28 -47.06 80.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.402 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.577 ' SD ' ' HE1' ' A' ' 174' ' ' PHE . 20.9 ptp -67.27 -25.71 66.2 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.01 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.78 -28.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.901 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.58 75.12 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 121.664 0.745 . . . . 0.0 109.268 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.91 -62.06 1.67 Allowed 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.575 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 38.1 t 64.6 -40.97 0.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.309 1.444 . . . . 0.0 114.176 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 -46.47 51.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.27 75.39 0.98 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 238' ' ' MET . 4.3 tt -92.89 116.34 28.95 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 3.3 mp -127.16 127.92 69.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 247' ' ' ILE . 36.4 pt -109.43 118.67 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.625 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 64.7 m -92.2 120.16 32.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.432 ' CG2' ' HG ' ' A' ' 212' ' ' LEU . 20.8 m -113.89 141.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.963 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.15 129.0 14.43 Favored Pre-proline 0 N--CA 1.42 -1.936 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.652 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 12.3 Cg_endo -56.03 130.9 42.77 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.24 2.626 . . . . 0.0 114.811 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.43 -7.39 44.66 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 68.44 101.91 0.05 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.953 -1.93 . . . . 0.0 112.45 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.11 118.79 37.2 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 . . . . . 0 C--N 1.27 -2.858 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.821 -177.14 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.159 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.5 p -88.88 -13.2 39.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.701 0.762 . . . . 0.0 110.398 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -87.51 156.57 19.47 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.705 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.2 m -88.54 114.05 24.75 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 133' ' ' ALA . 1.0 OUTLIER -107.81 132.76 53.07 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.442 ' N ' ' HD3' ' A' ' 132' ' ' LYS . . . -105.86 113.1 64.17 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.3 -159.91 0.12 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.05 2.5 . . . . 0.0 110.633 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.1 p -82.61 87.08 6.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.56 153.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.9 p -103.05 103.64 13.75 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.0 tt -92.83 114.73 63.41 Favored Pre-proline 0 C--N 1.275 -2.648 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.577 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.58 145.25 37.12 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.477 2.118 . . . . 0.0 111.727 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -97.73 114.45 26.45 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.706 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 4.0 p30 -90.24 154.08 20.0 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.4 t80 53.65 -145.37 0.6 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -110.37 69.15 0.68 Allowed 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 166.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 141' ' ' ASP . 77.2 mm-40 -71.88 110.49 6.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 174.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.64 131.22 43.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.862 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.7 p -73.81 126.89 31.41 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.915 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.56 103.3 15.42 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 121.211 0.529 . . . . 0.0 110.493 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 5.0 tp -75.9 99.25 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 25.8 pt -85.42 151.24 3.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.556 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -88.43 132.69 34.36 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.476 -176.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 m -76.25 89.45 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-O 123.504 1.621 . . . . 0.0 109.733 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -78.7 132.44 36.99 Favored 'General case' 0 C--N 1.252 -3.664 0 CA-C-N 112.29 -2.232 . . . . 0.0 111.973 -172.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.626 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 9.7 tp -82.12 158.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.2 t -97.36 106.67 33.85 Favored Pre-proline 0 C--N 1.316 -0.864 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 39.5 Cg_exo -65.47 151.97 83.34 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 123.26 2.64 . . . . 0.0 109.509 172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.547 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 13.1 pt-20 -58.7 88.07 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -93.08 116.0 28.63 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 171.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -91.56 109.51 20.81 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.495 ' HD3' ' N ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -120.74 134.87 55.26 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.499 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.8 ptt180 -113.92 123.03 48.77 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.647 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.429 HG22 ' NH1' ' A' ' 159' ' ' ARG . 47.4 t -90.03 115.69 30.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.439 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -96.11 145.15 25.73 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.975 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.8 mt -126.44 121.56 32.77 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.936 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 164' ' ' LEU . 1.7 pp -106.91 101.07 10.53 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-O 122.727 1.251 . . . . 0.0 108.689 169.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 165' ' ' LYS 0.259 0.0 OUTLIER -75.47 127.84 34.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -172.242 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -105.7 112.26 25.26 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.759 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.79 -4.2 80.41 Favored Glycine 0 C--O 1.222 -0.645 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.714 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.4 m 61.8 20.98 11.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.748 0.819 . . . . 0.0 112.137 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.59 102.46 3.81 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.331 0.586 . . . . 0.0 109.605 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -160.41 131.26 3.74 Favored Pre-proline 0 C--N 1.275 -2.64 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.098 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.88 141.42 93.15 Favored 'Trans proline' 0 C--O 1.254 1.319 0 C-N-CA 122.861 2.374 . . . . 0.0 112.698 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.6 130.85 38.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.107 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . -87.03 -23.57 40.77 Favored Glycine 0 C--N 1.289 -2.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -108.27 144.85 35.2 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -134.95 147.41 49.76 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.528 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 176' ' ' ILE . 2.8 mp -125.5 149.41 30.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 75.4 ttt180 -134.06 153.14 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.66 ' HA ' HG22 ' A' ' 195' ' ' ILE . 19.6 m-20 -74.73 151.73 39.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.073 0.463 . . . . 0.0 111.302 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.36 161.32 26.6 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 p -101.98 136.44 41.81 Favored 'General case' 0 N--CA 1.394 -3.242 0 CA-C-O 121.125 0.488 . . . . 0.0 111.62 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.4 t -111.6 120.3 41.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.0 p -91.16 123.59 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.668 0.746 . . . . 0.0 111.144 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.02 158.55 24.76 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.2 t -100.23 116.57 43.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 81.9 p -115.17 177.54 4.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.53 -21.4 61.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.044 0.45 . . . . 0.0 109.857 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.6 p -87.17 -1.27 57.77 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.61 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.75 -168.9 13.69 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.953 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.61 HD13 ' H ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -84.07 106.17 15.51 Favored 'General case' 0 N--CA 1.384 -3.737 0 CA-C-O 122.899 1.333 . . . . 0.0 110.593 175.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -111.46 155.42 23.23 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.387 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 7.7 mptt -116.93 127.2 53.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.48 153.58 47.69 Favored Pre-proline 0 C--N 1.263 -3.176 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.595 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 14.2 Cg_exo -68.11 113.4 3.04 Favored 'Trans proline' 0 N--CA 1.423 -2.629 0 C-N-CA 121.343 1.362 . . . . 0.0 109.013 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -132.31 92.06 0.27 Allowed Glycine 0 CA--C 1.457 -3.567 0 N-CA-C 106.889 -2.484 . . . . 0.0 106.889 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 178' ' ' ASP . 23.4 pt -77.22 135.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.34 -172.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.05 166.9 10.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.258 -173.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 66.3 mt -67.44 130.77 33.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 67.6 p -98.73 -36.46 9.83 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.507 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -151.01 146.02 25.93 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.557 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 52.4 tp -127.43 124.93 39.62 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.91 128.9 29.74 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 50.7 Cg_exo -57.63 126.86 23.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.16 1.907 . . . . 0.0 109.451 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.75 -9.87 60.46 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -84.87 149.87 24.66 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.82 -26.09 65.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -173.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -74.73 -32.36 62.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.009 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' N ' HD11 ' A' ' 200' ' ' LEU . 3.6 tm-20 -76.45 -38.85 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.0 m -57.88 -32.03 67.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.355 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.0 m -61.56 -43.55 98.66 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 78.52 -14.44 12.58 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.854 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 53.4 mt -85.93 -36.83 19.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.097 0.475 . . . . 0.0 111.099 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 249' ' ' VAL . 81.0 mt -115.33 146.92 41.06 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.34 163.84 17.24 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.666 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 13.7 p -45.84 -33.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.24 -24.26 66.24 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.612 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -69.29 165.91 19.62 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.28 142.18 45.08 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -171.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 14.1 m -95.82 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.487 HD13 ' HD2' ' A' ' 250' ' ' LYS . 25.1 pt -120.06 -41.9 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.432 ' HB2' ' OG1' ' A' ' 248' ' ' THR . 39.6 mt-10 -133.55 151.25 51.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.581 0.705 . . . . 0.0 112.75 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.76 108.73 23.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.54 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 27.1 t-20 70.22 -71.1 0.13 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.165 0.986 . . . . 0.0 110.72 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.14 21.75 0.13 Allowed Glycine 0 C--N 1.298 -1.574 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 15.8 mt -116.73 121.77 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 47.7 mt-10 -76.11 151.08 37.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 118.806 0.73 . . . . 0.0 111.5 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.55 -6.39 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.995 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.45 121.33 15.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.314 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.595 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 93.12 10.3 59.82 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.101 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -111.13 173.35 6.38 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 234' ' ' VAL . 90.4 m -100.9 158.52 15.92 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.007 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.37 -46.19 86.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.441 0.296 . . . . 0.0 111.62 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.25 -41.79 89.59 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.327 0.584 . . . . 0.0 110.286 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.58 -49.34 75.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.946 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 230' ' ' THR . 85.1 t -59.88 -45.92 94.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.946 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.511 ' HA ' ' HG2' ' A' ' 238' ' ' MET . 12.1 t -69.17 -37.13 78.02 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -42.56 90.56 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 52.4 mtp -56.5 -51.08 69.84 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.761 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 16.6 ptp -73.19 -15.03 61.46 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.356 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.561 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 98.1 t -91.4 -27.01 4.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.89 66.17 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.461 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -142.94 32.72 1.38 Allowed 'General case' 0 N--CA 1.419 -1.997 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.933 -173.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.561 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 61.7 m -54.19 -27.98 37.67 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 t -72.29 -29.62 64.04 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -126.22 56.48 1.44 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.8 122.65 29.44 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.733 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 67.0 mt -130.22 125.11 59.24 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.658 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.16 121.42 64.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.768 0.794 . . . . 0.0 110.513 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.432 ' OG1' ' HB2' ' A' ' 220' ' ' GLU . 15.3 m -94.15 128.57 40.65 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.21 -175.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 4.9 m -124.88 148.46 29.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.487 ' HD2' HD13 ' A' ' 219' ' ' ILE . 58.1 mtpt -130.28 138.24 32.62 Favored Pre-proline 0 CA--C 1.508 -0.658 0 C-N-CA 124.394 1.078 . . . . 0.0 109.366 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 26.5 Cg_endo -64.76 126.86 17.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.628 1.552 . . . . 0.0 111.423 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.4 -28.18 19.93 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 121.833 0.825 . . . . 0.0 109.721 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 251' ' ' PRO . 44.1 m-80 49.07 69.84 0.53 Allowed 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.113 -1.858 . . . . 0.0 112.024 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.88 126.76 35.83 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 . . . . . 0 C--N 1.287 -2.114 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.191 -178.573 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.726 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 53.8 m -93.69 157.16 16.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.207 0.504 . . . . 0.0 109.922 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 157.9 17.74 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.8 p -75.82 113.68 13.57 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.389 0.614 . . . . 0.0 112.25 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -94.61 110.83 22.62 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.19 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.45 104.16 55.82 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -93.48 12.51 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.887 2.392 . . . . 0.0 112.487 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m 68.36 94.89 0.07 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.927 0.891 . . . . 0.0 111.75 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.5 mt -81.48 157.12 4.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.4 m 71.58 96.02 0.07 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.582 -176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.1 tt -102.55 136.74 19.3 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.259 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 129.8 37.05 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.297 1.998 . . . . 0.0 109.953 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -98.13 161.02 13.92 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.267 0.556 . . . . 0.0 112.335 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.89 156.04 22.59 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -80.49 -29.12 37.35 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.038 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.549 ' HE ' ' HA ' ' A' ' 143' ' ' ARG . 1.7 mmp_? 64.08 62.49 0.86 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.008 0.923 . . . . 0.0 108.898 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -81.6 157.33 24.77 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.415 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.27 117.06 29.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 p -84.01 146.14 28.13 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.333 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.41 104.14 16.72 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.962 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.5 tp -66.97 157.48 5.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 149' ' ' ILE . 2.3 pp -83.54 134.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.873 0.845 . . . . 0.0 112.489 -177.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 151' ' ' VAL . 16.8 t70 -113.42 -152.16 0.5 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.403 ' H ' ' CG ' ' A' ' 150' ' ' ASP 0.333 15.4 m 50.45 92.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 C-N-CA 125.735 1.614 . . . . 0.0 114.24 -176.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.03 122.27 14.53 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.564 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tp -139.73 116.75 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-O 122.033 0.92 . . . . 0.0 111.662 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 p -100.72 114.08 65.73 Favored Pre-proline 0 N--CA 1.421 -1.894 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 130.74 41.77 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.547 2.164 . . . . 0.0 113.727 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.94 8.99 43.23 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.637 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -74.15 99.91 3.51 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.596 ' CE1' ' HE3' ' A' ' 250' ' ' LYS . 30.3 m170 -70.13 130.06 41.09 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.463 0.649 . . . . 0.0 112.423 -169.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -102.54 116.78 33.3 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.395 -167.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -100.73 135.81 41.58 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 205' ' ' LEU . 7.7 p -103.72 128.53 56.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.538 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 246' ' ' ILE . 36.8 ptt180 -108.62 126.88 53.45 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.81 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.2 mt -107.91 121.23 44.34 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.428 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.76 107.34 19.76 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.819 0.818 . . . . 0.0 111.662 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -88.27 120.47 29.66 Favored 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.919 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -152.5 102.33 2.73 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.432 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.75 63.66 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.113 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -130.26 178.23 6.73 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.67 -49.21 3.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.743 0.306 . . . . 0.0 110.689 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -166.58 100.13 0.68 Allowed Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.5 44.44 1.24 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 123.481 2.787 . . . . 0.0 113.768 -175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . 0.342 0.6 OUTLIER -69.59 90.78 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -178.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -97.84 38.93 2.91 Favored Glycine 0 C--N 1.308 -0.986 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.98 150.49 24.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 77.9 m-85 -136.71 134.88 37.66 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.794 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.497 HD12 HD11 ' A' ' 195' ' ' ILE . 20.2 pt -133.71 142.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.626 -176.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.09 159.7 41.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.44 1.096 . . . . 0.0 108.094 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.463 ' H ' HD22 ' A' ' 231' ' ' LEU . 15.4 t70 -91.44 122.24 33.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.461 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -119.38 114.89 2.89 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 104.584 -3.407 . . . . 0.0 104.584 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 191' ' ' LYS . 1.8 m -89.0 128.23 35.7 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.614 -165.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -92.85 127.52 38.39 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.855 -172.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.02 138.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.928 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 183' ' ' ARG . 27.6 mmt180 -121.23 152.77 38.46 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.44 107.99 24.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.2 p -115.42 177.31 4.71 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.422 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.71 -6.09 54.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.276 0.56 . . . . 0.0 109.577 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.1 m -88.04 -4.49 58.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.77 -142.4 17.44 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 189' ' ' LEU . 0.4 OUTLIER -101.86 115.59 30.88 Favored 'General case' 0 N--CA 1.392 -3.372 0 CA-C-O 121.169 0.509 . . . . 0.0 109.971 176.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.66 152.04 30.96 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.924 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.453 ' HB3' HG22 ' A' ' 180' ' ' THR . 95.7 mttt -122.22 146.44 47.26 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.734 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -127.07 147.91 63.67 Favored Pre-proline 0 N--CA 1.417 -2.125 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.36 137.04 64.39 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.949 2.433 . . . . 0.0 111.542 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -138.85 73.7 0.41 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.337 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 176' ' ' ILE . 11.9 tt -84.21 116.39 27.91 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.746 0.784 . . . . 0.0 109.091 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.64 ' CE2' ' HG2' ' A' ' 217' ' ' GLU . 87.2 m-85 -130.18 172.1 12.15 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.908 -175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.2 136.18 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 47.1 m -126.17 -16.89 5.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.345 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 175' ' ' TYR . 50.9 ttt180 -158.98 142.96 15.29 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.436 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' A' ' 206' ' ' ALA . 18.5 mt -128.4 139.31 52.44 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.94 124.59 45.06 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.88 129.47 32.22 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.689 1.593 . . . . 0.0 109.857 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 101.19 -9.83 57.98 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.02 153.25 46.62 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' A' ' 161' ' ' VAL . 2.6 mm? -59.15 -38.94 80.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.726 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -68.64 -33.45 74.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.035 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 200' ' ' LEU . 3.2 tm-20 -76.21 -43.5 42.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.204 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.4 m -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 m -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.92 -12.21 9.41 Favored Glycine 0 N--CA 1.465 0.58 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.935 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 36.7 mt -93.84 -15.78 24.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 71.9 mt -108.92 143.56 38.01 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.791 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.65 163.45 27.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.812 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.33 -14.44 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 121.582 0.706 . . . . 0.0 111.768 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.18 -22.35 58.09 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 58.9 m-20 -63.41 157.37 23.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -174.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.64 ' HG2' ' CE2' ' A' ' 196' ' ' PHE . 37.6 mt-10 -106.69 145.37 32.09 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.681 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.36 134.36 29.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.508 HG13 ' HD3' ' A' ' 250' ' ' LYS . 50.3 mm -116.2 -49.87 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.503 ' H ' ' HB ' ' A' ' 248' ' ' THR . 44.0 mt-10 -125.38 147.79 49.03 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.413 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.0 96.72 4.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 105.655 -1.979 . . . . 0.0 105.655 165.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.478 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 45.3 t30 68.41 -77.62 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 124.392 1.077 . . . . 0.0 111.333 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -146.0 10.27 1.59 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.562 ' HB ' ' HE2' ' A' ' 237' ' ' MET . 10.8 mt -107.14 133.05 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -81.32 149.77 28.78 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.11 2.24 8.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.519 0.676 . . . . 0.0 109.881 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.33 109.26 2.2 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.966 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.16 6.51 48.24 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.6 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 9.4 mmpt? -103.4 166.89 10.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 234' ' ' VAL . 16.9 m -118.59 159.77 22.99 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 173.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.463 HD22 ' H ' ' A' ' 178' ' ' ASP . 65.5 tp -50.37 -46.92 56.28 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.23 -37.15 84.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.3 0.571 . . . . 0.0 110.894 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.3 -37.82 74.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.215 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 230' ' ' THR . 96.8 t -63.09 -44.19 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 0.0 110.974 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 239' ' ' VAL . 11.7 t -67.89 -35.28 78.23 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.841 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.35 -43.15 86.86 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.948 0.88 . . . . 0.0 109.167 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.562 ' HE2' ' HB ' ' A' ' 224' ' ' ILE . 16.9 ttt -56.59 -45.82 81.18 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.372 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.467 ' HB2' HD11 ' A' ' 245' ' ' LEU . 19.1 ptp -76.28 -16.46 59.78 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.753 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 75.3 t -81.02 -33.78 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.277 0.56 . . . . 0.0 109.547 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.47 -22.48 43.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.188 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -132.91 30.24 4.03 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.243 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.753 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 67.8 m -74.1 -18.83 60.76 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 38.5 m -58.77 -48.04 82.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.37 0.605 . . . . 0.0 109.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -124.23 79.32 1.73 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.934 -2.246 . . . . 0.0 104.934 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 242' ' ' SER . 43.8 tp -86.4 118.65 25.97 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.349 -1.751 . . . . 0.0 111.06 -170.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 59.8 mt -127.03 133.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.843 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 7.3 tt -131.8 132.09 61.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 121.317 0.58 . . . . 0.0 111.981 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.503 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 61.8 m -102.35 125.68 49.13 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.872 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.23 139.98 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.596 ' HE3' ' CE1' ' A' ' 158' ' ' HIS . 57.4 mtpt -110.91 122.57 37.68 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.675 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 14.5 Cg_endo -60.27 133.12 47.63 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 122.645 2.23 . . . . 0.0 113.766 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -97.27 8.75 43.94 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -72.88 86.14 1.27 Allowed 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.731 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.83 144.89 37.05 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.836 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.589 ' HE ' ' C ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.487 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.792 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.9 m -97.21 101.84 13.48 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.279 0.561 . . . . 0.0 111.146 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -110.68 -45.27 3.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 t -108.27 145.02 34.98 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 175.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.443 ' HB3' ' NZ ' ' A' ' 132' ' ' LYS . 7.5 mtpm? -112.2 87.03 2.47 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.692 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.41 108.86 31.31 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.473 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.37 115.61 3.44 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 122.41 2.073 . . . . 0.0 111.079 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -75.69 94.52 3.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.271 0.558 . . . . 0.0 109.592 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.8 mt 72.51 138.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 125.662 1.585 . . . . 0.0 110.721 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t -120.98 100.7 7.22 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.902 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.2 tt -94.71 123.19 58.74 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.82 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -68.03 131.19 23.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.848 1.699 . . . . 0.0 109.048 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -76.32 150.24 36.94 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.26 155.85 23.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.95 117.54 25.75 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -85.68 70.84 10.75 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 122.382 1.087 . . . . 0.0 110.106 -175.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -90.01 160.16 16.5 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.005 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.1 154.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.5 t -66.28 114.81 5.62 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.48 111.3 23.8 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.229 0.538 . . . . 0.0 112.419 -171.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.0 tp -84.36 124.87 40.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.0 mm -87.6 151.71 3.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 71.83 105.91 0.07 Allowed 'General case' 0 N--CA 1.412 -2.332 0 C-N-CA 125.994 1.718 . . . . 0.0 111.892 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -59.88 -42.02 87.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.614 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -94.11 106.96 18.92 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.508 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 67.8 mt -95.64 122.39 47.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.12 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p -105.9 101.17 31.88 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-O 121.43 0.633 . . . . 0.0 110.338 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 7.9 Cg_exo -74.55 152.7 43.51 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.941 2.428 . . . . 0.0 109.601 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -63.93 83.29 0.03 OUTLIER 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 121.426 0.632 . . . . 0.0 109.898 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.1 m -82.82 111.09 18.41 Favored 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -82.32 110.86 17.86 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.531 ' HB3' HG13 ' A' ' 249' ' ' VAL . 77.8 ttt180 -94.3 116.78 29.22 Favored 'General case' 0 C--N 1.267 -2.992 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.89 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -125.66 109.62 12.83 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.588 -173.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 205' ' ' LEU . 27.7 m -105.29 132.32 52.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.434 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.407 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.2 mtm180 -114.89 147.96 39.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -170.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 90.5 mt -126.34 120.02 28.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.313 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.33 108.19 13.85 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.586 175.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.633 ' HD2' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.73 121.36 21.6 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -173.99 105.66 0.12 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.133 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.42 67.11 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.685 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -157.93 164.14 37.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -106.53 85.51 2.18 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.503 ' HD3' ' HB3' ' A' ' 242' ' ' SER . 24.5 pttm 38.5 97.45 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.663 1.985 . . . . 0.0 116.272 170.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 100.73 1.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.861 1.708 . . . . 0.0 110.461 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.81 99.69 2.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.546 0.689 . . . . 0.0 111.35 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -93.59 43.99 2.44 Favored Glycine 0 C--N 1.282 -2.425 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.007 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -170.29 145.69 2.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.889 0.876 . . . . 0.0 108.729 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.1 143.94 42.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.702 0.287 . . . . 0.0 111.051 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.463 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 2.3 pp -124.71 154.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.258 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -141.26 158.78 43.43 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.006 0.522 . . . . 0.0 110.321 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.8 131.96 36.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.26 -172.38 18.14 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.429 ' CG2' ' HB2' ' A' ' 191' ' ' LYS . 3.1 m -126.43 143.19 51.27 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.332 -0.947 . . . . 0.0 108.734 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t -120.3 119.77 34.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.68 123.38 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.791 0.805 . . . . 0.0 110.652 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 16.2 ptp180 -117.37 160.06 21.76 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.351 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 p -99.22 108.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.135 0.969 . . . . 0.0 110.811 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 69.8 p -108.13 178.21 4.57 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.82 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.91 -17.32 63.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.057 0.456 . . . . 0.0 109.944 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.7 m -87.9 -4.74 58.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.367 0.603 . . . . 0.0 109.424 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.04 -158.47 14.3 Favored Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 183' ' ' ARG 0.266 1.1 pp -84.6 106.9 16.51 Favored 'General case' 0 N--CA 1.4 -2.942 0 CA-C-O 122.224 1.012 . . . . 0.0 112.642 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -109.95 155.39 21.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.052 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 180' ' ' THR . 7.3 ptpp? -106.21 139.69 40.32 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 121.516 0.674 . . . . 0.0 111.362 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.447 ' NE2' ' HD2' ' A' ' 193' ' ' PRO . 56.3 tp60 -127.95 141.63 41.78 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -177.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.447 ' HD2' ' NE2' ' A' ' 192' ' ' GLN . 16.9 Cg_exo -66.16 125.58 14.31 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.654 2.236 . . . . 0.0 109.699 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -140.6 135.32 6.94 Favored Glycine 0 C--N 1.28 -2.559 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.629 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.469 HG13 HG21 ' A' ' 234' ' ' VAL . 49.7 mm -93.04 122.21 44.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -107.84 162.23 14.19 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.01 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 249' ' ' VAL . 58.6 mt -73.16 136.67 24.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.7 t -118.38 -61.02 1.72 Allowed 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.129 -1.029 . . . . 0.0 112.172 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -123.12 155.65 36.56 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 206' ' ' ALA . 17.0 mt -126.65 138.74 53.46 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.874 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.3 t -99.6 128.45 31.36 Favored Pre-proline 0 C--N 1.283 -2.313 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.29 126.81 22.59 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 121.952 1.768 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.37 40.16 6.55 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 -172.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.31 162.39 12.61 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.902 -0.649 . . . . 0.0 112.794 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 161' ' ' VAL . 92.8 mt -70.92 -43.43 68.28 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.086 0.555 . . . . 0.0 111.494 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -72.41 -26.64 61.94 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.932 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -67.64 -45.28 75.8 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.8 t -64.49 -38.23 90.3 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.281 0.563 . . . . 0.0 110.314 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 206' ' ' ALA . 17.1 p -79.19 -6.18 55.97 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 52.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 125.412 1.482 . . . . 0.0 116.518 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.55 -19.96 15.27 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.49 ' HB3' ' OD2' ' A' ' 216' ' ' ASP . 6.7 mp -109.69 149.91 29.05 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.479 -2.146 . . . . 0.0 107.261 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.13 162.36 16.77 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.467 0.651 . . . . 0.0 111.461 -170.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.49 -15.82 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.486 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -69.78 -23.63 63.38 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.55 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.592 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 71.2 m-20 -61.79 159.75 13.14 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -106.23 145.32 31.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.515 -170.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 195' ' ' ILE . 35.2 m -89.55 143.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.539 HD11 ' CB ' ' A' ' 250' ' ' LYS . 2.6 mp -115.27 -51.87 4.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -174.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.511 ' H ' ' HB ' ' A' ' 248' ' ' THR . 41.9 mt-10 -135.44 153.31 51.82 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.561 0.696 . . . . 0.0 112.597 -172.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 92.6 t -117.02 98.28 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.463 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 49.1 t-20 65.82 -78.53 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.522 1.129 . . . . 0.0 110.522 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -137.0 -0.52 2.77 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.9 mt -101.79 129.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -82.08 150.85 27.31 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.254 0.479 . . . . 0.0 110.409 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.603 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 12.5 m -117.02 6.49 7.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.207 0.527 . . . . 0.0 109.627 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.7 101.89 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.896 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.68 0.52 59.12 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.535 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 226' ' ' VAL . 47.3 mtmt -89.26 166.51 13.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.724 0.762 . . . . 0.0 112.729 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.459 HG22 HD23 ' A' ' 231' ' ' LEU . 34.2 m -87.58 158.59 18.86 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 -176.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 230' ' ' THR . 1.9 pt? -59.33 -45.12 92.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.8 -45.98 88.64 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.506 0.67 . . . . 0.0 110.515 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.486 ' OE1' ' HD2' ' A' ' 229' ' ' LYS . 33.8 tt0 -64.6 -39.0 92.93 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.97 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.546 ' HA ' ' HG2' ' A' ' 237' ' ' MET . 94.4 t -73.95 -36.41 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 239' ' ' VAL . 9.1 t -74.46 -35.16 63.3 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.761 -1.175 . . . . 0.0 110.483 177.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.62 -48.38 77.57 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.429 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.582 ' SD ' HG12 ' A' ' 226' ' ' VAL . 26.2 ptm -62.06 -39.16 91.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.229 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.432 ' HB2' HD21 ' A' ' 245' ' ' LEU . 20.7 ptp -72.29 -21.09 61.41 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.15 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.658 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 91.8 t -85.91 -32.5 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.01 66.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.899 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.88 21.69 13.62 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.722 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.6 m -60.91 -18.71 58.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.494 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 21.9 p -56.74 -48.79 76.99 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.0 0.428 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -129.93 90.37 2.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 3.1 tm? -99.7 122.76 43.17 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.29 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.2 mt -129.92 119.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.45 HD11 ' HB ' ' A' ' 218' ' ' VAL . 7.5 tp -109.78 129.63 64.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.131 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.511 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 15.2 m -103.56 131.52 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.35 -174.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 159' ' ' ARG 0.28 0.4 OUTLIER -134.44 139.3 48.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 123.308 0.643 . . . . 0.0 112.457 176.92 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.539 ' CB ' HD11 ' A' ' 219' ' ' ILE . 87.3 tttt -124.01 138.87 31.39 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.589 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.592 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 16.8 Cg_endo -56.0 126.8 23.6 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.708 2.272 . . . . 0.0 112.896 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.66 -30.73 16.96 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 55.96 40.96 30.38 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.766 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -65.14 128.15 34.61 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.618 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 . . . . . 0 C--N 1.285 -2.199 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -178.752 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.774 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -160.13 146.99 16.04 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -113.69 128.42 56.42 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.7 m -90.97 119.24 31.0 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 120.894 0.378 . . . . 0.0 110.938 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -151.03 156.5 41.25 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.04 99.57 40.84 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 120.374 -0.53 . . . . 0.0 112.23 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.7 105.23 1.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.258 1.972 . . . . 0.0 108.956 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.6 t -86.77 95.5 9.85 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 121.714 0.769 . . . . 0.0 111.52 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.4 148.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.6 t -160.65 123.95 3.4 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.0 tt -91.98 125.69 56.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-O 120.653 0.264 . . . . 0.0 110.776 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.12 122.83 10.44 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.878 1.719 . . . . 0.0 110.135 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -89.13 120.76 30.81 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -83.76 156.76 22.39 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -59.63 -57.22 13.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 51.96 83.38 0.06 Allowed 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.782 0.676 . . . . 0.0 110.346 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -80.99 109.29 15.43 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.78 117.01 29.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.079 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.8 m -101.43 123.79 46.06 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.84 103.37 8.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tp -82.36 105.01 11.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.556 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.1 mm -105.62 116.25 49.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 151' ' ' VAL . 13.7 t70 -151.01 -154.75 0.57 Allowed 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -175.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.464 ' H ' ' CG ' ' A' ' 150' ' ' ASP 0.312 14.1 m 48.7 94.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 C-N-CA 127.311 2.244 . . . . 0.0 116.182 179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -101.56 108.29 19.81 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.6 tt -153.42 171.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.599 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.87 110.48 49.87 Favored Pre-proline 0 C--N 1.295 -1.803 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 152.4 74.55 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.151 2.567 . . . . 0.0 110.779 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.491 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 3.4 mp0 -56.33 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.568 0.747 . . . . 0.0 111.359 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.493 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.5 m -98.0 147.82 24.11 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -126.61 113.54 16.87 Favored 'General case' 0 CA--C 1.474 -1.966 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.474 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 0.5 OUTLIER -98.76 114.97 27.74 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -177.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -97.44 100.99 12.43 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.474 ' HA ' ' NH1' ' A' ' 159' ' ' ARG . 7.3 p -89.38 110.44 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 121.731 0.777 . . . . 0.0 108.911 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.518 ' HB3' HG12 ' A' ' 246' ' ' ILE . 30.9 ptt180 -118.68 142.14 47.94 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.771 -173.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 245' ' ' LEU . 4.8 tt -129.94 141.85 50.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 166' ' ' HIS 0.26 0.7 OUTLIER -112.34 101.19 9.41 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 179.096 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.59 120.87 25.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.536 ' CE1' ' HB2' ' A' ' 164' ' ' LEU . 39.6 m80 -153.21 25.74 0.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 123.364 0.666 . . . . 0.0 109.625 -177.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.58 -11.46 57.99 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.4 t -100.66 101.05 11.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.8 80.91 1.36 Allowed 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.889 0.852 . . . . 0.0 111.894 -170.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.28 151.76 41.84 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.273 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.48 167.3 27.4 Favored 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 122.877 2.384 . . . . 0.0 113.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -102.33 143.06 32.57 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.163 177.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -114.45 56.37 0.5 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.573 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.32 145.39 23.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.35 145.62 43.56 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.166 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.97 152.32 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 40.2 ttm180 -141.13 153.25 45.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -96.83 144.12 27.09 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.792 0.683 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.01 -176.09 27.75 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.7 p -94.74 121.95 36.85 Favored 'General case' 0 N--CA 1.385 -3.72 0 CA-C-N 117.158 0.479 . . . . 0.0 110.375 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 t -110.67 119.38 38.95 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.03 123.36 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -107.33 155.16 20.28 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.79 110.26 31.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.182 0.515 . . . . 0.0 109.955 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 39.7 p -111.22 178.72 4.25 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.153 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.49 -3.25 32.92 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.288 0.566 . . . . 0.0 109.794 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.8 m -98.62 -4.43 33.95 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.89 -152.83 17.97 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 189' ' ' LEU . 1.8 pt? -92.32 134.41 34.93 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-N 117.164 0.482 . . . . 0.0 109.746 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -132.59 148.99 52.38 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -107.4 127.73 53.85 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.982 0.896 . . . . 0.0 111.03 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.34 160.06 54.51 Favored Pre-proline 0 C--N 1.259 -3.36 0 CA-C-N 113.595 -1.639 . . . . 0.0 108.618 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.02 122.66 6.84 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.158 1.906 . . . . 0.0 108.569 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.61 111.43 3.03 Favored Glycine 0 C--N 1.271 -3.033 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.331 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -98.97 116.68 42.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 14.1 p90 -131.59 172.3 12.4 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.386 -175.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mt -67.6 123.48 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 177' ' ' ARG . 79.2 p -87.08 -41.98 13.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -162.22 156.02 21.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.996 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 48.7 tp -122.91 138.53 54.64 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.536 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.07 133.69 20.51 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.3 Cg_endo -64.53 130.21 25.96 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.256 1.971 . . . . 0.0 110.511 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.79 2.64 81.28 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -175.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.23 30.21 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.6 mt -55.37 -38.58 69.02 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -76.45 -30.38 57.32 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.8 tm-20 -75.93 -34.03 59.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.0 m -55.53 -32.21 62.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.911 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 m -77.21 -44.89 28.39 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.501 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.97 21.65 63.81 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 114.006 0.362 . . . . 0.0 114.006 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt -107.48 -39.19 5.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.359 0.599 . . . . 0.0 111.001 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.56 HD22 HG23 ' A' ' 249' ' ' VAL . 6.8 mp -109.13 146.55 33.89 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.665 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.08 162.69 17.04 Favored 'General case' 0 C--O 1.198 -1.643 0 O-C-N 123.612 0.57 . . . . 0.0 112.086 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -50.16 -25.94 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -72.06 -25.26 61.71 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.617 -0.677 . . . . 0.0 111.722 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 250' ' ' LYS 0.457 0.8 OUTLIER -73.76 170.79 14.57 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.232 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.1 pt-20 -135.26 165.56 25.15 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -164.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 248' ' ' THR . 58.0 t -80.02 132.85 30.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.22 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.538 HG22 ' HG3' ' A' ' 220' ' ' GLU . 43.5 mm -112.72 -60.6 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.733 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.688 ' H ' ' HB ' ' A' ' 248' ' ' THR . 42.7 mt-10 -125.92 153.48 44.17 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.852 0.834 . . . . 0.0 111.947 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 234' ' ' VAL . 92.1 t -119.45 103.36 14.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.977 174.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.563 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.4 t-20 68.2 -69.34 0.15 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.847 0.859 . . . . 0.0 111.04 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.31 7.62 0.45 Allowed Glycine 0 C--N 1.308 -1.012 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.2 mt -104.43 120.81 55.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 43.3 mt-10 -76.3 158.4 31.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.01 7.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.744 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.33 108.07 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.43 . . . . 0.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.75 2.66 46.38 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.105 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.473 ' HE3' ' SD ' ' A' ' 237' ' ' MET . 34.8 mtmm -107.46 158.98 16.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 234' ' ' VAL . 55.1 m -85.26 158.47 20.31 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.224 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 232' ' ' ASP 0.254 1.2 pp -68.74 -31.99 71.45 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.536 ' N ' HD12 ' A' ' 231' ' ' LEU . 10.8 m-20 -64.21 -34.84 79.02 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.286 0.565 . . . . 0.0 110.052 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.584 ' O ' ' HG3' ' A' ' 237' ' ' MET . 6.0 tp-100 -69.51 -47.77 62.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 230' ' ' THR . 82.2 t -57.47 -49.47 80.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.931 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 239' ' ' VAL . 40.1 p -67.05 -36.59 82.4 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.199 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.08 -42.53 98.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.022 0.439 . . . . 0.0 109.99 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 30.3 mtm -59.63 -48.63 80.92 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.868 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 235' ' ' THR . 4.6 ppp? -71.26 -16.92 62.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.651 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 235' ' ' THR . 98.3 t -84.73 -33.04 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.337 0.589 . . . . 0.0 109.574 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.9 -12.02 61.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.891 0.853 . . . . 0.0 109.806 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.43 27.61 8.2 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.757 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 245' ' ' LEU . 69.4 m -57.59 -20.44 32.6 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.8 m -50.55 -56.96 9.36 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -131.6 84.9 2.21 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 245' ' ' LEU . 1.4 pt? -86.7 121.56 29.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.382 0.61 . . . . 0.0 110.403 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 32.0 mt -122.35 124.52 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.478 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 19.1 mm -110.24 139.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.688 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 30.1 m -117.63 125.3 50.5 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.56 HG23 HD22 ' A' ' 212' ' ' LEU . 17.0 m -114.59 148.73 17.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 216' ' ' ASP . 1.0 OUTLIER -139.46 131.18 14.97 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.438 -176.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 157' ' ' THR . 6.6 Cg_endo -47.44 136.09 20.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.309 3.339 . . . . 0.0 113.066 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -80.83 4.2 19.98 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.861 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.3 m120 65.88 88.38 0.11 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.837 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -75.53 124.06 26.54 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.583 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 5.5 tpm_? . . . . . 0 C--N 1.301 -1.506 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.26 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.69 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.8 m -137.07 148.29 46.66 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -113.28 118.25 34.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.8 t -91.94 136.34 33.23 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 132' ' ' LYS . 11.0 mptt -90.31 91.5 8.52 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.463 0.649 . . . . 0.0 111.771 -175.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.06 91.22 50.0 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.494 173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -96.14 162.37 1.31 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 122.36 2.04 . . . . 0.0 111.429 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.5 p -90.35 97.67 11.32 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 136' ' ' ILE . 2.7 mp -76.26 133.7 30.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.627 0.727 . . . . 0.0 109.237 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.4 t 177.85 108.98 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.8 tt -86.68 120.92 72.13 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.894 -172.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.53 124.33 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.277 1.985 . . . . 0.0 109.154 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -78.18 124.95 28.66 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.06 -174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.6 157.6 22.22 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.142 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -51.18 122.08 7.15 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 124.002 0.814 . . . . 0.0 110.521 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.421 ' HD3' ' C ' ' A' ' 143' ' ' ARG . 1.7 tmt_? -97.33 79.46 2.79 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 122.48 1.133 . . . . 0.0 108.243 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -88.85 145.25 25.68 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.057 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.6 m -75.22 116.55 18.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.265 0.555 . . . . 0.0 110.501 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -66.26 113.11 4.34 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.01 -176.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.56 103.88 11.46 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.9 mm -136.1 125.08 38.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 152' ' ' ASP . 26.0 pt -101.82 114.41 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-O 121.586 0.708 . . . . 0.0 110.306 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -120.75 -30.69 4.4 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.708 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.95 -39.73 15.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 149' ' ' ILE . 32.5 t70 -100.0 111.53 23.83 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.582 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 14.7 tt -156.61 -173.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.554 ' H ' HG12 ' A' ' 153' ' ' ILE . 51.7 t -96.86 101.6 9.78 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 153' ' ' ILE . 6.1 Cg_endo -87.5 152.36 7.72 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.139 2.559 . . . . 0.0 109.535 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 251' ' ' PRO . 1.6 mp0 -70.05 84.47 0.52 Allowed 'General case' 0 N--CA 1.418 -2.05 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.51 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 101.71 12.73 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -80.72 94.22 6.33 Favored 'General case' 0 CA--C 1.463 -2.404 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -115.22 126.78 54.96 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.592 -169.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.556 ' HB2' ' CG2' ' A' ' 246' ' ' ILE . 37.7 ptt180 -95.74 94.32 7.62 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.16 133.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.759 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 18.9 ptp180 -99.52 155.74 17.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.77 126.72 37.1 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . 0.258 1.1 pp -105.32 101.54 11.07 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-O 122.152 0.977 . . . . 0.0 113.039 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.618 ' HE2' ' O ' ' A' ' 168' ' ' SER . 12.6 tmtt? -65.2 121.01 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.597 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -162.23 132.89 4.9 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.62 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.37 90.12 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 114.548 0.579 . . . . 0.0 114.548 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.618 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 47.9 m -158.52 153.6 25.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.53 -47.63 69.35 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.702 0.626 . . . . 0.0 109.832 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.442 ' HG3' HD13 ' A' ' 172' ' ' LEU . 6.8 ttpm? -137.56 83.72 24.62 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 168' ' ' SER . 88.8 Cg_endo -91.91 25.08 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.236 2.624 . . . . 0.0 112.576 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 170' ' ' LYS . 5.6 mp -73.08 109.31 6.52 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.78 53.66 4.84 Favored Glycine 0 C--N 1.305 -1.176 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.529 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -170.41 142.26 2.11 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.25 158.89 42.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.46 ' O ' HD12 ' A' ' 176' ' ' ILE . 2.5 pp -131.08 143.31 41.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.181 0.515 . . . . 0.0 112.257 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 198' ' ' SER . 16.2 ttm180 -142.22 157.41 44.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -74.12 131.75 41.6 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.967 0.792 . . . . 0.0 110.62 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -144.8 125.91 2.51 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 191' ' ' LYS . 24.5 p -92.59 139.07 30.95 Favored 'General case' 0 N--CA 1.383 -3.777 0 CA-C-N 117.367 0.583 . . . . 0.0 111.959 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.2 m -110.86 130.54 55.55 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.31 128.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -109.66 155.4 21.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.07 118.86 56.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.255 0.55 . . . . 0.0 110.466 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 41.5 p -115.24 177.83 4.51 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.332 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.03 58.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.57 0.7 . . . . 0.0 109.99 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.0 m -101.1 7.47 43.28 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.558 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.18 -141.58 12.94 Favored Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.764 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 189' ' ' LEU . 2.9 pp -125.08 137.86 54.19 Favored 'General case' 0 N--CA 1.388 -3.549 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 153.11 46.56 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.76 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.461 ' HD2' ' HB ' ' A' ' 180' ' ' THR . 38.3 ttpt -121.27 144.09 48.81 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 121.394 0.616 . . . . 0.0 112.027 -172.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -122.2 140.51 32.57 Favored Pre-proline 0 N--CA 1.41 -2.43 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.346 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.08 134.79 18.1 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.214 1.942 . . . . 0.0 109.203 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.86 154.35 22.65 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.764 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.91 117.09 49.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -119.37 166.53 12.93 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 62.6 mt -67.09 129.79 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 177' ' ' ARG . 39.7 p -96.68 -51.68 4.21 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -137.5 143.54 41.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.362 0.601 . . . . 0.0 111.122 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 138.85 49.73 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.62 138.33 20.74 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -59.8 126.38 20.31 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 121.669 1.579 . . . . 0.0 109.339 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.7 16.36 68.4 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 156.5 29.81 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.862 -0.669 . . . . 0.0 113.218 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.28 -46.08 76.16 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 124.799 1.239 . . . . 0.0 111.446 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.31 -30.14 70.96 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.158 0.504 . . . . 0.0 111.077 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.44 -33.72 54.72 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.364 0.666 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.3 t -55.02 -32.85 62.14 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.375 1.07 . . . . 0.0 113.843 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.9 t -79.86 -44.02 21.26 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.38 -23.18 5.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.631 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.85 -40.34 54.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.938 0.875 . . . . 0.0 109.383 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.505 HD13 HG23 ' A' ' 249' ' ' VAL . 86.3 mt -109.64 147.37 33.2 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.568 -175.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.05 162.89 17.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.016 0.436 . . . . 0.0 111.289 -174.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.521 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 14.3 p -62.2 -15.45 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-O 121.987 0.899 . . . . 0.0 111.323 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -71.88 -24.02 61.6 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.822 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.684 ' CG ' ' HA ' ' A' ' 251' ' ' PRO . 65.4 m-20 -64.56 173.39 2.17 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -116.46 147.75 41.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.242 -172.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.67 142.69 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.065 0.546 . . . . 0.0 110.43 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 220' ' ' GLU . 2.5 mp -112.04 -51.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 110.456 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.557 ' H ' ' HB ' ' A' ' 248' ' ' THR . 46.3 mt-10 -140.48 149.74 42.9 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.56 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.0 t -113.62 108.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.505 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 6.9 t30 69.87 -68.82 0.18 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.332 1.453 . . . . 0.0 110.939 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.73 26.36 0.19 Allowed Glycine 0 C--N 1.301 -1.388 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.52 119.1 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.544 ' H ' ' CD ' ' A' ' 225' ' ' GLU . 1.2 pm0 -75.53 145.91 40.93 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-O 121.007 0.432 . . . . 0.0 111.985 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 219' ' ' ILE . 20.3 m -94.11 9.31 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.892 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -64.54 106.11 1.09 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.834 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.25 12.2 58.95 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.497 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 70.6 mmtt -87.03 170.58 11.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.27 1.033 . . . . 0.0 113.327 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 234' ' ' VAL . 86.0 m -110.26 157.09 19.83 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 113.363 -1.744 . . . . 0.0 106.65 174.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 231' ' ' LEU . 1.9 pt? -64.67 -34.35 78.08 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.34 -49.48 55.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.551 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -60.48 -40.57 91.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.681 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.559 ' HA ' ' SD ' ' A' ' 237' ' ' MET . 92.0 t -57.53 -43.31 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 O-C-N 123.266 0.354 . . . . 0.0 111.439 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 239' ' ' VAL . 60.2 p -65.19 -28.89 69.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.5 -40.75 63.83 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.559 ' SD ' ' HA ' ' A' ' 234' ' ' VAL . 54.3 mtp -55.84 -50.16 71.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.02 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 235' ' ' THR . 20.7 ptm -76.49 -10.67 59.57 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.046 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.673 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 59.0 t -91.81 -34.96 6.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.045 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.43 -22.07 66.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.643 0.735 . . . . 0.0 109.902 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -114.32 21.83 14.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.1 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 75.2 m -63.92 -32.0 73.38 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.8 m -51.94 -53.08 45.42 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 0.0 110.815 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -129.81 86.17 2.38 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 3.1 tm? -97.09 131.45 43.86 Favored 'General case' 0 C--O 1.191 -1.993 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.722 -174.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 160' ' ' ARG . 2.2 mp -117.07 118.86 60.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.42 130.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.922 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.557 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 18.7 m -97.35 120.18 37.23 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.505 HG23 HD13 ' A' ' 212' ' ' LEU . 5.4 m -124.93 150.4 29.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 123.781 0.675 . . . . 0.0 112.251 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.491 ' CB ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.04 130.36 15.11 Favored Pre-proline 0 C--O 1.247 0.921 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.684 ' HA ' ' CG ' ' A' ' 216' ' ' ASP . 34.8 Cg_endo -62.41 132.2 37.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.024 2.483 . . . . 0.0 115.119 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -110.58 -4.48 15.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.655 -1.157 . . . . 0.0 107.919 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -89.03 -1.8 58.28 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.766 -177.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.39 123.35 22.87 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.696 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 . . . . . 0 C--N 1.295 -1.778 0 O-C-N 124.25 0.969 . . . . 0.0 109.119 178.762 . . . . . . . . 0 0 . 1 stop_ save_